class,document,BONA_TFRF
ALZ,ALZ1,immunoreactive somatostatin senile dementia post mortem senile dementia sdat post mortem significant fall choline hippocampus amygdala sdat maximal fall significant immunoreactive somatostatin
ALZ,ALZ10,diagnostic primary degeneration alzheimers attentional dementia dementia range reversible conditions indistinguishable primary degeneration alzheimers alzheimers importance presumptive underscored diagnostic current evidence gradual progressive mental deterioration cognitive motivation eliminate reversible condition cognitive dysfunction
ALZ,ALZ100,cacetylcholine synthesis ccarbon prisms human neocortex cacetylcholine synthesis preparations human neocortex micrographs prisms human neocortex intact synaptic endings normal structure synthesis cacetylcholine prisms vivo synthesis prisms human neocortex neocortex incubations prepared degrees synthesis cacetylcholine presence post mortem synthesis neocortex human suitable system cacetylcholine synthesis cacetylcholine synthesis human condition alzheimers significant cacetylcholine synthesis normal significant
ALZ,ALZ1000,deterioration dementia observations implications read aloud read aloud independent deterioration dementia mental status results deterioration identification perceptual consistent instrumental dementia
ALZ,ALZ101,flow metabolic oxygen glucose lactate pyruvate ketone flow metabolic cmr glucose lactate pyruvate ketone presenile dementia normal values uptake oxygen healthy subjects values deterioration furthermore significant release lactate pyruvate positive correlation cmr ketone group dementia uptake significant release phenylalanine cmr threonine healthy subjects findings state normal shunt cmr glucose cmr ketone hydroxybutyrate consistent ketone
ALZ,ALZ102,mental confusional parkinsons tomographic signs ninety parkinsons mental oms motor signs extrapyramidal dysfunction cranial ct sulci enlargement ct signs different patterns intact mentation presence oms usual parkinsonian ct signs dysfunction independent typical parkinsonian evidence oms indistinguishable group parkinsonian permanent oms constitute parkinsonian likely dementias parkinsonian mental status findings factor
ALZ,ALZ103,parasynaptic corpora typical corpora amylacea synaptic subjects huntingtons alzheimers diseases distorted synaptic possible unusual synaptic lesion significant related synaptic
ALZ,ALZ104,senile tangles dementia hemodialysis dialysis des neurofibrillary tangles des group extent compatible alzheimers different neurofibrillary tangles tangles helical filaments alzheimers possible helical filaments alzheimers aluminum contents aluminum nervous system likely hemodialysis neurofibrillary tangles des support theories aluminum etiological alzheimers
ALZ,ALZ105,twins alzheimers alzheimers senile dementia died findings alzheimers sisters
ALZ,ALZ106,spongiform jakob spongiform important diagnostic rapid evolution presenile senile dementia neurological unusual alzheimers importance jakob typical ct general spongiform process limited specific
ALZ,ALZ107,method demonstration senile senile grey matter senile dementia method demonstration senile unstained paraffin ultraviolet senile autofluorescence autofluorescence neuropil
ALZ,ALZ108,ct dementia gray white matter discriminability dementia investigation gray white matter discriminability ct cognitive discriminability differentiation gray white tissues elderly dementia psychometric ct gray white matter centrum convexity gray white matter scores ct values methods significant correlations gray white matter discriminability convexity level cognitive gray white discriminability group gray white discriminability correlation gray white discriminability
ALZ,ALZ109,senile dementia cranial necropsy volumes white matter dementia less less whereas less findings support exaggerated underlie primary dementia
ALZ,ALZ11,serum parathyroid dementia alzheimers aluminum factor senile dementia sd dialysis dementia renal term hemodialysis pth aluminum gastrointestinal tract pth loads senile dementia status pth significant pth occur related renal dementia aluminum dialysis dementia sd
ALZ,ALZ110,uptake platelets huntingtons presenile dementia kinetics uptake platelets om eleven huntingtons ten presenile dementia uptake unchanged results ht uptake platelets huntingtons ht test
ALZ,ALZ111,lesions ansae peduncularis neuropsychiatric ansa peduncularis innominata neurons huntingtons alzheimers schizophrenia neurological neuropsychiatric conditions normal mental significance lesion granulovacuolar degeneration hippocampus distention pigment vacuolar imparts
ALZ,ALZ112,lesions hepatocerebral degeneration lesions venous shunts much presence primary liver alzheimers spongy degeneration grey matter severe deeper layers frontal parietal spongy degeneration close correlation borderland regions previous review evidence hepatocerebral degeneration effect grey matter metabolic lesions
ALZ,ALZ113,dementia findings specific findings status spongiosus outer layers thalamus report
ALZ,ALZ114,presclerosis general practitioners items inward irritability fatigue literature syndromes signs diminution physio neurons recent due process alzheimers many diminution occurs cues general today
ALZ,ALZ115,ultrastructure glia hepatocerebral hepatocerebral glia glycogen types glycogen nuclear endothelial glia defensive ions
ALZ,ALZ116,locus coeruleus senile dementia counts locus coeruleus lc middle preserved dementia sdat evidence gradual neurons group counts range fewer neurons sdat evidence exists severe terms neocortical lc neurons
ALZ,ALZ117,significance alzheimers specific specific neural types alzheimers neurological diseases normal csf human cultures neonatal human fetal dorsal root drg normal subjects indistinguishable neurones nuclear cultures oligodendrocytes fibroblasts degrees neurones sera csf
ALZ,ALZ118,human intracranial effect review effect nervous system intracranial effect lethal stem hand intracranial effect alzheimers terminal sepsis
ALZ,ALZ119,sporadic vitro fusion test vitro jakob cjd sporadic different nonneurologic sporadic transmission
ALZ,ALZ12,evidence nonhuman infectious etiology indistinguishable jakob cjd test months time presence transmission spongiform infectious cjd occurrence need diseases
ALZ,ALZ120,fibrous dementia fibrous peroxidase antiperoxidase method paraffin frontal senile dementia normals populations fibrous layers fibrous dementia times normal
ALZ,ALZ121,striate lateral normal subjects outer baillarger human luxol mbs normal individuals wide range group normal individuals normal myelin lateral slight cytoplasmic ribonucleic glial neurons results conditions myelin outer baillarger neurons lateral
ALZ,ALZ122,problems support group support group home home social problems problems lack support physicians anger fear problems identity group participation spouses primary providers spouses needs identity support programs way strengthen emotional well important alzheimers
ALZ,ALZ123,rapid method meningeal thioflavin microscopy senile degeneration severe vascular hyalinosis infarcts mental symptomatology less dependent ie quantity senile significant independent correlation mental illnesses dementia less whereas quantity
ALZ,ALZ124,tha dementia pilot anticholinesterase doses unselected senile dementia significant subjects results dementia related dementia statistical test
ALZ,ALZ125,health cost health costs dementia presenile senile dementia alzheimers psychotic conditions dementia depressive dementia due dementia impression costs total costs millionyear general homes annexes psychogeriatric ward costs extramural circa extramural general practitioners social psychogeriatric teams public health total costs total costs health careyear elderly income scientific gerontology dementia nil dementia receives today
ALZ,ALZ126,dysfunction spongiform nervous system functions spongiform sse presenile dementia huntingtons alzheimers dysfunctions lacrimation pupillary drugs subnormal face test atropine anhidrosis rise test functions normal dementia sympathetic
ALZ,ALZ127,lesions schizophrenics swollen degenerate neurons ansae peduncularis neurological diseases alzheimers huntingtons normal mental pigment neurons schizophrenia unselected schizophrenics
ALZ,ALZ128,alzheimers cytoplasmic rna nuclear alzheimers diagnostic craniotomy post mortem necropsy parameters nuclear cytoplasmic rna findings protein synthesis daily alzheimers primary nuclear
ALZ,ALZ129,hydroxylase alzheimers hydroxylase alzheimers frontal hippocampus alzheimers normal range dementia terminal comathe alzheimers fibres
ALZ,ALZ13,glycolytic human autoptic normal glycolytic human autoptic different hexokinase phosphofructokinase phosphoglycerate mutase effect dementia intensification normal isomerase isomerase lactate dehydrogenase normal process non vascular isomerase lactate dehydrogenase glycolytic human autoptic
ALZ,ALZ130,dementia normal elderly half dementia single subject group limits normal distance sylvian fissure dementia normal
ALZ,ALZ131,ultrastructure alzheimers neurofibrillary tangles ultrastructure alzheimers neurofibrillary tangles stem ammons pepe ant amine twisted tubules tubules width ceruleus st single tt st locus ceruleus ant pepe ant pepe alzheimers senile dementia
ALZ,ALZ132,histocompatibility hla patterns cognitive dementia recent primary degeneration hla tested range cognitive hla individuals hla cognitive different results attentional scores group different retrieval short term term support hypothesis dementia
ALZ,ALZ133,rcbf xe review recent rcbf xe method neuropsychological flow tasks rcbf mental dementia ethiology alzheimers dementia pseudodementia due method
ALZ,ALZ134,choline cognition alzheimers alzheimers choline mgkg hrs double crossover psychometric end subjects significant overall level plasma choline level
ALZ,ALZ135,presenile dementia alzheimers transmission time transmission time ctt fifth potential baep group presenile dementia alzheimers ctt healthy elderly results early potentials nervous system dysfunction diseases alzheimers related diseases
ALZ,ALZ136,time dementia implications normal elderly subjects dementia alzheimers time significant group normal elderly subjects rt subjects senile dementia rt tasks terms overall group counterparts eleven rts standard normals discriminative normals overall results sensitivity rt cognitive
ALZ,ALZ137,gerstmann straussler scheinker report histological findings gerstmann straussler scheinker gss group spongiform rare observed myoclonia dementia bulbar pyramidal typical csf normal eegs progressive general periodic dysrhythmia potential evidence demyelinization jakob cj alzheimers histology reveals multicentric spongiform glial minor transmission histological kuru slow scrapie disposition gss dominant
ALZ,ALZ138,cytogenetic sporadic cytogenetic findings sporadic relatives spouses normal prompted peripheral preparations patterns statistical results normals specific individuals effect
ALZ,ALZ139,alzheimers neurofibrillary tangle progressive palsy alzheimers senile dementia elderly alzheimers neurofibrillary tangles progressive palsy senile dementia elderly alzheimers neurofibrillary tangles progressive palsy alzheimers senile dementia elderly alzheimers neurofibrillary tangles
ALZ,ALZ14,hla alzheimers histocompatibility loci alzheimers results hla healthy donors significant hla cw group alzheimers group group elderly
ALZ,ALZ140,amine alzheimers vivo cognitive homovanillic hva methoxyhydroxyphenylglycol mhpg csf free alzheimers group significant csf hva mhpg alzheimers group monoamine oxidase kinetics dementia significant correlation mhpg previous literature dementia alzheimers
ALZ,ALZ141,structure alzheimers neurofibrillary tangles alzheimers neurofibrillary tangles microscopy alzheimers senile dementia progressive palsy alzheimers tangles filaments helical filaments progressive palsy tangles nm filaments helical filaments filaments helical filaments senile dementia helical filaments tangles filaments intermingle neurons
ALZ,ALZ142,neurofibrillary protein alzheimers alzheimers neurofibrillary tangles ones free results tangle non tangle values tangle tangle neighbours findings early alzheimers neurofibrillary disruption
ALZ,ALZ143,hippocampal diameters densities diameters densities hippocampal normal subjects alzheimers thick celloidin microvascular diameters general presence dementia increases whereas exchange potential alzheimers overall diameters densities important hippocampal zones increment lesions direct areacapillary neurofibrillary tangles granulovacuolar degeneration irrigation tangles related morphological vascular parameters
ALZ,ALZ144,alzheimers ethnic genetic alzheimers individuals jewish transmission dominant genetic trait byelorussia spoke lithuanian dialect signs parkinsons lateral sclerosis signs single correlation transmission segregation peripheral genetic sporadic
ALZ,ALZ145,histocompatibility alzheimers preliminary preliminary alzheimers excess whereas different locus findings
ALZ,ALZ146,neurofilamentous neurofilamentous normal lateral human sural thin prepared standard techniques unfixed perikarya utilized neurofilaments axolemma microtubules helicity dynamic state lattice open paracrystalline reversible transitions neurofilaments filaments structure giant swellings sural interpreted effect microtubules neurons alzheimers parts neurofilamentous paracrystalline concepts helicity transitions general
ALZ,ALZ147,physostigmine arecoline infusions dementia physostigmine arecoline saline minutes double dementia significant picture recognition test physostigmine arecholine physostigmine arecholine consistent
ALZ,ALZ148,aluminum methods aluminum vary nonspecific sophisticated types spectrometry techniques wide aluminum severe contamination problems contamination recent possible etiological alzheimers conditions aluminum alzheimers neurofibrillary tangles degeneration neurons tangles laboratory laboratory tangles alzheimers evidence alzheimers aluminum alzheimers des hemodialysis neurofibrillary tangles aluminum significance aluminum hemodialysis gastrointestinal aluminum aluminum phosphate gels dialyzate hemodialysis plasma aluminum values minimum phosphate gels purified water des hemodialysis aluminum alzheimers ubiquitous occurrence aluminum food water aluminum alzheimers many aluminum etiological alzheimers many papers aluminum des alzheimers aluminum conditions evidence support theory effect aluminum alzheimers
ALZ,ALZ149,dietary aluminum alzheimers current evidence dietary aluminum element neurological damage phosphate insoluble excess aluminum increases dietary needs anions antacid prevent phosphatemia severe damage alzheimers progressive rich membrane tangles aluminum stainable
ALZ,ALZ15,presenile dementia presenile positive spongiform subhuman intracerebral observations senile dementia genetic
ALZ,ALZ150,topography neurofibrillary tangles granulovacuoles downs normal alzheimers xy pen recorder stage scattergrams cytoarchitectonic neurofibrillary tangles granulovacuolar degeneration hippocampal neurones downs hence zones programmable calculator magnitude affliction rank neurofibrillary tangles entorhinal subiculum endplate granulovacuolar subiculum endplate entorhinal lesions normal subjects senile dements importance neuraxis key alzheimers
ALZ,ALZ151,lesions parkinsonian dementia pd guam guam lateral sclerosis parkinsonian dementia previous papers lesions hippocampus bizarre significant severe lesions degrees spongy gliosis lipofuscin presence granulovacuolar neurofibrillary tangles neurones hirano lesions mental
ALZ,ALZ152,pictures mongoloid different phases psychological problems early mongoloids serum triglycerides ldl hdl
ALZ,ALZ153,neurochemical human neuropeptide human post mortem cognitive significant cholinergic choline intestinal alzheimers neurochemical cognitive mental test neurochemical reductions hydroxylase somatostatin process alzheimers
ALZ,ALZ154,argyrophil iii method demonstration fibrous neuroglia fibrous ions ethylation subsequent najo developer metallic possible demonstration avoided pretreatments performic
ALZ,ALZ155,critical hla results hla hemangiomas alzheimers different method statistical important group negligible
ALZ,ALZ156,congophilic alzheimers manifestations valid alzheimers degeneration specific presence congophilic latter lesion presence neurofibrillary tangles types perivascular latter neurofibrillary tangles true peripheral alzheimers degeneration little presenium senium process congophilic alzheimers degeneration
ALZ,ALZ157,infantile striatal necrosis morphological report literature infantile striatal necrosis ibsn laboratory evidence neurometabolic ct degeneration side findings degeneration nigra tegmental regions lipids glial picture possible glutamate transmitters
ALZ,ALZ158,somatostatin alzheimers senile dementia choline somatostatin immunoreactive sli regions normal individuals senile dementia chat regions sli correlations extent reductions sli regions parietal sli elderly
ALZ,ALZ159,degeneration alzheimers dementia presenile occurrence findings severe degeneration system senile alzheimers neurofibrillary tangles rare degeneration alzheimers typical alzheimers tyrosine hydroxylase nigro striato system
ALZ,ALZ16,neurological disorders huntingtons friedreichs alzheimers lateral sclerosis myotonic duchenne muscular previous state membrane huntingtons findings results resonance components sodium dependent protein deformability neurological disorders huntingtons friedreichs alzheimers lateral sclerosis myotonic duchenne muscular results specific state friedreichs alzheimers latter diseases different primary defects different results extraneural huntingtons neurological disordes potential mechanisms diseases
ALZ,ALZ160,support different support caregivers senile dementia group open time limited group unstructured time caregivers ie spouses
ALZ,ALZ161,choline meynert alzheimers choline discrete punches meynert elderly alzheimers normal meynert alzheimers observations key alzheimers specific cholinergic neurones
ALZ,ALZ162,alzheimers correlation choline dementia histological choline frontal alzheimers dementia due dementia neurofibrillary tangles alzheimers dementia significant alzheimers dementia neurofibrillary tangles
ALZ,ALZ163,choline histopathology frontal neocortex frontal presenile dementia choline choline estimate cholinergic degrees histological evidence alzheimers examples significant chat year onset diagnostic histological jakob vascular dementia probable white matter evidence presynaptic cholinergic suspected suitable putative cholinergic therapy onset
ALZ,ALZ164,issues alzheimers alzheimers dementia aluminum pathophysiology alzheimers aluminum neurotoxicity deterioration protocols test antialuminum drugs protocols different test alzheimers problems antialuminum drugs humans
ALZ,ALZ165,autofluorescence emission lipopigment method emission regions lipopigment illustrated emission spectrum means sets readings regions lipopigment neurones lipopigment ceroid ncls evidence results ceroid method identification mechanisms neurones drugs
ALZ,ALZ166,vascular fibrils debris protein vascular membrane degeneration membrane debris tends transport vascular wall perivascular astroglial end feet perivascular senile alzheimers alzheimers
ALZ,ALZ167,choline neurological report concerns possible health preliminary neurological hypercholesteremia cognition much public dyskinesia alzheimers ameliorated varied tourettes friedreichs levodopa dyskinesia mania huntingtons myasthenic trials cholinergic drugs public intakes choline gastrointestinal distress salivation individuals health hazards supersensitivity cholinergic dopaminergic serotinergic intakes
ALZ,ALZ168,dementia preliminary report residents recall identification likely reflexes iq neuropsychiatric status downs ds individuals full dementia results dementia
ALZ,ALZ169,maternal effect dementia maternal dementia subjects general maternal different diagnostic group maternal group general group maternal
ALZ,ALZ17,demonstration csf gamma globulin presenile dementia electrophoretic serum csf presenile dementia csf electrophoretic patterns globulin
ALZ,ALZ170,dementia senile dementia functional terms tuberculin dinitrochlorobenzene total significant dement senile dementia whole related
ALZ,ALZ171,tangles histological hippocampus subjects presence extent dementia counts neurofibrillary tangles evidence significant correlation presence dementia neurofibrillary tangles significant much correlation presence dementia hippocampus neurofibrillary tangle senile dementia due alzheimers
ALZ,ALZ172,mild senile dementia diagnostic recruitment dementia explicit diagnostic histological possible selection subjects senile dementia free problems recruitment select longitudinal healthy short term preliminary support diagnostic
ALZ,ALZ173,computer dementia vascular primary dementia dementia classified senile dementia alzheimers multiinfarct dementia ct subdural hematomas ct diffuse ct signs results ct normal evidence dementia dementia much ct due disorders flow
ALZ,ALZ174,dementia senile dementia sdat nervous system united dysfunction report deals morphological histological neurofibrillary tangles work neurofibrillary second cholinergic system sdat cholinergic neurons innervation
ALZ,ALZ175,senile investigation possible direct senile senile dementia non subjects vascular direct correlation vascular vascular significant presence vascular significant correlation total scores subjects scores senile significant correlation vascular dementia
ALZ,ALZ176,lateral sclerosis dementia lateral sclerosis severe dementia populations western pacific report signs dementia discrepancy severe dementia alzheimers sight nonspecific findings alzheimers close resemblance japanese sporadic progressive dementia entity consistent western countries
ALZ,ALZ177,flow oxidative middle dementia primary dementias dementia dementia vascular dvt types types morphological pathobiochemical terms neurofibrillary tangles helical filaments whole presynaptic cholinergic system dvt infarcts white matter due microcirculation dementia related flow oxidative flow cmr oxygen normal ranges dvt flow cmr oxygen normal range cmr glucose dementia developed dvt flow ischemicanoxic lesions dementia types close correlation flow cmr oxygen dissociation glucose dementia flow final functional level dementia types possible general dementia flow normal much evidence dementia ie different normal dementia
ALZ,ALZ178,correlation cisternographic patterns sclerosis csf igg values sclerosis ms ic csf dynamics lateral sclerosis senile dementia ic ms senile dementia ic lateral sclerosis ms ic picture csf igg values ic ms csf transependymal flow igg
ALZ,ALZ179,enhancement alzheimers physostigmine physostigmine neuroleptic free alzheimers recognition physostigmine physostigmine physostigmine recognition results cholinergic alzheimers eventual therapy condition
ALZ,ALZ18,noninvasive flow flow dementias xenon xe health group normal progressive diffuse flow gray matter white matter subjects alzheimers dementia dementia mid hemispheric mid normal korsakoffs normal values due sclerosis significant normal subjects standard severe dementia normal increases
ALZ,ALZ180,dementia dementia fact many different types dementia alzheimers dementia irreversible dementias reversible important pseudodementia alzheimers dementia pseudodementia dementia diseases therapy
ALZ,ALZ181,csf homovanillic gamma aminobutyric alzheimers related fifteen alzheimers status psychometric group little mental deterioration group serious mental deterioration nineteen subjects homovanillic hva hydroxyindoleacetic hiaa gamma aminobutyric gaba lumbar csf fluorimetric radioreceptor gaba methods hva gaba hiaa alzheimers hiaa gaba hva level severe mental deterioration
ALZ,ALZ182,recognition dementia previous senile dementia alzheimers sdat verbal amnesia sdat verbal sdat healthy normal recognition tasks results dementia retention faculty verbal tests independent defects verbal severe tests verbal implications findings pathophysiology sdat
ALZ,ALZ183,stable xenon ct flow single double integration normal dementia programs single rapid computer derivation values flows stable xenon gas xes programs points th xes xes pexes double integration squares permitted pexes xes lcbf values values infinity method utilized cross results normal healthy values decreases flow white matter senile dementia alzheimers sdat values unchanged gray matter lcbf values normal
ALZ,ALZ184,cholinergic precursors neuropsychiatric diseases preclinical cholinergic precursors specific conditions cholinergic neuropsychiatric diseases dyskinesia huntingtons ataxias tourettes schizophrenia senile dementia general underactivity cholinergic mechanisms recent cholinergic viable disorders cholinergic underactivity dyskinesia choline whereas disorders mild preliminary ranges durations concomitant release
ALZ,ALZ185,alzheimers maternal findings alzheimers downs maternal risk factor mothers consistent little known risk alzheimers documentation hypothesis alzheimers maternal
ALZ,ALZ186,transglutaminase vitro human neurofilament insoluble human neurons insoluble weight nondisulfide covalent human presence transglutaminase endogenous protein presence insoluble gamma glutamyl intermolecular transglutaminase electrophoretic transglutaminase human normal individuals senile dementia neurofilament presence transglutaminase amine dansylcadaverine insoluble process neurofilament polypeptides microscopy reveals filaments neurofilament cystamine transglutaminase neurofilament glial filaments protein transglutaminase vitro helical filaments specific vitro conditions possible covalent filaments insoluble human
ALZ,ALZ187,effect desmopressin normal vasopressin process trials normal subjects disorders vasopressin desmopressin
ALZ,ALZ188,alzheimers findings contusional injury complications pugilistica rare alzheimers injury neurofibrillary interpretations year man recovery single episode severe deterioration due helical filaments neurons
ALZ,ALZ189,deterioration primary dementia cognitive consistent primary dementia unique phenomena deterioration primary dementia delineation deterioration primary dementia
ALZ,ALZ19,glial fibrillary protein senile dementia glial fibrillary protein gfap protein nm filaments senile dementia subjects dementia gfap positive results senile degeneration dysfunction protein gfap
ALZ,ALZ190,cavum vergae cavum pellucidi cavum pellucidi cavum midline posterior posterior cavum vergae cavum pellucidi cavum vergae cavum pellucidi time embryologic usual
ALZ,ALZ191,individuals ds expectancy health quality institutional overall fold specific diseases infectious diseases congenital heart neurological disorders disorders risk congenital heart respiratory diseases adulthood dementia significant
ALZ,ALZ192,golgi rapid golgi methods human disparate results results golgi rapid golgi techniques human hippocampal precentral methods times hours methods different results method impregnation many neurons rich dendritic plexuses normal overall irregular basilar dendritic segments rapid golgi method vast neurons rich dendritic plexuses normal rapid golgi method accompany human tissues golgi method
ALZ,ALZ193,investigation senile dementia fifty senile dementia normal elderly width subjects dominant rhythm subjects width index dominant rhythm width subjects
ALZ,ALZ194,predilection dementia herpesvirus senile dementia sdat lesions tangles granulovacuolar degeneration hirano occur system fibres meninges middle cranial fossae subfrontal mesial regions regions critical normal recall explantation cocultivation techniques simplex many humans lymphocytic infiltration sensory neurones histological latent ganglionic recurrent lesions typical alzheimers normal human
ALZ,ALZ195,spaces subjects forty subjects normal indices sulcal size pixel counts status subjects subjects significant subsample pronounced subjects findings results different sulcal size dementia normal
ALZ,ALZ196,dementia elderly silent impact helath system institutional term system health professionals federal state health many ameliorable curable emotional diseases irreversible laboratory important refinement laboratory investigation specific intervention dementia
ALZ,ALZ197,histiocytic lymphoma weight man weight months signs histiocytic lymphoma meningeal spread infiltration diencephalic leukemia encephalitis lethargica sclerosis ct csf
ALZ,ALZ198,specific neurological diseases csf neurological diseases csf specific serum protein patterns csf normal patterns specific alzheimers senile dementia sdat diseases prominent huntingtons
ALZ,ALZ199,dominant diseases hereditary disorders huntington onset rapid diseasesenile dementia progressive opposite
ALZ,ALZ2,somatostatin senile dementa alzheimers senile dementia adsdat progressive dementias presence neurofibrillary tangles abbreviation adsdat denote onset related parameters tissues adsdat date putative neurones reductions acetylcholinesterase consistent evidence neurones noradrenaline serotonin gamma aminobutyric adsdat cholinergic cholinergic neurones specific possible neurones transmitters recent recognition neurones review ria techniques peptides systematic investigation neuropeptides normal individuals report results ria somatostatin somatostatin adsdat
ALZ,ALZ20,presenile dementia normal signs dementia possible alzheimers tomographic ct normal ct pixel white matter centrum sizes pixels enhancement ct nondementia dementia non overlap ct independent presence prominent sulci ct senile dementia dementia ct presence prominent sulci
ALZ,ALZ200,senile alzheimers senile dementia morphological senile senile alzheimers senile dementia microscopy results senile fibrils endothelial senile lack fibrils degenerable fibrils findings fibrils senile membrane endothelial degeneration fibrils senile
ALZ,ALZ201,cholinergic hypothesis geriatric dysfunction electrophysiological evidence cholinergic dysfunction related identify pseudoissues misconceptions literature significant cholinergic dysfunctions nervous system cholinergic mechanisms subjects conditions subjects cholinergic conventional trials successful possible explanations disappointments directions future laboratory
ALZ,ALZ202,cck human neurological cck receptor alzheimers huntingtons healthy inthe huntingtons normal cingulate alzheimers findings cck receptor unique specific neurodegenerative diseases huntingtons implicated alzheimers
ALZ,ALZ203,onset alzheimers dementia implications alzheimers picks peaks whereas alzheimers increases disorders alzheimers comprise significant dementias dementing illnesses
ALZ,ALZ204,parameters alzheimers peripheral alzheimers elderly normal subjects normal subjects respect leucocyte proliferative whole neutrophil group healthy group peripheral mononuclear total ucht okt subsets dot discrete ucht leu okt healthy group proliferative pa
ALZ,ALZ205,vasopressin vasopressin cognitive double units vasopressin day different significant vasopressin tests time group effect contributed
ALZ,ALZ206,alzheimers senile dementia neuropsychological neuropsychological presenile alzheimers senile dementia lurias test methods motor functions neuropsychological functions process shape rapid senile significant alzheimers senile dementia neuropsychological investigation method severe dementia
ALZ,ALZ207,alzheimers senile dementia neuropsychological findings csf parameters alzheimers senile dementia sdat senile presenile presenile senile resistance process senile group signs dementia tremor presenile senile epileptic diffuse positive correlation dementia sdat correlation sdat insignificant correlation severe dementia severe dementia findings sdat sdat compose single entity entity alzheimers
ALZ,ALZ208,dementia search reversible many senile dementia implications dementia obvious dementia emphasis
ALZ,ALZ209,elderly dementing many problems relatives physicians ways terms senility dementia imprecise hopelessness laboratory specific half due alzheimers condition reversible problems physicians specific efforts ways teach
ALZ,ALZ21,nuclear alzheimers parietal atrio shunt alzheimers subjects normotensive previous types rodlet alzheimers types spherical vermicellar less glial
ALZ,ALZ210,post mortem cholinergic gaba senile dementia choline gamma aminobutyric gaba proven alzheimers chat frontal normal significant reductions significant reductions regions innominata cholinergic projections reductions normal histology consistent predominant alzheimers cholinergic forebrain
ALZ,ALZ211,differentiation neuroanatomy cognitive laboratory diagnostic plan promise specific illnesses alzheimers parallel diagnostic stage emphasis significant clues dementia
ALZ,ALZ212,alzheimers senile dementia immunoreactive somatostatin immunoreactive sli coa choline regions normal diseasesenile dementia adsdat regions adsdat sli parietal parietal presenile different values
ALZ,ALZ213,synthesis presynaptic autoreceptors observations human preparations effect choline presynaptic autoreceptor measuring synthesis human neocortical prisms benzilate qnb antimuscarinic synthesis synthesis human prisms range microm evidence human contains presynaptic effect qnb synthesis synthesis neocortex none antimuscarinics choline synthesis extent qnb synthesis human prisms alzheimers intracellular choline much antimuscarinic synthesis
ALZ,ALZ214,oral physostigmine cognitive mnesic alzheimers dementia physostigmine alzheimers dementia possible means neuropsychological implications results
ALZ,ALZ215,parameters alzheimers senile dementia serum serum presence senile alzheimers level igg igm significant
ALZ,ALZ216,congophilic report histological progressive mental disability transmission dominant gene histological findings severe congophilic spinal rise haemorrhages softenings hippocampus literature condition entity alzheimers
ALZ,ALZ217,picks tomographic golgi impregnation observations picks tomographic ct vivo golgi impregnation unique dendritic dementias
ALZ,ALZ218,cognitive geriatric geriatric underlying dementia cognitive dementia important coexist
ALZ,ALZ219,fluctuations free choline preliminary observations double trial senile presenile dementia plasma choline intervals values level months subsequent rise possible explanations significance dementia
ALZ,ALZ22,indices presenile alzheimers indices dependent presenile alzheimers group normal group normal subjects rabbits alzheimers normal human serum results serum igm ratio normal system normaly slight specific serum correlation possible senile
ALZ,ALZ220,therapy cerebro vascular cerebro vascular disorders short term mild parkinsonian symptomatology pseudobulbar signs senile dementia dementia cerebro vascular disorders hoc committee paris therapy cerebro vascular disorders drugs tends different risk modify neurological neuropsychological disorders nervous lesion
ALZ,ALZ221,evidence lack intracerebral amyloids alzheimers deposits immunoperoxidase method specific antiamyloid deposits positive protein whereas alzheimers neurofibrillary tangles positive protein intracerebral deposits due inability protein intracerebral deposits due inability findings support theory protein fibrils vascular findings protein fibrils
ALZ,ALZ222,diabetics human microvascular endothelial membrane vascular thickness membrane frontal diabetics nondiabetics diabetics thicken frontal diabetics significant membrane many microvascular endothelial membrane microvascular related vasculature diabetic retinopathy
ALZ,ALZ223,alzheimers carboxypeptidase regions alzheimers hippocampus parahippocampal frontal brodman alzheimers accumbens nigra posterior hippocampus amydgala
ALZ,ALZ224,mechanisms protein synthesis healthy ways volumes rna seem predetermined neurones replacement size situations hyperactivity damage protein requirements noted morphological need synthesis nervous system alzheimers motor
ALZ,ALZ225,cholinergic innervation alzheimers dementia presynaptic cholinergic cholinergic innervation unknown hypothesis neurites presynaptic cholinergic many neurons forebrain hypothesis acetylcholin red immature mature rich acetylcholinesterase neurites acetylcholinesterase end stage rich acetylcholinesterase observations cholinergic innervation important evolution
ALZ,ALZ226,horn dysfunction alzheimers electrophysiological alzheimers motor units digitorum brevis electrophysiological parameters potentials mild severe results dysfunction motor
ALZ,ALZ227,dementia mental deterioration disorders conditions important primary disorders office tests
ALZ,ALZ228,reovirus mental microdegenerative ansa peduncularis septum senile dementia parkinsons schizophrenia synaptic contain non cytopathic reovirus reovirus normal reovirus regions overall topography alzheimers parkinsons whereby reovirus human related mental types schizophrenia
ALZ,ALZ229,senile prealbumin neurofibrillary tangle microangiopathic lesion lesions nosologic findings alzheimers dementia senile dementia ie neurofibrillary tangle lesions share etiology specific lesions paraffin reactivity prealbumin amyloidotic polyneuropathy senile components types results deposits lesions prealbumin lesions likely prealbumin neurofibrillary tangle
ALZ,ALZ23,tangles senile neurofibrillary tangles normal neocortical tangles tangle densities hippocampus tangle densities tangles senile dementia dementia plethoric tangles
ALZ,ALZ230,alzheimers gray matter senile dementia sdat severe lesions neurofibrillary tangles senile granulovacuolar degeneration hirano normal results neurochemical cholinergic neurons trials choline precursors food hve unsuccessful theories genetic predisposition exogenous toxin slow latent satisfactory tissues time dementia
ALZ,ALZ231,ct neuropsychological alzheimers huntingtons dementia syndromes primary conventional ct inspection pictures dementia recent ct values systematic normal subtypes ct alzheimers huntingtons double dissociation frontal values significant correlation left verbal alzheimers
ALZ,ALZ232,huntingtons hungtingtons polypeptides spot spot position computer requiring operator interaction total individuals huntingtons risk sets twins neurological individuals neurofibromatosis alzheimers protein polypeptides minimum heterozygosity stringent homozygous heterozygous demonstration gene genetic protein identification single electrophoretogram potential linkage genetic protein ie specific huntingtons
ALZ,ALZ233,alzheimers senile dementia neurons forebrain recent evidence basalis meynert neurons cholinergic innervation profound presynaptic neurons alzheimers senile dementia alzheimers results neurons basalis meynert profound degeneration cholinergic demonstration degeneration neurons documentation specific points critical lesion alzheimers
ALZ,ALZ234,alzheimers helical filaments sodium sulfate urea method partial helical filaments human neurons alzheimers senile dementia helical filaments unusual sodium sulfate urea prevent helical filaments contain covalent cross filaments intracellular helical filaments neurons insoluble cross cross protein lens senile skin keratinocytes
ALZ,ALZ235,presenile dementia fifty scales identification alzheimers picks pd dementia mid ischemic items stepwise neurological signs mid scales items items differentiation dementias early spatial disorientation logoclonia muscular tension pd ia early early signs disinhibition amimia results differentiation types dementia systematic
ALZ,ALZ236,downs disorders diseases defects mental downs disorders endocrine dysfunction infection single factor downs presence excess genetic manifestations somatic genetics human methods possible downs disorders
ALZ,ALZ237,alzheimers proven alzheimers support hypothesis heston workers alzheimers downs immunoproliferative disorders size relatives immunoproliferative disorders hypothesis downs informative presenile dementia relatives many previous consistent polygenic sibs trisomy aneuploidies
ALZ,ALZ238,innominata alzheimers cholinergic innominata normal human neurones meynert cholinergic neocortex acetylcholinesterase innominata post mortem alzheimers choline innominata amygdala lentiform
ALZ,ALZ239,cholinesterase alzheimers plasma pseudocholinesterase alzheimers dementia red acetylcholinesterase plasma choline cholinesterase
ALZ,ALZ24,neurones human senile dementia dementia severe caeruleus reductions cytoplasmic rna histological findings noradrenaline regions cytoplasmic rna nigra regions vascular dementia noradrenaline regions findings evidence primary degeneration system dementia
ALZ,ALZ240,eegs elderly subjects eegs healthy elderly probable senile dementia alzheimers sdat subjects typical home ward laboratory customary sleep schedules normal subjects range stage stage sleep less sleep wakefulness sdat range less stage sleep stage sleep little sleep sleep awakenings different sdat plots patterns prominent sleepwaking rhythm sdat napping nighttime wakefulness significant group dominant qualitative spindle paroxysmal discharges sleep mental sdat
ALZ,ALZ241,early alzheimers psychological side drugs significance cognitive status quality speed significance cognitive status tests elderly fit
ALZ,ALZ242,lipofuscin dementia lipofuscin parietal inferior olivary post mortem dementia specimens individuals results populations olivary neurones group group lipofuscin parietal neurons lipofuscin olivary neurons group group possible lipofuscin dementia
ALZ,ALZ243,intrusions dementia intrusions subjects anticholinergic dementia alz diagnostic elderly nursing home residents mental status test senile immediate perseverations test group neurological dementia intrusions presumptive intrusion alz helpful phenomenon choline important deterioration alz
ALZ,ALZ244,system dementias melanin coeruleus vagus alzheimers protein reductions noradrenaline regions dementia unchanged findings degeneration specific process alzheimers
ALZ,ALZ245,reflections alzheimers increases face silent idiopathic dementias alzheimers cumbersome cluster signs idiopathic dementias idat exclusion demonstrates unfortunate dramatic scientific histology genetics evidence speculation cholinergic cognitive
ALZ,ALZ246,ornithine huntingtons ornithine huntingtons frontal parietal senile dementia schizophrenia previous findings disorders synthesis glutamate losses deterioration corticostriatal glutamatergic neurons
ALZ,ALZ247,stereotypy anticholinergic antiparkinson drugs report psychotic benztropine haloperidol extrapyramidal side symptomatology meets iii repetitive motor automatisms symptomatology benztropine bid sedative hypnotic drugs psychotic syndromes drawn occurrence stereotypy review stereotypies related nervous system repetitive motor automatisms alzheimers guidelines management anticholinergic
ALZ,ALZ248,dementia dementia emotional well impact social workers mental health professionals valuable stage constructs process examples group
ALZ,ALZ249,cognitive sleep rhythms cognitive dementia night sleep unimpaired presumptive alzheimers delta sleep time delta sleep sleep implications findings
ALZ,ALZ25,coenzyme alzheimers possible cholinergic pyruvate dehydrogenase cholinergic system coa synthesis possible means coa cholinergic alzheimers significant reductions dehydrogenase acetoacetyl coa thiolase post mortem alzheimers pyruvate dehydrogenase related extent cholinergic choline choline pyruvate dehydrogenase normal human observations support recent pyruvate dehydrogenase cholinergic neurones
ALZ,ALZ250,sleep mental dementia alzheimers sleep mental subjects probable senile dementia alzheimers sdat results sleep mental significant early mild stage sdat severe mental underwent significant sleep mental subjects mild dementia dominant rhythm results sleep mild sdat individuals
ALZ,ALZ251,alzheimers alzheimers senile dementia alzheimers latter group single alzheimers females alzheimers senescence dementia hypothesis alzheimers hypothesis dementia
ALZ,ALZ252,parkinson review pd parkinson sp dementia sdat weight less sp sdat pd shows insignificant lesions severe sp sdat occurrence pd types pd dementia pd lesions severe severe little nigral damage severe lewy dementia little pd severe non ones general good correlation dementia pd
ALZ,ALZ253,morphological possible significant neurons astroglia sdat synthesis turnover neurotransmitters system progressive th sdat parkinson progressive da striatal system ratio sdat human frontal parkinson types human debatable preliminary biogenic human parameters cyclase da da receptor human parkinson
ALZ,ALZ254,corticosterone vitro hippocampus aluminum senile dementia dialysis aluminum alzheimers aluminum intracellular aluminum nuclear work test aluminum hippocampus nuclear corticosterone receptor results corticosterone fmolmg dna dna hippocampal aluminum rabbits aluminum neurofibrillary degeneration possible functional presence aluminum morphological
ALZ,ALZ255,philothermal polymorphonuclear dementia philothermal ie tendency warmer dementia normal individuals total significant spatial populations motile individuals preliminary findings philothermal diagnostic
ALZ,ALZ256,rationale alzheimers histopathological alzheimers etiology elusive rationale slow etiology date induction histopathology successful transmission future successful infection potential
ALZ,ALZ257,somatomedins dementia disorders serum somatomedins healthy individuals dementia suspected serum somatomedin values normal subjects significant serum observed dementia somatomedin somatomedins hormones compensatory overcome receptor dementia disorders
ALZ,ALZ258,subject recruitment gerontological elderly subjects effect physostigmine alzheimers suitable subjects diagnostic contraindications potential subjects implications future
ALZ,ALZ259,picks neurofibrillary tangles dementia stehende redensarten besides pick fibrillary gliosis white matter layers neurofibrillary tangles vacuolar degeneration senile pseudocalcerous deposits alzheimers diseases extent sensory unusual picks literature
ALZ,ALZ26,cholinergic aluminum neurofibrillary degeneration choline acetylcholinesterase ache spinal rabbits aluminum neurofibrillary degeneration group saline neurofibrillary spinal ache different results observed senile dementia
ALZ,ALZ260,senile dementia astroglial neurofibrillary tangles types neurofibrillary tangles hippocampus senile dementia flame tangles compact tangles neurons neurofibrillary glial fibrillary protein gfa second tangles due fibrous helical filaments phf stimulus neuropil membrane
ALZ,ALZ261,senile neurofibrillary tangles individuals presenile unselected presence investigation nondemented none presenile dementia important unusual occurrence dependent diseases
ALZ,ALZ262,pathologo senile dementia alzheimers senile neurofibrillar neurofibrillar skeletons pole healthy subjects lifetime debilitating diseases senile dementia dotage alzheimers senile neurofibrillar neurofibrillar skeleton points senile dementia alzheimers total points healthy subjects method pathoanatomic diseases senile dementia alzheimers
ALZ,ALZ263,signs group signs damage important dementia md panel probable dementias signs occur mid senile dementia alzheimers important signs total context
ALZ,ALZ264,findings senile dementia normal findings senile dementia sda dementia mid sda dominant rhythm accentuation theta delta fluctuations paroxysmal sda paroxysmal sda group dominant rhythm mid group parameters findings findings sda mid findings mid normal elderly findings driving equal cs valuable differentiation dementia normal elderly differentiation sda
ALZ,ALZ265,findings senile dementia normal ct findings senile dementia sdat dementia sdat frontal horn index cella index width index sdat sdat group psychological test dementia ct dementia dementia group test scores
ALZ,ALZ266,indices presenile dementia ten presenile dementia group different serum csf electrophoretic techniques possible oligoclonal globulin nervous system
ALZ,ALZ267,alzheimers report probable alzheimers alzheimers western literature little matter neurological signs good alzheimers possible vascular congophilic investigation peripheral healthy significant hyper diploid alzheimers dysfunction microtubules results alzheimers alzheimers
ALZ,ALZ268,presenile dementia gerstmann straussler scheinkers generations alsace onset pyramidal pseudobulbar dementia fourth multicentric senile findings literature typical gerstmann straussler scheinkers entity multicentric symptomatology pyramidal pseudobulbar syndromes dementia presenile dementias alzheimers strassler scheinkers transmission places group dementias kuru jakobs alzheimers
ALZ,ALZ269,parkinsons receptor dynamics parkinsons ranks neurological diseases elderly primary etiology parkinsons unknown process important factor parkinsons senile dementia alzheimers seem parkinsons prominent significant progressive nigra neurons striatal specific parkinsonian levodopa therapy significant dissociation parkinsonian psychotic episodes neuroleptic drugs normal treated levodopa accumbens levodopa parkinsons supersensitivity postsynaptic receptor neostriatum latter parkinsonian term levodopa therapy levodopa drugs parkinsonian disability dopaminergic significant valuable therapy levodopa parkinsonian phenomena
ALZ,ALZ27,ischemic differentiation dementias histological senile dementia multiinfarct dementia dementia types evidence severe dementia psychological presence hachinskis ischemic vascular dementia dementia dementia dementia indistinguishable vascular dementia verify ischemic senile dementia vascular dementia
ALZ,ALZ270,senile serum formalin dements fifteen dements regions globulins serum senile cores perikarya vascular none findings positive reactions senile components likely leakage serum mechanisms workers
ALZ,ALZ271,spongiform alzheimers sporadic dementia normal neuropil vacuoles cjd spongiform prominent cjd mild vacuoles mild observed non specific cjd
ALZ,ALZ272,spongiform dominant progressive dementia onset findings vascular spongiform hyperplasia typical jakob senile extent spongiform
ALZ,ALZ273,longitudinal spinal neurofilament rapid method neurofilament longitudinal spinal substratum immunofluorescent results time methods substratum neurons vitro total serum specimens different neurological disorders healthy subjects immunofluorescent neurofilaments specimens serum jakob cjd kuru lateral sclerosis dementia guam alzheimers sclerosis cjd kuru healthy subjects
ALZ,ALZ274,neurofibrillary tangles alzheimers dementia neurofilament neurofilament alzheimers neurofibrillary tangles senile dementia peroxidase antiperoxidase cryostat frontal baskets half tangles preparations preparations glial fibrillary gfa protein immunoaffinity abolish preparations sodium sulfate polyacrylamide tangles neurofilament polypeptides neurofilament sodium sulfate polyacrylamide much purkinje baskets neurofibrillary tangles protein
ALZ,ALZ275,training alzheimers ten alzheimers range weeks double crossover training condition condition buschkes reminding evidence effect trial trials noninvasive flow nr xe method eegs effect latter indices impressions trials training conditions training immediate list
ALZ,ALZ276,hypersensitivity alzheimers immunostimulation alzheimers delayed hypersensitivity ubiquitous nondemented group immunostimulation vaccine skin tests weeks intradermal injections nonresponsive convert positive normal
ALZ,ALZ277,term vascular dementia dementia social importance dementia primary dementia dementia laboratory early vascular etiology therapy
ALZ,ALZ278,immunoperoxidase techniques possible presence serum corona neurites igg corona senile pro possible significance findings senile
ALZ,ALZ279,permanganate senile protein protein senile congophilic dyshoric sensitivity permanganate congophilic resistant protein rare senile fixation protein senile
ALZ,ALZ28,neurofibrillary tangles granulovacuolar degeneration dementia neurofibrillary tangle granulovascuolar degeneration hippocampal monogolism results values normal elderly granulovacuolar related much monogolism neurofibrillary tangles pyramidal neurons subjects range dementia normal search senile dementia
ALZ,ALZ280,alzheimers dementia jakob spongiform results results etiology spongiform hope cjd
ALZ,ALZ281,effect physostigmine alzheimers ten alzheimers tests physostigmine cholinesterase doses random physostigmine saline saline double cross total physostigmine saline item results items items physostigmine items physostigmine physostigmine consistent conditions
ALZ,ALZ282,red osmotic huntington osmotic individuals huntington risk individuals risk individuals individuals results osmotic red individuals incubated individuals fall normal osmotic osmotic risk normal limits red osmotic risk gene longitudinal support
ALZ,ALZ283,reinnervation extent compensatory reinnervation neuromyopathies computer motor techniques renal guillain barre motor alzheimers reinnervation uremic diabetic general reinnervation guillain barre reinnervation group reinnervation electrophysiological parameters normal concomitant motor units normal size reinnervation
ALZ,ALZ284,identification cross reactions senile heart polyneuropathy lack reactivity alzheimers senile polyneuropathy congophilic alzheimers immunoperoxidase method af serum pa serum kappa types senile af pa kappa cross reactivity pa types af syndromes japanese portuguese types af pa kappa determinants pa amyloids alzheimers amyloids different af kappa types
ALZ,ALZ285,morphological alzheimers downs year retarded female trisomy developed progressive dementia epileptic movements alzheimers picks neurofibrillary pick nm tubules neurofibrillary helical filaments neurites helical filaments tubules pick findings downs previous alzheimers alzheimers spectrum alzheimers
ALZ,ALZ286,presenile dementia lewy report presenile dementia alzheimers picks findings senile senile neurofibrillary tangles granulovacuolar degeneration pick lewy stem ultrastructure lewy components lewy types profiles lewy senile lewy
ALZ,ALZ287,downs alzheimers review review dementia ds heretofore retrospective methods findings techniques cognitive retarded definitive evidence alzheimers topography general ds precocious dependent nonantiviral ds interferon endocrine problems immune ds precocious noted elasticity valves superoxide dismutase significance regard potential intracellular damage compensatory glutathione peroxidase
ALZ,ALZ288,dementia observations manifestations downs ds neurological mental deterioration independent daily thirds manifestations deterioration sphincteric incontinence release reflexes severe peripheral temporary remission dementia da radiographic findings alzheimers
ALZ,ALZ289,nervous system neuropsychiatric disorders introduction techniques disorders possible cns huntingtons alzheimers systematic manner identification primary locus drugs disorders receptor therapy possible techniques level
ALZ,ALZ29,system senile dementia neurons human components senile dementia alzheimers choline hippocampus damage mental
ALZ,ALZ290,neuroinfections etiology principles results neuroinfections tick encephalitis sclerosis panencephalitis etc results virological genetic electrophysiological results hereditary peculiarities nervous system mechanisms outline general principles diseases
ALZ,ALZ291,neuropsychological therapy alzheimers neuropsychological alzheimers normals group elderly group rebound less facilitation speed non findings possible normal alzheimers hand normal elderly alzheimers systematic rebound short term time normal senile dementia gradual deterioration alzheimers heart eyeblink oculomotor conditions interpreted compelling evidence hypoactivity senile dementia support alzheimers myogenic heart curtailed group hydergine
ALZ,ALZ292,stereomorphometric normal subject alzheimers stereological frontal precentral alzheimers electronic system leitz layers frontal significant perikarya alzheimers significant results group results frontal senile dementia kind individuals normal group
ALZ,ALZ293,catecholaminergic innervation alzheimers catecholaminergic dementia dopaminergic system sub involves innervation system types irregular diffusion phenomena interruption specific senile alzheimers presence spherical dilatations endings senile synthesis flow membrane permeability hence uptake findings teams locus coeruleus severe endogenous noradrenaline personal literature method pre senile senile dementiaabstract
ALZ,ALZ294,neuropsychological alzheimers neuropsychological aims correlations mental disorders functional dementia stage alzheimers mental disorders single system cholinergic theory neurotransmitters specific mans mental
ALZ,ALZ295,evidence transport synaptosomes hippocampus neocortex alzheimers sodium dependent hemicholinium choline transport purified synaptosomes prepared necropsy senile dementia choline transport velocity terms lactate dehydrogenase synaptosomal preparations terms representative synaptosome transport purified synaptosomes prepared normal dependent hemicholinium choline uptake synaptosomes hippocampus synaptosomes frontal cholinergic innervation hippocampus hippocampal neocortical cholinergic endings synaptosomes alzheimers choline velocity transport synaptosomes frontal uptake hippocampal synaptosomal transport alzheimers degeneration cholinergic terminal boutons cholinergic overall sites terminal transport
ALZ,ALZ296,cholinergic neurons senile dementia alzheimers choline cholinergic neurons meynert sdat normal normal cholinergic neurons degeneration damage
ALZ,ALZ297,foals foals signs laboratory findings predominant signs icterus values ammonia ratio total serum gamma glutamyl transferase partial time prothrombin time foals sorbitol dehydrogenase laboratory findings predominant findings expected size day foals prominent necrosis mild fibrosis findings prenatal postnatal diseases hepatoxin predominant lesion presence fibrosis utero toxin oral foals
ALZ,ALZ298,neurites non human somatostatin normal somatostatin positive neurons amygdala periamygdaloid macaques immunoreactive neurites impregnation methods senile neurites deposits thioflavin neurites senile direct evidence neurons non human
ALZ,ALZ299,specific tritiated nanomolar nicotinic discrete bungarotoxin possible roles nicotinic transmission
ALZ,ALZ3,choline senile dementia intestinal post mortem senile dementia sdat post mortem significant fall choline sdat maximal fall intestinal
ALZ,ALZ30,alzheimers evidence aluminum neurofibrillary tangle neurons neurons microscopy spectrometry senile dementia elderly aluminum nuclear neurons neurofibrillary tangles dementia normal neurons free aluminum findings aluminum alzheimers level
ALZ,ALZ300,cytoarchitectonic basalis normal human recent neurons basalis alzheimers normal neurons human nissl acetylcholinesterase human basalis magnocellular normal human magnocellular neurons perikarya septum diagonal innominata furthest extent globus pallidus acetylcholinesterase positive human magnocellular observations magnocellular man important future neurons neurological diseases neurons different components magnocellular evidence dysfunction
ALZ,ALZ301,occurrence lateral sclerosis dementia report year man southwest year progressive dementia lateral sclerosis alzheimers neurofibrillary tangles nigra innominata locus ceruleus parahippocampal investigation th signs lateral sclerosis dementia recessive trait genetic epistasis
ALZ,ALZ302,normal verbal versus spatial test spatial vs uses reminding spatial objects verbal regard normal dementia results vs steeply factor vs independent vs normal vs dementia dementia dementia severe vs results vs dementia
ALZ,ALZ303,methods sulci sulci valid system support methods
ALZ,ALZ304,hair copper zinc dementia mineral alzheimers copper zinc alzheimers early middle healthy spouses hair copper zinc manganese serum hair hair serum mineral significant positive correlations hair manganese mn
ALZ,ALZ305,alzheimers elderly residents group senile dementia social emotional cognitive substudy evaluations womens year current womens regressions significant patterns related vigorous group significant declines year vigorous stable year fewer related process group significant declines emotional cognitive scales
ALZ,ALZ306,flow rcbf classify flow subjects vector detectors index detector cumulative index values values index values binary values sum binary detectors normal group group group rcbf alzheimers dementing diseases vector populations normal subjects representative scores abnormals scores abnormals representative scores vector significant vector values
ALZ,ALZ307,flow progressive dementias flow dementia progresses xe washout different times alzheimers vascular dementias rapid declines alzheimers showed dementia functional
ALZ,ALZ308,neurobiological discrete discrete different desmethylimipramine vitro smethionine comigration possible related alzheimers cholinergic innervation hippocampus
ALZ,ALZ309,ct senile dementia alzheimers tomograms cts senile dementia alzheimers healthy computer programs cts ct width lateral group second width ct valuable alzheimers senile range
ALZ,ALZ31,parkinson dementia correlations records specimens idiopathic parkinson pd results mild dementia senile fibrillary tangles severe dementia mild dementia normal mental status times pd shorter pd
ALZ,ALZ310,size presenile dementia alzheimers tomograms cts mild presenile dementia alzheimers healthy computer programs cts single width lateral group discrimination group size valuable alzheimers presenile range
ALZ,ALZ311,senile dementia public policy institutional costs institutional cost senile dementia alzheimers sdat group suffer cutbacks intermediate nursing reimbursement heavy ones dependent nursing homes incentives prevent time caregivers inadequate costs parts health backups home sdat backup diagnostic temporary need
ALZ,ALZ312,mental status elderly misdiagnosis dementia unmeasurable personal tragedy ds elderly dementia delusion physicians seek
ALZ,ALZ313,alzheimers glucose index alzheimers normal emission fluoro deoxy glucose overall glucose alzheimers group individuals posterior parietal contiguous portions posterior frontal consistent alzheimers dementia glucose cognitive metabolic decrements deterioration
ALZ,ALZ314,wechsler emission glucose emission wechsler wais scores subjects normal alzheimers subtest scores verbal iq group iq group correlation verbal subtests regions verbal subtest scores left parasylvian scores posterior parietal wais subtests verbal visuospatial cognitive functions parasylvian right posteroparietal
ALZ,ALZ315,alzheimers malnutrition etiological hypothesis etiological hypothesis alzheimers malnutrition malabsorption phenomena search literature downs alzheimers forty malnutrition hypothesis neurobiochemical choline nutritional
ALZ,ALZ316,metabolic regions alzheimers huntingtons parkinsons diseases cmrglc values regions alzheimers huntingtons parkinsons diseases ffluorodeoxyglucose emission intercorrelations state normal uncorrected correlations parkinsons huntingtons diseases disorders alzheimers regions
ALZ,ALZ317,serotonin receptor serotonin post mortem dementia atd ligand techniques losses neocortex hippocampus amygdala atd whereas significant forebrain losses related atd group stage process losses atd significant correlations atd group receptor somatostatin frontal early process neurones
ALZ,ALZ318,dementia parkinsons current parkinsons critical review inflated idiopathic parkinsons akinetic dementia confusional normal dementia overestimation conservative estimate parkinsons assertion rigorous
ALZ,ALZ319,metabolites dementia dementia losses cholinergic neurones evidence degeneration innervation cholinergic serotonin serotonin early stage frontal somatostatin individuals suicide consistent metabolites unchanged group suicide
ALZ,ALZ32,crystalline ribosomes senile humans paracrystalline hirano hippocampal humans senile presenile neurodegenerative diseases evidence sheets hirano sheets endoplasmic reticulum nissl orange ethidium rna spatial filtering micrographs techniques shape eukaryotic ribosomes quiescent state protein synthesis mechanisms hippocampus significant short term term
ALZ,ALZ320,protein incorporation epitopes neurofibrillary tangles neurofibrillary tangles normal human ultrastructure lesions nft unknown report labels nft dendritic different sites phosphorylation nft tangle findings neurofibrillary neurofilamentous nft normal neurofilaments
ALZ,ALZ321,cholinergic innominata quinuclidinyl benzilate quinuclidinyl benzilate irregular slow waves immobility face slow waves eg atropine sulfate effect factor kainic innominata acetylcholinesterase ache ipsilateral neocortex slow waves ipsilateral slow waves kainic thalamus slow waves neocortex dependent cholinergic input innominata findings alzheimers
ALZ,ALZ322,striatal dementia post mortem dementia atd significant atd whereas unchanged neurochemical striatal gaba neurones normal range results consistent cortico striatal neurones neurones unchanged
ALZ,ALZ323,somatostatin intestinal dementia somatostatin intestinal vli regions dementia normal orbital hippocampus significant vli atd insular angulate peptides results neurons atd
ALZ,ALZ324,alzheimers neurofilament insoluble helical filaments alzheimers neurofibrillary tangles react helical filaments neurofilaments rt wt neurofilament protein nft extraction sodium sulfate phf rt minority tangles nft unreactive rt sites conditions results neurofilament insoluble phf conformational
ALZ,ALZ325,dna protein profiles alzheimers dna protein profiles alzheimers dementia alzheimers thiocyanate nucleic sedimentation sodium sulfate conditions renaturation dna mr dna protein
ALZ,ALZ326,ultrastructure helical filaments alzheimers neurofibrillary tangle helical filaments phf alzheimers senile dementia adsdat stain techniques microscopy em helical structure phf tilt phf substructure protofilaments nm phf substructure neurofilaments microtubules
ALZ,ALZ327,alzheimers terminal stage alzheimers alzheimers neurofibrillary senile sp neurons sp wide little pia upper layers frontal orbital occurrence sp nft correlation regard basalis meynert neurons occurrence nft
ALZ,ALZ328,cisternographic presenile dementia radionuclide hakim stable early gait epileptic psychotic disorders hours radionuclide retention parasagital lighter cisternographic
ALZ,ALZ329,scores previous wechsler healthy statistical total scores subtest scores significant different subtest subtest results terms implications current theories
ALZ,ALZ33,depressive syndromes clinico anamnestic early group neurological signs vascular degeneratarive endogenous disorders dementia hypothesis single disorders hypothesis degeneration predisposition
ALZ,ALZ330,bucy man man controversy significant evolution rarity human kbs less literature kbs man entity oral tendency objects homo autosexual hypermetamorphosis touch attend stimulus movements disorders placidity pet lack recognition kbs man little encephalitis subarachnoid alzheimers partial removal hypoglycemia adrenoleucodystrophy porphyria neuroleptic previous lesions man man full partial kbs man different cognitive emotional human kbs evolution partial kbs dynamics kbs delineation pre stage full stage remission stage kbs etiology results ct nonspecific lesion subdural hematoma lesions kbs ct specific kbs wide range
ALZ,ALZ331,demential syndromes extent free radicals nervous system rise cross reactions lipofuscin free radicals autoperoxidation fatty fatty omega rods cones eye synaptosomes malondialdehyde phospholipids peroxidation process enzymic antioxidants gsh px superoxid dismutase gsh px metabolic transformation demential syndromes ie alzheimers parkinsons diseases regard free radical theory antioxidative vitamins types demential syndromes direct dopa parkinsons
ALZ,ALZ332,due necropsy intracerebral stroke headache prominent normotensive dementia haematoma inadvisable diffuse tendency stem compression
ALZ,ALZ333,geriatric subspecialty cognitive computer compatible psychometric laboratory health professionals relevant dementias
ALZ,ALZ334,recall amnesia search results normal recall amnesic free recall processing processing recall neuropsychological residual
ALZ,ALZ335,dementia related cholinergic dementia dementia mid wechsler wais formula fuld reflect mid wechslers deterioration quotient results neuropsychological investigation cholinergic avenue investigation
ALZ,ALZ336,alzheimers alzheimers noncognitive dysfunctions alzheimers item subjects alzheimers normal elderly subjects items items significant correlation range significant rank correlation range final alzheimers cognitive noncognitive dysfunction normal elderly subjects
ALZ,ALZ337,cognitive status processing investigation evidence alzheimers healthy intact results group perceptual interference mask intact group group random target subtest wechsler level cognitive results perceptual processing normal human
ALZ,ALZ338,protein iii specific phosphoprotein human protein iii specific phosphoprotein polypeptides mr iiib mr synaptic investigation protein iii human observations protein iiib mr human protein iiib mr protein iiib mr protein iiib mr iiia human electrophoretic maps iiia iiib electrophoretic preserved iii individuals neurological individuals types conditions alzheimers dementia parkinsons
ALZ,ALZ339,serum serum mercaptoethanol electrophoretic largest smallest serum healthy unknown senile dementia alzheimers serum serum thiol
ALZ,ALZ34,volumes white matter man total volumes white matter normal male normal female hemisphere ml ml correction secular size hemisphere ratio volumes white matter secular elderly female dements total group normals grey white matter
ALZ,ALZ340,neurochemical homeostatic mechanisms homeostatic mechanisms impulse traffic neural mechanisms maintain neural normal disruption impulse traffic dysfunction mental neurological disorders disorders impulse traffic homeostatic disorders parkinsons disorders conditions huntingtons alzheimers drugs disorders specific homeostatic mechanisms
ALZ,ALZ341,test cholinergic dysfunction dementia subtest scores wais dementia normal subjects cholinergic mental subtest dementia dementia senile presenile dementias specific verbal iq discrepancy points cholinergic dysfunction normal subjects discrepancy differentiate dementia subtest differentiation dementias cholinergic cholinergic
ALZ,ALZ342,afa cholinergic neurotoxin hippocampus term radial maze presynaptic cholinergic neurotoxin lateral related sensorimotor term cognitive male nmol afa csf injected hot test group nmol afa level group times nmol group retention nmol shorter partial retention test radial maze treated fewer total spatial maze neurochemical afa specific cholinergic system decreases hippocampus nmol frontal nmol group indoleamines metabolites regions histological doses damage hippocampus fimbria fornix septum support cholinergic hippocampus frontal important afa neurobiological cholinergic disorders dementia alzheimers
ALZ,ALZ343,serotonin receptor alzheimers parkinsons reductions sites receptor alzheimers findings sites parkinsons presence cognitive receptor sites significant extent alzheimers parkinsons cognitive receptor cholinergic choline disorders presence senile extent neurofibrillary tangle alzheimers parkinsons observations receptor important process
ALZ,ALZ344,desensitization cyclase alzheimers effect single isoproterenol hours isoproterenol intact alzheimers subjects significant subsequent isoproterenol
ALZ,ALZ345,vascular dementia csf lipotropin lph ep dementia underwent ct healthy csf lowest values dementia atd radiological evidence probable dementia lph ep normal range atd dementia vascular peptides ct findings typical dementia humans positive mnesic functions csf lph ep dementia vascular values differentiation vascular diseases nervous system cns
ALZ,ALZ346,cholinergic innervation chemoarchitectonics acetylcholinesterase prominent mesocortical regions frontal pole cingulate parahippocampal allocortex acetylcholinesterase gradual granular primary sensory motor laminar patterns primary somesthetic konio iv hand motor deeper layers sensory acetylcholinesterase positive patterns cholinergic innervation topography cholinergic mood alzheimers partial
ALZ,ALZ347,red cellplasma choline ratio dementia polysomnographic choline probable dementia healthy fifteen rbcplasma choline healthy significant observations rbcplasma choline shows dementia rapid eye normal rbcplasma choline group choline ratio significant inverse correlation sleep findings tissues context cholinergic sleep
ALZ,ALZ348,proline normal alzheimers double proline micromethod suitable proline little ml csf normal human csf proline level microm csf alzheimers dementias significant proline normal proline alzheimers cognitive proline significant individuals
ALZ,ALZ349,hereditary dysphasic dementia pick spectrum hereditary dysphasic dementia terms dominant manifestations dementia severe dysphasic adulthood reveals findings typical picks alzheimers paralysis depigmentation depletion nigra nonspecific spongiform degeneration layers unique morphological histopathological dysphasic dementia entity dementias conventional methods unusual dementing illnesses pick spectrum
ALZ,ALZ35,choline acetylcholinesterase dementia importance human post mortem specimens choline acetylcholinesterase human agonal transferase normal alzheimers jakob choline terminal conditions general choline yield significant results
ALZ,ALZ350,senile dementia neurophysiological presenile dementia senile dementia equivalent healthy synchronization potential maximal group right posterior extent midtemporal maximal senile group frontal maps presenile whereas senile dissimilarities interaction senile dementia neuropsychological test scores neurophysiological poorer test
ALZ,ALZ351,vitamins alzheimers dementias vitamins alzheimers dementias specific dementias significant alzheimers group total conventional vitamin vitamin cognitive state conventional vitamin malnutrition contribute disability subjects
ALZ,ALZ352,hypometabolism jakob emission jakob cjd slow infectious scrapie prion infection emission pet year man cjd fluorodeoxyglucose fdg hypometabolism hemispheric findings pet fdg metabolic evidence infectious prion
ALZ,ALZ353,perceptual spatial huntingtons alzheimers disorders neuropsychiatric cognitive visuoperceptual alzheimers huntingtons tasks egocentric visuodiscriminative double dissociation tasks extrapersonal test egocentric visuoconstructive personal patterns defects different
ALZ,ALZ354,preliminary report intracranial cholinergic alzheimers preliminary trial intracranial alzheimers months system bethanechol complications reversible cognitive social single saline infusions double trial preliminary results potential alzheimers
ALZ,ALZ355,simplex alzheimers search dna spot spot search post mortem dna simplex sequences neurological alzheimers simplex mice reconstruction micrograms extracts sequences infected mice none human sequences
ALZ,ALZ356,picks sporadic cytoplasmic picks group presence hippocampus neocortex cytoplasmic neurofilament antitubulin fibrils nm fibrils second group well neurofilaments microtubules fibrils granular ribosomes
ALZ,ALZ357,motor non specific dementia clinico sisters motor mnd progressive months necropsy severe non specific evidence alzheimers dementia non specific sporadic western world
ALZ,ALZ358,hkainic choline alzheimers hkainic alzheimers dementia sites choline
ALZ,ALZ359,alzheimers neurofibrillary tangles neurofilament helical helical filaments phf human neurons alzheimers normal neurofilaments unclear phf phf neurofibrillary tangles neurofilaments normal cross react tangles wt neurofilament phf serum neurofilament monoclonals neurofibrillary tangles double reagents tangles patterns fibrous extraction sodium sulfate normal neurofilaments phf intact tangles phf serum tangles rt reactivity neurofilament double labeling tangles gentle extraction conditions reactivity phf rt neurofibrillary tangles alzheimers heterogeneous contain neurofilaments unique normal neurofilaments
ALZ,ALZ36,alzheimers resonance polyacrylamide electrophoretic alzheimers state membrane alzheimers sodium dependent acetylcholinesterase profiles membrane extraneural membrane alzheimers membrane
ALZ,ALZ360,alzheimers specific hippocampal reveals specific subiculum hippocampal layers iv entorhinal hippocampal forebrain thalamus hippocampal much input output
ALZ,ALZ361,evidence myelin humans alzheimers wide myelin alzheimers degrees normal myelin bilayer diene alzheimers peroxidation myelin peroxidation human humans alzheimers normal
ALZ,ALZ362,dh ergotoxine gerontologicum components effect dh ergocornine dh eco dh ergocristine dh dh ergokryptine dh alfa ecp dh ecp single dh parts plasma ie radioactivity hours kbq male dh eco retention parietal year dh alfa ecp effect undesired peripheral flow hind limb urethanised perfusion substances microgram epinephrine vasoconstriction micrograms perfusion dh eco substances pool rabbits dh ecp dh eco hand substances velocity stream ld dh lowest dh alfa ecp substances heart effect qt ecg intervals substances desirable viewpoint index dh alfa ecp dh dh dh eco
ALZ,ALZ363,glucose ibotenate lesion ventromedial globus pallidus injections ibotenic micrograms vehicle ventromedial globus pallidus lesion primary cholinergic innervation metabolic glucose deoxy thalamus dorsal hippocampus mgkg ip ibotenic significant ibotenic injections hemispheric asymmetries observed less equal thalamus hippocampus hemisphere ibotenic injections hemispheric asymmetries lesions significant frontoparietal frontoparietal ibotenate oxotremorine eliminate hemispheric frontoparietal results support views metabolic decrements alzheimers due cholinergic innervation decrements
ALZ,ALZ364,csf silicon dementia csf silicon specific dementia related cognitive functional csf silicon atd nondemented atd csf silicon thirty types dementia csf silicon csf silicon specific atd functional onset atd
ALZ,ALZ365,monoaminergic alzheimers senile dementia locus caeruleus dorsal motor vagus dorsal tegmental nigra alzheimers neurological locus caeruleus level damage dorsal tegmental dependent damage dorsal motor vagus
ALZ,ALZ366,alzheimers myoclonus alzheimers myoclonic jerks convulsions kuru grumose degeneration dentate rare alzheimers multisystemic degeneration dentate
ALZ,ALZ367,potential dementia normal subjects subjects specific etiology alzheimers demonstration cognitive dysfunction dementia findings test dementia results normals second significant counts infrequent stimulus normal subjects dementia dementia normal subjects mild dementia etiology different
ALZ,ALZ368,short somatosensory potentials vascular dementia short somatosensory potentials dementia normal senile dementia dementia conduction time primary findings dementia dementia
ALZ,ALZ369,neurotoxicity substances aluminum ketones related solvents problems portions nervous system excretion diseases
ALZ,ALZ37,glucose synthesis alzheimers glucose incorporation vitro alzheimers conditions significant overall glucose synthesis choline psychological defects synthesis presenile dementia histological evidence alzheimers
ALZ,ALZ370,parkinsons possible laterality dementia neurochemical findings laterality neuropsychological neurochemical idiopathic parkinsons pd alzheimers senile dementia group csf homovanillic dihydroxyphenylacetic methoxy hydroxyphenylglycol hydroxyindolacetic serotonin acetylcholinesterase side parkinsonian left group right group group neuropsychological group group csf homovanillic acetylcholinesterase group findings neuropsychological neurochemical functional asymmetries cns
ALZ,ALZ371,intracranial ten sporadic caa intracranial caa intracranial intracranial spite senile dementia alzheimers tomographic diagnostic protein caa microaneurysms intracranial caa
ALZ,ALZ372,jakob jakob year group representation periodic unselected progressive stage deterioration shorter progressive terminal stage mental deterioration transmission successful group shorter durations differentiation alzheimers spongiosis prominent gliosis
ALZ,ALZ373,neurochemical method support serotonin peptides hemisphere asymmetries syndromes
ALZ,ALZ374,alzheimers alzheimers dementia evidence slow infection individuals proven exclusion neurochemical cholinergic primary emphasis cholinergic choline ineffective results prototype physostigmines due peripheral side short neural metabolic
ALZ,ALZ375,igg senile frontal hours senile degrees gray white matter sequential elution polyacrylamide gels nitrate gels immunoperoxidase igg quantitation igg neutral immunonephelometry neutral significant igg senile vascular support occurrence intraparenchymal immune
ALZ,ALZ376,descriptive neurofibrillary tangles december individuals university equal individuals neurofibrillary tangles parahippocampal total none many lesion presence many tangles significant lesions race correlation presence lesion correlation lesions females non lesions populations related hypothetical risk alzheimers
ALZ,ALZ377,direct health th individuals united th total year diseases term review issues diseases normal diseases emphasis genetics immunology neurology ultimate emphasis senescence
ALZ,ALZ378,nih dementia techniques emission fluoro deoxy glucose neuropsychological tests overall populations healthy different presumptive alzheimers glucose whereas decrement gray matter tomographic healthy subjects precede significant reductions glucose mild alzheimers visuoconstructive mild alzheimers hemispheric glucose downs strict findings
ALZ,ALZ379,intrusions perseverations subjects senile dementia alzheimers sdat dementia healthy intrusions perseverations perseverations immediate inappropriate whereas intrusions inappropriate intrusions perseverations aphasic subjects rare intrusions sdat sdat intrusions dementia intrusions dementia sdat subjects term short term perseverations aphasics subjects due frontal dysfunction prominent perseveration frontal injury monitor inability mental important perseverations significant correlation dementia perseverations correlations intrusions perseverations neuropsychological mechanisms
ALZ,ALZ38,psychological alzheimers progressive dementia laboratory evidence multiinfarct dementia dementia enlargement ct index ct index correlation index psychological psychological index results psychological alzheimers ct
ALZ,ALZ380,senile dementia etiology pathophysiology neurochemistry management senile dementia sdat etiology sdat unclear qualitative normal neurofibrillary tangles cognitive evidence sdat cholinergic choline cholinergic dementia exclusion neurological psychological laboratory sdat progressive deterioration management vasodilators metabolic unsuccessful therapy sdat antipsychotic drugs sdat neurochemical early prevent slow
ALZ,ALZ381,dementia motor golgi neurofibrillary tangles pick motor terminal bulbar lateral sclerosis regions senile dementia neurons findings dementia innominata somatostatin normal limits sponginess upper layers attrition pyramidal golgi successful severe degeneration motor multisystem
ALZ,ALZ382,electrode liquid electrochemical neurotransmitters liquid electrochemical resolution direct neurotransmitters coulometric electrochemical identification gate coulometric irreversible substances coulometric currentvoltage sensitivity pg gate favors reversible irreversible ones hydroxyphenylglycol vs ascorbate factor resolution electrode half potentials little monoamines monoamines state alzheimers
ALZ,ALZ383,diffuse lewy progressive dementia lewy term lbd types lewy group diffuse lbd remarkable lewy stem diencephalon group senile degrees group transitional group stem lbd idiopathic parkinsons lbd literature progressive dementia lbd entity diffuse lbd presenile dementia
ALZ,ALZ384,alzheimers posttranscriptional level alzheimers total rna rna many neurofibrillary tangles significant due protein synthesis translation messenger rna rna protein synthesis neurons
ALZ,ALZ385,alzheimers downs unique protein protein downs purified homologous protein alzheimers evidence alzheimers downs alzheimers protein human gene genetic alzheimers
ALZ,ALZ386,nmr ct dementia different types dementia nuclear magnetic resonance nmr ct overall correlation ct nmr findings good hypodensity white matter ct nmr white matter vascular dementias primary dementias presence white matter important factor vascular dementia primary dementia nmr ct findings lacunar state binswanger vascular dementia subgroups vascular dementia dementia
ALZ,ALZ387,extrapyramidal signs alzheimers occurrence extrapyramidal signs free extrapyramidal signs extrapyramidal hypokinetic tremor dyskinetic signs orofacial observations alzheimers striatal dopaminergic hypofunction hypokinesia dyskinetic signs dysfunction
ALZ,ALZ388,early putative alzheimers presumptive dementia techniques intermediate normal descriptors standard group results early
ALZ,ALZ389,stroop color test dementia color test patterns cognitive dementia atd non dementia color mild dementia scores dementia stroop interference effect time individuals atd mild non dementia atd subjects less stroop interference effect subjects time color findings speed due importance cognitive dementia
ALZ,ALZ39,observations cholinesterase elderly normal extent acetylcholinesterase hippocampus normal elderly alzheimers senile neurofibrillary tangles acetylcholinesterase alzheimers acetylcholinesterase positive senile cholinergic fibres acetylcholinesterase diminution cholinergic input fibres alzheimers
ALZ,ALZ390,nominal dysphasia senile previous nominal dysphasia senile dementia alzheimers evidence nominal dysphasia index dementia cognitive scales
ALZ,ALZ391,lithium accentuation extrapyramidal individuals alzheimers lithium elderly individuals alzheimers accentuation extra pyramidal eps eps plasma rbc lithium extrapyramidal
ALZ,ALZ392,hla alzheimers histocompatibility alzheimers hla hla hla cw dementia senile dementia
ALZ,ALZ393,nutritional nervous system metals downs picture individuals lifelong downss hippocampus concerned alzheimers damage mature ageing process
ALZ,ALZ394,dementia review dementia slowness mental processing forgetfulness cognition progressive palsy huntingtons parkinsons spinocerebellar idiopathic lacunar state dementia disorders dementia stem recent lesions mood motivation visuospatial dementia dementia alzheimers prominent amnesia
ALZ,ALZ395,biogenic metabolites dementia noradrenaline da serotonin ht homovanillic hva hydroxyindoleacetic hiaa regions dementia atd normal hiaa atd regions frontal cingulate amygdala lateral segments pallidus nigra lateral thalamus regions innominata lateral segments pallidus lateral thalamus na regions innominata thalamus significant reductions hva hiaa ht ratio atd coeruleus hvada ratio globus pallidus findings dopaminergic system atd
ALZ,ALZ396,psychopharmacologic cognitive disorders current drugs cognitive senile dementia cognitive underlying rationale drugs significant cognitive drugs strategy pharmacotherapeutic future
ALZ,ALZ397,deoxyglucose uptake choline lesions uptake dg regions lesions basalis choline regions lesions significant chat effect dg pentobarbital dg reductions lesions results cholinergic innervation glucose glucose alzheimers degeneration cholinergic
ALZ,ALZ398,infection specific unconventional slow diseases fibrils infected mice infected humans jakob kuru fibrils humans nervous system disorders scrapie kuru jakob fibrils preclinical scrapie spleens infected mice specific unconventional slow diseases
ALZ,ALZ399,correlation basalis alzheimers substantiate hypothesis cholinergic matrix alzheimers cholinergic neurons forebrain correlation neurons basalis meynert cholinergic innervation neurons important
ALZ,ALZ4,resolution alzheimers microscopy types filaments neurofibrillary tangles helical filaments second tilt stage microscopy bifilar helix microscopy observations twisted tubules
ALZ,ALZ40,cholinergic system alzheimers cholinergic system post mortem senile acetylcholinesterase butyrylcholinesterase receptor unchanged process normal choline extent related acetylcholinesterase findings possible cholinergic system normal alzheimers compatible terminal
ALZ,ALZ400,possible mechanisms presynaptic cholinotoxicity due ethylcholine aziridinium afa vivo afa toxin cholinergic transmission vivo disruption vivo specific cholinergic system afa nanomolar neurochemical alzheimers afa potential state report overview recent findings vivo findings aziridinium agnts propose possible vivo recent observations
ALZ,ALZ401,tetrahydrobiopterin senile dementia tetrahydrobiopterin subjects senile dementia results total biopterin subjects senile dementia synthesis neopterin normal specific dihydroneopterin triphosphate tetrahydrobiopterin
ALZ,ALZ402,dorsalis dementia neurofibrillary packing reticulate dorsalis predilection neurofibrillary tangle nft dementia primary stem nft histological significant fold nft histological significant overall significant neurons polygonal nrd target nft nrd
ALZ,ALZ403,xenon ct differentiates normal dementia senile dementia flow lcbf stable xenon gas ct normal individuals dementia mid dementia sdat gray matter flow values mid sdat declines values normals frontal lcbf values normals frontal mid sdat mid sdat normals values fronto thalamus mid multifocal lesions mid sdat normals
ALZ,ALZ404,possible therapy management
ALZ,ALZ405,cholinergic hippocampal term glucose alzheimers cholinergic neurons cholinergic lesions deoxy hglucose hippocampal hippocampal glucose lesions weeks lesions regions months intraregional hippocampal glucose values results cholinergic hippocampal permanent metabolic
ALZ,ALZ406,alzheimers report adrda work group health human force alzheimers alzheimers progressive cognitive functions motor sensory coordination early laboratory tests tests important possible dementia alzheimers confidence neuropsychological tests evidence dementia therapy serve guide probable possible alzheimers definitive
ALZ,ALZ407,maze basalis lesions paradigm maze pre training subjects ibotenic micrograms vehicle basalis important neocortical projections neocortical hippocampal significant side biases
ALZ,ALZ408,synaptic neurofibrillary synaptic subiculum neurofibrillary subcutaneous aluminum tartrate synapses ethanolic phosphotungstic postinjection aluminum tartrate significant synaptic aluminum tartrate synaptic postinjection aluminum tartrate postinjection synaptic synaptic depopulation neurofibrillary gradual process neurofibrillary
ALZ,ALZ409,lipofuscin alzheimers work ultrastructure lipofuscin spinal alzheimers diseases year male alzheimers afflicted forgetfulness disorientation grand pyramidal signs dysarthria visuo spatial general mild senile alzheimers neurofibrillary tangles senile medulla severe microscopy thalamus medulla oblongata spinal different types lipofuscin different lipofuscin methods morphological sites nervous
ALZ,ALZ41,dendritic degeneration alzheimers frontal alzheimers microscopy layers layers droplets layers findings techniques dendritic trees alzheimers diseases mental
ALZ,ALZ410,meynert idiopathic parkinsons meynert bnm idiopathic parkinsons histopathological magnocellular neurons parkinsons lewy significant correlation mental state hand significant bnm neurons damage meynert parkinsons less severe observed alzheimers progressive palsy
ALZ,ALZ411,aluminium alzheimers contribute cholinergic aluminium alzheimers dementia reductions parameters presynaptic cholinergic choline uptake synthesis choline aluminium choline transport endings human erythrocytes rabbits neurofibrillary tangles choline aluminium alzheimers cholinergic aluminium
ALZ,ALZ412,status cholinesterase neuropsychiatric disorders trait cholinergic identification subgroups neuropsychiatric specific diagnostic refinement specific neuropsychiatric disorders cholinergic transmission peripheral cholinesterase cholinergic transmission uncertain future specific cholinesterase diagnostic potential peripheral trait cholinergic
ALZ,ALZ413,genetics dementia genetic types dementia severe dementia parkinsons dementia dementia evidence many corroboration genetic dementia support early onset genetic risk evidence dna damage
ALZ,ALZ414,myoclonus alzheimers ten alzheimers trisomy downs myoclonic jerk myoclonus subjects potential myoclonic jerks myoclonus spongiform jakob
ALZ,ALZ415,dementia dementia diagnostic problems alzheimers senile dementia adsdat dementia mid group dementia mid group adsdat group adsdat free diseases mid thirty mid previous adsdat time investigation adsdat signs mid signs mid adsdat normal adsdat mid ecgs electroencephalography slow adsdat slow mid mid dilation system homovanillic adsdat group
ALZ,ALZ416,th stevenson lecture alzheimers cholinergic system tissues uniform dropout cholinergic forebrain locus coeruleus dopaminergic nigra diseases dependent alzheimers cholinergic coeruleus parkinsons nigra locus dementia alzheimers severe dementia less unknown method ineffective modest regimens cholinergic system alzheimers dementia many reticular activating system hypothesis cognition reinterpretation reticular system quarter locus coeruleus element recognition time forebrain system cholinergic
ALZ,ALZ417,hydroxylase acetylcholinesterase alzheimers recent neurochemical alzheimers cholinergic defects nervous system hydroxylase csf hydroxylase hydroxylase dementia cholinergic acetylcholinesterase csf hydroxylase acetylcholinesterase group
ALZ,ALZ418,neurochemical alzheimers picks neurochemical whole alzheimers yr picks yr yr alzheimers primary diseases glycolytic carbonic anhydrase acetylcholinesterase protein alzheimers picks picks pronounced dramatic process alzheimers picks
ALZ,ALZ419,cytomegalovirus infection alzheimers serum cytomegalovirus cmv alzheimers non functional cmv conventional cmv post mortem cmv histocompatibility hla raised hla immune cmv
ALZ,ALZ42,jakob dementia necropsy findings consistent spongiform jakob year alzheimers presenile dementia generations progressive presenile illnesses post spongiform lesions weight alzheimers jakob different manifestations genetic predisposition
ALZ,ALZ420,uptake indices aminopyridine neural transmission etiopathology alzheimers neurochemical cholinergic transmission current cholinomimetic situation search
ALZ,ALZ421,alzheimers isoproterenol receptor alzheimers parallel lymphocytic receptor lymphocytic receptor dementia
ALZ,ALZ422,test senile dementia alzheimers test dst presenile senile dementia alzheimers cognitive hamilton normal results dst results dst alzheimers likely confounded
ALZ,ALZ423,correlation cholinergic gaba findings senile dementia choline gamma aminobutyric gaba counts senile neurofibrillary tangles senile dementia sdat counts frontal whole group subgroups significant correlations counts total group sdat significant correlations neurofibrillary frontal midtemporal sdat correlations youngest dementia severe neurochemical neurochemical elderly group sdat illustrated trends gaba chat significant correlations gaba positive group neurofibrillary tangle little correlation gaba
ALZ,ALZ424,gamma aminobutyric homovanillic csf senile dementia alzheimers investigation metabolites senile dementia alzheimers sdat promising diagnostic metabolic reflections csf csf aminobutyric gaba homovanillic hva female sdat gaba exchange fluorimetric hva gaba csf sdat whereas hva level unchanged
ALZ,ALZ425,alzheimers cholinergic system giant neurons forebrain choline elderly senile dementia frontal mumolhr protein senile dementia cholinergic drops level chat dementia
ALZ,ALZ426,intracerebral findings cerebromeningeal previous meningeal hematomas vascular lesions meningeal lesions alzheimers significant presence unusual
ALZ,ALZ427,alzheimers csf alzheimers undemented presence alzheimers specimens oligoclonal igg group significant non gamma alzheimers double transferrin double tau protein alzheimers group genetic
ALZ,ALZ428,ergoloid mesylates dementias unanswered questions mesylates senile dementia peripheral vascular senile dementia ergoloid mesylates metabolic enhancer senile dementia uncertain doses range much optimal unknown evidence short term ergoloid trials many specific therapy senile dementia condition
ALZ,ALZ429,npy innominata alzheimers dementia alzheimers dementia atd accumbens amygdala pmolg innominata pmolg significant npy innominata pmolg atd pmolg less somatostatin atd somatostatin atd npy regions
ALZ,ALZ43,cognitive status alzheimers illnesses mid results free diagnostic primary degeneration alzheimers serum igg dementia serum igg symptomatology mental status serum igg
ALZ,ALZ430,alzheimers report protein protein twisted fibrils alzheimers sephadex column hc liquid computer search reveals homology protein protein unique serum diagnostic test alzheimers
ALZ,ALZ431,quantification biogenic metabolites gas spectrometry method biogenic metabolites gas spectrometry method level quantification conditions gas synthesis standard good correlation results liquid method
ALZ,ALZ432,receptor neocortex hippocampus senile dementia ligand serotonin benzodiazepine gaba neocortex hippocampus senile dementia sites serotonin dementia extent
ALZ,ALZ433,importance instructions retrieval cues senile dementia senile dementia categorized list different retrieval conditions structure retrieval structure list recall retrieval recall normal dementia senile dementia conditions list prepared pay potentials
ALZ,ALZ434,cholinergic system physostigmine alzheimers subcutaneous physostigmine geometric figures alzheimers remarkable minutes results evidence hypothesis cholinergic potentiation alzheimers possible important cholinergic system integration
ALZ,ALZ435,rapid eye sleep alzheimers dementia healthy individuals rapid eye sleep disorders alzheimers sleep mild severe dementia subjects probable alzheimers mild exclude time results sleep mild dementia none sleep mild subjects time total time severe night dementia results findings cautions sleep dementia geriatric populations
ALZ,ALZ436,parkinsons basalis concomitant alzheimers representative basalis meynert idiopathic parkinsons basalis parkinsons senile alzheimers neurofibrillary tangles neurons parkinsons less versus tests alzheimers
ALZ,ALZ437,severe neurological legal severe neurological legal questions laws physicians irreversible functions state law explicit regard legal courts physicians current litigation litigation severe neurological physicians legal authority problems criminal state supreme court
ALZ,ALZ438,motor dementia elderly senile dementia months electromyographic sporadic motor lateral sclerosis voluntary motor system pacific posterior lateral sclerosis dementia possible motor unitary hypothesis lateral sclerosis parkinsons alzheimers investigation motor dementia inquiry motor dysfunction evidence support hypothesis
ALZ,ALZ439,therapy dementia senile dementia results problems situation support specific strategy intervention helpful time
ALZ,ALZ44,emission senile dementia deoxy fluoro glucose fdg tracer glucose conjunction emission pet pet fdg vivo quantitation man normal senile dementia preliminary results senile dementia alzheimers elderly normal subjects significant diminution glucose sdat diminution metabolic cognitive results potential pet fdg normal dementia
ALZ,ALZ440,histopathological clot etiology intracerebral specimens intracerebral general pre malformations unknown intracerebral intraventricular clot specific etiology specific possible specific specimens time diagnostic
ALZ,ALZ441,alzheimers cytogenetic findings alzheimers normal due breakage individuals peripheral specimens cytogenetic staff end group underwent ct cultures deprived medium tc fragile minimum classified csg ctb csb results significant group total occurrence
ALZ,ALZ442,psychometric differentiation mild senile dementia ten psychological tests mild dementia alzheimers healthy social position healthy tests mental wechsler test fluency letters
ALZ,ALZ443,amnesia aminoalkyl oxo pyrrolidineacetamides pramiracetam dialkylaminoalkyl oxo pyrrolidineacetamides shock amnesia mice subsequent general test nervous system cns broadest methylethylamino ethyl dimethylpiperidinoethyl substituent dialkylamino substituent amnesia optimal methylethylaminoethyl pyrrolidineacetamide dialkylamino substituent preclinical toxicological name pramiracetam pramiracetam wide safety normal human open trial primary dementia pdd senile dementia alzheimers
ALZ,ALZ444,patterns glucose parkinsons ffluorodeoxyglucose method ffluorodeoxyglucose parkinsons normal subjects metabolic glucose parkinsonian bradykinesia mild dementia parkinsons parkinsons severe parietal hypometabolism alzheimers huntingtons hypometabolism glucose normal system metabolic process neurons parkinsonian
ALZ,ALZ445,senile dementia forty subjects senile dementia psychometric potential ct months entry subjects severe dementia mild many psychometric severe dementia ct subtest wechsler stage dementia year subjects
ALZ,ALZ446,term management parkinsons idiopathic parkinsons worse realistic future relatives levodopa significant therapy important questions progressive palsy effect dementia alzheimers degeneration senile tremor parkinsons therapy therapy assist amantadine anticholinergics drugs underlying condition parkinsons
ALZ,ALZ447,dementia diagnostic lattic relaxation times proton nuclear magnetic resonance elderly senile dementia sdat dementia mid results elderly values white matter dementia statistical correlation proton white matter mid potential results possible damage
ALZ,ALZ448,ct dementia today future ct senile dementia sdat sdat sulcal significant normal elderly ct cognitive indices sdat exclusion lesions computer methods technical hope future
ALZ,ALZ449,frontal syndromes senile dementias statistical group gerontopsychiatric mild severe dementia instruments psychological system correlations morphological statistical ct determinants frontal huckman width frontal fissure consistent frontal items symptomatology normal
ALZ,ALZ45,histocompatibility alzheimers preliminary preliminary alzheimers excess whereas different locus findings
ALZ,ALZ450,senile dementias nursing home residents nursing home residents different evidence values emotional incontinence evidence correlation single parameters somatic different correlation profiles emotional incontinence dementia subgroups
ALZ,ALZ451,cognitive disorders geriatric subjects many neurochemical choline monoamine oxidase senile dementia alzheimers sdat indices senile tangles many different techniques unsuccessful gerovital oxygen vasodilators hydergine much recent work techniques date precursors limited postsynaptic physostigmine hope future oral preparations piracetam recent influences membrane receptor future investigation
ALZ,ALZ452,social isolation elderly nursing home residents morbidity year residents geriatric nursing homes homes frg popn regard mental quality social contacts investigation direct findings excess mental syndromes nursing home residents homes home residents fewer social contacts less social contemporaries households little nursing homes homes observed significant statistical correction marital status implications findings geriatric
ALZ,ALZ453,downs serum csf ds progressive dementia transferrin prealbumin results obtained neurological igg ds serum csf serum level transferrin ds serum csf serum igm prealbumin normal ds serum csf evidence transudation csf intrathecal synthesis dementia ds
ALZ,ALZ454,presenile dementia neurological viewpoint dementia efforts terms diagnostics pictures easy dementia diagnostic therapeutical nihilism dementia inadequate hand invasive non invasive methods today computer laboratory tests methods findings significance mention rare diseases group panencephalitis refer jakob vitamin conditions dementia
ALZ,ALZ455,genetic osmotic huntingtons osmotic unmedicated subjects huntingtons individuals risk group normal subjects huntingtons alzheimers individuals osmotic red index index huntingtons group group huntingtons osmotic risk group subjects osmotic normal subjects group normal huntingtons individuals risk normal indices normal range huntingtons normal support hypothesis osmotic individuals risk huntington need genetic
ALZ,ALZ456,alzheimers dementia senile dementia middle basalis meynert locus caeruleus alzheimers senile neurofibrillary tangles alzheimers alzheimers slight extent alzheimers presenile dementia alzheimers senile dementia middle
ALZ,ALZ457,retrograde amnesia parkinsons retrograde amnesia parkinsons test remote results normal equal time illnesses ie huntingtons alzheimers diseases different amnesic disorders qualitative remote dementias amnesic syndromes
ALZ,ALZ458,seasonal human lumbar csf many humans year lumbar csf homovanillic hva hydroxyindoleacetic hiaa methoxy hydroxyphenyl glycol mhpg schizophrenia alzheimers hiaa mhpg
ALZ,ALZ459,monoamine alzheimers hydroxyphenylglycol mhpg hydroxy indoleacetic hiaa homovanillic hva lumbar csf senile alzheimers csf hva hiaa csf presenile subjects
ALZ,ALZ46,lateral sclerosis neutron results pd japanese manganese aluminum copper cns cns japanese japanese guam pd guam neutron results japanese japanese guam pd aluminum cns significant positive correlation aluminum manganese findings possible process metal soft interaction trivalent manganese cns cns diseases
ALZ,ALZ460,intralaminar neurochemical human midtemporal alzheimers normal intralaminar nontransmitter midtemporal normal individuals alzheimers normal choline acetylcholinesterase ache layers granular layers iv alzheimers outer middle layers matter whereas normal white matter patterns cholinergic alzheimers white matter pseudocholinesterase lactate dehydrogenase gamma aminobutyric gaba system normal much intralaminar glutamate decarboxylase level gaba cholinergic patterns alzheimers free different glutamic normal different gaba nontransmitter putative alzheimers findings microchemical alzheimers functional cholinergic input neocortical layers associative functions important
ALZ,ALZ461,human alzheimers senile dementia sdat human nervous utilized test possible human alzheimers human tangles induces fibrous gliosis filaments normal filaments infectious implant
ALZ,ALZ462,alzheimers possible roles illnesses personal alzheimers dementia race significant subjects contacts unusual dietary severe injury important associative premorbid demographic dementia evidence genetic factor excess dementia mental downs alzheimers
ALZ,ALZ463,structure dementia neocortex alzheimers treated micrococcal nuclease release linker diseases alzheimers picks alzheimers resistant salt release subjects results support hypothesis structure alzheimers
ALZ,ALZ464,recall dementia retrieval hypothesis senile dementia recall time recall letter results retrieval dementia processing stage
ALZ,ALZ465,dementia dementia prosperous suburban months progressive dementia year dementia vascular dementia different diagnostic support subspecialty identify progressive elderly risk deterioration prognostic
ALZ,ALZ466,mh findings locus ceruleus possible alzheimers cns peripheral normals methoxy hydroxyphenylglycol mhpg plasma subjects free weeks csf mhpg
ALZ,ALZ467,dementia pedigrees evidence transmission paternal lines
ALZ,ALZ468,neurofilament related techniques components neurofilament protein triplet neurofilament protein level filaments nm resistant extraction hot sodium sulfate mercaptoethanol covalent disulfide helical filaments alzheimers polyacrylamide techniques neurofilament sites uncovered extraction
ALZ,ALZ469,dna damage neurons damage nuclear dna damage evidence dna alzheimers parkinsons diseases dna repair mechanisms huntingtons dna likely effect process
ALZ,ALZ47,aluminum alzheimers dialysis aluminum nuclear human heavy heterochromatin euchromatin euchromatin euchromatin aluminum gram dna nuclear heterochromatin senile alzheimers nuclear preparations dialysis less aluminum whole fifteen times direct aluminum progressive neurofibrillary degeneration aluminum alzheimers normal cytoplasmic metal permitting aluminum dna
ALZ,ALZ470,related neuropsychological downs ds risk condition dementia alzheimers neuropsychological ds subjects retarded overall ds subjects scores general reflexes ds subjects findings support downs issues
ALZ,ALZ471,monoamine human method indolealkylamines neurological disorders methoxy dopa methoxy hydroxyphenylglycol dihydroxyphenylacetic hydroxyindoleacetic homovanillic human inexpensive rapid liquid electrochemical detector parkinsons decrement homovanillic methoxy dopa serotonin turnover hydroxyindoleacetic monoamine metabolites subarachnoid
ALZ,ALZ472,basalis meynert alzheimers pigment basalis meynert cytoplasmic rna alzheimers cytoplasmic rna extra alzheimers much alzheimers lipofuscin extent alzheimers cytoplasmic rna mechanisms pigment basalis meynert extreme degeneration alzheimers
ALZ,ALZ473,neurochemical types alzheimers alzheimers group cholinergic choline gamma aminobutyric somatostatin results th th cholinergic hippocampus somatostatin th th severe cholinergic noradrenaline gamma aminobutyric somatostatin overall group alzheimers support alzheimers process results alzheimers presenile dementia important respects
ALZ,ALZ474,glutamatergic innervation basalissubstantia innominata glutamatergic innervation basalissubstantia innominata uptake dependent release endogenous glutamate glutamatergic corticofugal input removal parietal modify parameters basalissubstantia innominata possess important glutamatergic innervation unknown innervation degeneration alzheimers cholinergic neurones sensitivity
ALZ,ALZ475,alzheimers current review alzheimers progressive cognitive level dementias etiology theories possible genetic exclusion dementia psychological definitive post mortem histological hallmarks neurofibrillary tangles management socialization support institutionalization resources
ALZ,ALZ476,serum vitamin dementia serum vitamin immunoassay subjects dementia subjects non dementia subjects dementia serum vitamin serum vitamin subjects dementia independent serum
ALZ,ALZ477,experiences voluntary nonverbal interaction elderly homes elderly nursing homes dependent nursing dementia institutional social work elderly voluntary client therapy reality orientation non verbal sensory training daily functions occupational therapy experiences verbal non verbal elderly results elderly confusion elderly voluntary
ALZ,ALZ478,hydroxylase hydroxylase dbh csf normal subjects serum dbh rd th th dbh csf subjects dbh senile dementia alzheimers sdat nmolesminml dementia mid nmolesminml nmolesminml serum dbh sdat prominent severe dementia severe dbh serum dbh csf sdat nmoleshml mid nmoleshml neurological diseases dementia nmoleshml dbh csf sdat less nervous dysfunction pathophysiology expectancy senile dementia alzheimers sdat
ALZ,ALZ479,patterns aphasic normal subjects normal subjects grammatical stimulus stimulus nouns adjectives paradigmatic adverbs elicit syntagmatic syntagmatic resistant deterioration dementia dementia paradigmatic due idiosyncratic normal subjects dementia anomic aphasics subjects mild dementia brocas aphasics fewer paradigmatic normals enough mechanisms idiosyncratic wernickes aphasics paradigmatic strategy due inability true metalinguistic ie strategy paradigmatic disruption mechanisms idiosyncratic
ALZ,ALZ48,histocompatibility pre senile dementia alzheimers interaction conventional infective hla locus hla conventional infective pre senile dementia alzheimers subject hla
ALZ,ALZ480,reversible dementia dementia cognitive dementia dementia retention mental speed occupational normal mental status discontinuation
ALZ,ALZ481,processing spatial sensitivity normal alzheimers functions senile dementia spatial sensitivity normal elderly subjects subjects time identify letters mask letter recognition spatial extent mask well time mask letter recognition equivalent normal tasks alzheimers functions peripheral ones
ALZ,ALZ482,dementia elderly dementia irreversible dementias dementia fifteen reversible dementias reversible dementia shorter prescription drugs severe dementia half diseases mental status reversible dementia normal coexistent diseases reversible irreversible dementia recognition dysfunction
ALZ,ALZ483,emission emission pet fluorodeoxyglucose fdg glucose means ct normal human metabolic sensory dysfunction ct metabolic patterns elderly fdg normal metabolic defects dementia parietal thalamus hypometabolic huntington interictal fdg hypometabolic zones onset partial zones normal ct future prospects
ALZ,ALZ484,cognitive parkinsons cognitive cognitive unmedicated parkinsons pd progressive dementias alzheimers untreated pd little cognitive pd specific cognitive findings boundaries cognitive
ALZ,ALZ485,correlations ct ct dementia sdat mid ct patterns group statistical ct findings normal subjects significant severe findings specific dementia eegs group ct correlation
ALZ,ALZ486,left early onset dementia dementia handedness handedness early onset group dementia alzheimers senile dementia
ALZ,ALZ487,hla alzheimers parkinsons possible senile dementia gene hla factor chido red glyoxalase senile dementia idiopathic parkinsons donors dementia parkinsons significant gene locus senile dementia rare locus risk less
ALZ,ALZ488,neural basalis innominata rhesus neurons basalis innominata ansa peduncularis cholinergic innervation neocortical projections parts neocortex neurons projections sensory motor parietal neurons input prepyriform orbitofrontal pole entorhinal position cholinergic relay neocortical direct way cholinergic input whereas cholinergic innervation cholinergic innervation neocortical
ALZ,ALZ489,intestinal immunoreactive intestinal lumbar csf neurological disorders rhesus human porcine column sephadex superfine evidence immunoreactive csf night lowest day lowest sclerosis severe injury significant dystonia parkinsons alzheimers neurons disorders findings important implications vasospasm subarachnoid
ALZ,ALZ49,membrane alzheimers width membrane alzheimers statistical process membrane significant alzheimers width membrane factor membrane
ALZ,ALZ490,exchanges kinetics alzheimers female alzheimers female range sces kinetics sensitivity cultures level sces significant rank sum test normal mitomycin mitotic index extent centromeres
ALZ,ALZ491,jakob intracerebral jakob white matter lateral walls hemisphere morphological findings jakob cores senile alzheimers
ALZ,ALZ492,ethical issues ethical problems elderly group wonders ways concomitant quality elderly dementia invasive recent thinking mental mind ethical problems huntingtons authoritarian relatives full
ALZ,ALZ493,morphological dementia parkinsons literature dementia parkinsonian mechanisms lewy neocortical lesions depletion cholinergic dopaminergic dementia depopulation dementia concomitant alzheimers different cognitive parkinsons
ALZ,ALZ494,basalis locus caeruleus alzheimers alzheimers neurons basalis meynert locus caeruleus severe basalis extent regions
ALZ,ALZ495,polymorphism dementia significant dementia
ALZ,ALZ496,geriatric many elderly needs state homes geropsychiatric multidisciplinary rehabilitation successful independent geriatric health system inappropriate state important mental health
ALZ,ALZ497,alzheimers many alzheimers stage process face specific problems onset mental health professionals alzheimers reactions make reestablish process mental health professionals specific problems work
ALZ,ALZ498,verbal fluency verbal different types verbal fluency lesions normal equation fluency index verbal subjects frontal lesions fluency scores verbal equation fluency subjects frontal lesions dements fluency verbal results fluency specific phenomenon frontal lesions deterioration dementia
ALZ,ALZ499,cognitive functional dementia impact functional elderly residents senile dementia alzheimers dementia dementia wechsler wechsler wms dementia significant group verbal iq iq wms quotient dementia full iq dementia wais wms subtest profiles significant cognitive functional functional dementia whereas dementia
ALZ,ALZ5,hippocampal free alzheimers free hippocampus alzheimers normal significant aminobutyric glutamic interpreted hippocampus tendency group statistical significance consistent proteolytic alzheimers
ALZ,ALZ50,evaluations senile dementia alzheimers senile dementia alzheimers sdat ct consistent findings results due methods evaluations populations presumptive sdat cognitive test independent ct methods rank techniques significant equal correlations rank methods system single powerful cognitive sulci significance cognitive sdat
ALZ,ALZ500,flow flow values xe method dementia mid senile dementia sdat normal healthy hemispheric gray matter flow values mid sdat less normal normal flow values gradual declines less mid significant decreases values less flow values normals reductions middle mid flow values correlation reductions flow values dementia less flow reductions related process perfusion true sdat process pre flow reductions
ALZ,ALZ501,emission human structure vivo elderly human subjects significant sulcal related emission glucose metabolic results normal metabolic correlations metabolic significant respect significant structure
ALZ,ALZ502,dementia elderly guidelines dementia emphasis alzheimers
ALZ,ALZ503,lithium increases red choline dementia rbc choline senile dementia sdat lithium sdat doses weeks tests intervals serum developed neurotoxicity serum scores dramatic increases choline rbc choline sdat
ALZ,ALZ504,normal influences hemodynamic flow gray matter normal xe flow values frontal gray matter csf lumbar puncture normal less complications flow gray matter removal csf normal oxygen normal csf removal flow normal
ALZ,ALZ505,spongy degeneration cns spongy degeneration cns cyclical megalocephaly convulsions coma findings neurons alzheimers demyelination membrane vacuoles blisters
ALZ,ALZ506,aluminum aluminum cytosolic mitochondrial hexokinase ic values presence level effect aluminum aluminum ic aluminum phosphofructokinase lactate dehydrogenase microm aluminum pyruvate aluminum inhibited lactate extracts effect glucose glucose phosphate ic lactate glucose microm hexokinase aluminum dialysis dementia mechanisms aluminum neurotoxin
ALZ,ALZ507,dementia specific early literature dementia agraphia hypothesis fad fad dominant genetic relatives apractic lifetime risks methods nursing home dementia year lifetime relatives times results identify entity dementia commonest dementia
ALZ,ALZ508,neurochemical dementia parkinsons mental status parkinsons normal severe cognitive neurofibrillary tangles granulovacuolar evidence presence parkinson cholinergic dementia alzheimers choline cholinergic neurochemical cognitive parkinson answered parkinson hippocampal noradrenaline
ALZ,ALZ509,cholinesterase cholinesterase che adsdat signs dementia che dementia adsdat somatostatin dementia findings observations acetylcholinesterase values
ALZ,ALZ51,test fusion jakob vitro neurological specimens cjd results cjd specimens fusion matched csf specimens types neurological diseases sharp fusion cjd sporadic different neurological significance results
ALZ,ALZ510,hketanserin ht dementia hketanserin specific ligand ht receptor specific preparations post mortem frontal subjects dementia significant receptor normal independent related cholinergic ht hiaa non significant presynaptic ht
ALZ,ALZ511,meynert progressive palsy magnocellular meynert progressive palsy psp alzheimers typical psp dependent psp neurons protein usual psp damage severe observed alzheimers state cholinergic
ALZ,ALZ512,occurrence acetylcholinesterase neurons human normal human neostriatum neurons microns acetylcholinesterase ache neurons less total striatal ache neurons ache pretreatment morphological striatal ache neurons unaltered ache basalis findings cholinergic neurons human neostriatum basalis alzheimers
ALZ,ALZ513,acetylcholinesterase somatostatin neurons cerebrum cultures acetylcholinesterase somatostatin coexist acetylcholinesterase neurons morphological subtypes acetycholinesterase neurons findings specific cholinergic cerebrum cholinergic alzheimers senile dementia importance
ALZ,ALZ514,neurofibrillary tangles neurofibrillary tangles tangles neurons extraction neurofibrillary tangles tangles neurofilaments demonstration neurofibrillary tangles tangles
ALZ,ALZ515,hepatopathy neonatal foals foals different breeds healthy mares normal icterus terminal coma half normal weight liver dark brown tract fibrosis hepatocellular necrosis lobular collapse liver peripheral severe stasis canaliculi thin marginal liver mild fatty necrosis alzheimers foals hours foals oral proprietary nutritional paste ingredients viable sp iron lesions foal
ALZ,ALZ516,dementia half progressive cognitive alzheimers exclusion dementia neurobiologic alzheimers neurons helical filaments specific filaments unusual severe cholinergic cholinergic neurons basalis meynert innominata specific alzheimers relatives
ALZ,ALZ517,olfactory bulbs alzheimers olfactory bulbs alzheimers undemented undemented alzheimers neurofibrillary tangles olfactory olfactory olfactory alzheimers olfactory sensory alzheimers
ALZ,ALZ518,proven easy impressions disability
ALZ,ALZ519,size alzheimers size dementia size normal probable alzheimers normative interpolated estimate normal size months size norms size longitudinal neurodiagnostic
ALZ,ALZ52,parkinsons evidence favours hypothesis dementia parkinsons term levodopa therapy alzheimers parkinsons cholinergic due process presence neurofibrillary tangles transferase process dopaminergic levodopa therapy dementia test hypothesis treated parkinsonian dementia gmsday kohs test confusion hallucinations levodopa movements motor preliminary progressive dementia parkinsons
ALZ,ALZ520,functional status dementia healthy individuals results investigation patterns cognitive healthy senile dementia sdat investigation cognitive test scores functional sdat sdat sdat cognitive tests recognition recall orientation functional investigation patterns sdat sdat investigation possible individuals attentional
ALZ,ALZ521,healthy alzheimers healthy health alzheimers dementia oral rectal level cosinor level dementia significant effect dementia time dementia primary degeneration alzheimers early disable neural homeostatic
ALZ,ALZ522,phases alzheimers conceptual health management progressive alzheimers disorders significant successful management conceptualization reactions professionals needs different phases provide management resources innovative
ALZ,ALZ523,dysfunction alzheimers emission glucose psychometric alzheimers healthy tests alzheimers group glucose emission fluorodeoxyglucose alzheimers group significant positive correlation overall dementia metabolic hypometabolism uniform posterior parietal contiguous portions posterior frontal spared findings compatible alzheimers future probes pathophysiology
ALZ,ALZ524,dementia cognitive dysfunction mental dysfunction sclerosis discrimination sensory motor work dementia alzheimers parkinson related potential
ALZ,ALZ525,senile review recent literature problems dementia deals untreated senile dementia alzheimers times scales fpb test system sandoz geriatrics shader geriatric grs test system grs grs hierarchical cluster significant values test system observer scales time right dementias severe test system factor factor social maladaption grs unchanged significant values standard points social maladaption scales means sum different stabile courses investigation correlation whole points fp standard points social maladaption psychometric methods fpb test system scales literature inconsistent problematic dementias fact importance trials senile dementia grouping statistical
ALZ,ALZ526,possible lithium extrapyramidal alzheimers extrapyramidal symptomatology term lithium report presence mental lithium severe extrapyramidal signs lithium serum lithium termination lithium possible pathophysiology phenomenon
ALZ,ALZ527,findings coexistent progressive palsy alzheimers year man forgetfulness senile dementia year gaze hoarse progressive dementia anarthria sphincteric incontinence progressive palsy progressive palsy alzheimers tangles granulovacuolar pons globus pallidus senile neurofibrillary tangles granulovacuolar hippocampus amygdala dementia
ALZ,ALZ528,alzheimers metabolic degeneration alzheimers onset system degeneration populations neurons metabolic occur metabolic tissues level tissues alzheimers metabolic cholinergic
ALZ,ALZ529,choline choline phospholipids hypothetical alzheimers axon cholinergic neurons senile dementia sdat cognitive normal hypothesis neurons system release dependent exogenous choline rest intracellular choline superfusates pool choline phospholipids choline choline free medium release choline putative endogenous pool utilized synthesis cholinergic neurons membrane impoverishment cholinergic neurons membrane reservoir neurotransmitters cholinergic sdat related disorders
ALZ,ALZ53,neurochemical findings normal glycolytic carbonic anhydrase protein human significant hk phenomenon release hk mitochondrial significant correlation imposes occur nak carbonic anhydrase important significant pco dependent ionic transport flow tendency protein progressive dependent dependent significant thalamus hippocampus amygdala globus pallidus importance phosphorylation membrane functional
ALZ,ALZ530,twisted filaments human pinealomas twisted filaments helices human nm wide maximal width helix nm constrictions protein filaments specific pinealocytes alzheimers helical filaments
ALZ,ALZ531,hippocampal mice scrapie lesions cns histopathological mice scrapie laboratory regions lesion hippocampus destructive degeneration hippocampus pyramidal necrosis glial reactions severe hippocampal sclerosis intracerebral infection identify hippocampus interdependence system sclerosis hippocampus conjunction system hippocampal sclerosis scores index estimate matter reveals hippocampal sclerosis scrapie hippocampus whole scrapie hippocampal sclerosis system lesions conditions alzheimers
ALZ,ALZ532,tangles human senile dementia tangles alzheimers observed platinum iridium sodium sulfate urea filaments nm periodic constriction substructure protofilaments periodic twist fibrils periodic constriction protofilaments fibrous protein neurofilaments
ALZ,ALZ533,manganese human alzheimers manganese regions alzheimers instrumental neutron mn grand regions significant less mn significant homeostatic mn significant positive correlation mn level
ALZ,ALZ534,helical filaments isolation protein method isolation neurofibrillary tangles helical filaments diseasesenile dementia adsdat neurofibrillary homogenization nylon cloth ant discontinuous glass column sodium sulfate ant birefringence polarized congo red phf preserved dimensions populations different ant ant insoluble ant repeated mercaptoethanol bme degrees sonication ant sodium sulfate polyacrylamide page ant reveals presence polypeptides weights minor polypeptides significant gels polypeptides enter phf enter polypeptides none none phf comigrate page neurofilament polypeptides myosin
ALZ,ALZ535,eye dysfunction dementia tasks dementia pseudodementia normal compensate system group dementia worse less pseudodementia subjects elderly normal correlation less dementia
ALZ,ALZ536,recent alzheimers visuospatial prominent neuropsychological alzheimers neuropsychological alzheimers unique neuropsychological alzheimers cognitive dementia
ALZ,ALZ537,dementia recent visuospatial total normals elderly normals subjects visuospatial recall subjects instructed window time stimulus test face valid relevant subjects everyday specific cognitive senile dementia alzheimers sdat tests recall spatial single stimulus subjects recall intervals recall subjects subjects normals smallest normals significant spatial stimulus stimulus recall subjects stimulus load normals time dementia correlation delayed spatial recall time cognitive status verbal recallabstract
ALZ,ALZ538,csf acetylcholinesterase dementia sequential csf acetylcholinesterase ache lumbar csf myelography significant significant correlation ache ache ml lumbar puncture neurosurgical recumbent hours ache ache unchanged korsakoff ache lumbar csf ache lumbar csf diffuse spinal csf ache
ALZ,ALZ539,social work alzheimers psychosocial management cure individuals alzheimers critical needs psychosocial psychosocial management specific caregivers maintain
ALZ,ALZ54,progressive dementia diffuse lewy report year male progressive dementia senile typical alzheimers parkinsons senile neurofibrillary tangles depigmentation nigra locus caeruleus lewy stem cns nosological paralysis alzheimers
ALZ,ALZ540,cornu cirrhotic immunohistological ammons sommer sector cirrhotic pyramidal neurons filaments helical helical filaments hand whereas whole gfap specific method
ALZ,ALZ541,cholinergic receptor laboratory man normal cholinergic hippocampus neurological alzheimers specific quinuclidinyl benzilate qnb receptor drugs receptor frontal specific qnb hippocampus vivo hypothermia antinociception locomotor hence contradictory results related cholinergic adapt
ALZ,ALZ542,dementia mild severe alzheimers dementia confrontation test bnt mental status alzheimers total tdrs dementia functional dementia profiles bnt mild subjects severe subjects range
ALZ,ALZ543,topography dementia normal neurofibrillary patterns signs dementia geriatric observers dementia subjects hippocampus severe dementia senile dementia
ALZ,ALZ544,early alzheimers alzheimers manifestations paraclinical findings
ALZ,ALZ545,dementia extent senile dementia alzheimers senile dementia alzheimers pole preparations bilshovsky senile neurofibrillar nodes neurofibrillar skeletons anamnestic findings correlation pole
ALZ,ALZ546,parietal signs senile dementia alzheimers nursing home senile dementia alzheimers sdat familiar surroundings rest sdat parietal test mental status sdat specific parietal
ALZ,ALZ547,human health situation exchange hereditary diseases alz fpc sces cultures nqo mnng fanconi sce normal kinetics cas divisions cultures results induction sces nonsmokers fa sces normal untreated cultures times cultures kinetics method normal related turnover times fa normal times induction sces cultures much sces nqo polyposis coli significant induction sces untreated cultures cultures nqo mnng
ALZ,ALZ548,trials cholinergic rs alzheimers senile dementia sdat rs alzheimers senile dementia sdat trials daily doses weeks typical peripheral cholinergic drugs arecoline positive cognitive functions social minority sdat psychometric tests functions speed rs suitable sdat
ALZ,ALZ549,lithium alzheimers pilot alzheimers pilot cognitive parameters none possible mechanisms
ALZ,ALZ55,senile methods senile dementia senile extraneural endocrine senile endocrine persistent birefringence congo red permanganate
ALZ,ALZ550,protein different regions dementia dementia protein specific phosphoprotein presynaptic regions cingulate hippocampus diseasesenile dementia adsdat dementia mid hippocampus mid significant regions
ALZ,ALZ551,neurofilament human neurofilament antiperoxidase method human neurofilament lateral sclerosis infantile neurofibrillary positive lewy neurofibrillary tangles palsy senile neurofibrillary tangles picks human neurofilament share determinants protein alzheimers neurofibrillary tangles picks
ALZ,ALZ552,helical filaments identification polypeptides neurofibrillary tangles helical filaments rabbits phf sera ant hippocampus ant sodium sulfate ant phf phf fold normal neurofilament preparations normal tangle tangle glial filaments myosin filaments neurofilaments basket phf sera polyacrylamide gels phf serum polypeptides normal neurofilament polypeptides phf preparations phf serum mw top mw tangles phf serum phf polypeptides weight polyacrylamide gels prepared neurofilament polypeptidesabstract
ALZ,ALZ553,evidence helical filaments originate neurofilaments observations neurites alzheimers neurites senile alzheimers neurofilaments helical filaments phf phf figures phf moreover figures nf phf nm plane axon contacts many degenerated phf nf observations phf originate nf filaments
ALZ,ALZ554,jakob clinico term observations possible creutzfeld jacobs cjd time cjd home works jacob observations manifestations diagnostic differentiation cjd pick
ALZ,ALZ555,alzheimers related disorders intervention alzheimers dementing disorders guide disorders social workers techniques methods intervention successful support
ALZ,ALZ556,immuno fibrils senile presence components senile mechanisms alzheimers senile degenerated glia important report deals fibrils senile presence level peroxidase products fibrils normal neurites neurofibrillary tangles results presence immune fibrils senile little senile neurofilament protein
ALZ,ALZ557,senile dementia infectious etiology individuals sdat infectious host standpoints genetic conditions evidence genetics plays many phenomena sdat human genetics gss scrapie genetic host infection scrapie lesions context human scrapie human
ALZ,ALZ558,electroencephalogram invasive investigation mental syndromes redundant instruments ct structure investigation dementia different complementary extent methods laboratory significant potentials functional specific diagnostic condition impact psychotic mental state individuals cognitive future cognitive erp phobic investigation direct work night sleep functional disorders early workers hypnotic valuable implications
ALZ,ALZ559,jakob year man jakob year mental deterioration alzheimers terminal florid jakob illnesses unknown paternal
ALZ,ALZ56,da serotonin metabolic csf alzheimers dementia conditions phospholipids hva hiaa ten presenile alzheimers csf serotonin presenile dementia normal lumbar puncture phospholipids iv significant csf serum phospholipids substances demential syndromes
ALZ,ALZ560,alzheimers optimum health management dementia elderly social unclear level elderly mental state functional health records physicians obvious training issues addressed alzheimers neurobehavioral parameters cryptogenic idiopathic alzheimers etiology definitive term management cure management psychological intercurrent maximization functional management alzheimers ameliorization caregivers
ALZ,ALZ561,effect polyvinyl monocytes effect il peripheral monocytes monocytes il extent lipopolysaccharide conjunction lps il superinduction alzheimers il monocytes healthy individuals effect synthesis vitro igm igg peripheral synthesis monocytes monocytes
ALZ,ALZ562,immune alzheimers preliminary implications remarkable nervous system immune system determinants cns immunocyte substances neurotransmitters alzheimers due cns excess equivalent severe dysfunction severe recurrent infection due months alzheimers frontal dysfunction responders vitro presence vitro correction months
ALZ,ALZ563,topography magnocellular forebrain system human neurons basalis meynert diagonal broca septum cholinergic system direct projections hippocampus recent evidence neurons system degenerate individuals alzheimers degeneration presynaptic cholinergic report neurons human neurons magnocellular system septum dorsal parts largest occur innominata globus pallidus neurons lateral edges pallidus neurons white matter accumbens edges white matter globus pallidus genu interal directions dissection system human
ALZ,ALZ564,downs nutritional intervention downs short prone infections leukaemia heart defects alzheimers mothers alzheimers latter sibs downs lymphomaleukaemia evidence downs food allergies sensitivity intolerance coeliac picture malabsorption state vitamins severe gluten sensitivity intolerance coeliac spermatogenesis trisomy aneuploidies release normal meiosis peptides foods synthesis food metal mechanisms alzheimers recommended mothers ds mothers free coeliac prevent ds prevent heart ds food allergy free relevant needs early
ALZ,ALZ565,downs alzheimers typical alzheimers tangles satisfactory dementia context mental unknown cholinergic losses basalis early onset alzheimers downs downs relatives dementia normal rare onset dementia less downs dementia gene gene trisomics
ALZ,ALZ566,pigment alzheimers lipofuscin pigment basalis meynert melanin pigment ceruleus alzheimers significant pigment
ALZ,ALZ567,enkephalin methionine enkephalin csf neuropsychiatric results specific modified stress
ALZ,ALZ568,congophilic neurofibrillary tangles neurofilament alzheimers immunohistological alzheimers neurofibrillary tangles neurofilament nf helical filaments nft preparations smears nf congo red phf congo red positive nft nf positive nft nf cross react typical nft ie birefringence conditions
ALZ,ALZ569,implications neuropeptides neurological diseases neuropeptides stable valid mortem human nervous human diseases somatostatin hippocampus neocortex alzheimers dementia huntingtons enkephalin trh lesion disorders potential manifestations human results disposition csf future specific dynamic tools specific human
ALZ,ALZ57,golgi dominant kufs dominant autosomic kufs golgis method positive sudanophile autofluorescent proximal axon neurons granular membrane compact typical lipofuscin scanty golgis method prominent double axon dendritic spines alzheimers huntingtons way
ALZ,ALZ570,preliminary free dementia free dementia atd normal glutamate gamma aminobutyric atd findings neurons
ALZ,ALZ571,neurotransmitters neurotransmitters measuring hydroxylase dbh hydroxylase cofactor tetrahydrobiopterine bph homovanillic hva vasopressin senile dementia alzheimers sdat basalis brodmann csf sdat dementia mid related subjects dbh sdat mid dbh serum sdat dementia severe ct serum dbh normal subjects equal csf subjects hva csf sdat dopaminergic sdat bph csf sdat vasopressin subjects many results noradrenaline vasopressin sdat evidence points search methods therapy sdat
ALZ,ALZ572,senile dementia alzheimers vascular alzheimers labeled cholinergic dopaminergic serotoninergic regions thalamus autoptic senile dementia vascular different patterns histological scores neurofibrillary tangles
ALZ,ALZ573,vascular senile alzheimers senile immunoperoxidase techniques unfixed findings support vascular senile recent prealbumin senile lesions peroxidase corona peroxidase
ALZ,ALZ574,csf somatostatin alzheimers somatostatin alzheimers somatostatin subjects non subjects parkinsons pd neurological conditions csf somatostatin neurological sem pgml pd subject level range group non pd range pd dementia disorders values explain
ALZ,ALZ575,somatostatin somatostatin lumbar examples alzheimers picks significant correlation sli histological examples picks specific histological sli presenium unaltered senile group specific histological sli lumbar csf
ALZ,ALZ576,specific disorders recent conceptualization pathophysiology cognitive disorders synaptic neurochemical reductions cholinergic projections alzheimers gm related synaptic human disorders dementia dynamic
ALZ,ALZ577,mental disorders mortem many neurotransmitters related stable post mortem evidence mental disorders neurochemical process exclude non specific influences agonal state therapy post mortem neurones problems post mortem alzheimers
ALZ,ALZ578,alzheimers neurochemical techniques neurotransmitters normal human alzheimers clinico entity possible types neuromediator neuro cholinergic aminergic different degrees cholinergic innominocorticoamygdalian ceruleocortical system serotoninergic pontocortical system somatostatin critical neurochemical shows alzheimers normal correlations lesions demential process valid time post mortem imperfect progressive lesions manner senile process presenile presence cholinergic fundamental lesions serotoninergic important dementia parkinsons questions disorders alzheimers unanswered extent lesions due dementia process disorders lesions sequential lesions intracortical
ALZ,ALZ579,neuropeptides dementia senile dementia alzheimers sdat recent sdat synonymous process normal populations neurophysin somatostatin sdat findings morphological consistent degeneration somatostatin neurophysin neurons sdat different nervous system support senile dementia alzheimers single neurochemical related lesions imbalances neuropeptide
ALZ,ALZ58,hypoglycemia alzheimers glucose tolerance tests gangrene non diabetic sugar dementia group alzheimers glucose
ALZ,ALZ580,system contribute disruption motor report da neurons nigra tegmental cbn nia da neurons human senile dementia alzheimers sdat swellings human sdat presence tangles morphological progressive cytoplasmic lipofuscin da histofluorescence neurons nigra human nonfluorescence heavy deposits morphological striatal system cbn human morphological related disruption motor presence tangles sdat da neurons sdat
ALZ,ALZ581,alzheimers effect fact effect principles identification subject focused infirmities alzheimers manifests mental dysfunction dementia thereof alzheimers individuals progresses
ALZ,ALZ582,alzheimers presence lewy mental deterioration year senile evidence senile degeneration neurons senile perivascular types degeneration lewy nigra innominata locus caeruleus vagus reticular neurons manifestations alzheimers parkinsons etiological lesions alzheimers parkinsons
ALZ,ALZ583,dysfunction alzheimers alzheimers range yr wet weight total protein specific thought reflect cholinergic neurones choline corticostriatal hglutamate stem serotonin hydroxyindoleacetate noradrenaline tracts evidence cholinergic dopaminergic neurons dopaminergic neurons observations monoamines hglutamate emphasis importance alzheimers
ALZ,ALZ584,reconstruction helical helical phf neurofibrillary tangles senile dementias patterns compact fibrous protofilament patterns reconstruction cross phf patterns presence results phf double helical descriptive helical rearrangements protofilaments structure single neurons tangles
ALZ,ALZ585,distinguishes dementia serotonin uptake normal subjects parkinsonian alzheimers elderly whereas serotonin normal subjects bmax values independent laboratory index dementia elderly
ALZ,ALZ586,pathophysiology senile dementia recent pathophysiology alzheimers dementia alzheimers neurons somatostatin somatostatin positive neurons many morphological consistent degeneration many neurons tangles somatostatin degeneration somatostatin neurons critical alzheimers
ALZ,ALZ587,hippocampal circuitry alzheimers human nervous system alzheimers lesions lesions entorhinal commissural associational dentate spread kainic sites expansion kainic receptor hippocampal alzheimers enhancement acetylcholinesterase cholinergic neurons results evidence nervous system plastic alzheimers growth
ALZ,ALZ588,factor senile dementia striatal factor human nervous system senile dementia sdat crf frontal brodmanns innominata parietal brodmanns hippocampus crf frontal sdat group findings neurons factor sdat cholinergic degeneration
ALZ,ALZ589,alzheimers vivo quinuclidinyl iodobenzilate emission vivo receptor alzheimers single photon emission quinuclidinyl iodobenzilate qnb perfusion iodoamphetamine perfusion posterior parietal uniform uptake qnb qnb ratio normal subject receptor alzheimers demonstrates receptor qnb single photon emission
ALZ,ALZ59,parkinsons alzheimers disorders parkinsons alzheimers parts primary projections system unique intervention replacement release neurones direct wide parkinsons alzheimers replacement human hypothesis primary lesion
ALZ,ALZ590,gene scrapie senile human complementary dna library messenger scrapie library objectives clones clones scrapie alzheimers gene scrapie complementary dna gene scrapie infected dna alzheimers
ALZ,ALZ591,flow basalis recent cognitive dementia choline deterioration fibres evidence fall dementia results trials cholinergic precursors inconsistent findings cholinergic disorders flow cholinergic fibres important extrinsic innervation neurones forebrain basalis impulse conduction cholinergic nb conduction frontal systematic depth conduction fibre projections intracortical results flow cholinergic input important element cognitive
ALZ,ALZ592,embryonic forebrain neurons lesions basalis sensorimotor cholinergic basalis normal dementia alzheimers functions system forebrain ibotenic lesions basalis normal cholinergic rich embryonic forebrain noncholinergic embryonic hippocampus lesions basalis water maze tasks hyperactivity trial habituation forebrain noncholinergic hippocampal retention water spatial effect habituation locomotor basalis second lesions sensory ipsilateral biases ameliorated forebrain results support hypothesis neocortical cholinergic system general system functions
ALZ,ALZ593,glial fibrillary protein alzheimers protein alzheimers electrophoretic non dementia normal weight protein glial fibrillary protein gfap crude nuclear electrophoretic presence gfap immunopositive immunocytologic methods neurofibrillary tangles
ALZ,ALZ594,bethanechol time senile dementia bethanechol cholinergic senile dementia time time non significant time second group senile dementia mental saline significant time observed results time dementia
ALZ,ALZ595,neuropsychiatric element likely many significance wide range topical neurological disorders
ALZ,ALZ596,alzheimers ten individuals alzheimers diagnostic significant neurofibrillary tangles vascular lewy individuals group fewer neurofibrillary tangles rare terminal dementia group respiratory alzheimers
ALZ,ALZ597,alzheimers educational dementia educational level alzheimers dementia months neurobehavioral status index functional protective effect early onset dementia
ALZ,ALZ598,ischemic dementia ischemic dementia current shortcomings interfere multipoint subscale confidence subscale aims instruments
ALZ,ALZ599,intracerebral due report year man alzheimers intracerebral related matter controversy
ALZ,ALZ6,elderly importance geriatric social nursing architectural evaluations support clinics group dementia alzheimers clinics broken clinics
ALZ,ALZ60,cognitive deterioration parkinson parkinsons dementia deterioration functions right functions left parkinson right hemisphere tests hemisphere tests tests left ninety senile presenile dementia parkinson non neurological functional tests cognitive functions scores results cognitive quotient clq hemisphere tests right hemisphere tests quotient total level cognitive group
ALZ,ALZ600,trh test dementia elderly dementia heterogeneous many manifestations trh test possible elderly none maximal tsh less equal microiuml micrograms concurrent
ALZ,ALZ601,ischemic vascular dementia thirty male female dementia dementia vascular dvt investigation diagnostic ischemic ct dementia types underwent psychometric neurological neurophysiological ct ischemic consistent dvt dvt ischemic items ischemic items importance vascular dementia insufficient latter general slowing findings dvt depressive enlargement related psychological dvt extent ischemic valid cranial psychological dementia differentiate dementia
ALZ,ALZ602,dementia psychometric investigation dementia longitudinal way psychometric methods tests vocabulary test test verbal spatial tests time test qualitative alzheimers picks dementias fronto degeneration dementia diagnostic scales cognitive profiles scores scales alzheimers fronto degeneration dementia
ALZ,ALZ603,potentials dementia korsakoff potentials presenile dementia atd korsakoff ks subjects free weeks atd group group group ks atd atd findings potential early atd
ALZ,ALZ604,endoplasmic reticulum regions huntingtons dementia post mortem huntingtons dementia endoplasmic reticulum cytochrome neutral glucosidase mannosidase glucose golgi fucosyl transferases dementia glucosidase huntingtons glucosidase fucosyl transferase specific synthesis processing disorders
ALZ,ALZ605,flow ultrasonic flowmeter dementia flowmeter noninvasive ultrasound flow laboratory test dementia
ALZ,ALZ606,glu phe homologous protein protein mice stain findings determinants protein likely protein protein
ALZ,ALZ607,somatostatin regions alzheimers hplc somatostatin elderly normal individuals somatostatin immunoreactive somatostatin somatostatin senile dementia sdat neurofibrillary tangles somatostatin frontal immunoreactive peaks normal group sdat frontal punch microdissection somatostatin meynert amygdala elderly normal somatostatin meynert sdat group revealed somatostatin sdat
ALZ,ALZ608,home alzheimers benzodiazepines elderly dementia safe benzodiazepines drugs alzheimers second tricyclics significant elderly anticholinergic side
ALZ,ALZ609,dementias psychological tests neurotransmitters preliminary investigation quotient dementia mawi version wais primary dementia mid pdd homovanillic hva hydroxyindole hiaa lumbar csf presenile dementia senile dementia alzheimers sdat dementia dementia types dementia verbal hewson index mid pdd mawi hiaa lumbar csf hiaa
ALZ,ALZ61,senile neurofibrillary tangles dementia senile dementia neurofibrillary tangles wide regions interference process extent non tangle related neurofibrillary tangle senile tangle neurofibrillary process reductions synthesis non tangle neurofibrillary tangles senile
ALZ,ALZ610,proteolytic alzheimers helical filaments alzheimers helical filaments proteases polypeptides weights daltons proteolytic specific phf purified phf monospecific daltons neurofibrillary tangles phf observations polypeptides proteases daltons phf
ALZ,ALZ611,serotoninergic system dementia serotonin serotonin ht htp hydroxyindoleacetic hiaa csf liquid multisensor coulometric system system conventional ht hiaa multisensor coulometric system observed ht htp csf ht hiaa csf csf results serotoninergic system diagnostic test
ALZ,ALZ612,neurotensin human neurological neurotensin normal human neurological huntingtons whilst parkinsons significant telencephalic neurotensin senile dementia lumbar immunoreactive liquid indistinguishable neurotensin
ALZ,ALZ613,viewpoint status international documented dementia personal problems developed countries gerontology dementia international whereas dementia time support scientific institutions countries
ALZ,ALZ614,work occur dementia subjects concepts airplane church subjects concepts preserved subjects importance concepts subjects rank healthy subjects disruption importance disruption dementias
ALZ,ALZ615,dementia lumbo csf csf mental deterioration unchanged different ratio csfalbumin serum normal multiinfarct dementia dementia csf
ALZ,ALZ616,dementia alzheimers dementia whereas dementia group hachinskis alzheimers vascular dementias extent weights items logistic confusion neurological vascular dementia
ALZ,ALZ617,aluminum alzheimers alzheimers progressive unknown etiology neurofibrillary tangles aluminum lesions neurofibrillary tangle aluminum alzheimers microscopy spectrometry level aluminum neurons alzheimers neurofibrillary tangles neurofibrillary tangle neurons island guam lateral sclerosis dementia evidence conditions aluminum fact rain bioavailable concerns possible human health risks phenomenon
ALZ,ALZ618,neurofibrillary tangles alzheimers contain protein cores alzheimers neurofibrillary tangles congophilic terminal peptides neurofibrillary tangles inner cores vascular non protein aluminum silicate possible protein alzheimers size scrapie polypeptides homologous components normal neurofilaments
ALZ,ALZ619,subtypes subtypes motor individuals progressive dementia early onset severe forty dementia risk independent myoclonus noniatrogenic extrapyramidal dementia
ALZ,ALZ62,instrumental neutron aluminum instrumental neutron aluminum regions grand aluminum level specimens wet weight level frontal hippocampal specimens aluminum wet weight water
ALZ,ALZ620,neurochemical white matter human alzheimers report myelin white matter human prominent alzheimers lipids unsaturated white matter specific myelin glycosphingolipids normal alzheimers related pathophysiology senile dementia alzheimers
ALZ,ALZ621,impact metals human metals metal man food water metal human methylmercury way fish seafood countries rise health food items possible methylmercury fish lakes human health segments general countries exists mobilization deterioration subsequent situation regard food exists countries human metal drinking water increases corrosiveness water mobilization metal metallic drinking water dissolution metals cu water soft waters metal water health healthy dissolution water aluminum water occurrence waters water water dialysis renal rise dementia disorders possible health normal renal eg alzheimers uncertain
ALZ,ALZ622,flow xenon ct correlations flow stable xenon ct standard ct indices senile dementia dementia idiopathic parkinsons normal significant correlations idiopathic parkinsons gray matter flow ratio mild stepwise reductions senile dementia dementia stepwise reductions overall correlations mild degrees
ALZ,ALZ623,emission ffluorodeoxyglucose normal dementia diagnostic normal differentiate condition dementia normal dementia healthy elderly emission ffluorodeoxyglucose fdg dementia normal metabolic different dementia dementia subjects hypometabolism normal subjects glucose
ALZ,ALZ624,emission alzheimers time neuropsychological early alzheimers metabolic emission fluoro deoxy intervals year man alzheimers metabolic healthy metabolic whereas second parietal parietal regions cognitive normal limits test results precede early alzheimers reductions neuropsychological
ALZ,ALZ625,effect senile dementia short receptor effect senile dementia double crossover trial dementia none day day neuropsychological tests dementia
ALZ,ALZ626,dopaminergic cholinergic lesions palsy progressive palsy homovanillic hspiperone benzilate sites post mortem accumbens innominata frontal homovanillic accumbens frontal dopaminergic system progressive palsy parkinsons mesocortical mesolimbic dopaminergic parkinsonian hspiperone parallel cholinergic neurons system degenerate levodopa anticholinergic therapy innominata frontal innominatocortical cholinergic system progressive palsy deterioration lesion alzheimers parkinsons diseases
ALZ,ALZ627,nucleotides dementia dihydroxyphenylacetic methoxy hydroxyphenylacetic hva methoxy hydroxyphenylglycol monophosphate guanosine monophosphate gmp csf hva rostral correlation onset
ALZ,ALZ628,huntingtons alzheimers huntingtons alzheimers morbidity dementia huntingtons group specific huntingtons latter non specific prodromal dementia
ALZ,ALZ629,neurofibrillary acetylcholinesterase rich neurons upper stem senile dementia alzheimers downs neurofibrillary cholinergic neurons upper senile dementia alzheimers sdat neurofibrillary rich neurons neurons neurofibrillary individuals results upper stem neurofibrillary sdat correlation neurofibrillary tangles acetylcholinesterase rich neurons cholinergic upper stem neurofibrillary tangles locus ceruleus individuals heavy significance downs evolution alzheimers sdat
ALZ,ALZ63,senile dementia alzheimers health system senile dementia important social problems nursing home dementia complications senile dementia alzheimers sdat implications patterns management
ALZ,ALZ630,dementia dementia huntingtons parkinsons progressive palsy deterioration mental dementia affords unique progressive dementia dementias alzheimers dysfunction dementia entity dementias group dementia
ALZ,ALZ631,senile dementia alzheimers sdat suppressor senile dementia alzheimers sdat respect suppressor igg regulator sdat suppressor sdat elderly sdat regard helper sdat suppressor neural influences
ALZ,ALZ632,alzheimers psychopharmacologic physostigmine alzheimers physostigmine oral physostigmine overall way tested extent cortisol physostigmine cognition extent specific cholinomimetic effect significant physostigmine results test physostigmine effect growth
ALZ,ALZ633,alzheimers neurochemical neuroendocrine cholinergic neurons alzheimers senile dementia sdat peripheral cholinergic csf cognitive adsdat metabolites neurotransmitters related cognitive state cholinergic degeneration cortisol growth plasma minutes hours day plasma cortisol csf methoxy hydroxyphenylglycol mhpg cognitive anticholinergic drugs cortisol cortisol dysregulation system growth different csf mhpg
ALZ,ALZ634,receptor frontal cholinergic drugs receptor months ivt cholinergic oxotremorine weeks oxotremorine bmax qnb sites frontal qnb receptor ivt bmax significant receptor oxotremorine qnb parameters frontal oxotremorine receptor cholinergic receptor important implications term elderly cholinergic drugs neurological disorders alzheimers
ALZ,ALZ635,investigation senile dementia manifestations dementia sdat individuals normal senile rigorous final total electronic system stereological size senile intercapillary distance frontal precentral size senile parameters whereas mountjoy correlation sdat significant perikarya layers iv stereological neuropil shrinkage sdat intercapillary distance findings shrinkage senile dementia importance
ALZ,ALZ636,aluminum workers aluminum smelter second man total tars index tars tar second december deceased december results province quebec hypertensive heart leukemia aleukemia malignant pancreas genital organs intestine deaths pneumoconiosis alzheimers expected deaths province quebec respiratory malignant malignant esophagus malignant hodgkins hypertensive malignant related malignant stomach respiratory twice tars excess hypertensive tars malignant excess quebec
ALZ,ALZ637,sensitivity resistant hold wais alzheimers wais resistant hold hold subtests dementia normal elderly subjects dementia wais test scores premorbid current hold test tests wais cognitive
ALZ,ALZ638,glial fibrillary protein gfap normal glial fibrillary protein gfap lumbar csf normal nph primary dementia pdd neurological diseases signs nervous csf gfap nph ngml sem pdd ngml less nph gfap range group gfapml csf significant pdd group group neurological diseases group gfap csf nph pdd lumbar csf gfap lumbar significant less results csf gfap discrimination
ALZ,ALZ639,laminar alzheimers senile alzheimers obvious importance eg dementia little etiology specific clues issues laminar neocortical wealth neocortical cytoarchitecture specific circuitry senile associative regions sensory corticocortical associative largest pyramidal inputoutput functions senile alzheimers innervation patterns system different neurotransmitters localized doubts primary cholinergic deterioration etiology neocortical senile
ALZ,ALZ64,lack effect months double trial gm times daily months choline level significant scores tests effect scores psychological test
ALZ,ALZ640,dementing group support alzheimers related disorders group principles cognitive subjects dementia subjects significant total whereas subjects significant subjects subjects dementia important ingredient intervention results short support positive effect
ALZ,ALZ641,related physostigmine arrhythmia report physostigmine cholinesterase potential primary dementia test physostigmine onset contractions bigeminy year man
ALZ,ALZ642,laminar cholinergic circuits human frontal alzheimers cholinergic choline acetylcholinesterase ache cholinergic receptor frontal brodmanns normal alzheimers ache normal significant ache severe frontal normal lamina upper lamina iii losses depths upper layers ache consistent cholinergic equal layers normal frontal laminar cholinergic normal
ALZ,ALZ643,transmission pig human diseases jakob alzheimers pigs csf jakob cjd csf alzheimers pigs csf cjd csf cjd cjd tremor convulsions lesions glial hyperplasia neurons alzheimers results
ALZ,ALZ644,elderly malnutrition immobility social isolation terms elderly important malnutrition malnutrition vitamin elderly alleviation many conditions dietary disorders needs satisfactory
ALZ,ALZ645,neuropsychological dementia subgroups neuropsychological alzheimers yield subgroups cluster severe level spatial cluster iii cluster iv indistinguishable terms verbal regard spatial verbal different neuropsychological profiles subgroups regard early process regard educational females time onset techniques little neuropsychological results subgroups significant effect results structure cognition alzheimers
ALZ,ALZ646,isolation unique techniques elution profiles immune cytotoxicity macrophages macrophages none cytotoxicity inhibited cytotoxicity macrophages cytotoxicity cytotoxicity macrophages cellsabstract
ALZ,ALZ647,nih alzheimers downs neurochemical downs alzheimers striking genetic relatives alzheimers risk alzheimers risk specific alzheimers downs neurochemical cholinergic dementia metabolic emission alzheimers parietal reductions metabolic downs cognitive metabolic downs
ALZ,ALZ648,alleviation cholinergic lesion cholinergic basalis meynert degenerate alzheimers cognitive lesions lesions retention habituation general exploratory second retention general phenomenon retention trial retention acetylcholinesterase physostigmine results support hypothesis cholinergic retention cholinergic lesion retention means
ALZ,ALZ649,vasopressin neurons human supraoptic senile dementia neuropeptides peripheral functions diuresis labour lactation senile dementia eg electrolyte cognitive functions concomitant neurohypophyseal system postulated literature possible human neurons supraoptic pvn son senile dementia sdat size significant gradual size observations sdat range group results support degeneration senescence sdat literature senescence previous findings wistar
ALZ,ALZ65,dementia evidence suppressor dementia sdat sdat elderly regard concanavalin interferon serum results exaggerated sdat elderly interferon sdat elderly results immunoregulatory mechanisms sdat nervous system
ALZ,ALZ650,suprachiasmatic human senile dementia suprachiasmatic scn endogenous clock ovulation sleep wake patterns things vasopressin human shape scn dimorphic shape scn spherical scn senescence pronounced senile dementia sdat presence scn general rhythms senescence sdat
ALZ,ALZ651,related senile dementia senile dementia stereological method combines observations neuropil micron less neurons glial consistent normal values neocortical neocortex subiculum hippocampus
ALZ,ALZ652,dr erich sternberg diagnostical strategy specialists pick experiences reversible dementia growth equation different dementia pick
ALZ,ALZ653,discrimination senile dementia normal test discrimination senile dementia sdat normal test fluency fl prose pm finger whole test tt weigls test wt sdat unexplored sdat neuropsychological tests diagnostic
ALZ,ALZ654,alzheimers management vital practitioners primary dementia alzheimers etiology signs method diagnostic work current methods management nursing phases alzheimers
ALZ,ALZ655,neuropsychological investigation cognitive dysfunction dementia items lurias neuropsychological investigation cognitive dementia ks atd group dementia
ALZ,ALZ656,recognition amnesic amnesic conditions retrieval different syndromes amnesia recognition paradigm miller amnesic senile dementia dementia types
ALZ,ALZ657,empty alzheimers empty picture subject alzheimers wernickes anomic aphasias normal alzheimers wernickes empty conjunctions wernickes verbal literal paraphasias many empty anomic confrontation tasks empty findings different
ALZ,ALZ658,receiver flow alzheimers roc detectors xe system populations flow rcbf values populations normal alzheimers homologous detectors flow normal group flow group alzheimers single values hemispheric flow hemisphere asymmetries dynamic true incorrect alzheimers detector flow values terms structure detectors frontal detectors
ALZ,ALZ659,diagnostic elderly dementia diagnostic dementia alzheimers dementia dementia state illnesses metabolic diseases year normal mental results importance illnesses dementia elderly illnesses elderly different diagnostic elderly dementia
ALZ,ALZ66,unifying hypothesis lateral sclerosis lateral sclerosis parkinson unknown conditions lacking disorders due lack specific neurotrophic target neurons postsynaptic exert presynaptic terminal motor syndromes lateral sclerosis motor neurotrophic horn parkinson neurotrophic inability striatal neurotrophic nigra hippocampus relevant cholinergic neurotrophic basalis neurons nervous system system neurotrophic hormones test hypothesis
ALZ,ALZ660,dementia year dementia cognitive severe dementia dementia nondemented frank dementia elderly risk dementia evidence extrapyramidal spinocerebellar hachinski ischemic mental status dementia confusion tricyclic illnesses little cognitive
ALZ,ALZ661,method effect dementia method ratio subarachnoid uses ct ratio elderly cognitive dysfunction preestablished method dementia alzheimers sdat pseudodementia hence limited sophisticated ct cognitive dysfunction
ALZ,ALZ662,alzheimers alzheimers morphological hypothesis damage alzheimers alzheimers leakage senile transport different intracellular neurofibrillary tangle neurones basalis meynert locus caeruleus dorsal evidence consistent hypothesis implications
ALZ,ALZ663,immunohistological granulovacuolar degeneration neurofilaments neurons granulovacuolar degeneration paraffin neurofilaments rt react neurofibrillary tangles granular granulovacuolar degeneration granulovacuolar degeneration olfactory
ALZ,ALZ664,gfap transblots white matter glial fibrillary protein gliosis immunosorbent elisa reflectance immunoperoxidase western methods gfap white matter gfap protein different findings support neurological gfap grey matter
ALZ,ALZ665,neuropsychological alzheimers presumptive alzheimers metabolic emission fluoro deoxy glucose conditions dementia mild alzheimers reductions metabolic whole reductions regions parietal severe metabolic findings reductions regions alzheimers severe reductions
ALZ,ALZ666,parkinsons alzheimers hypersensitivity lines lines primary dna damaging lines sporadic parkinsons pd alzheimers lateral sclerosis values parkinsons alzheimers lines lateral sclerosis lines normal lines results parkinsons alzheimers genetic somatic embryogenesis repair dna damage dna repair dna damage parkinsons alzheimers neurons
ALZ,ALZ667,alzheimers alzheimers months double significant effect terms scales cognitive functions
ALZ,ALZ668,basalis downs striking manifestations mental many alzheimers alzheimers significant neurons basalis meynert normal neurons reductions neurons size neurons sagittal range fewer neurons oldest lowest subjects size neurons results contains neurons normal
ALZ,ALZ669,cholinergic neurons basalis meynert degeneration cholinergic neurons forebrain cultures cholinergic neurons basalis meynert diagonal forebrains vibratome choline immunocytochemistry acetylcholinesterase cholinergic micron cultures neurons cholinergic electrophysiological neurons neurons steady depolarizations potentials neurons depolarization glutamic depolarization hyperpolarization depolarization membrane resistance
ALZ,ALZ67,structure alzheimers micrococcal nuclease presenile dementia neurological signs nonalzheimer dementia yield mononucleosomes oligomers glial yield mononucleosomes due related protein internucleosomal linker nuclease nuclease protein sodium sulfate gels results state
ALZ,ALZ670,effect double safety buflomedil dementia significant mood alertness emotional buflomedil superiority regard cognitive dysfunction psychosomatic dysfunction statistical significance interpersonal evidence statistical findings
ALZ,ALZ671,choline normal choline normal senile dementia chat immuno purified single single weight wt explain alzheimers
ALZ,ALZ672,neurons alzheimers dementia neurons npy senile dementia atd parietal severe parietal frontal neurofibrillary tangles regions npy neurons distorted misshapen sharp extensiveness delicacy plexus normal fewer npy double thioflavin npy npy npy rise speculation neurons unusual reorganization potential terminal neurological
ALZ,ALZ673,effect parameters alzheimers double nervous system alzheimers parameters months somatostatin cholinesterase dopaminergic hydroxylase homovanillic static results disturbed alzheimers
ALZ,ALZ674,receptor lesion innominata cholinergic neurones basalis meynert innominata cholinergic alzheimers effect lesion kainate microgram ache receptor weeks lesion ache frontal parietal ipsilateral lesion side parietal weeks receptor ipsilateral lesion time frontal parietal ache size lesion sites sites lesion sites subtypes sites lesion
ALZ,ALZ675,dementia implications dementia tests healthy primary cholinergic depletion primary terms cholinergic depletion possible disappointing results trials cholinergic replacement therapy hand consistent cholinergic depletion
ALZ,ALZ676,free post mortem dementia free post mortem dementia normal glutamate atd frontal orbital cingulate inferior gamma aminobutyric atd inferior findings neurons
ALZ,ALZ677,csf alzheimers intrathecal protein synthesis csf institutionalised alzheimers igm transferrin prealbumin csfserum ratio index protein csf transferrin institutionalised igg institutionalised csfserum ratio igg institutionalised csf indices evidence intrathecal synthesis csfserum csf permeability prealbumin ratio amyloidogenesis
ALZ,ALZ678,butyrylcholinesterases dementia neurochemical date senile dementia sdat cholinergic cholinesterases acetylcholinesterase ache plasma butyrylcholinesterase bche sdat disorders ache human sdat group significant ache plasma bche plasma ache unknown nervous system ache reflect release cholinergic neurons
ALZ,ALZ679,severe dementia biracial investigation severe dementia different racial county mississippi household populations severe dementia severe senile dementia alzheimers whites race females race individuals severe dementia individuals
ALZ,ALZ68,coexistent dementia dementia diagnostic emphasis sodium amytal ect significant lifting dementia
ALZ,ALZ680,flow cognitive parkinsons parkinsons dementia flow rcbf alzheimers possible decreases cognitive eg metabolic cholinergic neurons microvessels rcbf xenon cognitive neuropsychological test parkinsons hemispheric flows cognitive functions normal subjects rcbf presence deterioration different
ALZ,ALZ681,basalis dementia alzheimers possible cholinergic innervation senile dementia alzheimers basalis magnocellular mbn mbn nissl acetylcholinesterase thioflavin methods senile mbn mbn neurons neurofibrillary degeneration early due maturation neurofibrillary tangles normal contents theories mbn retrograde degeneration due injury perikarya primary neurons
ALZ,ALZ682,serum thyroxine previous female support
ALZ,ALZ683,significance elderly dementia significance heart elderly group dementia alzheimers multiinfarct dementia mid heart uncommon group heart hypertrophy heart times mid group times group heart uncommon general mid group less mid group
ALZ,ALZ684,chelation therapy unproved dementia dramatic neurochemical alzheimers largest progressive cognitive dysfunction elderly physicians lack health professionals physicians concerned chelation therapy individuals dementia undergone chelation therapy
ALZ,ALZ685,social related elderly reviewed little social fall fall related injury risk females hypnotics potential significance senile dementia alzheimers risk presence condition individuals final directions systematic social functional health status perceptual fall serious fall related injury important
ALZ,ALZ686,subtypes alzheimers conceptual critical review different subtypes review literature alzheimers subtypes psychological different subtypes alzheimers respects related significance subtyping
ALZ,ALZ687,jakob progressive progressive picks alzheimers unknown etiology report progressive due jakob
ALZ,ALZ688,nervous system review nervous system functional time psychological sensory neurological dementia due alzheimers normal
ALZ,ALZ689,double trial alzheimers term double trial senile dementia fifty gday soya lysophosphatidyl choline months months plasma choline group group compliers intermediate choline window condition
ALZ,ALZ69,senile evidence fibrils protein related prealbumin specific human prealbumin hpa senile reactivity specific protein asca tissues hpa react iaa primary iv medullary pancreatic onset alzheimers lichen hpa purified human prealbumin human types hpa purified protein purified hpa senile prealbumin protein related
ALZ,ALZ690,cholinergic forebrain dysfunction cholinergic cholinergic neurons basalis meynert cholinergic ibotenic lesions basalis lesions embryonic neurons forebrain noncholinergic hippocampal
ALZ,ALZ691,cholinergic kainic lesions magnocellular magnocellular mnbf cholinergic innervation frontoparietal homologous human basalis meynert structure cholinergic hypothesis cognitive alzheimers kainic ka lesions unoperated ka mnbf lesions choline hippocampus unchanged serotonin unchanged hippocampus parietal frontal neurotransmitters unchanged regions lesions retention daily avoidances spatial discrimination test snout mnbf worse rodent cholinergic system cognitive dysfunction
ALZ,ALZ692,neuropeptides human neuropeptides important verbal literature neuropeptides humans normal neurological disorders conditions intranasal psychometric tests mild alzheimers korsakoffs findings uniform improves tests normal alzheimers peptides primary effect discrimination repetitive tasks retarded subjects improves neuropsychological tests cognitive endogenous opioids enkephalin amnesic effect human uncertain naloxone cognitive alzheimers human rudimentary state mechanisms endogenous opioids important
ALZ,ALZ693,estradiol increases specific forebrain female female male choline diagonal frontal forebrain cholinergic choline implications possible estradiol senile dementia alzheimers
ALZ,ALZ694,alzheimers affliction alzheimers disorders dementia cure alzheimers double year elderly current estimate excess speculation costs money workforce search cure therapy condition promising alzheimers downs past mental deterioration alzheimers presence neurofibrillary tangles presence downs relatives alzheimers types relatives alzheimers leukemia lymphomas hodgkins immune system disorders key intercorrections alzheimers downs genetic abstract
ALZ,ALZ695,nervous system human neurones alzheimers overview human nervous system suitable alzheimers contains factor induces helical filaments alzheimers phe element aluminium human neurological disorders alzheimers aluminium interacts nuclear neurofibrillary degeneration
ALZ,ALZ696,zimeldine alzheimers cognitive neuropsychological neurochemical specific serotonin alzheimers double crossover doses target plasma zimeldine ngml overall significant effect zimeldine time hydroxyindoleacetic cereobrospinal serotonin uptake hydroxy phenylglycol homovanillic findings peripheral serotoninergic serotonin zimeldine time alzheimers
ALZ,ALZ697,neurofibrillary tangles demonstration ant neurofibrillary degeneration progressive palsy neurofibrillary degeneration lesion conditions different types neurofibrillary tangles neurofibrillary tangles ant peroxidase antiperoxidase neurofibrillary tangles palsy nm filaments share ants normal aluminum tangles lewy lateral sclerosis giant ants condition alzheimers downs parkinsons
ALZ,ALZ698,neurofibrillary tangles identification polypeptides neurofibrillary tangles ants mice senile dementia sdat methanol perikarya ant ants ant paraffin tangles tangles tissues sdat insoluble enter polypeptides tris weight normal sdat results epitopes ants unique determinants determinants normal unique determinants tangle tangle
ALZ,ALZ699,longitudinal senile dementia year longitudinal eegs senile dementia sdat healthy times year theta delta spectral values right healthy significant theta sdat group delta theta theta mild severe stage sdat theta different values stage different delta severe sdat significance
ALZ,ALZ7,impact ill reactions blame anger alzheimers presenile condition social workers clients problems spouses
ALZ,ALZ70,immunoperoxidase senile human alzheimers normal goat human plasma fab fc kappa fibrinogen lysozyme macroglobulin intracellular glial fibrillary gfa protein non myosin tubulin cholinergic neurofilament nf utilized peroxidase bridge perivascular intact igg reactions fibrinogen reactions fc fab macroglobulin nf dyshoric intracellular coronae many gfa tubulin nf congophilic plasma fibrinogen nf nf congophilic revealed peripheral adventitial whereas localized wall red nf positivity nf red nf congophilic apple birefringence hypothesis nf senile
ALZ,ALZ700,aminoacid neurological disorders neurotransmitters neurons palsy alzheimers huntingtons disorders antagonise disorders
ALZ,ALZ701,alzheimers somatostatin receptor alzheimers frontal brodmann brodmann values hippocampus significant postcentral pole receptor somatostatin frontal somatostatin somatostatin receptor alzheimers findings degeneration postsynaptic neurons afferents somatostatin alzheimers release somatostatin postsynaptic
ALZ,ALZ702,choline neonatal growth factor neurodegenerative disorders synthesis trophic support test hypothesis trophic specific neurons cholinergic neurons neonatal growth factor prominent dependent increases choline cholinergic neurons forebrain growth factor way growth factor normal forebrain cholinergic neurons neurodegenerative disorders
ALZ,ALZ703,profound lesions cholinergic choline severe meynert senile dementia functional neurons unknown fact report lesion basalis radiofrequency current ibotenic level lesion profound disorganization locomotor hoarding deterioration spatial incapacity radiofrequency ibotenic lesions chat prefrontal sensorimotor hippocampus ibotenic lesions basalis dopaminergic intact unchanged level endogenous terminal prefrontal results lesion cholinergic neurons likely lesion basalis alzheimers man neurones
ALZ,ALZ704,progressive dementing system prominent signs idiopathic alzheimers lack signs system proven alzheimers spatial disorientation progressive ten year second ophthalmic year agraphia spatial disorientation alzheimers complained ophthalmic perceptive
ALZ,ALZ705,somatostatin alzheimers senile dementia sdat progressive neurodegenerative types lesions neurofibrillary tangle significant reductions specific neuropeptide somatostatin sdat unclear neurons lesion somatostatin neurons regions positive profiles neurons
ALZ,ALZ706,neurochemical alzheimers possible recent alzheimers cholinergic replacement synthesis incorporation glucose specimens diagnostic craniotomy alzheimers synthesis cognitive results consistent presynaptic cholinergic system early neurons postsynaptic alzheimers
ALZ,ALZ707,alzheimers sp neuropeptidergic sp alzheimers alzheimers neuropeptide
ALZ,ALZ708,verbal alzheimers verbal alzheimers recall recognition context respect verbal fluency normal individuals tasks conditions normal subjects alzheimers due inability encode stimulus encoding limited findings korsakoff normal subjects
ALZ,ALZ709,senile dementia interim report tomographic cranial senile dementia sdat months ten dementia latter shorter shorter worse cognitive significant mental test sdat ct densities regions hypothesis parietal regions sdat rapid
ALZ,ALZ71,myelin protein neurofilament preparations mw protein whole unidentified mw protein human neurofilament nf report rodent human nf myelin protein amido identity mw protein nf perikaryal human protein human mbp deliberate contamination white matter ie myelin mw whole mbp intracortical
ALZ,ALZ710,evidence choline alzheimers alzheimers cholinergic choline previous membrane ghosts erythrocytes transport system cholinergic neurons ccholine erythrocytes free free results terms potential mechanisms cholinergic
ALZ,ALZ711,basalis lesions term recovery persistent cholinergic months radial maze sham ibotenic lesions basalis primary cholinergic neocortex lesion recent weeks gradual recovery lesions lesion recovery different test post lesion post mortem lesions neurodegeneration choline uptake effect evidence recovery neurochemical compensatory system parallel cholinergic hippocampus olfactory results support cholinergic important recent recent results direct issues mechanisms recovery extent degeneration severe cognitive neurodegenerative diseases alzheimers picks parkinsons
ALZ,ALZ712,spatial alzheimers general findings report sensitivity spatial alzheimers sensitivity subjects unique face recognition husband sensitivity intermediate whereas sensitivity equaled observations importance spatial face recognition
ALZ,ALZ713,early alzheimers dementia unusual alzheimers progressive dementia signs significant presence severe dementia
ALZ,ALZ714,sleep apnea alzheimers correlation mental deterioration sleep healthy elderly probable alzheimers sleep apnea apnea index significant sleep apnea dementia apnea index possible implications findings
ALZ,ALZ715,positive potential neurotoxicity urgent need invasive humans positive lpc potential lpc related speed neurological status lpc neurophysiological alzheimers parkinsons traumatic damage hyperkinesis mental schizophrenia lpc possible cognitive due substances neurological damage
ALZ,ALZ716,neurofibrillary tangles degrees homotypical parietal frontal whereas motor somatic sensory primary neurofibrillary tangles infragranular layers layers many tangles iii tangles infragranular layers layers layers iii different laminar tangles support regions process invariable severe olfactory somatic sensory primary olfactory
ALZ,ALZ717,observations presenile alzheimers senile dementia middle senile neurofibrillary tangles pyramidal neurones middle hippocampus alzheimers tangles due total hippocampus total total losses total losses due tangles hippocampus extent hippocampus correlations tangle non significant regions middle downs values alzheimers
ALZ,ALZ718,alzheimers downs evidence points alzheimers downs dementia occupational social incontinence observations tangles microns prefrontal hippocampal tangles longitudinal neuropsychological evaluations tests dementia retarded
ALZ,ALZ719,csf lipotropin alzheimers dementia csf peptides lipotropin alzheimers dementia dementia lipotropin csf level dementia
ALZ,ALZ72,oculomotor time dementia dysfunction dysfunction oculomotor time dementia alzheimers normal classified mild severe independent neurological neuropsychological neuroradiological saccadic targets parafoveal peripheral significant increases normal dementia terms oculomotor time evidence direct oculomotor time regulatory sensory motor integration
ALZ,ALZ720,mitochondrial alzheimers normal frontal alzheimers intercristal parallel polyhedric deposits dendritic degeneration results observations panencephalitis dendritic degeneration occur mitochondrial dendritic degeneration
ALZ,ALZ721,presenile dementia cjd lesions preliminary results unknown presenile dementia year female progressive dementia synchronous discharge ct prominent white matter sisters suffer state alzheimers severe degeneration conspicuous gemistocytic severe white matter degeneration lesions panencephalopathic jakobs cjd degeneration mild transmission neurochemical cholinergic literature
ALZ,ALZ722,alzheimers alzheimers recent unknown forgetfulness confusion early culminate total cognitive degeneration illnesses dementia choline specific symptomatology successful date antipsychotic many provide
ALZ,ALZ723,management dementia dementia dementia dementia united mesylates promising cholinergic drugs physostigmine sleep impulsivity benzodiazepines drugs nonpharmacologic
ALZ,ALZ724,repair dna lesions alzheimers fibroblasts methyl nitro nitrosoguanidine alzheimers fibroblasts fibroblasts normals results due types dna damage lysis dna double alzheimers repair
ALZ,ALZ725,dissociation somatostatin parkinsons hippocampus subjects parkinsons hydroxylase somatostatin somatostatin subject hippocampus significant npy npy independent somatostatin evidence neurochemical parkinsons alzheimers
ALZ,ALZ726,dementia post mortem different types dementia specific hqnb hqnb hippocampus amygdala alzheimers dementia dementia mid orofacial dyskinesias mid weight hqnb frontal results mid receptor cholinergic neurons system
ALZ,ALZ727,membrane excitability inward rectification much peptides excitability undecapeptide magnocellular cholinergic neurones pallidus neurones basalis meynert man degeneration alzheimers neurones conductance types modulation rectification element depolarization
ALZ,ALZ728,cluster cognitive subjects elderly normals subjects cognitive functions tests statistical results speed load elderly normals terms qualitative level cognitive group risk factor dementia tasks dementia rehabilitation
ALZ,ALZ729,dorsalis alzheimers neurofibrillary tangles neurons telencephalon dorsalis nrd manner cholinergic projections basalis meynert alzheimers many nrd neurofibrillary tangles significant neurons different boundaries report nrd times neurofibrillary tangles neurons senile nrd none
ALZ,ALZ73,year occupational former year competitive etiological year solvents neurological neuropsychological neuroradiological parameters findings unchanged slight headache neurological status neuropsychological deterioration argued different presenile dementia pick etiological findings term solvents occupational solvents risk syndromes
ALZ,ALZ730,monoamine oxidase primary dementia alzheimers alzheimers standard monoamine oxidase points cholinergic system alzheimers monoamine oxidase
ALZ,ALZ731,epinephrine physostigmine methscopolamine significant profound increases epinephrine physostigmine elderly alzheimers importance
ALZ,ALZ732,alzheimers vascular dementias dementia mid dementia diagnostic cognitive need home institutionalization previous mid vascular dementias cognitive
ALZ,ALZ733,red double unselected red cellplasma choline subjects non subjects less latter group intact subjects cognitive ratio red choline related increases red plasma choline results short evidence manifestations pathophysiology
ALZ,ALZ734,physicians management dementia physicians term management primary progressive dementia physicians respondents helpfulness physicians management physicians diagnostic physicians physicians explanations helpful physicians physicians frustration dementia acknowledged sensitivity social psychological physicians helpful issues health social outlines need management dementia
ALZ,ALZ735,geriatric successful therapy apathetic withdrawn tricyclic nortriptyline tricyclic tertiary fewer anticholinergic side sudden onset whereas dementias alzheimers dementia many concomitant
ALZ,ALZ736,neurobehavioral aluminum infant aluminum neurofibrillary tangles dendritic deterioration possible human alzheimers dialysis dementia infant rabbits aluminum tartrate microm saline right lateral day day zealand white rabbits day hippocampal neurofibrillary tangles rapid golgi stain dendritic microm qualitative observations signs microm group significant retention retention microm group neurofibrillary tangles microm group dendritic arborization consistent results implications terms neurobehavioral
ALZ,ALZ737,cholinesterase plasma cholinesterases pseudocholinesterase bche human plasma acetylcholinesterase ache csf possible varied significant total che plasma csf normal early presenile senile significant total csf significant total ache bche index cholinergic
ALZ,ALZ738,neuropsychological metabolic asymmetries early alzheimers cmrglc rcmrglc values emission pet mild alzheimers healthy frontal parietal less lateral rcmrglc visuospatial functions right rcmrglc vice versa results visuospatial related reductions glucose
ALZ,ALZ739,helical filaments components neurofibrillary tangles share determinants neurofilaments microscopy immunocytology determinants helical filaments components neurofibrillary bodians method neurofilaments microtubules bodians neurofibrillary tangles specific neurofilament neurofilaments immunostain neurofibrillary tangles protein half neurofibrillary tangles bodians helical filaments helical epitopes normal insoluble ionic detergent epitopes integral components helical filaments helical filaments normal
ALZ,ALZ74,diagnostic senile dementia senile dementia diagnostic individuals referred physicians normal laboratory physicians weighted kappa confidence kappa diagnostic cognitive tests specific normals cognitive test minutes dementia normal
ALZ,ALZ740,dementia correlations index senile dementia probable alzheimers correlation morphological wechsler wechsler volumes excess normal significant correlations size wais wms index pericerebral wais iq wms results alzheimers pericerebral dilation
ALZ,ALZ741,nursing update alzheimers many important issues health professionals reciprocity regard respect vital partnership schools curricula individuals innovative professionals social nursing implications alzheimers united process recent unexplored nursing herein alzheimers
ALZ,ALZ742,neurofilament phosphorylation perikarya react epitopes neurofilaments normal perikarya contain neurofilaments phosphorylation tangles phosphorylation sites many sites neurofilaments lesion specific phosphorylation different neurofilaments
ALZ,ALZ743,protein protein individuals protein multimeric terminal protein congophilic kda amyloids congophilic infectivity sequences scrapie polypeptides
ALZ,ALZ744,proteolytic rabbits aluminum aluminum neurofibrillary level alzheimers proteolytic protein degradation neurofibrillary structure rabbits aluminum spinal hippocampus spinal neurofibrillary cathepsins significant aluminum significant triton treated neurofibrillary structure noticeable spinal mgg
ALZ,ALZ745,direct bethanechol alzheimers investigation alzheimers deliver bethanechol csf neurosurgical immediate general contributions neurosurgical familiar herhis
ALZ,ALZ746,structure helical filaments alzheimers neurofibrillary tangles senile dementia contain helical phf method tangles yield microscopy shadowed preparations helical structure patterns filaments sharp transverse whereas maintain specimens phf handed manner observations phf limited extent helical strands substructure radial extent less nm whole structure twisted ribbon untwist flat phf collapse normal neurofilaments
ALZ,ALZ747,evidence middle basalis meynert locus caeruleus dorsal motor vagus dorsal tegmental nigra downs hippocampus senile neurofibrillary tangles youngest downs types middle significant basalis locus caeruleus dorsal motor vagus dorsal tegmental nigra types alzheimers downs alzheimers middle degrees damage cholinergic serotonin
ALZ,ALZ748,desferoxamine liquid aluminium disorders liquid method permits quantification desferoxamine aluminumiii desferoxamine method side patterns
ALZ,ALZ749,muscarine alzheimers cholinergic alzheimers cholinergic reductions presynaptic choline muscarine results evidence cholinergic release postsynaptic post presynaptic sites potential
ALZ,ALZ75,dementia genetics conditions relatives dementia subjects genetic investigation relatives excess consistent genetic transmission risk relatives group general lymphoma immune diatheses conditions likely severe relatives
ALZ,ALZ750,senile dementia dementia dementia senile dementia theory dementia
ALZ,ALZ751,lesions forebrain alzheimers bodian innominata basalis meynert alzheimers senile dementia time neurons gliosis dementia senile neurofibrillary tangles granulovacuolar degeneration rare lesions senile argentophilia glial lesions hippocampus amygdala significance final phases forebrain neurons senile
ALZ,ALZ752,evidence serotonin chat regions lesions basalis lesions chat serotonin lamina iv middle vs side hketanserin lesions autoradiograms results serotonin receptor sites cholinergic iv possible senile dementia alzheimers relevant
ALZ,ALZ753,alzheimers instrumental alzheimers senile lesion group ten magnification decisive brodmanns basalis coeruleus group histological alzheimers dementia dementia subclinical alzheimers neocortex group
ALZ,ALZ754,correlation senile neurofibrillary tangle counts alzheimers neurofibrillary tangles meynert locus coeruleus alzheimers correlations tangle tangles importance
ALZ,ALZ755,pyruvate dehydrogenase alzheimers pyruvate dehydrogenase pdhc values alzheimers frontal mitochondrial glutamate dehydrogenase normal time pdhc purified pdhc pdhc pdhc different normal pdhc pdhc normal pdhc protein pdhc mitochondrial damage
ALZ,ALZ756,cholinergic cognitive parkinsons alzheimers dementia parkinsons presence evidence dementia cholinergic system parkinsonian dementia reductions reductions choline reductions mental test extent tangle parkinsons alzheimers neocortical choline neurons meynert primary degeneration cholinergic neurons cognitive parkinsons
ALZ,ALZ757,alzheimers electrophoretic cytoplasmic mortem alzheimers dementia sodium dodecylsulphate polyacrylamide cytoplasmic dementia alzheimers cytoplasmic protein tubulin reductions weights daltons alzheimers indistinguishable tubulin results alzheimers
ALZ,ALZ758,disorders many uses dementia ct many ct observer disorders findings ct progressive onset intracranial
ALZ,ALZ759,lateral hemispheric asymmetries early onset dementia emission ffluorodeoxyglucose right hemispheric glucose probable alzheimers visuospatial
ALZ,ALZ76,synthesis neurotransmitters functions implications much evidence intracerebral synthesis neurotransmitters precursors choline tyrosinein food functions precursors conditions different neuro diseases due lack synthesis release neurotransmitters possible digestive diseases lack excess precursors
ALZ,ALZ760,verbal perseveration dementia perseveration verbal descriptive dementia etiology dementia normals etiology perseveration descriptive dementia normals discontinuous perseveration perseveration perseveration ideas perseverate typical dementia findings prominent theories perseveration
ALZ,ALZ761,alzheimers magnocellular neurones supraoptic locus caeruleus alzheimers locus caeruleus supraoptic furthermore types close functional linkage group alzheimervascular dementia senile neurofibrillary tangle damage locus caeruleus hypothalamic losses importance alzheimers
ALZ,ALZ762,hypersensitivity radiation trisomy neurodegeneration lines neurodegenerations hypersensitivity lethal lines lethal ultraviolet radiation lines lines normal donors lines ultraviolet different normal hypersensitivity repair dna damage
ALZ,ALZ763,reductions subjects sodium sulphate polyacrylamide downs reductions alzheimers protein alzheimers youngest downs protein alzheimers downs
ALZ,ALZ764,dementia lewy nigra locus ceruleus basalis lesions nigra locus ceruleus dementia level
ALZ,ALZ765,pumps diseases pumps way nervous system spinal subarachnoid alzheimers intraventricular bethanechol
ALZ,ALZ766,induction helical filaments human neurons histopathological senile dementia sdat neurofibrillary degeneration degeneration helical filaments crapper sdat contains factor induces alzheimers human cns neurons report fetal human spinal lesions extracts sdat sdat glu glu medium eagle medium glu neuropil synaptic contacts free presence cultures glu presence intermediate filaments intermediate filaments nm neurofilaments range overall sdat
ALZ,ALZ767,putative transmitters alzheimers free lumbar csf alzheimers glycine glutamine csf alzheimers glutamic alzheimers psychological glycine specific alzheimers
ALZ,ALZ768,neurofilament igg jakob diseases jakob diseases subjects reactivity preparations neurofilaments sera kda neurofilament neurofilament protein neurofilament protein sera neurofilament serum reactions trixon extracts spinal triton liver
ALZ,ALZ769,csf monoamine alzheimers parkinsons homovanillic hva hydroxyindoleacetic hiaa methoxy hydroxyphenylglycol mhpg lumbar csf alzheimers parkinsons pd csf values hva lowest metabolites hva group severe dementia rise mhpg
ALZ,ALZ77,acetylcholinesterase senile dementia possible cholinergic neurons ache csf sda neurological ache sda ache significant potential glia glucuronidase csf significant sda ache sda cholinergic neurons cholinergic
ALZ,ALZ770,disintegration dementia picture subjects senile dementia sdat subjects related dementia normal subjects normal subjects dementia subjects fewer total fewer unique fewer prepositional subordinate sentence lexical severe syntactic ones disruption dementia syntax dementia sdat subjects mental lexicon empty indefinite anaphora dementia subjects laconic diffuse injury sdat lexicon multifocal injury disproportionate effect syntax lesions posterior sdat subjects anomic whereas sdat subjects transcortical sensory subjects severe important sdat relevant observations perseverations sdat subjects whereas aposiopesis logorrhea palilalia typical sdat subjects laconic subjects
ALZ,ALZ771,csf neurotransmitters dementia mesylate level homovanilic hva hydroxyindolacetic hiaa methoxy hydroxy phenylglycol mhpg day intervals dementia atd correlation dementia psychometric csf
ALZ,ALZ772,topochemistry human normal human caudatus pallidus hippocampus posterior parts whereas gradients
ALZ,ALZ773,cutback time nih federal kind social evaporating grasp impact heres story scientists alzheimers conditions health reagan cutbacks nonprofit organizations grantseekers nih human side federal
ALZ,ALZ774,dementia parkinsons possible specific frontal neuropsychological cognitive subjects idiopathic parkinsons pd subjects alzheimers different subgroups parkinsonian second dementia subclinical specific dementia pd anticholinergics parkinsonian second cognitive pd dementia fact cognitive parkinsonian ones frontal lesions neuroanatomical neurochemical whole dopaminergic system pd ventromedial tegmental frontal cognitive dysfunction
ALZ,ALZ775,time dementia cognitive dementia pseudodementia time conditions group elderly shorter times faster dementia standard time elderly subjects conditions demands effect due neural cognitive dementia results different dementia pseudodementia
ALZ,ALZ776,cognitive elderly cognitive elderly homes mini mental state ninety whereas individuals scores disorders dementia thirty elderly range dsm iii condition dementia alzheimers
ALZ,ALZ777,dementia evidence subgroups records extrapyramidal signs functional daily little myoclonic severe severe functional psychotic typical gradual functional group myoclonus onset demographic dementia heterogeneous manifestations
ALZ,ALZ778,sleep healthy subjects sleep patterns elderly healthy elderly sleep sleep sleep sleep hamilton less sleep sleep normal cognitive less severe sleep ie nights normal subjects cut retrospective reynolds
ALZ,ALZ779,red choline kinetics alzheimers parameters uptake red alzheimers normal elderly values uptake red choline different choline choline uptake choline influx choline red plasma choline parameters uptake alzheimers normal choline uptake vmax values choline normal alzheimers alzheimers choline dementia possible significance findings choline alzheimers
ALZ,ALZ78,lipofuscin lipofuscin human neurones drugs lipofuscin unreliable methods techniques method autofluorescence lipofuscin autofluorescence lipofuscin
ALZ,ALZ780,red choline choline alzheimers free alzheimers normal elderly pairs participated rbc plasma choline values choline plasma choline ratio rbcplasma choline dementia choline correlation rbc choline equal rbcplasma choline ratio equal normals choline plasma choline less equal results support rbc plasma choline diagnostic identify index cholinergic alzheimers
ALZ,ALZ781,alzheimers alzheimers entity specific related entity dementia fourth united likely less disability neurofibrillary tangles cholinergic basalis functional disability extent damage deteriorate dementia compatible alzheimers dementia diagnostic optimal intercurrent social specific accelerating
ALZ,ALZ782,alzheimers ct findings tomographic early onset alzheimers subjects tomographic standard sulcal size indices results neuropsychological tests findings size alzheimers group sulcal size neuroradiologist less size less dementia presence neuropsychological tests findings tomographic alzheimers early onset
ALZ,ALZ783,korsakoffs issues etiology cognitive recent neuropsychological term etiology korsakoff visuoperceptual amnesic korsakoffs severe malnutrition report korsakoff alzheimers basalis meynert diencephalon amnesic disorders korsakoffs diencephalic amnesia
ALZ,ALZ784,lesions striatal somatostatin somatostatin neurons vary huntingtons alzheimers lesions knife effect striatal somatostatin lesions dorsal frontal pyriform olfactory effect striatal sli removal amygdala significant increases ipsilateral interaction terminalis lesions effect amygdalo striatal projections dorsal longitudinal findings support somatostatin amygdala amygdala ventromedial
ALZ,ALZ785,glutamate alzheimers huntingtons diseases senile dementia alzheimers sdat huntingtons sodium independent hglutamate glutamate normal normal sites specific quisqualate significant ligands observed huntingtons regions sdat normal possible probes glutamate sdat vivo emission
ALZ,ALZ786,tangles neurones alzheimers senile dementia progressive neuropsychiatric condition presence tangles neurochemical cholinergic aminergic projections somatostatin intestinal neuropeptides somatostatin tangles impregnation techniques alzheimers somatostatin immunoreactive perikarya morphological consistent degeneration many neurones tangles positive colocalization neuropeptides findings somatostatin positive neurones alzheimers neurones tangles somatostatin neurones critical process
ALZ,ALZ787,somatostatin alzheimers senile dementia alzheimers neurofibrillary tangles condition specific choline cholinergic neurones noradrenaline locus coeruleus neurones methods report immunoreactive human alzheimers cholinergic alzheimers cholinergic somatostatin alzheimers neurones targets degeneration presynaptic postsynaptic neurites neurones layers heterogeneous input surprising somatostatin alzheimers
ALZ,ALZ788,alzheimers parkinsons progressive palsy ace normal human csf ace subjects degrees dementia alzheimers parkinsons progressive palsy level group intact individuals results ace csf index dysfunction neurodegenerative disorders
ALZ,ALZ789,alzheimers fibrils infectivity scrapie proposal infectious proposal alzheimers infectious speculation evidence conventional alzheimers partial degradation host protein
ALZ,ALZ79,degeneration alzheimers histopathological components degeneration alzheimers process different width general process accentuated frontal consistent degeneration posterior cingulate parietal lobule less inferior parietal lobule inferior gyri sensorimotor calcarine cingulate degeneration width results parameters flow
ALZ,ALZ790,spiritual support caregivers united alzheimers dementias dependent caregiver caregivers caregivers scores spiritual support coping strategy spiritual psychosocial needs spiritual integral
ALZ,ALZ791,glutamate decarboxylase cholinergic weeks mice scrapie mice normal mice cholinesterase ache glutamic decarboxylase hindbrain significant scrapie middle ache scrapie
ALZ,ALZ792,invasive metabolic dementia metabolic nineteen dementia infarctual mid dementia neurological neuropsychological mid noninvasive neck supine position duplex scanner wide range mild hyperlipidemia hematocrit level extent mid results duplex scanner vascular vascular mid metabolic dementia vascular hand mid vascular prominent context dementia
ALZ,ALZ793,possible significance dementia male veterans minnesota race neighborhood relevant vital genetic possible occupational stress dementia occurrence ratio consistent literature dementia importance unclear
ALZ,ALZ794,alzheimers spastic paresis unusual alzheimers year japanese housewife progressive dementia severe mild severe degeneration tracts degeneration
ALZ,ALZ795,possible early alzheimers senile dementia senile neurofibrillary tangles unselected entorhinal hippocampus olfactory amygdala basalis meynert sps sps patterns single neurons structure whereas convexity cerebrum fibrillary types sp types morphological evolution
ALZ,ALZ796,ct senile dementia ct senile dementia sulcal radiological healthy cognitive sdat group ct ct dementia conjunction psychometric enlargement process cns technology ct
ALZ,ALZ797,superoxide dismutase isoenzymes normal dementia superoxide dismutase mn superoxide dismutase caudatus hippocampus cinguli little parts enzymic degeneration
ALZ,ALZ798,dementia normal aphasic transcortical sensory dementia dementia important diagnostic dementia
ALZ,ALZ799,maternal alzheimers maternal risk factor alzheimers washington state alzheimers university washington alzheimers alzheimers parkinsons university washington subjects records diagnostic evaluations mothers evidence mothers mothers test findings support theory mothers risk alzheimers
ALZ,ALZ8,aluminum neurofibrillary aluminum rabbits neurofibrillary neurons spinal cerebrum rabbits half rabbits weeks many months many rabbits neurofibrillary signs dynamics neurofibrillary aluminum months many neurofibrillary tangles neurons spinal cerebrum aluminum obvious correlation neurofibrillary signs aluminum fewer neurofibrillary tangles neurofibrillary neurofibrillary neurofibrillary
ALZ,ALZ80,occurrence jakob alzheimers occurrence jakob cjd total consistent dominant transmission sporadic maternal effect evidence prenatal transmission spatial time consistent transmission prenatal early postnatal uniform related marriage evidence transmission occurrence cjd alzheimers cjd dominant transmission maternal effect cjd cjd spongiform nonhuman spread cjd unknown results consistent hypothesis infection early mechanisms prenatal transmission infection likely
ALZ,ALZ800,flow normal human senile dementia review metabolic normal elderly group normal subjects health bethesda md usa significant metabolic oxygen values populations important parameters significant metabolic glucose cmrg newer methods emission findings normal human subjects mabp vascular resistance cvr normal mabp elderly hypertensive subjects subjects group significant fall venous po pronounced fall senile group iii cmrg subjects lapse psychological parameters overall related rise cvr agingabstract
ALZ,ALZ801,health promotion quality health human many initiative health quality health costs initiative elderly health willing adopt good health investigation target health promotion initiative safe drugs initiative cooperative programs nutritious food consumer programs force alzheimers health promotion health senior organizations hhs health organizations health second state sector programs participation health promotion efforts elderly proliferate
ALZ,ALZ802,enkephalin neurons human hippocampal alzheimers neurons enkephalin human hippocampal dentate neurons dentate hippocampus pyramidal subiculum dementia post mortem factor hippocampal nonspecific due dentate senile alzheimers normal
ALZ,ALZ803,tests dementia elderly elderly female group dementia senile dementia results dementia less less igg group less
ALZ,ALZ804,amygdalas human processing possible human amygdaloid processing evidence amygdaloid damage due intervention potentials hypothesis possible amygdala processing human amygdala emotional significance subjects sensory emotional cues evidence hypothesis human processing amygdaloid lesions evidence neuroanatomical amygdala
ALZ,ALZ805,meynert concepts neuropsychiatric pathophysiology nineteenth cognitive flow parallel regions dementia meynert basalis meynert provide cholinergic innervation structure alzheimers dementia dementia parkinsons dementia cholinergic contributions unproductive speculation neuropsychiatric diseases
ALZ,ALZ806,alzheimers dichotic alzheimers group significant dichotic scores quotient glucose glucose dichotic interaction dichotic consistent previous dichotic
ALZ,ALZ807,occurrence alzheimers downs ds institutions correlation alzheimers fifty tissues right prefrontal hippocampal microscopy bodian periodic schiff impregnation evaluations tangles tangles ds dementia records ds dementia tangles micron tangles ds observations correlation dementia tangles early growth condition prenatal granular layers prenatal postnatal synaptogenesis early tangles thirty times occur non ds
ALZ,ALZ808,neurotensin post mortem downs dementia neurotensin choline post mortem months months dementia atd months unaltered atd frontal year infant downs year year downs neurotensin downs presence neurofibrillary tangles
ALZ,ALZ809,jakob hirano cluster jakob probable proven single kuru fair correlation prominent vermis hippocampal typical jakob hirano ammons specific alzheimers senile
ALZ,ALZ81,neuropeptides alzheimers schizophrenia post mortem intestinal intestinal cck neurological alzheimers schizophrenia sephadex filtration cck different significant normal overall cck alzheimers
ALZ,ALZ810,amine infant severe alzheimers congenital defects cholinergic system male infant downs range healthy middle normals system ceruleus normal newborns ache glutamate decarboxylase tyrosine hydroxylase regions infant group normal ache downs serotonin metabolites neonatal
ALZ,ALZ811,longitudinal senile dementia longitudinal subjects senile dementia aphasic subjects progressive group nonaphasic subjects senile dementia heterogeneous presence early nonfamilial progressive
ALZ,ALZ812,tasks electrolytic globus pallidus tasks male wistar severe posterior level retention post training time dependent slight recovery weeks lesions way shuttle retention post training lesions intervals foot shock lesions kainic significant results lesions retention alzheimers senile dementia
ALZ,ALZ813,tyrosine metabolic electrochemical post mortem parkinsons alzheimers rapid indoles picogram liquid column electrochemical lcec method list pre column neurochemicals neurochemicals human dopa tyr mhpg hiaa trp da hva ht neurochemicals parkinsons catechol indole losses neurochemicals alzheimers sdat losses hva ht uniform sdat
ALZ,ALZ814,alzheimers posterior lateral hemispheric glucose dynamic emission tomographic subjects alzheimers healthy subjects glucose parietal group healthy parietal glucose subjects group striking lateral results important implications etiology alzheimers
ALZ,ALZ815,alzheimers dementia igg igg serum csf alzheimers senile dementia sdatad dementia mid igg serum csf occurrence intrathecal cut signs damage group mid whilst none signs igg index csfserum expressive igg
ALZ,ALZ816,alzheimers alzheimers pathologist usual marasmus senilis magnification hippocampal brodman group alzheimers
ALZ,ALZ817,injury risk factor alzheimers injury race injury consciousness neighborhood odds significant less times occurrence findings possible injury
ALZ,ALZ818,interferon gamma peripheral sclerosis neurological diseases peripheral leucocyte pbl alzheimers huntingtons tumours interferon gamma ifn gamma concanavalin pha pbl cultures sclerosis significant ifn cultures cultures healthy donors doses meningo encephalitis ms myasthenia gravis alzheimers huntingtons post craniotomy good concordance pha inducer general
ALZ,ALZ819,times neurological diseases jakob alzheimers diseases significant decreases mice transmission uninoculated mice mice results infectious etiology results alzheimers picks diseases undetermined infectious diseases sclerosis panencephalitis mice
ALZ,ALZ82,senile dementia glial perikarya ten size senile dementia normal specimens weight dementia group neurons dementia frontal weight thickness counts
ALZ,ALZ820,basalis meynert neurological morphological recent degeneration basalis meynert alzheimers possible cholinergic system neurological disorders degeneration alzheimers parkinsons diseases intermediate neurons dementia jakob progressive palsy nondementing diseases lateral sclerosis sclerosis counts group alzheimers parkinsons jakob diseases panencephalitis previous consistent statistical statistical significance degeneration alzheimers degeneration perspective spectrum neurological diseases statistical techniques group significance degeneration neurological
ALZ,ALZ821,dysfunction alzheimers peripheral alzheimers healthy elderly individuals il results il peripheral monocytes il vitro therapy il rosette alzheimers glucose healthy individuals
ALZ,ALZ822,delusions correlations delusions little systematic review literature reveals metabolic disorders system delusions general types persecutory delusions persecutory delusions delusions specific neurological defects paramnesia delusions delusions resistent delusional unusual delusions important management
ALZ,ALZ823,dementia alzheimers huntingtons man huntingtons nervousness chorea dementia findings huntingtons alzheimers findings diseases
ALZ,ALZ824,neurons glial normal review fundamental neurobiology normal
ALZ,ALZ825,pantoyl gamma aminobutyric cholinergic nervous system pantoyl gamma aminobutyric gaba atropine locomotor apomorphine locomotor ligand gaba bindings benzilate hspiroperidol hapomorphine hmuscimol gaba gaba release hacetylcholine hippocampus bicuculline tetrodotoxin results gaba gaba cholinergic nervous system results gaba alzheimers senile dementia
ALZ,ALZ826,serotonin hydroxyindoleacetic csf parkinsons dementia alzheimers serotonin ht hydroxyindoleacetic hiaa th th milliliters dementia alzheimers parkinsons pd aliquot csf pd positive correlation ht hiaa milliliter csf correlation senile hiaa csf pd results serotoninergic system pd
ALZ,ALZ827,mentation nursing intervention nursing different human nursing pathophysiology implications functional mentation movements
ALZ,ALZ828,potentials veps senile dementia non disorders elderly parameters senile dementia normal subjects elderly disorders inspection spectrum vep dementia components vep
ALZ,ALZ829,alzheimers alzheimers senile dementia presence neurofibrillary tangles hippocampus presence interneuronal
ALZ,ALZ83,evidence cholinergic neurons basalis basalis meynert cholinergic input basalis neurons cholinergic
ALZ,ALZ830,dementia dinucleotide nadh senile forebrain dinucleotide nadh amygdala innominata basalis meynert alzheimers senile dementia sdat senile presence nadh innominata neurons positive nadh alzheimers sdat nissl intact innominata former dementia normal whereas sdat nadh senile astrogliosis neurons alzheimers sdat terms energy
ALZ,ALZ831,alzheimers hippocampal dementia preliminary support hypothesis cognitive functions dementia histopathological neocortical lesions previous literature amply critical locus resistentiae cognitive observations evaluations hippocampal longitudinal histological neurochemical consistent typical alzheimers gliosis
ALZ,ALZ832,alzheimers losses alzheimers basalis locus coeruleus serotoninergic somatostatin interneurons dopaminergic neurons phenomena process hippocampus neurons specific losses symptomatology histological findings tissues disorders dementias hypothesis neurons
ALZ,ALZ833,autocannibalism choline membrane phospholipids alzheimers hypothesis cholinergic neurons alzheimers unique neurons factor factor cholinergic neurons factor choline phospholipids membrane free choline synthesis choline release neurons choline phospholipids membrane structure
ALZ,ALZ834,entorhinal allocortex isocortex human normal specific alzheimers allocortical entorhinal transform isocortex stretch transentorhinal allocortical isocortical multipolar entorhinal downward oblique outer layers star pyramidal pre neurofibrillary senile dementia pre neurons isocortical pyramidal layers iv inclined neurofibrillary transentorhinal tangle neurons oblique isocortical layers iv findings neurons allocortical pre specific profound stratum transentorhinal allocortical isocortical layers
ALZ,ALZ835,substructure nm filaments progressive palsy ultrastructure alzheimers neurofibrillary tangles helical nm filaments nm regular constrictions neurofibrillary ill structure psp tangles nm filaments tubules many different findings literature report morphological protofilamentous substructure filaments psp points protofilamentous architectures helical filaments alzheimers filaments nm protofilaments varied filaments neurofibrillary tangles psp identity level phf neurofibrillary tangles alzheimers
ALZ,ALZ836,mental dysfunction normal elderly cholinergic neurons many disruption dysfunction wide mental emotional effect many psychoactive drugs neural elderly drugs mimic mental alzheimers mental status short term tests day minutes saline presurgery normal total antimuscarinic competitive ml pretest time ml spinal spinal antimuscarinic equivalent pmoles serum pmoles csf significant short term significant effect scores mental state list
ALZ,ALZ837,amnesia damage emphasis amnesic introduction failures amnestic failures damage amnesia diencephalic regions damage evidence hm amnesic literature situations damage outline hypothesis regions damage critical amnesic diencephalic neuropsychological investigation korsakoffs diencephalic damage nutritional group amnesic forebrain damage alzheimers dementia damage damage specific failures neocortical damage retrograde amnesia prominent human human damage structure
ALZ,ALZ838,recognition alzheimers recognition types stimulus early alzheimers normal elderly verbal abstract geometric histology intact group positive general disinhibition processing positive responding previous findings alzheimers
ALZ,ALZ839,polymorphonuclear macrophages peripheral cytotoxic target pmn cytotoxic targets plasma factor cytotoxicity specific streptokinase factor maf possessed maf maf
ALZ,ALZ84,observations system alzheimers system alzheimers histological components system coeruleus hydroxylase dbh dbh locus coeruleus neurons previous observations reductions dbh locus coeruleus lesions extent morphological counts mental test scores related dbh non significant trends choline extent cholinergic system specific process system
ALZ,ALZ840,nigra centralis alzheimers presenile alzheimers neurons neurofibrillary tangles nigra sn centralis ncs significant ncs moreover significant correlation nft ncs helical filaments shape
ALZ,ALZ841,individuals primary dementia diazepam retrieval diazepam normal elderly individuals primary dementia conditions diazepam retrieval buschkes doses normal elderly individuals normal subjects diazepam
ALZ,ALZ842,neuropsychological senile dementia thirty neuropsychological method neuropsychological syndromes damage zones results computer tomographic neuropsychological method senile dementia
ALZ,ALZ843,dementia korsakoffs possible picture recognition test intervals korsakoff healthy amnesic alzheimers korsakoffs korsakoff healthy peterson test short term tests results respect underlying
ALZ,ALZ844,argentophilic congophilic senile elderly senile dementia neocortical regions frontal parietal congo red argentophilic true congophilic argentophilic congophilic parietal regions results senile precedes cores
ALZ,ALZ845,dorsalis dementia guam dorsalis diffuse alzheimers report dementia guam significant neurons presence alzheimers neurofibrillary tangles
ALZ,ALZ846,thermostable immunoassay thermostable human test serum cva sera neurological disorders normal subjects positive positive results tests values weeks none sera cva positive
ALZ,ALZ847,substructures helical filaments alzheimers neurofibrillary tangles nm filaments helical filaments protofilaments protofilaments structure longitudinal bars phf shows transverse bars transverse bars longitudinal bars phf neurofilament protofilaments profiles phf protofilaments longitudinal bars normal neurofilaments diagram phf structure
ALZ,ALZ848,muli dementia fifty dementia vascular dementia senile dementia alzheimers infarcts multiinfarction dementia dementia senile dementia alzheimers dementias multiinfarction dementia
ALZ,ALZ849,pathoarchitectonics pick architectonics picks pd alzheimers size whole figures process dementia involves indices hemisphere values inferior frontal regions postcentral insular regions general regularity size hemispherical regions pd parameters size hemisphere whole regions correlation macroscopic achitectonic formations
ALZ,ALZ85,choline uptake pre senile dementia serum choline senile alzheimers choline choline csf choline choline untreated neurological choline less choline influx male female male female influx erythrocytes range values less females results choline transport csf pre senile alzheimers
ALZ,ALZ850,potential potentials sdat normal components sdat group speed neural processing sdat significant correlations severe dementia dementia scales
ALZ,ALZ851,verbal dementia verbal mild dementia atd paradigm results atd subjects less term ltm short term stm elderly mild atd subjects less ltm atd subjects atd subjects items ltm mild atd subjects ltm retrieval atd subjects results inability atd subjects list conjunction mild atd subjects
ALZ,ALZ852,hirano purkinje alzheimers cylindrical perikaryon purkinje alzheimers scattered typical senile
ALZ,ALZ853,alzheimers psychological alzheimers recent deterioration unpredictable deterioration fourth elderly caregiver caregivers embarrassment denial frustration anger manifestations caregiver
ALZ,ALZ854,patterns glucose dementia alzheimers glucose disabled mid normal emission fluorodeoxyglucose method metabolic overlap metabolic normal evidence hypometabolic posterior inferior frontal marginal statistical significance mid metabolic defects extent parietal preserved thalamus cingulate pre post calcarine neurochemical
ALZ,ALZ855,neuropsychological patterns senile dementia thirty presumptive dementia presenile senile mental status dementia wais subtests presenile subjects subtests tests verbal full iq presenile group group effect digits presenile group significant embedded graphomotor speed dementia presenile senile counterparts mental
ALZ,ALZ856,slow wave healthy subjects sleep electroencephalogram delta slow wave sleep normal standard night slow wave sleep elderly delta second sleep subjects
ALZ,ALZ857,alzheimers dementia forty alzheimers kindred usa record personal picture uniform psychotic rapid evolution dementia akinesia prominent stage myoclonus grand interictal spike discharge repetitive periodic discharges genealogical possible free records subjects generations subjects ascentdescent marriage computer genealogical tree thereof computer bayesian techniques demographic possible estimate living subject transmitters different maternal effect segregation ratio sibships dominant monogenic transmission factor diversity fundamental alzheimers senile dementia
ALZ,ALZ858,dementia parkinsons correlation deterioration parkinsons cholinergic senile dementia alzheimers choline regions results parkinsonian signs severe senile hippocampus group senile anticholinergic drugs drugs hypersensitivity receptor cholinergic lesion specific dementia parkinsons parkinsonian spite histopathological evidence alzheimers parkinsonian dementia different parkinsons alzheimers results degeneration cholinergic neurones meynert deterioration extent degeneration
ALZ,ALZ859,senile dementia due select normal subjects senile dementia sdat test bts mental sdat normal different cm thick coronal thickness values significant correlation bts thickness results determinants histological hypothesis column sdat
ALZ,ALZ86,aluminum graphite furnace aluminum nonneurologic jakob normal aluminum aluminum specimens different huntington parkinson progressive lateral sclerosis normal normal sclerosis pick dementia significance aluminum values normal values jakob aluminum
ALZ,ALZ860,acetylcholinesterase senile dementia acetylcholinesterase ache csf individuals alzheimers normal dementias ache normal subjects effect ache csf senile dementia ache syndromes correlation mini mental state csf ache alzheimers ache range csf ache diagnostic test severe alzheimers
ALZ,ALZ861,different parts target alzheimers substantiate hypothesis cholinergic alzheimers cholinergic neurons basalis meynert neocortical target alzheimers different degeneration neurons subpopulations different alzheimers correlation neurons subpopulations basalis rise cholinergic innervation nonlinearity correlation different process mechanisms shape different regions subpopulations different basalis different cholinergic different findings degeneration cholinergic afferents neurons important
ALZ,ALZ862,neurofibrillary tangles alzheimers reactivity neurofibrillary tangles nft alzheimers immunocytochemistry prepared nft latter stainable bodian method nft vibratome antimicrotubular protein counterstained congo nft filaments twisted nft serum pre presence unique determinants
ALZ,ALZ863,dementia dementia mid gene significant gene significant
ALZ,ALZ864,endothelial mitochondrial alzheimers mitochondrial endothelial alzheimers stereologic methods endothelial findings support hypothesis alzheimers
ALZ,ALZ865,fingerprint alzheimers fingerprint dermatoglyphic senile dementia sdat group diseases norms fingertips whorls arches loops group sdat loops fingers group radial fourth fifth digits sdat fingerprint patterns sdat congruent patterns downs support diseases
ALZ,ALZ866,alzheimers postprandial ammonia alzheimers group ammonia eegs triphasic waves postprandial ammonia different
ALZ,ALZ867,alzheimers retrieval system computer method different subgroups dementia shorter day sem vs less day vs less malignant sooner effect significant kahn goldfarb mental status quotient haycox severe scores vs hachinski ischemic measuring signs vascular correlation male presenile onset
ALZ,ALZ868,alzheimers term excitement dedicated imperfect colleagues fact refinement alzheimers likely alzheimers element plenty work scientists term alzheimers different means need
ALZ,ALZ869,alzheimers paradigm functional sensitivity anticholinergic alzheimers ten different doses anticholinergic double cognitive related cognitive sensitivity temporary cholinergic index status cholinergic functional diagnostic test cholinergic system dementia way elderly populations neuropsychiatric disorders hypothesis
ALZ,ALZ87,homovanillic hydroxyindoleacetic senile dementia serotonin senile dementia homovanillic hva hydroxyindoleacetic csf senile dementia neurological dementia values ones significant hiaa hiaa severe senile dementia hiaa csf serotonin senile dementia severe hiaa
ALZ,ALZ870,oral physostigmine primary dementia double different level cholinergic enhancement senile dementia sdat oral physostigmine cross trial related verbal tests doses effect short term term retrieval
ALZ,ALZ871,potential trh alzheimers recent specific hippocampal cholinergic degeneration cholinergic neurons basalis meynert septum cholinergic cognitive cholinergic cns cholinergic limited strategy date trh literature unique cholinergic neurons neuraxis rationale trh lateral sclerosis progressive degeneration cns cholinergic neurons
ALZ,ALZ872,enhancement effect subcutaneous cholinergic alzheimers dementias conventional recent strategy drugs effect mice maze effect cholinergic drugs test drugs retention drugs arecoline oxotremorine tacrine possible retention test optimal increases retention
ALZ,ALZ873,degeneration tract portosystemic shunt spinal myelopathy creation porto caval shunt oesophageal degeneration lateral tracts spinal gray matter glia stem prominent findings tract degeneration lesions spinal gray matter spinal spinal flow creation portosystemic shunts severe liver
ALZ,ALZ874,rhesus alzheimers rhesus rh presenile dementia senile dementia sdat significant alzheimers statistical correction
ALZ,ALZ875,degeneration alzheimers alzheimers innominata progressive dementia alzheimers neurofibrillary tangles lesions presenile dementia dementia alzheimers much
ALZ,ALZ876,progressive dialytic aluminum neurotoxicity progressive dialytic identify effect aluminum uremic delayed neurotoxicity aluminum face risk mental deterioration neuromyopathies oral aluminum dementias lateral sclerosis aluminum possible factor proposal aluminum serum results electrodiagnostic tests psychometric aluminum neurotoxicity uremic
ALZ,ALZ877,meynert senile dementia alzheimers preliminary report meynert cholinergic innervation glucose metabolic senile dementia alzheimers sdat hypothesis glucose metabolic sdat electrode september year man repetitive months effect emission glucose metabolic ipsilateral parietal
ALZ,ALZ878,essay alzheimers translation time alzheimers regard context importance elaboration
ALZ,ALZ879,alzheimers alzheimers findings university western ontario uwo dementia group
ALZ,ALZ88,bungarotoxin sites human bungarotoxin sites conditions human significant sites correlation sites frontal mid normal humans mid significant sites
ALZ,ALZ880,guidelines senile dementia sdat dementia elderly antemortem sdat vivo histology sdat
ALZ,ALZ881,single effect overall cognitive plasma cortisol individuals probable alzheimers double individuals probable alzheimers doses cognitive plasma psychometric tasks token test enhancement token test previous cortisol subjects significant plasma cortisol alzheimers
ALZ,ALZ882,trial vasopressin disorders man double cross trial effect vasopressin dgavp documented components stabilized progressive amnesic disorders early dementia nervous system discrepancy
ALZ,ALZ883,temporary caregivers recent home caregivers emotional well caregivers policy issues investment
ALZ,ALZ884,vasopressin dgavp vasopressin peptides humans double parallel group subjects alzheimers vasopressin dgavp micrograms report dgavp subjects dementia dgavp group significant list needs dgavp results evidence dgavp related possible weight
ALZ,ALZ885,neural review recent potential neural valuable normal nervous system neurons regions host neuroendocrine cognitive disorders motoric dysfunctions rodents therapy human neurodegenerative diseases rodents cholinergic dopaminergic neurons extent host interaction subjects neural possible specific parkinsons alzheimers
ALZ,ALZ886,dementias dementia reversible irreversible dementias reversible intracranial conditions disorders recognition dementias alzheimers incorrect dementia
ALZ,ALZ887,size human index weight lateral weights lateral water lateral weight methods results conventional statistical methods observations normal significant correlation infratentorial parts significant correlation size lateral whole correction lateral size lateral shrinkage correlation weight cm weight size index emaciation size severe significant enlargement lateral general weight severe significant weight due concurrent emaciation severe changesabstract
ALZ,ALZ888,alzheimers gerstmann straussler scheinker dementia parkinsonian dominant neurofibrillary tangles kuru spinal pyramidal tract problems condition alzheimers straussler scheinker condition transmission relevant work
ALZ,ALZ889,oral physostigmine alzheimers alzheimers oral physostigmine hours alzheimers severe significant physostigmine phases inconsistent cortisol physostigmine oral physostigmine cholinergic
ALZ,ALZ89,presenile senile dementia polygraphic sleep dementia identification types normal sleep second identification types different advancement progressive lesions
ALZ,ALZ890,jakob spongiform jakob cjd kuru man mink diseases emphasis cjd pigs cjd scrapie findings cjd half pigs second spongiform neuropil inoculum eg less spongiform severe intracerebral intraperitoneal viremia maternal transmission lateral transmission organisms microscopy isolations spongiform elusive cjd permanent lines lines lines nude mice malignant evidence infectious etiology alzheimers exists cjd investigation dementias
ALZ,ALZ891,normal pagets senile dementia sdat commonest elderly important recognise reversible normal occur pagets skull rare date successful intervention normal pagets skull report geriatric year ventriculo
ALZ,ALZ892,search dna alzheimers dna specimens alzheimers normal hydroxyapatite mild conditions deoxynucleosides liquid hplc deoxynucleosides alzheimers deoxynucleosides restriction nuclease persistent damage dna alzheimers methods
ALZ,ALZ893,retrieval fluency test term fluency ambiguous normal laborious report confusion refer fluency retrieval different tasks frontal dementia condition subnormal test due dysfunction hemisphere disorders non significant dysfunction ie disorders
ALZ,ALZ894,dysfunction vigilance neurophysiological human computer spectral electroencephalogram significant normal delta theta dominant vigilance regulatory term vigilance mans turn dependent dynamic state total neural vigilance symptomatology mnestic elderly subjects good true time antihypoxidoticnootropic drugs dihydroergotoxine nicergoline vincamine alkaloids aniracetam etiracetam piridoxilate human vigilance methods man hypoxic hypoxidosis reversible
ALZ,ALZ895,functional antimuscarinic pirenzepine pz implications receptor machr hpz identify putative machr nervous system cns pz putative subtypes untoward drugs independent machr subpopulations drugs
ALZ,ALZ896,dementia basedows sjogren myoclonic dementia reversible therapy igg micro parallel neuro results support hypothesis vasculitis dementia year cure eventual apparition dementia
ALZ,ALZ897,neuropeptides recent remarkable identification neuropeptides known neuropeptides peptides structure hypothalamic functional significance neuropeptides conventional transmitters
ALZ,ALZ898,glucose huntingtons glucose emission ct fluorodeoxyglucose method subjects ct results glucose hypometabolism early precedes alzheimers parkinsons glucose normal rest shrinkage results hypometabolic dominant gene
ALZ,ALZ899,intra extraneuronal monoamineoxidase axotomy hemisection hemitransection side results side unoperated side extraneuronal compatible hypothesis alzheimers huntingtons growth extraneuronal rich
ALZ,ALZ9,protein human neurons protein neurons neurons techniques normal nonfibrillary dementia huntington microscopy neurons nuclear endoplasmic reticulum ribosomes helical filaments perikarya sporadic sodium dodecylsulfate polyacrylamide mw protein huntington hippocampal frontal neurons free phf presence phf neurons presence whole neurofilament tubulins protein mw protein striatal findings fibrous
ALZ,ALZ90,critical subjects frontal isocortex operative specimens senile alzheimers neurofibrillary degeneration months dementia subsequent evolution alzheimers retrospective good alzheimers
ALZ,ALZ900,atlas receptor human atlas emission tomographic serotonin receptor normal human cmethylspiperone tracer
ALZ,ALZ901,subpopulations alzheimers regulatory subpopulations proliferative pha alzheimers healthy normal total peripheral th suppressorcytotoxic group significant ts concomitant ratio thts proliferative significant results immune indices subsets unique alzheimers
ALZ,ALZ902,basilis meynert human neurons basalis meynert human neurons prominent nissl lipofuscin nissl many lipofuscin mosaic pale gray zones menbranous periodic transverse alzheimers neurofibrillary tangles fibrillary endoplasmic reticulum observed phenomenon unusual neurons nervous system cns lewy
ALZ,ALZ903,rostral parkinsons alzheimers rostal level posterior microscopy idiopathic parkinsons alzheimers senile dementia alzheimers parkinsonian rostral edinger lewy neurons neurofibrillary degeneration neurons alzheimers edinger neurons neurofibrillary degeneration whereas dementia alzheimers rare neurofibrillary degeneration edinger alzheimers cholinergic respects cholinergic diseases gray matter pretectal parkinsons patchy astroglia lewy gray matter neurofibrillary tangles diseases
ALZ,ALZ904,cytochemical alzheimers senile dementia identify ndpase senile alzheimers senile dementia senile positive ndpase important senile
ALZ,ALZ905,epinephrine skin dementia skin dementia fibroblasts growth sensitivity cultures healthy individuals growth epinephrine
ALZ,ALZ906,nuclear magnetic resonance nmr dementia proton investigative nmr parameters lattice relaxation time proton senile dementia sdat dementia elderly values dementia parameters regions damage
ALZ,ALZ907,occurrence human nervous system correlation occurrence conditions nervous system positive plasma diseases sclerosis guillain barre adrenoleukodystrophy inflammatory diseases inflammatory diseases positive demonstration nervous system
ALZ,ALZ908,alzheimers alzheimers downs polyisoprenoid different regions alzheimers nonalzheimer parts cerebrum values hippocampus dolichol isoprene units hippocampus normal downs ceroid ceroid lipofuscin
ALZ,ALZ909,nuclear membrane astrocyteneuron ratio huntingtons frontal huntingtons nuclear membrane indentations accumbens group huntington unique huntingtons diseases nervous system movements dementia picks downs alzheimers parkinsons jakob dyskinesia dementia way findings group huntingtonian jakob neurons nuclear membrane astrocyteneuron matter
ALZ,ALZ91,senile dementia senile dementias neurofibrillary alzheimers senile dementia senile dementia enables method mechanisms different genetic methods piaget qualitative dementia etiology much adultomorphism normomorphism concerned disorganization functions nervous system symptomatology manner process independent objectives
ALZ,ALZ910,quinolinic neurotoxicity basalis kynurenic quinolinic quinolinic neurodegenerative diseases kynurenic powerful quinolinic quinolinic kynurenic destroy cholinergic neurons morphological forebrain quinolinic kynurenic quinolinic quinolinic lesions basalis significant decreases choline acetylcholinesterase uptake release reductions cholinergic kynurenic quinolinic significant choline months quinolinic lesions basalis results quinolinic endogenous neurotoxin lesions cholinergic alzheimers
ALZ,ALZ911,functional neurochemical cholinergic lesions basalis effect kainic quinolinic cholinergic injections basalis frontoparietal release uptake hacu acetylcholinesterase injections kainic nmoles quinolinic nmoles cholinergic parameters injections kainic nmoles quinolinic nmoles parietal release hacu ache kainic quinolinic histological globus pallidus size lesion quinolinic proportional kainic quinolinic release hacu ache histological neurons results quinolinic endogenous neuroexcitant cholinergic senile dementia alzheimers quinolinic cholinergic due cholinergic
ALZ,ALZ912,non opioid peptides neurological disorders evidence csf post mortem peptides nervous system cns neuroanatomical neurochemical electrophysiological group neuroregulators neural circuits neuropsychiatric disorders much opioid peptides hypothesis non opioid peptides neurotensin neuropsychiatric disorders alzheimers huntingtons parkinsons schizophrenia
ALZ,ALZ913,alzheimers dementias specific individuals dementia due alzheimers parkinsons pd downs ds neurofibrillary tangles specific populations neurons specific neurochemical recent evidence neurochemical diseases telencephalon specific circuits cholinergic neurons forebrain neurons coeruleus many disorders examples ways multidisciplinary correlations wide neurodegenerative diseases specific populations neurons specific populations projections functions manifestations human disorders cognition
ALZ,ALZ914,neurobiological dementia dysfunction specific important alzheimers parkinsons neurochemistry settings subjects clarified macaques cholinergic recapitulate human pharmacotherapies neural trophic methods demonstration nonhuman implications therapies human
ALZ,ALZ915,dementia neumann gliosis year dementia neurotransmitters primary dementia alzheimers gliosis
ALZ,ALZ916,senile alzheimers senile dendritic tree enkephalinergic dentate subicular pyramidal pyramidal neurons alzheimers whereas somatostatin neurons somatostatin immature end stage senile much hippocampal alzheimers
ALZ,ALZ917,alzheimers senile dementia alzheimers senile dementia sd genetic lesions sd neurons coeruleus white matter dementia related sd sd acetylcholinesterase ache choline acetylcholinergic system da noradrenaline ht system end metabolites extent normal neurons metabolites turnover system methoxy hydroxyphenylglycol mhpg normal turnover na system monoamine oxidase sd extraneuronal gliosis sd neuropeptides somatostatin damage neuropeptides
ALZ,ALZ918,normal senile dementia functional likely neurons good golgi neurons level human cholinergic normal damage informational cholinomimetic drugs adsdat due inability informational normal transmission normal much noradrenaline results intact instructions cues attend normal functions system directions influences noradrenaline neurons motor neuro normal adsdat neuroanatomical elderlys motor motor hippocampus neurochemical subjects
ALZ,ALZ919,alzheimers significant monoaminergic individuals alzheimers neurobiological histological hallmarks ie neurofibrillary tangles specific populations date specific therapy
ALZ,ALZ92,correlations spectral plasma prolactin elderly subjects plasma prolactin elderly subjects presence hyperprolactinemia normal rhythm elderly subjects normal state health spectrum delta rhythms findings dopaminergic
ALZ,ALZ920,neurons alzheimers neurofibrillary tyrosine hydroxylase investigation tyrosine hydroxylase immunohistochemistry tyrosine hydroxylase neurons alzheimers neurofibrillary nigra locus ceruleus specimens alzheimers picks progressive palsy alzheimers dementia guam normal conditions neurons alzheimers neurofibrillary tyrosine hydroxylase results neurons alzheimers neurofibrillary tyrosine hydroxylase protein synthesis
ALZ,ALZ921,helical filaments polypeptides normal human sera neurofibrillary tangles senile diseasesenile dementia adsdat sera tangles smears tangles sodium sulfate impurities helical filaments tangle sera human phf neurofilament triplet myosin fibroblasts tangles wt polypeptides neurofilament triplet wt cns neurofilament preparations tangles polyacrylamide gels phf sera polypeptides phf phf sera phf polypeptides polyacrylamide gels tangles polypeptides phf different tubulin neurofilament triplet myosin
ALZ,ALZ922,different alzheimers transform fft different alzheimers neuropsychological test mild theta ratio powers theta range healthy ratio powers delta different mild accentuation delta dominant rhythm accentuation irregular slow waves mild
ALZ,ALZ923,enkephalin nigra huntingtons parkinsons alzheimers diseases enkephalin huntingtons parkinsons alzheimers normal peroxidase antiperoxidase method human enkephalin human huntingtons globus pallidus nigra enkephalin globus pallidus normal parkinsons alzheimers diseases globus pallidus nigra enkephalin globus pallidus decreases parkinsons methods human neuropeptidergic disorders
ALZ,ALZ924,share determinants neurofilaments determinants neurofilaments cross react neurofibrillary tangles senile dements alzheimers sdat react linker sdat
ALZ,ALZ925,helical filaments identification helical filaments dementia polypeptides western size less kilodalton kda prominent kda phf polypeptides tangles microtubules normal electrophoretic patterns different microtubules neurofilaments weight phf polypeptides normal
ALZ,ALZ926,somatostatin csf senile dementia lumbar spinal senile dementia sdat specific immunoassay sli group group group sli deterioration sdat dementia sli sdat dementia insignificant decreases observed sli permeation peaks weights somatostatin precursors srif sli weight dementia
ALZ,ALZ927,problems dementia syndromes psychological tests psychological methods early dysfunctions dementia psychological tests scales depressive different psychological tests geometric retention test time different dementia types means psychological tests vascular dementia ischemic good
ALZ,ALZ928,therapy metabotisme sedative side claims drugs therapy dementia day cholinergic hypothesis alzheimers dementia results pilotstudies therapies dements future
ALZ,ALZ929,parkinson neuropsychological cognitive subjects idiopathic parkinsons pd subjects alzheimers different subgroups parkinsonian dementia second dementia subclinical specific dementia pd anticholinergics parkinsonian less second patterns cognitive pd dementia fact cognitive parkinsonian ones frontal lesions neuroanatomical neurochemical whole dopaminergic system pd tegmental frontal specific cognitive pd different dopaminergic fact second prefrontal cognitive parkinsonian
ALZ,ALZ93,senile dementia enlargement necropsy pericerebral senile dementia enlargement diagnostic normal size senile dementia alzheimers
ALZ,ALZ930,enkephalin immunoreactive hippocampal pyramidal neurofibrillary tangles humans alzheimers neurofibrillary tangles histopathological normal alzheimers utilized neuropeptides congo red enkephalin somatostatin som cck intestinal neurons tangles immunoreactive pyramidal subiculum contain tangles many immunoreactive neurons som cck contain tangles
ALZ,ALZ931,phf lesions alzheimers bodians impregnation immune serum helical filaments stain senils neurofibrillary tangles lesions phf immunochemistry bodian nft sp fronto neo hippocampus elderly subjects sp methods whereas nervous nft discrete easy specific phf literature good identification phf components
ALZ,ALZ932,san diegos alzheimers alzheimers san diego possible provide day dementia ratio times registered emphasis social interaction possible integral educational key staff management verbal
ALZ,ALZ933,vitro peptides different lengths homologous alzheimers protein peptides alzheimers protein sp vitro fibrils congo red fibrils senile alzheimers sp microscopy fibrils insoluble polyacrylamide gels fibrils monomers sp sp neurofibrillary tangles western sp kda preparations kda tetramer protein little protein fibrils kda protein important intermediate size
ALZ,ALZ934,protein tau filaments protein tau factor helical filaments tau polymerization previous glutamine glutamic
ALZ,ALZ935,hnicotine hacetylcholine sites frontal nicotinic cholinergic human frontal hnicotine hacetylcholine presence atropine receptor parallel hnicotine less hacetylcholine frontal benzilate less adsdat
ALZ,ALZ936,human hippocampus alzheimers methyl nmda hglutamate human hippocampal alzheimers nmda stable electrophysiology nmda terminal hippocampal collaterals output subiculum little hippocampal receptor hippocampal nmda predilection neurofibrillary tangles
ALZ,ALZ937,congophilia pathogens tissues deposits spongiform sse congophilia jakob cjd gerstmann straussler gss profiles scn hcl phenol unfixed human gss congo birefringence formalin paraffin gss congo red hand senile alzheimers senile dementia congo red deposits senile methods differentiation senile paraffin tissues
ALZ,ALZ938,basalis alzheimers severe alzheimers dramatic cholinergic losses meynert nucleoli shrinkage good correlation choline healthy basalis meynert half choline basalis meynert choline transport sub divisions basalis meynert non obvious sub basalis meynert counts discontinuous process
ALZ,ALZ939,dendritic meynert diagonal alzheimers golgi investigation golgi reticular neurons multipolar giant neurons neurons meynert diagonal alzheimers alzheimers irregular swellings reticular neurons extent multipolar giant neurons reticular neurons perisomatic filopodia size soma dendritic arborization spatial dendritic tree signs compensatory degeneration
ALZ,ALZ94,nonspecific entity conditions prominent dementia implications deposits close senile alzheimers senile dementia presence senile deposits successful therapy
ALZ,ALZ940,psychopathometric dementia cognitive factor dementia typical normal eg crystallized alzheimers psychometrical dementia requirements diagnostic test dementia
ALZ,ALZ941,senile dementia senile dementia elderly severe dementia senile dementia vascular dementia senile vascular dementia senile findings results senile dementia elderly severe dementia related senile dementia senile vascular dementia senile senile neurofibrillary tangle deciduation senile dementia tendency weight lighter senile dementia
ALZ,ALZ942,vasopressin alzheimers alzheimers alzheimers specific parallel liquid normal significant reductions hippocampus accumbens pallidus normal regions vasopressin system alzheimers
ALZ,ALZ943,topography locus caeruleus alzheimers locus caeruleus alzheimers dorsal rostrocaudal locus significant parts rostrocaudal neurones neurones spinal damage caeruleus alzheimers terminal perikaryal retrograde senile damage
ALZ,ALZ944,qualitative dementia choline choline coa dementia atd subjects post mortem significant choline coa frontal brodmanns brodmanns significant correlation choline coa column sephadex sucrose atd different results qualitative
ALZ,ALZ945,cognitive parkinsons dementia forty idiopathic parkinsons pd underwent cognitive cognitive typical senile dementia alzheimers sdat typical sdat cognitive likely severe pd psychological picture sdat diagnostic cognitive cognitive thirds
ALZ,ALZ946,dementia ct healthy male mild dementia whereas male severe dementia lateral volumes less gray matter significant correlations dementia scales dementia
ALZ,ALZ947,dementia alzheimers retrospective review records questions dementia alzheimers term cognitive status different term subjects dms iii records tricyclic evidence mood signs adls record cognitive folstein mini mental state months quarter therapy mood adls
ALZ,ALZ948,senile alzheimers cholinergic input dentate entorhinal input regions regions sprouts stimulus injury trophic alzheimers mechanisms intact
ALZ,ALZ949,psychobiologic cognitive failures structure related cognitive functions neuropsychiatric disorders many methods presence little possible determinants cognitive dysfunction framework mental functions terms noncognitive cognitive latter episodic recent biographical noncognitive sensitivity reinforcement sensorimotor mood time retrieval findings amnestic disorders dementias mood disorders determinants cognitive dysfunction diagnostic tools cognitive dysfunctions
ALZ,ALZ95,reversible dementia year dementia reversible elderly dementia reversible reversible dementia neurological results support dementias reversible invasive diagnostic dementia
ALZ,ALZ950,neuropsychiatric disorders somatostatinlike csf normal healthy iii schizophrenia dementia specific significant decreases populations findings previous csf dementia findings reductions diseases cognitive
ALZ,ALZ951,hnicotine human alzheimers normal putative human hnicotine hnicotine presence naedta dissociation ligand rapid degrees values single dissociation nm hill effect sites frontoparietal human unaltered human normal receptor frontal brodmann alzheimers values infratemporal brodmann alzheimers hnicotine choline pole values postsynaptic frontal alzheimers infratemporal significant severe choline replacement therapy sites alzheimers
ALZ,ALZ952,alzheimers binswangers diseases alzheimers binswangers diseases rare previous literature findings
ALZ,ALZ953,jakob implications jakob cjd continental genealogical investigation identification total cjd jews tunisian jews thirds ethnic group overall occurrence consistent dominant transmission wide pedigrees hypothesis open scrutiny sporadic cjd possible short cjd sporadic cjd effect evidence maternal transmission hypothetical transmission mechanisms occurrence marriage transmission early intervals geographictemporal clinico gerstmann straussler gss nosological genetic host important cjd scrapie constitute neurological diseases alzheimers senile dementia sdat
ALZ,ALZ954,metal renders intensification diaminobenzidine neurofibrillary developers end products reactions oxidative polymerization diaminobenzidine iodide ions alzheimers neurofibrillary coating nonspecific argyrophil iii developers reveals iii metal ions hydrogen developer intensification alzheimers neurofibrillary pre lanthanum nitrate mmliter hydrogen diaminobenzidine intensified copper sulfate mmliter hydrogen peroxidase intensification neurons horseradish peroxidase immunohistochemistry peroxidase antiperoxidase method
ALZ,ALZ955,immunocytes neuropsychiatric disorders evidence functional immune system nervous system analogies proposal neuropsychiatric diseases functional peripheral immunocytes results subpopulations immunocytes alzheimers retinitis pigmentosa
ALZ,ALZ956,disorders picks picks emission method functional picks presenile dementia alzheimers alzheimers different picks glucose frontal temporobasal regions significant computer magnetic resonance emission easier
ALZ,ALZ957,tomographic senile dementia normal elderly cranial ct senile dementia sdat normal elderly group lateral ratio width frontal horns lateral intracranial regions group normal respect regions
ALZ,ALZ958,pet mri ct proven alzheimers emission pet fluorodeoxyglucose fdg magnetic resonance mri ct alzheimers months mri ct pet findings metabolic glucose fdg uptake gliosis senile severe metabolic profound neurons gliosis alzheimers mri ct
ALZ,ALZ959,inobvious stroke dementia ct mental state nineteen delusional state onset dementia mania lesions right previous cognitive excess neurological signs mild post mortem localised evidence lesions alzheimers metabolic possible evidence representation
ALZ,ALZ96,trial alzheimers double trial severe severe alzheimers group weeks trial side confusion mild significant
ALZ,ALZ960,vitro phosphorylation mr protein vitro conditions normal human conditions fold level mr protein phosphorylation mr protein phosphorylation phosphoproteins time phosphorylation level mr prominent mr protein phosphorylation level phosphorylation level mr mr protein phosphorylation mr protein
ALZ,ALZ961,alzheimers tau components helical filaments helical filaments neurofibrillary tangles phf level neocortex hippocampus immunocytochemistry phf weight kda tau tau neurofibrillary tangles tau process tau protein synthesis unknown lesion pyramidal neurons tau
ALZ,ALZ962,acetylcholinesterase alzheimers parkinsons hydrolases ace acetylcholinesterase ache dihydroxyphenylacetic homovanillic hva total protein csf group alzheimers group parkinsons healthy elderly group significant milliliter distinguishable csh hva parkinsons group hva different group hva alzheimers group csf ache milliliter milligram protein csf total protein significant independent csf protein ace milliliter positive correlation ache milliliter parkinsons significant correlation csf alzheimers group csf profiles mild dementias alzheimers parkinsons neurochemical hva milliliter csf functions subjects alzheimers parkinsons healthy
ALZ,ALZ963,diazepam neuropeptide human spinal schizophrenia alzheimers diazepam purified human diazepam gamma aminobutyric gaba neurons gabaergic gaba benzodiazepine gaba receptor gabaergic neuropsychiatric disorders human diazepam csf endogenous schizophrenia dementia alzheimers human diazepam csf normal csf diazepam schizophrenics dementia alzheimers csf human diazepam functional disinhibition gabaergic
ALZ,ALZ964,alzheimers downs manifestations inconsistent picture many issues longitudinal
ALZ,ALZ965,recognition time normal alzheimers neurological disorders tests retention recognition elderly severe disorders subjects read sentences normal sentences ones general elderly subjects sentences short elderly retention speed recognition items read dissociation tests disorders items sentences retention time sentences retention item specific time sentences retention general item specific elderly subjects pairs sentences minutes recognition pairs sentences sentence pairs sentences results retention tests elderly items disorders recognition speeded items items results pairs items results tests disorders utterly explicit tests previous
ALZ,ALZ966,electrophysiological subtypes dementia subtypes dementias potential huntingtons parkinsons alzheimers components normal subjects significant electrophysiological group huntingtons parkinsons group alzheimers group electrophysiological classify logistic results support distinguishable subtypes dementia
ALZ,ALZ967,somatostatin parkinsons dementia acetylcholinesterase somatostatin homovanillic early parkinsons parkinsons less values parkinsonian homovanillic parkinsonian less acetylcholinesterase parkinsons somatostatin csf previous post mortem parkinsons alzheimers neurochemical
ALZ,ALZ968,alzheimers alzheimers brodmann acetylcholinesterase ache significant membrane ache significant increases significant choline hypothesis globular unchanged neurons membrane ache neurons transport cholinergic basalis meynert significant cholinergic neurons insignificant significant cholinergic significant cholinergic perikarya cholinergic neurons cholinergic perikarya slow transport cholinergic neurons
ALZ,ALZ969,spectral elderly normal subjects spectral alzheimers healthy elderly significant theta bandwidths theta parasagittal end spectrum delta theta group parasagittal correlation spectral parameters parasagittal delta theta theta folstein folstein scores
ALZ,ALZ97,neurofibrillary tangles neurofibrillary tangles dementia sdat immunoperoxidase techniques antiserums humanbrain sea urchin egg tubulin antibeef tubulin human neurofilamentnf kilodaltonkd protein neurofibrillary tangles serum neurofibrillary tangles sdat normal neurons sdat tangles human xmt serum antiserums tanglelike less tangles neurons results sites nf neurofibrillary tangles different human prominent protein ferritin weight cross human human ferritin serums ferritinlike protein ferritin stain neurofibrillary tangles human elicit tangles serum tangles protein neurofibrillary tangles normal
ALZ,ALZ970,alzheimers alzheimers means hypersensitivity dth concanavalin vaccine normal group minimum normal group normal range previous
ALZ,ALZ971,vitro orosomucoid human peripheral uptake hthymidine vitro orosomucoid plasma level cultures pha mgml non monocytes orosomucoid donors normal healthy immunodeficiency alzheimers consistent immunostimulatory
ALZ,ALZ972,test hypothesis general general method significant morbidity downs populations
ALZ,ALZ973,oral tetrahydroaminoacridine term senile dementia severe alzheimers oral tetrahydroaminoacridine tha anticholinesterase significant subjects pretreatment status orientation test test second subjects double cross subjects tha results orientation test alzheimers test subjects iii term oral tha subjects months serious side tha results tha term palliative alzheimers stress observations
ALZ,ALZ974,somatostatin parkinsons dementia alzheimers sli parkinsonian parkinsonian parkinsonian normal hippocampus amygdala globus pallidus parkinsonian frontal brodmann brodmann findings parkinsonian dementia alzheimers somatostatin
ALZ,ALZ975,choline observed choline positive human neocortex amygdala hippocampus human cholinergic system alzheimers senile dementia
ALZ,ALZ976,alzheimers parkinsons abiotrophic interaction hypothesis alzheimers parkinsons due damage specific regions nervous system damage subclinical prone attrition proposal neurodegenerative diseases methylphenyltetra hydropyridine poliovirus infection post lathyrism unidentified factor lateral sclerosis pd guam latent factor disorders implications subclinical damage search mechanisms subclinical damage due factor normal process nervous system process
ALZ,ALZ977,alzheimers synaptic densities frontal layers iii necropsic senile dementia results frontal biopsic alzheimers densities neurons different cognitive functions neurons morphological alzheimers senile dementia
ALZ,ALZ978,sleep pick polygraphic sleep picks group total sleep time awakenings stage sleep disappearance stage sleep total sleep time different sleep short
ALZ,ALZ979,neurono glial frontal human cerebrum normal alzheimers frontal right sound thick cresyl layers pyramidal neurons gliocytes neurons satellite glia gliocytes ratio parameters process normal specific normal iii alzheimers slight associative
ALZ,ALZ98,myoclonus alzheimers progressive deterioration year trisomy final condition jakob alzheimers
ALZ,ALZ980,dementia necropsy elderly geriatric alzheimers cns half alzheimers alzheimers little
ALZ,ALZ981,gerstmann straussler scheinker observations dementia gerstmann straussler scheinkers morphological spongious state gray matter latter close jacob creutzfelds presence extreme different senile alzheimers corresponds infectious protein
ALZ,ALZ982,diagnostic deprivation sleep deprivation dementia possible psychometric cognitive state
ALZ,ALZ983,vitro nmr alzheimers possible metabolic alzheimers nuclear magnetic resonance nmr peaks intermediate phosphomonoesters phosphoethanolamine phosphodiesters glycerophosphorylethanolamine nmr inorganic index vivo energy evidence phosphomonoesters phosphodiesters frontal parietal regions inorganic resonance peaks energy stores preliminary consistent hypothesis contribute possible membrane dysfunction cholinergic
ALZ,ALZ984,choline human neurological subjects alzheimers dementia mid mid dementia choline cacetyl coenzyme benzilate sites equal frontal hippocampal bmax hippocampal endplate equal vs subiculum equal vs sites frontal mid less equal results specific
ALZ,ALZ985,cholinergic disorders cholinergic subtypes putative nicotinic hippocampus cognitive disorders alzheimers parkinsons huntingtons diseases dementia normal disorders pre synaptic cholinergic choline alzheimers parkinsons downs nicotinic receptor reductions subtypes extent alzheimers whereas parkinsons cholinergic alzheimers disorders endogenous nicotinic identity unknown possible endogenous nicotinic receptor observations alzheimers nicotinic receptor future potential probes cholinergic system
ALZ,ALZ986,cholinergic hypofunction choline mustard aziridinium neurochemical histological parameters alzheimers early choline mustard az laboratory cholinergic hypofunction injections dorsal hippocampus lesions lesions time dependent lesions septum hippocampus results non specific damage ht normal choline mustard az circumvent mustard non specific damage
ALZ,ALZ987,compensatory dendritic growth process alzheimers normal human neurons hippocampal compensate related alzheimers pyramidal neurons compensatory spite probable exaggerated related neurons dentate hippocampus compensatory normal compensatory plastic normal dendritic growth
ALZ,ALZ988,primary dementia primary dementia non pdd neurochemical cholinergic system consistent pdd accessioned findings lbd picks degeneration motor cdmnd hippocampal sclerosis nonspecific disorders findings lbd picks pdd presenile group disorders pdd motor cognitive important lesions cholinergic system consistent severe lbd cdmnd
ALZ,ALZ989,correlation vascular lesions alzheimers hippocampal significant normal alzheimers fact zones ammons tangles granulovacuoles vascular system hippocampus posterior hippocampal diameters diameters normal calcarine normal alzheimers dementia significant phases alzheimers good normal senile cores calcarine normal congregate correlation normal conditions
ALZ,ALZ99,human critical review primary focused problems important concomitant functional statistical problems morphological unstated underlying theories process many morphological close problems human lesions shrinkage neurons corpora amylacea senile deposits neurofibrillar degeneration granulovacuolar degeneration hirano vascular lesions group specific non correlation functional lesion second group dementia condition alzheimers sensu current hypothesis condition
ALZ,ALZ990,investigation longitudinal alzheimers investigation alzheimers time exciting longitudinal problematic brevity grant intervals year turnover support biostatistical management objectives neuropsychological manpower distillate effect many grant alzheimers specialized scientific optimization early significant achievements demonstration researchers careers neurology neurodegenerative protocols psychometric neuroradiological elderlyabstract
ALZ,ALZ991,aluminum neurotoxicity potential neurofibrillary tangle alzheimers progressive neurodegenerative neurofibrillary tangles populations evidence alzheimers neurofibrillary tangle aluminum neurofilamentous lesions neurofibrillary tangle man evidence aluminum alzheimers microscopy spectrometry neurofibrillary tangle neurons alzheimers neurofibrillary tangle neurons natives dementia lateral sclerosis aluminum neurofibrillary tangle important
ALZ,ALZ992,basalis meynert alzheimers basalis meynert significant group counts paraffin intermediate posterior human subjects group dementia group test months group non neurological group insignificant subdivision normal neurons posterior significant group dementia
ALZ,ALZ993,structure scrapie alzheimers human neurodegenerative condition alzheimers report structure dna effect structure structure micrococcal nuclease release dna effect tonicity release scrapie micrococcal nuclease types signs human conditions alzheimers picks scrapie scrapie dna release different mechanisms alzheimers
ALZ,ALZ994,alzheimers conceptual issues alzheimers hampered insufficient time issues lack singular standard identification longitudinal significance issues longitudinal investigation normal individuals problems efforts resources
ALZ,ALZ995,dissolution alzheimers alzheimers important time frank individuals fluency second alzheimers severe progressive literature subject controversy stage dissolution anomic transcortical sensory wernickes aphasias alzheimers important episodic pathophysiology
ALZ,ALZ996,dementia terms dementia alzheimers parkinsons prototypical dementia share presence alzheimers parkinsons review mechanisms neurological disorders functional neuropsychological alzheimers parkinsons tasks da dr frontal system damage discrimination tol parietal system damage alzheimers tasks whereas dr neuroanatomical neuropsychological mechanisms da dr tol sharpened alzheimers parkinsons dementia alzheimers dorsolateral frontal orbitofrontal parietal dementia parkinsons prominent dorsolateral frontal system damage
ALZ,ALZ997,dementia lack sequential findings dementia alzheimers dementia alzheimers previous eegs condition presence diffuse delta bisynchronous spikes different scores subjects alzheimers findings
ALZ,ALZ998,neurological dementia alzheimers findings neurological alzheimers attended disorders dementia dementia logistic presence reflexes neurological gait neurological diagnostic signs early
ALZ,ALZ999,dementias unknown close laboratory etiology senium laborious psychogeriatric rural diagnostic guidelines dementia due primary process vasculature due degeneration mistakes
CAN,CAN1001,water health report drinking water process attendant microbial health interagency regulatory liaison group academy institute academy council safe drinking water committee washington dc mhda cdat nbk bookaccession medline da dcom lr print ip dp fall nursing facility home health hha possible highlights overwhelming episodes post snf hha episodes post demographic post post snf hha types likely female nervous vascular system types types england middle pacific divisions likely post united institutional institutional input price index quantity index
CAN,CAN1002,human serum usage md anderson institute human serum hsa cost early hsa usage therapy largest gastrointestinal thirds hsa hyperalimentation ivh hsa ivh ivh daily hsa therapy times non ivh total ivh non ivh total hsa cost serum level therapy serum termination therapy serum level hsa therapy ninety serum level
CAN,CAN1003,sphincter rectum resection rectum abdominoperineal resection problems ureteral complications recurrent radical months results programs concluded sphincter limited radiochemotherapy
CAN,CAN1004,cyclophosphamide vincristine chop non unfavorable histology preliminary results untreated unfavorable histology non lymphomas dpdl dm dh chop cyclophosphamide iv day iv day iv day po day early stage radiotherapy stage stage stage iii iv partial therapy early remission marrow nausea support therapy months remission remission free chop remission unfavorable histology non lymphomas
CAN,CAN1005,estrogen metastatic renal preliminary report untreated metastatic renal underwent transperitoneal radical nephrectomy mpa estrogen method healthy evidence progressive months receptor results multicentric trial therapy human renal
CAN,CAN1006,lymphography soft sarcomas experiences institutions institutions total primary soft sarcomas lymphography diagnostic lymphograms positive metastases metastases osteosarcoma ewings chondrosarcoma soft regard rhabdomyosarcoma anaplastic sarcoma neurogenic sarcoma synovial sarcoma group primary spread times lymphogenous spread soft sarcomas lymphatic spread consistent lymphatic metastases significant worsening lymph correlation evidence overall diagnostic
CAN,CAN1007,intraductal findings presence mammary overt intraductal cribrous cribrous papillary human parameters parameters productive fibrosis nuclear significant inverse intraductal productive fibrosis direct presence intraductal less intraductal less significant intraductal papillary less nuclear intraductal less papillary subclassification nos
CAN,CAN1008,kinetics lewis growth kinetics proliferative parameters early stage growth th day growth mitoses occurrence proliferative due time critical results preliminary
CAN,CAN1009,tobramycin infections different metastatic defenses documented ie positive probable laboratory tests picture infection therapy tobramycin good results infection probable infection unknown infections therapy rise reversible therapy tobramycin complications
CAN,CAN1010,cmf oral cyclophosphamide many many results effectiveness iv rationale proposal mild
CAN,CAN1011,lithium leukopenia trial effectiveness lico leukopenia results lico significant extent serious side due neutrophil granulocytes
CAN,CAN1012,polyamines leukemia leukemia due successful increases urine serum polyamines tissues test rise spermidine spermidine significant level ones fall normal increases putrescine significant level putrescine
CAN,CAN1013,genetic possible carcinogenesis hypothesis genetic endogenous genomes transformation important growth possible differentiation
CAN,CAN1014,immunohistological patterns dysplasias igg igm carcinomas tissues peripheral double direct fitc tritc cryostat paraffin plasma epithelium plasma carcinomas medullary types lesions lesions scanty plasma igg plasma rare igm epithelium igg results correlation patterns
CAN,CAN1015,erythroleukemia report cytogenetic gtg work cytogenetic introduction techniques
CAN,CAN1016,therapy pheochromocytoma signs importance receptor sudden pheochromocytoma moreover pheochromocytoma medullary parathyroid neuroma neurofibroma chemodectoma pheochromocytoma detect time
CAN,CAN1017,entity manner general influences pessimistic plea phenomenon tribal
CAN,CAN1018,soft sarcoma fibrous half severe injury year malignant fibrous elbow severe injury
CAN,CAN1019,cytostatic hypernephroid renal thirty hypernephroid renal sequential cytostatic partial tumour growth results time limited miss term remission
CAN,CAN1020,growth plasma tripeptide copper uptake plasma glycyl ghl nanomolar wide group disparate growth differentiation tripeptide many types organisms isolation ghl copper iron maximal copper iron growth medium structure tripeptides linkage ghl copper homology copper transport atom histidyl ghl copper transport factor report copperii metal hepatoma
CAN,CAN1021,initiation rna prepared human direct initiation rna promoter phosphocellulose deae dna components initiation rna promoter components random rna components rna iii
CAN,CAN1022,iii free extracts kb direct iii iii kb components different protein phosphocellulose rna iii gene trna gene components gene components initiation rna matsui weil chem
CAN,CAN1023,primary aldosteronism ct primary aldosteronism severe hypokalemia hyperaldosteronism plasma group normal minor classified idiopathic hyperaldosteronism enlargement normal ct
CAN,CAN1024,dna cross monoadduct repair human tumour nitrosoureas drugs dna cross chloroethyl group position dna second hours free cross slow chloroethyl group opposite dna chloroethyl cross time dna repair prevent cross cross normal transformed human day coworkers previous human tumour mer repair methylguanine lesions repair methylguanine dna chloroethyl chloroethylnitrosourea cross evidence hypothesis methylguanine repair chloroethylnitrosourea
CAN,CAN1025,dihydroxyvitamin increases vitamin dependent protein osteosarcoma osteosarcoma dihydroxyvitamin fold intracellular dependent protein bgp rise intracellular bgp half maximal precedes medium bgp time consistent dihydroxyvitamin effect half maximal vitamin ngml effect bgp dihydroxyvitamin effect total protein synthesis protein synthesis possible functions
CAN,CAN1026,repair dna human tumour sv human group human tumour support growth preparations methyl nitro nitrosoguanidine mnng support growth tumours different organs mer tumour sensitivity mnng mnng dna repair synthesis rapid mnng conservative dna synthesis report mer methylguanine meg dna cmmng mer tumour tumours mer normal fibroblasts sv transformation mer human fibroblasts mer mnng exchanges sces mer
CAN,CAN1027,embryo protein sv transformation specific weight mw immunoprecipitation sv early half sv protein dna different sv specific human sv infected sv sarcomas protein tumorigenicity report protein primary cultures day embryos day embryo protein indistinguishable sv protein tumorigenic possess protein
CAN,CAN1028,src gene growth sarcoma embryo fibroblasts report growth embryo fibroblasts sarcoma concerned src gene process mutants ts transformation growth regulatory lesion findings stationary embryo fibroblasts regulatory compartments brooks stationary degrees serum deprivation normal state ts state whereas normal state conditions infected degrees enter src gene src protein growth cultures
CAN,CAN1029,receptor internalization leukaemia transport vitamin cyanocobalamin serum protein tcii leukaemia membrane rapid independent slow dependent process delineate tcii submicrometre latex report tcii degrees microscopy sem microvilli results internalization transmission microscopy endocytotic process occur clathrin pits
CAN,CAN1030,purified gene sarcoma tyrosine sarcoma gene src phosphoprotein daltons potential recent findings protein possesses protein filtration daltons ppsrc possesses independent methods ppsrc monospecific purified ppsrc protein igg ppsrc conditional src thermal protein protein ppsrc phosphorylates target protein phosphorylation tyrosine tyrosine artifact phosphorylation th general ppsrc
CAN,CAN1031,membrane human neuroblastoma membrane purified human neuroblastoma human neuroblastoma lines nonidet hglucosamine double column membrane goat igm sepharose column column glycopeptides human neuroblastoma chp column methods target polyethylene glycol removal wheat column
CAN,CAN1032,dependent vitro translation system reinitiation vitro translation system polysomes discontinuous sucrose topmost sucrose times incorporation system optimal range vitro products vivo products polyacrylamide gels chem system reinitiation partial methylguanosine monophosphate terminal end vitro products system translate polysomes tissues liver liver translation liver carbamoyl phosphate immunoprecipitation monospecific results minor translation products system
CAN,CAN1033,gamma human gamma presence human fc gamma lysate detergent lymphocytic leukemia carboxynonyl hexadecylglycero phosphorylcholine sepharose pc sepharose human igg sepharose igg sepharose adsorbants urea filtration presence urea pc igg filtration points maps preparations hydrolysis release fatty position optimal presence fc gamma preparations fc igg human rosette peripheral mononuclear identity pc igg functional human fc gamma receptor plasma membrane
CAN,CAN1034,lactate dehydrogenase estrogen receptor human level lactate dehydrogenase human estrogen dehydrogenase human estrogen receptor therapy specimens estrogen receptor level lactate dehydrogenase iu protein presence estrogen receptor level lactate dehydrogenase endocrine
CAN,CAN1035,excretion urine serum serum excretion protein urine renal
CAN,CAN1036,osteosclerosis mastocytosis report year man pigmentosa mastocytosis marrow severe osteosclerosis skeleton marrow mast reticulin structure review literature osteosclerotic mastocytosis marrow pigmentosa
CAN,CAN1037,excess malignant melanomas malignant melanoma populations countries malignant melanoma zealand populations tumours dependent melanoma populations
CAN,CAN1038,significance ulcers histological necrotic ulcer lymphoma carcinomatous ulcer mycosis time dysplastic mucosa ulcer demonstration ulcer exclude
CAN,CAN1039,lymphogenic malignant melanoma melanoma retrospective histological level clark tumour thickness breslow related tendency lymphogenic expectancy level prognostic tumour thickness lymphogenic metastases proportional level primary tumour metastases females level iii figures level iv females females level year females level iv metastases worse females
CAN,CAN1040,manifestations early tumours tumours consciousness diffuse psychosyndromes psychosyndromes unselected tumour psychopathometric possible detect disorders early unmistakeable lesions specific differentiation psychopathometric possible future
CAN,CAN1041,isolation heparin human mastocytoma human mastocytoma proteolytic cetylpyridinium exchange deae final mw standard heparin exchange glucosamine sulfate heparin total glucosamine anticoagulant heparin units whole system units thrombin chromogenic units chromogenic results occurrence heparin human
CAN,CAN1042,von von evolution year man ristocetin cofactor vitro degrees serum independent igm subsequent igg results
CAN,CAN1043,report due campylobacter cancerous campylobacter cancerous bacterium cultures
CAN,CAN1044,intestinal general review different intestinal emphasis types genetic polyposis peutz polyposis genetic histological utmost importance
CAN,CAN1045,lymphocytic eac rosettes lymphocytic leukemia differentiated lymphosarcoma lymphosarcoma lymphoma histiocytic lymphoma tests malignant peripheral lymph nodes malignant malignant differentiated lymphosarcoma non lymphosarcoma results functional maturation lymphoma
CAN,CAN1046,leukemia leukemia presence membrane marrow peripheral lymphoblasts lymphoblasts non lymphoblasts eac rosettes techniques structure
CAN,CAN1047,disorders weeks neuroradiological diagnostic findings methods regular increases observations selection scanner invasive neuroradiological socio morphological
CAN,CAN1048,pseudo tumoral human due trypanosoma gambiense tomodensitometry due trypanosoma gambiense signs progressive hemiplegia papillary vascular pseudo tumoral unusual asymetrical heterogenous hypodensities semioval dominant ct scanner confrontation ct scanner evolutive presence demyelination hypodensities severe general signs importance neurological arsenical doses rapid
CAN,CAN1049,cytoplasmic rich rich points protein weight specific radioactivity cpmmg significance
CAN,CAN1050,synthesis mice rpc abpc non gamma abpc mice tumours mice vitro methionine electrophoretic patterns profiles mice tumours
CAN,CAN1051,manner excess serum excretory products replenishment serum hydrolysis nicotinic contribute preferential prpp phosphorylribose pyrophosphate priority intracellular inhibits dna synthesis tissues
CAN,CAN1052,histology melanomas melanomas histological medium results test thirty scleral melanomas growth
CAN,CAN1053,immunoadjuvant drugs leukemia schedules respect histocompatible host system lstra ascitic lymphoma leukemia mice ip histocompatible cdf mice ip drugs cyclophosphamide ipho nitrogen mustard nm doses day system synergistic doses significant synergistic drugs day immunochemotherapy different antineoplastic cure mice
CAN,CAN1054,estrogen receptor positive estrogen little endocrine therapy group estrogen receptor positive comments possible explanations phenomenon
CAN,CAN1055,therapy cytotoxic metastatic receptor metastatic therapy cytotoxic therapy endocrine therapy cytotoxic drugs presence cytotoxic
CAN,CAN1056,quality receptor receptor methods receptor extraction receptor important condition sine qua non receptor values different multilocal immediate homogenization presence sulfhydryl extraction medium important standard method protein dna quality lyophylized uterus nuclear speed recommended
CAN,CAN1057,quality receptor report quantitation suitable discrepancy results
CAN,CAN1058,receptor management cytoplasmic estrogen rec progesterone rpc human receptor residual nuclear rec metastatic rec endocrine rec rpc rpc remission rpc rec rpc rec rpc group triple positive whereas triple remission fifty primary metastatic rpc rec rpc primary free rec receptor status primary subsequent receptor status primary metastases
CAN,CAN1059,estrogen receptor positive primary metastases favorable sites positive metastases soft metastases positive endocrine therapy recurrent endocrine selection therapy radiation therapy hormones antihormones inadequate endocrine sequential endocrine positive desirable
CAN,CAN1060,current receptor oncology estrogen receptor estrogen receptor primary metastatic half institutions results positive institutions sole therapy sharp premenopausal receptor
CAN,CAN1061,extramural review cytotoxic extramural inadequate documentation review estrogen receptor cytotoxic findings possible standard methods
CAN,CAN1062,estrogen therapy cytotoxic endocrine estrogen receptor positive estrogen receptor retrospective cytotoxic endocrine therapy status cytotoxic
CAN,CAN1063,estrogen receptor status tufts pondville estrogen receptor cytotoxic single laboratory single cooperative oncology group positive status predominant stage free cytotoxic status
CAN,CAN1064,workers graphical plots methods suboptimal statistical vs satisfy subject interdependent independent furthermore non uniformity estimate parameters weighted squares total ligand independent bt dependent nonlinear weighted nonlinear squares estimate values computer estimate nonspecific nonsaturable desirable provide standard confidence limits parameters confidence limits fit degrees sites goodness fit select statistical plots nonlinear insufficient sites techniques slopes parameters discrete values specimens general squares different specimens computer programs
CAN,CAN1065,significance estrogen estrogen receptor regard significance ten prognostic total courses therapy merits receptor qualitative logistic qualitative logistic receptor important single introduction status receptor means endocrine therapy significant correlation receptor time consistent results support receptor primary time mastectomy resistant implications
CAN,CAN1066,estrogen progesterone estrogen receptor standard management endocrine therapy recent status primary good endocrine metastatic time furthermore primary important independent prognostic shorter progesterone receptor methods therapy positive pgr preliminary presence pgr
CAN,CAN1067,human endocrine therapy correlation presence estrogen progesterone pgr pgr receptor therapy pgr pgr pgr time positive sequential positive significance receptor mastectomy specimens therapy future
CAN,CAN1068,receptor carcinoembryonic therapy previous estrogen receptor metastatic mammary multiconcentration sucrose ers discrimination carcinoembryonic cea important therapy
CAN,CAN1069,estrogen progesterone endocrine therapy review estrogen progesterone endocrine therapy stage iv presence fmolmg protein antiestrogen tamoxifen hypophysectomy therapy presence pgr endocrine therapy findings antiestrogen therapy hypophysectomy metastatic
CAN,CAN1070,estrogen receptor endocrine cytotoxic human free estrogen receptor situations test quantification therapy prognostic positivity cytotoxic metastatic presence free independent status size lymph
CAN,CAN1071,quality receptor united kingdom estradiol receptor preparations institutions united kingdom results importance suitable quality programs receptor values
CAN,CAN1072,estradiol progesterone receptor progesterone receptor rp contents primary human anaplastic rp positive rp positive group evidence positive rp rp estrogen rp receptor therapy preliminary evidence rp primary sensitivity subsequent metastatic
CAN,CAN1073,estrogen receptor status receptor status cytotoxic retrospective extramural review receptor rich lowest postmenopausal programs favorable receptor rich
CAN,CAN1074,progesterone cytoplasmic progesterone receptor receptor progesterone ligand nonspecific coated techniques method progesterone receptor nuclear progesterone
CAN,CAN1075,lack estrogen receptor status possible estrogen situations post status cytotoxic time undergone extramural review significant status therapy classified failures due status prognostic postsurgical therapy prognostic nonhormonal therapy settings proven
CAN,CAN1076,prognostic estrogen receptor primary update receptor positive free primary presence presence metastatic lymph nodes positive pre postmenopausal
CAN,CAN1077,progesterone receptor management estrogen progesterone receptor specimens laboratory erp positive erp positive erp erp positive endocrine antihormonal therapy overall positive responders group vs treated endocrine overall treated endocrine overall therapy progesterone receptor utilized select endocrine estrogen presence
CAN,CAN1078,mastectomy estrogen receptor significant human tissues rich endocrine therapy thirds rich endocrine therapy results endocrine therapy time primary lesion nonetheless uncommon time unchanged general tendency time
CAN,CAN1079,ablations metastatic estrogen premenopausal oophorectomy postmenopausal metastatic estrogen receptor positive remission oophorectomy receptor remission oophorectomy endocrine significance endocrine therapy endocrine estradiol progesterone progesterone remission endocrine therapy
CAN,CAN1080,estrogen progesterone endocrine therapy progesterone pgr specimens significant positive unusual postmenopausal receptor thirds therapy whereas presence pgr prognostic presence
CAN,CAN1081,investigation thermostability powder vacuum thermostability lyophilized powder estrogen glucocorticoid steroids lyophilization powder hours slight specific sites estradiol stable hours specific estrogen sites glucocorticoid less hours estrogen less quality receptor
CAN,CAN1082,primary receptor status minimum months underwent mastectomy primary status effect free positive positive primary underwent minimum months endocrine therapy cytotoxic primary
CAN,CAN1083,estradiol receptor uterus human estradiol lyophilized human uterus method lyophilized uterus months weeks human months weeks minor sites recommended target tissues interlaboratory quality receptor
CAN,CAN1084,endometrium israel israel year primary endometrium females thirds times european stage correlation infertility year stage myometrial differentiation
CAN,CAN1085,oral unique specific relatives oral derived types noninvasive lesions grandmothers aunts oc noninvasive lesions oc usage grandmothers fh relatives grandmothers aunts mothers sisters significant covariable oc usage specific usage increases grandmothers reduces
CAN,CAN1086,rapid institute salah azaiz december reproductive potential risk rural recent pregnancy risk premenopausal rural menarche significant risk rural rural forty rapid general tunisian evidence progressive risk different
CAN,CAN1087,asbestos workers united deaths asbestos workers december little deaths asbestosis less general important asbestos diseases asbestosis pleural mesothelioma possible early full
CAN,CAN1088,malignant melanoma lesion female superiority efforts explain female superiority stage malignant melanoma female superiority prognostic correlation thickness many primary lesions favorable sites lesions favorable lesions lesions fact lesions group group fact womens lesions consonance thickness thin lesions thickness primary lesions thick
CAN,CAN1089,parametric total different surgeons serosal spread group parametric normal parameters sd times parameters conventional year time group prognostic lesions values cure risk due method prognostic values different
CAN,CAN1090,esophagogastric junction report occurrence carcinomas histological esophagogastric junction uncommon rare problems carcinomas uncommon carcinomas
CAN,CAN1091,male second report report second male son papillary male index son time correlation occurrence time
CAN,CAN1092,metastasized lymph second
CAN,CAN1093,carcinoembryonic juice early cea serum juice level serum cea satisfactory cea level juice normal subjects diseases cea juice early cea level level juice little glandular structure mucus
CAN,CAN1094,serum zinc copper ratio malignant lesions zinc copper ratio lesions malignant lesions evidence significant scl ratio malignant lesions related range scl scl ratio malignant lesions parameters malignant lesions
CAN,CAN1095,malignant lymphoma plasma differentiation unusual malignant lymphoma predominant histiocytic lymphoma discrete typical microscopy wide spectrum types immature developed plasma findings support process immunoblastic sarcoma plasma
CAN,CAN1096,pulmonary manifestations mycosis fungoides mycosis fungoides pulmonary findings open roentgenographic nodular pulmonary infiltrates interstitial atelectasis interstitial intra infiltrates skin short dissemination mycosis fungoides heralds
CAN,CAN1097,kinetics human parameters hthymidine index range stage values wall metastases discrete consistent theory intralesional lesions lilesion representative lesions little lesion lesion poorer metastatic less equal weeks weeks metastatic weeks growth growth important prognostic
CAN,CAN1098,malignant paraganglioma metastases paraganglioma cbp year female metastases lymph nodes metastases microscopy microscopy presence exclude sustentacular microscopy primary report malignant cbp cbp sustentacular microscopy types lesion hyperplasia
CAN,CAN1099,histogenesis brenner ultrastructure histology proliferative brenner brenner evidence celomic cysts transitional metaplasia cyst progressive growth branching transitional epithelium lesions brenner significance
CAN,CAN1100,sarcoma second malignant radiation genetic predisposition group osteosarcoma chondrosarcoma second malignant individuals genetic genetic predisposition radiation intervals sarcomas genetic therapy hypothesis genetic etiology
CAN,CAN1101,non hodgkins therapy hodgkins non hodgkins evidence radiotherapy none radiation therapy lymphocytic nodular histocytic nodular lymphocytic important respect histology presence sternberg time conventional months report ten uncommon significant therapy
CAN,CAN1102,results metastases radiation metastases recurrent primary headache weakness problems mental second weeks weeks
CAN,CAN1103,cytotoxic human cytotoxicity specific reactivity sera specific cytotoxicity significant cytotoxic sera different
CAN,CAN1104,primary serum cystine aminopeptidase serum cystine aminopeptidase normal primary sera method babuna normal nonpregnant uterus sarcoma normal primary size serum laboratory quick method qualitative nonpregnant valuable
CAN,CAN1105,second look epithelial anderson institute underwent exploratory second look status fifty evidence second look second look management important second look stage residual courses second look positive second look time second look radiation therapy poorer positive second look
CAN,CAN1106,cystic teratomas postmenopausal cystic teratomas year group collagenization teratoma end stage process group vigorous extent
CAN,CAN1107,glucose tumour pyruvate glucose landschutz tumour phosphate krebs ringer salt approx fructose conditions gradual recovery normal fructose values energy glucose preventable pyruvate oxobutyrate presence glucose protective effect pyruvate phenazine medium glucose depletion stage glyceraldehyde phosphate dehydrogenase phosphofructokinase results fructose constitutes energy phosphate primary metabolic pyruvate resultant inability unimpaired pyruvate lactate dehydrogenase regulatory phenomenon
CAN,CAN1108,balbcbyj methylcholanthrene sarcomas total methylcholanthrene sarcomas balbcbyj mice results direct correlation
CAN,CAN1109,presensitization human extrinsic signals carcinogenesis human populations carcinogens carcinogen methyl nitro nitrosoguanidine mnng aflatoxin glutamine medium estradiol insulin anthralin carcinogen carcinogen early treated mnng aflatoxin transformation populations carcinogen colonies soft pdl colonies soft nude mice
CAN,CAN1110,vitro nk vivo resistance leukemia beigenude wild mice partial nk vivo nk report resistance ascitic lines syngeneic bgbg mice normal heterozygous sc inocula leukemia lines bgbg mice lines mice idurd labelled leukemia bgbg mice pulmonary splenic radioactivity iv direct splenic cr leukemia vitro bgbg independent rapid doses tests possible free mice nk nude mice nude wild beige non nude mice results nk intact syngeneic host beige nude mice primary
CAN,CAN1111,receptor normal renal carcinomas glucocorticoid pairs normal tissues hormones tissues glucocorticoid renal tissues time sem normal fmolmg protein significant fmolmg protein normal sem versus sem significant receptor male sem nm females sem nm less fmolmg protein positive normal tissues occurrence estrogen normal endocrine therapy renal
CAN,CAN1112,colo rectal rectum calgary alberta toronto total neighbourhood undergone subject personal potential non risk months dietary recent bowel time findings risk bowel polyps total total protein crude fibre vitamin linoleic risk logistic risk evidence findings sets risk rectal neighbourhood females polyps
CAN,CAN1113,possible correlation exchanges lines exchange sce lines lymphatic sce lines normal lines malignant sce values lines general sce
CAN,CAN1114,demographic patterns nasopharyngeal united demographic nasopharyngeal united whites white lymphoepithelial carcinomas transitional carcinomas nasopharyngeal indices minor teenaged whites year nasopharyngeal recent females uniform nasopharyngeal demographic uniform
CAN,CAN1115,lines unique hodgkins vitro lines pleural histological independent pathologists demonstration nude mice intracranial subcutaneous plasma clot specific vca ia cytoplasmic htla igg fc lysozyme peroxidase chloracetate macrophages reed lack vitro explained conditions lines hodgkins
CAN,CAN1116,vitro sensitivity human melanoma drugs correlation vivo chemosensitivity single human melanomas nude mice vitro dacarbazine ccnu procarbazine vinblastine cancerostatic ricin vitro chemosensitivity soft growth doses drugs vitro sensitivity different vivo results evidence soft test sensitivity human vitro chemosensitivity tests
CAN,CAN1117,trends malignant melanoma skin cutaneous malignant melanoma respect time females south due year secular increases cohorts early cohorts generations stabilization recent cohorts persistent secular total melanoma
CAN,CAN1118,tumours tract report tumours tract tumours parameters diagnostic problems means literature favourable malignant tumour radical subject risk ups
CAN,CAN1119,lactic dehydrogenase mice lactic dehydrogenase shifts mammary
CAN,CAN1120,pulmonary choriocarcinoma pulmonary open thoracotomy conjunction fifteen remission effect hcg values pulmonary operative intervention pulmonary choriocarcinoma modifying good risk intervention primary uterus angiographical evidence pelvic evidence metastatic roentgenologic evidence pulmonary hcg
CAN,CAN1121,erythrophagocytic vinblastine platelets months unknown hepatosplenomegaly pancytopenia erythrophagocytic fel marrow open liver vincristine vincristine target platelets vinblastine th disappearance peripheral normal range marrow weeks pseudomonas sepsis months deliver merits exploration
CAN,CAN1122,effect lentinan migration factor syngeneic mice effect lentinan methylcholanthrene fibrosarcoma aphmcsi isografts hypersensitivity syngeneic enlargement lymph nodes dna synthesis migration factor lymph lentinan mice different times th day lymph mice time mice early enlargement lymph nodes bearers lentinan likely enhancement mif mif vitro employed micro migration
CAN,CAN1123,migration vitro aspecific migration vitro reactivity results investigation immunopathological theories
CAN,CAN1124,estrogen valid estrogen receptor underwent trials independent extramural positive remission adriamycin therapy remission adriamycin support lack estrogen receptor favorable
CAN,CAN1125,rapid estrogen estradiol estrone th detect estrogen ers lines human mammary mcf copenhagen prostatic ers techniques ethanolic tissues due human positive specific glandular epithelial specific nucleoli mcf vitro cultures estrogen key estrogen problems quantitation
CAN,CAN1126,phosphate estradiol estrogen tissues phosphate pep estrogen human pep receptor antiestradiol estrogen receptor system female pep estradiol diethylstilbestrol saline estrogen target uterus non target diaphragm unoccupied cytosolic estrogen dcc pep antiestradiol sites results dcc antiestradiol estradiol receptor vitro vivo pep receptor sites pep dcc receptor estradiol
CAN,CAN1127,techniques hormones immunoperoxidase estradiol progesterone human different degrees positive observations respect progesterone estrogen post eg nuclear estradiol cytoplasmic estradiol nuclear estradiol diethylstilbestrol conditions estradiol specific results specific due sites
CAN,CAN1128,estrogen receptor status polychemotherapy retrospective polychemotherapy female estrogen receptor status estrogen uptake primary metastases positive values fmolmg protein extramural review significant positive status free dominant utilized european evidence presence estrogen receptor remission retrospective cytotoxic status
CAN,CAN1129,antiestrogen therapy immunotherapy stage trial results cmf endocrine therapy immunotherapy undergone mastectomy stage months cmft therapy cmf free effect limited receptor positive estrogen receptor fmolmg
CAN,CAN1130,malignant lymphoma nonlymphoid leucocyte human reactivity human leucocyte human leucocyte hemopoietic normal epithelial tissues demonstrates cryostat serum ia serum membrane different isotypes epithelial normal positive types system express
CAN,CAN1131,histogenesis brenner cea brenner transitional metaplasia transitional intestinal epithelium goblet proliferative brenner metaplasia celomic epithelium brenner proliferative brenner contain carcinoembyronic cea transitional epithelium
CAN,CAN1132,resistance hybrid mice murine lymphomas immunopharmacology sequential mice lethal doses triazeno imidazole cyclophosphamide term endogenous profound mice conventional nude mice lymphoma homozygous resistance tumour host terms times lymphoma liver uptake dna iodo deoxyuridine idurd results vivo tests tests cytotoxic dependent resistance lymphoma level hybrid mice conventional nude idurd uptake resistance hemopoietic histocompatibility system pretreatment carrageenan antimacrophage nk mice vitro cytotoxicity test ie time vivo functions antilymphoma resistance resistant mice doses
CAN,CAN1133,isoenzymes human malignant lymphoma ief malignant lymphoma lymphocytic leukemia cll centroblasticcentrocytic lymphoma cbcc lymphoplasmacyticlymphoplasmacytoid lymphoma immunocytoma ic pc kiel results lymphoma types range cll bccc ic pc lymphomas possible transformation stage normal conditions ief normal regions phenotypical lymphomas ief patterns cll cbcc normal isoenzymes pc ic pc due isoenzymes results close lymphoma
CAN,CAN1134,short term radiation peripheral effect radiotherapy subpopulations peripheral hodgkins fc igg tg fc igm tm red orbc igg igm untreated tg tm radiotherapy severe depletion total values normal untreated treated unchanged radiation therapy partial progressive tm tm tg remission subsets peripheral group radiation seminoma radiation therapy effect subsets human
CAN,CAN1135,immunotherapy oral immune leukemia thirty oral immunotherapy significant immune parameters ppd group skin evidence tuberculin sensitization group recovery immune functions dissociation humoral weeks peripheral non igm significant rise parameters subsequent weeks normal parameters less time term equal serum status
CAN,CAN1136,vincristine etiology methotrexate therapy year methotrexate gm vincristine citrovorum standard sarcoma signs vincristine jaw reflexes clearance serum methotrexate severe methotrexate
CAN,CAN1137,tumorigenicity murine erythroleukemia lines differentiation tumorigenicity vitro differentiation friend erythroleukemia lines lines unmutagenized selection lines syngeneic mice lines proportional differentiate lines indistinguishable times resistance lines different differentiation lines proportional differentiation differentiation
CAN,CAN1138,malignant tumours cerium human observed malignant tumours angiosarcomas tumours cerium ce hind close tumours sarcomas angiosarcomas metastases time primary tumour tumour parameters tumours intraperitoneal hthymidine index primary tumours tumours angiosarcomas time mitotic indices less mitoses different times hthymidine ts tg tc tg results malignant tumours ce human problems malignant tumours man
CAN,CAN1139,cytomorphological lymphomas malignant lymphomas hodgkins non hodgkins manifestations nervous system time lumbar puncture positivity group leukemia positivity myeloblastic leukemia normal lymphocytic lymphoma importance systematic leukemia prevent intrathecal radiotherapy
CAN,CAN1140,intracellular putrescine spermidine deprivation induces uptake polyamines bisguanylhydrazone synthesis difluoromethylornithine uptake exogenous putrescine spermidine spermine medium tumour intracellular spermidine less untreated transport system spermidine micromolar deprivation tumour polyamines extent putrescine spermidine likewise methylglyoxal bisguanylhydrazone methylethanedylidinedinitrilodiguanidine previous tumour bisguanylhydrazone rapid proliferative effect
CAN,CAN1141,rna friend cytoplasmic rna friend tumoral rna sffv dna complementary rauscher rna size helper disappearance helper process
CAN,CAN1142,monocytogenes epithelioma growth monocytogenes normal monocytogenes phagocyte functions monocytogenes dissociation different macrophages functions
CAN,CAN1143,therapy observations prognostic factor therapy mycosis fungoides stage significant prognostic cutaneous visceral manifestations stage findings skin significant factor lymphadenopathy iv organomegaly sezary significant stage review stage skin lesions different types beam occupational employed industries risk risk industrial severe occupational etiology mycosis fungoides previous
CAN,CAN1144,nk macrophages mice nk cytotoxicity presence splenic suppressor vitro nk normal mice suppressor macrophages plastic radioresistant supernatants mice nk suppressor release
CAN,CAN1145,effect mammary chbi mice mammary mumtv sera chbi akr mice immunosorbent elisa sera chbi females male chbi female chbi foster females akr mice mumtv mammary inhibited mumtv lowest observed sera mice calday sera mice calday sera mice libitum correlation size dietary restriction mammary mumtv
CAN,CAN1146,hepatitis infection hepatocellular thirty philadelphia hepatocellular donors sera hepatitis hepatitis hbc none positive serologic infection donors seropositive positive hbc seropositive donors positive positive hbeag none sera hbeag seropositivity hypothesis infection conditions uncommon wide disparity seropositivity hbc unusual effect
CAN,CAN1147,human laz elutriation dihydrothymine dehydrogenase phosphorylase dtmp human laz different elutriation synchrony stage flow microfluorimetric dna incorporation dna manyfold phases dna synthesis specific thymidylate dihydrothymine dehydrogenase phosphorylase dtmp fate different level
CAN,CAN1148,receptor human sucrose estrogen preparations human profiles estrogen regard exchange specimens findings related receptor quantification quality laboratory uniformity quality receptor cooperative trials ensures correlations laboratory results
CAN,CAN1149,estrogen progesterone correlation endocrine therapies progesterone pgr primary recurrent metastatic ligand conjugates estradiol hydroxyprogesterone serum results conventional receptor specimens pgr endocrine therapies iv successful
CAN,CAN1150,correlation human correlations progesterone status mammary carcinomas positive lymphocytic plasmacytic estrogen receptor elastosis primary carcinomas endocrine therapy elastosis primary receptor positive estrogen receptor receptor valuable
CAN,CAN1151,correlation estrogen progesterone differentiation mammary system observed progesterone receptor mammary carcinomas receptor estrogen progesterone receptor rank correlation iii carcinomas receptor progesterone receptor iii specific types mammary
CAN,CAN1152,techniques receptor mammary techniques sucrose estrogen receptor carcinomas epithelial bsa fluor cmo estradiol bsa fluor estrogen phosphateanti estradiol methods correlation methods sucrose techniques method bsa fluor cmo estradiol techniques correlation bsa fluor estrogen preincubation diethylstilbestrol convincing problems receptor cryostat clarification techniques method estrogen receptor
CAN,CAN1153,hydrophilic human mammary carcinomas estrogen receptor receptor positive equal receptor ones heterogeneous progesterone receptor positive less estrogen receptor positive ones results inexpensive method human
CAN,CAN1154,medullary cortisol cushings metastatic medullary cortisol immunohistochemistry normal total liver metastases lymph lines lines total disappearance
CAN,CAN1155,radiotherapy implications patterns radiotherapy literature radiotherapy implications patterns radiotherapy emphasis patterns complications radiation results published ld complications outside spite cm safety ipsilateral primary evidence growth hence radiotherapy growth literature results size diagnostic patterns spread factor impact radiotherapy radiotherapy responders
CAN,CAN1156,year therapy radiotherapy programs stage iiimo months ipsilateral supraclavicular nodes iiimoscn distant metastases iiimi cranial latest cns programs date little effect metastatic vigorous need management iiimoscn valid distant metastatic
CAN,CAN1157,versus chemoimmunotherapy undifferentiated thirty cyclophosphamide adriamycin vp mer radiotherapy inferior untreated limited ninety remission cr limited cr limited months months months months responders extent months months limited free months therapy months mer serious infections deaths therapy morbidity extent
CAN,CAN1158,hepatocellular uganda thirty hepatocellular hc uganda institute hc intraarterial adriamycin selection drugs azacytidine rezoxane cyclophosphamide effectiveness alphafetoprotein observed adriamycin possible antagonisms drugs ligation good palliative iv adriamycin myelosuppression gastrointestinal mucous
CAN,CAN1159,occult occult hemoccult means colorectal diagnostic populations test results full investigation term hemoccult enema proven colorectal positive hemoccult test proven colorectal polyps hemoccult test colorectal colorectal positive presence gastrointestinal
CAN,CAN1160,pulmonary pulmonary fifteen monochemotherapy year pulmonary results worse none male months none histology year pulmonary
CAN,CAN1161,side quality trial primary nodes single chlorambucil chlorambucil methotrexate vincristine side quality side nausea malaise severe interfere lifestyle single side unbearable severe side hence
CAN,CAN1162,pancreatic results trial forty pancreatic trial initiation cyclophosphamide methotrexate vincristine mitomycin intervals weeks weeks metastases weeks group weeks metastases weeks weeks significant previous radiotherapy results general
CAN,CAN1163,second iii iv ovary non lesions courses second look remission second courses stage iii iv
CAN,CAN1164,monoblastic leukaemia results monoblastic leukaemia hyperleucocytic tumoral equal subjects sombre time meningeal nervous system level gingival cutaneous modest results
CAN,CAN1165,nasopharyngeal angiofibroma nasopharyngeal angiofibroma invasive non tumour male world uncertain management conditions experiences tumours schuur year excision wide operative oestrogen
CAN,CAN1166,early early undergone gastroscopy recurrent uncharacteristic early selection
CAN,CAN1167,true due technicalregistrational official figures factor true expectancy factor due deaths due liver european true
CAN,CAN1168,vertebral column ten primary macroscopic vertebral metastases recent normal tc nonvertebral metastases defects vertebral column metastases radiotherapy positive primary
CAN,CAN1169,transformation harvey murine sarcoma dna terminal dna sequences src protein harvey murine sarcoma end ligation terminal dna end src dna src dna
CAN,CAN1170,modulation vitro transformation direct potential vitro transformation host specific modulate vitro transformation little known hormones presence vitro transformation early diploid embryo
CAN,CAN1171,carcinogenicity nitrosodiethanolamine oils many preparations nitroso human diethanolamine triethanolamine possible risk human nitrosodiethanolamine test liver oral doses nasal doses subcutaneous carcinogenic nitrosodiethanolamine parts ppm drinking water months report hepatocellular carcinomas many doses nitrosodiethanolamine carcinogen short term tests mutagenesis test ames
CAN,CAN1172,friend leukaemia normal stem colonies partial total normal intact host differentiation normal malignant little known host host normal tumour induction recessive mutations steel sl locus normal haematopoietic stem leukaemia slsld mice malignant transformation tumour results microenvironment slsld mice report infection leukaemic spleens contain normal haematopoietic stem macroscopic colonies slsld vivo leukaemic friend
CAN,CAN1173,dna synthesis dna synthesis sarcoma dna synthesis dna synthesis aphidicolin dna synthesis sarcoma aphidicolin respect deoxycytidine triphosphate non competitive respect deoxynucleoside aphidicolin dna synthesis sarcoma liver sensitivity dna results compatible dna dna synthesis dna dna synthesis
CAN,CAN1174,human walker carcinosarcoma asparaginyl trna human placenta human liver liver trnaasn trna sequences walker carcinosarcoma trnaans primary cytoplasmic trnaasn eucaryotes trnas psi psi qg ta psi aoh propyluridine dihydroxyl yl aminomethyl deazaguanosine unknown qg replacement walker carcinosarcoma trnaasn primary post techniques sequences rnaase polyethylenimine thin trna partial
CAN,CAN1175,sequences heavy sequences germline gamma gamma gene pseudogene gene homologous gamma sequences sequences gamma gene tandem homologous repeats gamma gene kb orientation repeats kb gamma recombination heavy switching sequences recombination homologous sequences hypothesis sequences recombination sites gamma gamma
CAN,CAN1176,identification partial endogenous mammary rna restriction presence mammary mice mtv mammary restriction mtv virions mtv rna cleavage restriction rise mtv restriction
CAN,CAN1177,sv recent eukaryotic dna insoluble nuclear skeleton matrix dna loops matrix nuclease residual dna nuclear matrix sequences sequences nuclear matrix southern residual dna sv sv sequences matrix dna points total dna different lines infected globin residual matrix dna spatial dna sequences loops sequences
CAN,CAN1178,sv differentiation murine teratocarcinoma express histocompatibility express early embryos infection viruses types differentiation retinoic ecc parietal endoderm sv tumour primary sv gene following differentiated somatic sv abortive infection sv gene differentiation ecc single sv plasmid simplex gene sv report retinoic synthesis sv gene products specific normal hallmarks differentiation membrane protein
CAN,CAN1179,hypercalcemia evidence humoral nonhumoral hypercalcemia nephrogenous excretion plasma dihydroxyvitamin immunoreactive parathyroid specific nephrogenous excretion suppressed means vs nmol ml overlap primary hyperparathyroidism group excretion reductions excretion vs ml reductions vs pg milliliter immunoreactive parathyroid excretion nephrogenous hypercalcemia hypercalcemia humoral factor parathyroid subtypes hypercalcemia distinguishable primary hyperparathyroidism
CAN,CAN1180,nucleosomes intact evidence acetylase intact hepatoma htc htc prepared results vitro system nucleosomal coa different acetylase purified nuclear ha hb free hb ha acetylase cytoplasmic free acetylate nucleosomes vitro nucleosomes purified nuclear acetylase patterns intact coa crude preparations endogenous preference versus acetylase much extent whereas preference endogenous acetylases second nuclear acetylase cofactor acetylase support ha hb urea salt ethylmaleimide different extent htc untreated nucleosomes inaccessible cousens gallwitz alberts biol chem nucleosomal purified guide acetylases nucleosomes
CAN,CAN1181,retrospective polymyositis dermatomyositis diagnostic weakness proximal neck flexors single important diagnostic range underlying dermatomyositis connective
CAN,CAN1182,melanoma malignant melanoma retrospective overall year overall factor year
CAN,CAN1183,structure helix protein dna trypsin helix protein protein dna protein dna protein single dna ssdna double dna dsdna resistant sulfate elution ssdna method herrick alberts alberts biol chem heterogeneous regard weight range mr primary structure homology predominant preparative focusing protein tm polyda degrees helix protein sedimentation boundary noncooperative protein presence ssdna subcellular protein nuclear primary structure protein group protein hydrolysis protein discrete weights presence ssdna mr hdp ssdna hdp presence ssdna polydt thymus dna polynucleotides hdp dt hdp hdp hdp terminal end protein mr terminal end protein ssdna hdp ssdna hdp trypsin
CAN,CAN1184,protein phosphorylation insulin release intact insulinoma protein phosphorylation intact insulinoma insulin release phosphorylation mr insulinoma sulfate polyacrylamide slab phosphorylation half maximal plateau presence omission methyl gamma aminopropyl trimetho xyphenylacetonitrile hydrochloride effect glucagon microm insulin release dependent manner effect phosphorylation possible phosphorylation moreover insulin release phosphorylation half maximal insulin release phosphorylation microm microm consistent phosphorylation dependent protein resultant insulin
CAN,CAN1185,specific determinants myoglobin specific sperm whale myoglobin hyperimmune mice genetic trait myoglobin clones plots ka congruent none sperm whale myoglobin competitive human myoglobins myoglobins different determinants myoglobin competitors determinants
CAN,CAN1186,lactate dehydrogenase isoproterenol dehydrogenase messenger glioma dibutyryl monophosphate dibutyryl induction lactate dehydrogenase glioma hleucine lactate dehydrogenase lactate dehydrogenase lactate dehydrogenase sodium sulfate polyacrylamide gels isoproterenol isobutyl methylxanthine dibutyryl hleucine incorporation glioma lactate dehydrogenase kinetics induction deinduction degradation lactate dehydrogenase presence induction due synthesis synthesis isoproterenol isobutyl methylxanthine specific synthesis lactate dehydrogenase level functional lactate dehydrogenase free protein system glioma rna isoproterenol dibutyryl translation isoproterenol dibutyryl fold rna synthesis lactate dehydrogenase isoproterenol dibutyryl level lactate dehydrogenase glioma determines extent synthesis lactate dehydrogenase
CAN,CAN1187,cathodic serum stomach coagulation rare serum cathodic year male stomach coagulation upper gastrointestinal serum mb serum lactate dehydrogenase preferential leakage mitochondrial glutamate dehydrogenase presence damage
CAN,CAN1188,excretion hexosaminidase different excretion hexosaminidase different proteinuria stage renal dysfunction hexosaminidase excretion findings excretion good correlation excretion level proteinuria bence jones possible renal injury
CAN,CAN1189,angiodysplasia vascular malformations spine exploration spine malformations cervicocephalic vascular malformations embolization lesions lesions venous fistulae vertebral medullary lesions pseudomalformations embolization vascular miniaturization enables vascular malformations micro emboli
CAN,CAN1190,hypoglycemia glucose insulin results identification hypoglycemic operative quantity insulinemia insulino secretory technical excess minutes glycemia gl level significant observations hyperplasia removal lesion fall insulinemia noticeable level hyperplasia fall latter test results enucleo corporal splenopancreatectomies post operative
CAN,CAN1191,unusual recurrent pericarditis esophageal leiomyosarcoma primary cortico year recovery months esophageal leiomyosarcoma tumoral purulent esophagobronchial fistula tumoral cryptogenetic corticotherapy fistulae severe months leiomyosarcoma published literature possible esophageal lesions unknown
CAN,CAN1192,leiomyosarcoma inferior leiomyosarcoma inferior total published literature renal excision venous reconstruction renal malignant symptomatology upper middle inferior upper budd obstruction atrium middle early cavography
CAN,CAN1193,report review literature malignant lymphoma manifestations compression murmur oslers complications due published literature iatrogenic post radiotherapy pericarditis cobalt radiotherapy lymphomas etiology
CAN,CAN1194,sarcoma lines day ix permanent lines sarcoma presence veratridine na uptake dependent channels classify glial degrees transformation anchorage independence growth dependent growth lines degrees transformation normal respect veratridine na uptake growth specific protein glial fibrillary protein differentiation non
CAN,CAN1195,cancerous diseases normal malignant disorders immunoassay values discrepancy serum hepatobiliary disorders serum level normal range renal renal diseases diseases serum plasma bence jones diseases
CAN,CAN1196,problems personal encounter openly regard needs comfort reassurance
CAN,CAN1197,idiopathic fibrogenous interstitial pneumopathy personal observations literature general review idiopathic fibrogenous interstitial pneumopathy diffuse idiopathic interstitial fibrosis emphasis functional ventilationperfusion ratio interstitium lavage runs evolution episodes infection concurrent respiratory complications pre coronary transformation elderly recent structure respect lavage gallium scintigraphy disappointing corticotherapy azathioprine fibrosis pneumoconiosis extrinsic iatrogenic pneumopathy pulmonary fibrosis specific entity
CAN,CAN1198,lymphoma heart unusual pericardial effusion report tamponade laboratory pericardial unhelpful exploration presence lymphoma myocardium right obstruction flow satisfactory date successful tumour
CAN,CAN1199,grey cholangiography tract obstructive tract cholangiography unhelpful grey cholangiography findings grey obstructive hepatocellular obstruction obstruction cholangiography obstructive hepatocellular obstruction cholangiography ampullary grey cholangiography complementary invasive diagnostic cholangiography grey ducts provide diagnostic cholangiography drainage grey shows ducts retrograde contract
CAN,CAN1200,myeloblastic leukaemia non lymphoma myeloblastic leukaemia aml non lymphoma lymphoma nodular months months preleukaemia pancytopenia leukaemia myeloblastic risk amls nhls management lymphoma favourable
CAN,CAN1201,diffuse polypoid lipomatosis coli hypertrophy appendices congenital lipomatosis year diffuse polypoid lipomatosis hypertrophy appendices subcutaneous lipomata lipomatosis coli picture uniform dysplasia
CAN,CAN1202,malignant immunomorphologic results malignant hodgkins non hodgkins pseudolymphomas histology immunomorphology tumour hodgkins non hodgkins kiel lymphocytic leukaemia cll immunoblastic lymphomas ib ib ib histiocytic reticulosarcomas immunomorphology formalin paraffin cut cll lymphomas ic ic lymphoplasmacytoid plasma igmk ic biclonal ml double ib lymphomas contained igmk hodgkins hypothesis lymphogranulomatosis lymphoepithelioid lymphoma pseudolymphomas plasma immunomorphology ml extent derivation ml
CAN,CAN1203,lateral naevi handle problems suitableness operative therapies remarkable skin defects malignity ways lateral naevi group skin results significant radiotherapy
CAN,CAN1204,intracranial important problems intracranial emphasis herniation due intracranial important neuroepithelial regard therapy related meningeomas neurinomas metastases
CAN,CAN1205,sarcoma adenylosuccinate state sarcoma purified sepharose weight sw weight hcl values optimum km values gtp competitive respect ki mono diphosphate inhibitions specific full presence mn divalent metal ions zn cu mn hg sh group important
CAN,CAN1206,nitrosoureas malignant glioma weeks definitive intervention malignant glioma regimens meccnu radiotherapy carmustine bcnu radiotherapy semustine radiotherapy total valid group skin reactions radiotherapy reversible leukopenia due radiotherapy nitrosourea semustine group carmustine radiotherapy carmustine radiotherapy semustine radiotherapy significant carmustine radiotherapy modest term level radiotherapy post malignant glioma search radiotherapy
CAN,CAN1207,leukaemia mice important process polytropic viruses recombination regions endogenous viruses sequences regions envelope gp akr hrsj mice unique oligonucleotide sequences specific peptides refs viruses mice findings random recombination rise polytropic viruses weissman target malignant transformation specific diversity polytropic gp hypothesis diversity verify
CAN,CAN1208,energetics diffusion transport folic methotrexate fluxes energetics transport influx fluxes net exchangeable intracellular methotrexate level intracellular methotrexate steady state na intracellular water electrochemical potential methotrexate steady state intracellular methotrexate level fluxes na transmembrane gradients methotrexate little effect fluxes steady state level methotrexate influx steady state glucose presence glucose presence iodoacetate trans hmethotrexate influx methotrexate phenomenon na results methotrexate transport parameters reveals system
CAN,CAN1209,plasma membrane isolation heavy membrane glycogen free work report isolation plasma membrane free sucrose heavy short term mild dounce homogenization postnuclear pii portions membrane prepared plasma membrane discontinuous sucrose sucrose sedimentation velocity conditions fold heavy overall yield protein contamination nuclear minor mitochondrial contamination heavy sedimentation golgi presence membrane microscopy sialic membrane thin etch microscopy heavy membrane
CAN,CAN1210,human histocompatibility histocompatibility hla man gene serum components sets histocompatibility review michael michael crumpton recent structure hla bv
CAN,CAN1211,growth key subpopulations immune system investigation lymphoma lines effector functions growth lines human review james colleagues outstanding questions bv
CAN,CAN1212,wtl oncology programs participants therapy significant ninety personal needs related ninety
CAN,CAN1213,fifty current theory easy inflammatory hand transformation tissues leucocytic factor transformation reactions tissues due transformation
CAN,CAN1214,sarcoma botryoides extrahepatic ducts sarcoma botryoides year cross striation many thin thick filaments rhabdomyosarcoma paraffin
CAN,CAN1215,unusual histological pelvic radiation therapy uterus ovary unusual parts sarcomatous primary tumour metastases
CAN,CAN1216,hemangioendothelioma true anaplastic critical histological malignant hemangioendothelioma anaplastic spindle giant obvious traumatic shrinkage artefacts due fixation repair due malignant hemangioendothelioma nodular vascular spaces angioblastic tumour differentiation epithelial arrangements malignant hemangioendotheliomas lack diagnostic anaplastic spindle giant european endemic regions anaplastic spindle giant extrathyroid tumours trachea oesophagus lymph distant metastases different malignant hemangioendothelioma tumours malignant hemangioendothelioma goitrous growth anaplastic spindle giant tumour
CAN,CAN1217,insulin islets insulinoma islets pancreas diabetics insulinoma microscopy immunohistological insulin labeled insulin microscopy fibrils protein related insulin protein weight
CAN,CAN1218,epidermal sh human metastases presence human epidermal sh human different types double radial immunodiffusion specific immunoreactive protein tumours anaplastic polygonal carcinomas immunoreactive protein primary tumour metastases contain identity carcinomas epidermis methods results epidermal sh epithelial differentation epithelium
CAN,CAN1219,cytophotometric nuclear dna mastopathy epithelial hyperproliferation introduction histogenesis significance mastopathy epithelial hyperproliferation lesion hamperl scirrhous types carcinomas problems cytophotometric dna methods dna leitz microspectrophotometer plug intraductal extraductal epithelial results extraductal pseudoinfiltration intraductal hyperproliferation dna patterns apocrine intraductal apocrine metaplasia dna malignant lesions mastopathy epithelial hyperproliferation risk invasive lesions term epithelial hyperproliferation lesions wide excision whereas subcutaneous mastectomy plastic
CAN,CAN1220,secretory secretory carcinoembryonic bowel carcinomas epithelium bowel carcinomas presence secretory sc secretory carcinoembryonic tumour transitional mucosa scores histological dukes cea parametric correlation tumour sc histological tumour related dukes tumour secretory sc tumour cea correlation parameters contents sc secretory transitional mucosa dukes stage plasma epithelial primary malignant unknown tumour sc prognostic
CAN,CAN1221,induction intestinal metaplasia mucosa optimal condition induction intestinal metaplasia mucosa female wistar daily times group times group effect immunization stomach daily times group group group stomach process group results times group intestinal metaplasia fundic mucosa due parietal parietal fundic rise intestinal metaplasia
CAN,CAN1222,malignant degeneration condylomata uganda vulva penis derived wide elderly geographical correlations districts condylomata elderly histological report elderly malignant degeneration group condylomata whereas none time condylomata values months review literature malignant degeneration months medium range observations findings adduce malignant degeneration tentative direct evidence postulated condylomata condylomata lesions risk time risk short time
CAN,CAN1223,histogenesis cavernous hemangiomas skin hemangiomas skin microscopy histogenesis findings histogenetic hemangiomas fetal undifferentiated angioblastic anlage rise buds stage corresponds early embryonic vasculogenesis growth due fetal postnatal vasculogenesis mature findings theories angiomas angioblastic theories possible normal skin process sprouting open cavernous tele angiectasias
CAN,CAN1224,evidence fibrils granular subcutaneous granular phosphotungstic reveals intracellular fibrils outside ribosomes ergastoplasmic sacs pericellular membrane precollagen true membrane granular fibroblasts sheaths precollagen
CAN,CAN1225,occur gonads somatic genetic endocrine females possess tumour gonadoblastoma connective hyalinization obliteration lesion gonadoblastoma overgrown dysgerminoma malignant tumour occurs normal female normal elderly tumours admixed different patterns proliferative rare metastases
CAN,CAN1226,open heart concomitant pulmonary resection concomitant diseases amenable underwent pulmonary resection severe bron chiectasis mitral mitral replacement coronary pulmonary bilobectomy concomitant coronary operative techniques
CAN,CAN1227,congenital esophageal cysts cysts rare cysts cysts problems congenital esophageal cysts
CAN,CAN1228,demonstration malignant pericardium pericardial effusion mediastinal findings ct ct findings urgent pericardiocentesis pericardial tamponade renal papillary mesothelioma pericardium ct pericardial
CAN,CAN1229,successful methotrexate therapy oral florid papillomatosis oral florid papillomatosis rare name papillomatosis oris scheicher gottron condition malignant degeneration excision methods fact methods literature favourable doses multifocal oral florid papillomatosis excision inadequate extensiveness lesion methotrexate remission methotrexate oral florid papillomatosis
CAN,CAN1230,effect sarcomagenesis foreign subcutaneous intact cellophane rise sarcomas latent cellophane neu sarcomas latent cellophane intraperitoneal neu latent morphological sarcomas neu tht resultant cellophane cellophane
CAN,CAN1231,cea therapy management early cea diagnostic methods metastatic spread pretreatment cea early adaption metastatic spread group metastases group group cea values time months positive possible cea group group cea successful radiotherapy normal cea values unchanged cea normal range
CAN,CAN1232,flow cytometry neoplasia polarization detect pha peripheral early state single flow cytometry epi arrangements polarization usual polarization human diacetate preincubation pha group healthy donors polarization pha whereas group malignant polarization pha
CAN,CAN1233,bestatin immunomodulator metastatic types bestatin daily single weeks counts unchanged rosette fc igg weeks peripheral chang ppd slight significant pha observed weeks bestatin bestatin nontoxic functions human
CAN,CAN1234,lumbar spine metastases invasive diagnostic investigation spinal column total scanners metastatic lumbar spinal sarcoma normal lesions ct lesion spinal column investigation contribute metastatic lumbar spinal column
CAN,CAN1235,tumoral cysticercosis granulomatous lesions due cysticercosis ct fixation test cysticercosis etiological craniotomy
CAN,CAN1236,thoracic extramedullary extramedullary homozygous thalassemia progressive paraparesis ectopic spinal epidural removal radiotherapy successful second posterior mediastinal intervention heterotopic marrow thoracic
CAN,CAN1237,transaxillary pleurectomy pneumothorax year transaxillary pleurectomies definitive pneumothorax persistent nonexpansion operative unsuspected reexploration clot removal ten episodes recurrent ipsilateral pneumothorax pulmonary results significant values
CAN,CAN1238,marlex methyl methacrylate prosthesis wall resection methyl methacrylate layers wall anterolateral resection coverage latissimus myocutaneous reconstruction
CAN,CAN1239,nipple independent screens mastectomy risk risk nipple areolar nipple signs cutaneous signs size subareolar multicentricity fifty mastectomy york cornell university underwent risk risk screens risk group nipple group screens risk group nipples group
CAN,CAN1240,exophytic malignant melanoma cleveland exophytic malignant melanoma uncertain report cleveland deaths lymph distant metastases year free year lesions clark level iii iv correlation lesions thickness free lesions thickness free lesions findings support exophytic malignant melanomas malignant potential malignant melanomas clark thickness
CAN,CAN1241,nuclear dna estrogen human mammary carcinomas dna estrogen receptor primary mammary carcinomas female mammary carcinomas dna diploid tetraploid dna values normal mammary epithelium hand mammary carcinomas dna normal dna synthesis degrees unmeasurable results correlation nuclear dna patterns primary carcinomas
CAN,CAN1242,prognostic significance nuclear dna chondrosarcoma nuclear dna chondrosarcomas chondromas ackerman chondromas normal nuclear dna chondrosarcomas dna chondromas diploid hyperploid nuclear dna ploidy year ploidy significant prognostic conventional diploid chondrosarcomas favorable hyperploid chondrosarcomas prognostic ploidy ploidy level bydifferent courses malignant primary chondrosarcomas hyperploid direct metastases hyperploid
CAN,CAN1243,cytomorphometric intermediate microphotometric intermediate normal consistent presence premalignant malignant normal intermediate diagnostic potential
CAN,CAN1244,zypab processing system zypab durch automatische bildverarbeitung system past processing system camera diagnostic nuclear statistical unknown normal epithelial possible differentiate inadequate smears
CAN,CAN1245,genital swedish ten year retrospective symptomatology diagnostic genital swedish genital gynecologic genital postmenopausal infertility conservative radical therapy primary conservative normal pregnancy nil risk ectopic pregnancy
CAN,CAN1246,different current literature experiences management therapy nodules isthmectomy dominant nodules total proven possible lymph nodes visceral prevent significant functional deformity therapy therapy experiences recurrent metastatic regressions therapy
CAN,CAN1247,management cutaneous malignant melanoma cutaneous malignant melanoma stage incapable metastases excision recognition impact system excisional primary melanoma enables primary lymph nodes refinement melanoma immunotherapy awaits demonstration
CAN,CAN1248,subdural hematoma metastatic subdural hematoma tomographic possible support obstruction subsequent subdural
CAN,CAN1249,dynamic arachnoid cysts intracranial arachnoid cyst diagnostic problems ct csf perfusion paramedian cysts hand functional dynamic unknown ct metrizamide ccm time arachnoid dynamic
CAN,CAN1250,promutagen rodent postmitochondrial microsomal normal rodent aroclor promutagens aminofluorene benzanthracene benzoapyrene presence lytk compatible preparations carcinogens varied aroclor aroclor induction mutagenicity benzoapyrene methylcholanthrene preparations aminofluorene mutagenic swiss liver blu ha icr polycyclic general mutagenicity cytotoxicity promutagen methylcholanthrene metabolizing th aroclor degrees degrees weeks liver anthracene anthracene aroclor induction anthracene mutagenicity mutagenicity benzanthracene current state somatic
CAN,CAN1251,exchange induction carcinogens vitro system htc exchanges carcinogens exogenous microsomal preparations nitrosodiethylamine den aflatoxin significant sces ultraviolet significant sces induction sces inhibited estradiol microsomal carcinogens htc sce test sensitivity sce htc system carcinogens system potential hormones carcinogens
CAN,CAN1252,toxin resistance human normal prone individuals mutants toxin dipr human normal subjects individuals genetic predisposition xeroderma fanconi blooms methyl nitro nitrosoguanidine mnng dipr mutants dipr mutants dependent manner mnng ethyl toxin mutationscellgeneration gm mutationscellgeneration bloom
CAN,CAN1253,radiographic thoracic disorders thoracic disorders cattle buffaloes total diaphragmatic disorders metastatic neoplasia pericarditis foreign hydrothorax foreign
CAN,CAN1254,sequences infection human encodes early products early infection normal different times lytic sequences infection cultures infected mutants deletions infections mutants dna protein synthesis genomes ei sequences products dna early ei dna free genomes mrnas sequences early sequences results recognition infection regulatory signals free ei dna free sequences different host transcripts lytic
CAN,CAN1255,surfaces teratocarcinoma lethal lethal normal pre embryos teratocarcinoma homozygous recessive mutations early homozygosity post lethal tr results definitive time genotypes
CAN,CAN1256,pharmacokinetics oral humans pharmacokinetics single iv oral doses female plasma level unchanged microgramml half plasma clearance mlmin flow oral unchanged plasma microgramml half overall oral unchanged individuals oral doses evidence
CAN,CAN1257,teratoma neonatal cardiorespiratory distress amenable teratoma early severe cardiorespiratory distress results infant recent cardiorespiratory distress enlargement cardiothymic demonstration pericardial effusion early recognition successful
CAN,CAN1258,synergistic effect hyperthermia murine neuroblastoma hyperthermia murine forty ajax mice subcutaneous implants group therapy group radiofrequency hyperthermia milliwattscm group mgkg group single intraperitoneal cyclophosphamide cpm vincristine vcr mgkg group cyclophosphamide vincristine group hyperthermia group hyperthermia cyclophosphamide vincristine group hyperthermia cyclophosphamide vincristine therapy implant size cm free wk group group group hyperthermia group less versus wk group responders group group group group versus synergistic effect hyperthermia murine neuroblastoma observations nonresponders conventional therapy
CAN,CAN1259,inflammatory fibroid polyp inflammatory fibroid polyp lesion tumoral inflammatory kind
CAN,CAN1260,human malignant human astrocytoma electrophysiological membrane specific ohm cm specific capacitance microfaradscm time membrane potential input resistance megohms contactual noncontactual resistance membrane potential time cel cycling
CAN,CAN1261,glucose uptake murine leukemia ly decreases glucose reactions murine leukemia ly uptake minutes dna rna protein synthesis hours kinetics rapid uptake rapid uptake growth membrane transport specific observed synthesis
CAN,CAN1262,electrolyte non electrolyte previous evidence state water total water ww water minimum total na milliequivalents liter water electrolytes water evidence na exists second exchangeable ethylene glycol volumes ethylene glycol water urea water stage water final urea urea time results osmotic urea
CAN,CAN1263,adsorptive neuroblastoma ricin horseradish peroxidase ricin cultures morphological techniques ricin ricin ligand process constants ricin ricin sites ricin monolayers proportional receptor fewer sites neuroblastoma positive golgi ricin residual uptake ricin times free ricin monolayers fold uptake peroxidase residual results adsorptive ricin residual uptake uptake possible ricin ricin ricin grain degrees evidence plasma membrane
CAN,CAN1264,techniques stage reconstruction cheek rotation flaps cheek lateral cheek defects methods bilobed cranial rotation flaps lateral defects
CAN,CAN1265,terminal deoxynucleotidyl transferase lymphoma terminal deoxynucleotidyl transferase clones radiation murine leukemia rl male tumourigenicity syngeneic mice lines predominant cytoplasmic equal male positive tumourigenic overall different elution patterns rl male tumourgenic findings tumourigenicity
CAN,CAN1266,cytotoxic therapy therapy results quality guidelines tactics regard kinetics
CAN,CAN1267,perforation bowel enteritis report term bowel enteritis perforation bowel rare bowel bowel enteritis obstructive
CAN,CAN1268,gallstones risk gallstones necropsy countries bowel stomach deaths gallstones positive correlations countries results share metabolic
CAN,CAN1269,porcine intestinal epithelial dysplasia infiltration intestinal pia epithelial dysplasia infiltration epithelium tissues lymphatics drainage lymph nodes intracellular bacterium campylobacter pia epithelial dysplasia infiltration related damage
CAN,CAN1270,crohns morbidity crohns term review morbidity geographical tumours risk less tumours sites digestive system risk significant excess tumours upper less gastrointestinal tract excess digestive system
CAN,CAN1271,protein membrane friend different values interaction friend hfl weight adsorbate fewer weight adsorbates weight way polysarcosine components gelatin lysozyme polysarcosine concanavalin non components
CAN,CAN1272,growth mammary concurrent endogenous protein phosphorylation mammary retinoic drugs results growth cultures endogenous protein phosphorylation gamma prominent retinoic cultures phosphorylation regions drugs extracts regions phosphorylated extracts concurrent growth
CAN,CAN1273,murine lymphoma degrees murine lymphoma lines lyr degrees lines lethal date lines radiation leakage degrees degrees observed net observed protein
CAN,CAN1274,tumours hexachlorobenzene group female ppm hexachlorobenzene weeks liver tumours none evidence skin lesions nervous doses liver tumours mrc wistar female weeks
CAN,CAN1275,dna damage repair hematoporphyrin photoradiation induction repair lesions single hpd photoradiation equal dna damage photoradiated time magnitude repair dna damage repair repair
CAN,CAN1276,correlation carcinogen dna synthesis human incorporation hthymidine dna human mutagenic hthymidine incorporation hthymidine incorporation theophylline dna damaging incorporation hthymidine dna effect theophylline depletion hthymidine incorporation dependent normal carcinogen theophylline removal theophylline ribose dna repair human
CAN,CAN1277,method surfaces intact human membrane method surfaces human membrane vitro membrane intact human placenta membrane single epithelium membrane thin epithelium membrane impermeability serum membrane glycoproteins microscopy immunoperoxidase iv membrane metastatic intact membrane dissolution lamina
CAN,CAN1278,inner mitochondrial hepatoma outer inner hepatoma liver whole ratio phospholipids inner outer diphosphatidylglycerol hepatoma inner membrane results previous work
CAN,CAN1279,vitro murine epithelial epithelial liver spectrum malignant cysts subcultures adenocarcinomas invasive metastatic potential growth malignant potential homotypic metastatic cultures valuable epithelial human
CAN,CAN1280,serum benzolapyrene injected chylomicrons vivo chylomicrons benzoapyrene bap carcinogenic hydrocarbon disappearance bap removal cm rapid decay slow decay end rapid total injected bap serum total bap slow bap serum specific liver tissues results polycyclic tends chylomicrons
CAN,CAN1281,nuclease types types mammary dbah hepatoma chloroleukemia degradation degrees polysomes normal tissues ribosomes normal counterparts degradation polyu nuclease preparations presence chloromercuribenzoate rnaase preparations free nucleases ribosomes protein synthesis vitro presence endogenous exogenous preparations normal tissues nuclease
CAN,CAN1282,primary female urethra management female primary urethra condition gynaecological urological units good condition non specific urological interstitial implants tumours beam deeper tumours possible recurrent resistant
CAN,CAN1283,oestrogen prostatic prostatic primary oestrogen partial primary oestrogen therapy ineffective
CAN,CAN1284,management overall year ninety deaths radiotherapy term future
CAN,CAN1285,radiotherapy minimum invasive tumours radical radiotherapy tumours radiation developed complications crude year tumours pre operative radiation overall important tumour populations tumours radiosensitive crude year tumours crude year tumours good radiotherapy insist
CAN,CAN1286,tnm satisfactory papillary tumours problems invasive invasive tumours
CAN,CAN1287,transitional residents bradford health districts districts sequential rank method excess deaths stage tumours
CAN,CAN1288,urothelial upper tract urothelial tumours tumours ureteric tumours multifocal tumours transitional carcinomas year year multifocal occurrence differentiation coat conservative resection tumours poorer
CAN,CAN1289,cryosurgery lichen sclerosus atrophicus vulva sclerosus atrophicus vulva cryoprobe severe relieved post operative proven leukoplakia post
CAN,CAN1290,morphological tumours tumours early glial glioma ethyl nitrosourea ix lengths time vitro frontal tumour yield gliomas malignant differentiated size shape presence necrosis vascularity tissues morphological tumours vivo glial
CAN,CAN1291,propyl formylhydrazine mice propyl formylhydrazine pfh drinking water swiss mice tumours lungs preputial tumour incidences tissues whereas untreated pfh conditions tumours lungs incidences mice tumours adenocarcinomas lungs papillomas carcinomas preputial investigation inquiry formylhydrazine
CAN,CAN1292,hyperphagocytosis effect tumour mice hybrid mice sc mammary carcinomas weeks mice plasma micron coli endotoxin iv mice plasma non tumour progressive tumour growth liver parallel mice tumour transplant uptake labelled transaminase ornithine carbamoyl transferase oct rise lps lps level rise mice tumour hepatocytes rise tumour mice
CAN,CAN1293,method misonidazole method neurotoxicity misonidazole miso fluorimetric glucuronidase galactosidase nervous tissues sciaticposterior tibial sptn cut ip wistar mgkgday maximal increases glucuronidase galactosidase sptn weeks increases significant miso weeks miso peripheral damage method potential sensitizing drugs
CAN,CAN1294,cytotoxicity tumour vivo vitro sarcomas sensitivity tumour tumours vivo vitro tumours cbsaf vitro resistant vivo vitro adriamycin excision resistant vitro explain discrepancy vivo resistance vitro sensitivity discrepancy due growth factor chemosensitivity plateau much resistant important factor chemosensitivity tumour range important
CAN,CAN1295,vivo interaction drugs misonidazole metronidazole cyclophosphamide bcnu misonidazole miso metronidazole metro cyclophosphamide tumours effect tumours doses ineffective hypoxic mice weight myelosuppression index miso growth bcnu sarcoma effect tumours drugs host ovary vitro serum mice results miso metabolites hypoxic hypoxic bcnu presence undetermined normal misonidazole metronidazole bcnu cyclophosphamide
CAN,CAN1296,vivo interaction drugs misonidazole metronidazole methotrexate adriamycin growth tumours mice misonidazole miso metronidazole metro methotrexate fu adriamycin adr nitroimidazoles effect growth tumour miso mgg mammary fibrosarcoma growth miso metro fu delayed growth tumours growth single miso miso host miso metro little fu adr miso deaths adr anticancer drugs myelosuppression metro miso tumour drugs host nitroimidazoles
CAN,CAN1297,clostridia minor stool specimens nuclear dehydrogenation ndc total fba mumolg faeces significant degradation bowel fba ndc isolation oestrogen aetiogy
CAN,CAN1298,primary degeneration haemodynamic ninety valves evidence degeneration thirty valves degeneration valves significant degeneration primary degeneration findings catheterisation results results presence primary degeneration echocardiography helpful histological primary mitral degeneration mitral mitral lesions evidence none degeneration syphilis primary degeneration valves
CAN,CAN1299,diffuse sclerotic diffuse sclerotic lesions metastatic hodgkins malignant early prominent diffuse sclerotic lesions review literature
CAN,CAN1300,cytotoxicity rheumatoid normal peripheral mononuclear human lines cytotoxicity unfractionated peripheral mononuclear rheumatoid normal individuals human lines preferential recognition lines rheumatoid
CAN,CAN1301,retrospective primary thoracic neuroblastoma respiratory neurological tract tract normal tract previous infections minimum months direct tumour partial excision primary thoracic neuroblastoma sites
CAN,CAN1302,sputum asbestos former asbestos workers tissues asbestos sputum former amosite asbestos workers subjects subject sputum cough day hypertonic saline induction papanicolaous stain total significant correlation gram sputum positive asbestos sputum specimens workers lungs
CAN,CAN1303,review mammograms helpful needle needle excisional circumareolar incision mastectomy layers manifestations
CAN,CAN1304,extrathoracic esophagectomy esophageal extrathoracic potential results resectional therapy esophagus pulmonary complications report operative functional results extrathoracic esophagectomy reconstruction esophageal results nonrandomized standard esophagogastrectomy extrathoracic esophagectomy pulmonary dysfunction standard esophagogastrectomy significant standard esophagogastrectomy group months none esophagectomy group months anastomotic extrathoracic standard esophagogastrectomy
CAN,CAN1305,mice future teratoma teratocarcinoma transformation system genetic mice early embryos portions sites due presence stem multipotential proliferate differentiate tissues types representative embryonic layers blastocysts pseudopregnant normal host blastocyst malignant differentiate types contribute subsequent selection blastocysts contains possible stock mice lesion system selection genetic mice
CAN,CAN1306,shipfitters workers boilermakers afl cio shipyards metal boat method race risk malignant nonmalignant respiratory deaths malignant nonmalignant respiratory diseases nonmalignant respiratory excess related cumulative specific job suicide shipfitters burners
CAN,CAN1307,patterns types females fold ratio papillary carcinomas females papillary specific cohorts progressive increases coincides radiation therapy conditions neck fitting logistic risks cohorts consistent radiation
CAN,CAN1308,dna repair peripheral radiotherapy dna excision repair peripheral repair betatrone normal conditions schedules therapy dna repair inhibits repair therapy short time extent dna repair normal level
CAN,CAN1309,melanoma growth fish xiphophorus partial doses hereditary melanomas xiphophorus helleri dorsal gene sd introgressive maculatus helleri hybrids helleri melanotic fish sibs brood total partial doses melanomatous regions peduncle dorsal dorsal fins rest trunk radiation time second intervals melanotic prints planimetrical measuring total dorsal significant melanoma growth fish
CAN,CAN1310,vitamins group vitamin tumour vitamin pyridoxine pyridoxal phosphate single gy significant radiation excretion urine growth radiation gy radiation metabolic typical vitamin
CAN,CAN1311,radiation therapy early radiation therapy stage ovary possible paraaortic intradiaphragmatic direct lymphatic gy target radiation therapy system lateral circular satellites rectangular satellites intestine good geometrical satellites
CAN,CAN1312,endoscopic retrograde cholangio pancreaticography computer pancreatitis pseudocysts pancreas retrograde cholangiopancreaticography ercp computer ct short time ercp ct pancreatitis pseudocysts carcinomas pancreatitis ercp ct valuable method findings method complementary pseudocysts ct ercp primary whereas findings
CAN,CAN1313,lymphatic leukemia chromosomic cytogenetic medulla lymphatic leukemia possible supernumerary acrocentric group related literature chromosomopathy
CAN,CAN1314,health therapy management critical providing therapy rural therapy homes visits nearby practitioners therapy visits significant rank sum test neutropenia infection findings practitioners management system total therapy
CAN,CAN1315,oral tongue oral tongue combines radiation therapy results results year level tongue oral pharyngeal group commission audit college surgeons results institutions probable cure time
CAN,CAN1316,regard findings signs findings thirty unusual findings dependent factor recurrent laryngeal term radiation year cure distant metastatic radiation term
CAN,CAN1317,hemilaryngectomy glottic total laryngectomy invasive carcinomas side many compatible margins laryngeal remnant creation tracheopharyngeal shunt functions expiration constricts recurrent laryngeal myomucosal glottic side myomucosal soft tissues hypopharyngeal mucosa safe laryngoscopic pathologist management review invasive margins satisfactory significant pressures tracheotomy cm water cm water phonation results depend dangers obvious
CAN,CAN1318,schwannomas neck rare schwann sheaths peripheral schwannomas neck slow growth schwannomas neck short findings year female schwannoma posterior side neck skull vagus spinal hypoglossal year female nasal right nasopharynx management
CAN,CAN1319,results operative results group underwent group times osteosynthesis cement regard mobilization significant group cement complications immediate complications immobilization quality
CAN,CAN1320,short allyl methylallyladenosine chloropurine excess presence vitro vivo good increases mammary allyl allyl mammary growth fourth short carcinomas leukemia sarcoma
CAN,CAN1321,synthesis structure skin melanophores cyclase synthesis melanotropins substitutions methionine diiodotyrosine tyrosine phenylalanine normal melanocytes skins melanocytes melanoma cyclase range full skin nle nle phenle tyr tyr cyclase system nle nle equal phenle tyr tyr melanotropin
CAN,CAN1322,nn dialkylbisdichlorophenylethylenediamines imidazolidines structure estradiol receptor diastereomeric nn dialkylbisdichlorophenylethylenediamines imidazolidines chlorine receptor ka values nitrogen chlorine interaction hydrophobic receptor possible substances significant effect growth dmba dependent mammary
CAN,CAN1323,dna potential pyridocarbazole pyridocarbazole quaternization pyridinic nitrogens different pyridocarbazole rings halogenoamino alicyclic aliphatic monomers bisintercalation ionization state monointercalate constants range dna pairs murine leukemia dependent position pyrido ccarbazole bisethylpiperidinyl hand ellipticine results process
CAN,CAN1324,dna potential pyridocarbazoles pyridocarbazole ellipticines olivacines related pyridocarbazoles single photochemical process intercalate dna dna range substituent nitrogen quaternization factor position pyridinic nitrogen dna antileukemic mice leukemia pyridocarbazoles pyridocarbazoles ellipticines olivacines
CAN,CAN1325,chemotherapeutics synthesis alkoxycarbonyl alkoxycarbonyl benzoyl toluyl heptanoyl phenoxycarbonyl benzyloxycarbonyl substituents synthesis direct conditions benzoyl toluyl significant toluyl promising investigation retain good level oral
CAN,CAN1326,radiological oesophageal radiological folds tortuosity interruption stiffness
CAN,CAN1327,neck general principles neck neck neck tests neck neck thorough thoughtful hasty open inadvisable significant therapy neck
CAN,CAN1328,verruciform xanthoma skin verruciform xanthoma unusual lesion epithelial prominent replacement oral vulva year verruciform xanthoma skin lesion inner inguinal verruciform xanthoma rare inflammatory epithelial lesions hyperplasia
CAN,CAN1329,sebaceous trichofolliculoma sebaceous trichofolliculoma hitherto trichofolliculoma usual differentiation therapy male sebaceous trichofolliculomas sebaceous rich skin lesions lateral borders hamartoma thick terminal trichoids fistula tract paranasal sinus techniques sebaceous trichofolliculoma hamartomatous growth sinus loose epidermoid corneocytes debris many sebaceous picture sebaceous ducts hair units terminal hair hair growth dermoid cysts sacs ducts paranasal histological differentiation trichofolliculoma pilar sheath acanthoma sebaceous hyperplasia steatocystoma therapy excision
CAN,CAN1330,cutaneous year many nodular lesions indistinguishable dermatofibromas mucin fibroblasts dermis wide lucent endoplasmic reticulum granular fibroblasts intracellular figures prominent term fibromyxoma designate
CAN,CAN1331,tumour pancreatic serum inflammatory malignant conditions pancreatic condition liver
CAN,CAN1332,primary findings rare tumour
CAN,CAN1333,appendiceal intussusception appendiceal intussusception year enema
CAN,CAN1334,spinal osseous angioma gelfoam embolization osseous spinal angioma severe compression severe decompression feeding second successful osseous spinal angioma severe medullary compression intervention pre operative embolization feeding
CAN,CAN1335,pseudocyst pancreas pancreatic pancreas pancreatic pancreatic pseudocyst
CAN,CAN1336,cystic ultrasound potential identification cystic pelvic confusion techniques potential
CAN,CAN1337,oncology ct second computer parameters primary significant normal ct results specific yield investigation normal ct management overall ct diagnostic yield inappropriate ct
CAN,CAN1338,postcricoid pseudotumor normal defects hypopharynx upper esophagus lesion postcricoid pseudotumor simulate
CAN,CAN1339,preconception report radiation healthy infant reconsideration terminate pregnancy radiation physicians
CAN,CAN1340,digestive tract cowdens year white man gastrointestinal polyps esophageal gastrointestinal endoscopic lesions
CAN,CAN1341,epidermodysplasia verruciformis lutz report japanese marriage epidermodysplasia verruciformis wart lesions warts wart lesions epidermodysplasia verruciformis report time flat warts epidermodysplasia verruciformis recovery matter
CAN,CAN1342,spectrophotometric test tetrazolium monocytes monocytes components serum factor modified spectrophotometric tetrazolium nbt test human peripheral monocytes zymosan endotoxin vitro neutrophil pmn non lymphoma polychemotherapy non lymphoma bronchogenic nbt monocytes presence serum serum group healthy donors nbt healthy donors correlation presence immune bronchogenic
CAN,CAN1343,tumour ovary hysterectomy vaginal university preserved tumours months praemalignant lesions uterus second uterus histological uterus vaginal hysterectomy tumours carcinomas ovariectomy time hysterectomy prophylaxis
CAN,CAN1344,congenital anophthalmia intracranial year anophthalmia evidence hypothalamic dysfunction pineal previous report teratoma possible bith early
CAN,CAN1345,epidermoid splenic cyst intrapancreatic year man nausea cystic lesion tail pancreas primary epidermoid cyst tail pancreas report splenic cyst ectopic search world literature
CAN,CAN1346,crohns bowel crohns stress importance bowel time crohns predisposition segments malignant transformation occurrence rectal stresses segments crohns radiographic endoscopic fact biopsied
CAN,CAN1347,serum gastrin secretin gastrin secretin secretin test hypergastrinemia due hypergastrinemia due ellison zes serum gastrin secretin duodenal ulcer evidence evidence secretin serum gastrin rise pgml zes hand serum gastrin increments pgml pgml rise serum gastrin secretin zollinger ellison
CAN,CAN1348,report severe report year man left severe rare fingers toes months spread lymphomatous transformation mediastinal lymph nodes cyclophosphamide significant resolution progressive enlargement roentgenographic deterioration sedimentation
CAN,CAN1349,cardiotoxicity limits adriamycin total exceeds months therapy developed progressive half cardiotoxicity
CAN,CAN1350,pulmonary manifestations polyvinyl interstitial newer newer occupational diseases due vast industrial technology preeminent newer vinyl vc polyvinyl descriptive literature desquamation macrophages minor interstitial inflammatory pulmonary restrictive therapy industrial hygiene total atmospheric pollutants none evidence pulmonary occupational degrees urine phthalic significance
CAN,CAN1351,resuscitation system resuscitation sloan voluntary subsequent arrests status resuscitation status primary withhold resuscitation group half stage successful resuscitations metastatic uncontrolled discharge localized observations efforts resuscitation cpr cure
CAN,CAN1352,neurogenic phaeochromocytoma free fold values primary hypertensive subjects spinal plasma values whereas spinal plasma primary spinal noradrenaline values noradrenaline whereas values primary plasma noradrenaline regions tumours phaeochromocytoma spinal phaeochromocytoma
CAN,CAN1353,intestinal polyposis report intestinal polyposis spotting shaft propose hamartoneoplastic
CAN,CAN1354,possible parathyroid gastroduodenal ulcers hyperparathyroidism hyperacidity parathyroid correlation serum time positive correlation serum gastrin hyperacidity parathyroid gastrin
CAN,CAN1355,progressive multifocal hodgkins report year stage iii underwent mild cytostatic therapy months neurological died months progressive multifocal paracristallinic glial papovavirus formations microscopy
CAN,CAN1356,oxyphil lacrimal caruncle oxyphil lacrimal caruncle transmission microscopy lesions tumour tumours lacrimal secretory ducts
CAN,CAN1357,microepithelial cysts subjects weeks lens male subject ocular microepithelial cysts cysts recovery
CAN,CAN1358,eccrine sweat orbital year man sweat right upper lid tissues deeper sheath malignant patterns results eccrine sweat
CAN,CAN1359,misdirection critical oculomotor primary oculomotor misdirection intracavernous lesions oculomotor ophthalmoplegia provide synkineses subsequent oculomotor peripheral misdirection motor inconsistent observations concepts ephaptic transmission impulses chromatolysis reorganization nuclear synapses
CAN,CAN1360,possible meningioma year progressive eye year radiological investigation tomographic ct exploration sheath meningioma recovery removal
CAN,CAN1361,end mucous fistula formal method bowel end mucous fistula formal end colostomy mucous fistula dissection parietal sites drawn tunnel morbidity early discharge underwent results satisfactory intraperitoneal tunnel safe method bowel many complications incisions
CAN,CAN1362,idiopathic hypogonadotropic eunuchoidism postpuberal immature idiopathic hypogonadotropic eunuchoidism junctions junctions lanthanum months iu eunuchoidism postpubertal pituitary ectopic pinealoma year pituitary junctions dependent gonadotropins
CAN,CAN1363,plasma cea stratification resection colorectal forty colorectal plasma carcinoembryonic cea times months months metastases time none primary dukeskirklin dukeskirklin colorectal primary correlation cea values subsequent risk times colorectal primary cea values risk ninety cea ngml time months lesions ngml insufficient time dukeskirklin primary ngml cea cea resection cea values cea important factor resection dukeskirklin colorectal
CAN,CAN1364,operative risk resection december underwent resections virginia operative risks elderly pulmonary renal metabolic nutritional morbidity complications resections deaths pre conditions factor deaths conditions infectious complications emergency true pulmonary nutritional problems significant sepsis correction pre pulmonary nutritional emergency morbidity resections elderly
CAN,CAN1365,selection operative midstomach implications strategy pathoanatomic spread middle stomach lymphatic resection seek evidence results retrospective radical sg radical total tg total etg overall year tg etg stage lethal resection early stage resections tg versus sg early stage presence juxtagastric lymph nodes direct observations resection midstomach
CAN,CAN1366,stage iii year stage iii single dominant thirty thirty fiveand year extent worse positive nodes infiltration positive group signs therapy enough time results underwent oophorectomy radiation therapy signs group iii unfavorable time save expectancy intent cure
CAN,CAN1367,management papillary papillary year recurrent total less total total partial side resection isthmus excision lymph nodes
CAN,CAN1368,hypogonadism collagenoma catheterization predominant right primary collagenoma evidence mild findings skin lesion congestive heart findings genetic
CAN,CAN1369,methods radioallergosorbent test phadebas hoffman sera radioallergosorbent test lots reagents different rast protocols rast tracer phadebas methods standard pru cut sensitivity pru cut sensitivity method sensitivity lowest significant positive scores uml rast significant non specific method suitable
CAN,CAN1370,total nitrogen techniques gamma neutron total nitrogen whole total nonmuscle protein normal male female subjects yr size nonmuscle compartments investigation protein subjects individuals metabolic disorders diseases significant size compartments noted protein nonmuscle process
CAN,CAN1371,occurrence man times peptic ulcers hyperacidity partial nonirradiated normal year specific due deaths group group deaths due stomach deaths normal
CAN,CAN1372,retinopathy tilorone hydrochloride year year tilorone hcl total subepithelial infiltrates retinopathy pigment peripheral fundus mild peripheral constriction results electro total second subepithelial infiltrates severe mild pigment erg eog goldman normal limits hcl free radical scavenging pigment epithelium tilorone hcl detect manifestations
CAN,CAN1373,ocular uptake test ocular overall overall lesions
CAN,CAN1374,adenomyosis adenomyosis problems uterus recent files gynecologic laboratory johns significance true invasive
CAN,CAN1375,radical hysterectomy underwent radical lymph metastases time radical hysterectomy nodes lymph size lesion stage previous pelvic
CAN,CAN1376,pregnancy malformations growth normal results support trimester normal time fetal damage results risks
CAN,CAN1377,staphylococcus leukemia staphylococcus leukemia year episodes less microliters episodes episodes respiratory tract spectrum antimicrobials episodes specific antistaphylococcal therapy episodes therapy therapy oral therapy total therapy evidence endocarditis endocarditis staph rare leukemia shorter therapy endocarditis
CAN,CAN1378,group infection epicardial septicemia group bacterium occur ventriculoatrial shunt prosthetic documents epicardial group year epicardial
CAN,CAN1379,cutaneous neural examples sheath dermis noticed second occur face female male lesions matrix nuclear atypia mitotic figures inadequate excision propose name neurothekeoma sheath
CAN,CAN1380,myxoma report review auscultatory manifestations rare report concerns signs right myxoma systole loud midsystolic murmur obstruction diastole prominent vibration echophonocardiography noise sudden halting retrograde excursion right analogus antegrade myxoma early diastole
CAN,CAN1381,subepithelial renal antopol goldman lesion goldman lesion nephrectomies lesion rapid disappearance
CAN,CAN1382,pseudosarcomatous unusual pseudosarcomatous lesion year malignant epithelial cystitis support entity important intervention
CAN,CAN1383,rhabdomyosarcoma rhabdomyosarcoma tunica tissues rare rhabdomyosarcoma year man total half time
CAN,CAN1384,embolization disorders disorders underwent embolization removal hypernephromas hypercalcemia proteinuria renal due results embolization varied localized single embolization successful diffuse due embolization
CAN,CAN1385,leukosis review findings leukosis leukosis possible complications review sporadic leukosis sporadic leukosis calves sporadic leukosis cattle sarcoma sporadic cutaneous leukosis sporadic mast leukosis findings importance
CAN,CAN1386,persistent hyperparathyroidism persistent hypercalcemia exploration primary hyperparathyroidism rare retrospective review lessons pitfalls minimize occurrence concur van primary review underwent exploration primary hyperparathyroidism normocalcemic morbidity operative
CAN,CAN1387,oophorectomy versus radiation metastatic retrospective methods primary therapy metastatic records institute radiation ablations time receptor status metastatic free status presence metastases results method oophorectomy
CAN,CAN1388,paraganglioma paraganglioma rare obstruction
CAN,CAN1389,parotid year results parotid morbidity support hypothesis parotidectomy general group single
CAN,CAN1390,medullary medullary year pretibial myxedema ophthalmic signs stimulator medullary
CAN,CAN1391,retroperitoneal retroperitoneal fibrosis uncommon etiology retroperitoneal fibrosis retroperitoneal fibrosis onset metastatic bowel ureteral obstruction possible term
CAN,CAN1392,reflections federal nuclear regulatory commission contain restriction mci mb sound theory mci doses need radiation safety programs therapy
CAN,CAN1393,methods therapy effectiveness methods therapy urine pretherapy diagnostic work urine method potential risk diagnostic work time estimate direct potential safe method
CAN,CAN1394,flow structure specific flow ba wagrij degrees flow degrees minutes values hours consistent histopathological observations dilation temporary hyperthermia degrees minutes virtual flow consistent findings rupture range
CAN,CAN1395,effect hyperthermia vascular flow skin fourfold degrees walker flow hours degrees walker due inefficient dissipation sluggish flow vascular sck degrees sck hyperthermia vascular acidity progressive
CAN,CAN1396,doses residual mci partial papillary thyroxine triiodothyronine weeks weeks normal tsh months successful mci unreliable residual
CAN,CAN1397,gray spectrum hypernephromas report findings echogenic cysts diagnostic dilemma shows evidence neovascularity end diagnostic work
CAN,CAN1398,gallbladder gallbladder carcinomas ct ct findings gallbladder lesion ct findings gallbladder wall intraluminal findings gallbladder misleading signs liver differentiate gallbladder direct lymph metastases
CAN,CAN1399,teratomas teratomas skin intrapelvic presacral confusion findings teratoma
CAN,CAN1400,radiographic correlation histological histological radiographic evidence lymphocytic depletion fair lymphocytic nodular sclerosis good histological types permeative
CAN,CAN1401,lesions duodenal heterotopic mucosa heterotopic mucosa duodenal lesions radiological endoscopic findings glucagon duodenal facilitates
CAN,CAN1402,technical excision removal excision excision deposits normal skin
CAN,CAN1403,intrathoracic latissimus intrathoracic merits single stage repair tracheoesophageal fistula true flaps many possible uses
CAN,CAN1404,gonadoblastoma xo year female primary hypoplastic reproductive organs stigmata turner ovaries uterus gonadoblastoma total hysterectomy oophorectomy rationale malignant
CAN,CAN1405,united edometrial early postmenopausal
CAN,CAN1406,vitro transformation toluene diamine isomers diamine tda transformation primary embryo hec sa transform hec tda sa tda protocols isomers tda sa isomers good increases hec good none tests
CAN,CAN1407,mucous argentaffin adenocarcinomas tamarins primary metastatic adenocarcinomas tamarin saguinus oedipus adenocarcinomas microscopy mixtures mucous argentaffin metastatic sites endocrine integral populations differentiation mucous argentaffin mitotic figures argentaffin observations
CAN,CAN1408,histogenesis prostatic aciseghapbr male aci aciseghapbr months prostatic months lesions intraalveolar lesions intraalveolar cribriform carcinomas spread alveoli ducts nodular invaded tissues months intraalveolar prostatic invasive carcinomas unique etiology prostatic
CAN,CAN1409,embolization metastases report metastases renal nephrectomy embolization thirds severe radiotherapy embolization embolization satisfactory renal nephrectomy
CAN,CAN1410,plea renal von report renal von excision lesion free followup months multifocal lesions normal renal spared morbidity hemodialysis
CAN,CAN1411,transaxial angiomyolipoma diagnostic dilemma review angiomyolipomas findings echoes transaxial findings diagnostic dilemma lesion prevent need intervention
CAN,CAN1412,renal cysts renal operative intervention important presence malignant manifestations management renal cysts techniques entity exploration cyst
CAN,CAN1413,renal dysplasia perineal report renal dysplasia non renal perineal perineal penis teratoma respiratory distress dysplastic kidneys kidneys histological typical renal dysplasia
CAN,CAN1414,rhabdomyosarcoma rhabdomyosarcoma underwent radical radiotherapy radiotherapy former latter radiotherapy radical
CAN,CAN1415,ultrasonic urology ultrasonic scanner seminal integral cystoscopy transducer cystoscope transducer water rectum scanner rectal seminal prostatic prostatic size seminal
CAN,CAN1416,whole early metastatic renal whole renal metastatic lesion whole renal lesion renal metastatic lesions whole tomograms positive renal positive results shadows
CAN,CAN1417,pelvic lymphadenectomy risk versus total underwent limited lymphadenectomy stage stage positive nodes complications pelvic dissection dissection dissection little morbidity
CAN,CAN1418,human prostatic diseases specific human total white white subjects risks risks none risks significant significant human
CAN,CAN1419,complications ureteroileal conduit radical review complications ileal conduit radical significant renal calculi ureteral obstruction pyelonephritis deterioration renal months ureteroileal intestinal severe intestinal obstruction infection dehiscence operative deaths complications conduit conduits conduits radical evidence superiority
CAN,CAN1420,home home home structure successful participation home nonmedical burdens home terminal management nursing support home
CAN,CAN1421,parathyroid renal renal microscopy primary hyperparathyroidism renal tertiary hyperparathyroidism fibrous compression parathyroid amidst parathyroid hyperplasia hyperplasia tertiary hyperparathyroidism microscopy primary hyperparathyroidism tertiary hyperparathyroidism histological histological important tertiary hyperparathyroidism histological spectrum renal related parathyroid
CAN,CAN1422,lymphatic lymphatic tumour popliteal lymph walker walker footpad albino progressive popliteal thence para lymph nodes lymphatic footpad popliteal output tumour macrophages footpad popliteal para nodes coulter counter subsequent smears nodes tumour lymphoreticular early tumour nodes tumour primary primary tumour transmission microscopy lymphatics cytoplasmic endothelial tumour gaps tumour results lymphatics defects walls
CAN,CAN1423,pituitary report pituitary management rare entity
CAN,CAN1424,cryptic avm pontine report year pertussis tetanus dpt booster tomographic hyperdense pontine pontine months cryptic avm pons vascular malformations stem courses
CAN,CAN1425,intracranial report rare olfactory mucosa nasal neurological complications intracranial progressive
CAN,CAN1426,cavernous angiomas pineal report cavernous angiomas pineal pineal angioma early trial radiotherapy
CAN,CAN1427,cavernous angiomas cavernous angiomas sole lesion intracerebral malformations fifth white matter intracranial signs usual many ct malformations ct findings cavernous angiomas
CAN,CAN1428,spinal epidural metastases radiotherapy spinal epidural compression spinal encountered physicians recent past radiotheray thought advocated effectiveness radiotherapy radiotherapy spinal epidural metastases trial significant methods sphincter myelographic size unforeseen defects results conclusive future method spinal epidural metastases
CAN,CAN1429,electrophysiological spinal roots equina lesions electrospinogram espg somatosensory potentials conus equina lesions compression equina traumatic dislocation lumbar vertebrae midline herniation pulposus tumoral significant lesion way sensorimotor tumoural compression significant traumatic injury diagnostic latent sensory roots electrodiagnostic tests
CAN,CAN1430,malignant lymphoma infiltration roots malignant lymphoma cranial lymphoma lesions inconspicuous infectious mononucleosis neurological condition progressive
CAN,CAN1431,idiopathic aldosteronism importance renin system primary apa idiopathic aldosteronism iha plasma pa cortisol pc night intervals day supine position pra night pa iha apa pa pc pa equal recumbent pa iha apa equal subjects posture pa pc apa iha posture pa group supine position pa values iha short time fluctuations night apa iha different pa group renin system predominant pa pa apa posture iha
CAN,CAN1432,rainbow salmo carcinogenesis dietary rainbow hepatocarcinogenicity aflatoxin method single rainbow eggs minutes eggs water swim onset usual fish year time thirds hepatocellular liver sensitivity carcinogen sensitivity embryo system carcinogen half optimum embryo system hepatocarcinogenicity aflatoxicol aflatoxin aflatoxin dimethylnitrosamine methyl nitro nitrosoguanidine latter nephroblastomas kidneys results potential embryo economical whole system carcinogenesis
CAN,CAN1433,morphine identify related morphine retrospective analgesic total little weight range total twice oldest group youngest group observations factor morphine
CAN,CAN1434,mitochondrial serum metastatic liver metastatic cathodal cathodal ckm sulfate sephadex urea ckm column electrophoretic migration position cathodal ckm ckm ckm mitochondrial mitochondrial isoenzymes isoenzymes different
CAN,CAN1435,patterns peripheral normal peripheral lesions peripheral column isoenzymes normal peripheral peripheral malignant schwannoma isoenzymes different normal peripheral
CAN,CAN1436,hydrocarbon hydroxylase hydrocarbon hydroxylase ahh embryo growth confluency km values approx microm nm nadph confluent nm nadph different growth benzaanthracene ba aminophylline phosphodiesterases mid growth aminophylline induction ba early confluence ba aminophylline ahh fact different regulatory mechanisms aminophylline induction nucleotides growth times less microm confluent moreover km values nadph confluency microm nm treated nm nadph nutritional conditions km values confluent
CAN,CAN1437,cytoplasmic nuclear estrogen human qualitative cytoplasmic estrogen total nuclear estrogen cytoplasmic progesterone primary metastatic human tissues positive correlation th ern pgr level significant correlation ern pgr pgr ern positive ern presence significant correlation pgr ern findings support induction pgr estrogen human nuclear ern receptor sensitivity human
CAN,CAN1438,mercaptopurine mice leukemia dba mice dba mice ip leukemia day day injections mgkg ip daily single sc lms mgkg dba mice total lms day day therapy mercaptopurine time mice lms day vitro growth day dba mice significant total vitro growth lms day daily day daily lms day conspicuous growth significant total results effect mercaptopurine
CAN,CAN1439,vitro parameters renal hkc short term vitro hthymidine oxygen index vivo method mitoses method phases mitoses vivo results vitro limited time possible
CAN,CAN1440,rearrangements skin fibroblasts hereditary skin fibroblasts hereditary leukemia medullary nonconstitutional rearrangements consistent th rearrangements rearrangements cluster leukemia gene medullary rearrangements cluster sites procancer dominant mutations diseases insertion mutations transposable
CAN,CAN1441,exchanges malignant lymphoma exchanges malignant lymphoma radiation months exchanges group significant individuals significant
CAN,CAN1442,effect female nude mice shionogi sc medullary compact receptor male female ds mice strict ds male female nude mice female nude mice spindle shaped receptor female nude mice morphological sc female nude mice significant histological receptor values growth female nude mice growth speed sc intact male ds mice subline sc male female ds mice female mice nude mice nude results status
CAN,CAN1443,specific interaction liposomes methotrexate carboxyfluorescein liposomes methotrexate carboxyfluorescein murine dinitrophenyl hapten mopc phosphorylcholine hapten much microscopy patchy intact liposomes liposomes presence excess hapten relevant effect methotrexate incorporation deoxyuridine little deoxyuridine incorporation contents liposomes cytoplasmic compartments
CAN,CAN1444,lymph arabinofuranosylcytosine system leukemia leukemic right forefootpad right lymph significant lymph nodes organs day forefootpad extent right inguinal lymph liver lymph lymph ip mice method lymph elapse time effect lymph right forefootpad right lymph day extent lymph method right forelimb day extent day method system behenoyl arabinofuranosylcytosine parent arabinofuranosylcytosine ftorafur lymph lymph
CAN,CAN1445,linkage electrophoretic oxygen uptake electrophoretic oxygen uptake leukemic nonleukemic growth endogenous nonleukemic leukemic increases suppressed oxygen uptake results dinitrophenol ionogenic sites neuraminidase nonleukemic presence membrane sites rnase ionogenic sites membrane inner oxygen uptake results leukemic hand oxygen uptake presence glucose oxygen uptake dinitrophenol significant consistent ionogenic rnase leukemic oxygen uptake leukemic nonleukemic electrophoretic
CAN,CAN1446,effect partial liver aflatoxin effect partial aflatoxin liver male dna synthesis times level ip inhibitions intact sham possible dna synthesis mgkg dna synthesis sham uninjected weeks hepatocellular lesions term terms dna synthesis
CAN,CAN1447,quantification gas nn chloroethyl phosphorodiamidic plasma method gas specific flame detector nn chloroethylphosphorodiamidic isophosphoramide putative isophosphamide human plasma phosphoramide mustard standard trimethyl presence process gas impact spectrometry plasma isophosphamide gsq plasma
CAN,CAN1448,effect hyperglycemia flow hyperthermia degrees sarcoma hyperglycemia glucose mmolliter flow sarcoma feet fractional xe clearance flow normal gastrocnemius flow unaltered hyperglycemia uniform flow glass electrode due lactate intracellular dimethyloxazolidinedione membrane glucose mmolliter host total water glucose lactate dimethyloxazolidinedione exchange hyperglycemia means sarcoma host hyperthermia
CAN,CAN1449,hydroxy methylglutaryl coenzyme hepatoma mevalonic effect iv mevalonate microsomal hydroxy methylglutaryl coenzyme non hepatoma single mevalonate non male hydroxy methylglutaryl coenzyme mevalonate significant host cmevalonate ratio specific utilized mevalonate synthesis liver non endogenous microsomal membrane hydroxylase synthesis hepatoma general host liver liver
CAN,CAN1450,effect tetradecanoylphorbol growth embryo tetradecanoylphorbol tpa growth microgram tpa ml refractile beady logarithmic confluent cultures subsequent microscopy significant immediate many term ascribable tpa tpa minor growth presence fetal serum slight increases densities presence tpa non fetal serum serum dependent growth tpa conditions times tpa doubling time densities tpa fetal serum tpa growth different different transformed presence total serum tpa fetal serum growth
CAN,CAN1451,transformation epidermal lines primary epidermal underwent malignant transformation malignant epidermal lines carcinomas syngeneic lines epidermal vitro growth lines lines specific epidermal pemphigoid quantified ornithine decarboxylase promoter tetradecanoylphorbol lines malignant lines normal epidermal normal malignant proliferate differentiative functions results malignant transformation fundamental terminal differentiation proliferative differentiation normal keratinocytes select process carcinogenesis vitro
CAN,CAN1452,early carcinogenesis carcinogen report early direct carcinogen specific normal short term carcinogen reductions unique ways carcinogen carcinogens way amide aminoazo dye methyl dimethylaminoazobenzene ethionine interaction carcinogen specific carcinogenpolypeptide reductions hepatocarcinogenesis types early liver carcinogenesis target weight growth
CAN,CAN1453,resistant position sugar human human rectal different nude mice drugs deoxydoxorubicin mice iv weeks stage significant effect drugs significant significant overall less deoxydoxorubicin carcinomas rectal carcinomas results structure drugs different human antracycline good trial nude mice system potential identification anthracycline general anticancer
CAN,CAN1454,identification colonies concanavalin beads vitro identification epithelial hepatoma preferential concanavalin beads aagarose colonies aagarose attaches specific interaction dependent receptor membrane interfere interaction colonies colonies colonies size index epithelial lines colonies malignant liver
CAN,CAN1455,endothelial monolayers gels mammary mammary mts confluent monolayers endothelial top gels early endothelial monolayers early mts endothelial early mts mts top underneath edges endothelial top early phases endothelial giemsa presence microvilli noted time polyionic mts results system mechanisms interaction walls
CAN,CAN1456,macrophages target discrete phases vitro cytostatic macrophages phases target mitotic selection target discrete phases synchrony normal macrophages macrophages mice subsequent dna normal macrophages little effect target target time macrophages dna synthesis subsequent mid time dna synthesis macrophages impending results target dna synthesis macrophages effector target multiplication
CAN,CAN1457,palmitate lewis schedules primary lewis metastases mice sc single iv ip sc growth time palmitate ip effect growth mice metastases palmitate ip daily injections synergistic day free nonparametric statistical test time growth different term
CAN,CAN1458,dietary lipogenesis vivo host tissues fatty fa synthesis glucose units mice mice ho tracers nutritional conditions refed libitum lipogenic regulatory mechanisms mice fa synthesis glucose units day mice refed half refed condition fa synthesis units carcasses day different dietary refed mice day fa synthesis whole half fa synthesis glucose mice refed nourished mice day lipogenic units lipogenesis host tissues due lipogenic growth fa synthesis whole lipids
CAN,CAN1459,adriamycin cytotoxicity rubidium transport wild resistant uptake reversible cytotoxicity wild hand uptake irreversible cytotoxicity wild oua uptake wild resistant uptake extent confluent wild oua resistant oua resistant mutants cross resistant daunomycin dm cytotoxicity cytotoxicity confluence dm displace glycosides digitoxin anthracycline uptake confluent wild growth wild confluent wild cardiotoxic potentials dm system cytotoxicity oua cytotoxicity evidence consistent oua evidence system cardiotoxicity
CAN,CAN1460,vitro epithelial lines nitro furyl fanft standard techniques noninvasive fanft stage invasive fanft stage sc fanft stage invasive metastatic noninvasive counterparts nuclear pleomorphism size ratio nucleoli junctions tumorigenicity normal vivo fanft isolation histological isografts fanft femurs served invasive potential isografts invasive metastatic due collagenolytic rapid degradation isografts resistance cartilage lines normal epithelial counterparts connective laboratory provide unique system
CAN,CAN1461,effect polyethylene glycol cytotoxicity mopc bearer presence stimulator noncytotoxic mice sc mopc medium polyethylene glycol peg mopc cytotoxicity cr release level cytotoxicity growth stimulator peg bearer cytotoxicity level sum cytotoxicity presence mitomycin maximal responderstimulator ratio bearer peg mopc stimulator cytotoxicity noncytotoxic syngeneic peg vivo bearer presence peg regimens histocompatible cytotoxicity reactivity normal
CAN,CAN1462,acinetobacter acinetobacter coli resistance lines pharmacology single daily injections plasma iv single doses kinetics half doses resultant glutamate whole phlebotomy single doses glutamine nondetectable daily doses glutamine depletion reversible nervous system coma related manner prominent reactions respiratory hyperglycemia nausea leukemia neurotoxicity close leukemic
CAN,CAN1463,dna synthesis tb liver saccharin tetradecanoylphorbol deprivation proliferative tb phases dna synthesis promoter didecanoate phenobarbital saccharin tetradecanoylphorbol relatives tetradecanoylphorbol methyl tetradecanoylphorbol didecanoate initiate dna synthesis elicit prompt dna vitro potential
CAN,CAN1464,urine carcinogen lesions urine carcinogen nitro furyl thiazolyl early lesions invasive nitro furyl weeks half male ureterosigmoidostomy sham half nitro furyl regular half months sacrificed months ureterosigmoidostomy sham invasive carcinogen urine influences preinvasive lesions carcinogen urine significant effect sham versus urine system findings early transitional
CAN,CAN1465,specific cytogenetic cytogenetic papillary serous adenocarcinomas ovary clonal originate quantity ie tqq uncertain papillary serous ovary
CAN,CAN1466,preferential sites growth human mice subcutaneous growth human sc different regions mice observed lateral thoracic wall posterior trunk ones less necrosis lymph nodes findings independent histogenetic morphological vascular key factor
CAN,CAN1467,phenomenon documented literature potential importance fundamental nutritional plateau ha nutritional degrees second induction full medium salt effect degrees conditions time inhibited degrees end salt complementary trigger resistance disappearance decay trigger hyperthermic ie degrees ha interpretations kinetics
CAN,CAN1468,human fluids ascitic fluids normal effect lines fluids inhibited hthymidine uptake growth different different hsb lines sensitivity lines fluids lines oligodendroglioma lines different preparations fluids lines degrees normal fluids
CAN,CAN1469,possible critical degrees lines critical degrees hyperthermia critical arrhenius resistant critical normal due presence normal induction time hyperthermic induction time critical degrees due due true degrees critical infection
CAN,CAN1470,mutagenesis morphological transformation non bay polycyclic emissions transform oxide direct transform results oxide mutagenic parent hydrocarbon
CAN,CAN1471,trachea synchronization time identification subpopulations total time specific phases utilized cycling carcinomas tracheas benzoapyrene sequential indices cultures release second equal growth release dna synthesis release second dna synthesis tc ts tg tg tm values normal epithelium deviant populations serve synchrony specific
CAN,CAN1472,catalysis purified microsomal cytochrome hydroxylation different cytochrome tetrachlorodibenzo hydroxylation hydroxy metabolites cytochrome cytochrome tetrachlorodibenzo liver cytochrome half metabolites cytochromes phenobarbital cytochrome hydroxylation occurrence cytochrome cytochrome induction tetrachlorodibenzo magnitude vitro microsomal
CAN,CAN1473,early dimethylhydrazine carcinogenesis hyperplasia interaction early dimethylhydrazine dmh carcinogenesis random nih swiss mice hyperplasia mice bacterium dmh atypia mice hyperplasia single dmh mgkg mice hyperplasia dmh atypia doses dmh mgkg normal mice effect early dmh carcinogenesis due hyperplasia direct interaction bacterium atypia single dmh mgkg neoplasia fewer atypia months atypia reversible lesion tissues neoplasia hyperplasia
CAN,CAN1474,cyclophosphamide sensitivity methods cyclophosphamide vitro tests sensitivity satisfactory results pretreatment cyclophosphamide removal microsomes microsomes drugs
CAN,CAN1475,vitro test drugs human developed human utilized short vitro incorporation dna rna protein drugs range replicates
CAN,CAN1476,htetradecanoylphorbol didecanoate htpa didecanoate hpdd types rapid htpa hpdd much human fibroblasts day fibroblasts nonradioactive tpa htpa fold excess pdd effect htpa primary cultures epidermal term epidermal htpa hpdd human human hepatoma htpa much metabolites hpdd types decanoate equal decanoate decanoate tested decanoate times pdd induction ornithine decarboxylase uptake
CAN,CAN1477,chemoimmunotherapy leukemia leukemia noncurative nonlethal immune time therapy peripheral chemoimmunotherapy leukemia lysis immune weeks ultimate eradication mice weeks chemoimmunotherapy lethal results chemoimmunotherapy therapy positive influences time
CAN,CAN1478,dna repair malignant transformation damage malignant transformation photoproduct ho dna damage consistent state cytogenetic damage terms phases normal malignant metaphase dna damage whereas single double malignant normal caffeine inhibits repair damage normal malignant dna repair normal damage malignant caffeine normal damage level different malignant caffeine caffeine little damage malignant malignant dna damage
CAN,CAN1479,identification alanosine alanosyl imidazolecarboxylic ribonucleotide adenylosuccinate alanosine hydroxyn nitrosaminopropionic imidazolecarboxylic ribonucleotide good yield means liver imidazole succinocarboxamide ribonucleotide adenylosuccinate locus ki alanosyl imidazolecarboxylic ribonucleotide adenylosuccinate frm leukemia dba hereafter bdf mice microm ki alanosine microci dl calanosine unlabeled alanosine mgkg bdf mice sc nodules compatible alanosyl imidazolecarboxylic ribonucleotide alanosyl imidazolecarboxylic resolution system bratton marshall positive inhibited adenylosuccinate nodules microm alanosine marginal leukemic adenylosuccinate time vivo alanosine reduces specific adenylosuccinate synthesis dna equivalent extent mgkg latter effect purine alanosine concert alanosine imidazolecarboxylic adneylosuccinate turn synthesis dna alanosine
CAN,CAN1480,identification somatomedin polypeptides mammary mice mammary outgrowth lesions dimethylbenzaanthracene cultures whole mammary somatomedin polypeptides mammary cultures polypeptides serum free medium polypeptides medium weight sephadex conditions acidurea mw polypeptides dna synthesis embryo cultures multiplication epidermal growth factor embryo fibroblasts
CAN,CAN1481,xenotropic methylcholanthrene genetic linkage infectious xenotropic genetic status sc microgram methylcholanthrene trioctanoin progeny second backcrosses status methylcholanthrene carcinogenesis mice evidence fibrosarcomas genetic system single dominant gene methylcholanthrene fibrosarcomas segregate
CAN,CAN1482,index hinda foundation award lecture undesired index therapy index herein humans marrow complications tamoxifen specific cytotoxic estrogen transport range marrow stem heterogeneous potential different phenylalanine mustard stem permanent stem mice cyclophosphamide stem proliferative normal structure radiation therapy excision results mastectomy
CAN,CAN1483,metastases metastatic unusual primary buttock histology state important factor metastases
CAN,CAN1484,ameloblastoma principles important types intraosseous multicystic lesion rare peripheral extraosseous ameloblastoma different ameloblastomas cyst cystic lining enucleation inadequate fibrous connective wall ameloblastomas spaces cancellous invade compact posterior lesions mandible proximity posterior vital ameloblastoma cautery cryotherapy radiotherapy
CAN,CAN1485,olfactory report world literature prognostic uncommon olfactory epithelium specific distant related cure methods results recent treated statistical permits equation minimum months free months statistical report
CAN,CAN1486,mycosis fungoides nodular hodgkins report transformation mycosis problematic illustrated examples literature report documented man nodular hodgkins mycosis fungoides
CAN,CAN1487,melanomas palm sole acral lentiginous melanoma malignant melanoma volar skin primary volar melanomas acral lentiginous nodular melanomas subclassification plantar skin palm nailbeds melanomas level time year melanomas mitotic inverse ratio volar skin melanomas melanomas ninety melanoma thumb toe year melanomas acral lentiginous melanoma melanoma unique volar melanomas acral lentiginous
CAN,CAN1488,peripheral neuroepithelioma peripheral microscopy lesion root plexus year female half recurrent excisional progressive differentiation wright rosettes non cytoplasmic glycogen
CAN,CAN1489,influences patterns mammographic patterns risk indices investigation patterns mammograms mothers daughters pairs reproductive personal drawn files hutzel test daughters sisters dy patterns relatives risk dy patterns
CAN,CAN1490,presence retinoic dihydrotestosterone murine human protein embryonic limits protein malignant murine lungs primary cultures rise protein rabp specific sucrose sedimentation protein subcutaneous mice rabp extracts fourth day day onwards rabp extracts pulmonary lungs metastatic rabp primary subcutaneous pulmonary metastatic th day subcutaneous mice rabp none protein intraperitoneal rabp peaks liver extracts normal human extracts dihydrotestosterone protein human rabp human tissues
CAN,CAN1491,spinal meningeal uptake methylene meningeal malignant lymphoma meningeal relies presence malignant csf tests ct myelogram report unusual uptake tc methylene presence malignant csf radionuclide diagnostic test
CAN,CAN1492,ultrasound pancreatic retrospective ultrasound ct possible pancreas unsatisfactory due intestinal gas ct unsatisfactory due technical ct significant nondiagnostic ct findings ct diagnostic possible pancreatic
CAN,CAN1493,prognostic significance mediastinal hodgkins radiotherapy prognostic significance mediastinal hodgkins intent radiotherapy mediastinal ratio largest transverse transverse equal forty mediastinal mediastinal known prognostic mediastinal size intent inadequate therapy mediastinal whole
CAN,CAN1494,prostatic adriamycin cyclophosphamide trial adriamycin bcnu cyclophosphamide prostatic group seg therapy bcnu cyclophosphamide iv day adriamycin iv day therapy weeks estrogen therapy partial partial overall responders time months time months stable responders months months stable months pretreatment status nadir counts nadir granulocyte counts resistant metastatic prostatic
CAN,CAN1495,therapy megestrol megestrol postmenopausal progressive metastatic remission stabilization time subsequent months postmenopausal remission remission dominant sites sites lesions free importance remission remission megestrol hormones side negligible weight retention therapy megestrol therapy postmenopausal soft metastases
CAN,CAN1496,synchronous renal total excision synchronous renal undergone total excision true surgeons underwent renal sparing stage successful resection kidneys ten underwent nephrectomy hemodialysis underwent renal group renal
CAN,CAN1497,transcortical transcallosal removal intraventricular tumours functions callosum intraventricular cysts cysts congenital callosum callosal lesions
CAN,CAN1498,vitro conditions radiobiological parameters tumour parameters anaplastic tumour acd vivo soft vitro hypoxic conditions hypoxic values soft soft gy hypoxic gy gy hypoxic gy parameters hypoxic hypoxic vivo pld repair hypoxic factor parameters tumour gy tcd correction rbe gamma kv tcd repair soft repair tcd
CAN,CAN1499,results results radioisotope records year ct lesions means lesions eg neuromas pituitary tumours stem lesions cystic lesions many types lesion invasive atraumatic ct scanner
CAN,CAN1500,vascularization echographic patterns metastases echographic microangiograhic echographic metastatic echographic vascularization hypervascular lesions hyperechogenic patterns hypovascular lesions hypoechogenic
CAN,CAN1501,pituitary parapituitary tumours review retrospective tumours emi matrix entity previous literature resolution scanner tumours centimetre ct results ct chordomas findings need neuroradiological tests pituitary many ct entity specific ct findings possible valuable exclude lesions vascular neovascularity sinus
CAN,CAN1502,glucuronidase normal human normal peripheral specimens malignant lymphoma lymphocytic leukemia la rosette naphthyl anae results normal non peripheral tonsil lymph specimens presence ebg laslge lymphomas lymphocytic leukemia plasma normal populations latter state stage differentiation differentiation investigation
CAN,CAN1503,ovary correlation second look stage iii iv ovary results ultrasound abdomen second look restage tumour ultrasound ultrasound tumour correlation diaphragmatic metastases correlation findings detect intraperitoneal spread presence correlation situation size deposits resolution lesions findings ultrasound important management ovary
CAN,CAN1504,vein fibrinolysis gynaecological effect oral malignant underwent gynaecological positive fibrinogen venous overall oral pelvic conditions hysterectomy rarity post operative thromboembolism rise due injury venous shutdown plasminogen macroglobulin level oral plasminogen iii venous level iii level diagnostic venous
CAN,CAN1505,maturation index quantification fab leukaemia french group leukaemia lines subgroups less introduce maturation index formula see subgroups mi values mature myeloblastic monoblastic leukaemia mi morphological positive naphthylacetate ane fab disagreement discrepancy
CAN,CAN1506,significance protein serum evidence macroglobulinaemia lymphoma fifty observed group group significant serum protein group serum protein group serum protein evolution months retrospective marrow picture size serum presence urine serum level residual stable evolution stable condition possible physiopathology occurrence evolution
CAN,CAN1507,primary second literature positive demonstration neurosecretory microscopy tracheal carcinoids
CAN,CAN1508,papilloma nasal septum papillomas lesions lateral papillomas nasal septum controversy papillomas septum lateral nasal wall paranasal review records eye infirmary papilloma nasal septum papilloma pathologists nasal papillomas papillomas lateral nasal wall papillomas vestibule papillomas septum lateral wall papillomas nasal septum papillomas wide excision
CAN,CAN1509,radiotherapy nasal primary epithelial nasal distant metastases beam techniques rads conventional primary failures lymph months neck primary overall literature
CAN,CAN1510,diagnostic problems correction usual findings lesions vertigo tests total removal interruption residual
CAN,CAN1511,bse important early stage importance methods bse acceptability bse year
CAN,CAN1512,health public possible presence carcinogens harmful extent risks individuals populations time deaths serious morbidity whole rapid computer individuals identity system manner files problems
CAN,CAN1513,costs motor vehicle coronary heart impact injury costs year assign costs year entails year health gains immediate rehabilitation costs united coronary heart motor vehicle importance motor vehicle public health expenditure costs motor vehicle coronary heart constitute conditions costs stroke importance
CAN,CAN1514,tuberculous mediastinal lymphadenitis wall tuberculous mediastinal lymphadenitis unusual primary mediastinal wall findings mediastinal wall
CAN,CAN1515,primary popliteal cyst pseudothrombophlebitis systematic therapy
CAN,CAN1516,bleb peripheral pre blebs peripheral blebs literature bullae exploration excision possible occult lesion bullae ordinary
CAN,CAN1517,synergistic macrophages macrophages lungs normal vitro dipeptide minimum free supernatants rich factor maf maf dilutions doses cytotoxic microgramml significant cytotoxicity syngeneic xenogeneic targets preparations maf maf maf polymyxin interfere preparations lipopolysaccharide maf liposomes prerequisite synergistic
CAN,CAN1518,split radiation therapy pulmonary bronchogenic pulmonary bronchogenic split radiation vital respiratory second second phases therapy weeks weeks functions half
CAN,CAN1519,antineoplastic southern southern remedies extracts tumour test hirsuta cheilanthes anticancer medicines rodent test results lore haemanthus emetics urginea capitata preparations vaccinate chiefs significant cytotoxicity kb test system infusions radulosa remedies troubles amaryllis leukaemic mice amaryllis bellandonna extracts amaryllis significant antitumour lymphocytic leukaemia test system
CAN,CAN1520,papillotomy tract pancreas retrograde cholangiography ercp gastrointestinal endoscopic specific diagnostic pertaining tract pancreas definitive therapy safe primary hands cannulation successful cholangiography pancreatography significant diagnostic yield direct cannulation pancreatic secretions ercp endoscopic papillotomy successful papillary results morbidity convalescence safety diseases tract pancreas specific definitive therapy
CAN,CAN1521,cea gynecologic significance therapy carcinoembryonic cea primary gynecologic double method positive correlation stage subjects invasive positive values resection pretreatment cea values chemio radiotherapy findings investigation support theory cea diagnostic test gynecologic helpful plasma values time cea test plasma second look chemio therapy
CAN,CAN1522,motility growth sarcoma vitro motility growth sarcoma cinematographic methods locomotory motile sarcoma motile hand motile locomotory motile inhibited growth sarcoma range microgramml
CAN,CAN1523,metastatic skin sunlight skin metastases actinic metastatic potential representative metastases prognostic lesion differentiation size primary lesion prone lymph nodes lungs skin metastasize potential strategy
CAN,CAN1524,esophageal manifestations diseases conditions esophageal process situations primary process
CAN,CAN1525,effect tumour viable tumour mice microgramg cycloheximide results moribund tumour microgramg tumour mice microgramg undefined minimum level protein synthesis presence tumour minimum irreversible interaction tumour maximal microgramg cycloheximide irreversible tumour microgramg tumour microgramg cycloheximide
CAN,CAN1526,transformation bhk polycyclic method styles polycyclic transformation method styles bap chrysene methylcholanthrene benzaanthracene ba benzobfluoranthene dba liver effect transformation due method results purchase styles discrimination carcinogens noncarcinogens pa anthracene effect possible benzoepyrene bep positive fold colonies
CAN,CAN1527,correlation pulmonary metastases benzidine dihydrochloride water ppm mice total hepatocellular carcinomas lungs heavier prone contained prominent trabecular
CAN,CAN1528,vivo synchronization murine recent partial synchronization vivo normal tissues synchronization valuable kinetics radiation specific specific synchronization effect specific synchronization time normal metaphase mitotic spindle less optimum metaphase less normal tissues synchronization release synchrony release sarcoma mice mitotic microgramhr microgramhr hours mitotic microgramhr hours mitotic time dependent limited range mitotic increment pyknoses dna synthesis hours microgramhr severe damage mitotic hours partial synchronization synchronization compatible synchronization vivo optimal possible potential specific drugs synchronization moreover synchrony infusions
CAN,CAN1529,electrospinogram spinal evoked electrospinograms spinal means spinal damage dogs eesg spinal dogs spinal compression level bipolar supramaximal rectangular pulses second current eesgs spinal compression weeks results spike potentials short potentials posterolateral tracts spinal spike potentials histological degeneration gray matter side spinal spike potentials spinal compression temporary disappearance spike potentials compression spinal disappearance spike potentials compression spinal spike potentials spinal compression motor voluntary motor spike potentials dogs half full recovery hind limb paralysis dogs half paralysis disappearance potential severe paralysis eesg spinal method spinal correlation spinal
CAN,CAN1530,total duodenopancreatectomy pancreatitis report total duodenopancreatectomy employed pancreatitis due year resistant therapy efforts kg painful pancreasneoplasm ten diabetes total duodenopancreatectomy general operative pancreatitis
CAN,CAN1531,risk morbidity lethality undergone transanal transabdominal size transabdominal segmental resections resections lethality results coloscopic polyps coloscopic
CAN,CAN1532,computer rectum conventional scintigraphy insufficient diagnostic many rectum early report computer recurrent computer time infiltrative growth lymph enlargement second intervention therapy computer resection rectum
CAN,CAN1533,effect anticancer immune effect anticancer immune hepatoma chhe mh anticancer target immune cytotoxicity tests mitomycin xenogeneic mh cytostatic effect target mh anticancer cytotoxicity tests xenogeneic treated ddd mice mh anticancer mh mh results effect anticancer immune
CAN,CAN1534,transport lymphoma cimicfugoside triterpenoid cimicifuga simplex uptake raji hela growth uptake purine pyrimidine deoxyribosides phosphorylation transport nucleic nucleosides results cimicifugoside transport plasma membrane
CAN,CAN1535,effect leupeptin mice effect leupeptin mice mice group leupeptin leupeptin end group mice liver females group male mice liver significant incidences leupeptin females
CAN,CAN1536,tetrahydropyranylsecalonic anticancer obtained oxalium anticancer acin anticancer effect adriamycin initiation day immunodeficient host growth host
CAN,CAN1537,phosphorylase growth phosphorylase patterns growth liver growth level fetal prototype fetal liver subcutaneous vitro growth conditions hybrid types liver results phosphorylase patterns vary growth different conditions
CAN,CAN1538,metabolic fate nn metabolic fate nn dbn correlation carcinogenicity organs unchanged dbn urine dna underwent metabolic transformation ways metabolites omega carboxypropylnitrosamine bcpn minor omega metabolites urine conjugates omega dbn bcpn induction products omega omega induction liver
CAN,CAN1539,metabolic fate metabolic fate bbn metabolites carcinogenicity nitrosamine bbn carboxypropylnitrosamine minor metabolites transformation products knoop ie hydroxy propylnitrosamine carboxymethylnitrosamine oxopropylnitrosamine conjugates bcpn bbn urine possible correlation excretion bcpn induction carcinogenic bcpn
CAN,CAN1540,hyperplastic liver nodules nitrosodiethylamine hepatocarcinogenic non hepatocarcinogenic non carcinogenic hyperplastic liver nodules nitrosodiethylamine den initiator male ppm weeks test end hyperplastic nodules color processor effect den hyperplastic liver nodules hyperplastic nodules non noncarcinogens hyperplastic nodules phenobarbital saccharin promoter hyperplastic nodules results many liver carcinogenesis carcinogens results
CAN,CAN1541,precancerous cancerous lesions golden nitrosobis oxopropylamine transmission cancerous lesions nitrosobis oxopropylamine bop weeks weeks initiation findings epithelium pancreatic epithelial secretions weeks precancerous prominent nucleoli irregular endoplasmic reticulum weeks weeks pancreatic good accord histological oval granular endoplasmic reticulum microvilli prominent nucleoli endoplasmic reticulum secretory precancerous cancerous lesions microvilli luminal cytodifferentiation findings different normal epithelial findings pancreatic nitrosobis oxopropylamine evidence acinar
CAN,CAN1542,neonatal carcinogenesis nitrosourethan acin nitrosourethan bnur butylurethane bur bnur acin neurogenic mother bnur stage pregnancy subcutaneous bnur neurogenic bur
CAN,CAN1543,induction intestinal metaplasia glandular stomach oral methyl nitro nitrosoguanidine cdcrj localized stomach methyl nitro nitrosoguanidine mnng drinking water treated sacrifice months mnng intestinal metaplasia histology whereas mnng intestinal metaplasia
CAN,CAN1544,saframycin different mice saframycin growth microgramml saframycin ddy mice mgkg ip mgkg iv chhe mice lds ip mgkg iv saframycin leukemia leukemia melanoma saframycin times saframycin saframycin resistance rechallenge hand carbazilquinone adriamycin drugs mice rechallenge saframycin mgkg mice microgramml microgramml total recovery urine saframycin different organs mice
CAN,CAN1545,target cytotoxicity hybrid fab ricin hybrid fab murine leukemia igg ricin disulfide prepared thiol group cysteine sephadex superfine hybrid cytotoxicity unconjugated fab significant cytotoxicity hybrid fab normal igg cytotoxicity results hybrid manifests target fab
CAN,CAN1546,vitro carcinogenesis hepatocytes treated liver promotion growth phenobarbital times proliferative hepatocytic carcinogen weeks hepatocytic growth soft months growth
CAN,CAN1547,peripheral pulmonary blesovskys pleural peripheral pulmonary radiographs peripheral opacity lie opacity thoracotomy visceral pleural thickening underlying parietal pleural adhesions removal visceral normal appreciated unchanged radiographic malignant condition lateral diagnostic recognition need thoracotomy removal visceral release relieving
CAN,CAN1548,sequential conventional direct diagnostic sensitivity flexible bronchoscope bronchoscope instruments general bronchoscope conventional histological bronchoscope final bronchoscope histology bronchoscope showed disagreement methods flexible bronchoscope general method
CAN,CAN1549,carcinoembryonic serum carcinoembryonic cea diagnostic tests results stage positive cea stage stage stage stage cea stage significant less positive correlation cea level results histological cea undifferentiated oncofetal mucosa serum cea extent tumour potential tumour management
CAN,CAN1550,dual primary jejunum previous primary intestine uncommon tumour times primary neoplasia bowel growths rare malignant lesions jejunum previous carcinomas review literature
CAN,CAN1551,bowel lymphoma coeliac perforation bowel lymphoma coeliac management protein bowel drawn ways bowel lymphoma coeliac coeliac months bowel lymphoma drawn rapidity tumour
CAN,CAN1552,unique bowel obstruction unique bowel obstruction year man obstruction caecum caecum scrotal sac inguinal
CAN,CAN1553,epidermal cysts findings epidermal cysts relevant literature epidermal cysts findings histological hair epidermal cysts contents cysts protein sebaceous cysts lesions cyst
CAN,CAN1554,vero medium antimeasles medium cyclical manner growth dependent viruses propagation wild functions host yield dependent growth
CAN,CAN1555,carcinogenic effect methylcholanthrene mice water products hydrocarbon day females balbcf maternal fetal injected ip day mgkg mgkg nf fetal liver fold results maternal effect mgkg fold induction mgkg complementary carcinogenesis mothers ip nf mgkg day methylcholanthrene mgkg day vehicle mice progeny weeks mgkg nf extent inducer mgkg nf half induction carcinogen maternal fetal possible
CAN,CAN1556,system diagnostic system diastu retrieval results diagnostic system process yield diagnostic system pdp computer iv programs general handler dsent second prints portions dstat parameters time size loops
CAN,CAN1557,shunt sequential hepato scintiphotography mtc hida effectiveness sequential scintiphotography liver mtc hida ssfh post operative derivation observations laborious cholangiography investigation term ups
CAN,CAN1558,transversotomy rectum personal personal rectum transversotomy transversotomy sole method anastomotic hence therewith doubts regard method technical shortcomings transversotomy
CAN,CAN1559,personal nodes nodes hot carcinomas hot carcinomas nodules nodes true hot nodes importance recent diagnostic techniques
CAN,CAN1560,pregnancy mammary pregnancy advocate prompt possible concomitant pregnancy constitute
CAN,CAN1561,cavitary carcinomas cavitary possible growth due colliquaive process phenomena autophagism carpet cysts wall cavitation cavitation problems fact instrumental needle sputum decisive evolution picture time
CAN,CAN1562,cystadenocarcinoma pancreas pancreatic cystoadenocarcinoma pancreatic pseudocyst problems cystic tumours cystoadenocarcinoma lesions stress importance intra operative cyst wall radical
CAN,CAN1563,pleural fistula retrograde methods endoscopic retrograde ercp recent targets pancreatic diseases recurring pleural effusion pseudocyst level report clinico instrumental pre operative pleural fistula
CAN,CAN1564,resections tract tumours tumour confluent demolitions hemihepatectomy right hemihepatectomies tree bloc reconstruction demolitionary radicality notions tumoral literature statistical effectiveness method possible results presuppositions
CAN,CAN1565,resections angioma resections rt hemihepatectomies hemihepatectomies lateral vith anatomopathological angioma angiomas diagnostic standpoint outstanding presence quality demonstration vascular lacunae angiomas surgeons resections typical true giant tendency growth rupture angiomas cuneiform resections sites risk stationary personal tendency expansion
CAN,CAN1566,plasma membrane transport akr transport nonadherent normal leukemic akr mice akr mice vivo concanavalin splenic normal akr mice transport components values whereas mice akr mice components values millimolar range current results splenocytes mice transport components values lowest km system akr splenocytes transport cross akrj mulv time dependent time dependent akv akv transport unique transport presence murine leukemia
CAN,CAN1567,training cooperative trials viewpoint methods trials courses personal apprentice desirable qualifications statistician biostatistics trial statistical ideas meetings papers potential ethical issues issues context training personal comments viewpoint statistician trials
CAN,CAN1568,lateral laryngeal concerns lateral aryteno fold intersection folds lymphatic lymph nodes histological results partial stage tumoral
CAN,CAN1569,second need lymphatic lymph stage results total partial lesion lymphatic
CAN,CAN1570,epithelioma laryngeal marginal second lateral laryngeal entity lateral posterior total margins free laryngeal side epiglottis laryngeal side epiglottis oropharynx lateral fold fold ajc cartilage lateral marginal marginal lymphatic
CAN,CAN1571,unusual papillary cystadenolymphoma parotid report unusual hyperplastic pseudopapillary epithelial histogenetical hypothesis recent publications works
CAN,CAN1572,sulcus neurofibroma schwannoma apropos vagus rare hundred develops sulcus position pharyngeal chronical lymph usual signs inconsistent important cough enucleation possible recurrent intact nervous ends results definitive paralysis vocal easy neurofibroma schwannoma share cytogenetic many electronic microscopy litigious importance schwannoma neurofibroma schwannoma rare neurofibroma vagus favorable nervous possible
CAN,CAN1573,techniques risks level radiation man radiation hazards utilized investigation radiation forward time specific previous radiation radiation cohorts eg important leukemia prenatal fo risks rr ie excess doses radiation direct observations estimate populations range doses interpolation estimate populations doses time effect level health
CAN,CAN1574,radiation nervous system humans ionizing man radiation mutations growth carcinogenetic nonlethal laboratory humans nervous system injury mechanisms radiation man observations humans results human radiation utero current timetable radiation human examples japanese utero bomb hiroshima
CAN,CAN1575,reactivity igg human carcinomas haemagglutination reactivity igg human carcinomas igg tumours fab igg intact fc igg carcinomas igg free tissues tumours igg reactivity tumours bnormal liver malignant diseases igg igg tissues
CAN,CAN1576,igg human carcinomas free different prepared degrees flow igg serum non malignant diseases healthy individuals free non malignant diseases metastases igg carcinomas free renal whereas carcinomas free renal malignant tissues free renal ratio igg serum extracts igg
CAN,CAN1577,tc phosphate histological suitable malignant isotope sites uptake uptake sites slight uptake mastectomy early intervals malignant intervals malignant stage stage versus postmenopause
CAN,CAN1578,ocular orbital cellulitis orbital cellulitis sinusitis report emphasizes signs laboratory findings orbital cellulitis orbital cellulitis therapy diagnostic ct cautious therapy intervention drainage
CAN,CAN1579,cystic tuberous sclerosis occurrence tuberous sclerosis normal tuberous sclerosis wall intracranial due csf neurological signs cyst year year moths headache time lesions lateral cyst lateral calcified lateral months weakness right tendency progressive past non ct sebaceum walls tuberous sclerosis university march right hyper reflexia write right hand normal general skin lesions sebaceum second ct time size unchanged parietal craniotomy cystic lateral tuberous sclerosis lateral horn histopathological typical giant astrocytoma immediate temporary right motor weakness shunt signs intracranial due weeks time dismissal free mild right literature cyst tuberous sclerosis
CAN,CAN1580,glycerol enhancement ct enhancement ce ct ce effect due extravascular components ce effect gliomas extravascular water glycerol method drip glycerol ce effect usual drip ce gliomas malignant glioma vascular gliomas thought ce effect malignant gliomas vascular malignant glioma cyst ct cystic minutes
CAN,CAN1581,embolization embolization embolization method embolization cheek olfactory neuroblastoma catheterization femoral infant emboli emboli size normal saline instillation heparin emboli effect emboli embolization effect hand emboli proximal restored effect minimize important embolization effect emboli embolization effect ligation effect emboli day embolization cheek olfactory neuroblastoma primary minimize untoward side ophthalmic middle meningeal vertebral pay vascular prevent possible catastrophe
CAN,CAN1582,non genetic resistance fibrosarcoma meth genetic hybrid resistance fibrosarcoma meth tumour hybrid mice syngeneic mice females significant resistance subcutaneous intraperitoneal tumour dbaf mice significant resistance meth linkage backcross mice significant resistance meth results hybrid resistance meth non resistance resistance meth colour loci
CAN,CAN1583,occupational solvents referent personal occupational solvents hodgkins referents solvents hodgkins referents risk hodgkins solvents solvents occupational risk regard
CAN,CAN1584,extracranial metastases pulmonary metastases radiological documentation non metastases osteoblastic skeleton fourth lesions single pulmonary metastatic spread diagnostic
CAN,CAN1585,pulmonary pulmonary coin lesions institute ten disadvantages different parameters select diagnostic complications risks non oncologic
CAN,CAN1586,diagnostic double conventional stomach diagnostic double conventional stomach conventional investigation double double bigger conventional much bigger negatives double
CAN,CAN1587,method stomach standard method correlations method stomach endoscopic radiological results previous method trial policentrico double method
CAN,CAN1588,xeroradiographic rheumatoid hand hands rheumatoid non conventional xeroradiography xeroradiograph subperiosteal erosion soft deformity metacarpophalangeal proximal interphalangeal xeroradiographic radiographic techniques documented conventional synovial xeroradiographs conventional rheumatoid hand xeroradiographic
CAN,CAN1589,post time lag many post bleedings short stage importance post slight
CAN,CAN1590,calciotropic hormones dihydroxyvitamin parathyroid renal female prolactin none parameters mineral normal limits effect mineral calciotropic hormones results assign prl mineral man
CAN,CAN1591,transferase malignant non malignant transferase different methods plasma malignant non malignant malignant non malignant ones wide range malignant non malignant lines results presence glycoproteins malignant membrane synthesis
CAN,CAN1592,hybrid transferase malignant non malignant report method transferase wide range lines results preparations malignant non malignant km sialic presence excess preparations malignant vmax level transferase malignant populations sialic whole preparations
CAN,CAN1593,tests dopa carbidopa nomifensine nom dopa carbidopa dopa carb dopaminergic prolactin prl drugs pituitary tumours functional hyperprolactinaemia oral nom forty dopa carb carb doses dopa carb thirty normal subjects group proven prl pituitary tumours group prl radiological evidence pituitary tumour hyperprolactinaemia unknown functional hyperprolactinaemia group polycystic serum prl group disorders hyperprolactinaemia prl normal values nom dopa carb serum prl group dopa carb group group group hypersecretion
CAN,CAN1594,effect serum prolactin normal subjects prolactin micrograms healthy subjects evidence pituitary tumour serum prolactin values significant serum prolactin values fifteen healthy subjects evidence pituitary tumour findings human prolactin pituitary suppressible hyperprolactinaemia prolactin pituitary level normal pituitary human
CAN,CAN1595,metastatic wide metastatic orbital metastases different diagnostic techniques carcinoembryonic report orbital metastases specific estrogen receptor illustrated report
CAN,CAN1596,system calices neck renal lesion neck important complications renal calyces neck findings time excretion urogrammes renal renal calyces findings renal calyces shaped necks calyces calyces stasis cirrhoses renal calyces correlation laboratory findings pyelonephritis latent motility urodynamics results uttered male healthy kidneys renal calyces means urologist exclusion neck
CAN,CAN1597,experiences ultrasound differentiation ultrasound method diagnostics renal cyst cyst formations method diagnostic method simultaneously findings methods
CAN,CAN1598,orthopaedic viewpoint carcinomas diagnostic problems differentiation primary tumour malignoma metastases parts tumour size right upper
CAN,CAN1599,expansion cysts upper end unusual size year resection cyst cyst year female picture cystic transformation histodiagnosis repeated cystic lesions important findings
CAN,CAN1600,sonography framework spectrum ultrasonic method growths framework inflammatory tumours sonography valuable respect presence tumour soft tissues structure sonography valuable diagnostic complementary
CAN,CAN1601,results malignant malignant proximal femur incision fate results sarcomas ewings sarcomas
CAN,CAN1602,results nephrectomy second group nephrectomy group second group less metastatic spread
CAN,CAN1603,diagnostic importance intestine polyps malignant recurrent radical months recurrent carcinomas group group oncological risk
CAN,CAN1604,extrahepatic ducts duodenal ducts duodenal ulcer obstruction lesion resection stomach choledocholithiasis sclerosis pancreas
CAN,CAN1605,complications peptic ulcer stomach complications peptic ulcer institute specific methods different complications immediate results
CAN,CAN1606,malignant degeneration stomach ulcers stomach disorders group oncological risk conservative ulcer ulcer complications
CAN,CAN1607,tomographic intracranial midline cysts intracranial cystic lesions cranial ct eliminates invasive neuroradiological cystic lesions walls midline skull diagnostic management therapy intracranial lesions noncystic lesions diagnostic ct lesions related skull cystic lesions spatial resolutions due partial effect complementary ct metrizamide dynamics management therapy
CAN,CAN1608,convulsions significance convulsions group excision meningioma convulsions half convulsions anticonvulsant occurrence
CAN,CAN1609,cysticercus racemosus fourth report racemosus fourth consciousness intracranial condition times cysts
CAN,CAN1610,myxoid lipoadenoma parathyroid myxoid lipoadenoma parathyroid primary hyperparathyroidism rare unusual epithelial way epithelial lipoadenoma parathyroid
CAN,CAN1611,mucinosis mucin emboli adenocarcinomas nonbacterial thrombotic endocarditis coagulation vascular channels thrombotic valves mucin vascular resultant organs heart mucin magnitude thromboemboli infarcts
CAN,CAN1612,theory carcinogens neoplasia organisms carcinogens destroy vital second stem gradual deterioration machinery compensatory stem size organisms demands pool stem replenish leukemia peripheral pretreatment level explain effect stem stem replenishment conditions law introduces carcinogenesis process machinery carcinogen extirpation normal stem carcinogens
CAN,CAN1613,induction group group individuals red possess sera synthesis group structure individuals glycosyltransferases normal tissues
CAN,CAN1614,skeleton effectiveness scintigraphy scintigrams roentgenographic months final group group prostatic time group roentgenographic sensitivity time scintigrams results prostatic little management
CAN,CAN1615,esophageal cyst report review literature esophageal cyst rare literature thoracotomy cyst esophagus cyst recovery findings yellow mucus contents cyst cyst ciliated epithelium evidence cartilage st occurrence herein related literature
CAN,CAN1616,significance choledocholithiasis underwent primary gallstones drip cholangiograms healthy parallel review congenital choledochal cysts literature gallstones gallstones called drainage choledochoenterostomy strict
CAN,CAN1617,liver scintigraphy liver gastrointestinal digestive tract pancreatic colorectal presence group scintigraphy mesenteric colorectal scintigraphy tract pancreatic ratio ie liver group positive scintigraphy cm ratio liver scintigraphy hence liver scintigraphy liver angiographical entails possible complications
CAN,CAN1618,venous permeation colorectal fifty rectum paraffin venous stain elastic histological evidence venous perirectal wall structure total obstruction identification venous depth differentiation size lymphatic permeation lymph venous year dukes extent venous elastic stain prognostic
CAN,CAN1619,intestinal diffuse laurens underwent resection university faculty intestinal diffuse intestinal lymph lymphatic vascular liver infrequent diffuse subjects serosa lymphatic permeation bloodstream infrequent due dissemination serosal serosa worse diffuse intestinal
CAN,CAN1620,institutions mammary problems diagnostic points incisional excisional second radical mastectomy influences prognostic excisional prognostic excisional lapse time radical mastectomy safe conditions
CAN,CAN1621,test fabia excess related occupations comprised massachusetts group significant hydrocarbon occupations gas station cleaners dyers significant paternal pulp mill parts nervous system odds paternal machinist tract odds evidence reluctant leukemia lymphoma
CAN,CAN1622,pituitary tumours pituitary excess pituitary tumour report pituitary tumour triiodothyronine thyrotoxicosis hypophysectomy prompt fall serum return euthyroid state
CAN,CAN1623,unsuspected schizophrenia unsuspected intracranial schizophrenic ct porencephalic cyst meningioma cystic enlargement pineal subdural haematoma drawn ct schizophrenia
CAN,CAN1624,prone position pulmonary nodules lungs supine position prone position important pulmonary vascularity expansion posterior prone position possible prone significant diagnostic
CAN,CAN1625,pheochromocytoma pheochromocytoma cystic suprarenal tomographic manifestations possible etiology cystic suprarenal lesions
CAN,CAN1626,versus pheochromocytoma report ct ct methods pheochromocytoma single left year year extraadrenal pheochromocytoma right lesion cm pheochromocytomas films extraadrenal pheochromocytoma cm ct ct contribute significant pheochromocytoma
CAN,CAN1627,rib pulmonary protuberance rib pulmonary typical true frontal
CAN,CAN1628,renal angiomyolipoma tuberous sclerosis angiomyolipomas easy way tumoral facilitates tuberous sclerosis cartilage deposits
CAN,CAN1629,bronchogenic thirty non oat primary bronchogenic ct ct underwent mediastinoscopy exploration lymph nodes nodes cm malignant lymph nodes lymph nodes cm thoracotomy ct ct primary investigation
CAN,CAN1630,ct inflammatory diseases clarity clarity mediastinoscopy overall ct lesions
CAN,CAN1631,innervation walls human fibres sensory human wall possible fibres juxta
CAN,CAN1632,rare compression groove commonest compression groove literature rare neurinoma compression due arthrogenic ganglion due gout due post traumatic fibrosis
CAN,CAN1633,brodies radiographic diagnostic brodies radiographic conditions likely questions brodies radiographic inflammatory lesion
CAN,CAN1634,chondrosarcoma chondrosarcoma chondrosarcoma chondroblastoma osteoblastoma
CAN,CAN1635,liquid references values laboratory neural crest liquid free epinephrine day analytes negligible urine recovery epinephrine urine preliminary laboratory neural crest
CAN,CAN1636,secretions mammary plasma steroids mammary mammary chf xvii mice pituitary parameters mammary trans broparestrol tbp parameters
CAN,CAN1637,host metabolic total vitamin serum liver sarcoma total serum liver sarcoma group total vitamin hydroxycobalamin adenosylcobalamin cyanocobalamin methylcobalamin chromato bioautographic tissues significant total vitamin different tissues vitamin requirements host cobalamin stores significant values different cobalamin coenzyme preferential uptake host cobalamin coenzyme sarcoma adenosylcobalamin cyanocobalamin components pool
CAN,CAN1638,intestinal intestinal hormones growth mice gastrin times hepatoma sarcomas intestine injections growth mice intestinal hormones carcinogenesis intestinal tract growth many intestinal pancreatic liver prophylaxis intestinal tract
CAN,CAN1639,nervous system glucuronidase carcinoembryonic cea substances detect presence infiltration infiltration lymphoma metastases spinal epidural glucuronidase infectious whereas favorable metastases effectiveness glucuronidase cea promise metastatic
CAN,CAN1640,serum lymphoma electrophoretic patterns normal inflammatory conditions different normal less equal inflammatory conditions less equal due reactant occurs neoplasia globulins different globulins equal group igm
CAN,CAN1641,osseous lesion diagnostic problems year male eye months soft right ethmoid sinus evidence malignant ethmoid months lesion cranial resection wide range lack experts
CAN,CAN1642,paraganglioma paraganglioma review literature intrathyroidal paraganglioma findings support unusual sites primary paragangliomas
CAN,CAN1643,papillary elastofibroma septum papillary elastofibromas heart findings valves papillary fronds elastic hyperplastic endothelial catherization lesion
CAN,CAN1644,neoplasia analgesic nephropathy urothelial analgesic nephropathy urothelial renal report nephrectomy specimens severe urothelial dysplasia invisible invasive lesion urothelium findings support invasive carcinogenic analgesic metabolites urine atypia urothelium
CAN,CAN1645,nipple skin nipple skin mastectomy primary carcinomas nipple pagets ducts lymphatics encountered size sector intraductal carcinomas skin underlying nipples emboli lymphatics random nipples flaps underlying emboli lymphatics skin metastases nipple skin
CAN,CAN1646,epithelial metaplasias report epithelial metaplasia refers normal glandular epithelium normal endometrium inconspicuous unusual process report concerns findings metaplasia metaplastic metaplasia syncytial papillary metaplasia metaplasia metaplasia eosinophilic metaplasia hobnail metaplasia metaplasia metaplastic transformation postmenopausal oral estrogen replacement therapy months time curettage
CAN,CAN1647,nephrotic year man nephrotic renal lesion total remission nephrotic nephrotic
CAN,CAN1648,complications resections inflammatory bowel right resections inflammatory bowel ibd records ibd group ibd group complications group due problems group complications complications infection group complications group due group complications
CAN,CAN1649,report review literature year microangiopathic hemolytic leucoerythroblastic peripheral picture ulcer marrow trephine metastatic mucin gastroscopy primary temporary months peptic ulcer radiographs ulcers
CAN,CAN1650,adamantinoma report adamantinoma tibia rare primary malignant tumour problems
CAN,CAN1651,haemangiopericytoma review literature report intraosseous haemangiopericytoma exarticulation metastases intraosseous haemangiopericytomas record
CAN,CAN1652,musculoskeletal disorders ct diagnostic musculoskeletal system malignant lesions method ct disorders musculoskeletal tissues extent lesions malignant lesions
CAN,CAN1653,soft disorders ct important soft ct different normal true extent lesions soft ct lesions malignant lesions specific values helpful differentiation types cysts
CAN,CAN1654,nonspecific vitro cytotoxicity human macrophages human macrophages effector growth vitro effect human macrophages growth human presence human macrophages lipopolysaccharide vitro tdr uptake human normal human diploid non macrophages lps macrophages tdr uptake microscopy macrophages degeneration macrophages macrophages plasma types interdigitate results growth macrophages close macrophages mediators macrophages
CAN,CAN1655,correlation immune histopathological primary lesion radiation therapy viewpoint histological reactions lymph nodes test cutaneous hypersensitivity peripheral blastoid transformation peripheral subpopulations test cutaneous hypersensitivity significant correlation skin reactivity pha ppd skin reactivity test blastoid transformation peripheral counts good enlargement lymph nodes radiosensitivity ppd skin reactivity observations host effect histological parameters immune reactions
CAN,CAN1656,early recurrent early signs methods mortem findings manifestations died free progressive ipsilateral abdomen signs intra pelvic walls infection hydro nephrosis pelvic obstinate cough pulmonary serum esr peripheral recurrent group positive vaginal final enlargements
CAN,CAN1657,histological hydatidiform seek risk group hydatidiform classified hertigs peripheral index iia iib iii subsequent destructive iib iii subsequent destructive iii correlation histological weeks ratio syncytiotrophoblast cytotrophoblast iii cytotrophoblast syncytiotrophoblast iii less peripheral histological
CAN,CAN1658,effect human plasma incorporation pha peripheral human plasma pha plasma human plasma pha free human plasma plasma pha normal plasma stage plasma stage plasma pha stage stage results factor plasma stage human plasma pha normal pha stage pha stage plasma pha
CAN,CAN1659,primary primary female genital tract rare differentiated papillary pleomorphic giant rer rich membrane spaces prominent observations structure unusual normal epithelium ciliated secretory fact secretory
CAN,CAN1660,laser radiation laser enhancement tumour growth shorter mitotic turn due enhancement related proliferative pool
CAN,CAN1661,ibo nigeria university nigeria enugu racial geographical year group half menorrhagia good early
CAN,CAN1662,single method carcinomas invasive metastases sensitivity ultimate effect significant
CAN,CAN1663,radiotherapy hypernephroma radiotherapy significant hypernephroma short term radiotherapy results work colonies radiation positive short term radiotherapy
CAN,CAN1664,renal carcinomas spread renal permits metastatic spread operability
CAN,CAN1665,oral conditions lesions means sonography oral time lesions nodular hyperplasia cavernous oral liver disorders nodular hyperplasia vascular important oral liver nodular hyperplasia nodular reparative necrosis due segmental vascular intimal obliteration lesions true findings uncharacteristic whereas typical nodular hyperplasia regular oral group serious intrahepatic
CAN,CAN1666,ewings metastatic clivus report ewings lethal primary orthopedic shaft fever sedimentation ewings sarcoma trochanter clivus th palsy presence fever photophobia rapid evolution radiological signs
CAN,CAN1667,perioperative management pituitary microadenoma systematic method perioperative management pituitary microadenoma microsurgery methods year utilized management pituitary problems trans neurosurgical endocrinological otorhinolaryngological eliminate management assure safety perioperative therapy cost possible
CAN,CAN1668,chloroethyl nitrosourea bcnu pulmonary fibrosis bcnu therapy primary intracranial glioma suspected pulmonary fibrosis therapy pulmonary diffusion cough onset process specimens wide spectrum membrane interstitial fibrosis granuloma bcnu pulmonary fibrosis related
CAN,CAN1669,human peripheral lymph populations populations lymph human cytotoxic normal rosette less rfc eac rfc rosettes rosettes eac rfc normals significant significant significant normals cytotoxicity times lymph less cytotoxicity normals less limited tendency tissues pool
CAN,CAN1670,keratoplasty congenital total opacity results results condition eye
CAN,CAN1671,diagnostic carcino embryonic diagnostic tapping cea serum filtration index possible much report method metastases
CAN,CAN1672,effect replacement therapy renal renal glucocorticoid renal glucocorticoid replacement microgramsday clearance mlmin replacement fludrocortisone microgramsday replacement iv normal microgramsday net excretion plasma total cumulative nae sigma delta nae independent meq fifth day plasma total magnitude sigma delta nae less averaged meqkg wt day plasma total sigma delta less findings evidence renal tonic normal subjects normal sodium extent tonic renal direct effect renal hydrogen transport effect dependent renal sodium transport investigation findings significant renal condition dependent presence renal glucocorticoid endogenous
CAN,CAN1673,results underwent malignant renal specific shifts hyperproduction malignant daily excretion renin therapy results hyperaldosteronism aldosteroma
CAN,CAN1674,jfs paralysis ix xith cranial general cranial jfs traverse otitis second glomus vascular infections jfs radiological techniques investigation jfs
CAN,CAN1675,dysgenesis xy gonocytoma xy dysgenesis iii teters left ovary year genetic dysgenesis gonadectomy
CAN,CAN1676,leiomyosarcoma renal report year general ill health right hypochondrium leiomyosarcoma renal retroperitoneal lack right renal partial inferior findings independent excretory
CAN,CAN1677,exploration retroperitoneal lymphography non hodgkins lymphomas systematic manner lymphography hodgkins latter investigation upper coeliomesenteric adenopathies possible lesions kidneys possible lipiodol easy radiological sensitivity lymphography
CAN,CAN1678,possible human right malignant etiology spread nephro urotomography results
CAN,CAN1679,concepts investigation ill ill girls healthy girls means results terms theory
CAN,CAN1680,cultures neurones subject qualitative switchover potter landis walicke campenot conjunction specification complementary specification receptor synaptic force nervous system spatial membrane post synaptic useless presynaptic release post synaptic outstanding nervous system report receptor membrane functional synaptic connexions early maturation synaptic networks contingent contingency functional networks networks mature wiesel hubel potentials synaptic maturation nervous system
CAN,CAN1681,epinephrine maculopathy epinephrine maculopathy reversible macular topical epinephrine flame macular onset commencement epinephrine therapy months maculopathy irvine gass pharmaceutical recovery pre maculopathy cystic macular
CAN,CAN1682,skin dermatitis tar year coal tar ointments many eczematoid dermatitis possible carcinogenic effect coal tar ointment ultraviolet goeckerman physicians year dermatitis neurodermatitis treated coal tar ointments ultraviolet mayo results coal tar ointments ultraviolet results skin populations united risk skin dermatitis neurodermatitis coal tar ointments ultraviolet goeckerman
CAN,CAN1683,epidermal cyst painful lesion epidermal cyst epidermal cysts lesions
CAN,CAN1684,hartmann hartmanns potential stapler hartmanns diverticulitis hartmanns morbidity results diverticulitis emergency
CAN,CAN1685,stapler stapler stapled gastrointestinal tract middle rectum anastomose hartmann easier results rectum
CAN,CAN1686,gardner apropos hereditary different blastoderm layers colorectal polyposis female male polyposis polyposis risk presence polyps polyposis underwent total polyps level rectum malignant transformation extra colic manifestations condition polyposis gut attract early
CAN,CAN1687,related omas tumours presented intestine colorectal different tumour tumour lymph nodes metastases carcinoidosis weeks carcinoidosis zollinger ellison probable
CAN,CAN1688,manifestations intestine malignant year due operative stage complications perforation obstructive peptic lesions stomach stasis upper bowel bowel peptic ulcer heal conservative
CAN,CAN1689,perforation stomach ulcer stage results partial resection perforation perforation due ulcer ulcer emergency resection pulmonary embolism perforation died severe emergency resection results literature perforation due ulcer emergency resection results suture
CAN,CAN1690,stomachs endoscopic results histological investigation endoscopic resection ulcer histological results early dysplasia intestinal metaplasia resection early histological mucosa resection ulcer ups mucosa
CAN,CAN1691,lymphomas pseudolymphomas report hodgkins lymphomas nodular lymphocytic lymphoma diffuse lymphocytic lymphomas diffuse lymphomas diffuse histiocytic lymphomas pseudolymphomas ive ann arbor lymphomas months lymph ie stage iie phenomenon non ganglionary lymphomas good remission histiocytic stage remission ganglionary lymphomas possible localised triple therapy radiotherapy histological unfavorable
CAN,CAN1692,short review oesophagus report resections operative technical literature guide oesophagus
CAN,CAN1693,basaloma meningioma term arsenic therapy carcinomas term arsenic arsenic whereas arsenic therapy results arsenic meningioma
CAN,CAN1694,early childbearing white united deaths extent possible risk factor early full term pregnancy marriage state significant correlations state specific teens south southwest northeast correlation
CAN,CAN1695,pancreatic carcinoembryonic cea pancreatic juice carcinoembryonic cea pancreatic juice total pancreatic cea pancreatic juice pancreatic pancreatitis miscellaneous diseases normal cea pancreatic juice pancreatic liver serum cea pancreatic juice stage liver cea sera cea pancreatic juice important diagnostic pancreatic early stage
CAN,CAN1696,enanthate fifty undergone hemodialysis enanthate evidence liver hepatoma findings enanthate
CAN,CAN1697,specific sensitivity lymphoma hybrids hybrids different lymphoma lines sub lines glucocorticoid wild wt defects receptor nuclear receptor glucocorticoid glucocorticoid resistant lymphoma wild glucocorticoid sensitivity dominant resistance wt hybrids glucocorticoid types defects wt hybrids resistant hybrid clones glucocorticoid doses resistant segregants concomitant wild receptor sensitivity resistance results direct evidence hemizygosity glucocorticoid receptor gene system suitable glucocorticoid receptor gene specific
CAN,CAN1698,structure anthracycline structure developed melanoma cardiotoxicity anthracycline exploitable indices increases cardiotoxicity demethoxylation demethoxylation position effect cardiotoxicity potential quinone structure possible index introduction hydrophilic adriamycin functions
CAN,CAN1699,potential pharmacokinetics platinum dichlorodiammine platinum pharmacokinetics equivalent renal dichlorodiammine platinum metastatic cddp disposition platinum biexponential rapid slow peripheral fluids tissues volumes serve platinum reservoir peripheral platinum diffuses peripheral platinum findings volumes platinum faster adjusted cddp
CAN,CAN1700,migration gels fibres collagenolytic migration permanent lines gels fibres substratum growth migration ovary rpmi melanoma tumorigenic migration matrix migration types matrix degradation possible implications observations vivo
CAN,CAN1701,postmenopausal postmenopausal adenomyosis yr time menopause yr values yr estrogen estrogen therapy obese signs estrogen extraglandular estrogen
CAN,CAN1702,oral risk pituitary report retrospective hyperprolactinemic pituitary treated mount oral oc pituitary discordant group appendectomy time risk less significant oc pituitary hyperprolactinemia
CAN,CAN1703,retinol retinoic human adenocarcinomas human adenocarcinomas cancerous normal presence crbp retinoic crabp sucrose male crabp normal female fold normal findings retinoic human
CAN,CAN1704,investigation occupational carcinogenesis identification occupational carcinogens problems jobs time problems cumulative involves work year year hire method job year method angiosarcoma liver vinyl polymerization method level likely occupational health retrospective
CAN,CAN1705,prolactin pituitary primary empty sella endocrine test primary empty sella pituitary prolactin primary empty sella pituitary normal subjects primary empty sella normal prolactin normal prolactin release whereas pituitary prolactin findings invasive pituitary typical empty sella endocrinopathies normal normal serum prolactin intact
CAN,CAN1706,platinum diaminedichloride kidneys platinum diaminedichloride side effect renal evidence diminution renal size evidence renal cpdd recommend radioisotope early renal damage
CAN,CAN1707,transnasal pituitary transnasal pituitary neurosurgeon plastic eleven review
CAN,CAN1708,polyorchidism teratoma duplication torsion right inguinal malignant teratoma trophoblastic choriocarcinoma scortal right side scrotal impalpable normal side pulmonary metastases
CAN,CAN1709,complications resection recognition underwent resection complications perforation wall transfusion infection many infections much group deaths morbidity perforation free drainage hyponatremia
CAN,CAN1710,resection snare snare resection easy resection bloc rapid less customary methods
CAN,CAN1711,retinoids normal human vitro human normal tissues retinoic plasminogen synthesis skin fibroblasts epithelial effect retinoic retinoid plasminogen fibroblasts normal tissues consistent release magnitude retinoid effect
CAN,CAN1712,isolation transformation lines tracheal epithelial respiratory carcinogenesis rodents tracheal epithelium target induction carcinogens tracheal epithelial epithelial tracheal mucosa golden morphological types polygonal populations lines mucin membrane alcian blueperiodic schiff mucin medium second possess cilia mucin dependent lines repeated soft proteases hydrocarbon hydroxylase anaplastic carcinomas syngeneic transformation differentiation respiratory epithelial lines questions
CAN,CAN1713,plasminogen harvest mammary harvest human mammary lines mb nontumorigenic human mammary mammary incorporation confluent quiescent dependent manner hfcs lines plasminogen plasminogen hfc preparations growth potential protein hfcs plasminogen hfcs hbl unique tumorigenic mammary human lines hst mb plasminogen plasminogen hfcs hfcs human mammary bt plasminogen bt hfcs fetal serum dependent manner bt serum
CAN,CAN1714,human melanoma papain human malignant melanoma rabbits melanoma membrane papain red lines reactivity different human types membrane radioimmunoprecipitation techniques different maa human melanoma melanoma group specific different melanoma lines second oncofetal melanoma fetal melanoma membrane lactoperoxidase non ionic detergent sodium sulfate polyacrylamide peaks weights daltons oncofetal melanoma lines
CAN,CAN1715,subarctic disastrous hunger diseases remarkable iceland times ie leprosy hydatid th infectious diseases iceland importance infant vascular diseases remarkable fall infant expectancy prosperity
CAN,CAN1716,immunoenzymatic prolactin decidual endometrium nonpregnant immunoenzymatic method decidual endometrium early weeks normal pregnancy weeks pregnancy weeks pregnancy nonpregnant progestogen lynestrenol specific endocrine trophoblastic prolactin decidual endometrium
CAN,CAN1717,hypokalemia due intestinal watery hypokalemia watery hypokalemia hypercalcemia plasma intestinal effect endocrine neoplasia insulinoma pancreas hyperplasia parathyroid hormones gastrin plasma glucagon pancreatic gastrin pancreatic gastrin plasma pancreatic glucagon plasma results good due plasma results hormones pancreatic glucagon plasma
CAN,CAN1718,introduction stereology microscopy stereology mathematics organs stereologic methods anatomists guide stereologic techniques methods methods densities shape size rotatory ellipsoids topics methods correction thickness index reconstruction
CAN,CAN1719,dichlorodiaminoplatinum dichlorodiammineplatinumii weeks progressive conventional cytotoxic therapies different drugs months electrolyte furosemide mannitol severe side
CAN,CAN1720,vitro resistance human vitro test resistance human metabolic effect cds vivo resistance primary incorporation dna rna precursors maximal incorporation tenth resistant maximal incorporation test total human cds weeks therapy vitro test resistance resistance cds good lack resistance
CAN,CAN1721,vitro resistance sarcoma walker results resistance human incorporation metabolic precusors rna synthesis presence cds time equal post explantation supravital stain trypan cr release
CAN,CAN1722,impulse cytophotometric significance dna flow techniques tumours dna ploidy tumours diploid dna patterns tumours tumours tumours diploid tumours diploid dna tumours diploid tumours malignant non tetraploid tumours possible dna results instillation adriamycine
CAN,CAN1723,exfoliative urine histological results results possible malignant results iii papanicolaou
CAN,CAN1724,reactivity human immunofluorescent specimens progesterone tc medium serum degrees immunofluorescent fitc igg rabbits estradiol oxime bsa progesterone oxime bsa specimens steroids nuclear estradiol progesterone respect nuclear immunofluorescent cytoplasmic estradiol progesterone nuclear patterns cytoplasmic nuclear normal results subcellular dynamics normal reactivity
CAN,CAN1725,tests colorectal guidelines eat day time stool rectal bowel occult guaiac method findings tests positive dietary instructions meat beets horseradish vitamins hemoccult quikcult fecal tested positive sigmoidoscopic upper gastrointestinal radiography evidence early lesions cure
CAN,CAN1726,different hyperaldosteronism renin plasma picture values concomitant hyperaldosteronism renin plasma due substantiate nonoperative aldosteroma hyperplastic process
CAN,CAN1727,reactions radiation review deals radiation dermatology biophysics recent damage current radiotherapy methods potential risks radiation nonstochastic somatic radiation skin radiogenic current methods risk radiation carcinogenesis radiation potential genetic
CAN,CAN1728,stapler resections resections conventional stapler radiological stapler technical important successful stapling importance rings purse suture technical stapler rectal resections complications
CAN,CAN1729,cryoglobulinemia plasmocytoma report cryoglobulinemia typical skin lesions unusual
CAN,CAN1730,system human participation macrophages host immune mechanisms host immune review current tests frame results
CAN,CAN1731,colorectal review bowel confusion options review options regard metastases primary tumours bowel removal recurrent colorectal evidence total excision palliating total excision recurrent tumour possible side
CAN,CAN1732,colorectal review colorectal dissemination overall metastases colorectal primary vary months months many specific due
CAN,CAN1733,nutritional uses doses normal human doses severe vitamin scurvy doses metabolic mention therapy colds wounds scientific fact
CAN,CAN1734,erythroleukemias induction glycoproteins hematopoietic lines express express significant synthesis friend erythroleukemia total protein synthesis shows selection growth synthesis hemoglobin synthesis lines cytotoxic presence induction hemoglobin synthesis terminal differentiation friend erythroleukemias
CAN,CAN1735,human tubulin normal leukemic purified human tonsil filtration weight human tubulin weights polypeptides human tubulin partial identity tubulin human tubulin double immunodiffusion human tubulin presence gtp protein microtubules localized juxtacentriolar microscopy time decay level normal gg protein lymphocytic leukemia unusual values level decay weight normal lymphocytic leukemia normal quantity tubulin lymphocytic leukemia
CAN,CAN1736,watery diarrhoea intestinal ganglioneuroblastoma persistent watery diarrhoea hypokalaemia face trunk intestinal resection suprarenal serum level intestinal normal diarrhoea tumour ganglioneuroblastoma intestinal serum secretory watery diarrhoea due neural crest tumours respect
CAN,CAN1737,infection immune effect radiation neutropenia infection prone nosocomial infection fever pathogens transmission usual exogenous means conventional protective isolation exogenous transmission infection physicians infection serious types infections endogenous infection fungi ward autoinfection cannulae meticulous nursing important endogenous spread exogenous endogenous infections laminar flow leukemia
CAN,CAN1738,misuse androgens esters mouth side esters replacement therapy male hypogonadism esters free therapy plasma endogenous induction normal spermatogenesis androgens situations male hypogonadism nonvirilizing side disorders effect hereditary angioneurotic due marrow
CAN,CAN1739,primary monomorphic middle monomorphic respiratory epithelium middle greyish histology micrographs report entity malignant compendium radiographic audiometrical typical conductive second paralysis reversible resection histology year resection
CAN,CAN1740,non intraoperative cultures subsequent infection neck neck intraoperative cultures risk infection infection skin operative neck oropharynx nares intraoperative pharyngeal irrigated water cultures laboratory wadsworth infections cefazolin perioperative noninfected potential pathogens potential pathogen infected wounds pathogens correlation nasal staphylococcus isolation subsequent recovery infections intraoperative risk subsequent infection neck
CAN,CAN1741,cutaneous side normal skin microscopy radioautography incorporation psoriatic methotrexate polychemotherapy osteosarcoma recruitment synchronization blockage specific phases lethal signs epidermis vacuolar cytoplasmic keratinocytes dyskeratosis bullae epidermal necrolysis index normal keratinocytes hyperchromatic endothelial index fibroblasts eccrine lines recruitment synchronization blockage
CAN,CAN1742,neuroblastoma implications little neuroblastoma recent recent tumour implications therapy different human neuroblastoma linesfresh tumours reagents metastatic spread marrow vivo differentiation tumour vitro human murine neuroblastoma lines work therapy ways vivo differentiation tumour ganglioneuroma
CAN,CAN1743,dna repair defects dna different mechanisms photoreactivation excision repair postreplication repair specific defects individuals prone methods possible individuals results mechanisms carcinogenesis
CAN,CAN1744,recent management recent reviews intestinal polyposis syndromes none none management rare genetic surgeons gastroenterologists researchers management rare early premalignant questions
CAN,CAN1745,vs colorectal colorectal stapled end end hand sutures stapled fistula subsequent hand sutures fistula peritonitis stapled sutured colorectal enables range resection level resection
CAN,CAN1746,hyperthermia conquer elusive hypoxic implications normal microcirculation radiobiology hypoxic important recent evidence hypoxic regions hyperthermia hyperthermia microenvironment
CAN,CAN1747,stereotaxic removal nervous system lesions results computer stereotaxic reconstruction removal nervous system lesions types nervous system representative
CAN,CAN1748,intracerebral method parietal hippocampal proven inadequate problems intracerebral growth significant extracranial tissues lungs spinal nitrosourea nervous system lines rapid stereotaxic method optimal intracerebral growth medium operative yield intracerebral growth size extracranial distant results method satisfactory radiation trials time index size
CAN,CAN1749,synthesis schwann sulfolipids purified cultures schwann schwann sulfolipids different track fibroblasts significant previous detect myelin components schwann mirsky results schwann neurons
CAN,CAN1750,identification skin lymphoproliferative disorders disorders immunofluorescent serum gma serum preliminary specimens lymphocytic infiltration skin lis lymphadenosis benigna cutis lbc lymphoma cutis lc mycosis fungoides lis lbc dominant immune etiology
CAN,CAN1751,centrilobular degeneration marrow marrow histology leukemia leukemia post early lesions centrilobular degeneration lesions fibrous obliteration centrilobular sinusoidal fibrosis subclinical lethal typical wk post transplant sudden weight enlargement statistical leukemia pretransplant rigorous regimens fourfold dimethyl busulfan liver tests versus host severe hepatitis centrilobular lesions degeneration sinusoidal fibrosis phlebosclerosis non specific hepatitis versus host
CAN,CAN1752,specific peptides human fibroblasts serum free human fibrosarcoma mw polypeptides peptides free diploid human fibroblasts cultures fibroblasts sodium hypotonic procollagen unidentified polypeptides dishes peptides free medium polypeptides release procollagen cleavages protein matrix collagenase peptides collagenase matrix hand mw matrix mw matrix peptides peptides polypeptides matrix results behaves specific human fibroblasts
CAN,CAN1753,mutagenicity hydroxamic probable carbamoylation hydroxamic propiono benzo nitrobenzo typhimurium yield benzoyl mutagenic nitrobenzohydroxamic minimum significant mutagenic microm benzoyl benzohydroxamate microm acetohydroxamate human lymphoblasts microm mutagenic benzohydroxamate wih atom benzoyl group vitro dna polyguanylic level dna phosphate polyguanylic phosphate
CAN,CAN1754,identification mutagenic dihydrodiols benzojfluoranthene benzokfluoranthene benzoj fluoranthene benzokfluoranthene supernatants benzojfluoranthene benzokfluoranthene mutagenic typhimurium ta metabolites liquid mutagenicity typhimurium ta mutagenic dihydrodiols dihydroxybenzojfluoranthene standard dihydroxybenzojfluoranthene mutagenic typhimurium ta dihydrodiol dihydrodiol benzokfluoranthene standard dihydroxybenzokfluoranthene dihydrodiol dihydrodiol mutagenic typhimurium ta results benzojfluoranthene benzokfluoranthene ultimate typhimurium ta
CAN,CAN1755,macrophages liposomes iv optimal macrophages pulmonary retention liposomes size iv mice multilamellar mlv unilamellar liposomes mlv amphiphiles neutral revs revs amphiphiles liposomes amphiphiles optimal mlv prepared phosphatidylserine ps pc ratio ratio liposomes iv wide range mumol due iv volumes ml retention liposomes iv pspc mlv serum pulmonary lavage iv pspc mlv preparations rich factor maf macrophages injections unencapsulated maf liposomes supernatants maf cytotoxic neutral pc mlv limited retention ineffective mlv liposomes liposomes macrophages
CAN,CAN1756,report review year findings prostatic osteoblastic normal serum undifferentiated outer metastases lungs nodes undifferentiated usual individuals immature prostatic review literature individuals undifferentiated normal serum level
CAN,CAN1757,intracortical osteosarcoma osteosarcoma tibial osteosarcoma jaffe intracortical sarcoma review literature osteosarcoma predilection lesion jaffe periosteal osteosarcoma
CAN,CAN1758,sinusoidal histiocytic lymphoma sinusoidal histiocytic lymphoma lymph lymphoma recognition important misdiagnoses metastatic metastatic malignant melanoma malignant histiocytosis comment prognostic implications
CAN,CAN1759,human nodular lymphoma vitro malignant lymphoma nodular histiocytic growth months floating medium time total hours cytoplasmic synthesis gamma heavy xya xyp tq pttq biopsied lymph tight cytoplasmic structure nodular lymphoma nodular growth lines
CAN,CAN1760,importance stable trials prostatic stable delineate conditions stable partial primary status partial stable valid
CAN,CAN1761,management stage malignant lymphoma types thirty stage malignant lymphoma types histiocytic treated remission rendered free time excisional free free status free evidence stage stage free results cure avoids morbidity results obtained radiotherapy radiation
CAN,CAN1762,granulocyte granulocyte factor gm csf vitro differentiation granulocytic regulator hemopoietic csfs vitro method functional subclasses organs gm csf wt csf fetal conditioned medium cm cm murine endotoxin serum csf gm csf csf cofractionates factor leukemic human gm csfs csf eo human cm none purified subclasses human csfs gm csf cm multipotential eosinophil mature gm gm csf differentiation leukemic respect gm csf modulators specific target vivo
CAN,CAN1763,metabolic mutagenicity intact hepatocytes untreated aroclor male female golden mutagenesis anthracene polycyclic benzoapyrene nitrosamine diethylnitrosamine dena hepatocytes preparations equivalent intact treated whereas results preparations intact male hepatocytes dena results system kind
CAN,CAN1764,streptococcal streptococcal nsc nk exudate mice ip injections cytotoxic pec early day day yac molt target pec target nylon column cytotoxic pec nylon column pec resistant asialo gm serum glycosphingolipid asialo gm nk results mice
CAN,CAN1765,regulatory murine lymphoma murine pha secrete il pha lbrm il il il supernatants lbrm exchange filtration ief reveals indistinguishable size murine il lbrm il spectrum il growth lines cytotoxic cultures cultures splenic il il likely single lbrm il regulatory
CAN,CAN1766,gene cytoplasmic lytic infection kb mrnas iii mrnas initiation termination polypeptides translation iii different frame splice cytoplasmic rna template vitro protein synthesis free system polypeptides weights
CAN,CAN1767,human serum sorter human br fetal normal peripheral br sezary mycosis fungoides lymphocytic leukemia normal pbl normal marrow normal pbl normal marrow fetal br differentiation immature hematopoietic marrow
CAN,CAN1768,igg ricin igg ramigg ricin cahin sulfhydryl ramigg ramigg ricin filtration sephadex sodium sulfate polyacrylamide disc double immunodiffusion protein synthesis free system ramigg purified inhibited protein synthesis cytotoxicity igg excess ramigg unlinked ramigg cytotoxicity negligible
CAN,CAN1769,report destructive lesion plasmacytosis protein report hepatomegaly lesions diagnostic points lymphoma heavy
CAN,CAN1770,embolization gastroduodenal embolization gastroduodenal results method method level possible complications good effect embolization method embolization
CAN,CAN1771,hemophilia gastrointestinal commonest manifestations hemophilia christmas successful concomitant factor ix findings japanese hemophilia underwent
CAN,CAN1772,radius hypoplasia forearm report radius hypoplasia forearm results
CAN,CAN1773,evidence cytotoxic functions human clones term cultures normal individuals presence tcgf cytotoxic targets subpopulations different cytotoxic clones yield direct isolation single preliminary cytotoxicity clones cytotoxic pha target cytotoxic due different stage maturation hypothesis
CAN,CAN1774,suprasellar arachnoid cysts membrane suprasellar arachnoid cyst ct positive ventriculography transfrontal exploration rd findings consistent cyst fact diverticulum arachnoidal membrane arachnoid cysts previous infection
CAN,CAN1775,peripheral non hodgkins lymphoma lymphographic findings lumbar iliac inguinal nodes bipedal lymphograms peripheral counts untreated non hodgkins counts normal range normal lymphographic findings peripheral occult non hodgkins
CAN,CAN1776,significance lacrimal significance lacrimal important serious time antiproteinase
CAN,CAN1777,structure hypoxic radiosensitizers substituents nitroimidazole sidechains nitroimidazoles functions lipophilicity hypoxic vitro nitro imidazolylalkylamines magnitude sensitization cytotoxicity nitroimidazoles quaternary nitro imidazolylalkylamines quaternization sensitization nitro imidazolylalkylamines investigation hypoxic radiosensitizers
CAN,CAN1778,radiotherapeutic therapy radiation sensitizers affinic hydroxyurea busulfan cyclophosphamide electrons much slowly electrons affinic sensitizers potentials values sensitization hydroxyurea busulfan cyclophosphamide affinic hydroxyurea possible radiosensitizers
CAN,CAN1779,marrow syngeneic mice leukemia effect lymph nodes marrow akr mice leukemic syngeneic system pre leukemic syngeneic stem index leukemia marrow proliferative normal leukemic mice
CAN,CAN1780,ct leukemia malignant non hodgkins ct leukemia non lymphoma thirty cns radiation intrathecal methotrexate therapy ten csf spaces subsequent observations findings values cns findings therapy effect ct literature ct demonstration csf spaces prognostic significance
CAN,CAN1781,idiotypic human leukemic peripheral typical positive lymphocytic leukemia paraprotein serum pentameric igm range contribute idiotypic fab idiotypic idiotypic sera total total serum igm idiotypic igm findings typical lymphocytic leukemia idiotypic usual occurrence
CAN,CAN1782,diagnostic radiology emphasis diagnostic introduction utilized diagnostic vascular renal examples embolization removal calculi foreign palliative management malignant intraarterial embolization renal tracts techniques complications
CAN,CAN1783,immunoblastic sarcoma immunoblastic sarcomas non hodgkins immunoblastic sarcomas lucent immunoblastic sarcomas cytoplasmic polysomal irregular strands endoplasmic reticulum pale amphophilic differentiation identification immunoblastic sarcomas types
CAN,CAN1784,seminoma human seminoma fc rosette method peripheral seminoma seminoma seminoma peripheral whereas favorable seminoma lymphocytic infiltration
CAN,CAN1785,dual flow cytometry lymphomas dual flow cytometry coulter dna monodisperse human lymphoma lymphocytic leukemia hairy leukemia coulter lymphomas due coulter presence non overall coulter minor presence coulter good correlation coulter lymphomas evidence normal lymphomas flow cytometry diploid coulter components diploid mixtures components vs findings histopathological lymphomas clonal selection clonal evolution
CAN,CAN1786,heterotopic oxyntic mucosa rectum heterotopic mucosa rectum rare condition significant rectal heterotopic mucosa secrete pentagastrin lesion pentagastrin maneuver helpful excision lesion
CAN,CAN1787,subpopulations peripheral tissues immune functions human helpers peripheral infiltrates ia positive forty untreated peripheral gamma normal peripheral ia positive peripheral ia positive lymphoma subjects tissues specific lymphocytic infiltrates double specific gamma ia positive peripheral profiles positive infiltrates
CAN,CAN1788,lymphoma hypergammaglobulinemia lymphoma hyperglobulinemia monotonous pale medium infiltration eosinophilic histiocytic branching deposits perivascular residual findings consistent immunoblastic lymphoadenopathy ibl degrees hypergammaglobulinemia ibl rosette lymph receptor positive medium terminal deoxynucleotidyl transferase findings peripheral helper
CAN,CAN1789,enhancement healthy subjects proliferative healthy subjects whole enhancement responders responders healthy subjects enhancement remission system effect purified exerted enhancement effect presence monocytes monocytes
CAN,CAN1790,reacts fetal identify pre mature lymphocytic leukemia non lymphoma leukemia hairy leukemia non non latter undifferentiated leukemia positive leukemia crisis normal leukemic erythroid hla dr ia gp
CAN,CAN1791,leukemia implications normal differentiation leukemia heterogeneous techniques membrane subtypes non non standard subgroups subgroups normal
CAN,CAN1792,vitro sensitivity leukemic normal sensitivity cll vitro tested sensitivity eventual lysis malignant vitro whereas aml normal peripheral resistant cll specific lysis malignant normal immediate cytolytic effect possible mechanisms specific glucocorticoid
CAN,CAN1793,findings system schwannoma warm calorizations utriculus ampulla sensory epithelium utricular ampullar crista normal patchy necrosis sensory epithelium quality sensory intact microscopy sensory differentiate reactions reactions
CAN,CAN1794,uses possible side market safe effect short term peptic ulcer documented helpful ulcer diseases mental confusion presence renal elderly potential problems sperm potentiation
CAN,CAN1795,clonal mice mice plasmacytomas precursors colonies mice plasmacytomas size mice colonies normal theta rads mice sephadex plastic dishes direct normal immune mice level mononuclear
CAN,CAN1796,populations proliferative syngeneic meth mice proliferative sarcoma meth syngeneic proliferative sensitization responders resistant lysis ia lysis responders sensitization removal macrophages effect proliferative preparations nude mice negligible preparations findings responders preparations whole fold types optimal proliferative meth helper effect maximal helper effect equal parts slight excess results proliferative syngeneic meth independent dependent
CAN,CAN1797,regulatory isolation lymphomas stable growth factor murine leukemia lymphoma clonal helper il lines il radiation splenic lymphoma bbr lbrm unitsml il il supernatants cultures pha lbrm il serum free serum cultures times quantity il conventional cultures il lbrm cultures optimal pha suboptimal lbrm lbrm ly ly ly qa qa qat ly evidence il il valuable isolation immunoregulatory
CAN,CAN1798,thymoma growth factor thymoma vitro growth factor il il mw il thymoma il il
CAN,CAN1799,epidermal growth factor progesterone human choriocarcinoma epidermal growth factor egf progesterone jeg clonal human choriocarcinoma time dependent manner egf increases incorporation jeg progesterone synthesis
CAN,CAN1800,time evolution discrete tri xi critical system xj psi recent ergodic theory results pianigiani yorke process examples rx second growth myelogenous leukemia importance results
CAN,CAN1801,distractibility term leukemia neuropsychological test term leukemia leukemia identify patterns neuropsychological scores normal limits term range test scores standard term test scores distractibility academic scores leukemia risk neuropsychological dysfunction programs academic
CAN,CAN1802,kininogenase kininogenase purified preparations human liver leukemic leukemia liver specific inhibits interaction liver cathepsin human plasma weight kininogen ks results bradikinin bradikinin inflammatory peptides mediators protein kininogens lysosomes
CAN,CAN1803,giant leukemia leukemia remission vpd coap consolidation sleepiness cough dying interstitial post mortem giant pneumopathia level resembles typical symptomatology siegel due interstitial immunodeficient importance immediate prophylaxis
CAN,CAN1804,vitro gamma leukemic mice pigs gamma leukemia rads gray effect leukemia weeks syngeneic mice doses rads leukemia months results leukemia extracts results leukemic leukemia gamma rads inhibits leukemic leukemia syngeneic prevent leukemia previous rads leukemia leukemic vitro gamma lc leukemic rads effect leukemia effect leukemia pigs doses rads leukemic doses rads
CAN,CAN1805,human melanoma surfaces report human melanoma melanoma melanoma astrocytoma kind normal second many melanomas hla locus dr protein normal occurs
CAN,CAN1806,enhancement methyl nitro nitrosoguanidine transformation independent exchanges tpa promoter transformation embryo nitro nitrosoguanidine mnng microgramml potentiation lethality exchanges sces cultures mnng results tpa mnng stationary growth transformation tpa pretreatment tpa mnng transformation mnng transformation mnng transformation tpa effect transformation mnng polycyclic benzoghiperylene benzaanthracene noncarcinogens transformation tpa transformation transformation doses much rise colonies tpa mutations promotional transformation parallel sce
CAN,CAN1807,transformation embryo fibroblasts carcinogen transformation vary explain phenomenon theory system carcinogen equation pp loci carcinogen confluence generations confluence equation pp single methylcholanthrene transformation
CAN,CAN1808,malignant transformation murine conditions progeny potential yield wide range dilutions cultures independent observations clones direct hypothesis clonal products induction many progeny occurrence second transformation conditions confluence
CAN,CAN1809,invasive villous adenomata invasive villous adenomata malignant potential rare appendiceal lesions
CAN,CAN1810,ureteric obstruction metastatic oesophagus ureteric metastatic tumour oesophagus report condition
CAN,CAN1811,test differentiate aneurysmal cyst osseous cystic lesions pressures osseous cysts spinal aneurysmal cysts osseous cystic lesions sites readings aneurysmal cysts results
CAN,CAN1812,partial total results partial total partial invasive tumours operative deaths year total operative deaths radical half year total presence multicentric non invasive tumours invasive tumours invasive tumours early
CAN,CAN1813,intraarterial evidence tissues evidence standard means documents evidence many side hair inflammatory mucosa intraarterial iii limb isotope limb opposite limb hours side marrow severe intra evidence way surgeons plan management
CAN,CAN1814,review past diagnostic traumatic thalassemia commonest biggest idiopathic thrombocytopenic purpura itp lymphoma spleens intrathoracic complications traumatic complications gallstones deaths
CAN,CAN1815,tumours rectum retrospective tumour rectum general lipomas ten leiomyomas rectum lipomas rectal diarrhoea leiomyomas rectal lipomas leiomyomas complications tumours signs
CAN,CAN1816,positive findings clearance council many management early positive sheets participants registered related findings extent clearance subjects positive lymph nodes nodes correlation tumour size tumours extent tumours less total mastectomy total clearance operative pectoralis pectoralis clearance nodes upper nodes status
CAN,CAN1817,search occult metastases methods operable underwent occult histological findings primary tumour nodes fundamental early histological valuable histology early group nodes metastases unfavourable positive
CAN,CAN1818,early heme dependent friend differentiation differentiation friend erythroleukemia promoter tetradecanoylphorbol tpa early differentiation early transport occur presence tpa differentiation induction heme synthesis proliferative tpa friend differentiate cultures presence inducer tpa results rapid hemoglobin synthesis parallel results heme dependent friend differentiation
CAN,CAN1819,dna terminal deoxynucleotidyl transferase molt lines toxin htdr incorporation terminal deoxynucleotidyl transferase thymus lines toxin immune system htdr incorporation doses toxin ngml toxin ngml inhibitions toxin dna protein synthesis
CAN,CAN1820,polycythemia erythroleukemia viruses erythroid vitro rlv fvp vitro transformation marrow vitro erythroid bursts methylcellulose epo fva rlv preparations erythroid bursts epo bursts less hemoglobin epo cultures fva rlv bursts fvp bursts fva preparations epo sffv fva fvp erythroid bursts helper murine leukemia viruses sffv erythroid transformation hemoglobinization bursts
CAN,CAN1821,gangliosides human lipids leucocyte pellets methanol deae sephadex column gangliosides sodium methanol sephadex column reagents gangliosides normal human gangliosides different gm ganglioside normal leukaemic leukaemic gangliosides much myelogenous lymphocytic
CAN,CAN1822,remission leukaemia thirty leukaemia unselected significant effect remission remission significant remission times total white fab coarse system wbc equal leukaemia less risk different lengths remission risk trials stratification
CAN,CAN1823,venous sinus leukemia leukemia sagittal sinus peripheral remission walls leukemic nervous system leukemia diagnostic test intracerebral hematoma subdural hematoma sinus remission leukemic process techniques
CAN,CAN1824,lymph nodes lymph nodes typical cutaneous nevi metastatic
CAN,CAN1825,acinic salivary occurrence acinic salivary oral recent papers fifty record findings unreported examples minor salivary
CAN,CAN1826,juxtacortical sarcoma jaws literature report juxtacortical sarcoma jaws mandible review literature juxtacortical sarcoma juxtacortical sarcomas jaws
CAN,CAN1827,spindle oral fifty results fifty oral circumstantial evidence favors metaplastic malignant epithelial spindle lip tongue ridge polypoid exophytic male military occurrence patterns spindle mitotic pleomorphism giant vascularity infiltration well time year significant cure distant prognostic wide excision radical neck dissection successful radiation ineffective
CAN,CAN1828,myelogenous leukemia report review literature condition johns second less literature occurrence second
CAN,CAN1829,rfv gene recovery friend leukemia nonleukemic marrow rfv recovery fv leukemia mice chimeras recovery marrow fetal liver marrow recovery recovery leukemia mice recovery rfv recovery nonleukemic marrow leukemic specific nonleukemic types recovery unknown fv fv specific cytotoxic
CAN,CAN1830,cysts skin lesions cysts manifestations dentists early seek condition odontogenic keratocysts followup early nevoid carcinomas
CAN,CAN1831,fibromyxoma mandible report year typical findings myxoma half mandible lesion partial mandibulectomy condyle prosthesis periapical panoramic radiographs lesion bitewings periapical films panoramic
CAN,CAN1832,megakaryocytes pleural fluids significance cytohistological correlation pleural fluids fluids agnogenic metaplasia leukaemia lymphocytic lymphoma persistent serous serous fluids ratio unlobed anucleate cytoplasmic agnogenic metaplasia serous surfaces megakaryocytes presence megakaryocytes serous fluids haematopoietic
CAN,CAN1833,invasive episodes invasive leukemia review literature invasive etiology mortem therapy dissemination
CAN,CAN1834,metastatic mandible metastatic angiosarcoma oral lesions tumour
CAN,CAN1835,primary intra primary intra previous literature rare lesion
CAN,CAN1836,congenital congenital removal dentition residual swelling congenital lesion respiratory problems
CAN,CAN1837,dermoid cyst mandible mid cyst mandible histological cyst intra osseous dermoid cyst mandible lesion odontogenic non odontogenic cysts mandibular mid
CAN,CAN1838,gigantiform cementoma review literature report gigantiform cementoma rare lesion jaw year female condition relevant literature definitive histological lesion cemental
CAN,CAN1839,intestinalis occurrence leukemia therapy agammaglobulinemia granulomatous pulmonary gastrointestinal mechanisms intestinalis immediate helpful significance intestinalis
CAN,CAN1840,cluster granulocytic leukemia cluster peripheral granulocytic leukemia cgl double colonies ten diseases normal normal colonies colonies times many colonies phases cgl time blastic crisis colonies cluster phases
CAN,CAN1841,concurrent lactic hypoglycemia leukemia lactic hypoglycemia diseases leukemia leukemic infiltration metabolic leukemia malignant disorders significant liver infiltration metabolic presence prompt
CAN,CAN1842,septicum infection septicum sepsis duke university year disorders sepsis disarticulation gas gangrene sepsis metastatic cultures positive cecum prompt enema
CAN,CAN1843,mandible rare primary mandible etiology literature subject
CAN,CAN1844,mastoid chloroma leukaemia leukaemic infiltration petrous uncommon remission leukaemia sites mastoid chloroma radiotherapy wide decompression
CAN,CAN1845,pseudomalignant myositis heterotopic pseudomalignant myositis due diagnostic confusion lesion malignant lesions diagnostic problems underwent radical pseudomalignant myositis lesion lucent underlying radiolucent peripheral maturation diagnostic problems ultrastructure lesion shows regular angstroms excision
CAN,CAN1846,lymphatic spread tc scintigraphy osteosarcoma stream pulmonary management less commonly lymphatics detect progressive lymph nodes
CAN,CAN1847,peroxidase cytochemical pink pseudo chediak myelogenous leukemia giant congruent micrometers myeloblasts promyelocytes myelocytes myelogenous leukemia preliminary marrow smears red azurophilic marrow specimens demonstration peroxidase diaminobenzidine ho peroxidase positive limited single membrane red vasuoles peroxidase obvious crystalline structure unstained grid giant slyck rebuck immature leukemic granulocytes pseudo chediak giant purple leukemia peroxidase positive azurophil primary azurophilia due
CAN,CAN1848,significance marrow positive granulocytic leukemia fifty positive granulocytic leukemia metaphases initiation antileukemic therapy blastic stage mitoses related short cgl antileukemic therapy conventional yr leukemia yr minority antileukemic therapy presence
CAN,CAN1849,implications receptor leukemia parallel leukemia glucocorticoid nucleic precursors short term trial drugs results glucocorticoid receptor leukemia hand glucocorticoid
CAN,CAN1850,glycosaminoglycans tumorigenic nontumorigenic melanoma gg tumorigenic lines nontumorigenic immunoprotective melanoma naso hglucosamine gg densities methods medium gg cultures nontumorigenic immunoprotective heparin sulfate total tumorigenic lines less heparin sulfate chondroitin sulfate chondroitin sulfate tumorigenic lines amelanotic significant sulfate none lines nontumorigenic immunoprotective times total gg growth medium tumorigenic lines
CAN,CAN1851,ellipticine growth nuclear friend leukemia fl rna tetraploid dna lines removal subsequent medium hours dna fl cultures size fl medium normal proliferate slight dna hours removal
CAN,CAN1852,carcinogen metabolic hdthd incorporation dna concanavalin splenic end rapid vitro discrimination carcinogenic noncarcinogenic results hdthd incorporation dna dna carcinogens methyl nitrosourea nitroquinoline oxide benzoapyrene dimethylbenzaanthracene benzaanthracene non dna metabolic dimethyl sulfoxide ethanol hydroxyurea cycloheximide cyanide hdthd incorporation carcinogens noncarcinogens pairs nitroquinoline versus quinoline oxide benzoapyrene versus pyrene hdthd incorporation carcinogen dimethylbenzaanthracene carcinogen benzaanthracene carcinogens anthracene hdthd incorporation vitro end carcinogenic hypolipidemic xylidino pyrimidinylthioacetic wy
CAN,CAN1853,preimplantation embryos embryos random unfertilized oocytes hours ovulation presence types viruses intracisternal inner blastocysts trophoblast mature cytoplasmic many embryos stage embryonic
CAN,CAN1854,cytotoxicity mice normal normal cheb fej mice syngeneic mai specific cytotoxic current findings normal syngeneic cytotoxicity mai specific cytotoxic current findings normal syngeneic cytotoxicity cytotoxicity specific normal lymph effect previous findings presence recruitment instruction whereas
CAN,CAN1855,methyl nitrosourea mammary carcinogenesis effect dietary postinitiation state methyl nitrosourea mammary carcinogenesis noninbred female mammary single iv mammary results effect dietary postinitiation stage mammary carcinogenesis
CAN,CAN1856,macrophages intraperitoneal hepatoma hepatoma immunized male sd macrophages rejection specific immunization double sc viable lavage intervals hours lavage total prepared different counts level results early intervals immunized day concurrent macrophages mitotic disappearance day
CAN,CAN1857,effect zinc growth igm tepc zinc significant female mice tepc libitum mice size zinc group whereas hthymidine incorporation hthymidine zinc
CAN,CAN1858,mice growth kinetics host immune reactivity growth metastases mice intrafootpad different doses host total metastatic mice doses mice doses growth metastases size removal removal medium volumes pulmonary metastases metastases mice growth metastases doses removal effect observed mice doses mice metastatic growth lungs inoculum size mice growth optimal stimulus growth removal nonimmunologic mechanisms metastatic growth
CAN,CAN1859,leukemia positive human human leukemia positive leukemia alla malignant cytoplasmic granular leukemia mast malignant pre ie cytoplasmic igm positive malignant cytoplasmic igm results support subgroups alla
CAN,CAN1860,malignant diagnostic doses size radiation versus malignant size group diagnostic doses sd diagnostic doses risk malignant possible risk united nations scientific committee radiation
CAN,CAN1861,growth human mcf serum plasma growth mcf metastatic mammary hbl primary human milk medium whole serum plasma plasma serum plasma anticoagulant phosphate dextrose growth mcf plasma growth final densities presence fetal serum cultures level donors hbl plasma components level extracts plasma clotting dialysis weight factor plasma coagulation
CAN,CAN1862,remember individuals specific laboratory techniques techniques diagnostic techniques results different one past specific risk current optimal mouth throat diligent search risk mental status important findings rest search coarctation renal bruits positive findings techniques specific assemble current needs views social technical perfect technology important functions human nuclear
CAN,CAN1863,nursing management meningeal carcinomatosis meningeal carcinomatosis symptomatology views adjust process gradual deterioration current therapy
CAN,CAN1864,plasma prekallikrein factor lymphocytic leukemia plasma prekallikrein factor lymphocytic leukemia likely occurrence peripheral ellagic unique factor
CAN,CAN1865,mammary start therapy therapy good mastectomy possible therapy time aspecific immunotherapy early therapy therapy possible results plasma urine
CAN,CAN1866,morphine morphine intrathecal nonoperative group group ml saline operative group group ml glucose induction hours group respiratory morphine group hours respiratory naloxone
CAN,CAN1867,normal cytoplasmic actins human hut normal diploid human fibroblasts nonmuscle actins gamma parent stable actins gamma actins normal nonmuscle actins ax single position results compatible nonmuscle human diploid fibroblasts principles gene vertebrates
CAN,CAN1868,non evidence important single primary growths ml non lymphosarcoma adhesion monolayers adhesion lactoperoxidase radioiodination ml adhesion monolayers overall peripheral fucose consistent types electrophoretic findings significance
CAN,CAN1869,diseases heterosexual homosexual diseases heterosexual homosexual visits std months overall homosexual likely heterosexual vs vs warts vs likely nongonococcal urethritis vs genitalis vs vs scabies genital warts significant race syphilis contacts potential sites mucosa venereal warts
CAN,CAN1870,oxidoreductase normal hc normal oxidative hepatocellular hc differentiated normal liver aci results mitochondrial oxidase succinate dehydrogenase oxidase hc hc peroxisomal oxidase oxidase hydroxy oxidase liver xanthine oxidase cytoplasmic liver oxidative level normal liver oxidase varied wide range results inverse correlation possible implications results
CAN,CAN1871,importance nitroreductases niridazole mutagenesis niridazole nitrothiazole anthelmintic presence nitro group desnitro niridazole mutagenic ta ta frame conditions desnitro niridazole results liver conditions mutagenicity niridazole standard liver niridazole resistant histidine dependent mutants ta ta mutants nitroreductase mutagenic niridazole presence niridazole ineffective mutagenicity niridazole results mutagenicity niridazole dependent nitro group specific nitroreductase
CAN,CAN1872,hepatocytes hepatocytes support fetal time microfilament microscopy microscopy compact plasma membrane medium heavy meromyosin arrowhead contain extraction hepatocytes ionic disruption reversible reappearance less compact early removal times compact reappearance dependent protein synthesis sodium sulfate polyacrylamide hepatocytes smethionine hepatocytes weight sodium sulfate polyacrylamide gels radioactivity synthesis protein polymerization demonstration cultures dnase hepatocytes nonmuscle due synthesis
CAN,CAN1873,phagocytosis occurrence phagocytosis metastatic marrow leukocytes phagocytosis phagocytosis epithelial literature
CAN,CAN1874,isolation hybrid phenylalanine hydroxylase fusion kohler isolation phenylalanine hydroxylase cross reactivity phenylalanine hydroxylase human cross reactivity double immunodiffusion polyacrylamide electrophoretic phenylalanine hydroxylase
CAN,CAN1875,diethylnitrosamine hepatoma biphenyls dams hepatocarcinogen diethylnitrosamine den ppm weeks wistar biphenyls pcb utero mothers liver den early stage male
CAN,CAN1876,tetrahydrofuryl uracil tetrahydrofuryl ft uracil uft ft uracil tracer oral uft ft uracil interaction absorptions tissues fu urine uft fluoro fu tissues ft fluorouridine fluoronucleotides normal tissues uft ft uracil uft fu metabolites ft
CAN,CAN1877,mechanisms phenobarbital methyl dimethylaminoazobenzene hepatocarcinogenesis mechanisms phenobarbital methyl dimethylaminoazobenzene dab hepatocarcinogenesis dab dab phenobarbital weeks phenobarbital promoter size islands phenobarbital dab significant size islands dab phenobarbital inhibits initiation carcinogenesis carcinogen liver
CAN,CAN1878,requirements release costimulator costimulator cos cos medium concanavalin requirements cos maximal operative interaction nylon nude mice inductive stimulus nude inductive stimulus factor non tumour process inductive populations
CAN,CAN1879,serum lipids vegetarians normal dietary diseases coronary heart serum kinetics group healthy male vegetarians daily respect fatty dietary fibre vegetarian group serum vegetarian significant kinetics hcholic cdeoxycholic output input vegetarians dehydroxylation input synthesis vegetarians results vegetarian support vegetarian reduces
CAN,CAN1880,significance diamine oxidase serous diamine oxidase dao pleural ascitic fluids non diseases serous non dao serum malignant fluids epithelial dao serum values results importance diagnostic points presence carcinomatous
CAN,CAN1881,permanent murine nsi ns akrj mice chdi thymus subsequent growth selection hybrid permanent agc igg repeated soft growth colonies presence ml thymus ml vitro vivo products serum free medium optimum conditions mgml iagc mgml mgml mgml electrophoretic isolation cytotoxicity presence aph athy agc specific whereas thymus lymph nodes thymus lymph cytotoxicity functional test lipopolysaccharide presence
CAN,CAN1882,melanogenesis human neuroblastomas catecholic homovanillic neuroblastomas dopa homovanillic dopa tumours histological neuroblastoma human sympathoblasts dopa homovanillic melanocytes concurrent disappearance granular noticed modulation metastatic neuroblastoma permanent
CAN,CAN1883,non status productus exoskeletal pco cco hemolymph osmolality productus emersion hyperoxia torr degrees emersion hyperoxia hemolymph cco pco pco cco values discrepancy pco excess vitro hemolymph vivo metabolic emersion cco evidence caco stores hyperoxia branchial uptake hco cco hyperoxia shell aquatic crustaceans means conditions branchial
CAN,CAN1884,delta tepc enough isolation delta prepared dna techniques selection immunoprecipitable delta shows delta human protein different delta tepc tepc
CAN,CAN1885,distant carcinomas successful cure tumour hard therapy many complications former time time latent metastatic carcinomas lymph nodes growth histological kind tumour diseases palliative
CAN,CAN1886,prospects preparations problems related preparations recent preparations suitable different state much preparations specific uses
CAN,CAN1887,reconstruction esophageal defects jejunal segments report free jejunal dogs different microvascular esophageal defects free jejunal jejunal revascularization end microvascular esophageal defects ten successful
CAN,CAN1888,pseudo tumoral ossification periosteum fifty pseudo tumoral ossification myositis periosteum radiographic histological evidence condition hyperplastic callus periosteum typical radiographic pseudo tumoral periosteal ossification conditions osteogenesis imperfecta neurofibromatosis sane kullman hyperplastic cranial ossification paretic due lesions hyperplastic callus congenital syphilis subject develops months maturation partial abe radiotherapy accelerate maturation maturation
CAN,CAN1889,rhabdomyosarcoma report mandible signs neck evidence report rhabdomyosarcoma mandible months evidence mandible onset mandible subsequent time
CAN,CAN1890,angiolipoma cheek oral lipoma rare angiolipoma cheek histopathology
CAN,CAN1891,angiomyoma oral rare oral leiomyomas derived vascular leiomyomas angiomyomas leiomyomas vascularity differentiation neurofibromas spindle
CAN,CAN1892,maxillary cyst maxillary cyst maxillary sinus sinus cystic lesion infected sinus mucosa sinus maxillary cysts buccal maxillary teeth panoramic radiographic findings maxillary cyst cystic sclerotic floor maxillary sinus
CAN,CAN1893,dimensions incisive fossae dimensions incisive fossae negroid random conditions dimensions incisive fossae dimensions incisive widths specimens anteroposterior dimensions specimens cysts radiographic incisive different dimensions cysts
CAN,CAN1894,macro malignant jaw subject jaw mandible malignant osseous comprised due faciocranium group females group fibrosarcomas radiographs films folialess cassettes soft preparations means lamp microradiograms malignant infiltration intraoperative segments
CAN,CAN1895,synthesis heavy visceral kappa marrow sharp serum level non kappa sera liver manifestations renal nephrotic lesions nodular glomerulosclerosis hepatomegaly neurological normal short ones free weight secretions extracts glycosylation results emergence therapy
CAN,CAN1896,term mastocytosis receptor mastocytosis hypersecretion duodenal ulcer daily months ulcer cutaneous hypersecretion months vitamin normal cutaneous intradermal leucocyte release results term hypersecretion cutaneous mastocytosis
CAN,CAN1897,urine test malignant melanoma usual laboratory total excretion melanoma metastases malignant melanoma metastases excretion normal excretion metastases metastases metastases conspicuous excretion normal diagnostic laboratory results excretion melanoma metastases melanoma laboratory bsr early
CAN,CAN1898,cytotoxic drugs melanomas microgrammouseday adriamycin fu nitrogen mustard thiotepa vincristine subcutaneous lighter weight melanoma cytotoxic effectiveness previous mice synthesis endogenous growth mice
CAN,CAN1899,lichen iggkappa lichen rare disorders cutaneous mucin presence papular mucinosis report iggkappa skin fibroblasts arylsulfatase antineoplastic therapy remission skin lesions
CAN,CAN1900,genetic sensitivity leukemia mice rmv immune different resistance viremia leukemia mice rmv less regions regions regions murine leukemia mulv virions leukemic infectious conclusive due different stimulations absorptions problems igg specific antimmulv correlation resistance infection rmv immune results surprising rmv rmv histocompatibility rmv gene immune
CAN,CAN1901,potentials neurology evoked potential different reversible infiltration sclerosis mesodiencephalic braindeath findings buchwald components evoked potentials waves iii components sequential ie shows significant subsequent components observations components different potential disorders
CAN,CAN1902,post traumatic cs coherence vigilance waves react sensory waves waves
CAN,CAN1903,effect intestinal gnotobiotic chhe male mice gnotobiotic chhe male mice coli streptococcus faecalis paraputrificum effect intestinal bifidobacterium longum acidophilus eubacterium rectale
CAN,CAN1904,isolation melanogenic subcellular compartments amelanotic melanomas sephadex column different melanogenic status specific amelanotic melanoma effect hand melanotic melanoma effect melanosomal evidence amelanotic melanoma vivo related membrane system amelanotic melanoma
CAN,CAN1905,galactorrhea hyperprolactinemia manifestations parasellar meningioma galactorrhea cranial palsy serum prolactin sella turcica suprasellar prolactin suprasellar investigation exploration parasellar findings parasellar meningioma hypothalamic pituitary dysfunction
CAN,CAN1906,diagnostic implications wall thickness wall thickness lesions wall lesions malignant thick malignant wall benignancy thinnest
CAN,CAN1907,eggshell lymph nodes update peripheral lymph nodes silicosis coal workers blastomycosis scleroderma histoplasmosis disorders eggshell eggshell
CAN,CAN1908,esophageal esophageal primary obstruction esophageal primary esophageal esophagoscopy normal mucosa resembles esophageal esophageal plays significant diagnostic esophagus
CAN,CAN1909,ct primary craniocerebral neuroblastoma craniocerebral primary metastatic ct findings primary neuroblastoma findings primary neuroblastoma supratentorial neuroblastoma osseous subperiosteal spaces epidural neuroblastoma cranial sutures epidural deposits sutural margins sutural diastasis intracranial intracranial sutural diastatis ct findings epidural deposits venous confluence
CAN,CAN1910,fourth review fourth ct year lateral subsequent shunt revisions signs intracranial posterior signs different intervals lateral findings specific fourth ct fourth needs posterior cysts cystic fourth condition
CAN,CAN1911,sonography normal normal transverse longitudinal evidence posterior transverse longitudinal longitudinal oblique transverse single method normal thick normal right sonography ct normal sonography test many obese positive ct resolution
CAN,CAN1912,digital human system system digital dsa human system equipment computer system fluoroscopic radiographic heart femoral quality conventional many settings nonselective dsa organs
CAN,CAN1913,results report underwent radiation therapy radiation st university obstetrics vienna uniform histological fact recent year time results radiation importance different programs
CAN,CAN1914,cost effectiveness management system methods quality costs specialists management costs management specialists primary physicians management costs obtained specialists nonmedical costs food home income management system management utilized total cost management direct pocket savings costs income total accrue management
CAN,CAN1915,excretion methylhistidine index protein effect effect different nutritional regimens nitrogen methylhistidine mehis excretion day kjkg day kjkg day kjkg day group mehis excretion mumoleday nitrogen nitrogen nitrogen excretion mehis excretion mumoleday nitrogen excretion nitrogen protein protein protein synthesis less net protein state gday mumole mehis human protein protein day metabolic damage
CAN,CAN1916,neck intermediate tubes method nasogastric intermediate neck reinsertion risk rupture suture date complications extubations
CAN,CAN1917,regulatory identification human leukemia stable human il growth factor human leukemia lines il leukemia jurkat uml il il supernates jurkat cultures microgramml concanavalin fatty cultures jurkat il uml il times conventional cultures normal human peripheral splenic jurkat conditioned medium equal vitro murine human lines jurkat human il human il valuable isolation immunoregulatory
CAN,CAN1918,beckers beckers dopa oxidase noninvolved nearby skin melanocytes
CAN,CAN1919,gonadoblastoma xy dysgenesis gonadoblastoma xy dysgenesis tall values male level tumour lines granulosa differentiation differentiation ovaries removal
CAN,CAN1920,macroglobulinemia subclinical disorders hla drw manifestations odds favors hla gene lymphoproliferative disorders hla prone sicca
CAN,CAN1921,kappa glomerulosclerosis kappa microscopy renal nodular glomerulosclerosis minor renal microscopy demonstration granular transformation vascular kappa lacks likely renal tubules tendency kappa renal mechanisms unknown
CAN,CAN1922,immunohistochemistry results immunohistochemistry typical observations support
CAN,CAN1923,results radiation therapy radical records radiotherapy radical free intervals stage lymphatic permeation previous stage stage lymphatic previous possible therapy free intervals
CAN,CAN1924,hypoxic therapy neutron brachytherapy neutron beam therapy neutron therapy dependent energy therapy beam therapy radiotherapy beam neutron therapy beam photon therapy findings concepts conventional therapy therapy
CAN,CAN1925,definitive radiation therapy prostatic mayo primary radiation therapy prostatic safe date radiation therapy free free date radiation significant less free less stage time significant equal stage prostatic radiation therapy underwent post prostatic radiation therapy prostatic results positive urologic progressive instrumental
CAN,CAN1926,beam radiotherapy followup post beam radiation therapy subsequent followup results residual months positive positive therapy positive disese
CAN,CAN1927,urine hypotonic saline normal tissues sephadex elution urine second urine normal urine plasma diffusion fixation urine normal individuals tract infections diffusion none urine normal individuals urine tract infections urine papillomas positive reactions fixation urine iv fixation micrograms tract infections fixation micrograms urine specimens normal individuals fixation
CAN,CAN1928,tract infection urine normal individuals papillomas tract infections presence urine specimens ouchterlony diffusion human monospecific urine normal individuals papilloma urine individuals tract infections significant reactivity many monospecific papilloma proteinuria tract infection potential importance specific components early
CAN,CAN1929,ornithine normal subjects cornithine proven normal iv microci ornithine nmoles decarboxylation ionization reed tolbert normal subjects sd ten initiation therapy recovery sd test confidence level significant means normal little ornithine results evidence presence
CAN,CAN1930,induction tolerance pigs dimethylbenzaanthracene dimethylbenzaanthracene dmba dmsoglycofurol pigs induction sensitization dmba topical results pigs dmba emulsion dmba topical sensitization unresponsiveness mammary latent pigs dmba emulsion topical sensitization dmba
CAN,CAN1931,ultrasonic primary gallbladder review findings gallbladder localized gallbladder wall eleven contiguous size different
CAN,CAN1932,ultrasonic pancreatic ultrasound normal pancreatic wirsung normal pancreatic wirsung santorini wirsung pancreatic pancreatitis pancreatitis pancreatic
CAN,CAN1933,carcinoembryonic carcinoembryonic cea specific iii ionic goat cea specific sites specific cea cea plasma results roche goat cea
CAN,CAN1934,dna mercaptopurine dna mercaptopurine cultures dna dna presence substances dna nucleic gene specific dna mercaptopurine cultures mutants different genetic loci dependent effect extent trichloroacetic insoluble radioactivity dna cultures level incorporation equivalent mercaptopurine dna incorporation transforming units incorporation dna
CAN,CAN1935,promotion enhancement tracheal carcinogenesis stage carcinogenesis tracheal epithelium dimethylbenzaanthracene dmba initiator tetradecanoylphorbol tpa promoter heterotopic tracheal microgram dmba tpa tpa beeswax pellets microgramday months microgramday subsequent months epithelial hyperplasia tracheal metaplastic dysplastic tracheas dmba tracheas dmba tpa tpa induction time group dmba weeks weeks group dmba tpa tpa tracheal manner promotion skin
CAN,CAN1936,human sac nude mice functional human sac oe tt nude mice histology different structure inconspicuous sinus structure due element vascular plasma nude mice human plasma prealbumin alb transferrin tf types plasma varied intracellular afp tf alb microscopy plasma afp membrane endoplasmic reticulum golgi microvilli results human sac normal counterparts
CAN,CAN1937,synthesis heavy bence jones leukemia intracellular igg plasma leukemia kappa bence jones serum urine plasma intracellular gamma kappa determinants short heavy daltons normal partial heavy slow
CAN,CAN1938,retroperitoneal venous year ureteral compression extrinsic removal normotensive severe hypertrophy latter related occur
CAN,CAN1939,retinoid lingual carcinogenesis observations male female golden auratus equal group lateral borders tongues times dimethylbenzaanthracene group dmba retinoic peanut oil pipette group retinoid group group weeks retinoic leukoplakia epidermoid carcinomas differentiation fewer microvilli less dispersion heterochromatin lamina regular
CAN,CAN1940,induction specific resistance mycobacterium tbc subsequent immunization ppd syngeneic effect tuberculin ppd amplifier induction syngeneic helper amplifier chhej mice immunization mycobacterium tbc immunization tbc mice ppd syngeneic contingent presence ppd amplifier splenic winns whereas mice tbc ppd immunization viable specific specific immunotherapy immunization ppd early state pretreatment mice cyclophosphamide suppressor tbc conditions effect ppd amplifier induction specific method immunotherapy
CAN,CAN1941,leukemia myelogenous leukemia problems months marrow headache backache nausea posthypnosis unpleasant hypnotic techniques issues
CAN,CAN1942,concanavalin suppressor peripheral normal donors suppressor concanavalin proliferative normal suppressor rosette inverse suppressor proliferative significant increases resection primary likely nonspecific suppressor
CAN,CAN1943,computer tomographic primary aldosteronism scintigraphy primary aldosteronism idiopathic hyperplasia underwent ct scintigraphy ct lesions rare ct findings scintigraphy differentiation subgroups primary aldosteronism hyperplasia invasive methods helpful venous catheterization
CAN,CAN1944,sonography pseudotumours lesion sonography normal results cysts malignant lesions tumours inflammatory lesions pseudotumours due structure lesions excretory urogram shows normal excretion renal sonography cystic
CAN,CAN1945,needle histoplasmosis histoplasmosis bronchogenic needle capsulatum organisms needle exploratory thoracotomy specific lesion
CAN,CAN1946,pleuroma atelectatic pseudotumor kv radiography bronchography pulmonary needle atelectatic pseudotumor pleuroma needle due usual results needle radiographic benignity lesion radiographic lesions pa lateral oblique kv radiographs fluoroscopy spot films pulmonary needle helpful typical lesion
CAN,CAN1947,plasminogen prostatic lysis time method blix radial immune diffusion mancini donors plasminogen group finished therapy methods plasminogen values therapy normal therapy significant plasminogen importance findings possible fibrinolysis
CAN,CAN1948,epidermal chalone factor urine chalone skin methods mucosa urine chalone extracts transitional metaplasia signs metaplasia transitional carcinomas epidermal chalone urine positive
CAN,CAN1949,specific immune immunization mice gamma rise specific suppressor optimal suppressor induction conditions identification elution target specific suppressor gamma precursors
CAN,CAN1950,effect streptococcal picibanil rise serum urogenital effect streptococcal liver injury urogenital serum alt picibanil picibanil alt rise weeks alt weeks transfusions rise induction interferon immunopotentiation antihepatotoxic due antioxidant rise alt
CAN,CAN1951,murine plasma plasma leukemia female zealand nzb serum gamma globulin serum lines igga iggb igm regions serum growth igg igga iggb membrane igg syngeneic nzb mice histological findings findings single plasma
CAN,CAN1952,myelocytic leukemia fifty myelocytic leukemia cml hematological results techniques hand standard diploid stage early stage blastic stage iii blastic stage iv remission leukemic extra extra leukemic partial excess isochromosome isochromosome tdic xp blastic hematological results
CAN,CAN1953,human mcf nude mice mcf human nude mice metastasize lungs estradiol growth estrogen insulin mcf secrete types insulin collagenase enhancement collagenase
CAN,CAN1954,congenital congenital sac congenital sac mature teratoma diverticulum ipsilateral inguinal congenital
CAN,CAN1955,dehydrogenase malignant interstitial partial due dehydrogenase metastatic interstitial serum ngml ngml sulfate estrone lh estradiol hcg fluoxymesterone androgens values lh support partial exogenous gonadotropins
CAN,CAN1956,tests tests peripheral extent due peripheral ficollhypaque gradients informative values stage uniform stage lg test test values counts buoyant many immune tests counts valuable
CAN,CAN1957,metastatic adriamycin univariate methods potential prognostic adriamycin cyclophosphamide university different important related equations types possible liver freedom sites equal equations tables initiation
CAN,CAN1958,single weeks trial single iv push nausea diabetes partial stabilization good risk little marrow limited previous good marrow reserve
CAN,CAN1959,ascitic damage bowel possible positive tumour preclude group therapy findings months second look ovary
CAN,CAN1960,thickness tension pituitary thickness tension group thickness sd pituitary thickness sd significant tension applanation mmhg sd group sd significant applanation thickness tension mmhg magnitude tension
CAN,CAN1961,granular year granular university female preponderance multicentricity lesions malignant transformation support schwann theory lesion metabolic
CAN,CAN1962,lymphoma nuclear epstein tl lymphoma ileocecal past time hours ie lymphomas nuclear eb nude mice histological consistent findings nuclear blebs clefts lymphoma tq lymphoma
CAN,CAN1963,sensitivity fibroblasts coli peutz transformation murine sarcoma skin fibroblasts coli peutz pj morphological transformation murine sarcoma msv contain dualtropic murine leukemia mlv fibroblasts individuals subjects pj subjects transformation normal individuals subjects nonmanifest subjects fibroblasts normal individuals sensitivity pj transformation pseudo types msv transformed infection standard msv none xenotropic promoter transformation normal
CAN,CAN1964,thermosensitive transformation ts express degrees degrees chk ts degrees dependent growth typical normal fibroblasts vitro ts serum serum growth degrees degrees parent anchorage growth whereas transformed respect release protein parameters
CAN,CAN1965,mucus csf primary carcinomatosis identification mucus lumbar puncture csf neurological signs
CAN,CAN1966,effect propranolol glucose insulin effect propranolol insulin pancreatic streptozotocin mgkg mgkg glucose propranolol mgkg insulin glucoses propranolol insulin normal effect glucagon load insulinoma propranolol insulin
CAN,CAN1967,insulin insulinomas housewife severe rheumatoid hypoglycemic syncope sugar serum immunoreactive insulin iri insulin gamma globulin insulin column iri void significant iri pancreas hypoglycemic insulinomas rheumatoid insulin
CAN,CAN1968,human lines clonal human lines human tonsillar epstein semi weeks colonies months initiation clones cytoplasmic membrane secretory supernatants double immunodiffusion patterns lines heavy single clones clones clones igg membrane clones cytoplasmicsecretory igm igg membrane
CAN,CAN1969,parotidectomy systematic total parotidectomy multifocal fact multifocal wide parotid topography
CAN,CAN1970,viruses ocular viruses human techniques recent definitive lines evidence human documented viruses evidence viruses human human retinoblastoma ocular malignant melanoma
CAN,CAN1971,embolization system effect embolization parasitary collaterals embolization medium sinusoids safe embolization viscosity gelfoam powder ibc substances ligation wistar ligation insufficient transport medium islands intact easy total necrosis embolization dependent glucose homogenous peripheral transport
CAN,CAN1972,pituitary senile beagle bitches untreated beagle bitches specific pituitary general pituitary nodules findings histological observed immature observed findings immature intermediate possible histogenesis pituitary immature
CAN,CAN1973,transmit viruses viable sperm akr nzb mice infectious murine viruses whereas sperm mice interaction viable akr nzb sperm infectious mulv likely infection sperm possible introduction dna viruses sperm sperm mulv mice
CAN,CAN1974,leukaemia cytomegalovirus cytomegalovirus mcmv leukaemia mcmv units leukaemia significant mice mcmv salivary kidneys weeks cyclophosphamide infection mcmv positive results cytomegalovirus infections leukaemic leukaemia
CAN,CAN1975,mammary tumour riii mice sera extracts riii mammary tumour mmtv monospecific envelope specific patterns mammary tissues thymus salivary sera mice onwards mice weanlings lymph nodes points possible infection salivary digestive tract lymph nodes male genital organs female mammary mammary pregnancy lactation values mammary tumours results mmtv infection riii mice swiss albino mice
CAN,CAN1976,subgroups test fifteen polycystic pco group group lh daily group significant normals sulphate dhas hydroxy progesterone ohp dihydrotestosterone serum group steroids steroids group group less hand different normal group normal group cortisol normal range group normal group less cortisol ohp cortisol group normal subjects prolactin values normal group group less
CAN,CAN1977,effect oestrogen lhhcg endogenous steroids prostatic progesterone hydroxy progesterone dihydrotestosterone prostatic group phosphate group injections months oestrogen non oestrogen hcg ngg less ngg oestrogen level treated months injections time significant peripheral serum lh endogenous significant decreases pregnenolone ngg ngg ngg whereas significant steroids evidence direct human steroidogenesis
CAN,CAN1978,isolation cutaneous lymphoma lines ctcl peripheral cutaneous lymphoma mycosis fungoides lines viruses htlv crhtlvcr hut induction iodo deoxyuridine th ctcl second mature immature thin micrographs typical intracellular mature membrane lucent sucrose rna dna typical transcriptase rt rna dependent dna conditions htlvcr rt preference mn dna human viruses dna gamma purified htlvcr rt conditions positive homologous dna lack close htlvcr rt dna rt viruses daltons htlvcr consistent sizes subgroups
CAN,CAN1979,dna sequences junctions dna clones necrosis integration clones direct dna junctions dna sequences direct repeats different homology dna sequences homologous ends dna integration sites
CAN,CAN1980,reversible growth human fibroblasts reversible growth human fibroblasts replacement methionine growth medium immediate metabolic homocysteine methionine medium resume rapid lag subconfluent methionine medium growth mitotic techniques phases methionine medium densities cultures normal fibroblasts specific dna premitotic methionine cultures
CAN,CAN1981,leukemia unique genetic structure rna leukemia nonproducer fibroblasts rnacdna sets sequences group specific sequences related nondefective group related specific sequences mcv myelocytomatosis leukemia viruses classified viruses spectrum group specific sequences rna partial delta pol gag gene gag deltapol mcv deltaenv specific group specific genetic gag deltapol mcv codes nonstructural specific protein gag gene intact gene regulatory rna sequences nondefective viruses gag gene gene products different viruses share terminal gag mcv sequences gag pol mcv related sequences probable products gag related previous designs different onc viruses sequences sarcoma myeloblastosis onc sequences hybrids specific sequences erythroblastosis fujinami sarcoma
CAN,CAN1982,metastatic lobular metastatic lobular concurrent dissemination primary important successful management time primary lobular due metastases diagnostic
CAN,CAN1983,hepatocellular johnson right year man hepatocellular liver johnson right serum level radical resection decisive johnson
CAN,CAN1984,hepatocellular thirty primary hepatocellular ct ct postcontrast findings hypervascular visualized hypervascularity medium embolization ct obstruction densities important flow significant ct hepatocellular
CAN,CAN1985,complementary heavy plasmid vector hybrid plasmid pmu inset terminal untranslated
CAN,CAN1986,cushings due medullary tumour year man due ectopic severe proximal myopathy malignant tumour phaeochromocytoma successful months hypothalamic pituitary normal months
CAN,CAN1987,meningeal review multifocal malignant glioma meningeal rare intracranial malignant gliomas meningeal total positive csf multifocal diffuse meningeal distant primary spinal subarachnoid spinal roots lateral spinal compression thoracic lumbar level meningeal malignant glioma meningeal versus less meningeal weeks weeks significant malignant glioma living meningeal meningeal csf
CAN,CAN1988,primary records primary michael reese chicago discharges primary primary micronodular retrospective positive positive hepatocellular cholangiocellular
CAN,CAN1989,metastatic gastrointestinal tract review year primary metastatic lesions gastrointestinal tract single gastrointestinal lesions gastrointestinal tract general occurrence signs gastrointestinal premortem gastrointestinal metastatic overlooked
CAN,CAN1990,observations normal leukemic human pgf normal subjects lymphocytic leukemia lymphocytic leukemia cll normal pgrams pgf normal pgrams pgf normal normal pha level pgf nucleotides monophosphate level level pgf oscillations guanosine monophosphate values pha cll pha level pgrams level pgf pgrams level pgrams gmp results modulation cyclase nucleotides regulatory leukemic
CAN,CAN1991,precancers pseudocancers genitalia review management leukoplakia penis balanitis xerotica precancerous lesions queyrat extramammary pagets carcinomas lesions types skin conditions genital means pseudomalignancies giant acuminatum behaves papulosis entity
CAN,CAN1992,subcutaneous fibrosis radiotherapy radiotherapy subcutaneous fibrosis months good therapy term soft sarcoma
CAN,CAN1993,leukemia leukemia malignoma splenogenous liver positive hepatitis progressive year end year hepatocellular hematological remission therapy hepatocellular literature
CAN,CAN1994,management liver nodular hyperplasia females nodular hyperplasia females oral pills pills group nodular hyperplasia underwent intraabdominal resections possible oral group nodular hyperplasia underwent liver resection recurrent recommend resection risk embolization ligation possible oral hand conservative nodular hyperplasia resection growth
CAN,CAN1995,results resection stomach term overall year free lymph nodes year lymph nodes resection total resection significant quality total resection radical resection resection
CAN,CAN1996,nodular hyperplasia oral nodular hyperplasia oral serious vascular lesions possible oral
CAN,CAN1997,prospects past dramatic gather momentum future cooperative future review current management surgeons controversy
CAN,CAN1998,microfluorometric mammary malignant lesions cytophotometric dna breasts dna values diploid invasive dna values different diploid iii triploid results pilot cytophotometric dna conventional microfluorometric methods
CAN,CAN1999,effect glucosamine stomatitis sarcoma effect glucosamine stomatitis sarcoma asv glucosamine presence glucosamine presence glucosamine units asv units milliliter results asv asv
CAN,CAN2000,klinefelters megalencephaly year white male klinefelters mental psychotic right megalencephaly gyri klinefelters xo syndromes related
DBT,DBT2001,illnesses nursing facility home health nursing facility home health hha possible highlights overwhelming episodes post snf hha episodes post demographic post post snf hha types likely female nervous vascular system types types england middle pacific divisions likely post united institutional institutional input price index quantity index
DBT,DBT2002,pharmacy diabetic south diabetic physicians south gauge potential pharmacy results favorable diabetes pharmacist diabetic physicians congruent favorable physicians significant incapable respondents
DBT,DBT2003,tobramycin infections different metastatic defenses documented ie positive probable laboratory tests picture infection therapy tobramycin good results infection probable infection unknown infections therapy rise reversible therapy tobramycin complications
DBT,DBT2004,home management results diabetics term home glucose hbgm means dextrostix glucose meters work glucose subsequent months fluctuations hypoglycaemia silent rebound hyperglycaemia somogyi effect insulin standard mmoll mmoll less hypoglycaemia extreme hyperglycaemia daily insulin sd units units day less insulin regimens results urine tests hbgm hbgm urine subjects management hbgm diabetic hbgm urine method diabetic
DBT,DBT2005,cytotoxic serum insulin dependent diabetes serum insulin dependent diabetes iddm cytoplasmic ica iddm ica icsa normal non insulin dependent presence icsa positive serum significant lysis release cr serum icsa positive serum lytic double ethidium insulin findings cytotoxic icsa iddm mere presence icsa diabetes fourth serum relatives diabetic positive cytotoxic
DBT,DBT2006,proteinuria diabetic nephropathy results investigation diabetic nephropathy proteinuria increases renal consistent qualitative total excretion findings possible dysfunction diabetic nephropathy
DBT,DBT2007,functional vasopressin neurons neurons normal brattleboro polydipsia polyuria antidiuretic neurons insipidus nervous system neurons
DBT,DBT2008,presence filtration plasma polyacrylamide gels plasma dm subjects significant sfc sfc sd sfc evidence cross plasma clots presence polyacrylamide gels normal iii fibrinogen diabetics fibrinogen iii macroglobulin plasminogen dm dm enhancement fibrinogen degradation weight
DBT,DBT2009,protective factor functions vasodilation important vascular wall overwhelming endogenous important antihypertensive factor diseases obliterative arteriopathy haemolytic uraemic synthesis key vascular lesions hand haemorrhagic diathesis uraemics vascular release trial therapy peripheral obliterative arteriopathy haemodialysis
DBT,DBT2010,plasma glucose level glucose tolerance different search normal post prandial plasma glucose glucose tolerance test gtt different postprandial glucose level gtt post glucose gl sd mn gl mn glucose level limits search points subjects load enough
DBT,DBT2011,hyperlipidemia pancreatitis diabetic keto report year man semi comatose digestive troubles diabetic keto diabetes year half laboratory hyperlipidemia pancreatic insulin therapy chronology hyperlipidemia pancreatitis keto
DBT,DBT2012,endometrium israel israel year primary endometrium females thirds times european stage correlation infertility year stage myometrial differentiation
DBT,DBT2013,induction oxoglutarate glucagon glucocorticoid vitro oxoglutarate liver times alloxan diabetic insulin primary hepatocytes glucagon glucagon dibutyryl insulin induction induction cycloheximide day level day level intra glucagon precocious induction liver results oxoglutarate neonatal liver glucagon glucocorticoid
DBT,DBT2014,general investigation important diseases critical investigation repetitive auscultation bruit significant coarctation aorta uncovering renal phaechromocytoma rare diseases therapy heart contraindicate blockers severe methyldopa gout aggravated thiazide
DBT,DBT2015,rapid glucose test diabetic subjects test automated hexokinase method glucose test boehringer reflomat glucose values hexokinase method mmoll hexokinase methods range mmoll mmoll glucose mmoll hypoglycaemia test valuable instructed staff management urine direct methods
DBT,DBT2016,glyceraldehyde diabetics retinopathy cataract aldose subjects diabetics retinopathy cataract diabetics retinopathy cataract diabetics retinopathy cataract diabetics senile cataract diabetic normal diabetics retinopathy normal fold diabetics retinopathy cataract fold senile cataract fold diabetics level maturity diabetics significant glyceraldehyde normal diabetics retinopathy cataract significant polyol dehydrogenase group haemoglobin hbac glyceraldehyde due elaboration
DBT,DBT2017,vaccine diabetics dependent diabetics immunized vaccine pneumovax populations diabetics double diabetics vaccine saline weeks second saline vaccine general insulin dependent diabetics weeks reactions diabetics correlation glucose insulin dependent diabetics vaccine
DBT,DBT2018,tokelau island migrant migration industrial zealand females migration rise zealand time arrival zealand significant diabetes time intermediate way zealand weight adiposity adiposity risk diabetes nonspecific weight diabetic females females energy work patterns diabetes serum uric fertility
DBT,DBT2019,diabetic diabetic parent preliminary familiarisation staff quality close psychosocial concerned home theory general time much whole virtual disappearance mutual many places oral telephone busy general unknown records little time letter sisters keen home gps diabetic handicap prime cost effectiveness sisters range illnesses handicaps
DBT,DBT2020,evidence vasopressin isoprenaline release vasopressin release isoprenaline plasma ei plasma ei isoprenaline vasopressin hereditary lack vasopressin isoprenaline release ei vasopressin
DBT,DBT2021,sugar insulin dependent endocrine pancreas subcutaneous insulin conventional insulin therapy insulin pancreas open subcutaneous insulin conventional insulin therapy preprandial injections regular insulin zinc insulin bring hyperglycemia insulin dependent diabetic subjects normal subjects glucose glycemic values methods regimens diabetic subjects normal subjects insulin glycemic values normal subjects short term regimens normal sugar insulin requirements conventional therapy
DBT,DBT2022,insulin islets insulinoma islets pancreas diabetics insulinoma microscopy immunohistological insulin labeled insulin microscopy fibrils protein related insulin protein weight
DBT,DBT2023,diabetes humans regard islets little literature extrainsular whole review reconstruction
DBT,DBT2024,thoracic extramedullary extramedullary homozygous thalassemia progressive paraparesis ectopic spinal epidural removal radiotherapy successful second posterior mediastinal intervention heterotopic marrow thoracic
DBT,DBT2025,psychic situation diabetics literature results investigation presence diabetics references psychic findings possible diabetological
DBT,DBT2026,male results forty male partners psychogenic erectile primary ejaculators diabetes related impotence due diabetics group healthy partners group healthy partners situation parameters films reactions subjects parameters systolic fluctuations resistance erection erection erection diabetic group erection parameters group primary psychogenic erectile impotence parameters fluctuations resistance group psychogenic erectile impotence diabetics sharp systolic fluctuations resistance erection parameters ejaculators correlations
DBT,DBT2027,symptomatology psychological male results forty male partners psychogenic erectile primary ejaculators diabetes related impotence diabetics group healthy partners group healthy partners results psychological scales questions group diabetics erectile impotence less disturbed impotence severe psychogenic erectile impotence important insecure diabetics partners mothers subgroups ejaculators group group psychological group erectile impotence
DBT,DBT2028,identification retinopathic sucrose rich fructose sucrose lack factor microvascular system retinopathy possible factor vascular fructose dietary microangiopathic retinopathy microvascular lesions diabetic cross microvascular lesions degeneration neural vice versa signs neural damage significant fructose slight significant fructose phosphate fp results sorbitol fructose fip lactate diabetes
DBT,DBT2029,occupancy due problems problems reactions problems december general units general casualty general practitioners problems fifth conditions problems second problems occupancy due diseases complications diabetes
DBT,DBT2030,fluorophotometry pigs normal treated pigs sodium level glucosuria normal little glucosuria diabetic humans pig vasculature
DBT,DBT2031,lens diabetic vitrectomy results fifty lenses plana vitrectomy diabetic retinopathy complications lenses lensectomy time vitrectomy management pressures peripheral iris rubeosis neovascular glaucoma group
DBT,DBT2032,disc disc swelling second year disc disc specific therapy normal weeks arcuate fiber defects positive correlation diabetic retinopathy disc progressive retinopathy disc diabetics entity intracranial
DBT,DBT2033,open glaucoma effect eye eye effect open glaucoma oag heart glaucoma types defects functions cup disc spot enlargement standard glaucoma standard defects spot enlargement iop
DBT,DBT2034,glucose semen quality glucose seminal plasma findings spermatozoa time ejaculation seminal glucose utilized spermatozoa presence fold interindividual spermatozoa parameters semen glucose motility spermatozoa semen substitute glucose energy glucose semen semen
DBT,DBT2035,vascular serum parameters aorta vein pv aii cacl alloxan diabetic serum parameters glucose triglycerides alloxan mgkg diabetic diabetic glucose diabetic wk glucose triglycerides diabetic wk serum parameters sensitivity ie diabetic saline unchanged mild diabetes aii cacl diabetes cacl severe maximal contractions contractility severe diabetes contractions diabetic tension aortas contractility stage pv sensitivity aii diabetes diabetes saline reactivity contractility pv progressive diabetes venous diabetic state
DBT,DBT2036,gestational diabetes ultrasonic fetal growth transverse fetal factor selection gestational diabetic oral glucose tolerance test potential gestational diabetes potential diabetic transverse fetal ninety thirty group oral glucose tolerance test moreover gestational diabetic transverse biparietal weight normal
DBT,DBT2037,pakistani retrospective diabetic female preponderance overall group male female ratio sub group overall diabetic renal unimpressive vast
DBT,DBT2038,dysfunction motor diabetic severe diabetics mild peripheral conduction normal subjects rapid spike motor postprandial diabetic mild postprandial motility diabetic severe postprandial motility correlation motility liquid peripheral conduction neostigmine spike motor diabetic subjects severe postprandial gastrocolonic
DBT,DBT2039,transport hepatocytes streptozotocin diabetic liver glucogenic precursors insulinopenic diabetes level transport hepatocytes streptozotocin diabetes na dependent uptake cisobutyric aib non metabolizable hepatocytes diabetic aib influx aib uptake diabetic hepatocytes due ie twofold vmax transport system whereas km aib transport diabetic hepatocytes due transport system much extent system cysteine system aib entry diffusion diabetic hepatocytes aib transport diabetic hepatocytes normal insulin
DBT,DBT2040,insulin dependent diabetic genetic transmission hla genotypes insulin dependent diabetic pairs diabetic diabetic times likely diabetes significant zygotic assortment hla pairs conclusive evidence dominant recessive likely presence hla disequilibrium predisposition evidence diabetic hla risk predisposition
DBT,DBT2041,observations pleomorphic microorganisms diabetic adultorum diabetic adultorum rare connective scleroderma skin neck diabetics coccoid giemsa gram skin positive microaerophilic propionibacterium sp wall findings connective disorders rheumatoid stimulus
DBT,DBT2042,diabetic congestive heart humans coronary diabetic state female wistar streptozotocin mgkg papillary weeks relaxation velocity loads force elastic range lengths glucose effect possible influences malnutrition diabetic evidence uptake sarcoplasmic reticulum actomyosin cardiomyopathic state induction mechanisms entity
DBT,DBT2043,fetal movements maternal hyperoxia effect maternal oxygen fetal movements significant effect normal insulin dependent diabetes pre eclampsia significant fetal movements severe pre eclampsia fetal growth
DBT,DBT2044,diabetes context normal water highlights antidiuretic adh insipidus diagnostic homeostatic diabetes polyuric adh replacement promise therapy future
DBT,DBT2045,effect adipocyte glucose obese diabetic dietary glucose transport intracellular obese insulin diabetic obese obese diabetic diabetic insulin obese diabetic insulin output diabetic glucose transport glucose lipogenesis obese glucose lipogenesis glucose transport plasma insulin obese glucose plasma insulin diabetic glucose unchanged transport lipogenesis dietary insulin hyperinsulinemia
DBT,DBT2046,oscillatory potential diabetics proliferative retinopathy term oscillatory potential proliferative diabetic retinopathy diabetics oscillatory potential diabetics valuable risk proliferative retinopathy oscillatory potentials
DBT,DBT2047,total duodenopancreatectomy pancreatitis report total duodenopancreatectomy employed pancreatitis due year resistant therapy efforts kg painful pancreasneoplasm ten diabetes total duodenopancreatectomy general operative pancreatitis
DBT,DBT2048,renal radioisotope clearance group diabetics early recognition diabetic nephropathy unselected filtration gfr renal plasma flow rpf diagnostic work unselected manifestations possible lack selection statistical results onwards extent rpf dependent clearance clearance substances method renal early recognition diabetic nephropathy
DBT,DBT2049,quality diabetic health quality wide diabetic group health insulin oral level haemoglobin social iv social level general practitioners populations diabetic haemoglobin microvascular
DBT,DBT2050,plasma normal subjects diseases food plasma normal subjects disorders plasma normal subjects single range pgml fluctuations stomach significant rise plasma progressive secretory episode hand oral glucose plasma liver diseases normal limits plasma diabetic normal subjects plasma normal subjects fluctuations rise plasma whereas glucose plasma
DBT,DBT2051,human diabetic endoneurial sorbitol fructose myo related sural sural diabetic maturity onset techniques results values healthy fructose diabetic healthy diabetic fructose values myo inositol inositol diabetic fructose inositol neurophysiological signs neurophysiological fiber former trials diabetic presence fiber diabetes untreated diabetics normal segmental demyelination remyelination untreated diabetics segmental demyelination remyelination degeneration diabetics degeneration
DBT,DBT2052,ulcers feet occlusive ulcers feet occlusive systolic digital systolic sabp gauge skin perfusion heel thirty feet diabetes conservative feet ulcers months feet amputation months parameters closest correlation sdbp final ie ulcer amputation mmhg sdbp mmhg mmhg significant diabetic feet non diabetic feet infection peripheral diabetic group systolic digital valuable prognostic
DBT,DBT2053,diabetic complications es salaam diabetic complications diabetics es salaam peripheral retinopathy proteinuria ecg findings compatible heart ecg complications obesity occupational group quality complications related serum related
DBT,DBT2054,diabetic lymphatic tegument dorsal side membrane dilatations intercellular dislocation desquamation growth micropinocytic intracellular vacuoles lysosomes permeability important phenomenon diabetic
DBT,DBT2055,orthostatic posture load contractions orthostatic position systolic orthostatic position minutes individuals group diastolic gradual orthostatic position healthy individuals nephropathy diastolic systolic orthostatic position rcc diabetic growth systolic less healthy individuals systolic rcc disorders nervous system peripheral
DBT,DBT2056,glucose glucose phosphate dehydrogenase method glucose stable glucose range mmoll minutes lipemia drugs interference fructose slight good correlation method method recovery good method sugar profiles diabetic diabetic
DBT,DBT2057,porcine ulcers heterografts cutaneous ulcers bandages speeding epithelialization clean protein
DBT,DBT2058,oscillatory potential nyctometry insulin dependent diabetics draws oscillatory potential electroretinogram dark nyctometry nyctometry diabetics insulin dependent diabetics significant correlation oscillatory potential dark results nyctometry risk proliferative retinopathy subsequent
DBT,DBT2059,parallel dysfunctions pancreatic pp insulin dependent test etiological insulin dependent functions pp secretory pancreatic hyperglycemia hypoglycemia insulin dependent extent hand functions insulin independent diabetics diabetic results pp parallel insulin dependent diabetes independent diabetes possible types diabetes
DBT,DBT2060,insulin release insulin sensitivity intolerance different degrees intolerance insulin glucose second sensitivity insulin glucose oral glucose weights subjects normal tolerances oral glucose computer glucose insulin glucose test possible parameters ip potentiatory kp glucose insulin release sensitivity endogenous insulin kg subjects oral normal glucose tolerance tests kp ki ip normal ki ip group kg normal oral glucose tolerance tets oral glucose tolerance tests subjects mild diabetes ip kg whereas kp normal intolerance initiate insulin release sensitivity insulin enhancement potentiate insulin release subjects oral normal glucose tolerance tests
DBT,DBT2061,plasma insulin glucose obese diabetic diabetic subjects glucose test obese diabetic subjects obese insulin nondependent diabetics glucose mgkg glucose mgkgmin healthy plasma insulin start second obese subjects normal insulin obese subjects glucose intolerance plasma obese subjects normal ogtt overt mild insulin rise insulin second plasma insulin increments obese subjects normal obese subjects obese diabetics
DBT,DBT2062,physiopathology ketotic hyperosmolar coma hyperosmolar diabetic coma extreme hyperglycaemia hypernatremia plasma hyperketonaemia recent peripheral plasma insulin lack ketosis lipolysis hyperosmolar coma peripheral insulinopenia liver free fatty nonketogenic
DBT,DBT2063,hemoglobin diabetics insulin hemoglobin well glucose values weeks slight hbai healthy subjects diabetics sulfonylurea drugs good correlations hbai single random morning glucose glucoseh whereas diabetes correlation treated values single morning glucose ns correlation hbai index regular glucose clinitest home term insulin diabetics single random glucose
DBT,DBT2064,pancreatic insular embryonic reactivity normal utero mothers diabetes insulin theophylline system pancreas normal react glucose th day prenatal normal mothers day nervous endocrine utero sensitivity glucose normal diabetic mothers
DBT,DBT2065,bactericidal infections diabetics staphylococus untreated infection uninfected diabetics bactericidal infection subjects latter plasma glucose level ml plasma glucose ml diabetics parallel uninfected diabetics normal subjects diabetics diabetics underwent insulin withdrawal bactericidal insulin insulin vitro results neutrophil bactericidal infection diabetics
DBT,DBT2066,severe diabetic psychological year diabetic episodes day vigorous management psychological early gastrointestinal sensitivity management relaxation training mental exercises dramatic
DBT,DBT2067,hyperkalemia hyperglycemic increments diabetes persistent hyperkalemia unknown hyperkalemia meql ten insulin pm hyperkalemia meql plasma values glucose values ten plasma free insulin glucagon values hyperkalemia occur hyperglycemia insulin epinephrine lack glucagon excess direct plasma important hyperkalemia insulin diabetic
DBT,DBT2068,protein methylhistidine excretion diabetic protein uncontrolled diabetes synthesis results net methods vitro results methylhistidine mh excretion diabetic wistar diabetes diabetes urine urea nitrogen nitrogen mh excretion nonacetylated subcutaneous insulin doses total mh excretion mh mh normal nonacetylated results protein insulin therapy untreated diabetic limited mh excretion
DBT,DBT2069,glucose tolerance insulin release rabbits male zealand white rabbits single iu escherichia coli mannitol iu coli mannitol kgbody glucose immunoreactive insulin iri rabbits wk wk iri end preinjection iri glucose load post time iri end single iukg hyperinsulinemic diabetes zealand white rabbits persist mild
DBT,DBT2070,senile process senile group unique protein components group elderly many significance
DBT,DBT2071,vasopressin evidence immunoperoxidase immunoreactive ang many magnocellular neurons supraoptic posterior pituitary vasopressin neurophysin ang parvocellular neurons suprachiasmatic peptides magnocellular neurons reveals vasopressin vasopressin ang homozygous brattleboro insipidus increases neurophysin increases ang determinants vasopressin way vasopressin neurons
DBT,DBT2072,metoprolol effect glucose hypertensive diabetic subjects hydrochlorothiazide glucose glucose insulin glucagon oral glucose load weeks therapy metoprolol metoprolol hydrochlorothiazide plasma renin therapy metoprolol
DBT,DBT2073,urine insulin excretion method diabetic endogenous insulin diabetic urine insulin group diabetic doses negligible excretion exogenous insulin requirements normal excretion diabetic ketoacidosis recovery urine specimens excretion endogenous insulin diabetic
DBT,DBT2074,insulin human venous endothelial primary endothelial prepared human endothelial venous cultures presence endothelial palade viii venous typical plots profiles dissociation kinetics times venous specific human human venous endothelial insulin endothelial different vascular
DBT,DBT2075,sensitivity intact insulin kinetics propose sensitivity glucose intact dynamic plasma insulin glucose terms mathematical posthepatic insulin insulin clearance plasma insulin dynamics glucose tolerance tests mgkg dogs steady state glucose plasma insulin early microuml peaks plasma insulin insulin dynamics parameters clearance insulin insulin plasma glucose rise insulin glucose plasma specific sensitivity insulin glucose phi sensitivity glucose phi microumg glucose second ml dynamic insulin parameters kinetics phi single ivgtt insulin single parameters kinetics ivgtt potential insulin intact man
DBT,DBT2076,release pancreatic insulin release micrometers golgi membrane full effect insulin release dependent manner insulin release insulin release glucose insulin release system
DBT,DBT2077,insulin membrane potential intracellular free sodium insulin intracellular free sodium membrane potential epididymal adipocytes potential insulins direct intracellular nai membrane potential conventional microelectrodes microelectrodes parameters insulin potentials unchanged insulin glucose effect results results direct nai ki subsequent transport membrane potential intracellular sodium ions
DBT,DBT2078,lecture pregnancy progeny fuel economy mother normal pregnancy evidence pregnancy mechanisms gestational starvation food pregnancy food metabolic oscillations shuttlings state provide therapy exogenous insulin endogenous insulin pregnancy fetal maternal fuel economy pregnancy diabetes normal maternal insulin maternal fuels mothers mildest reserve gestational diabetes sensitivity concepts teratogenesis subsequent organogenesis differentiation fetal range anthropometric metabolic functions expressions teratogenesis pregnancy gestations maternal fuel
DBT,DBT2079,effect diabetic plasma lipoprotein conventional therapy subcutaneous insulin short term diabetics conventional insulin subcutaneous insulin plasma glucose conventional significant fall plasma significant total plasma total ldl diabetic method plasma perfect metabolic plasma lipoprotein
DBT,DBT2080,effect male weeks sugar ml heart growth heart glucose diabetic output work pressures significant systolic flow dpdt oxygen extraction lactate lactatepyruvate glycogen stores glycogen pyruvate diabetics oxygen diastolic right diabetics diabetic insulin glucose perfusion medium food heart weights diabetics findings streptozotocin diabetes results due restrictions flow oxygenation glucose insulin perfusion medium
DBT,DBT2081,japanese japanese insulin dependent onset jod hla dr significant hla pf rr hla pf rr hla dr hon wiax linkage disequilibrium hla pf rr jod japanese
DBT,DBT2082,radiographic diabetic rhesus diabetic rhesus mulatta techniques subject periodontal pdl radiographic calculus carious lesions glucose results diabetic group significant calculus group single group pdl glucose hyperglycemic possible resistance infection intolerance hyperglycemia radiographic system system radiographic calculus deposits carious lesions parameters
DBT,DBT2083,components serum system infection immune disorders system components system element element element diabetics individuals glucose intolerance glucose intolerant subjects hyperglycemia components plasma glucose glucose intolerant group components overall nondiabetics diabetics diabetic components diabetic inverse correlation level components presence diabetic microvascular intolerance metabolic components diabetic diabetic
DBT,DBT2084,glucosuria second specimens time day products questions second urine specimens different results clinitest clinitest tape keto diastix glucosuria diabetic glucosuria subjects second specimens way findings significant time day effect second specimens significance
DBT,DBT2085,cortisol functional maturation diabetic rabbits maturation alloxan cortisol saline injections functional lavage ratio ls dspc alloxan rabbits alloxan rabbits intermediate alloxan functional pulmonary lavage alloxan cortisol ls lavage alloxan cortisol findings maternal cortisol diabetic specific functional maturation alloxan diabetes
DBT,DBT2086,effect insulin glomeruli kidneys normal diabetic glomeruli diabetic contents dna ratio insulin vivo diabetic effect glucose degradation glomeruli normal diabetic synthesis unchanged glomeruli diabetic significant diabetic normal synthesis rna synthesis vitro insulin effect glomeruli diabetic conditions insulin rna synthesis insulin vivo incorporation glomeruli normal dependent glucose results insulin sugar level protein
DBT,DBT2087,spectrum phosphatide synthesis alloxan diabetes significant phospholipids test tissues glycerophosphate dehydrogenase direct reactions
DBT,DBT2088,severe hypoglycemia human findings irreversible hypoglycemic injury year diabetic man insulin food died months year man months coma injury gliosis preponderance hippocampus lesions whereas pallidus thalamus destroyed lesions different hypoxic ischemic injury hypoglycemic vs hypoxic ischemic injury second slight neurons gliosis hypoglycemic sulfonylurea preparations irreversible injury due hypoglycemic effect
DBT,DBT2089,patterns diabetic term glycosaminoglycans powder diabetic normal term densitometric abc identity glycosaminoglycans hexosamine diabetic tissues diabetes unchanged toxemia sulfate sulfate unaltered occur conditions glycosaminoglycans patterns
DBT,DBT2090,pituitary diabetes serum lh tsh prl gh cortisol diabetes insulin hypoglycemia lrh trh test gh tsh lh results pituitary dysfunction diabetes
DBT,DBT2091,insulinopenic diabetes unique diabetes man diabetic ketoacidosis pyridylmethyl nitrophenyl urea rh yr poison insulinopenia glucagon specific cytotoxic effect evidence lethal investigation rh diabetogenicity islets direct effect concomitant streptozotocin findings nongenetic insulinopenic diabetes yr unique test man hyperglycemia metabolic diabetic genetic predisposition
DBT,DBT2092,peptides urine diabetic system peptides system unmodified hydrolyzed human diabetic hemoglobin valine reducible products aminophenyl boronic system rapid nonenzymatic glycosylation diabetic tissues urine diabetic normal positive peaks borohydride reducible quantity normals weight level mumol equivalent diabetics times urine normal subjects
DBT,DBT2093,direct streptozotocin cr release prepared collagenase pancreatic islets subsequent yield chromium optimal cpm cpm cr incubated streptozotocin cr release lag time hours positive correlation streptozotocin release cytotoxicity phenomena diabetes
DBT,DBT2094,human mcf nude mice mcf human nude mice metastasize lungs estradiol growth estrogen insulin mcf secrete types insulin collagenase enhancement collagenase
DBT,DBT2095,fluorophotometry iii direct ocular effect diabetic state hyperglycemic insulin non insulin normal group group sodium mgkg femoral vein hyperglycemic normal plasma fluorophotometry significant insulin non insulin normal significant hyperglycemic normal
DBT,DBT2096,single weeks trial single iv push nausea diabetes partial stabilization good risk little marrow limited previous good marrow reserve
DBT,DBT2097,remote membrane normal diabetic membrane lens underlying epithelial normal membrane membrane diabetic different membrane synthesis opposite eye membrane sympathetic effect due substances humour eye membrane eye
DBT,DBT2098,serum presence severe retinopathy serum
DBT,DBT2099,peripheral streptozotocin diabetic velocity sciatic vivo vitro weeks induction streptozotocin uncontrolled diabetes velocity previous streptozotocin diabetic normal respect potential potential clamp membrane fibres normal permeability
DBT,DBT2100,disc onset photographic records diabetes nonneurologic disc female male normal normal spot incontinent neovascularization disc laser photocoagulation therapy months findings reversible due
DBT,DBT2101,effect streptozotocin hypothalamic pituitary pituitary streptozotocin stz diabetic wistar plasma plasma pituitary tsh contents hypothalamic trh ria conditions diabetic stz plasma tsh pituitary tsh stz diabetic hypothalamic trh pituitary tsh diabetic libitum diabetic group pituitary sensitivity tsh thx diabetic thx thx daily saline fractional microgram microgram thx microgram pituitary tsh microgram effect thx thx pituitary tsh thx group doses thx thx fact hypothalamic trh primary pituitary diabetic metabolic diabetes undernutrition
DBT,DBT2102,somatostatin glucose diabetes glucose normal diabetic sem level somatostatin diabetic significant somatostatin glucose diabetic pgml glucose significant somatostatin diabetic results somatostatin streptozotocin short
DBT,DBT2103,ankle foot diabetics joints diabetics ankle foot little literature diabetic management importance weight
DBT,DBT2104,somatostatin pancreatic islets diabetic glucose release pancreatic islets diabetic induction withdrawal insulin replacement therapy glucose effect theophylline glucagon somatostatin release glucose diabetic islets glucose release system somatostatin diabetic islets secretory
DBT,DBT2105,diabetics diabetics hypertensive drugs hypertensive diabetics non diabetics side important glucose tolerance diabetic dietary drugs therapy orthostatic hypotension diabetics uric risk diabetics liable blockers non blockers hypertensives vasodilators side diabetic blockers different hypertensive accumulated normalization morbidity diabetics
DBT,DBT2106,somatostatin insulin dependent diabetic subjects reevaluate somatostatin insulin dependent diabetics normal subjects vivo insulin diabetics microgramhour minutes somatostatin glucose glucagon significant adp progressive significant adp saline normal subjects diabetics normals epinephrine normals diabetics somatostatin adp saline induces diabetics potentiates epinephrine vitro normals diabetics man
DBT,DBT2107,residual ircp residual insulin diabetics ircp diabetics significant correlation ircp daily insulin correlation glucosuria ircp glucosuria endogenous residual importance metabolic diabetic
DBT,DBT2108,somatostatin release diabetic pancreas pancreatic somatostatin insulin pancreatic somatostatin release streptozotocin stz diabetic male wistar stz group iii iv mgkg diabetic weeks pancreatic somatostatin stz iii iv ngg wet wt reductions insulin significant increases iii iv pancreatic somatostatin release iii iv pg decreases release glucagon release results pancreatic somatostatin release stz diabetic insulin
DBT,DBT2109,damage general disorders cranial findings general disorders patterns diffuse damage lesions valvular heart obstructive airways renal damage individuals
DBT,DBT2110,types diabetes iddm mature genetic sets system significant iddm niddm healthy observed non hla system observations genetic iddm niddm insulin dependent
DBT,DBT2111,specific igm diseases immunosorbent elisa test specific igm pericarditis positive specific igm heart congestive positive specific igm sera bornholm diabetes specific igm weeks sera valvular heart mycoplasma pneumoniae infections infections viruses viruses positive results sera titres factor
DBT,DBT2112,impotent oral glucose tolerance tests impotence normal ejaculation pre glucose tolerance serum glucose diabetes group covariance weight glucose hours glucose diabetes glucose tolerance inorganic serum phosphate group subjects diabetic impotence
DBT,DBT2113,metabolic diseases hemoglobin scope diabetic retrospective quality metabolic stabilization months possible momentary sugar fatty past esters unsaturated fatty weeks method longterm purine size uric pool
DBT,DBT2114,induction cumulative viruses emc induces pancreatic resistant emc insufficient glucose many specific toxin diabetes reserve mice emc diabetes sub diabetogenic doses emc diabetes mice infected viruses little damage developed mice sub diabetogenic doses findings diabetes cumulative damage sequential
DBT,DBT2115,estradiol serum diabetic doses estradiol diabetic streptozotocin estrogen hypercholesterolemic vldl intermediate idl ldl hdl vldl populations idl contains latter unusual contain apolipoprotein usual estrogen ldl residual vldl idl hdl protein fold fold fold doses uptake ldl liver sites sites uptake components
DBT,DBT2116,diabetic records system diabetic records computer combines usual handwritten records minimum suitable computer tape record date time time cheap system busy diabetics computer chiefly registers complications date index months
DBT,DBT2117,diabetes insulin preliminary results diabetics diabetics insulin months open insulin system system insulin insulin home time doses extra work personal sugar glucoquant glucosuria clinitest term insulin metabolic glucose values glucose excretion hemoglobin complications technical
DBT,DBT2118,fibre diabetic hypertriglyceridemic insulin requirements diabetes increases fibre diabetics energy fibre cal plasma glucose level insulin sulfonylurea serum individuals hypertriglyceridemia modified fibre energy protein fibre cal term months weight nutritional
DBT,DBT2119,intact polysaccharides diabetes immune azotemic ten dialysis insulin dependent diabetics vaccine diabetics uremic normal immunization vaccine renal term
DBT,DBT2120,islets bioartificial endocrine pancreas single islets diabetes diabetic state weeks islets intact term weeks
DBT,DBT2121,plasma synthesis occur manner refs pg
DBT,DBT2122,diabetic proteinuria statistical records diabetics proteinuria uni thiry diabetes macroangiopathic complications results risks diabetic nephropathy
DBT,DBT2123,diabetic venous report diabetes dm uptake venous results dm hyporeactivity diabetic aorta
DBT,DBT2124,ornithine decarboxylase insulin ornithine decarboxylase tissues normal diabetic streptozotocin diabetic libitum ornithine decarboxylase liver heart thymus ornithine decarboxylase group diabetic insulin starvation ornithine decarboxylase values tissues normal diabetic normal group liver ornithine decarboxylase fold second increases decarboxylase heart thymus single liver ornithine decarboxylase diabetic normal second peripheral tissues ornithine decarboxylase ornithine decarboxylase food food fold ornithine decarboxylase diabetic food diabetic ornithine decarboxylase refed findings ornithine decarboxylase many tissues diabetes starvation integral growth effect insulin factor dependent insulin
DBT,DBT2125,retinopathy haemoglobin forty mining town kalgoorlie western primary retinopathy diabetic thirty sets females diabetes insulin forty retinopathy haemoglobin sd total haemoglobin plasma glucose mmoll mmoll sd mmoll positive correlation haemoglobin plasma glucose less diabetics retinopathy haemoglobin level retinopathy insulin
DBT,DBT2126,pregnancy non insulin dependent diabetics half year schuur year insulin independent diabetes metformin glibenclamide therapy insulin oral drugs diabetic glucose mmoll post prandial glibenclamide metformin safe drugs overall perinatal untreated group respiratory distress membrane hypoglycaemia glibenclamide neonatal hypoglycaemia tablets insulin insulin hours double diabetic mothers
DBT,DBT2127,subdermal estradiol pellets hysterectomy oophorectomy effect serum estrone estradiol globulin estradiol globulin lipids hot flushes subderman pellets hysterectomy oophorectomy serum daily weeks intervals months significant range pgml months pgml months pellets eestrone ratio unity subdermal pellets rise lh gonadectomy months insertion pellets postmenopausal undergone oophorectomy serum serum globulin serum estradiol globulin unchanged pellets lipoprotein total triglycerides rise triglycerides severe hot flushes flushes months replacements pellets pellets estrogen replacement therapy
DBT,DBT2128,retinopathy proteinuria plasma glucose risks microvascular complications plasma glucose pima microaneurysms haemorrhages neovascularisation plasma glucose mmoll plasma glucose glucose retinopathy glucose subjects post load glucose subjects subsequent heavy proteinuria urine retinopathy related plasma glucose microvascular complications individuals plasma glucose plasma glucose diagnostic
DBT,DBT2129,diabetic liquid hyperlipidemic condition diabetes specific serum lipids triglycerides esters diabetic state serum lipids chromtographic liquid triglycerides esters components minor diabetic diabetics
DBT,DBT2130,effect dobesilate permeation plasma diabetic effect months dobesilate sedimentation factor total protein electrophoretic serum protein diabetics significant retention significant serum globulins total protein parameters unchanged results evidence transcapillary permeability vascular system diabetics
DBT,DBT2131,diabetic work heart effect alloxan diabetes different afterload isoproterenol conditions rise diabetic coronary flow output diabetes isoproterenol unaltered diabetic isoproterenol coronary flow dpdt output diabetic normal equivalent recovery mmhg afterload whereas recovery diabetic afterload diabetic many diabetic glucose insulin perfusion
DBT,DBT2132,implications recent aquisitions conditions previous somatostatin diabetes somatostatin growth implications effect cns viewpoint encephalic level
DBT,DBT2133,effect guar crispbread products leguminous glucose diabetics effect glucose crispbreads unprocessed fibre foods diabetics total test breakfasts wholemeal bread cheese guar crispbread bread glucose bread soya beans guar crispbread soya beans soya beans porridge cornflake breakfasts favourable results leguminous guar products leguminous guar
DBT,DBT2134,hyperosmolar diabetic coma ketoacidosis purulent hyperosmolar diabetic coma ketoacidosis purulent diagnostic due slow onset hyperosmolality misinterpretation fits consciousness therapy anticonvulsants sodium sugar sodium serum osmolality oedema slow normalisation sugar sodium satisfactory unconsciousness complications doses hypotonic female
DBT,DBT2135,hypothalamic pituitary water hypothalamic pituitary water partial antidiuretic adh severe adh severe adh osmotic release polyuria polydipsia true diabetes whereas primary polydipsia endogenous adh polydipsia true diabetes odds views adh condition
DBT,DBT2136,glucagon growth cortisol insulin hypoglycemia insulin dependent diabetics insulin non counterregulation different hormones exists idd non diabetics glucagon cortisol growth insulin hypoglycemia importance glucagon insulin non diabetics glucagon insulin hypoglycemia idd independent doses exogenous see glucose sth non diabetics idd insulin hypoglycemia effect hypoglycemic counterregulation sth diencephal stress situation cortisol gluconeogenetic effect cortisol hypoglycemia term insulin different hormones glucagon counterregulatory insulin
DBT,DBT2137,amputation cutaneous vascular diseases report vascular diseases total amputation movements rehabilitative prosthesis possible method amputation diabetes
DBT,DBT2138,growth insipidus preparations diabetes mexico useless infantil hydrochlorothiazide aminopyrine volumes thirds growth endocrine females idiopathic histiocytosis psychogenic polydipsia traumatic sequel tuberculous idiopathic traumatic histiocytosis psychogenic nearest whole histiocytosis psychogenic post idiopathic percentile parallel histiocytosis idiopathic centile latter growth concluded therapy limits growth possible presence
DBT,DBT2139,importance risk importance risk hyperlipidaemia diabetes hemodynamic quality year risk factor risk risk factor coronary heart risk diabetes hyperlipidaemia favourite risk hyperlipidaemia correlation risk kind index pulmonary heart sound correlation risk rhythm reinfarction normal lipids significant bradycard tachycard rhythm hyperlipidaemia diabetes bicycle tests hypertensive regular cigarettes diabetic quality possible
DBT,DBT2140,intolerance hemoglobin glucose intolerance increases diagnostic intolerance hb glucose time oral glucose tolerance test ninety japanese hb hb test system results critical plasma glucose increment critical values ml ml load critical plasma glucose intolerance ie group plasma glucose plasma glucose ml group plasma glucose plasma glucose ml hb group group index group group subjects group subjects group glucose intolerance
DBT,DBT2141,hla diabetes jod histocompatibility gene healthy subjects hla jod risk jod times jod shows japanese less jod less diabetes
DBT,DBT2142,ocular sugar menopause obesity time day year speculation ocular hypertensive state
DBT,DBT2143,coa wall coa wall maximal dependent coash km values substances liver serum divalent phospholipids conditions hypercholesterolemia significance free fatty results
DBT,DBT2144,haemoglobin double hbac focussing diabetics glucose mmoll presence haemoglobin glucose schiff intermediate
DBT,DBT2145,diastolic heart reactions diabetes orthostatic diabetics healthy diastolic subject unchanged fall diabetics short retinopathy subjects immediate heart sem lowest index heart brake index diabetics short retinopathy diabetics retinopathy accleration vs index vs vagal
DBT,DBT2146,renal urine tests diabetic renal glucose important urine tests method renal urine tests group dependent diabetic wide renal range rise renal glucose glucose convert urine tests method significance urine test results
DBT,DBT2147,diabetic diabetes insulin dependent diabetic combines diabetic reinforce significant retention subjects subjects intervention reinforcement retention intervention
DBT,DBT2148,computer menus computer plan menus diabetic input prescription usual daily food food selection combines food menus foods vary day day food item satisfies dietary prescription output daily menus summaries list menus food item food name units types exchanges exchanges plan exchange diabetic diary
DBT,DBT2149,plasma iii thrombin time correlation hemoglobin serum glucose diabetic parameters thrombin time iii iii partial time atpp parameters diabetic serum glucose fg hemoglobin ahba diabetic females normal insulin dependent diabetic trimester insulin dependent diabetic subjects serum glucose values nonpregnant diabetic subjects diabetic subjects females diabetic females females diabetic subjects diabetic diabetic subjects positive correlation hba fg diabetic diabetic subjects diabetic females correlation iii fg iii hba diabetes pregnancy diabetic subjects lowest iii iii diabetic females serum glucose hba strict diabetic diabetes
DBT,DBT2150,peripheral vascular diabetic peripheral vascular pvd residents minnesota evidence pvd time diabetes subsequent pvd cumulative subsequent pvd yr residents pvd yr
DBT,DBT2151,maturation alloxan diabetic rabbits maturation lungs diabetic alloxan lungs alloxan less mature lungs significant areal increases epithelium alloxan techniques times areal glycogen times endoplasmic reticulum migration fusion membrane epithelium alloxan lungs alloxan glycogen protein lungs alloxan maturation consistent previous findings functional maturation
DBT,DBT2152,coma epidural diabetic intermediate insulin sudden coma epidural diagnostic doses advisable diabetic epidural
DBT,DBT2153,etiology management year proliferative diabetic retinopathy detachment vein detachment proliferative miscellaneous unknown emphasis importance specific specific therapy
DBT,DBT2154,ecg orthostatic posture load ecg half ecg orthostatics heart sympathetico results salt metabolic disorders orthostatic test salt index therapy ecg tupical coronary heart tolerance orthostatic salt tests damage different metabolic
DBT,DBT2155,open glaucoma risk eye practitioners glaucoma definitive diagnostic equal risk glaucoma protocols risk periodic current risk glaucoma regard
DBT,DBT2156,diabetes streptozotocin fluorophotometry horseradish peroxidase tracer sodium single leakage vasculature horseradish peroxidase tracer types pigment epithelial rpe lesions rpe lesions
DBT,DBT2157,glucose tolerance plantaris glucose tolerance results findings plantaris
DBT,DBT2158,yugoslavia iv representative croatia results fourth croatia yugoslavia representative northern adriatic croatia functional psychotic illnesses educational level occupational group excess nutritional disorders extent functional general
DBT,DBT2159,end stage ischemic intact many limb amputation peripheral vascular unamenable conventional microsurgical vascular techniques free omental ischemic limb intact omentum limb vascular flow intact omental functional indefinite trials intact omentum conventional revascularization
DBT,DBT2160,prenatal maternal estrogen male urogenital system utero male perinates female hormones hypertrophy metaplasia prostatic utricle ducts maternal diabetes congenital steroidal hormones group interaction hormones trimester findings exogenous female hormones factor human male prostatic ducts maternal estrogen health unknown
DBT,DBT2161,disorders sympathetic neural human hypoadrenergic hyperadrenergic hypotension sympathoadrenal diabetic ketoacidosis sympathoadrenal general nonketotic diabetes stable nonketotic diabetic hypoadrenergic patterns hyperadrenergic patterns recent evidence diabetic hypoadrenergic hypotension diabetic sympathetic postganglionic lesion hypotension hyperadrenergic hyperadrenergic hypotension red underlies phenomenon hypotension diabetic remediable
DBT,DBT2162,emptying time diabetic tc oatmeal metoclopramide emptying time bget severe diabetes vascular damage peripheral sensory bget sem normal diabetic bget bget return normal values tc oatmeal test bget metoclopramide
DBT,DBT2163,glucosylation human diabetes complications rich tissues glucosylation hemoglobin serum diabetes glucosylation insoluble human protein little turnover method presence glucose collagenase glucosylation onset diabetes glucosylation individuals maturity diabetes glucosylation human level term diabetes
DBT,DBT2164,muller diabetic wistar diabetic months eye tissues prepared acpase microscopy products muller diabetic vitreoretinal deposits products golgi endoplasmic reticulum functional significance muller uncertain phenomenon eliminate debris necrotic pericytes glycogen diabetic conditions
DBT,DBT2165,receptor liver insulin receptor covalent cross receptor insulin adipocyte liver mr mr mr betamr mr stoichiometries betaalpha adipocyte receptor dithiothreitol mr mr receptor dissociation free receptor plasma receptor mr nonreducing conditions liver plasma insulin receptor
DBT,DBT2166,glucose intolerance due insulin resistance spinal intolerance occurs spinal injury sci spinal oral glucose tolerance tests subjects glucose intolerance insulin glucose tolerant normal subjects hyperinsulinism presence glucose intolerance insulin resistance peripheral insulin ogtt glucose intolerant sci values sci subjects exogenous insulin subjects insulin tolerance tests ogtt presence sensitivity resistance exogenous insulin spite presence insulin resistance insulin sci monocytes different subjects
DBT,DBT2167,obliterans risk dependent non insulin dependent obliterans legs noninvasive tests dependent non insulin dependent diabetic subjects aso iddm group niddm group aso increases iddm group significant correlations hemoglobin obesity effect risk aso
DBT,DBT2168,red sorbitol diabetic intact human intracellular sorbitol mediums glucose vitro incubations gas liquid sorbitol likely glucose medium tetramethylene specific aldose sorbitol dependent diabetics nondiabetics good correlation exists sorbitol plasma glucose red sorbitol vivo polyol important diabetes complications
DBT,DBT2169,haloalkane hepatotoxicity exogenous ketones metabolic ketosis haloalkane liver injury structure recent ketonic butanone methyl butylketone hexanedione kepone ketones butanol hexane potentiate liver injury haloalkanes potentiation haloalkanes state metabolic ketosis diabetes observations consistent hypothesis ketonic substances liver haloalkanes
DBT,DBT2170,diabetic emotional social impact diabetic perspective problems
DBT,DBT2171,coronary onset coronary findings male months single coronary findings severe coronary early inferior select group severe coronary suitable early therapy
DBT,DBT2172,plasma glucose degrees glucose glucose degrees intervals oral glucose tolerance tests normal subjects tolerance overnight insulin dependent diabetics positive glucose plasma glucose
DBT,DBT2173,glycosylation hemoglobin glycosylation hemoglobin hba hba diabetic ketoamine hexoses hexoses degrees glycosylation hemoglobin gram globin protein hmf index hmf index sd diabetic sd index glucose preceding weeks wide glucose values hemoglobin ketoamine hexoses hmf index independent methods hbac
DBT,DBT2174,diabetic vein obstruction retinopathy previous vein obstruction results investigation normotensive healthy hypertensive short diabetic hypertensive diabetic possible significance findings fundamental
DBT,DBT2175,developed gastrointestinal vascular complications myocardium arteritis diabetic ketoacidosis unique known
DBT,DBT2176,coronary preliminary report kahn nursing oscilloscope rhythm year deaths results pre coronary mention
DBT,DBT2177,heart diabetic develops diabetic cblksj dbdb mice dbdb mice littermate pairs weeks obob mice mannosidase glucosidase galactosidase glucosidase total rho nitrophenyl iv progressive mice weeks glucosidase glucosidase mannosidase galactosidase iv total rho nitrophenyl whereas enzymic obob mice glucosidase residual interstitial myocardium dbdb
DBT,DBT2178,correlation filtration filtration diabetic hyperfunction direct filtration filtration group short term diabetics filtration fold group close correlation filtration filtration factor diabetic hyperfunction possible term implications functional
DBT,DBT2179,liver liver tests unselected diabetics insulin oral liver tests plasma glutamyl twice upper normal correlation diabetic results liver tests evidence bright ultrasound fatty infiltration liver rise plasma transferase significant liver uncommon diabetic
DBT,DBT2180,oral glucose tolerance tests glucose insulin intervals normal dogs pre test starvation time glucose test ml oral test way oral test glucose tolerance test glucose intolerance glucose tolerance test conditions diabetic dogs glucose disappearance constants normal diabetic disparity normal diabetic glucose disappearance less intolerance
DBT,DBT2181,angiopathies angiopathies restriction todays resistance permeability principles diseases parameters substances rutosides
DBT,DBT2182,term forty severe vascular glaucomatous defects dragees weeks intervals funduscopy odg results regard serious disorders
DBT,DBT2183,lesions year man lesions lesions disc diameters size flat eye transmission lesions reflectivity diagnostic metastases primary primary nevi general heart oral mucosa mediastinal lymph undifferentiated compatible primary enlargement lesions months undifferentiated metastases eye discrete melanocytomas diffuse tract melanocytomas uncertain recognition melanocytomas general exclude primary
DBT,DBT2184,phenylephrine hydrochloride phenylephrine hydrochloride safe ocular side side topical instillation uncommon severe ten phenylephrine aneurysms insulin dependent diabetes ophthalmic elderly phenylephrine narrow glaucoma monoamine oxidase tricyclic
DBT,DBT2185,vitrectomy management diabetic detachment diabetic detachment underwent vitrectomy december months tests vitrectomy scleral scleral resection recurrent rubeosis iridis phthisis bulbi iatrogenic rhegmatogenous detachment iatrogenic cataract
DBT,DBT2186,diabetic detachment final group diabetic identify parameters selection detachment important hammock flat good top tent florid diabetic retinopathy preretinal iatrogenic tears
DBT,DBT2187,pancreatic oral glucose diabetes pancreatic pp plasma pp oral glucose normal subjects diabetic plasma pp oral exaggerated rise plasma pp diabetic normal subjects pp oral glucose plasma insulin results pp metabolic endocrine
DBT,DBT2188,hemoglobins hemoglobins friedreichs insulin dependent diabetics healthy diabetic non diabetic results non diabetic friedreichs diabetic friedreichs dependent diabetics hemoglobins
DBT,DBT2189,malignant otitis elderly diabetic malignant otitis pseudomonas skin tests hypersensitivity ppd sd mumps peripheral serum normal paraprotein igg peripheral tetrazolium nbt test normal limits results immune predisposes malignant otitis elderly diabetic
DBT,DBT2190,retention report paralytic stomach atony retention radiographs group diabetic disorders many peripheral findings diagnostic problems conservative therapy management
DBT,DBT2191,laser photocautery contraindications laser photocautery time vitrectomy posterior tears flat sensory fibrovascular fronds flat neovascularization rubeotic iris means panretinal endophotocoagulation contraindications flat disc neovascularization disc infrared laser photocautery
DBT,DBT2192,gastrointestinal radiology iopanoate cultures familiar manifestations necrosis specific diagnostic tests uptake etc diagnostic impact management many obvious significance drugs medium iopanoic fact drugs aspirin cholestyramine laboratory iopanoic systematic pharmacology desirable laboratory parameters observations empirical observations mechanisms vivo unanesthetized identification possible little interaction conjunction colleagues pharmacy iopanoate aspirin iopanoate interaction cultures preliminary significance results potential
DBT,DBT2193,diabetic oculomotor paresis pupillary diabetic paresis concomitant dissociation slit lamp verify dissociation
DBT,DBT2194,diabetic foot calcis methods diabetics soft problems experiences soft defects hindfoot intact forefoot
DBT,DBT2195,effect insulin glycine methionine incorporation alloxan diabetic incorporation total diabetes insulin hormones inhibits glycine methionine incorporation total diabetic hormones effect insulin level glucocorticoid hormones
DBT,DBT2196,frusemide salt depletion normal subjects diabetic hyporeninaemic hypoaldosteronism immunoreactive pga plasma plasma renin pra subjects diabetic hyporeninaemic hypoaldosteronism restriction frusemide pra increases pga depletion normal pga diabetic fact individuals pga frusemide salt depletion renal renin obscure increases increases due renin system
DBT,DBT2197,hemoglobin insulin results hemoglobin obesity latent hemoglobin diabetes oral therapy insulin dependent latter method factor components insulin dependent remission hemoglobin insulin therapy index insulin
DBT,DBT2198,marrow plasmocytosis diabetic diabetes year lethal marrow significance marrow plasmocytosis marrow diabetics
DBT,DBT2199,lipoprotein obese plasma lipids plasma insulin pima hyperinsulinemia obesity plasma lipoprotein synthesis little heart lipoprotein group lipoprotein endogenous tg synthesis obese pima obese normal weight normolipidemic multicompartmental tg synthesis process stepwise delipidation obese obese pimas vldl synthesis synthesis fractional pimas group vldl tg delipidized time shorter vldl tg plasma insulin plasma insulin vldl tg hand vldl tg plasma free fatty plasma lipids heart vldl tg synthesis vldl tg vldl hyperinsulinemia
DBT,DBT2200,glucose endotoxin diabetic glucose endotoxin shock diabetic non diabetic exaggerated hyperglycemia diabetic hyperglycemia output glucose gluconeogenesis exaggerated glucose turnover endotoxin diabetic non diabetic respect heart hematocrit plasma lactate endotoxin urine flow glucose excretion diabetic non diabetic
DBT,DBT2201,cadaveric renal cadaveric renal stockholm figures group undergone term dialysis year group transplant poorer figures group complications serious infections heart conditions irreversible rejection hand less group findings renal
DBT,DBT2202,maturation diabetic pulmonary maturation diabetic pregnancy day diabetic untreated treated insulin diabetic state single iv wk onset pregnancy incorporation fetal group fetal insulin transmission delayed pulmonary maturation cytoplasmic glycogen epithelial
DBT,DBT2203,potential glucose tolerance factor glucose tolerance factor gtf vivo dietary chromium enhancer insulin insulin fold gtf stable modulation insulin ailments hyperlipidemia hypoglycemia obesity protein malnutrition malabsorption endogenous gtf
DBT,DBT2204,diabetic renal onset diabetics renal allografts related donors cadaveric donors time related cadaveric renal related year cadaveric renal year pre transplant coronary selection recent perioperative
DBT,DBT2205,haemoglobin dependent diabetes haemoglobin hba microcolumn insulin dependent hba day therapy day day glucose plasma bicarbonate hba nadir weeks months insulin hba months results hba level stabilization insulin dependent glycosylation hba consistent remission postremission phases
DBT,DBT2206,management critique management diabetes metabolic emphasis conflict influences interaction mutual influences individuals problems inadequate unreliable indices metabolic future management much diabetic impact recognition support stress diabetes
DBT,DBT2207,diabetic staff simulation insulin dependent diabetic diabetic staff wk insulin dependent respondents underwent urine results daily insulin snacks pseudo staff important staff pitfalls simulation staff diabetic
DBT,DBT2208,hypoglycemia parameters diabetes insulin diabetic subjects parameters insulin discontinuation insulin hypoglycemia enhancement adp normal time hypoglycemia return serum normal significant fibrinogen ethanol gelation test positive insulin counts insulin hypoglycemia coagulation diabetic
DBT,DBT2209,effect guar insulin requirements dependent diabetic subjects pancreas effect guar insulin requirements glucose mbg glycemic insulin dependent diabetic subjects endogenous insulin pancreas fifty hours insulin pancreas conditions guar second day insulin requirements day guar significant mgg
DBT,DBT2210,subcutaneous insulin insulin dependent diabetic subcutaneous sc insulin home glucose infusions significant growth cortisol secretory patterns plasma glucose values hemoglobin hba well normalization metabolic minor glucose sc injections glucose home complications
DBT,DBT2211,manifestations hypothalamic regulatory nervous system endocrine metabolic many coordinated hypothalamic
DBT,DBT2212,impotency current investigative impotency recent psychogenic problems thorough tests differentiation etiology tests impotency guide intervention irreversible impotency impotence psychogenic nonjudgmental psychogenic impotence method urologists problems primary urologic university san therapy resident physicians
DBT,DBT2213,contractile streptozotocin diabetic contractures phenylephrine pe relaxation theophylline theo untreated insulin streptozotocin diabetic weeks induction pe diabetic units neutral diabetes decreases contractures contractures pe contracture theo contracture untreated insulin diabetes weeks induction vivo insulin decreases relaxation pe contracture prevent relaxation contracture weeks results mechanisms pe contractures diabetes contracture relaxation induction relaxation pe contracture
DBT,DBT2214,insulin release hypoglycemic remission healthy subjects gm insulin ukg asthmatics insulin glucose asthmatics hypoglycemia output growth insulin recovery glucose asthmatic economical insulin hypoglycemic hypoglycemic asthmatics diabetes
DBT,DBT2215,normal human kidneys renal immunoperoxidase paraffin normal human kidneys disorders normal glomeruli bowmans mesangium peripheral loops significant types glomerulopathy related histopathological segmental diabetic nodules glomeruli
DBT,DBT2216,insulin man effect insulin subjects underwent oral glucose tolerance tests conditions doses subjects normal glucose tolerance insulin oral glucose glucose tolerance subjects glucose tolerance insulin tolerance weight group influences insulin
DBT,DBT2217,reevaluation sand sand obesus valuable diabetes laboratory free food sand obese hyperglycemia ketoacidosis sand obese hyperinsulinemic hyperglycemia rare ketoacidosis nonexistent obesity sucrose risk attempted group sand obesity time sucrose rich normal starch group hyperglycemia significant glucose insulin insulin resistance obesity dietary sand circulating tg tg sand plasma tg normal tg removal obesity psammomys obesus human
DBT,DBT2218,insulin secretory reserve insulin dependent time insulin dependent start insulin significant plasma residual insulin fall glucose start insulin therapy parallel glucose insulin therapy maximal standard test thirds maximal sensitivity
DBT,DBT2219,epinephrine glucose effect epinephrine stress plasma normal humans hyperglycemic due glucose output glucose hyperglycemia latter results endogenous insulin direct effect insulin glucose hyperglycemic effect epinephrine rise plasma glucose due epinephrine insulin epinephrine glucose output diabetic subjects effect epinephrine glucose unchanged diabetic state normal subjects hyperglycemic epinephrine cortisol former increases rise glucose output epinephrine latter converts hyperglycemia normal subjects concomitant insulin hormones diabetes group hormones findings stress extent diabetics normal subjects
DBT,DBT2220,plasma noradrenaline system insulin noradrenaline system due hypoglycemia insulin diabetics plasma noradrenaline heart filtration renal peripheral flow plasma excretion insulin whereas excretion glucose glucose insulin filtration renal flow unaltered whereas noradrenaline heart excretion excretion decreases filtration renal flow insulin due fall glucose rise excretion insulin fall glucose renal term diabetic nephropathy albuminuria insulin excretion due renal vasoconstriction plasma noradrenaline alloxan diabetic rabbits heart insulin short term streptozotocin diabetic endothelial free micropinocytotic insulin insulin plasma noradrenaline heart plasma excretion rise plasma noradrenaline insulin hypovolemia insulin findings diabetic insulin normal endothelial
DBT,DBT2221,effect chromium rich yeast glucose tolerance lipids elderly subjects non insulin dependent diabetics daily wk chromium rich brewers chromium torula yeast yeast serum glucose insulin oral glucose intervals serum total lipids triglycerides total group normals diabetics diabetic subgroups tolerance insulin output total lipids total group hypercholesterolemic subjects group significant tolerance insulin total lipids diabetic group chromium rich brewers glucose tolerance total lipids elderly subjects torula yeast insulin sensitivity brewers elderly level chromium chromium repletion brewers tolerance total lipids serum total group presence hypocholesterolemic factor chromium brewers yeast
DBT,DBT2222,resistance insulin glucagon human kinetics group nonobese humans endogenous hypertriglyceridemia increments glucagon tracer methods glucose turnover non steady state conditions disappearance fractional disappearance range glucagon insulin findings normals weight kg glucose glucose serum insulin plasma glucagon normals parameters resistant glucagon glucagon glucose normals total glucose disappearance normals fractional disappearance glucose serum normal insulin respect glucose insulin obesity
DBT,DBT2223,different hypothermia insulin release pancreas pancreas conditions perfusion liquid degrees degrees start perfusion medium mmoll glucose glucose mmoll mmoll micromolel glucagon nmoll isoprenaline micromolel degrees insulin glucose glucagon different degrees insulin insulin glucagon degrees degrees glucose glucagon second different glucose hand glucagon hand degrees degrees second isoprenaline insulin different
DBT,DBT2224,epinephrine hypoaminoacidemia normal diabetic human subjects effect effect epinephrine epinephrine normal human subjects diabetic insulin epinephrine pgml rise plasma epinephrine normal subjects progressive total circulating unchanged insulin effect plasma epinephrine insulin diabetics fall total plasma saline insulin diabetics effect plasma insulin withdrawn diabetics hypoaminoacidemic propranolol normal diabetic subjects prevented epinephrine fall plasma increments observed stress hypoaminoacidemic effect rise plasma insulin diabetic subjects findings glucose epinephrine insulin antagonistic
DBT,DBT2225,hepatoma system insulin cultures hepatoma insulin ki insulin insulin subsequent degradation hepatocytes time insulin receptor degradation insulin little degradation less degrees membrane homone uptake degradation insulin intralysosomal degradation degradation insulin procaine lidocaine energy dinitrophenol sodium cyanide degradation inhibits vinblastine insulin degradation methylamine prevent receptor insulin processing findings consistent insulin receptor endocytotic uptake intralysosomal degradation release degradation products insulin maximal incorporationof glycogen insulin less receptor occupancy concanavalin vinblastine insulin glucose incorporation glycogen excess insulin glycogen synthesis level intermediate degradation receptor system insulin receptor receptor termination
DBT,DBT2226,diabetic dbdb permanent insulin investigation mechanisms obesity diabetes independent endocrine whole system skin diabetic mice fewer littermates many generations insulin related genetic trait diabetes
DBT,DBT2227,isoproterenol insulin diabetic nonobese normal subjects extraction endogenous insulin iv micrograms peripheral plasma insulin nonobese normal subjects maturity diabetic subjects insulin obese diabetic subjects nonobese normal subjects insulin increments obese diabetic subjects nonobese diabetic subjects insulin extraction insulin increment increment isoproterenol nonobese obese diabetics normals significant nonobese obese diabetics sulfonylurea therapy predisposition diabetic retinopathy increments glucose diabetics insulin extraction diabetics normal insulin extraction isoproterenol insulin increments diabetics insulin extraction normals insulin extraction nonobese obese diabetic subjects insulin diabetics insulin extraction
DBT,DBT2228,pre operative residents heart institute risk current problems pulmonary coagulation problems renal risk usual presence risk dysfunction heart recent significant diabetes renal significant pulmonary dysfunction emergency non presence important thoracic usual risk usual risk current
DBT,DBT2229,quantitation quantitation transformation important host laboratory methods techniques results normal hyperlipidemia normal pregnancy populations diabetics subpopulations maturity onset pregnancy ethanol attainable human results hexose monophosphate shunt hmps pentose sugar diabetic hmps reversible normal collected techniques
DBT,DBT2230,oral report parapsilosis pathogen deals manifestations oral emphasis therapy literature many drugs lozenges condition drawn pathogen parapsilosis
DBT,DBT2231,white protestant clergy risk clergymen white protestant denominations favorable clergymen deaths total renal diseases white total total white clergymen motor vehicle leukemia extent lymphoma different findings social emphasis critical clerical
DBT,DBT2232,connective review recent connective tissues systematic degradation intercellular matrix glycoproteins matrix synthesis matrix state differentiation synthesis matrix degradation diseases diseases connective tissues diabetes osteoarticular diseases intercellular matrix matrix interaction specific matrix turn influences matrix informational importance connective tissues
DBT,DBT2233,lipoprotein previous report lipoprotein slpc sucrose risk rds slpc deliveries results slpcs severe preeclampsia sfd infant hand slpcs maternal diabetes rh isoimmunization normal pregnancy normal rds evidence maturation fetal severe preeclampsia maternal diabetes rh isoimmunization anencephaly fetal excretion fetal effect
DBT,DBT2234,possible risk proximal femur statistical rheumatoid primary hyperparathyrodism hip risks conditions noncontributory minor risk factor overall hip hip risk hemiplegia malabsorption syndromes therapy conditions thyrotoxicosis significant significant correlation previous hemiplegia side subsequent hip osteoporosis hemiplegic limb recent hip estrogen therapy therapy hemiplegia thyrotoxicosis conditions osteopenia hip
DBT,DBT2235,carbostimulin effect metabolic carbostimulin fixation tissues therapy level restores total ketoacids free increases normal limits urea urine
DBT,DBT2236,histiocytosis year male oral ulcers diabetes insipidus histiocytosis tests histiocytosis
DBT,DBT2237,friedreichs overview physiopathology quebec cooperative physiopathology results hypothesis unifying possible hypothesis demonstration state mitochondrial energy deprivation important weakness independent entry pyruvate diabetes stem dorsal root putative neurotransmitters correction intraventricular mitochondrial energy deprivation inner mitochondrial membrane phospholipids decreases membrane interference normal incorporation fatty search specific friedreichs
DBT,DBT2238,hypothalamic pituitary trh male diaetics therapy hypoglycemic nph insulin dietary therapy intact normal group glibenclamide therapy exaggerated lh prl tsh normal results lh tsh prl intact uncomplicated diabetes lh subjects related primary pituitary group
DBT,DBT2239,importance insulin release oral glucose tolerance pancreatic cephalic insulin release oral glucose tolerance diabetic intraportal islets insulin release weight glucose tolerance tests unstressed state permanent gtt oral gtt tests peripheral insulin gtt insulin release oral gtt cephalic normal insulin insulin peripheral insulin minutes glucose values time insulin oral gtt exogenous insulin insulin glucose different cephalic insulin release important factor glycaemia food plays oral glucose tolerance diabetic intraportal
DBT,DBT2240,spermatogenesis hypogonadotropic hypogonadism persistent spermatogenesis normal semen fertility face hypogonadotropic hypogonadism normal serum serum normal values consistent hypogonadotropic hypogonadism standard replacement therapy literature evidence roles spermatogenesis evidence gonadotropins fertility spermatogenesis doses exogenous spermatogenesis individuals hypogonadotropic hypogonadism sterile fertility semen time
DBT,DBT2241,crisis pancreatitis diabetic ketoacidosis diabetic ketoacidosis crisis pancreatitis phosphate depletion interaction diseases crisis pancreatitis rare
DBT,DBT2242,residual insulin glibenclamide insulin dependent diabetics residual insulin presence serum urine insulin diabetics significant serum urine weeks daily usual insulin metabolic glibenclamide insulin therapy insulin diabetics
DBT,DBT2243,direct time hydroxybutyrate acetoacetate computer spectrophotometer glucose onset diabetics methods hydroxybutyrate acetoacetate time enzymic iia computer spectrophotometer gilford system method micro plasma rapid recovery results instruments metabolic methods
DBT,DBT2244,lipoprotein lipase treated lipase lpl tissues hours diabetes streptozotocin glucose level fold level diabetic state lpl white tissues diabetic level lpl hours streptozotocin lpl hours significant hours pulmonary lpl diabetic significant hours results specific lpl diabetes lpl transport adipocytes proposes
DBT,DBT2245,polyuric megalocystis treated bladders polyuria diabetes medullary cystic insipidus panhypopituitarism psychogenic polydipsia polyuria urine volumes obstruction flowmetry cystourethrography
DBT,DBT2246,interstitial cylinder shrinkage diabetic maximal conduction velocity diabetic weeks intoxication intermediate onset conduction velocity streptozotocin group attributed maturation lack maturation cylinders growth cylinders group group fiber shape index circularity transverse cylinder shrinkage cylinders size shape cylinders hyperosmolar fixation streptozotocin cylinder effect operative
DBT,DBT2247,specific insulin cytoplasmic diabetic insulin specific insulin rise diabetes effect preincubation insulin liver liver diabetic less insulin diabetic membrane phosphorylation insulin resistance
DBT,DBT2248,ventromedial hypothalamic lesions pancreatic sensitivity streptozotocin electroytic lesions ventromedial sham streptozotocin stz mgkg lesions stz wk none sham doses diabetic terms hypoinsulinemia sham stz mgkg occur important factor sensitivity stz pancreatic injury important man
DBT,DBT2249,effect insulin serum serum radioreceptor values insulin glucose serum somatomedin values day untreated diabetic somatomedin total intakes nontreated diabetic diabetic lack insulin significant correlation serum somatomedin values glucose glucose diabetic insulin protein serum somatomedin interfere somatomedin effect radioreceptor
DBT,DBT2250,acrodystrophic trophic peripheral normal neurogenic primary primary qualitative fiber preparations unmyelinated lesions sural ankle degeneration sensory neurological trophic sensory important trophic sporadic unmyelinated acrodystrophic peripheral trophic usual tissues
DBT,DBT2251,serum serum pancreatic exocrine pancreatic insulin biguanides results serum immunoreactive trypsin pancreatic insulin dependent diabetics serum immunoreactive trypsin overall correlation observations evidence pancreatic exocrine diabetes serum inexpensive rapid
DBT,DBT2252,nitroanisole aniline hepatocytes diabetic nitroanisole aniline hepatocytes male female diabetic streptozotocin male diabetic metabolites microsomes diabetic cytochrome hepatocytes microsomes diabetic male disposition cytochrome hepatocytes metabolites hepatocytes mono oxygenase microsomes diabetes cytochrome hepatocytes microsomes results effect microsomal preparations disposition whole hepatocytes diabetic condition dependent hepatocytes
DBT,DBT2253,glucagon plasma man glucagon plasma infusions glucagon somatostatin microgram somatostatin glucagon normal insulin somatostatin insulin slight significant delta max mmol sem somatostatin glucagon glucagon insulin glucose somatostatin delta max mmoll hyperkalaemia results insulin evidence phenomenon hyperglycaemia insulin glucagon underlie hyperkalaemia serious stress diabetes
DBT,DBT2254,effect release hypoglycaemia insulin dependent diabetics previous blockers hypoglycaemia possible mechanisms key hormones insulin hypoglycaemia insulin dependent diabetics subjects propranolol metoprolol hypoglycaemia blocking glucagon cortisol growth hypoglycaemia adrenaline hypoglycaemia less diabetics non diabetics insulin release key glycogenolytic gluconeogenic hormones blockers clearance delayed recovery glucose non due lack gluconeogenic glycerol
DBT,DBT2255,hypersection pancreatic somatostatin obese zucker food restriction islets obese zucker somatostatin srif glucose islets srif contents obese islets obese glucose insulin release insulin islets obese wk weight obese pancreatic delta different srif glucose srif release reductions insulin glucose insulin islets obese zucker times contents srif insulin islets obese glucose intolerance srif islets glucose range delta obese sensitivity glucose obese glucose conditions srif insulin islets obese results pancreatic delta obese zucker hypersecretion pancreatic srif obesity zucker obscure
DBT,DBT2256,gas spectrometry unsaturated dicarboxylic urine unsaturated dicarboxylic urine total methyl method employed dicarboxylic individuals normal fatty group isomers mesaconic citraconic isomers methylglutaconic muconic methyl esters dicarboxylic diabetic ketoacidosis total succinic adipic ketoacidotic
DBT,DBT2257,peptides water sodium neuroactive peptides sodium different peptides normal vertebrates many birds reptile fish brisk drinking time day doses water intracranial sodium onset many hours repeated injections increases sodium isorenin second neuroactive undecapeptide salivary cephalopods extent intracranial dipsogens indistinguishable substances antidiuretic adh profound effect water diabetes mechanisms direct nervous system adh osmotic peptides claim neuroactive dipsogenic injected sodium sodium manifestations endocrine system paracrine system system concerned
DBT,DBT2258,trial doses ethisterone pregnancy term mothers trial doses ethisterone fetal diabetic random tablets respondents unaware hormones overall times england wales deaths complications diabetes tumours reproductive tract group malignant none non findings support evidence oestrogen latent tumour
DBT,DBT2259,hypersensitivity vasculitis granulomatous hepatitis glybenclamide report second literature hypersensitivity vasculitis time lesions histopathological male glybenclamide general condition hepatomegaly red nodes tips hands laboratory parameters normochromic normocytic eosinophil sedimentation slight serum hyperbilirubinemia skin lesions anular lesion diabetics histopathological liver hypersensitivity conspicuous vicinity different withdrawal histopathological cure early therapy
DBT,DBT2260,stable maturity diabetics insulin maturity diabetics oral year stable ill fatigue legs none ketoacidotic glucosuria less sugar months glucosuria sugar disappearance reluctant insulin months therapy stable diabetics
DBT,DBT2261,infections current mucous whon home homes infections mucous thrush units previous infant mycosis intercrural skin leiners cutaneous incontinence obese intestinal diabetes hand conditions homes
DBT,DBT2262,endocrine primary endocrinological diseases respect dysfunction parathyroid hypophysis
DBT,DBT2263,water glycogen synthesis glucogen synthesis liver vivo incorporation ho glycogen incorporation glycogen glycogen incorporation maximal values glycogen incorporation pre feeding values post prandial streptozotocin diabetes rise glycogen effect ho incorporation insulin glycogen glucose degradation glucose glycogen ho incorporation rapid hexose phosphates isomerase triose phosphate isomerase
DBT,DBT2264,risk arteriopathic arteriopathy matter risk vascular risk heart hyperuricaemia obesity renal immediate results barrage haemorrhagic pancreatitis results good prosthesis non vascular risk extraperitoneal transperitoneal problems aortobifemoral bypasses state risk short term results correction
DBT,DBT2265,unique participants multimorbidity concomitant diseases subdivision diseases second group diseases hyperlipoproteinaemia diabetes hyperuricaemia hypertensive metabolic degradation diseases results unique risk hypertensive metabolic manifestations heart
DBT,DBT2266,peculiarities therapy hyperlipoproteinemia complications importance hypertriglyceridaemia monosaccharides suitable etiopathogenesis general valid risk inclination rhythm pancreatitis
DBT,DBT2267,therapy feeding diabetes therapy specific peculiarities diabeticum pre intra time points coma therapy insulin way usual methods guide lines diabetic pre intra problems pragmatic points
DBT,DBT2268,prolactin trh insulin dependent obese diabetic obesity obese iri gh prl conditions obese diabetic gh values normal iri iri gh test plasma conditions obese diabetic obese different values subjects insulin independent obesity stimulus specific hypofisary system prl gh
DBT,DBT2269,microcirculation diabetic subject diabetic foot male subject slight diabetes typical serious limb mild dysmetabolic picture normal evidence damage districts whereas typical diabetic foot concomitant position important early microcirculation
DBT,DBT2270,colour diabetic retinopathy glucose effect colour diabetic retinopathy diabetic method glucose diabetics colour status glucose oxidase peroxidase test laboratory values colour diabetic retinopathy significant effect method glucose vast diabetics monitor method defects
DBT,DBT2271,effect therapy remission diabetic elctroconvulsive therapy ect diabetes recent onset non insulin dependent free diabetes
DBT,DBT2272,tract infection postmenopausal diabetic nonhospital populations tract infections diabetic non diabetic former conditions infections tract infection postmenopausal diabetics non diabetics tract infection premenopausal coli mirabilis versus klebsiella versus diabetic sepsis infection diabetic versus severe renal plasma clearance ml postmenopausal none non diabetics renal damage
DBT,DBT2273,glucose insulin oral sucrose fructose sorbitol pancreas means glucose insulin sorbitol fructose sorbitol group maturity diabetics steepest insulin return laxative smallest insulin return fructose sorbitol results insulin return sucrose shows effect fructose sorbitol
DBT,DBT2274,hdl therapy metabolic plasma hdl metabolic atherosclerotic lesions diabetics hdl values females diabetes insulin therapy hdl values diabetics oral latter metabolic hba insulin diabetics correlation metabolic hba hdl hdl diabetics hdl suitable risk atherosclerotic complications
DBT,DBT2275,cultures diabetic dbdb demonstration insulin insulin skin diabetic dbdb mice specific time dependent maximal porcine insulin desalanine insulin insulin insulin insulin types fibroblasts dissociation constants diabetic fibroblasts insulin diabetic fibroblasts fibroblasts fibroblasts diabetic fibroblasts fibroblasts time dependent insulin normal insulin prevented cycloheximide diabetic fibroblasts maximal deoxy glucose uptake nm nm insulin fibroblasts diabetic cultures nm insulin half maximal deoxy glucose uptake nm insulin diabetic fibroblasts nm ornithine decarboxylase results cultures diabetic insulin receptor many generations insulin
DBT,DBT2276,plasma triglycerides diabetic diabetic females hypertriglyceridemia females obesity important factor hypertriglyceridemia hypercholesterolemia correlation haemoglobin triglycerides little correlation plasma glucose triglycerides
DBT,DBT2277,diabetic nephropathy review current status etiopathogenetic personal select significant current regard diabetic nephropathy update daily questions aetiopathogenesis renal diabetic nephropathy conventional unsatisfactory results recent replacement therapy dialysis
DBT,DBT2278,hyperlipoproteinemic subjects values normalweight normolipemic healthy serum uric subjects iv hyperlipoproteinemia much significant positive correlation serum level correlation hypertensive hyperlipemic subjects uric normotensive ones hand hyperlipoproteinemic hyperinsulinism turnover obese hypertriglyceridemic subjects synthesis purines uric
DBT,DBT2279,effect glucose level normals diabetics effect glycemia diabetic normal method toluidine jeun glucose minutes cigarettes glycemia group diabetics glucose values glycemia rise free cigarettes cigarettes glycemia due mobilization sth cortisol diabetics normal subjects
DBT,DBT2280,recent sympathetic system sodium state renin system functional heart components important complementary normal components non vascular reactivity review recent observations concepts antihypertensive
DBT,DBT2281,diabetics diabetic glomerulopathy hemodialysis glucose intolerance insulin dependent diabetics normal kidneys filtration subsequent glomerulosclerosis progresses overt nephrotic manifestations nephropathy clearance less mlmin plan nephrotic azotemic diabetic involves management renal extrarenal complications proliferative retinopathy preparations hemodialysis renal short term favorable
DBT,DBT2282,flexion contractures diabetic rosenbloom fingers joints diabetic slight contracture little finger diabetes progressive process results findings connective vital lungs
DBT,DBT2283,depot serum hdl depot dmpa year group significant serum hdl weeks
DBT,DBT2284,glomeruli diabetics glomerulonephritis method glomeruli hydroxylysylglycosides glomeruli normal subjects diabetics subjects glomerulonephritis hydrolyzate glomeruli glomeruli nmoles sd nmoles diabetics nmoles subjects glomerulonephritis hydroxyproline glomeruli diabetics glomerulonephritis nmoles glomeruli diabetics nmoles glomeruli glomerulonephritis subjects
DBT,DBT2285,diabetics nailfold cp direct microinjection insulin dependent male diabetic cp conditions acclimatization parts positive correlation skin cp limb values summit venous limb values diabetics warm conditions limb values summit venous limb values limb cp hyperemia diabetics diabetic group evidence digital vasoconstrictor intact findings evidence microvascular lesion precapillary sphincter level insulin dependent diabetic vasodilatation stress
DBT,DBT2286,diabetics antipyrine test vivo index kinetics liver cytochrome direct microsomal wide interindividual diabetics fold antipyrine antipyrine subjects normal liver inflammatory vivo vitro parameters histology hand metabolizing diabetics
DBT,DBT2287,cross diabetes aminopropionitrile cross polyester fabric time diabetes streptozotocin diabetic implants total implants total diabetics diabetic half ratio diabetics aminopropionitrile diabetics observations intermolecular cross diabetic cross interfere degradation collagenase intimal sclerosis membrane diabetes
DBT,DBT2288,plasma plasma ketotic diabetes glucose plasma short term term glucose important renin system diabetic
DBT,DBT2289,cataractogenesis vitro sorbitol fructose intact medium intact incubated medium normal glucose times normal microscopy lenses globular degeneration lenses depth degeneration glucose medium opacity opacity globular degeneration lens sorbitol fructose globular degeneration cataractogenesis osmosis risk diabetes glucose medium times normal level hours minimum times normal level hours
DBT,DBT2290,plasma diabetic severe hyperlipidaemia severe electrolyte hyperlipidaemia insulin dependent electrolyte values fallacious problems management regard replacement plasma elecytolyte values
DBT,DBT2291,homozygosity manifestations arthropathy hepatomegaly transaminasemia skin splenomegaly hypogonadism congestive hepatomegaly serum iron transferrin serum ferritin iron excretion deferoxamine stainable iron iron iron times female important damage early therapy early unexplained transferrin
DBT,DBT2292,denmark method conscript unbiased method danish conscript danish total male cohorts occurrence diabetes conscript identification omissions cumulative cohorts thousand total thousand
DBT,DBT2293,effect glucagon short term insulin dependent diabetics short term insulin dependent male diabetics glucagon filtration renal plasma flow steady state excretion plasma glucagon pgml pgml pgml filtration subjects glucagon mlmin filtration rise plasma glucagon renal plasma flow glucagon mlmin excretion micrograms excretion unchanged glucagon results glucagon reversible filtration insulin dependent diabetics diabetics
DBT,DBT2294,diabetes dates diabetes results diabetes likely diabetic general sibships year dates less months results onset non genetic diabetes months
DBT,DBT2295,removal injury starvation conditions man injury conditions man removal metabolic starvation injury diabetes muscular half doubled starvation severe injury intralipid free fatty ketone effect removal load clearance muscular ketone traumatized energy nitrogen load different conditions different
DBT,DBT2296,granulomatous nephritis renal granulomatous nephritis previous literature nephropath granulomatous nephritis important morbidity interstitial diseases albuminuria sterile pyuria renal size defects diabetes renal inappropriate glucosuria interstitial granulomas epithelioid giant usual picture intimal infrequent granulomas findings specific
DBT,DBT2297,growth diabetics diabetic serum weight serum ketotic diabetic serum normal subjects growth synthesis fibroblasts diabetic growth effect diabetic serum weight components wt daltons weight components diabetic serum daltons initiation growth growth diabetic serum daltons normal serum serum growth growth limited importance much vitro results vivo situation vascular diabetics risk diabetes
DBT,DBT2298,status coronary diabetic evidence coronary heart observations necropsy dm onset dm chd dm chd evidence coronary heart chd observations coronary chd dm right circumflex coronary cross atherosclerotic diabetic chd dm chd chd dm coronary dm chd severe coronary chd severe proximal halves halves severe cross narrowing coronary versus level random sugar severe coronary narrowing necropsy
DBT,DBT2299,yersinia enterocolitica septicemia human yersinia enterocolitica septicemia uncommon condition review literature septicemia previous disorders diseases indistinguishable sepsis organisms enterobacteriaceae important mind yersinia enterocolitica resistant aminoglycosides trimoxazole ten fecal cephalosporins cefamandole cefoxitin ones ly
DBT,DBT2300,pregnancy diabetic retinopathy diabetic retinopathy term pregnancy photocoagulation successful diabetic group nonpregnant diabetes proliferative diabetic retinopathy
DBT,DBT2301,growth fetal biparietal different types total fetal biparietal biparietal normal diabetes dates significant
DBT,DBT2302,obesity pregnancy obesity literature pregnancy risks disagreement complications obesity growth gestational deliveries computer uniform perinatal record pregnancy risk obese nonobese obese time pregnancy obese obese group antepartum risk inadequate pregnancy induction cesarean obese complications current primary cesarean group infant apgar scores perinatal fewer weight macrosomic obese accounted percentile significant
DBT,DBT2303,staff manuals teach staff manual staff manual outline process manual concrete examples relevant process manual organize
DBT,DBT2304,isolation partial human neurophysins specific radioimmunoassays neurophysins nps primary protein hormones human pituitary sucrose human neural nps vp ot human np hnp vp hnp ot vp hnp vp hnp ot hnp ot hnp specific rias hnp range pg protein protein correction rias rias human plasma healthy subjects vp hnp ot hnp pgml sem significant values females oral times normal hnp normal hnp eleven inappropriate antidiuretic hnp hnp plasma vp hnp ot hnp subjects dramatic release vp hnp plasma times values lithium diabetes plasma sensitivity rias
DBT,DBT2305,correlation coronary onset ischemic heart uncertain findings findings onset diabetes significant correlation overall coronary presence correlations results spurious diabetic overall coronary diffuseness coronary coronary infarcts results diabetes condition coronary subject subjects atherosclerotic
DBT,DBT2306,ultrastructure human nonsmoking white group diabetic mothers effect diabetic human vascular wall fetal system ultrastructure diabetic mothers white group healthy nonsmokers intimal cushions membrane multilaminal glycogen rich underlying endothelial pseudoendothelium due myocytes
DBT,DBT2307,strict instrumental elicit importance iatrogenic risk ischemic heart possible arteritis injury oral coagulation disorders cardiogenic embolism etc risk
DBT,DBT2308,empirical test transmission recent revealed independent subtypes method reich workers independence transmission techniques non unitary mental subjects reed reed believe limited repertoire methods researchers issues
DBT,DBT2309,photocoagulation photocoagulation literature emphasis bruchs membrane pigment epithelium diffusion conditions choriocapillaries marginal angiograms coagulation literature hypothesis coagulation marginal photocoagulation conditions metabolic exchange shunts
DBT,DBT2310,correlation diabetic preretinitis ninety typical diabetic preretinitis year pigment extravasation shunts significant occlusive diabetic preretinitis hence rapid
DBT,DBT2311,effect bordetella pertussis vaccine glucagon normal alloxan dogs effect bordetella pertussis vaccine plasma glucose insulin glucagon normal alloxan dogs th day vaccine normal alloxan dogs glucose plasma level iri level saline hand level significant alloxan dogs vaccine plasma level saline glucose th day normal alloxan dogs normal dogs bordetella pertussis vaccine plasma glucose promotion insulin effect glucagon alloxan dogs vaccine hyperglycemia enhancement insulin glucagon
DBT,DBT2312,plasma uric urban rural plasma uric melanesian residents moresby residents village mml triglycerides urban rural residents uric urban urban rural mml previous rural populations plasma lipids urbanised residents diabetes obesity unexplained
DBT,DBT2313,membrane components health different types iv noncollagenous glycoproteins gp sulfate renal diseases diabetic membrane membrane glycosylation components important effect interaction membrane components membrane
DBT,DBT2314,insulin diabetics different insulins dependent diabetics types insulin group diabetics single insulin onset conventional insulins novo lente insulin related insulin demands presence insulins much products
DBT,DBT2315,diabetic glomerulosclerosis current status diabetic glomerulosclerosis metabolic state uniform thickening membrane gbm mesangial matrix observed glomeruli extent diffuse nodular deposits glycoproteins mesangium nodular nodules specific diabetic nodular glomerulosclerosis insudation plasma loops gbm contradictory gbm human diabetes gbm due synthesis slow review different concepts glomerulosclerosis attemps possible current
DBT,DBT2316,mesangium juxtaglomerular diabetic intact uninephrectomized diabetic dbdb mice cblksj littermates renal months renal tissues regular microscopy techniques intact dbdb mice peripheral mesangial thickening dbm mice due mesangial matrix mesangium juxtaglomerular uninephrectomized dbdb mice dbdb un intact dbdb mice dbm un mesangial thickness intact dbmice dbdb mice intact dbdb mice mesangial igm dbm mice igm diabetic mice peripheral mesangium mesangium level juxtaglomerular membrane epithelial epithelial epithelial igm glomerulus diabetic lesions diabetic mice important mesangial processing mechanisms
DBT,DBT2317,isolation insulin pyruvate dehydrogenase insulin adipocytes weight stable intact adipocytes extraction subsequent sephadex single mitochondrial pyruvate dehydrogenase pyruvate dehydrogenase naf fact presence naf pyruvate dehydrogenase pyruvate dehydrogenase dichloroacetic intracellular second messenger insulin
DBT,DBT2318,diabetes zealand obese obese nzo potential nzo mice obesity glucose intolerance insulin resistance igm receptor dna single dna females related nzb nzw nzbw lupus erythematosus nzo normal nzbw mice nzbw mice succumb immune proliferative glomerulonephritis yr whereas nzo mice nzo kidneys diabetic lupus mesangial deposits membrane glomerulosclerosis eosinophilic nodules hyalinization igm granular nzo evidence immune obesity diabetes
DBT,DBT2319,glutathione insulin release pancreatic islets glutathione gsh oxidized glutathione gssg related manner concomitant nadph gsh level exogenous insulin microuml gsh presence insulin effect thiol parachloromercuribenzoate cmb observations gsh pancreatic islets exogenous insulin pentose phosphate shunt nadph results compatible hypothesis exogenous insulin state nadphnadp gshgssg sensitivity insulin cmb
DBT,DBT2320,insulin synthesis marrow normal marrow erythroid possess insulin inverse stage differentiation mature mature insulin incorporation protein human peripheral reticulocytes range phenomenon microuml
DBT,DBT2321,insulin human erythrocytes overnight healthy subjects insulin concomitant plasma insulin microuml insulin insulin different insulin insulin occupancy unlabeled insulin specific insulin insulin receptor erythrocytes consistent receptor
DBT,DBT2322,vivo incorporation insulin normoglycemic hyperglycemic hypoglycemic glucose insulin mci hyperglycemia hypoglycemia system pancreatic islets pancreas radioautography insulin immunoprecipitation tca tissues tca precipitable incorporation insulin times hyperglycemic hypoglycemic grain sensitivity nonhormonal protein pancreatic plasma glucose unique tissues pancreatic
DBT,DBT2323,pancreatic radioautographic glucose pancreatic islets vitro hleucine htryptophan ringer bicarbonate glucose incorporation radioautographic incorporation hproinsulin hinsulin immunoprecipitation trichloroacetic incorporation pancreatic patchy uniform regions islets incorporation peripheral nonbeta incorporation nonbeta endocrine glucose incorporation incorporation hleucine insulin glucose specific immunoprecipitation grain densities times glucose incorporation htryptophan nonhormonal glucose radioautography sensitivity nonhormonal protein medium
DBT,DBT2324,serum diabetic wtwt diabetic streptozotocin mgkg hypercholesterolemia vldl intermediate idl hdl vldl unique apo apo iv usual apo apo idl apoprotein hdl apo qualitative increases idl apoprotein hyperlipoproteinemia due inadequate removal intestinal diabetes
DBT,DBT2325,food effect glipizide diabetics healthy subjects single kinetics healthy diabetics sulfonylurea plasma insulin glucose food half food glipizide significant plasma glucose serum glipizide former plasma insulin glucose latter glipizide concurrent glipizide serum metabolic impact insulin release glucose disposition concurrent
DBT,DBT2326,glucose insulin plasma immunoreactive insulin mice desired time doses htp mgkg iv dependent mice eg htp mgkg mmoll significant plasma immunoreactive insulin mul htp mgkg mul induction alloxan mgkg iv effect htp alloxan abolished hyperinsulinaemic mgkg htp mgkg htp diabetic mice htp mmoll htp mgkg mmoll normal mice pre nialamide monoamine oxidase much doses mgkg hypoglycaemia plasma insulin doses mice hyperinsulinaemic normal mice pretreatment benserazide decarboxylase modify plasma glucose normal htp normal mice plasma insulin likely mechanisms
DBT,DBT2327,chlorpropamide flush lack non insulin dependent flush chlorpropamide diabetics genetic non insulin dependent chlorpropamide flush subjects insulin dependent diabetics non insulin dependent non insulin dependent diabetics chlorpropamide flush skin tests chlorpropamide flush specific non insulin dependent diabetes flush
DBT,DBT2328,chenodeoxycholic dissolution trial operative risk radiolucent gallstones gallbladders risk double group group chenodeoycholic cdcday group cdcday months oral cholecystograms duodenal collected months intervals months cdcday group group gallstones dissolution group partial group group lowest dissolution lithogenic index vs doses optimal ill
DBT,DBT2329,epithelial diabetic method humans noninvasive photographic techniques method primary diabetic epithelial different diabetic tendency recurrent epithelial defects diabetic
DBT,DBT2330,open renal transplant renal transplant open related complications deaths deaths specimens specific nonspecific specific different nonspecific diabetes leukopenia therapy early infectious group specific
DBT,DBT2331,glycohemoglobin normal pregnancy insulin dependent diabetics minor components hemoglobin aab presence maternal glucose correlation hemoglobin components usual shorter term indices diabetic correlation hemoglobin values weight weight glycohemoglobin values index term sugar helpful plan
DBT,DBT2332,hypothalamic pituitary functions encephalocele midfacial hypothalamic pituitary functions pituitary herniation midfacial floor sella male short plasma gh level insulin hypoglycemia normal plasma tsh serum prl prl trh evidence hypogonadism insipidus mild mental need sella turcica hypothalamic pituitary functions midfacial
DBT,DBT2333,fasciitis streptococcal gangrene face report literature fasciitis rare infection hemolytic streptococcus cutaneous necrosis fasciitis vascular problems prominent neck rare literature report management doses penicillin early drainage necrotic
DBT,DBT2334,insipidus hypoparathyroidism addisons mucocutaneous diabetes idiopathic hypoparathyroidism mucocutaneous time cortisol mucocutaneous hypocalcaemia vasopressin desmopressin insipidus endocrine secretory idiopathic hypoparathyroidism
DBT,DBT2335,streptozotocin diabetes normal cba post diabetic condition reduces allografts normal sugar level close normal range urine glucose output diabetic pre removal results rapid diabetic condition
DBT,DBT2336,diabetic rabbits eye hyperopic induction enhancement hyperopia enhancement diabetic lens aldose polyol synthesis
DBT,DBT2337,igg heavy allotypes diseases gravis hashimotos lupus erythematosus insulin dependent behcets leprosy duchenne progressive muscular normal gm allotypes gm gravis hashimotos gm myasthenia hashimotos total different gm haplotypes myasthenia hashimotos presence gm polygenes disorders
DBT,DBT2338,scientific discipline position discipline science true situation look backwards trends helpful philosophy science work potential future work discipline emergence end th methods organisms mechanisms human possible evolution philosophical social
DBT,DBT2339,diabetic develops diabetic cblksj dbdb mice dbdb mice littermate pairs weeks obob mice mannosidase glucosidase galactosidase glucosidase total nitrophenyl iv progressive mice weeks glucuronidase glucosidase residual interstitial myocardium dbdb
DBT,DBT2340,ions insulin diabetic ketoacidosis insulin glucose insulin diabetic ketoacidosis females terms plasma acidemia ketoacidosis values severe insulin hours acidemia ketoacidosis insulin insulin severe ketoacidosis due vascular collapse ketoacidosis severe ketoacidosis glucose insulin
DBT,DBT2341,operative pancreas pancreas south male female ratio group operative pancreaticoduodectomy depth serum transaminase stage ecg evidence heart serum urea level months pancreatoduodenectomy months extent
DBT,DBT2342,pig insulin insulin pig sulfate deae rechromatography sephadex rechromatography single position polyacrylamidegel disc pig immunization rabbits rechromatography pig membrane identity ouchterlony double immunodiffusion immunoprecipitin inhibited normal serum insulin porcine subcellular insulin significance
DBT,DBT2343,insulin glycogen human diploid fibroblasts effect insulin glycogen human diploid fibroblasts little insulin glycogen total maximal half maximal insulin glucose starvation magnitude glycogen insulin insulin half maximal glucose level human diploid fibroblasts effect insulin vitro senescence total glycogen insulin half maximal unchanged glycogen human diploid fibroblasts insulin system vitro insulin sensitivity
DBT,DBT2344,insulin human growth peptides terminal human growth hgh insulin different insulin tolerance tests specific plasma hepatocytes modulation insulin dependent glycogen glycogen phosphorylase results minimum hgh hn leu phe cooh insulin peptides insulin specific glycogen phosphorylase hypoglycemia glycogen liver
DBT,DBT2345,ileal serum glucose tolerance obese plasma insulin glucose oral glucose tolerance tests lipoprotein obese weight kg significant decreases parameters weight kg hyperinsulinaemic glucose overt serum total normal hdl months significant reductions plasma insulin serum total lipoprotein triglycerides hdl increases significant decreases correlations lipoprotein values glucose plasma insulin ogtt parameters likely intestinal synthesis hdl turn synthesis hdl obese
DBT,DBT2346,effect diabetic plasma whole viscosity diabetic diabetic hba sd home glucose level mmoll months hba home glucose level mmoll significant plasma fibrinogen plasma viscosity whole viscosity ten diabetics complications diabetics current significant whole hyperviscosity hyperglycaemia quality diabetic
DBT,DBT2347,management diabetics management diabetic glucose glucose good glucose many problems diabetics
DBT,DBT2348,overview epidermis renal tubules diabetes diabetics thickness bl renal tubules bl phenomenon renal tubules accumulates human tissues renal tubules renal tubules diabetics bl diabetics extent bl renal tubules diabetes fact bl observations bl dependent bl bl man
DBT,DBT2349,gene insulin dependent sibs insulin dependent iddm hla results hypothesis hla locus iddm sd sa iddm estimate general risk penetrance doses sasd sd recombination hla pairs estimate penetrance penetrance hypothesis penetrance gene dominant recessive hla pairs hla recombination hla upper
DBT,DBT2350,insulin dependent subdiabetogenic doses functions insulin dependent nude mice heterozygous streptozotocin single streptozotocin weight rapid permanent hyperglycemia mice total subdiabetogenic doses day progressive hyperglycemia thymus mice female mice streptozotocin mice thymus hyperglycemic doses splenic mice diabetic injections glucose intolerance mice diabetic diabetic state splenic results direct thymus dependent functions subdiabetogenic doses observations evidence mechanisms etiology diabetes humans
DBT,DBT2351,vitro method pancreatic pancreatic islets daily wk units medium functional islets system islets islets streptozotocin diabetic intraportal islets diabetic normal weight hyperglycemia polyuria diabetic normoglycemic state plasma glucose clearance kg normal islets islets results islets system vivo vitro system
DBT,DBT2352,membrane streptozotocin diabetic sucrose starch months streptozotocin mgkg diabetic weight kidneys polyuria glucose sucrose normal glucose kidneys membrane sucrose diabetic membrane different hexosamine hydroxylysine hydroxyproline hexosamine non diabetic weight components membrane diabetic sodium sulphate glucosyltransferase supernatants sucrose nmolhkidney starch sucrose induces diabetes induction diabetes little sucrose
DBT,DBT2353,motor sensory conduction term streptozotocin diabetic sensory conduction sural tibial stz diabetic alloxan diabetic velocity cv weeks months induction diabetic alloxan diabetic time way range test reductions diabetic sensory motor reductions sensory diabetic sensory cv motor cv sensory sensory sensory alloxan diabetic stz diabetic significant cv months induction motor sensory tibial stz diabetic diabetic general severe diabetic stz alloxan sensory diabetes
DBT,DBT2354,stable prolactin level estradiol sulfate sulfate dheas estradiol prolactin prl pregnancy maternal serum prl hours dheas total normal pregnancy pre eclampsia intrahepatic pregnancy serum prl normal prl level group spite serum lack prl rapid rise maximal prl factor maximal pituitary lactotrophs estrogen pregnancy
DBT,DBT2355,effect fiber plasma hdl level streptozotocin diabetic fiber metabolic diabetic metabolic diabetic dietary fiber group dietary fiber libitum group libitum fifty glucose dietary fiber group group values cholesteroltotal ratio fiber group results effect glucose diabetics
DBT,DBT2356,peripheral peripheral physicians teach dysfunction methods peripheral nervous system daily significant
DBT,DBT2357,factor diabetes insipidus posterior pituitary vitro insipidus posterior pituitary factor crf crf preincubation posterior medium crf effect neural extracts normal crf vasopressin discrepancy crfs hypothetical crfs endings effect
DBT,DBT2358,diabetes nondiabetogenic emc isolation stable diabetogenic nondiabetogenic sjlj male mice hypoinsulinemia hyperglycemia none mice diabetes pancreata mice necrosis whereas islets little islets infectious moreover emc whereas infection induction diabetes developed mice interferon interferon mice induction interferon
DBT,DBT2359,management adenoid cystic cylindroma report literature report cystic cylindroma invasive elderly obese diabetes postmenopausal vaginal malignant exfoliative uniform scanty cytoplasms cystic spaces nodules spaces ib iib iib iiib invasive adenoid cystic world literature review
DBT,DBT2360,liver insulin ie gh microsomal male female gh sites specific gh female liver diabetes females therapy competitive consistent independent equal nm sites equal nm females less excess prl little diabetic sites unchanged normal sites insulin therapy serum immunoreactive gh normal diabetic male female resistance gh somatomedin release normal serum gh gh condition
DBT,DBT2361,ocular coagulation day ocular argon laser methods coagulation direct methods specific whereas tests coagulation epithelium coagulation hemoglobin stage selection suitable coagulation suitable parameters laser times
DBT,DBT2362,diabetic retinitis ninety diabetics diabetes diabetic retinitis workers retinitis pronounced results disposition plays decisive diabetic retinitis diabetics
DBT,DBT2363,plasma plasma hemoglobin serum diabetic diabetic complications level complications serum values normal plasma level undue platelets hemoglobin
DBT,DBT2364,endothelial fenestrae proliferative diabetic retinopathy ultrastructure neovascular preretinal proliferative diabetic retinopathy eye photocoagulation matrix rich mature viable ghost viable different calibers endothelial fenestrae diaphragms tight junctions endothelial fenestrae junctions leakiness
DBT,DBT2365,neovascularization friedenwald lecture evidence ashton vasoproliferative factor neovascularization oxygen neovascularization key evidence newer neovascularization
DBT,DBT2366,diabetic ketoacidosis diabetic ketoacidosis rapid exclusion conditions consciousness diabetics lactic hyperosmolar ketosis infections recent therapy specific close laboratory successful
DBT,DBT2367,storm diabetic ketoacidosis year female mmi months months general fatigue insulin uday mmi remarkable effect radioisotope ward kumamoto regular insulin ten storm diabetic ketoacidosis volumes regular insulin mmi propranolol digitalis hours ketoacidosis mmi agranulocytosis mmi year euthyroid diabetes state good monocomponent lente insulin uday euthyroid state
DBT,DBT2368,human membrane patterns immunofluorescent serum sap normal plasma protein normal human membrane sap membrane normal patterns renal glomerulonephritis mesangiocapillary nephritis vasculitis goodpastures
DBT,DBT2369,risk disorders luteal hyperestrogenism stage risks related legs distention water retention depressive genital types investigation possible fibroma hyperplasia genital menopause estrogen increases lm risk endogenous obesity hyperplasia exogenous estrogen therapy vulva risks untreated estrogen therapy
DBT,DBT2370,hypertensive institutions slight excitability preliminary diseases heart renal diseases many concerned heart furthers stable early recognition unknown suitable
DBT,DBT2371,intra growth diabetic mothers weight circumference diabetes diabetics heavier weightlength ratio circumferencelength ratio size diabetics normal hairiness pinna diabetics infant diabetic mother
DBT,DBT2372,pancreatitis emphasis term typical patterns term pancreatitis pancreatitis complications early recurrent episodes severe pancreatic pancreatic complications pseudocysts different persistent many different complications gastrointestinal duodenal obstruction complications early steatorrhea pancreatitis occurrence
DBT,DBT2373,haemoglobin insulin dependent diabetics haemoglobin hba insulin dependent diabetic day hba time increases metabolic subsequent months hba diabetics
DBT,DBT2374,metabolic risks salbutamol diabetic somatostatin salbutamol diabetic ketoacidosis metabolic salbutamol day somatostatin whilst srif rd day sub group infection srif exogenous glucagon ngkghour somatostatin insulin glucagon exogenous glucagon metabolic conditions diabetes rise glucose insulin free fatty glycerol ketonic endogenous glucagon srif significant metabolic presence srif salbutamol metabolic glucagon ketonic whilst lipolytic ketogenic non diabetic insulin hypersecretion insulin extent excess glucagon diabetic close insulin
DBT,DBT2375,human salmonellosis human salmonellosis gastroenteritis bacteraemia formations organs infections salmonellae gastroenteritis peritonitis hip replacement tumour infections malignant tumours condition isolation positive gallbladder operative infections spread risk prevent bacteraemic metastatic
DBT,DBT2376,insulinfree rehydration diabetic pts diabetic effect therapy regard metabolic endocrine functions height venous serum insulin group pts severe diabetic ketoacidosis mmoll bicarbonate mmoll insulinfree rehydration hrs retention ml osmolality serum mosmkg ho glucose mmoll correlation glucose expansion glucose effect renal glucose excreation mmol glucose glucose clearance rehydration gluconeogeneses glucose exogenous insulin plasma pgml ns cortisol micrograms adrenalin ngml gas rehydration plasma hormones lipolyses diabetic ketoacidosis group pts nonacidotic diabetic glucose mmoll bicarbonate mmoll insulinfree rehydration hrs retention ml serum osmolality mmoll glucose effect renal glucose excreation mmoll total glucose clearance mlmin gluconeogenese glucose tissues pts nonacidotic diabetic rehydration
DBT,DBT2377,insipidus removal medullary medullary mtc sporadic endocrine year enlargement lymph nodes right side uptake right serum mtc total mas hours picture insipidus liters output hours vasopressin weeks different mechanisms diabetes especulate important synthesis release adh sudden depletion removal diabetes insipidus literature close possible onset diabetes
DBT,DBT2378,home glucose retrospective insulin diabetics retrospective daily glucose weeks insulin dependent diabetics diabetics diabetics glucose home significant glucose weeks due short fewer episodes
DBT,DBT2379,colorimetric haemoglobins haemoglobin guide methods haemoglobin laborious inexpensive method haemoglobin colorimetric day
DBT,DBT2380,problems distaste pill due comments anxieties doses hormones todays occurrence reactions tendency thromboembolism ovulation gamma thrombotic incidents micropill gamma regular glucose tolerance dependent estrogen gestagen estrogen gestagen glucose deterioration plasma triglycerides risk complications due steroids correlation episodes pancreatitis lipoprotein due oral protective effect rheumatoid contraindications oral
DBT,DBT2381,anaphylactoid extrinsic coexistent insulin dependent anaphylactoid dextrose dextrose effect normal non diabetic diabetic non preliminary results release diabetic diabetic individuals hypoglycaemia significant risk factor diabetic individuals adrenoreceptor drugs
DBT,DBT2382,hyperkalemia severe hyperkalemia renal synthesis hyporeninemic hypoaidosteronism renal nonsteroidal inflammatory renal serious
DBT,DBT2383,infection elastic bandages perfringens infections nonsterile elastic outer bandages diabetic undergone amputation vascular second elastic bandages perfringens report sterile nonpermeable inner prevent transudation potential sterile elastic outer bandages vascular
DBT,DBT2384,therapy fifty fifty postprandial early satiety metoclopramide obstruction upper standard upper gastrointestinal none burger previous drainage diabetic gastroparesis idiopathic scores idiopathic significant metoclopramide metoclopramide significant metoclopramide effect effect emptying
DBT,DBT2385,significance hbac diabetics suitable method range situation diabetics level glucose quantity glucose hbac level single glucose rapid method representative whole position glycaemia hbac glucose glucose
DBT,DBT2386,physicians guidelines diabetic update guidelines diabetic management job safe work diabetic non diabetic
DBT,DBT2387,demonstration sugar secretor status urine diabetics preliminary urine presence group specific substances elution urine prozent prozent urine test sugar positive urine prozent benedicts sugar forensic science urine crime abh substances urine
DBT,DBT2388,headaches jerusalem headaches western jerusalem physicians nmh nmh appraisals health emotional unsatisfactory past situations tendency harder significant marital status status oral importance headaches nausea aura times guttman findings support specific entity single headache manifestations
DBT,DBT2389,neurotransmitters release canine stomach canine stomach effect neurotransmitters intestinal glucagon release glucagon release ngml glucagon release effect independent flow results sharp lack effect vagus glucagon stomach innervation canine explain situation
DBT,DBT2390,motor conduction velocity insulin dependent non insulin dependent diabetics peripheral motor conduction velocity mcv sciatic popliteus subjects females insulin dependent noninsulin dependent signs diabetic diabetes mcv insulin dependent non insulin dependent diabetics metabolic signs peripheral
DBT,DBT2391,programs non insulin dependent importance diabetic state obese non insulin dependent diabetic health providers therapist programs full daily boredom programs condition motivation techniques providers programs psychological well
DBT,DBT2392,maturity glucose weight glucose fbg level mmoll maturity diabetic general postprandial oral hypoglycemic therapy significant hemoglobin intervals plasma glucose mmoll glucose level mmoll glucose general glucose oxidase regular urine glucose
DBT,DBT2393,importance health health diabetic male race record symptomatology physicians current health diabetic good health diabetic health visits symptomatology satisfied health group health diabetic health good health important diabetic health concordance group different
DBT,DBT2394,glycosylation normal diabetic subjects extent vivo glycosylation hemoglobins individuals trait individuals subjects normal hemoglobin glycosylation tba elution hemoglobin colorimetric hemoglobin trait individuals diabetes different individuals normal hemoglobin values individuals slopes findings individuals heterozygous hbc individuals extent glycosylation hba normoglycemic hyperglycemic range tba direct method extent glycosylation individuals column values
DBT,DBT2395,chlorpropamide genetic diabetic presence chlorpropamide cpaf diabetes jod maturity flush genetic diabetes
DBT,DBT2396,oxidative decarboxylation keto oxidative decarboxylation irreversible degradation effect streptozotocin free liver preparations calpha ketoisocaproate diabetes ketoacid dehydrogenase bckd liver protein bckd mitochondrial unchanged cytosolic ketoacid decarboxylase coa diabetics insulin diabetics km bckd microm diabetes vmax nmol km cytosolic ketoisocaproate decarboxylation microm diabetes km microm vmax diabetes glucagon pretreatment mitochondrial cytosolic ketoisocaproate liver diabetic skeleton mitochondrial
DBT,DBT2397,multisystem manifestations diabetic diabetic total orthostatic hypotension pupillary sudomotor functions glucagon hypoglycemia signs peripheral second total due diabetic literature
DBT,DBT2398,spinal diabetic hereditary diabetes functional disorders spinal correlations motor ones segmental motoneuron supraspinal disorders segmental motoneuron recovery phenomenon latent neurological predisposition neurological metabolic
DBT,DBT2399,serum immunoreactive trypsin diabetic immunoreactive trypsin recent girls ranges non diabetic non infectious illnesses level weeks months diabetes months tests limited
DBT,DBT2400,spectrum etiology year spectrum etiology mount sinai rhinocerebral pulmonary cutaneous subcutaneous infections rizopus rhizopodoformis proven presence antirhizopus sera preliminary results extent independent
DBT,DBT2401,saphenous vein femoropopliteal investigation femoropopliteal vein cumulative year patency year limb results patency claudication year patency maximal vasodilatation intraoperative flow good run patency flow run factor flow presence patency
DBT,DBT2402,glucose normal diabetic fifty normal diabetic method glucose tears urine glucose load normal subjects glucose tears ml mmoll diabetic ml mmoll urine glucose diabetic normal glucose load test glucose level satisfactory index diabetic normal glucose load test level ml mmoll diabetics normal diabetics
DBT,DBT2403,glucose tolerance tests senile cataract diabetes senile cataract tests modified standard tolerance test glucose tolerance test standard glucose tolerance test diabetics glucose excess mmoll modified standard tolerance test glucose tolerance test standard tolerance test forty glucose level renal mmoll diabetes glucose intolerance senile cataract normal sugar
DBT,DBT2404,systolic diastolic time intervals diabetics systolic diastolic time intervals diabetic heart pre ejection index pepi ejection time index electromechanical systole index pep lvet ratio apexcardiogram ratio rapid wave rfw ao conventional manner diabetics healthy heart diastolic peplvet ratio ratio ao lvet diabetic group pepi rfw normal group systolic time diastolic time intervals difinite evidence subclinical diabetic
DBT,DBT2405,diabetes nonobstructive dilation tract insipidus hypothalamic nonobstructive dilation hydroureteronephrosis options important general subject insipidus urologic implications
DBT,DBT2406,hyperbilirubinemia diabetic mothers gestational lga dependent diabetic mothers gestational aga idm mothers neonatal hyperbilirubinemia hours idm serum ml aga idm ml ml serum lga idm ml aga idm mgml ml carboxyhemoglobin significant lga idm aga idm significant pitocin apgar scores isoimmunization hemoglobin hours weight lga idm risk hyperbilirubinemia heme turnover significant factor
DBT,DBT2407,noninvasive diabetic diagnostic ultrasound peripheral vascular diabetic diabetes charity diabetics clinics ulcers ultrasound diabetic
DBT,DBT2408,athlete illnesses participation conditions fever upper respiratory infection infectious mononucleosis fungal parasitic traumatic diseases problems congenital lesions athlete orthopaedic yield findings
DBT,DBT2409,hemoglobin literature review minor normal hemoglobin hemoglobin glycohemoglobin hgb subgroups hgb aia aie name hgb hexose important subgroups glucose glycosylation hgb dependent glucose hgb total glycohemoglobin times diabetics nondiabetics hgb glycohemoglobin normal values hemoglobin time glucose level glucose hgb exchange hgb column exchange methods total glycohemoblobin exchange column test
DBT,DBT2410,myo inositol foods myo inositol myo inositol dietary foods gas liquid inositol fruits beans nuts vegetables fruits contain myo inositol salt free products report myo inositol myo inositol range myo inositol diabetes renal possible neuropahties dietary myo inositol diseases
DBT,DBT2411,primary health workers diabetes allied health professionals short term term effectiveness symposium primary health workers dieticians health educators health professionals symposium group primary health professionals year symposium group university symposium group group group group educational level job kentucky correlation group significant group group sem scores group year significant deterioration year results emphasis diabetes methods
DBT,DBT2412,hereditary diabetes indolamine heterozygous brattleboro homozygous diabetes steady state septum level disappearance hyl tyrosine septum striatal level disappearance monoamine known endocrine homozygous
DBT,DBT2413,retinopathy onset diabetes early microvascular early signs diabetic retinopathy manifests points normal functional stable cover possible functions static critical flicker
DBT,DBT2414,hla insulin dependent hla genotypes french insulin dependent diabetic different loci hla dr index healthy individuals drw drw bff excess hla disequilibrium hypothesis hla homozygosity drw drw whereas excess heterozygosity hla drwdrw diabetic evidence hla dr
DBT,DBT2415,hemoglobin components hemoglobin components glycohemoglobin hemoglobin aabc evidence minor fact glucose hemoglobin minor diabetic
DBT,DBT2416,diabetic status findings mich random participants mich glucose diabetics subjects overt diabetics probable diabetics nondiabetics diabetic nondiabetics glucose plasma insulin serum serum glucose insulin diabetics glucose diabetics nondiabetics adiposity intolerance adiposity persistent hyperglycemia metabolic diabetics diabetics hyperglycemia risk recent glucose overt diabetics
DBT,DBT2417,group mi group second group group time group group group good risk group group group shock rupture elderly group shock pulmonary congestive heart heart
DBT,DBT2418,clonidine diuresis evidence renal clonidine unanesthetized brattleboro homozygous hereditary hypothalamic diabetes diuresis due antidiuretic adh release heterozygous sc doses prompt related diuresis diuresis sc osmotic minipump clonidine diuresis plasma osmolality mosmkg plasma adh unchanged clonidine adh excretion muuhr parallel diuresis excretion sodium total phenoxybenzamine prevent diuresis clonidine clonidine antidiuresis clonidine clonidine antidiuretic adh homozygous diabetes clonidine diuresis due adh release direct renal
DBT,DBT2419,effect carbostimulin rabbits rabbits alloxane incorporation components carboxylation conditions intensifies incorporation kidneys serum globulin level lipids liver total serum specific radioactivity intensification diabetes carboxylation
DBT,DBT2420,plasma vasopressin exchange plasma vasopressin blank values recovery sensitivity pg normal overnight pgml pgml oral water significant correlations osmolality pituitary diabetes plasma whereas frankly bartter pgml
DBT,DBT2421,mnesic idiopathic diabetes mnesic idiopathic diabetes ddavp therapy general scores specific general benton test substitutive therapy general scores results positive vasopressin mnesic observed effect due metabolic ie cognitive
DBT,DBT2422,diabetic feet cultures infected diabetic dissection intact skin distant ulcer results obtained ulcer swabs pre postamputation iii curettage ulcer iii needle normal saline transport cultures anaerobes growth gram anaerobes anaerobes concordance results results results results saline obtained ulcer swabs organisms enterococci microbial therapy concomitant presence
DBT,DBT2423,effect vasopressin plasma man vasopressin doses normal deprivation insipidus diastolic mmhg sem mmhg sem normal subject group plasma fmolml water diastolic mmhg plasma fmolml increases normal subjects increments man significant effect
DBT,DBT2424,significance neurohypophyseal hormones peptides neurohypophyseal system important related importance respect pituitary brattleboro synthesize vasopressin neurohypophyseal hormones peptides
DBT,DBT2425,intermediate insulin preparations lente nph lente insulins size zinc lente beef insulin hypoglycemic effect lente insulin whereas nph insulin ukg nph lente insulins stable mixtures neutral insulin nph insulin regular insulin specific effect regular insulin purified porcine nph lente porcine insulin monotard side purified lente insulin beef insulin purified porcine nph insulin
DBT,DBT2426,traumatic chiasmal uncommon traumatic chiasmal defects hemianopia arcuate scotomas craniocerebral insipidus half
DBT,DBT2427,diabetic retinopathy update therapy diabetic retinopathy laser photocoagulation therapies diabetic retinopathy interim see ophthalmologist therapy
DBT,DBT2428,insulins insulin unitsml make time units ordinary ml different insulin manufacturers diabetic clinics state hot
DBT,DBT2429,hyperosmolar ketotic diabetic coma year female non ketotic hyperosmolar hyperglycemic coma insulin saline glycosaline sera convalescence left iliofemoral coma stage close normal insulin pancreas
DBT,DBT2430,granuloma annulare granuloma annular ga inflammatory skin subcutaneous regular presence mononuclear ga remedies ga hard resolution usual ga solar radiation recent vascular injury hypersensitivity ga obscure
DBT,DBT2431,oral glucose increases excretion normal subjects dependent diabetics oral glucose load excretion normal subjects oral glucose excretion oral glucose whereas water vehicle excretion oral glucose effect excretion insulin dependent diabetics effect oral glucose insulin oral glucose excretion insulin parameters
DBT,DBT2432,sophisticated programmable insulin pre programmable system insulin diabetic subjects system parts programmable digital converter motor drives contains profiles injections digital hours insulin selection profiles insulin values previous pancreas values choose time food
DBT,DBT2433,glucose insulin dynamics mathematical modeling organs glucose insulin dynamics parameters plasma flow intra extra vascular glucose insulin spaces specific organs tissues insulin disappearance glucose uptake parameters typical kg accept glucose insulin infusions different diabetic observed glucose insulin total uptake group peripheral sophisticated dynamics glucose transport liver uptake liver gut direct glucose total uptake peripheral insulin dependent tissues glucose load
DBT,DBT2434,hla hla insulin dependent diabetics insulin dependent diabetics healthy hla locus significant hla risk presence hla significant risk significant hla group significant heterozygosity hla hla healthy risk hla french english populations hla english extraction tht hla allele insulin dependent persist migratory european
DBT,DBT2435,immune diabetics persistent diabetics pancreatic igg pancreatic immune insulin cytoplasmic hla sera insulin diabetics icab time investigation agab persistent icab icab diabetics normal donors agab positivity hla positive icab significant correlation agab titres presence cytoplasmic
DBT,DBT2436,significance pancreatic glucose tolerance pregnancy subjects glucose tolerance venous plasma glucose mmol cytoplasmic icab cyto sera insulin dependent diabetes year pregnancy none conjunction presence glucose tolerance pregnancy obesity insulin dependent year
DBT,DBT2437,perfect normalization glucagon human significance pancreatic hypersecretion immunoreactive glucagon nonobese hypoinsulinemic non insulin dependent niddm insulin dependent diabetic iddm subjects glucose immunoreactive insulin iri healthy subjects system niddm iddm subjects glucose iri equivalent healthy subjects insulin glucose healthy subjects results exaggerated insulin diabetics insulin lack perfect normalization plasma insulin glycemic simulate healthy subjects
DBT,DBT2438,nonobese diabetics calorimetry calorimetry glucose load group normal subjects oral glucose load load glucose group insulin dependent diabetics glucose load glucose urine glucose group nonobese non insulin dependent diabetics glucose load glucose results diabetics insulin mechanisms glucose ie glucose diabetics insulin
DBT,DBT2439,insulin fructose maturity normal subjects glucose maturity diabetes insulin glucose insulin glucose ratio glucose insulin insulin serum time fg plasma results normal subjects important insulin fructose group plasma glucose diabetics normal fructose plasma glucose fructose
DBT,DBT2440,degradation semisynthetic insulin human semisynthetic replacement terminal phenylalanine phenylalanine degrees insulin human degrees maximal due degradation insulin degradation insulin sephadex insulin intact insulin little radioactivity single sephadex degradation insulin contains insulin insulin intact
DBT,DBT2441,dichloroacetate vivo sodium dichloroacetate dogs double isotope glucose glucose gluconeogenesis mgkg fall plasma level whole lactate level uptake lactate fractional extraction lactate glucose slight intrahepatic gluconeogenic process plasma insulin level presence unchanged plasma glucagon fall gluconeogenic precursors overall glucose lactate glucose compensatory glucose intrahepatic unclear
DBT,DBT2442,effect insulin insulin serum sodium streptozotocin diabetic insulin insulin serum sodium excretion diabetic normal kidneys hg krebs ringer bicarbonate serum glucose insulin antinatriuresis kidneys diabetic normal insulin sodium excretion diabetic normal filtration gfr insulin milliliter perfusate brisk kidneys normal insulin normal pig serum perfusate normal kidneys perfusate diabetic kidneys insulin diabetic normal kidneys normal kidneys specific effect ais insulin support insulin antinatriuresis endogenous insulin insulin sites
DBT,DBT2443,insulin release fetal pancreas dynamics insulin release fetal pancreas vitro perifusion system theophylline day glucose early insulin release insulin day theophylline phases release glucose day theophylline glucose insulin release fetal pancreas dependent early insulin release due glucose half maximal term fetal pancreas values results mechanisms insulin release fetal fetal insulin likely qualitative
DBT,DBT2444,cleavage insulin pancreatic insulin ratio immunoassay urine insulin direct insulin insulin insulin dependent diabets residual insulin insulin dependent year th year insulin diabetes stable diabetes insulin less ketosis prone idd unknown
DBT,DBT2445,insulin early questions insulins usage recent importance diabetic microvascular conventional insulin therapy insulin eg pumps technology porcine insulin complications therapy human insulin dna technology insulin promise diabetic many
DBT,DBT2446,health thirty insulin diabetic individuals homes diabetic report direct level insulin urine hypoglycemia management foot points half group points points good group regard insulin urine level cues correlation overall level health motivation correlations motivators cues
DBT,DBT2447,membrane concomitant glucose dependent diabetes ten diabetes glucose insulin glucose group normoglycemia onset systolic index quadriceps membrane bmt bmt maintain hemoglobin observations intervention
DBT,DBT2448,sucrose sorbitol fructose normal diabetic subjects sorbitol fructose normal diabetic subjects calorie normal diabetic subjects increment plasma glucose sucrose normal subjects diabetic subjects lowest sorbitol normal subjects diabetic subjects fructose normal subjects diabetic subjects normal subjects increment plasma immunoreactive insulin diabetic subjects significant fructose sorbitol results glucose normal diabetic subjects insulin release
DBT,DBT2449,oral fructose normal diabetic glucose tolerance subjects oral loads sucrose fructose post prandial serum glucose insulin plasma glucagon normal subjects subjects glucose tolerance non insulin dependent diabetic subjects protein test fructose serum glucose insulin dextrose fructose glycemic hexoses glucose fructose glucose intolerant subject glucose excretion dextrose fructose fructose results serum glucose insulin dextrose sucrose test glucose tolerance worsens glycemic fructose
DBT,DBT2450,recent management diabetic recent pregnancy perinatal general morbidity congenital diabetic assurance pregnancy favorable
DBT,DBT2451,turnover diabetes day protein turnover diabetic sera diabetes protein synthesis preparations fall rna protein synthesis rna diabetes elongationtermination work protein synthesis diabetic insulin protein synthesis heart whole heart protein degradation diabetic serum conditions work insulin protein degradation diabetic term diabetes nitrogen work
DBT,DBT2452,extraction fatty ketone diabetes dogs diabetes glucose insulin non fatty ketone extraction ketone myocardium intensification extraction ketone enhancement nekb likely due
DBT,DBT2453,free total insulin diabetes free total insulin secretin injections diabetes healthy total insulin free insulin diabetic secretin normal total insulin synthesis ones free insulin zinc insulin total free insulin insulin level unchanged
DBT,DBT2454,streptozotocin diabetes renin release iv mgkg mgkg streptozotocin diabetes female tail flow signals plethysmography phenomenon vein due effect streptozotocin streptozotocin inthe awake state cannula pentobarbital normal mgkg mgkg microgramkg noradrenaline iv latter group renal renin streptozotocin plasma renin normal mgkg renal renin diabetic state medullary hydroxylase streptozotocin
DBT,DBT2455,insulin insulin dependent diabetes lack erythrocytes dependent diabetes nonketotic state dependent diabetes normal insulin rbcs total insulin range insulin receptor receptor insulin normal parameters diabetic insulin erythrocytes target tissues insulin dependent diabetes little exogenous insulin state
DBT,DBT2456,plasma glucagon insulin insulin independent acromegalic subjects diabetic insulin plasma glucagon subjects acromegalic independent diabetes insulin glucose insulin tendency plasma glucagon diabetic group acromegalic achieve statistical significance state glucose amd tests
DBT,DBT2457,good versus alloxan diabetes nonarteriosclerotic nonarteriosclerotic diabetic alloxan doses doses obese weight weight months glucosuria good circulating nonesterified fatty triglycerides normalised insulin therapy hypertrophy thymus corticosterone alloxan diabetic insulin diabetic good vascular
DBT,DBT2458,reserve insulin dependent glucagon residual secretory short term months term dependent diabetics serum tests glucagon term diabetics tests short term diabetics test reserve glucagon pmolml short term responders test stimulus correlation tests haemoglobin glucose glucose oral glucose tolerance test tests endogenous reserve less diabetics little insulin reserve
DBT,DBT2459,management subcutaneous insulin pulses premeal boluses months growth normalization forestall microvascular complications year diabetes year attain hypoglycemia maximal possible conventional insulin glycohemoglobin hgba urine sugar urine sem urine glucose glycemia hgba year weeks normal normal months proteinuria growth pace months inconvenience usage intolerance overzealous hypoglycemia possible health method
DBT,DBT2460,immune insulin resistant diabetic obese subjects immune process vitro release mif ketosis prone insulin dependent diabetic nonketotic diabetic nonhyperglycemic obese results mif release insulin dependent diabetic nonketotic diabetic nonhyperglycemic obese subjects insulin ketosis prone diabetic normal mif release insulin therapy insulin resistant nonketotic diabetic nonhyperglycemic obese mif release possible vitro immune process insulin resistant state infection insulin resistant diabetic
DBT,DBT2461,peripheral hereditary diabetes peripheral sensory mice cblksj dbdb hereditary diabetic human maturity onset mild peripheral degeneration disruption myelin schwann schwann schwann hind limb sensory ganglion neurons normal chromatolytic peripheral morphological hyperplasia hypertrophy sprouting degeneration diabetic condition important factor peripheral diabetic
DBT,DBT2462,hydro osmotic different fetal microhydroosmotic units different diseases insipidus trypsin presence hypothesis
DBT,DBT2463,health brb pigment epithelium inner endothelial membrane tight junctions transport predominate occurrence findings introduction fluorophotometry fluorophotometry situations means early functional brb diabetes
DBT,DBT2464,leukemia vasopressin diabetes rare leukemia vasopressin insipidus polydypsia polyuria lday findings tomographic lumbar puncture normal limits condition vasopressin injections rare leukemia chlorpropamide leukemic infiltration supraopticohypophyseal tract posterior pituitary
DBT,DBT2465,vascular important lesions coagulation endothelial evidence predominant endothelial coagulation prevent normalization sugar possible methods
DBT,DBT2466,biomaterials glucose biomaterial components insulin electronic glucose open insulin whole pancreatic encapsulation potential social prime public health magnitude heart united future miniaturization biomaterials technology arsenal glucose mere interim phases final
DBT,DBT2467,insulin glycogen human fibroblasts short term insulin human fibroblasts effect insulin glycogen fibroblasts glycogen dependent glucose phosphate independent glucose phosphate presence insulin state glycogen independent insulin insulin maximal insulin effect insulin rapid serum glucose insulin effect insulin human possess insulin glycogen metabolic
DBT,DBT2468,effect glibenclamide glucose insulin maturity diabetics term glibenclamide non insulin dependent diabetic nidd hyperglycaemia glucose insulin porfile conditions months glibenclamide rapid satisfactory plasma glucose months glibenclamide day consistent plasma glucose effect plasma insulin term respect atherogenesis episodes flushing
DBT,DBT2469,reversible lactic diabetic metformin diabetic metformin daily retention prostatic functional renal hyperlactacidemia plasma urine time lactate pyruvate normal time context lactic diabetics functional renal metformin
DBT,DBT2470,malignant otitis yr diabetic right neck pseudomonas inflammatory vertebrae malignant otitis cure malignant cranial cranial half vertebrae
DBT,DBT2471,neuroendocrinological histiocytosis nervous system neuroendocrine histiocytosis galactorrhea insipidus needle ct scanner emphasis endocrine hypothalamic histiocytosis
DBT,DBT2472,effect protein malnutrition male streptocozin diabetic libitum protein energy protein energy dietary vehicle iu insulin ip fourth group intact vehicle day urine excretion urea methylhistidine mehis food daily end plasma insulin gastrocnemius digitorum results diabetic weight food intact weights diabetic protein urea output mehis output diabetic protein results streptocozin diabetic myofibrillar protein
DBT,DBT2473,level pyruvate mannitol sorbitol mannitol sorbitol pyruvate lactate level substances effect mannitol effect hours sorbitol mannitol pyruvate level group lactate pyruvate results problems therapy lactid general shock dysfunctions risk sorbitol
DBT,DBT2474,perioperative stabilization glucose total diabetic total glucose significant diabetic sodium slight serum slight total glucose electrolyte insulin doses diabetic
DBT,DBT2475,hypoxic tolerance hydroxybutyrate glucagon ketones tolerance mice previous alloxan diabetic mice mice butanediol ketotic tolerance hypoxic tolerance direct ketones ip hydroxybutyrate bhb hypoxic tolerance bhb inasmuch alloxan diabetes glucagon hypoxic tolerance tests bhb mice bhb hypoxic times different saline bhb times bhb
DBT,DBT2476,butanediol ketosis increases tolerance previous positive correlation ketone time st oxygen alloxan diabetic mice test hypothesis ketosis tolerance mice ketosis oral po intraperitoneal iv hydroxbutyrate po iv ip st po effect ta phenomenon degrees ta iv mmolemouse st st ta degrees group induction ketosis st mice
DBT,DBT2477,year minister stereotyped face jaw neck specific hymn hymn interictal weakness face side tongue right temporofrontal partial
DBT,DBT2478,hypoglycemic effect insulin year male insulin unitsday hypoglycemia correction tachycardia sugar withdrawn insulin minimum unitsday insulin results hypoglycemic effect
DBT,DBT2479,alloxan streptozotocin homo neonatal total male female th diabetic single alloxan kg streptozotocin kg weeks intrafamiliar homoallotransplantation collagenase non newborns sisters renal total cured glucose tolerance test iv gtt year normonoglycemia postglucose values kg range latent male gtt months weight normal time bring forth newborns islets
DBT,DBT2480,diabetic hereditary diabetic mice single protein iap protein iap prepared medium bordetella pertussis diabetic hereditary diabetic mice time single iap microgramkg wt mice non glucose normal weeks gradual return pre iap level glucose tolerance glucose urine second iap diabetic mice normoglycemia mice iap epinephrine isoproterenol ddy mice plasma insulin glycerol
DBT,DBT2481,idiopathic haemochromatosis idiopathic haemochromatosis iron deposits post stimulative values renin normal repleted subjects iv furosemide tests salt depletion iv furosemide tests results healthy cortisol values normal microgram ml cortisol normal microgram ml ml ngmlh values normal furosemide increases ml ngmlh values ml much values ml idiopathic haemochromatosis spite iron deposits
DBT,DBT2482,growth prolactin reversible correlations growth prolactin hypothalamic plasma vasopressin insulin hypoglycaemia adenohypophysial hormones instrumental secretory sodium restriction unusual dysfunction replacement unfortunate crisis correlation antemortum endocrine
DBT,DBT2483,glucocorticoid early different level plasma insulin hypoglycemia early latent diabetic diabetes obesity significant rise indices intensification glucocorticoid enhancement hypophysis adrenocorticotropic
DBT,DBT2484,human polyomavirus infection human polyomaviruses nuclear urothelial identification viruses human polyomavirus viruses transmission microscopy evidence infection diabetic urine human polyomavirus infection microscopy presence polyomavirus positive specimens previous human polyomavirus excretion therapy congenital pregnancy evidence human polyomavirus infection disorders defects concerned human polyomavirus
DBT,DBT2485,fatty diabetic subjects subcutaneous triglycerides fatty degeneration liver fatty normal liver rise size correlation quantity inflammatory liver diseases diabetes hyperlipoproteinemia less results obvious diminution triglycerides liver antilipolytic creation droplets metabolic recent antiaggregatory effect fatty
DBT,DBT2486,neovascularization situations ocular neovascularization venous obstructive many presence non perfusion vasoproliferative
DBT,DBT2487,antisomatostatin gamma globulin insulin glucagon vitro evidence endogenous somatostatin pancreatic endogenous somatostatin pancreatic islets antisomatostatin gamma globulin somatostatin insulin glucagon islets islets gamma globulin nonimmune serum islets antisomatostatin gamma globulin insulin glucagon insulin release vmax km glucose glucagon release maximal ki unaltered augmentative effect antisomatostatin gamma globulin prominent glucose insulin release glucose glucagon release glucose insulin glucagon release antisomatostatin gamma globulin results evidence endogenous somatostatin regulator insulin glucagon effect insulin glucagon dependent glucose
DBT,DBT2488,choroidovitreal neovascular photocoagulation proliferative diabetic retinopathy proliferative diabetic retinopathy photocoagulation preretinal preretinal developed subsequent permanent obliteration networks
DBT,DBT2489,term functional results vitrectomy diabetic retinopathy term successful vitrectomies complications diabetic retinopathy ten significant final months months flat neovascularization final fibrovascular important complications complications
DBT,DBT2490,diabetic macular diabetes diabetic retinopathy maculopathy diabetes neovascularization early maculopathy diabetes maculopathy group diabetes
DBT,DBT2491,axoplasmic transport vagal fibres normal alloxan diabetic rabbits slow components axoplasmic transport sensory fibres alloxan diabetic rabbits incorporation ganglion diabetic rabbits months glucose mmoll growth slow axoplasmic transport diabetic results axoplasmic transport findings axoplasmic transport human diabetic
DBT,DBT2492,transport crush streptozotocin diabetic transport streptozotocin diabetic weeks induction protein fucose precursors fifth lumbar spinal ganglion tca insoluble proximal sciatic different time intervals crush start glycoproteins total protein insulin findings crush peripheral diabetes
DBT,DBT2493,vascular man synthesis pgi th th peripheral synthesis system important level pgi synthesis position vascular complications
DBT,DBT2494,peripheral immunoreactive somatostatin diabetic bbl wistar insulin immunoreactive somatostatin irs plasma vein pv inferior ivc diabetic wistar insulin diabetic extracts gastrointestinal tract irs pancreatic irs ivc untreated diabetic ivc pv insulin wk pv ivc pancreatic irs diabetic gut irs unchanged insulin peripheral irs peripheral irs endocrine somatostatin diabetes pancreatic irs streptozotocin diabetic
DBT,DBT2495,glucose somatostatin insulin release pancreas somatostatin release pancreas conditions glucose parallel insulin serum significant effect glucose insulin release spite somatostatin release perfusate glucose somatostatin insufficient glucose insulin release pancreas
DBT,DBT2496,somatostatin release diabetic pancreas whole pancreas pancreatic endocrine streptozotocin diabetic whole pancreatic insulin glucagon somatostatin release lewis male normal diabetic diabetic whole pancreas normalization glucose plasma insulin release healthy pancreas diabetic glucagon diabetic different normal group plasma glucagon pancreas significant somatostatin release diabetic pancreas insulin release normal glucagon release hand somatostatin release host pancreas normal significant insulin glucagon release endocrine normal pancreatic somatostatin release insulin pancreatic insulin level
DBT,DBT2497,somatostatin metabolic obese diabetic mice somatostatin extracts pancreas obese obob dbdb diabetic cblksj dbdb obob mice normal littermate metabolic srif diabetic obese mice srif mice obese mice weight hyperglycemia hyperinsulinemia wk pancreatic srif obese littermate pancreatic srif weight protein obob dbdb diabetic cblksj mice metabolic wk pancreatic srif progressive fall serum insulin rise serum glucose pancreatic srif hyperphagic syndromes hypothalamic srif pancreatic srif increases hypoinsulinemia genetic mice gene db ob determines pancreatic srif
DBT,DBT2498,strongest insulin factor gut incretin release pancreas glucose insulin less release gut food neural insulin influences enteroinsular ie hyperinsulinaemia obesity maturity diabetes gastrointestinal diseases malabsorption gastrointestinal disorders rapid duodenal ulcer intestine hypersecretion insulin significant hypoglycaemia conditions
DBT,DBT2499,effect oxprenolol metoprolol metabolic insulin hypoglycemia insulin dependent diabetics effect single oral oxprenolol metoprolol insulin hypoglycemia insulin dependent diabetics double glucose effect insulin plasma glucose recovery hypoglycemia diabetics iv glucose hypoglycemia effect lack plasma glucose recovery glucagon hypoglycemia drugs hypoglycemia significant diastolic oxprenolol whereas systolic metoprolol oxprenolol rise insulin termination extent metoprolol hypoglycemic results plasma glucose recovery metoprolol hemodynamic hypoglycemia hypertensive diabetics
DBT,DBT2500,effect oxprenolol metoprolol metabolic insulin hypoglycemia normal subjects double effect single oral oxprenolol nonselective metoprolol insulin hypoglycemia normal subjects drugs hypoglycemic effect insulin recovery hypoglycemia phases effect release counterregulatory hormones cortisol gluconeogenic release hypoglycemia drugs hypoglycemia tachycardia oxprenolol diastolic hypoglycemia hypoglycemia drugs cut glycemic insulin hypoglycemia oxprenolol drugs insulin hypoglycemia
DBT,DBT2501,evidence free fatty somatostatin normal alloxan diabetic dogs effect plasma free fatty ffa splanchnic somatostatin peripheral venous pancreatic venous normal alloxan diabetic dogs emulsion heparin normal dogs emulsion ffa level plasma sli pgml pgml glycerol emulsion heparin heparin saline effect plasma level ffa group dogs emulsion heparin fold rise venous pancreas fundus ffa group diabetic dogs emulsion heparin ffa level sli level pgml pgml sli normal dogs time points ffa magnitude increment diabetic dogs normal results rise ffa stimulus sli pancreas ffa important regulator sli
DBT,DBT2502,effect dietary fibre serum diabetic rich glucose serum diabetic insulin oral drugs different different day fibre fibre fibre post prandial glucose daily glucose total ldl total vldl hdl dietary fibre fibre normal fibre fibre atherogenic diabetic effect independent
DBT,DBT2503,ps tension pulmonary fetal maturity fetal maturity palmitin stearic quotient ps ratio normal th pregnancy ratio wilhelmy significant correlation methods correlation ellipsis ps ratio nd th pregnancy maturity th pregnancy maturity time amniocentesis tension normal eph gestosis slight pregnancy statistical trends due limited group methods pulmonary ratio positive findings tension method methods equal negatives optimum results ps ratio tension
DBT,DBT2504,side therapy unwanted side therapy guidelines contraindications dealt therapy mineral eg osteoporosis time cortisone corticosterone complications gastrointestinal infections psychic side skin general risk
DBT,DBT2505,rheumatoid coeliac serum rheumatoid sympatomatological picture evidence components fold genetic biohumoral
DBT,DBT2506,receptor wide pseudohypoparathyroidism insipidus bartters congenital unresponsiveness wide receptor diseases inquiry many pseudohypoparathyroidism php insipidus ndi bartters congenital unresponsiveness caua partial none seminal females thirds soft prominent none normal phosphate ndi females hereditary ndi subtypes neonatal early onset important early onset growth remarkable early male female bartters
DBT,DBT2507,pancreatic damage infections infections different viruses lesions islets cytopathology coxsackievirus infection infection zoster infection congenital rubella inflammatory infiltrates islets infections islets zoster infections evidence viruses damage human
DBT,DBT2508,diabetes chlorpropamide severe idiopathic diabetes diabetes chlorpropamide urine litresday mlmin litresday mlmin ten months therapy chlorpropamide significant rise urine months therapy urine litresday mlmin obvious side months serum vasopressin pgml free water clearance method insipidus diabetes single lesion hypothesis imply chlorpropamide endogenous oral non drugs chlorpropamide report
DBT,DBT2509,primary hyperparathyroidism primary hyperparathyroidism endocrine diseases manifestations test verify phpt recurrent phpt normalcalcemic phpt parathyroid terminal results
DBT,DBT2510,possible ketogenic ketogenic effect normal diabetic presence somatostatin mugkg wt endogenous insulin glucagon mmolkg wt hydroxybutyrate acetoacetate glucose lactate fatty glycerol hydroxybutyrateacetoacetate unchanged mmolkg wt decreases ketone hydroxybutyrate acetoacetate normal diabetic metabolites mmolkg wt ketone disappearance cacetoacetate metabolic clearance unchanged primary effect ketogenesis mmolkg wt ketone mmolkg wt increases glutamate malate lactate phosphoenolpyruvate phosphoglycerate glucose significant decreases acetoacetate oxaloacetate malate ketone mmol wt ketogenic effect oxaloacetate hence coa ketogenesis ketone important non regulatory system
DBT,DBT2511,islets diabetes islets parameters stage extent evidence progressive
DBT,DBT2512,puerperal sterilization puerperal sterilization operative complications morbidity intraoperative complications operative time minutes concurrent open ligations puerperal sterilization safe viable
DBT,DBT2513,diabetic insulin diabetic polyamines glycogen nucleic protein decarboxylase adenosylmethionine decarboxylase streptozotocin diabetic insulin diabetic total dna liver protein dna whereas dna glycogen liver insulin diabetic hypertrophy hyperplasia spermidine diabetic rna insulin spermine diabetes unchanged insulin ratio diabetic typical insulin ratio tissues ornithine decarboxylase diabetic positive correlation endogenous ornithine correlation insulin significant ornithine decarboxylase diabetic decarboxylase fold diabetes insulin glucogenic glutamine glycine diabetes insulin proline isoleucine valine diabetic insulin diabetes threonine histidine insulin effect histidine fall threonine
DBT,DBT2514,metabolic diabetic insulin injections metabolic profiles diabetic single daily injections monotard actrapid daily actrapid home overall diabetic regimens glucose glucose glucose excretion hyperglycaemia regimens significant ketone plasma free insulin single night glucose values rise plasma free insulin daily injections insufficient insulin daily injections night plasma residual endogenous insulin diabetic childrenconclusions superiority insulin specific diabetic achieved provided specific regimens normal profiles
DBT,DBT2515,search somogyi effect insulin diabetic rapid hyperglycaemia episodes hyperglycaemia somogyi effect unopposed hypoglycaemia test theory episodes untreated hypoglycaemia glucose less mmoll pm hypoglycaemia glucose mmoll mmoll rebound hyperglycaemia growth cortisol glucagon little recovery glucose close inverse correlation glucose free insulin hyperglycaemia due insulin night early untreated hypoglycaemia due free insulin hormones
DBT,DBT2516,renal oligo renal ivu collapse literature post ivu renal renal diabetic geriatric risk reversible osmolality nephrotoxic pathophysiology ivu
DBT,DBT2517,serum trypsin pancreatic trypsin insulin dependent serum trypsin pancreatic trypsin output secretin pancreozymin insulin dependent diabetes possible correlation indices pancreatic serum trypsin subnormal pancreatic trypsin output significant correlation correlation serum trypsin residual plasma cpr subjects trypsin previous results significant serum trypsin qualitative index exocrine pancreatic
DBT,DBT2518,test hypothesis hemoglobin compensatory little evidence support hypothesis oxygen expected way ie oxygen inverse correlation minor significance
DBT,DBT2519,plasma secretin level pancreatic intraduodenal hydroxy hcl duodenal juice endogenous exocrine pancreatic plasma immunoreactive secretin irs intraduodenal hydroxy php hcl normal subjects diabetes pancreatitis pancreatic flow bicarbonate irs php hcl normal subjects tendency exocrine pancreatic php hcl pancreatitis pancreatic flow bicarbonate amylase output pancreatic flow bicarbonate hcl hand pancreatic amylase output hcl php php morespecific secretin hcl
DBT,DBT2520,water excretion hypokalaemia insipidus water hypokalaemia insipidus day plasma excretion oral normal renal medulla papilla values normal evans day excretion normal different normal excretion renal plasma normal hypokalaemia water renal medulla papilla zones effect mild water deprivation excretion renal water deprivation oral water excretion mild modest renal excretion correction cages hypokelaemic condition
DBT,DBT2521,optometric management diabetic office diabetic management diabetic health providers optometrist sound total diabetic insulin diabetes insulin oral antidiabetic health providers office
DBT,DBT2522,optometric management diabetic diabetes united fifth metabolic complications polyol diabetes findings laboratory laboratory diabetics complications optometrist diabetic
DBT,DBT2523,epinephrine growth uncontrolled plasma glucose ic glucose ic epinephrine ic cortisol ic growth ic gh ic aldo plasma renin pra nonobese nonketotic diabetic hyperglycemia subjects nonthrombogenic iv diabetic noticeable rise ic ic ic gh ic aldo significant ic ic pra subjects
DBT,DBT2524,exocrine pancreas diabetic normal mice polyploidy insular peri insular exocrine pancreas dbdb diabetic mice normal littermate state polyploid diabetic normal weeks nuclear size polyploid results normal diabetic mice peri insular tele insular regions polyploidy peri insular regions lowest islets insular regions polyploidy normals diabetics weeks weeks diabetics unchanged normal normal diabetic insular regions polyploidy normals diabetics
DBT,DBT2525,post hypothalamic pituitary pituitary developed hypothalamic pituitary simplex whereas regulatory pituitary stalk pituitary permanent
DBT,DBT2526,wide serum chlorpropamide serum chlorpropamide related findings maturity diabetes daily doses mgkg fold cpa fold significant correlation cpa drugs drugs subjects extreme values plasma clearance cpa correlation serum cpa glucose values dietary probable cpa likely partial oral antidiabetic drugs general correlation cpa glucose values cpa
DBT,DBT2527,irregular serum chlorpropaminde maturity diabetes chlorpropamide glucose fbg routines noted time irregular statistical fbg half dietary important cpa important dietary maturity diabetes
DBT,DBT2528,diabetes conduction diabetes diabetic inconsistent electrophysiological morphological tibial streptozotocin diabetic diabetic posterior tibial motor conduction sd evoked techniques diminution largest normal mid posterior tibial sizes fiber growth motor posterior tibial proximal segments lesion diabetic conduction consistent diabetic mid lateral plantar demyelination entrapment peripheral diabetes
DBT,DBT2529,hyperosmolar ketotic diabetic coma sodium therapy hyperosmolar non ketotic diabetic coma identify review condition thirds diabetics uraemia fall hyperglycaemia hyperglycaemia rehydration insulin osmolarity serum sodium serum osmolarity hyperosmolar state risk oedema electrolyte hours dextrose water
DBT,DBT2530,choroidoretinal vascular choroidoretinal unusual hemodynamic ocular histoplasmosis diabetic maculopathy venous drainage congenital choroidoretinal photographic fluorangiographic many
DBT,DBT2531,diabetic year year man diabetic retinopathy conditions diabetic diabetic papilledema neovascularization diabetic retinopathy
DBT,DBT2532,endothelial diabetics endothelial diabetics proliferative diabetic retinopathy corneas normal subjects specular microscopy diabetic group steeper significant endothelial
DBT,DBT2533,unidirectional fatty intestine effect resistance unstirred water vitro unidirectional jd homologous fatty jejunum streptozotocin dm conditions resistance intestinal unstirred water uwl conditions taurodeoxycholic tdc uwl th jd fa jejunum dm streptozotocin free energy fa dm jd fa induction dm jd dm wide range tdc tdc jd unstirred uwl jd fa dm results permeability diabetic intestine fatty dm jd jejunum dm conditions salt micelle functions intestinal membrane
DBT,DBT2534,submaxillary diabetic mice streptozotocin submaxillary mice sugar insulin th diabetic mice normal level focusing submaxillary points diabetes
DBT,DBT2535,insulin dependent single insulin dependent diabetes size hla onset seasonal onset consistent hypothesis single recessive gene hla current compatible theory hla interaction diabetic simplex onset pedigrees diabetes
DBT,DBT2536,obesity diabetic obese dbdb mice importance thermoregulatory thermogenesis importance thermoregulatory thermogenesis metabolic diabetic obese dbdb dbdb mutants libitum food weeks different degrees degrees thermoregulatory thermogenesis diabetic obese total energy mice degrees thermoneutrality thermoregulatory mutants significant total energy protein diabetic obese metabolic diabetic obese obese obob energy expenditure thermoregulatory thermogenesis
DBT,DBT2537,rapid haemoglobin short term haemoglobin short term vitro vitro degrees hbac glucose time normal diabetic erythrocytes normal erythrocytes mmoll glucose increases maximal stable increases time hbac mmoll glucose erythrocytes hbac preincubation glucose free medium degrees mmoll glucose glucose hbac stable saline rapid hbac due stable hbac ketoamine glucose hbac thiobarbiturate method diabetics rapid glucose mmoll increases hbac rapid vivo increases reversible normalization glucose rapid diabetic hbac diabetics saline hours degrees degrees range time hbac glucose haemoglobin interference hbac
DBT,DBT2538,hla insulin dependent south negroes south negroes onset insulin dependent diabetes vs vs cross correction vs
DBT,DBT2539,obesity interassociations male parish athetosclerosis obesity diabetes diseases effect habit obesity inverse habit obesity direct habit coronary wall thickness calc coronary rlaa lesion aorta lesion coronary positive thickness whites coronary thickness obesity atherogenic atherogenic aortas coronary whites
DBT,DBT2540,diabetic hypertensive hypertensive wistar kyoto wkr diabetic single streptozotocin mgkg untreated wkr microscopy months subendothelial types lesions sparse ramifications indentations wall diabetic arabesque ramification ramifications normal contiguous lesions narrow cytoplasmic endothelial hypertensive ramifications conspicuous endothelial diabetic hypertensive endothelial lesion cubic spherical diabetic hypertrophy endothelial membrane endothelial overall effect hyptertension diabetes
DBT,DBT2541,synthesis glomeruli papillary kidneys brattleboro diabetes adh heterozygous incubations degrees presence arachidonic specific results papilla glomeruli arachidonic adh opposite glomeruli papilla different synthesis tissues
DBT,DBT2542,reamputation gangrene danish amputation voluntary orthopaedic investigation diabetic gangrene ipsilateral reamputation immediate months months total amputation year months tapers total normal significant months significant months
DBT,DBT2543,urine test urine glucose urine diabur test gdl results hexokinase method possible substances minor glucosuria
DBT,DBT2544,factor aorta heart work informativeness factor hereditary aorta conditions hereditary galtons law presence relatives second hypertensive diabetes obesity sudden
DBT,DBT2545,diabetic foot diabetic foot ulcers diabetic ulcers group diabetic tests galvanic skin gsr ulcers evidence severe somatic diabetic subjects ulcer gsr conventional tests diabetic foot ulcers gsr ulcer time plantar ulcers gsr means diabetic risk foot
DBT,DBT2546,renal petersen lesion proximal renal none recognize entity sophistication radical possible diagnostic wheel normal sharp margination vascular puddling normal total nephrectomy patterns rare concomitant renal polar lesion partial recognition possible color sharp demarcation necrosis forth policy violate gerotas renal specific possible nephrectomy proximal oncocytic urologic entity recognition time
DBT,DBT2547,somatic growth diabetic mothers size maternal diabetes growth diabetic mothers providence perinatal perinatal deaths enroll diabetic mothers insulin dependent diabetes gestational diabetes sequential evaluations months year positive maternal pre weight weight pregnancy neonatal weightheight index diabetic diabetic mothers obese obese obesity index equal likely macrosomia diabetic mothers factor obesity
DBT,DBT2548,insulin dependent sera insulin dependent diabetes specific human iddm none iddm specific hla risk iddm specific specific relatives iddm yield white addison iddm microsomal likely specific
DBT,DBT2549,effect glucose pagets sct human ct hct term serum glucose results significant rise serum glucose single sc hct glucose level months daily sct results term ct diabetes glucose results consistent effect ct hypocalcemia
DBT,DBT2550,term patency pancreatic lateral pancreaticojejunostomy pancreatitis ten intractable due pancreatitis lateral pancreaticojejunostomy puestow endoscopic pancreatography pancreatic endoscopic yr free continiue pancreatic deterioration malabsorption diabetic malabsorption exocrine pancreatic decompression pancreatic means pancreatitis prevent pancreatic glandular
DBT,DBT2551,serum diabetes cholesterolprotein apoprotein serum maturity diabetics group nondiabetics whole diabetics normal ldl hdl diabetics whole cholesterolprotein hdl correlation hdl lipoprotein vldl apolipoprotein hdl diabetic subjects vldl ciii ratio apolipoprotein ciiapolipoprotein ciii diabetic vldl
DBT,DBT2552,risk coronary report coronary cass findings risk results coronary interinstitutional coronary cass level coronary coronary presence risk coronary level females females coronary risk spite correlations gains nondisease coronary findings presence coronary
DBT,DBT2553,kinetics normal diabetic viable hepatocytes collagenase perfusion normal diabetic irreversible explain flocculation dependent respect concanavalin normal diabetic hepatocytes constants cm cm normal diabetic findings cytoplasmic normal possess diabetic
DBT,DBT2554,primipara obstetric deliveries multiparas toxemia op group incidences deliveries induction vacuum extraction cesarean op group postnatal significant perinatal morbidity incidences prematurity obstetrician much terminate pregnancy op group prematurity perinatal op group risk
DBT,DBT2555,diabetic dependent diabetic strict postprandial sugar prenatal contacts pregnancy exclusive fetal deaths neonatal diabetes perinatal helpful perinatal risks perinatal maternal morbidity complications serious overall social diabetic method
DBT,DBT2556,insulin receptor interaction plasma adipocytes different insulin insulin receptor interaction plasma insulin insulin sites adipocytes obesity hyperinsulinism streptosotocin diabetes correlation insulin accounted insulin receptor
DBT,DBT2557,home glucose insulin dependent diabetics preliminary results glucose glucose insulin diabetic successful term pancreatic transplant pancreas time home glucose viable conventional successful methods insulin diabetes
DBT,DBT2558,morphological findings pancreas isografts allografts previous morphological findings pancreas streptozotocin diabetic wag histocompatibility pancreas granulated inflammatory wag allografts severe pancreatitis polymorphonuclear mononuclear exocrine vascular group wag allografts months wag pancreas pancreas months severe fibrosis mononuclear vascular intimal picture pancreatitis pancreas allografts ligation results rejection fibrosis effect insulin thence fibrosis
DBT,DBT2559,conduction velocity weeks glucoregulation insulin pumps normal glucoregulation insulin dependent wk subcutaneous insulin therapy significant motor conduction velocity peroneal values significant motor conduction velocity sensory conduction conventional insulin results hyperglycemia diabetic term provide findings
DBT,DBT2560,insulin effect zinc effect zinc crystalline insulin zinc lipogenesis epididymal index insulin zinc effect lipogenesis vitro insulin effect insulin effect zinc insulin hitherto unreported significance level
DBT,DBT2561,turnover intracellular diabetes effect streptozotocin liver previous work normal diabetic insulin dependent starvation weight losses results fundamental stable double isotope protein bicarbonate fundamental degradation general incorporation diabetic state specific liver quantity subcellular little proteolytic machinery liver insulin dependent fundamental degradation severe diabetes severe
DBT,DBT2562,specific insulin dependent diabetes insulin dependent diabetes iddm iddm yr none diabetes yr ica ica overall ica results iddm yr ica persistent ica yr iddm parietal microsomal former ica regions iddm onset yr different etiology rapid disappearance ica iddm group
DBT,DBT2563,insulin resistance pineal metabolic effect hypophysectomy resistant diabetes somatic condition short term problems resistance persist likely condition insulin
DBT,DBT2564,plasma trivalent chromium glucose tolerance insulin diabetes plasma trivalent chromium cr glucose tolerance insulin healthy onset cr oral glucose tolerance test different glucose tolerance insulin diabetics results plasma cr glucose tolerance insulin
DBT,DBT2565,contributions consumer health primary review health quality primary primary direct time primary health physicians important critical incidents empirical health conditions congestive heart streptococcal infections contributions health primary schools settings possible health programs
DBT,DBT2566,disorders bullous critical review bullous dermatoses pemphigus bullous pemphigoid dermatitis herpetiformis dh porphyria tarda disorders bullous lesions specific disorders important bullous disorders specialized pemphigus thymoma myasthenia gravis pemphigus pemphigoid dh disorders important rheumatoid dh disorders cutaneous lupus erythematosus bullous dermatoses porphyria lymphoma gastrointestinal tract
DBT,DBT2567,insulin maturity islets insulin maturity diabetes insulin vivo related primary islets intraoperative insulin release vitro insulin vivo normal insulin normal insulin release glucose results primary glucose extrapancreatic glucose level diabetic
DBT,DBT2568,insulin release diabetic cblksj dbdb mice insulin release diabetic cblksj dbdb mice hyperglycemic mice cblksj mice islets glucose insulin types islets islets insulin release islets diabetic mice insulin insulin release isobutyl methylxanthine islets release types islets potentiation glucose types islets glucose uses diabetic mice
DBT,DBT2569,intraperitoneal insulin microinfusion intraperitoneal insulin healthy insulin dependent diabetic insulin glucose supper intraperitoneal insulin glucose glucose plasma free insulin rise fall normal short term intraperitoneal insulin hyperglycemia diabetic man intraperitoneal insulin pancreas
DBT,DBT2570,bouins paraffin human pancreas pancreatic sera insulin dependent diabetic polyendocrine immunofluorescent microscopy cryostat human pancreas bouins paraffin trypsin human pancreas results cryostat sera insulin dependent diabetic serum non insulin dependent diabetic sera normal individuals serum paraffin easier conventional cryostat method
DBT,DBT2571,glucose dependent insulin noninsulin dependent maturity glucose dependent insulin glucose insulin release dependent maturity diabetics healthy normal subjects plasma healthy subjects pgml overnight insulin glucose slight insignificant rise plasma overnight slight rise pgml subjects group healthy subjects times release dependent nervous system modulation
DBT,DBT2572,method insulin insulin immune free total insulin insulin insulin immune free insulin ratio insulin serum run well insulin correlation total insulin ratio adsorbed fold second removal free insulin index presence insulin insulin immune tests single time discrimination sera insulin immune
DBT,DBT2573,probable endocrine ketone infectious inflammatory state infection streptococcus pneumoniae francisella tularensis venezuelan encephalitis inflammatory stress turpentine endotoxin plasma ketone white stresses significant plasma insulin infection diabetic infection noticeable plasma ffa insulin stress
DBT,DBT2574,morphine hyperglycemia insulin glucagon iv morphine plasma glucose rise alloxan diabetic dogs little effect normal dogs plasma glucagon diabetic insulin nondiabetics hyperglycemic morphine glucagon release insulin
DBT,DBT2575,gastrointestinal retrospective gastrointestinal tract group group idiopathic ms none idiopathic
DBT,DBT2576,measuring hemoglobin term diabetics hemoglobin hemolysates normal subjects diabetes column trivelli hbaab hbac sum hbaab hbac hbaabhbac normal subjects slight hbaab sd different normal subjects wide range hbac hbaabhbac hbac hbaabhbac significant correlation hemoglobins glucose hemoglobin glucose months hemoglobin correlation plots plasma glucose months correlation findings hemoglobins time glucose diabetics months measuring hemoglobins term diabetics
DBT,DBT2577,cytotoxic pancreatic human serum serum sephadex pancreatic serum uptake erythrocytes treated signs damage plasma membrane serum prompt insulin release epinephrine serum mild degrees degrees serum egta mgcl trypsin human serum exocrine pancrease liver whole islets homologous serum effect liver uptake serum noticeable effect discriminators
DBT,DBT2578,glycogen insulin vasopressin glycogen phosphorylase liver normal hepatocytes vasopressin glycogen glucose phosphorylase hepatocytes incubated egta effect epinephrine insulin effect vasopressin vasopressin elicit presence glucose findings consistent liver glycogen dependent protein phosphorylase
DBT,DBT2579,partialis continua nonketotic hyperglycemia partialis continua early nonketotic hyperglycemia hyponatremia mild hyperosmolality epc hyponatremia consciousness hyperglycemia hyperosmolality serious evidence lesion metabolic hyperglycemia mild hyperosmolality hyponatremia lack ketoacidosis contribute epc damage
DBT,DBT2580,spurious serum diabetic ketoacidosis depletion review diabetic ketoacidosis urea nitrogen level compatible true renal investigation artifactual due interference acetoacetate methods manual method noncreatinine chromagens interference manual method ketoacidosis exclude coexistent renal
DBT,DBT2581,myo inositol transport renal myo inositol uptake renal proximal membrane transports inositol glucose electrochemical medium intravesicular medium myo uptake fold gradients ineffective inositol transport system electrogenic electrochemical dependent uptake myo inositol myo inositol km micro glucose dependent uptake myo inositol glucose glucose accelerative exchange diffusion myo inositol myo inositol na dependent transport glucose glucose inhibits inositol uptake membrane potential myo inositol myo inositol transport membrane glucose inosituria
DBT,DBT2582,insulin resistance resistance recent insulin resistance immune nonimmune types resistance immune resistance presence exogenous insulin insulin receptor nonimmune resistance obesity ketoacidosis infection endocrinopathies insulin resistant diabetics weight insulin selection less pork fish insulin oral therapy human insulin dna technology insulin true insulin resistance rare phenomenon vigorous
DBT,DBT2583,acetylglucosaminidase diabetes plasma acetylglucosaminidase nag streptozotocin diabetic diabetic diabetic normal subjects diabetic diabetic insulin diabetic non diabetic nag diabetics less normal subjects metabolic significant diabetics liver correlation nag adhesiveness nag plasma results plasma nag increases significant correlation total plasma nag subfractionation nag significant correlation
DBT,DBT2584,dissociation plasma lipase insulin streptozotocin wk male plasma glucose lipase lpl epididymal gastrocnemius diabetes underwent significant lpl total heparin fall lpl little rise plasma lpl unchanged diabetic normal food pm food withdrawal hypertriglyceridemia insulin lpl
DBT,DBT2585,pseudo omnivorous related hypothesis wide range disparate non infectious diseases reveals single related pseudo omnivorous dietary omnivorus liberal types food suitable structure digestive metabolic
DBT,DBT2586,pituitary diabetes pituitary male homozygous heterozygous brattleboro normal vasopressin plasma adenohypophyses factor secrete vitro factor trophic extent results vasopressin factor
DBT,DBT2587,antagonistic insulin elution extracts sephadex insulin dependent protein glycogen phosphoprotein dependent protein glycogen insulin
DBT,DBT2588,extraction vasopressin octadecasilyl silica octadecasilyl silica vasopressin femtomole fluids method substances serum interfere quantitation consistent results liquid identity
DBT,DBT2589,nucleotides epithelium human macular neural human photoreceptor inverse gmp epithelium evidence uniform
DBT,DBT2590,serum insulin serum somatomedin liver human growth streptozotocin diabetes female serum level somatomedin radioreceptor insulin therapy serum insulin significant insulin normal serum uml human growth hgh significant serum tracer normal serum hgh normal liver tracer results insulin serum effect liver half maintain normal serum
DBT,DBT2591,diabetic fiber level diabetics fiber unknown nineteen diabetics total day guar intakes total calorie significant intakes dietary fiber
DBT,DBT2592,pancreatic damage occurrence neonatal coxsackievirus pancreata coxsackievirus evidence pyknotic total necrosis lesion coxsackievirus pancreata neonatal infections coxsackievirus shows insular lesions types theory reconstitute injury
DBT,DBT2593,diabetic retinopathy diabetics hunter valley retinopathy diabetic populations hunter valley regions overall diabetic retinopathy proliferative retinopathy macular macular photocoagulation diabetics town singleton close retinopathy onset diabetes guidelines eye diabetics
DBT,DBT2594,macular scatter laser photocoagulation proliferative diabetic retinopathy perifoveal leakage macular scatter laser photocoagulation proliferative diabetic retinopathy scatter laser photocoagulation important factor inthe macular
DBT,DBT2595,term vein term vein disorders venous ocular findings final venous time presence favorable vein none vein neovascular glucoma venous neovascular glucoma enucleation significant maladies correlation vein
DBT,DBT2596,histocompatibility diabetic retinopathy histocompatibility insulin dependent diabetics proliferative retinopathy hla hla bhla hla hla healthy proliferative retinopathy positive hla pc nonproliferative retinopathy hla proliferative retinopathy group nonproliferative retinopathy proliferative retinopathy pc risk hla nonproliferative retinopathy proliferative retinopathy pc risk histocompatibility proliferative retinopathy genetic diabetic retinopathy
DBT,DBT2597,transport diabetic transport sciatic streptozotocin diabetic proline fifth lumbar dorsal root ganglion proline slow transport system diabetic terms synthesis half transported calibre hypothesis primary neurological retrograde transport transport
DBT,DBT2598,effect polyadenylic rna hpolyu rna normal induction streptozotocin diabetic insulin rna total rna types diabetes ribosomes injected insulin rna ribosomes size rna rna results insulin synthesis diabetic translation pre sucrose less rna diabetic normal rna ribosomes diabetic untranslated ribosomes
DBT,DBT2599,chlorpropamide non insulin dependent total non insulin dependent diabetics chlorpropamide group claudication foot pulses significant results non insulin dependent flush chlorpropamide likely hence
DBT,DBT2600,changeover diabetics insulin doses doses times advisers diabetics insulin recognition correction
DBT,DBT2601,chlorpropamide diabetic vascular complications cpaf many non insulin dependent free vascular complications complications vascular diseases pairs twins pairs disocrdant diabetes genetic cpaf diabetic vascular complications metabolic types
DBT,DBT2602,dopaminergic man dopaminergic normal subjects yrs diabetics yrs untreated yrs cannula antecubital vein metoclopramide plasma renin normal subjects pgml metoclopramide metoclopramide pretreatment metoclopramide competitive level dopaminergic receptor diabetics plasma level pgml normal subjects less metoclopramide tendency diabetics complications metoclopramide dopaminergic hypoaldosteronemic state normal subjects diabetics untreated normal subjects
DBT,DBT2603,endocrine remnant insulin system sandmeyers tolerance insulin system resection canine pancreas types pancreas developed insulin system glucagon hypoglycemia insulin load degeneration insulin sugar close total weeks pancreas sandmeyers diabetes glucose tolerance insulin system normal early insulin system pancreatic glucagon hypoglycemia insulin load degeneration results fact insulin sugar sandmeyers times total removal pancreas diabetes glucose tolerance insulin system significant islets pancreas insulin therapy disturbed insulin system
DBT,DBT2604,insulin needle units insulin dependent diabetics insulin needle units times safety time weeks total injections signs infections insulin needle units safe cost
DBT,DBT2605,serum serum dietary oral insulin regimens significant positive correlations hydroxyproline excretion osteoporosis stepwise correlations parameters matrix serum glucose parameters oral results support metabolic etiology
DBT,DBT2606,diabetic gastroparesis year diabetes need insulin roentgenological findings tumour means schindler hypoglycemic shock defects yellow histology food gastritis settlement food carency lavages normal findings roentgenological findings gastroparesis optimum diabetes intervention advisable
DBT,DBT2607,gmp phosphodiesterases diabetes diabetes tissues gmp liver heart uterus
DBT,DBT2608,postal recent onset illnesses months months concurrent morbidity general significant excess months diabetes excess results diabetes recent mumps infection
DBT,DBT2609,non insulin dependent non insulin dependent dysfunction electrophysiological tests reflexes group diabetes time investigation dysfunction evidence peripheral group evidence sympathetic parasympathetic dysfunction parasympathetic dysfunction subclinical uncommon occurrence insulin dependent emphasizes
DBT,DBT2610,hemoglobin insulin dependent hbac insulin dependent diabetic hbac level hyperglycaemia weeks methods diabetic hbac test periodic insulin dependent diabetes valuable level metabolic regimens
DBT,DBT2611,glucose lactate dogs kg wt plasma glucose lactate dogs versus time calanine normal dogs dogs turnover kg twofold turnover much lactate glucose whereas unidentified gluconeogenesis lactate
DBT,DBT2612,hyperglycemia diabetic strict intraoperative glucose level glucose mgkghr serum glucose serum glucose unithr insulin diabetic glucose serum glocose ie level less
DBT,DBT2613,islets diabetic mice islets degrees single
DBT,DBT2614,phosphoenolypyruvate carboxykinase normal diabetic ferrous phosphoenolpyruvate carboxykinase gtpoxaloacetate normal quinolinate time increases sensitivity returns phosphoenolpyruvate carboxykinase diabetic fold microm quinolinate inhibits non respects diabetic vitro normal normal inability quinolinate gluconeogenesis assayable phosphoenolpyruvate carboxykinase diabetic inconsistent quinolinates vitro phosphoenolpyruvate carboxykinase normal diabetic cytosolic phosphoenolpyruvate carboxykinases normal pigs rabbits fold quinolinate presence mitochondrial carboxykinases quinolinate ineffective presence
DBT,DBT2615,foods postprandial glycaemia normal diabetic subjects portions lentils soya beans bread hours human digestive effect glucose lentils soya beans oligosaccharides bread healthy portions lentils soya beans glucose bread diabetics results important factor rise glucose vitro vivo food identification foods diabetics
DBT,DBT2616,leo insulins experiences term unselected diabetics leo insulins primary diabetes oral antidiabetics training successful diabetic important regular metabolic ups results leo insulins therapy subsequent good good satisfactory
DBT,DBT2617,endoprosthesis subcapital femoral replacement non austin moore prosthesis subcapital cross problems lesions renal term therapy followup months followup results satisfactory normal daily female hemiplegic wheelchair ectopic hip second prosthesis uncontrolled diabetes hypoglycemic episodes slack
DBT,DBT2618,food exchanges diabetic infant dangers need lifelong positive diabetic infant toddler foods diabetes exchanges diabetic foods exchanges tools metabolic level current growth status conflict normal health
DBT,DBT2619,glucose urine glucose diabetic subjects discrimination training diabetic prepared glucose glucose clinitest method results gdl negatives discrimination training results subjects incorrect trials training
DBT,DBT2620,health locus noncompliant diabetic noncompliant obese non insulin dependent diabetic subjects demographic health locus hlc index health subjects severe noncompliant locus noncompliant
DBT,DBT2621,ocular diabetic nephropathy severe diabetic nephropathy diabetic retinopathy eye group dialysis group renal group diabetic eye ophthalmologic cataract extraction scleral cyclocryosurgery complications glaucoma persistent detachment group group intra courses eye therapy diabetic nephropathy hemodialysis
DBT,DBT2622,diabetic mi diabetic ds mi ward rupture shock pulmonary ds intraventricular conduction disorders ds mi excess ds limited second day ds mi liability insulin dependent diabetic risk conduction disorders risk ready phenomenon
DBT,DBT2623,rubeosis iridis plana vitrectomy rubeosis iridis plana vitrectomy vasoproliferative diseases detachment uveitis risk rubeosis iridis rubeosis iridis progresses irisangiography iridic neovascularization rubeosis iridis influences rubeosis iridis half condition
DBT,DBT2624,parietal parietal diabetic titres girls presence pca group pca group bao maximal output serum gastrin group group achlorhydric group hyposecretion obvious group gastritis group severe hyposecretion group group gastritis serum ferritin diabetes mucosa lowest values
DBT,DBT2625,hemoglobin plasma onset plasma lipoprotein atc diabetic onset diabetics girls day day daily linoleic healthy values day day slight significant hemoglobin atc vs total hb sem vs mmoll sem triglycerides mmoll sem correlation hemoglobin day urine glucose excretion hemoglobin lipids end
DBT,DBT2626,pregnancy neonatal obesity bon obesity rural weight ponderal index gestational nutritional index maternal nutritional general tendency protein effect maternal
DBT,DBT2627,peculiarities plateau uptake microgramsdl values microuml sugar serum immunoreactive insulin iri values nondetectable normal values microuml mechanisms diabetes hyperinsulinic normal iri tolerance glucose latter due hormones
DBT,DBT2628,obese somatic anthropometric parameters subjects girls obesity obesity obesity obesity functional adiposo genital cushings peculiarities somatic whole adiposity obesity
DBT,DBT2629,vascular diabetic diabetic means normal angiograms less showed diabetic
DBT,DBT2630,trial retrospective equal parameters obesity menopause menarche tumours radiation statistical significant obesity radiation significant menarche results investigation literature
DBT,DBT2631,methods serum diabetics diabetics hdl non diabetic diabetic ultracentrifugation manganese heparinmn sodium ptmg results methods diabetics non diabetics lowest ptmg intermediate ultracentrifugation heparinmn magnitude diabetic treated insulin hdl non diabetic heparinmn ultracentrifugation ptmg discrepancy ptmg ultracentrifugation hdl
DBT,DBT2632,noninvasive vascular diabetics fifty diabetic free signs noninvasive techniques vascular distensibility values diabetic terms diabetes results inverse vascular distensibility diabetic subject normal non diabetic group distensibility normal diabetic subjects group values diabetics little
DBT,DBT2633,endocrine side renal recurrent idiopathic sodium phosphate intestinal hyperparathyroidism thiazides calciuria glucose tolerance removal year group conventional therapy nieron group sodium phosphate group sodium phosphate hydrochlorothiazide year short effectiveness significant calciuria group respect hyperparathyroidism group group group worsen glucose tolerance drugs mentioned side
DBT,DBT2634,conjunctival diabetes state system eye cojunctiva diabetes healthy diabetic structure microvessels permeability resistance conjunctival microcirculation onset severe diabetic results conjunctival conjunctival microcirculation disturbed normal picture fundus diabetic early microhemodynamic
DBT,DBT2635,fatty group antidiabetic drugs hypoglycemic effect phenformin intraperitoneal phenylpropionic gluconeogenesis oleate glucose normal diabetic significant hypoglycemia intact hyperglycemia hours glucose intact diabetic effect fatty whereas intact hypoglycemia hyperglycemia fatty means therapy
DBT,DBT2636,naphthylimidoacetic months diabetes effect naphthylimidoacetic glucose fructose sorbitol dehydrogenase level biomicroscopy iris microscopy niaa mgkg sugar level significant fall sorbitol dehydrogenase microvascular
DBT,DBT2637,emphysematous pyelonephritis emphysematous pyelonephritis diabetic electrolyte hyperglycemia matrix renal optimal therapy conservative
DBT,DBT2638,rehabilitation diabetic cuba important cuba rehabilitation diabetic participation advisable severe office visits participation vocational social psychological orientation antidiabetic vocational camping diabetic homes television programs diabetes
DBT,DBT2639,primary exogenous obesity group obese females kgs weight obesity year weight obesity significant obesity year obesity obese diabetes obesity antecedents prevent
DBT,DBT2640,prurigo prurigo prurigo simplex prurigo nodularis hyde trunk likewise lesions simplex localised nodularis hyde bites insects gastrointestinal disorders prurigo simplex metabolic endocrine disorders diseases dermatitis prurigo prurigo diathetique besnier metabolic endocrine disorders diabetes hyperlipidemia diseases stomach bowels androgene conditions nodularis hyde extreme prurigo inefficiency therapy diseases
DBT,DBT2641,enkephalin heart baroreceptor peptides enkephalin leu increases lateral ici iv heart nmoles independent doses enkephalin vagal baroreceptor findings increases decreases iv ang ivt ici iv ivt leu ivt leu effect receptor bratteboro homozygous hereditary diabetes total antidiuretic adh synthesis decreases ivt leu observed evans increases leu hypertensive prone sp normotensive sp humoral adh due opioid peptides hormones possible participation system sp
DBT,DBT2642,urine adh gfr reductions filtration gfr urine depend luid henle much gfr urine adh values vs partial constriction diabetes vs wt osmolality vs mosmolkg ho less gfr gfr filtration systematic adh gfr potential loops unchanged
DBT,DBT2643,henle water antidiuresis brattleboro mathematical renal medulla patterns urea flow water diuresis antidiuretic adh micropuncture clearance endogenous adh urine flow urea excretion patterns avr urea adh urea lag limb henles dlh dlh water dlh wall negligible results lag therby significant entry dlh conditions companion renal electrolyte permeation dlh limits hypertonic urine inner medulla thin transport
DBT,DBT2644,lamina human diabetic glomerulosclerosis diabetic glomerulosclerosis method renal tubules lamina due epithelial endothelial diabetic nephropathy diffuse epithelial lamina nephron peripheral diabetic endothelial lamina predominant nodular diffuse mesangial sclerosis mesangial evidence epithelial lamina nodules juxtamesangial epithelial tuft
DBT,DBT2645,coronary risk risk factor intervention trial vpbs vpbs overall positive vpbs positive vpbs significant overall risk ratio confidence limits vpbs morbidity coronary heart nonsmokers
DBT,DBT2646,thirds coronary heart thirds coronary heart chd serum weight work free systolic risk risk chd serum unchanged previous
DBT,DBT2647,logistic risk evans georgia logistic risk overall health effect year significant systolic obesity quetelet index race social index risk risk values values results systolic public health problems powerful risk factor effect limits potential overall effect intervention fact intervention trials overall demonstration specific state risk state overall health effect suitable trials intervention public
DBT,DBT2648,nutritional renal renal institutions tertiary diabetes veterans utilized formulate guidelines nutritional therapy renal optimal nutritional support renal important nutritional dietary anthropometric ratio circumference triceps serum protein total protein transferrin provide valuable nutritional status serum urea nitrogen serum ratio urea nitrogen optimal protein serum urea nitrogencreatinine ratio respect ie urea clearance urea nitrogen nutritional therapy electrolyte mineral balances dialysis uremic nutritional therapy superimposed illnesses formula total
DBT,DBT2649,permanent insipidus observations permanent diabetes uncommon roentgenographic findings condition unconsciousness skull findings cranial damage pituitary replacement less automobile standard water deprivation tests total antidiuretic adh partial test urine plasma osmolality normal subjects
DBT,DBT2650,red glycolytic diabetic glycolytic red diabetic normal significant glucose fructose sugar metabolic crossover
DBT,DBT2651,hemoglobin diabetic exchange hemoglobins system akron oh usa laboratory normal transitional range diabetic range isolab degrees hemolyzed instructions triplicate runs degrees degrees degrees degrees degrees degrees resultant increases results hemoglobin degrees microcolumn hemoglobin hemoglobin interassay half hemoglobin diabetic subjects hemoglobin diabetic diabetic endocrine non diabetic subject hba level diabetic normal range transitional range uncontrolled diabetic range
DBT,DBT2652,rapid exchange many methods hemoglobin total hemoglobin exchange methods method tests laboratory conditions method results method results isolab kits hemoglobin ionic elution elution hemoglobin final method results isolab methods method hemoglobin
DBT,DBT2653,hyperemic ankle hyperemia differentiation normal femoropopliteal fp system proximal aortoiliac hyperemic fpn normal subjects diabetics normal subjects diabetics significant fp inexpensive test severe claudicator critical resting conditions
DBT,DBT2654,eosinophilic granuloma female eosinophilic granuloma female genital tract localized organs insipidus insipidus radiotherapy hypothalamic genital lesions radiotherapy condition extent early malignant lesion
DBT,DBT2655,knee amputation rehabilitation amputees primary permanent prosthesis multidisciplinary intraoperative prosthesis motivation
DBT,DBT2656,ratio rds possible mechanisms controversy positive correlation maternal diabetes progeny respiratory distress rds rds occur mature recent insulin antagonism normal fetal culprit strict maternal glucose diabetic rds infant diabetic mother
DBT,DBT2657,mammograms diabetics sugar level glucosuria diabetes diabetic diabetic nondiabetics findings mammograms diabetes
DBT,DBT2658,normal pregnancy radioimmunologic techniques primary chenodeoxycholic human healthy toxemia intrahepatic pregnancy general serum values intrahepatic values diabetic specimens limited significant correlation signs fetal distress time amniocentesis lowest maternal serum human lactogen values
DBT,DBT2659,hypoglycemic phenformin dbi mechanisms phenformin glucose diabetic subjects glucose diabetic subjects subjects consistent pronounced level biguanide glucose output removal glucose glucogenesis lactate lack presence significant lactate glucogenesis hypoglycemic restriction glucose liver support drugs glucogenesis glucose glycogenolysis
DBT,DBT2660,effect potential release hemidiaphragms free diaphragm diabetic sacrifice salt methylene diaphragms diabetic free taurine glutamate less glutamine histidine threonine citrulline carnosine diabetic hemidiaphragms diabetic less glutamate less half much glutamine much glutamate less glutamate medium glutamine release different methylene free water release diabetic diabetic group release diabetic methylene diabetic ketoglutarate methylene methylene ketoglutarate medium effect diabetics diabetic less pyruvate lactate release different methylene pyruvate release diabetic lactate release ratio methylene group effect phenazine methosulfate methylene compatible hypothesis ratio effect release progressive ratio eventual gluconeogenesis process uncompensated diabetes
DBT,DBT2661,nonalcoholic steatohepatitis mayo experiences hitherto nonalcoholic steatohepatitis hitherto liver hepatitis findings nonalcoholic unknown presence fatty evidence lobular hepatitis inflammatory infiltrates mallory evidence fibrosis specimens obese many obesity diseases presence hepatomegaly mild findings therapy
DBT,DBT2662,myocardium diabetic effect diabetes iv streptozotocin mgkg wk diabetes glucose tes myocardium homogenized synthesis proline incorporation synthesis diabetic wk related phenomenon results
DBT,DBT2663,immune red immune streptozotocin sz diabetic mice immune red system sz diabetic mice weights organs time sz whereas sz diabetic mice level hypersensitivity dth normal level sz diabetic mice sz diabetic mice dth sz diabetic mice normal thymus marrow diabetic mice partial pfc normal diabetic mice splenic pfc normal mice insulin system findings insulin diabetic state differentiation
DBT,DBT2664,catatonia csf lactate conditions reversible catatonia insulin dependent diabetic catatonia csf lactate values recovery csf lactate reflect uncommon mental weakness perceptive migh group conditions syndromes
DBT,DBT2665,diabetic electromyographic fifteen diabetic subjects thoracic wih paraspinal elderly mature diabetics hyperesthesia thoracic radicular none localized paraspinal positive waves level subjects wih peripheral electromyographic important diabetic
DBT,DBT2666,sorbitol diabetic male diabetes iv streptozotocin mgkg diabetes infertility male glucose post prandial level normoglycemic male seminal sciatic diabetic sorbitol tissues aldose food weeks sorbitol organs diabetic possible male fertility
DBT,DBT2667,hepatitis diabetic presence serum diabetic normal diabetics hbc group diabetics oral hypoglycemic therapy results
DBT,DBT2668,vasopressin water excretion glucocorticoid glucocorticoid impairs renal water excretion replacement glucocorticoid water load hours fo glucocorticoid day less less water load plasma vasopressin pgml values water load glucocorticoid day less less effect plasma vasopressin water excretion glucocorticoid brattleboro diabetes water excretion day glucocorticoid water excretion index vs mlminkg renal flow vs less observed day glucocorticoid insipidus water load vs less day glucocorticoid results glucocorticoid impairs renal water excretion vasopressin dependent vasopressin independent mechanisms dependent renal renal
DBT,DBT2669,glucose diabetic glucose tolerance oral glucose tolerance tests index related deterioration glucose group healthy diabetic potential diabetes extent glucose tolerance deterioration theories deterioration normal range glucose tolerance
DBT,DBT2670,koyanagi koyanagi harada referred uveitis oriental racial detachment months persist vasculitis pregnancy effect hemoglobin effect good ascuity eye
DBT,DBT2671,pancreatic test obese diabetic metabolic reactivity cpr cpr diabetic non diabetic cpr insulin diabetics stable brittle diabetes obese brittle diabetes obese maturity diabetics cpr obese insulin cpr test inadequate diabetics positive correlation glucose cpr diabetics correlation parameters cpr diabetics importance residual correlations obese diabetics insulin effect metabolic
DBT,DBT2672,serum level therapy diabetic sulfonylureas effect metabolic serum prebeta lipoprotein normal diabetic prebeta lipoprotein insulin treated metabolic insulin sulfonylureas serum iri lipoprotein lipoprotein sugar lipoprotein exogenous endogenous insulin metabolic
DBT,DBT2673,serum lipids lipoprotein vldl diabetic oral insulin therapy diabetic females group treated insulin oral therapy good metabolic glucose urine less total serum tc triglycerides vldl tctg ratio double pre parameters significant results metabolic good vldl
DBT,DBT2674,ultrastructure streptozotocin diabetes diabetes transmission microscopy streptozotocin ip mgkg mgkg pancreata serum glucose values islets types diabetic islets pyknotic islets golgi secretory pleomorphic nuclear peripheral endoplasmic reticulum prominent spite diversity morphological findings diabetic metabolic
DBT,DBT2675,effect insulin glucose level normal diabetic deals effect insulin ratio liposomes normal diabetic wistar glucose level glucose level insulin diabetic effect glucose level insulin liposomes effect normal significant glucose level diabetic insulin glucose level insulin normal possible mechanisms insulin liposomes
DBT,DBT2676,insulin serum diabetes significant serum hdl diabetes glucose serum diabetic group second diabetes porcine insulin unitsday group glucose serum doses significant serum insulin insulin glucose glucose range mmoll serum glucose significant glucose serum
DBT,DBT2677,polyglandular hla polyglandular respect hla whereas insulin dependent thyroiditis hla goitrous thyroiditis positive normal hla goitrous polyglandular hla bdrw positivity polyglandular results disorders bdrw mother non positive mothers drw bff rga transmission search haplotypic uncommon diseases
DBT,DBT2678,insulin dependent diabetic diabetic insulin dependent diabetic risk oral preparations obvious unusual metabolic interaction diabetic endometrium group diabetic progestogen pill successful side irregularities diabetic progestogen pill method female sterilization progesterone method
DBT,DBT2679,hemoglobin correlations plasma glucose serum lipids hemoglobin glhb plasma glucose fpg urine glucose serum triglycerides hdl diabetic thirty insulin sulfonylurea therapy
DBT,DBT2680,hemoglobin hemoglobin hbac glucose daily injections total hbac group values hbac level normal therapy plateau yr level normal subjects sem insulin ukg hbac endogenous insulin yr hbac less serum glucose standard hbac hbac values postprandial glucose hbac group sem
DBT,DBT2681,microcirculation diabetic retinopathy early stage diabetic retinopathy recent results diabetic retinopathy hbac dpg level oxygen
DBT,DBT2682,pancreatic peptides lipoatrophic diabetes aqueduct sylvius manifestations lipoatrophic diabetes diabetes ventriculo shunt aqueduct sylvius dramatic diabetic state insulin units months insulin level months effect metabolic pro insulin iv tests screenings peptides urine sephadex patterns hypothalamic disorders different urine congenital lipodystrophy mice peptides urine hyperglycemia mechanisms hypothalamic unknown polypeptides hypothalamic peptides
DBT,DBT2683,haemoglobin remission insulin dependent diabetic hbac diabetic metabolic months hbac time remission diabetic significant correlation hbac remission glucose excretion insulin less ukgday serum results hbac remission diabetic
DBT,DBT2684,adenohypophyses obesus adenohypophyses sand protodiabetic diabetic group types hypophyses sth gamma lh delta hypophyses group size types sand values rodents granular protodiabetic group prominent types peculiarities prolactin diabetic group prolactin colonies golgi developed types adenohypophyses state sand laboratory laboratory state weight state sand adenohypophyses prolactin
DBT,DBT2685,investigation insulin sensitivity insulin resistance diabetics thirty non obese obese subjects glucose test normal tolerance non obese ten obese tolerance diabetes insulin sensitivity subjects glycemia insulin less insulin non obese obese diabetics insulin inverse plasma glucose insulin glucose test results insulin resistance obese non obese diabetics
DBT,DBT2686,duodenal secretin coeliac sprue maturity diabetes presence single endocrine human secretin types sprue sera fifty elderly diabetics drugs sera positive cytoplasmic duodenal reactions secretin somatostatin glucagon gut identify thirty donors sera endocrine results unfixed cryostat duodenal mucosa secretin coeliac values diabetes metabolic dificiencies presence endocrine
DBT,DBT2687,method linkage hla insulin dependent lod method informative insulin dependent jidd recessive linkage hla locus lod scores recombination level penetrance hypothesis jidd specific hla haplotypes due linkage disequilibrium hla locus jidd
DBT,DBT2688,insulin general unitsml introduced strengths months insulin dependent diabetics system syringes mistakes fewer insulins general practitioners
DBT,DBT2689,neonatal diabetes infant hypertonic ethiology rare endovenous insulin
DBT,DBT2690,metabolic responders responders muscular metabolic muscular bicycle ergometer healthy diabetics insulin dependent diabetics hours insulin group hours insulin group group non insulin dependent diabetics glycemia responders values responders non responders less presence insulin hypoglycemic effect extent fall glycemia insulin independent responders non responders tolerance test
DBT,DBT2691,renin system insipidus plasma renin plasma level pa diabetes conditions standard sodium day sodium furosemide load morning rest slow walk healthy pa method renin pa level level healthy sodium types rise diabetes hyperreninemia compensatory water retention unusual pa level time
DBT,DBT2692,immune immune emphasis specific diabetic occurrence humoral antipancreas hla insulin dependent specific subpopulations diabetic possible viruses diabetes humoral granulocyte host infectious human diabetics diabetes
DBT,DBT2693,induction renin release exogenous hyporeninemic hypoaldosteronism renal synthesis hyporeninemic hypoaldosteronism renin release infusions pga microgramkgmin total renal excretion normal vs nghr normal subjects posture furosemide vs ngmlhr renin normal subjects showed infusions hypotensive pra total renal normal hyporeninemic hypoaldosteronism orthostasis furosemide nitroprusside renin stimulus renin release
DBT,DBT2694,serum insulin dependent diabetics normal subjects ngml oral glucose tolerance test normal subjects ngml ngml insulin dependent diabetic hypoglycemia free insulin insulin dependent diabetics free total immunoreactive insulin maturity diabetics presence insulin serum total polyethylene glycol immune free immunoreactive subnormal diabetics normal maturity onset diabetics
DBT,DBT2695,normal diabetic man interorgan exchange healthy subjects insulin dependent diabetics renal diabetic uptake protein isoleucine valine insulin normal intracellular isoleucine normal respect diabetic state due fold splanchnic extraction glucose normal man normal uptake glucose glucose insulin normal uremic subjects many share insulin
DBT,DBT2696,dbj mice pancreatic pancreatic islets dbjdbj littermate mice glucagon insulin serum free medium dulbeccos medium dmem significant effect medium glucagon time dbjdbj cultures medium glucagon littermate normal populations glucagon insulin significant less medium dbjdbj preparations times much insulin secretory mutatn dmem mmoll dmem versus mmoll chase day dbjdbj cultures incorporation protein biogel glucagon glucagon reveals sensitivity dbjdbj term
DBT,DBT2697,dbj mice histological recessive mice db locus dbj hyperphagia severe obesity mutants excess months littermates mild hyperglycaemia severe obesity db gene mice mutants sudden weight hypoglycaemia months females months sugar sem glucose normoglycaemic values mutants months mutants hyperinsulinaemic plasma insulin months fold normal females glucagon mutants pgml versus pgml normal mice fold vaues group versus pgml normal mice histopathological findings pancreas necrosis exocrine endocrine mutants pancreas hyperplastic islets hyperplasia fold pancreatic insulin mutants whereas pancreatic glucagon less fold gene hyperglucagonaemia face hyperinsulinaemia
DBT,DBT2698,parabiosis serum glycosidase diabetic mice diabetic non obese mice icr shionogi laboratory diabetic glucose ml serum insulin state parabiosis normal icr mice weeks glucose level ml serum insulin less acetylglucosaminidase galactosidase diabetic mice decreases less restored normal weeks renal mannosidase diabetic mice parabiosis serum acetylglucosaminidase galactosidase glucosidase diabetic mice returned normal parabiosis
DBT,DBT2699,murine gene rubidium islets islets diabetic cblksj dbdb mice normal cblksj mice micro nonradioactive medium sum functions constants rapid normal diabetic mice slow plasma glucose medium slow diabetic normal mice normal mice diabetics slow permeability ksj dbdb depolarization glucose
DBT,DBT2700,normalization plasma insulin profiles insulin diabetic man plasma insulin insulin diabetic related increases free insulin short insulin rotary insulin short insulin minutes intraperitoneal insulin maximal plasma free insulin minutes mul sem mul supper rise gradual plasma free insulin normal plasma insulin injected insulin maximal plasma free insulin observed intraperitoneal insulin minutes insulin peripheral plasma free insulin short term
DBT,DBT2701,haemoglobin home glucose diabetics glucose intervals months total haemoglobin hba end fluckiger method hba column significant correlations glucose months confidence limits total haemoglobin confidence limits good correlation results methods less correlations glucose months glucose mmoll glucose support hypothesis hba total haemoglobin satisfactory short term diabetic
DBT,DBT2702,plasma serum insulin diabetic pancreatic serum insulin diabetic pancreatic exogenous insulin weeks plasma level glucose glucagon damage level rejection level plasma direct index pancreatic insulin level half level total igg results insulin removal stimulus withdrawal xenogeneic insulin
DBT,DBT2703,insulin glucose gestational glucose test insulin gestational diabetic weeks glucose tolerance normal weeks glucose test weeks weeks results normal non normal insulin normal th insulin pregnancy insulin insulin sensitivity index sd gestational diabetic group pregnancy group less findings support hypothesis gestational diabetes achieve pregnancy insulin sensitivity gestational diabetes
DBT,DBT2704,renal therapy rejection renal hemodialysis terms rehabilitation cost minority stage renal complications related therapy morbidity therapy transplant rejection methylprednisolone group september oral group september december group group versus year less related donors versus year significant infections rejection episodes risk group group rapid rejection therapy rejection episodes renal hemodialysis
DBT,DBT2705,whole pancreas membrane alloxan diabetes thickness membrane male lewis group normal iii iv diabetes alloxan group untreated induction iii isografts pancreas thickness membrane diabetic significant thickening membrane normal significant pancreas diabetic membrane membrane thickness normal pancreaticoduodenal isografts equal membrane membrane untreated diabetic group
DBT,DBT2706,glucagon precursors immunoprecipitation products free translation messenger rna rna anglerfish islets wheat free system smethionine presence microsomal canine pancreas translation products immunoprecipitation porcine glucagon translation products polyacrylamide gels microsomal mr antiglucagon serum microsomal translation reactions diminution mr immunoreactive protein mr protein mr resistant degradation proteolytic translation reactions microsomal results consistent synthesis anglerfish glucagon mr leader protein microsomal intermediate mr pancreatic glucagon mr
DBT,DBT2707,early onset insulin diabetes keeshond dogs diabetes nonobese keeshond dogs hereditary onset diabetic dogs ketotic hyperglycemic hypercholesterolemic hypoinsulinemic glucagon cortisol serum tsh normal presence diabetic dogs single puberal diabetic male semen quality diabetics normal lesions dependent diabetes valuable biomedical
DBT,DBT2708,diabetes rabbits male zealand white rabbits single iu coli kilogram wt diabetogenic significant weight day day day random serum glucose sem day day immunoreactive insulin iri day iri level pgml sem iri regular insulin glucose less single iu coli kilogram wt induces hyperinsulinemic insulin resistant diabetic rabbits
DBT,DBT2709,nonenzymatic glucosylation serum hemoglobin glucose diabetic serum diabetes serum glucose glucosylated serum protein serum protein glycosylation glucose withdrawal insulin diabetic half times steady state serum reinstitution insulin therapy half times values glucose consistent times hemoglobin incubations serum protein short term glucose diabetes
DBT,DBT2710,papillary necrosis factor factor specific tissues serum specimens diabetic episode papillary necrosis factor tissues
DBT,DBT2711,hypothesis alloxan hypothesis hypothesis alloxan diabetes importance cytotoxicity alloxan mitochondrial sulfhydryl dependent transport system inorganic phosphate dependent oxidative phosphorylation mitochondrial lesion synthesis glucose release insulin due fall intracellular necrosis mitochondrial inverse alloxan sensitivity antagonism induction free permeability glucose
DBT,DBT2712,diseases immune microscopy means microscopy sem diseases hepatitis lupus erythematosus lymphocytic leukemia cytochemical immune emphasis superiority sem eac rosette tests identification therapy diseases laboratory morphological findings microscopy
DBT,DBT2713,hypolipidemia streptozotocin nephrectomy significant serum feeding diabetic normal
DBT,DBT2714,impact issues styles impact healthy cystic fibrosis renal rheumatologic diseases total impact eg leukemia colds ill healthy respondents concerns restriction freedom disruption disruptive rheumatologic disruption disruption oncologic former sexuality impact rheumatologic cystic fibrosis healthy status ill hopeful positive quality
DBT,DBT2715,psychological forty healthy serious diseases health locus health healthy ill ill oncologic renal rheumatologic disorders less health healthy cystic fibrosis time signs serious overall normalcy health realistic importance serious day day deviance
DBT,DBT2716,mandible osteomyelitis report mandible osteomyelitis therapy resection iliac months second diabetes condyloid process actinomyces infection extraction prevent human gamma globulin signs evidence year
DBT,DBT2717,glucose normal streptozotocin diabetic work normal streptozotocin diabetic results incorporation lipids cnucleic results insulin hypothalamic
DBT,DBT2718,diabetic ketoacidosis electrolyte diabetic ketoacidosis ecg hyperkalemia hypocalcemia ecg laboratory values electrolyte ecg therapy shock ecg lethal importance electrolyte management diabetic ketoacidosis standard management diabetic ketoacidosis
DBT,DBT2719,growth prolactin diabetic growth gh prolactin prl tsh trh insulin dependent diabetic plasma gh mul trh significant rise plasma gh rise plasma gh values significant group whole tsh normal trh gh release diabetics mechanisms gh many diabetics gh factor diabetic
DBT,DBT2720,half hypoglycemic effect insulin diabetic ketoacidosis insulin ukg intervals diabetic ketoacidosis glucose plasma insulin values hours glycemia plasma insulin values hours glycemia insulinemia insulin half discontinuous iv insulin doses resistance insulin risks easy iv
DBT,DBT2721,fetal pancreas rejection pancreata day gestational embryos related diabetic streptozotocin cyclosporin weeks exocrine isografts vitro cultures pancreata maturation exocrine components full maturity rejection tissues humoral rejection rejection endocrine parts fetal pancreas
DBT,DBT2722,estrogen insulin dimethylbenzaanthracene mammary insulin regulator estrogen ers dimethylbenzaanthracene mammary diabetic insulin induction lesions insulin dependent lesions diabetic insulin independent intact fmolmg protein insulin dependent lesions insulin independent diabetic insulin dependent growth lesions insulin independent lesions diabetic patterns insulin growth whereas insulin protein equal level intact static growth due insulin static static insulin growth induction insulin growth insulin independent growth
DBT,DBT2723,synthesis kidneys lungs microsomal synthesis kidneys diabetic pretreatment alloxan streptozotocin unchanged lungs kidneys diabetic streptozotocin diabetic kidneys lungs group renal diabetes
DBT,DBT2724,suppressor insulin dependent suppressor sca insulin dependent diabetes iddm effect peripheral concanavalin incorporation concanavalin normal sca peripheral healthy individuals findings diabetics sca months different healthy individuals significance immune reactions findings sca insulin dependent
DBT,DBT2725,fetal hyperplasia diabetic pregnancy fetal pancreatic terms total dna insulin dna diabetic intraperitoneal streptozotocin mgkg second day day pancreatic insulin diabetic mothers ngmicrogram dna significant day ngmicrogram dna day ngmicrogram dna day ngmicrogram dna significant total pancreatic dna test day maternal streptozotocin fetal effect
DBT,DBT2726,renal glucosyltransferase diabetic glucosyltransferase gelatin time dependent sublines glucosyltransferase unitg sugar subline dependent glycosyltransferase diabetic sublines glucosyltransferase kidneys renal glucosyltransferase sugar level
DBT,DBT2727,effect streptozotocin diabetes renal ornithine decarboxylase diabetes renal ornithine decarboxylase hours renal vehicle sz suppressed wk insulin sz early presence mild hyperglycemia ketosis hyperglucagonemia diabetic subsequent diabetic
DBT,DBT2728,nesidioblastosis hyperplasia insulinoma islets unusual insulinoma yr pancreas lymph hyperplasia islets nesidioblastosis proliferative evidence ductular
DBT,DBT2729,effect glucose kinetics insulin non insulin dependent diabetic group oral group latter test twice standard oral glucose tolerance test glucose glucose peripheral glucose tolerance group peripheral glucose effect glucose group group insulin glucose glucose tolerance metabolic clearance mcr glucose effect insulin obscure
DBT,DBT2730,effect dietary fiber normal subjects diabetic subjects glucose serum insulin immunoreactive pancreatic glucagon fiber guar pectin normal healthy subjects weight non insulin dependent maturity diabetic subjects niddm glucose tolerance normal subjects insulin significant glucagon glucose tolerance niddms insulin significant glucagon subjects niddms glucose tolerance fiber insulin diabetic subjects glucose tolerance glucagon insulin unchanged fiber improves tolerance insulin nervous gastrointestinal tract important effect
DBT,DBT2731,ketoconazole coccidioidomycosis nonpregnant coccidioidomycosis ketoconazole coccidioidomycosis pulmonary coccidioidomycosis cutaneous coccidioides identification fungus ketoconazole day day one coccidioidomycosis ketoconazole fewer
DBT,DBT2732,vasopressin medullary tubules hereditary diabetes previous renal unresponsiveness vasopressin vp mice hereditary diabetes ndi specific segments nephron cyclase pdie medullary tubules medullary thick henles mice normal mice hereditary ndi cyclase vp naf ndi mice ndi mice naf cyclase specific pdie ndi mice different ndi mice vitro conditions intact mice vp striking elicit ndi mice pdie methyl isobutyl xanthine vp significant ndi mice conditions ndi mice values vp cholera toxin mice ndi mice results vitro functional unresponsiveness ndi mice vp inability tubules intracellular vp inability vp pdie cyclase ndi mice unidentified possible cyclase ndi mice renal resistance vp
DBT,DBT2733,effect streptozotocin diabetes early glucagon liver effect early glucagon glucagon glucagon presence ibmx mmoll liver streptozotocin mgkg diabetic hepatocytes diabetic much insulin plots due significant glucagon diabetic liver sites glucagon nmoll diabetics normals glucagon pmol diabetics pmol normals equal nmoll diabetic pmol normal quantity cyclase glucagon glucagon sites insulin
DBT,DBT2734,plt dp hla dr hla dr plt determinants vitro primings positive individuals parallel positive reactions individuals positive plt reactions related individuals total results hla dr ltm plt plt none dpltm positive individuals hla dw ddph plt dpltm hla dp
DBT,DBT2735,interferon system interferon plasma interferon insulin zink insulin insulin vitro interferon fold interferon plasma interferon unitsml unitsml
DBT,DBT2736,peripheral proliferative peripheral neovascularization growth peripheral vascular arcades wide ocular diseases vascular inflammatory diseases peripheral neovascularization review ocular peripheral neovascularization diagnostic peripheral proliferative retinopathy techniques neovascularization panretinal photocoagulation
DBT,DBT2737,protein synthesis slow day term day synthesis initiation types white slow short term diabetes level rna initiation red little initiation hemicorpus insulin medium rapid initiation effect possible fatty term diabetes rna protein synthesis perfusion insulin term diabetes elongation termination reactions
DBT,DBT2738,insulin erythroblastic leukemic erythrocytes insulin insulin normal erythroblastic leukemic ebl standard insulin competitive insulin degradation time dependent serum degradation dependent insulin fold specific ebl consistent increases insulin ebl transport aminolsobutyric incorporation ribonucleic insulin ebl maturation
DBT,DBT2739,streptozotocin plasma insulin glucagon somatostatin endocrine stz female rhesus mgkg resultant diabetic state dependent daily insulin injections insulin stz glucose glucose disappearance times glucose tolerance test insulin dependent plasma glucagon glucagon disturbed somatostatin insulin dependent delta populations pancreatic islets diabetic significant decreases increases delta stz diabetes diabetic state stz resembles human respect islets
DBT,DBT2740,coronary heart risk glucose tolerance male civil year coronary heart chd sugar oral glucose load chd subjects glucose tolerance igt sugar th centile equal sugar th centile igt group systolic subsequent chd findings relevant diabetes igt risk risk
DBT,DBT2741,fatty gamma linoleic arachidonic human daily linoleic linoleic equivalent gdie dietary allowance rda safety gdie fatty linoleic synthesis linoleic equivalent arachidonic antihypertensive effect unsaturated fatty therapy dietary effect insulin atheromatosis hesitate rich
DBT,DBT2742,policy early discharge risk group presence pulmonary serious rhythm disorders risk suitable home months weeks year complications early discharge day provisional selection short suitable hours free complications early selection risk subsequent discharge weeks overt complications fourth day results policy risk group
DBT,DBT2743,insulin lipoatrophy evidence immune skin diabetic lipoatrophy insulin diabetic lipoatrophy components lipoatrophy insulin lipoatrophic components walls whereas serum insulin micrograml micrograml findings insulin lipoatrophy results immune fixation release inflammatory mediators
DBT,DBT2744,reevaluation glucagon test pheochromocytoma vitro release medulla pheochromocytoma effect glucagon excretion system conditions flow system secretory drugs fluorimetric medium pig medulla human pheochromocytoma release hours glucagon minutes hours preincubation adrenaline nonadrenaline outputs second effect drugs release vitro medulla results previous healthy glucagon slight significant catecholaline effect glucagon normal subjects disorders
DBT,DBT2745,insulin overdosage diabetics diabetics insulin insulin overdosage insulin requirements avid hunger vertigo emotional glucosuria evidence insulin overdosage
DBT,DBT2746,erythrocytic diphosphoglycerate diabetes red dpg equal normal red dpg hb
DBT,DBT2747,insulinemia glucagonemia normal diabetic subjects gastrin sugar insulin glucagon protein cymethidine normal subjects anacidotic diabetes state glycometabolic significant enhancement gastrin rise total gastrin sugar insulin glucagon results rise gastrin cymethidine due dependent rise slight glucagon
DBT,DBT2748,effect streptozotocin diabetes turnover liver pyruvate carboxylase pyruvate dehydrogenase techniques effect streptozotocin diabetes carboxylase pyruvate dehydrogenase degradation diabetic pyruvate carboxylase normal terms dna immunoprecipitable protein ratio synthesis pyruvate carboxylase mitochondrial protein times diabetic degradation diabetic due synthesis dehydrogenase pyruvate dehydrogenase diabetic immunoprecipitable protein state degradation pyruvate dehydrogenase diabetes
DBT,DBT2749,effect estradiol pituitary diabetic estradiol pituitary normal receptor protein synthesis diabetic normal range
DBT,DBT2750,exogenous findings postmenopausal exogenous unexposed non likely menopause obesity risk estrogen extent stage tendency myometrial hysterectomy non unfavorable types short term non tendency independent stage significance risk ratio estrogen
DBT,DBT2751,insulin hepatocytes streptozotocin diabetic obese insulin uptake aminoisobutyric hepatocytes obese nonketotic streptozotocin diabetic hepatocytes obese size maximal insulin insulin aminoisobutyrate uptake insulin aminoisobutyrate uptake insulin resistant regard maximal insulin uptake aminoisobutyrate aminoisobutyrate maximal insulin insulin maximal aminoisobutyrate uptake hepatocytes diabetic uptake whereas maximal insulin insulin insulin insulin uptake aminoisobutyrate insulin resistance regard aminoisobutyrate hepatocytes obese insulin resistance hepatocytes interaction insulin receptor insulin insulin true hepatocytes diabetic
DBT,DBT2752,streptozotocin diabetes golden single diabetogenic doses return normoglycemia induction diabetes injections
DBT,DBT2753,double suprasellar pineal potomania suprasellar pineal year male potomania diabetes insipidus
DBT,DBT2754,sauna insulin subcutaneous effect finnish sauna insulin subcutaneous insulin dependent diabetic disappearance rapid insulin sauna minutes degrees insulin sauna glucose ml day fall glucose values proportional insulin effect sauna insulin diabetics due insulin effect snack insulin
DBT,DBT2755,traffic noise risk traffice noise traffic noise factor inhabitants minimum carsday carsday traffic volumes gout peptic ulcer noisy quiet respondents male females hypertensive noisy less
DBT,DBT2756,hemoglobin hemoglobins mini column methods vary lines diabetic healthy individuals different method correction
DBT,DBT2757,dietary management maturity dietary management maturity diabetes rigorous non insulin diabetic dietetic dietary group maturity diabetic group significant fall plasma glucose months chiefly due good dietary good dieting weight plasma glucose
DBT,DBT2758,insulin dependent insulin dependent diabetes full motor vehicle licence idd licence group unaware requirements declaration idd motor insurance severe hypoglycaemia months regularly insulin hypoglycaemia important factor diabetic retinopathy severe
DBT,DBT2759,shunt diabetic preretinopathy diabetic preretinopathy shunt significant diabetes evidence shunts occurrence perfusion
DBT,DBT2760,photocoagulation diabetic retinitis results diabetic retinitis pdr photocoagulation regular ups months photocoagulation techniques peripheral xenon coagulator laser successful therapy condition total photocoagulation pdr retinitis occurrence
DBT,DBT2761,experiences homologous vascular homologous method february femoro femoral femoro popliteal months open good results due conditions implants histological free good technical hence receiver subject vascular substitute
DBT,DBT2762,myopathy insipidus safe antidiuretic insipidus myopathy insipidus due hypothalamic lesions physicians occurrence serum gpt insipidus latent overt favors myopathy
DBT,DBT2763,diabetic diabetic drugs bradykinin simulate anaphylactic general
DBT,DBT2764,pancreatic exocrine work pancreatic diagnostic support status pancreas ultrasonic pancreas stool
DBT,DBT2765,hemoglobin canine minor hemoglobin hbac normal dogs dogs hemoglobin hbac diabetic dogs glucose status effectiveness insulin therapy
DBT,DBT2766,antidiuretic ligation effect ligation renal haemodynamics urine ligation maximal plasma normal output normal intrarenal determinants water excretion maximal intact congenital diabetes ligation ligation dependent antidiuretic
DBT,DBT2767,alloxan diabetes functional vein vitro tension idt diabetic medium magnitude normal removal contractile vs diabetics normals pyruvate lactate diabetics idt lactate overcame idt insulin contractile recovery glucose normal diabetic preparations diabetics group incubated unincubated ones glycerol diabetic diabetes induces fatty mitochondrial idt recovery pyruvate lactate
DBT,DBT2768,serum due metal ions induction zinc minutes usual hyperglycaemia hours induction manganese rise glucose chromium cobalt chlorides glucose level extent alloxan diabetic gpt normal serum chromium cobalt zinc manganese serum gpt cobalt chromium zinc manganese serum gpt cobalt chromium zinc manganese diabetic serum cobalt chromium zinc manganese significant normal effect serum coeruloplasmin
DBT,DBT2769,tolerance pyloric treated military discover pyloric previous condition gm oral glucose tolerance test glucose tolerance
DBT,DBT2770,renal hypertrophy renal hypertrophy diabetes sterological techniques total growth whole growth whole growth growth total proximal luminal luminal rapid growth fractional nephrectomy results disturbed glomerulo early phases diabetic renal hypertrophy
DBT,DBT2771,membrane morphological diabetic hypertrophy renal phases renal hypertrophy streptozotocin diabetic significant increases peripheral membrane luminal total unchanged cross whereas normal cross filtraton weeks normal
DBT,DBT2772,diabetic diagnostic heart heart diabetic tests heart heart hundred diabetics heart hrv diagnostic index diabetics peripheral hrv tests permanent damage diabetic observations little overall deterioration hrv year tests provide bedside heart normal
DBT,DBT2773,hypertriglyceridaemia diabetic hyperglycaemia hypertriglyceridaemia insulin independent diabetic hyperglycaemia insulin independent obese sem plasma insulin dependent diabetics normal subjects lipoprotein insulin independent mgkgh kgh mgkgh normal subjects insulin dependent diabetes plasma lipoprotein diabetics normals diabetic equivalent degrees postprandial hyperglycaemia plasma free fatty independent mmoll insulin dependent mmoll postprandial plasma insulin normal independent diabetics insulin dependent diabetics insulin independent diabetics hyperglycaemia lipoprotein normal plasma insulin triglyeride dependent diabetics due hypoinsulinaemia
DBT,DBT2774,effect xenon photocoagulation normotensive diabetic diabetic normal pressures effect panretinal xenon photocoagulation suction cup tonograph mmhg significant untreated fellow eye magnitude photocoagulation neovascular glaucoma
DBT,DBT2775,results photocoagulation diabetic retinopathy term eye photocoagulation untreated dark biomicroscopy photography fundus severe untreated minor unnoticed scotomas dark values untreated recordable term complications
DBT,DBT2776,diabetic diabetic thirds pubescence diabetic retinopathy results puberty probable factor diabetic retinopathy
DBT,DBT2777,diabetic diabetic normal slight diabetic retinopathy findings results diabetic normal exclude presence diabetic retinopathy antiography valuable method early diabetic retinopathy
DBT,DBT2778,transfusion therapy diabetes tactics transfusion therapy mutual burn metabolic transfusion methods successful possible
DBT,DBT2779,plasma dermato endocrine polyneuropathy oedema skin gynaecomastia females osteosclerosis hepatosplenomegaly good drugs year female aetiopathogenic
DBT,DBT2780,impact expectancy results decrement framework diseases heart diabetes elderly expectancy deaths due specific tapes impact expectancy females specific
DBT,DBT2781,motor conduction velocity hoffmann early diabetics results correlations term complications motor conduction velocity parameters insulin diabetics maturity diabetics groupe healthy diabetic subject evidence funduscopic renal status serum proteinuria parameters different diabetics results group parameters index motor conduction velocity diabetic
DBT,DBT2782,glucose disappearance diabetic mothers glucose disappearance glucose tolerance neonatal hypoglycemia lowest glucose disappearance glucose disappearance dextrose insulin dependent diabetic mothers disappearance endogenous kt exogenous kt dextrose hypoglycemia glucose disappearance endogenous kt equal significant inverse correlation lowest glucose endogenous kt correlation endogenous exogenous kt lowest glucose hypoglycemia maternal diabetes diabetic pregnancy maternal glucose glucose glucose disappearance diabetic mothers hypoglycemia
DBT,DBT2783,pre membrane diagnostic dilemma probable management
DBT,DBT2784,health lactic deals management types lactic appaent conditions cure underlying electrolyte
DBT,DBT2785,mongolian gerbil mongolian gerbil morbidity gerbil semi desert rodent biomedical weeks maternal diseases salmonellosis potential gerbil colonies hyperadrenocorticism non lipoid lesions organs ovary skin gerbil normal periodontal many respects man
DBT,DBT2786,interaction rifampin chlorpropamide year man chlorpropamide daily subsequent chlorpropamide rifampin months chlorpropamide
DBT,DBT2787,renal review literature diabetes vascular proteinuria risk renal renal obscure risk
DBT,DBT2788,phycomycosis obstruction mycetoma intermedius due phycomycetes literature prominent phycomycosis indolent lesions diabetics fungal localized complications pulmonary mucoid impaction bronchocentric resection therapy lesions
DBT,DBT2789,oxygenation results electro polycardiograms characteristis right parts heart right chambers heart functional pulmonary accepted therapy oxygenation tendency
DBT,DBT2790,diabetic retinopathy pregnancy year latent diabetics diabetics pregnancy diabetics retinopathy pregnancy proliferative fetal diabetic latent diabetic group proliferative pregnancy risk mother direct ocular complications
DBT,DBT2791,xenon photocoagulation diabetic maculopathy interim report results diabetic maculopathy ninety chosen random untreated treated untreated lines deterioration treated untreated good treated diabetic retinopathy severe occurs
DBT,DBT2792,invasive primary cutaneous phycomycosis diabetic ulcers cutaneous phycomycosis diabetic ulcers demonstration invasive fungal infection skin lesion therapy ulcer second hyperglycemia renal infection amputation phycomycetes diabetic ulcers infections early recognition subsequent successful therapy
DBT,DBT2793,pituitary ten prolactin growth gh gh level normal gh range partial gh level pituitary level permanent diabetes deaths gh hypoglycemia levodopa normal removal
DBT,DBT2794,pancreatitis review idiopathic miscellaneous pancreatitis underwent group emergency group pancreatitis findings diabetes fifty underwent deaths pancreatitis emergency deterioration uncertain operative pancreatitis operative pancreatitis specific pseudocysts pancreatic ducts specific objectives failures
DBT,DBT2795,diabetic diabetic protein degradation methods lateral sacs sparse hysosomes nuclear poles diabetic extent day lysosomes fusion tubules folds motor post intervals deposits sarcoplasm sarcoplasmic deposits cytochemical free medium naf nahpo glycerophosphate
DBT,DBT2796,tight metabolic pregnancy pregnancy glucose weeks pregnancy plasma glucose plasma glucose glucose perinatal congenital close term possible weeks deterioration fetoplacental test results results tight metabolic fetal morbidity overt diabetes pregnancy
DBT,DBT2797,hyperglycemia hyperglycemia unknown participants diabetes less unknown diabetes plasma glucose equal less diabetes stable many ratio obesity
DBT,DBT2798,ischemic heart risk ischemic heart representative total significant correlation incidences significant correlation weight significant diastolic pressures glucose serum serum triglycerides uric
DBT,DBT2799,pyelonephritis diabetes tomographic ct findings diabetic pyelonephritis excretory normal results denisty ct previous ct conventional techniques infectious renal
DBT,DBT2800,maternal term diabetic ischemic heart significant recent onset diabetic literature reveals maternal diabetic healthy infant weeks
DBT,DBT2801,effect diabetes electroretinogram components slow components observed weeks induction streptozotocin diabetic state urine glucose polydipsia polyuria effect diabetic weeks progressive wave epithelium diabetic
DBT,DBT2802,critical glycohemoglobin hba glycohemoglobin management conditions critical exchange method tolerance limits phosphate column phosphate hemoglobin soret nm total hemolysate overall run cv normal diabetic hbac hemolysates recovery results glycohemoglobin hemoglobin hbf method whereas red transport range glycohemoglobin diabetic good glycohemoglobin results normal range diabetics fair glycohemoglobin results total hb normal range
DBT,DBT2803,plasma pancreatic obesity plasma pancreatic group normal obese subjects second group normal obese pp protein rich results pp values obese subjects second possible pp obesity
DBT,DBT2804,risk current correction risk results morbidity important risk risk evidence date correction risk likely effect risk outweighs risk
DBT,DBT2805,vagus palsy vagal vagus palsy cranial vagal vagal laryngoscopic laryngeal recurrent laryngeal palsy recurrent laryngeal palsy idiopathic diabetes diabetic vagal entity subjects upper respiratory tract partial recovery half
DBT,DBT2806,term retrospective year overall year year previous year diabetes obesity nonsmokers time time nonsmokers
DBT,DBT2807,subclinical insulin dependent primary serum tsh insulin dependent diabetics serum tsh females less onset less time less females significant normal serum tsh tsh insulin dependent diabetics insulin months sulfonylurea insulin months subclinical primary female onset insulin dependent diabetics risk
DBT,DBT2808,critical test screenings early random trial subjects early correlation test latter method results possible test ogtt whereas preliminary subjects deeper investigation
DBT,DBT2809,oral components components related world important introduced eg
DBT,DBT2810,method insulin human erythrocytes insulin receptor ml enough possible insulin group mononuclear insulin method insulin normal subjects non obese diabetics insulin diabetic group due insulin insulin receptor insulin resistance
DBT,DBT2811,pancreatic insulin plasma urine problems methods significance literature review kinetics peptides urine problems free insulin possible methods insulin dependent diabetics
DBT,DBT2812,hypoglycemia hydroxycholecalciferol administraton mice hypoglycemia hrs hydroxycholecalciferol mice significant serum insulin hypoglycemic due extrapancreatic pretreatment alloxan diabetes
DBT,DBT2813,effect metabolic state diabetic sand psammomys obesus group male sand libitum hyperglycemia cabbage libitum weeks cabbage rapid weeks glucose tolerance insulin glycerol serum intraperitoneal glucose test way group mature sand cabbage hyperinsulinemia glucose tolerance diabetic hyperglycemia disturbed glucose tolerance insulin state glycerol serum range cabbage insulin plasma values sand glucose tolerance sand cabbage lipolytic fit sand hyperinsulinemia state glucose tolerance interaction insulin hormones lipolytic diabetic dietary
DBT,DBT2814,halothane insulin pyruvate dehydrogenase mammary effect halothane mitochondrial pyruvate dehydrogenase mammary liver pyruvate dehydrogenase starvation streptozotocin halothane effect halothane insulin rapid mammary liver effect insulin abolished starvation halothane mitochondrial pyruvate dehydrogenase insulin
DBT,DBT2815,metabolic glucose normal diabetic dogs metabolic glucose normal dogs diabetic dogs insulin peripheral glucose glucagon lactate pyruvate plasma non fatty state glucose normal normoglycaemic diabetic dogs circulating times hormones metabolites dogs pyruvate plasma fatty minor consistent glucose plasma insulin glucagon minor metabolic status metabolic glucose dogs peripheral hyperinsulinaemia hyperalaninaemia
DBT,DBT2816,triglycerides diabetic subjects effect insulin triglycerides glycogen specimens lateralis ergometric maximal year obese male subjects normals dependent diabetic good insulin dependent diabetic withdrawn rest subjects serum triglyceridesp glucose stores diabetic protein normal subjects diabetic triglycerides rest insulin glycogen rise serum glycerol non fatty
DBT,DBT2817,dependent diabetic mothers diabetics unselected insulin mothers method correction total diabetes non insulin dependent mothers dominant diabetes mody dependent diabetes second paternal relatives dependent diabetics insulin dependent dependent mothers non diabetics
DBT,DBT2818,effect insulin heart noradrenaline excretion glucose effect insulin renal haemodynamics excretion recent onset diabetics glucose unchanged glucose ml mlmin mmhg sd insulin heart beatsmin plasma noradrenaline ngml versus position insulin filtration renal plasma flow insulin findings insulin plasma glucose excretion insulin excretion significant rise heart plasma noradrenaline excretion insulin glucose excretion insulin due direct effect insulin endothelial epithelial
DBT,DBT2819,diabetic insulin haemoglobin insulin diabetic standard normal correlations significant correlation hbaic random plasma glucose random plasma glucose normal ml mmoll times day short insulin significant inverse correlation daily insulin injections results daily insulin injections diabetic insulin injections single plasma insulin different social psychological status shorter
DBT,DBT2820,propranolol wide range doses effect propranolol tolerance test correlation propranolol schizophrenia daily propranolol phenothiazine tolerance test gtt ten group mild diabetes significant gtt propranolol observations doses phenothiazine schizophrenia safe standpoint glucose insulin dependent diabetic severe hypoglycaemia glycogenolysis propranolol
DBT,DBT2821,biofeedback onset insulin diabetic frontalis biofeedback subject healthy stable units regular insulin daily weeks standard relaxation frontalis subject daily insulin weeks subject units regular insulin hyperglycemic hypoglycemic disturbing biofeedback months time subject healthy stable equivalent units regular insulin daily biofeedback subject biofeedback diabetic
DBT,DBT2822,important renal perfusion fifty ibm computer important prognostic term warm perfusion flow perfusate gases osmolarity race renal hla rejection final etc significant correlation parameters perfusate flow important effect term prognostic renal important mention significant diabetes cadaver matches group
DBT,DBT2823,cultures pancreatic fibroblasts method permits pancreatic fibroblasts system endocrine standard
DBT,DBT2824,degradation receptor insulin dissociation short term insulin interalization degradation receptor insulin processing insulin short term degradation insulin former time dependent insulin intact insulin degradation products trichloroacetic dissociation degradation release degradation plasma degradation insulin medium endocytotic uptake receptor insulin miroscopy ferritin insulin microm ferritin findings consistent degradation receptor insulin effect insulin glucose transport epinephrine lipolysis degradation receptor insulin insulin short term
DBT,DBT2825,glycosylation serum level serum normal diabetic subjects sugar preparations hydroxymethylfurfural hmf hydrolysis degrees normal diabetic subjects glucose sugar hemoglobin hbaia glycosyl insulin diabetic different glucose hemoglobin time results valuable sugar intervals turnover serum hbaia
DBT,DBT2826,serum glucagon subjects subjects diabetic subjects subjects glucose insulin glucagon growth prompt glucose serum insulin serum glucagon glucose glucagon peaks diabetic subjects growth subjects findings hypothesis glucose intolerance due release glucagon
DBT,DBT2827,eosinophilic granuloma proven histiocytosis thirty lesions polyostotic pulmonary lesions insipidus presented lesions lesions hand christian size lesion months subsequent soft lesions prognostic
DBT,DBT2828,determinants primary problems ocular ocular manifestations optometric determinants primary optometric shows primary record color presence conditions computer condition system facilitates retrieval color ready review specific conditions computer permits condition
DBT,DBT2829,look diagnostic diabetes typical signs plasma glucose controversy diagnostic diabetes oral glucose tolerance test ogtt world wide recognition need diagnostic cross world health organisation committee normal subjects glucose tolerance group diabetics uniform ogtt minimum diabetes
DBT,DBT2830,factor allele bff diabetogenic rare factor insulin dependent diabetes normal risk iddm positive positive linkage disequilibrium bff marks diabetogenic hla bff iddm evidence genetic iddm
DBT,DBT2831,evidence factor osteopenia diabetic idiopathic haemochromatosis osteopenia idiopathic haemochromatosis parameters diabetic idiopathic haemochromatosis intestinal double radiotracer mineral forearm camerons iii plasma ngml competitive protein radioassay results obtained ten diabetics haemochromatosis haemochromatosis significant fall total fractional diabetics haemochromatosis furthermore plasma haemochromatosis ngml less diabetics haemochromatosis ngml less results haemochromatosis important ie plasma oh intestinal latter rarefaction
DBT,DBT2832,coma diabetics diabetic coma deaths due coma hypoglycaemia ketoacidosis hyperosmolar coma lactic ketoacidosis deaths diabetes group many important factor ketoacidosis hyperosmolar coma phenformin lactic coma rare treated diabetic
DBT,DBT2833,aldose eye aldose seminal specific prepared rabbits unlabeled tissues sites diabetic lesions eye epithelial lenticular inner epithelium posterior iris muller contain immunoreactive inner medulla specific thin henle tubules inner medulla transitional epithelial pelvic podocytes tubules tubules proximal tubules contain immunoreactive
DBT,DBT2834,aldose peripheral aldose seminal deae sephadex column pool pool rabbits subcutaneous pool specific immunoprecipitation ouchterlony double immunodiffusion methods unlabeled tissues sites diabetic lesions cross ouchterlony competitive protein localized tissues sheath peripheral sustentacular
DBT,DBT2835,stimulus insulin release pancreatic islets decarboxylation ketoisocarproate compatible acetoacetate atpadp ratio normal values whereas ratio nadphnadp ratio release insulin ketoisovalerate valine mimicks effect islets insulinotropic effect less glucose endogenous metabolic secretory islets fuel hypothesis insulin release
DBT,DBT2836,bicarbonate diabetic oxygen metabolic therapy bicarbonate nahco partial hcl acidemia diabetic ketoacidosis unanesthetized dogs full correction bicarbonate significant less pcsf hcl acidotic dogs torr torr ketoacidotic dogs torr torr hours ketoacidotic dogs bicarbonate significant pcsfo inverse lactic level po concluded nahco therapy diabetic ketoacidosis dysfunction initiation therapy acidemia
DBT,DBT2837,thromboxane synthesis diabetic vascular arachidonic lewis male diabetic streptozotocin results matched parameters release fatty platelets aortas fatty thromboxane keto pgf platelets diabetic platelets release arachidonic thrombin stimulus arachidonic thromboxane diabetic release arachidonic diabetic vascular keto pgf vascular tissues arachidonic vascular tissues thrombin vascular arachidonic specific effect arachidonic significant thromboxane pgi diabetic microvascular diabetes
DBT,DBT2838,fiber gastrointestinal microecology gastrointestinal tract unique microecology microorganisms mouth stomach foods important homeostatic mechanisms salt enterohepatic recent importance foods hemicellulose pectins polysaccharides importance food microflora intestinal microecology human host glucose tolerance diseases intestinal microecology need elaboration
DBT,DBT2839,glucagon curable condition mallinson skin rash glucagon typical skin rash necrolytic migratory erythema weight glossitis cheilitis angularis prominent glucose tolerance slight half malignant year man glucagonoma tail pancreas cure disappearance skin rash weeks extirpation impressive year man pancreatic left
DBT,DBT2840,antidiuresis desamino vasopressin ddavp correlation plasma nephrogenous effect ddavp desamino vasopressin plasma nephrogenous insipidus single intranasal micrograms plasma ddavp pgml subsequent time plasma ddavp irregular plasma ddavp pgml antidiuresis level nephrogenous different ddavp fold correlation nephrogenous free water clearance results ddavp gradual slow metabolic clearance persistent receptor level antidiuretic synthesis exert
DBT,DBT2841,pituitary functions diabetic male effect receptor intact diabetic pituitary single alloxan mgkg weeks lh prolactin receptor weeks ethylamide second day lh receptor weight intact diabetic seminal weight diabetic diabetic pregnenolone progesterone progesterone dihydrotestosterone normal limits possible diabetic plasma lh weeks plasma unchanged pituitary intact diabetic lh diabetic
DBT,DBT2842,insulin evidence insulin somatomedin receptor vivo ketone ions ions insulin receptor glucose effect insulin full insulin receptor much questions
DBT,DBT2843,metabolic specific therapy diabetes genetic epidermal differentiation arachidonic evidence critical metabolic pathophysiology
DBT,DBT2844,pituitary middle man weight hypokalemic melanosis free cortisol micrograms plasma pgml ectopic plasma hydroxycorticosteroids plasma level metyrapone free cortisol hydroxycorticosteroids venous plasma peripheral venous laboratory findings ectopic occurrence exploration pituitary pituitary rare documents severe melanosis cushings consistent pituitary melanosis pituitary ectopic nelsons
DBT,DBT2845,endocrine pancreas normal pregnancy diabetic pregnancy different celltypes pp normal diabetic non normal juxta duodenal pancreas pp versus fewer glucagon pregnancy total versus diabetic endocrine juxta duodenal pancreas non diabetic pancreas diabetic glucagon islets diabetic diabetic versus
DBT,DBT2846,glycemia insulin release man pgi intra peripheral vascular hyperglycemic effect normoglycemic pgi ngkgmin unmasked rapid glucose diabetic glucose ngkgmin glucose glucose hypoglycemic non diabetic insulin release normoglycemic hyperglycemic reversible pgi usual risk diabetes
DBT,DBT2847,pancreatic somatostatinoma pancreatic somatostatinoma yr steatorrhea pancreatic somatostatin calcitoninlike substances extracts sephadex peaks somatostatin human hypothesis single cross neutral components less total permeation plasma somatostatinlike components different components weights peptides standard preparations somatostatin pancreas components related somatostatin inappropriate secretions
DBT,DBT2848,intra deaths uncertain normal fetal heart fetal times risk intra labour results normal abruptio deaths many intra complications due placenta infection true test results haemolytic double heart normal security
DBT,DBT2849,homotransplant pancreas exocrine results pancreas allotransplantations diabetic exocrine acrylate glue system metabolic glycidic whole acrylate glue pancreatic exocrine athrophy islets
DBT,DBT2850,reversible mild chlorpropamide onset diabetes oral chlorpropamide oral tolerance weeks therapy sequential tests significant intolerance normal insulin therapy remission group diabetes significant remission sulphonylurea therapy
DBT,DBT2851,glucose insulin glucose intolerance review differentiate glucose tolerance related frank etc time evidence insulin glucose intolerance questions
DBT,DBT2852,management diabetic home glucose meters insulin dependent diabetic glucose meter non meter weeks day glucose weeks weeks metabolic profiles normal equivalent gestational glucose non meter non diabetic glucose mmoll meter group non meter group diabetic meter home mmoll meter good glucose diabetics
DBT,DBT2853,diabetes effect hdl independent serum hdl hdl serum serum sugar haemoglobin hba diabetic diabetic estimate diabetic diabetic insulin serum hdl diabetic insulin normal diabetic insulin normal diabetic insulin serum hdl different normal diabetic diabetic populations terms serum hdl correlation serum hdl male female diabetic insulin diabetes significant serum hdl insulin diabetic marginal hba serum hdl insulin diabetes diabetes insulin
DBT,DBT2854,histological glucagonoma year dermatitis insulin dependent previous embolism immunoreactive plasma glucagon pgml plasma metastases dermatitis streptozotocin good results histological cutaneous lesions epidermal bullous intra epidermic detachment pancreatic tumour trabecular important sclerosis microscopy tumoral syncitial different typical glucagon
DBT,DBT2855,oral glucose tolerance test oral glucose tolerance tests non diabetic relatives diabetics second intervals individuals logarithmic values values values lowest significant individuals term short term total glucose random random single ogtt
DBT,DBT2856,effect insulin damage ccl histological damaging healthy diabetic mgkg histological hyperinsulinemia slight protective damage ccl liver
DBT,DBT2857,effect insulin damage ccl damaging healthy diabetic mgkg hyperinsulinemia effect damage ccl bilirubinemia transaminasemia
DBT,DBT2858,incorporation pphosphate pyruvate dehydrogenase heart evidence sites heart pyruvate dehydrogenase procine heart phosphorylation methods incorporation heart oxoglutarate malate total sites phosphorylation normal diabetic phosphorylation diabetic normal normal pyruvate results incorporation diabetic incorporation effect phosphorylation heart evidence phosphorylation sites dephosphorylation heart
DBT,DBT2859,autograft pancreatic dogs intrasplenic autotransplant pancreatic dogs total prevent normoglycaemic condition normal insulinaemic iv pancreatic short collagenasis time minutes normal glucidic
DBT,DBT2860,pituitary diabetic male serum diabetic male intact male serum diabetic
DBT,DBT2861,pancreatic report review literature pancreatic islets typical skin rash migratory necrolytic erythema stomatitis glucose tolerance time resection metastatic sites liver streptozotocin stz dimethyl triazeno imidazole stz therapy dermatitis stz specific stz delta man
DBT,DBT2862,diabetic heart fact significant diabetics heart excess due coronary athersclerosis many risk diabetics non diabetics fact heart synonymous coronary heart evidence heart coronary atheroma micro autonomioc
DBT,DBT2863,volatile metabolites normal diabetic profiles volatile metabolites normal individuals individuals diabetes degrees polyneuropathy transevaporator extracts glass column silar id normal subjects diabetic subjects therapy correlations ketones diabetic normal sera spectrometry
DBT,DBT2864,olfactory sensitivity humans genetic olfactory sensitivity isobutyric sec male pairs extent odor evidence heritability olfactory sensitivity odor cigar pipe
DBT,DBT2865,diabetic report maturity diabetes thoracic aorta right femoral diabetics vascular disorders white diabetics
DBT,DBT2866,orthopedic many functions early skin liver serum iron serum iron serum ferritin level hand bunion replacement need
DBT,DBT2867,congenital diabetes growth recessive insulin dependent neonatal onset endochondral growth radiological histological observed types likely occur genuine entity condition recessive possible
DBT,DBT2868,eye cataract glaucoma diabetic retinopathy macular degeneration general ophthalmologic glaucoma diabetic retinopathy macular degeneration massachusetts heart subjects protocols record diagnostic specific screen diseases tables quality findings tables eye institute
DBT,DBT2869,multifocal banal concussion process orbital glaucoma lymphostasis severe eye insipidus hypophysis postchiasmatic hemianopia severe apart process remarkable harmless concussion unfit work
DBT,DBT2870,emotional educational disorders diabetic emotional educational status group diabetic interaction diabetic diabetic girls rutter schools diabetic means group diabetic diabetic diabetic figures diabetic presence backwardness diabetic psychosocial diabetic presence psychosocial serious diabetic insulin emotional problems
DBT,DBT2871,shwachmans review male female months exocrine pancreatic neutropenia erythroleukaemia severe infections rd centile growth maturation deformities respiratory tests thoracic gas wall forced vital neurological iq neurological retinitis pigmentosa neonatal problems birthweights evidence liver dental renal dysfunction icthyotic rash puberty diabetes dysmorphic findings stress manifestations segregation support hypothesis
DBT,DBT2872,neonatal macrosomia maternal diabetes effect maternal diabetes somatic growth mechanisms fetal growth dna maternal status normal glucose excretion diabetic gday glucose diabetic gday glucose total dna contents sem normal diabetic diabetic mothers dna results neonatal macrosomia maternal diabetes dna possible sites diabetic
DBT,DBT2873,viscosity male diabetics retinopathy viscosity determinants plasma fibrinogen plasma viscosity male insulin diabetics diabetic subjects habit diabetics retinopathy viscosity cp cp cp cp correction viscosity standard haematocrit plasma viscosity cp vs cp plasma fibrinogen gl vs gl diabetics viscosity diabetics retinopathy cp vs cp cp cp haematocrit viscosity haematocrit
DBT,DBT2874,gangrene serious peripheral vasopressin vasopressin pitressin peripheral esophageal report gangrene vasopressin infiltration esophageal explanations diabetic peripheral vascular compression proven vasoconstrictive vasopressin
DBT,DBT2875,eye introduction monograph monography eye cataract glaucoma diabetic retinopathy macular degeneration general liebowitz maunder ophthalmology eye institute diseases severe handicap united protocols record specific tables quality findings
DBT,DBT2876,ill staff hemophilia lymphoma neuroblastoma renal cystic fibrosis many diseases conditions today little emotional reactions important process emotional reactions framework emotional reactions staff ill types emotional settings
DBT,DBT2877,diabetes successful primary university southern schools pharmacy pico rivera health educational diabetic posttests pharmacist interns
DBT,DBT2878,haemoglobin subject rapid dependent diabetic pancreas recent haemoglobin hba subject rapid verify insulin dependent diabetic underwent normalization glycaemia pancreas significant hba sd different due non methods subfraction haemoglobin schiffs likely reversible manner
DBT,DBT2879,plasma vasopressin standard test polyuria standard test vasopressin plasma vasopressin nonglucosuric polyuria severe neurogenic diabetes tests vasopressin partial neurogenic diabetes normal vasopressin direct primary polydipsia insipidus primary polydipsia test evidence partial vasopressin direct inability test partial neurogenic diabetes primary polydipsia sensitivity former maximal incorporation vasopressin improves polyuria
DBT,DBT2880,risk coronary computer risk factor census risk obesity day census different presence heart fewer nonsmokers group group prevent prevent heart
DBT,DBT2881,ketotic dicarboxylic aciduria vitro omega monocarboxylic diabetic monocarboxylic adipic suberic sebacic hydroxybutyric vivo unstarved diabetic ketotic octanoic decanoic dicarboxylic lauric dicarboxylic unstarved lauric dicarboxylic myristic myristic ketotic diabetic palmitic dicarboxylic diabetic ketotic monocarboxylic gas liquid spectrometry decanoic lauric micrometers whereas octanoic negligible dicarboxylic aciduria ketotic monocarboxylic free adipic suberic omega monocarboxylic dicarboxylic liver octanoic decanoic lauric myristic palmitic omega dicarboxylic lengths correction dicarboxylic vitro dicarboxylic monocarboxylic endogenous dicarboxylic monocarboxylic palmitic strongest effect fact palmitic omega starvation endogenous vitro hexadecanedioic
DBT,DBT2882,diabetes glycerolipid streptozotocin diabetes significant rise serum liver triacylglycerol triacylglycerol vivo microsomes incorporate sn cglycerol phosphate neutral diacylglycerol triacylglycerol presence coa palmitate streptozotocin microsomal neutral rise microsomal phosphatidate phosphohydrolase streptozotocin diabetic dependent increases phosphatidate phosphohydrolase serum triacylglycerol fatty insulin units zinckg intervals doses streptozotocin diabetic rise triacylglycerol insulin streptozotocin increases triacylglycerol phosphatidate phosphohydrolase monolayers plasma diabetic streptozotocin incorporate sn cglycerol phosphate triacylglycerol plasma importance plasma acylglycerol monolayers plasma normal plasma components diabetes glucose oleate ketones increases diabetic plasma fatty oleate diabetic plasma rise triacylglycerol phosphatidate phosphohydrolase
DBT,DBT2883,evidence insulin dependent investigation insulin dependent hla genotypes healthy conventional ica igg fixation cf ica techniques regular diabetic year range months igg positive cf ica positive observations initiation onset important implications possible future prophylaxis
DBT,DBT2884,liver streptozotocin diabetic liver prepared normal streptozotocin diabetic liver diabetic diabetic metabolites fold quinolinate synthesis findings consistent picolinate carboxylase types fluxes fluxes whereas diabetic fold fold picolinate carboxylase diabetic synthesis unchanged whereas insulin metabolic fate
DBT,DBT2885,glucose tolerance diabetes manihiki atoll island group diabetes females glucose tolerance females glucose tolerance obese normals diabetes glucose tolerance manihiki good income copra pearl shell way probable glucose tolerance living patterns subsistence cash economy
DBT,DBT2886,penile sonography impotent diabetics systolic method diabetic erectile impotence urodynamic tests neurological impotence results double sole neurogenic vascular diabetic subjects
DBT,DBT2887,normal diabetic intestinal microvillous effect streptozotocin diabetes intestinal microvillous membrane weeks purified microvillous intestine borohhydride membrane sialic sodium metaperiodatesodium borohhydride protein diabetic galactoprotein sialic unchanged galactoprotein protein monomers less results intestinal microvillous membrane protein glycosylation diabetes membrane proteolytic degradation microvillous protein membrane presence systematic membrane protein glycosylation diabetic state
DBT,DBT2888,hyperlipoproteinaemia diabetic bezafibrate hyperlipoproteinaemia phospholipids investigation trial protocols pretreatment bezafibrate months triglycerides sugar hdl bezafibrate parameters achieved sugar hba hdl values epl bezafibrate epl
DBT,DBT2889,sugar insulin rapid insulin dependent diabetics total insulin insulin contents single insulin portions insulin insulin dependent diabetics insulin requirements investigation endocrine pancreas conditions dietary total calory input day insulin dependent diabetics less cost
DBT,DBT2890,diabetic wistar potential clamp single fibres sciatic diabetic wistar diabetes demyelination paranodal potential clamp fibres potential na currents specific permeability axoplasmic na fibres permeability conductance excitability fibres permeability findings dysfunction permeability precede permeability paranodal demyelination
DBT,DBT2891,renal functional hemispheric diabetic diabetic minor vascular ischemic episodes renal comatose episode severe neurological functional due neurological
DBT,DBT2892,phagocytosis dependent cytotoxicity phagocytosis dependent cytotoxicity healthy phagocytosis cr diabetics phagocytosis diabetics less ones leucocytes
DBT,DBT2893,convulsions electrographic etiopathogenic prognostic neonatal convulsions status convulsions gestational weeks hours onset convulsions previous ones populations term pre post ictal neurological severe precocious onset convulsions interictal status epilepticus terms ie gestational eegs lesions lesions gestational mild convulsions status epilepticus convulsions discharges prognostic presence sleep early hours onset convulsions neonatal convulsions asphyxia meningo encephalitis due metabolic unknown unknown convulsions day full term newborns recent due obstetrical neonatal
DBT,DBT2894,cns cesarean newborns university obstetrics cesarean morphological hypoxic ischemic cns lesions cesarean vaginal significant risk lesions cesarean correlation group cesarean cns lesions risk factor para iii maternal diseases eph gestosis placenta rupture prematurity apgar significant risk social unemployed mothers mothers rural hours transverse hydramnion previous cns lesions cesarean different social
DBT,DBT2895,results vitrectomy diabetics report vitrectomy intravitreal incipient recurrent proliferative diabetic retinopathy deterioration
DBT,DBT2896,rubeosis iridis vitrectomy diabetics retrospective diabetics diabetic retinopathy rubeosis iridis thirds operative rubeosis iridis stage diabetic retinopathy means
DBT,DBT2897,diabetic retinopathy male diabetics diabetes diabetic retinopathy condition hcg lh rh tests results normal full findings hypothalamic hypophysogonadal dysregulation inverse correlation leydigs correlation lh normal lh rh test retinopathy
DBT,DBT2898,hb glycohemoglobin pregnancy tolerance hb hb normal significant postnatal significant correlation glycohaemoglobin healthy protodiabetic diagnostic means glucose intolerance protodiabetic observations hb dynamic dependent condition
DBT,DBT2899,diabetics histological exazerbations diabetics underwent healthy findings normal male diabetics epithelium middle foreground effect fertility childlessness diabetic coeundi important
DBT,DBT2900,serum lipids effect sera group nigerian diabetics group range normal total hdl normal ratio total hdl level hdl total occurs lipoprotein disturbed
DBT,DBT2901,medicines tolerance diabetic cay mice medicines tolerance diabetic cay mice tolerance cay mice mathematical types effect ka jio byakko ka ninjinto effect whereas tendency effect crude drugs blended medicines effect rehmanniae rhizoma ka jio byakkoto ginseng radix byakko ka effect rehmanniae rhizoma ginseng radix effect hypoglycemic ginseng radix dpg effect dependent manner drugs crude blended medicines effect
DBT,DBT2902,electrodiagnostic peripheral dogs dogs diabetes term canine electromyographic findings potentials positive sharp waves potentials dogs values motor conduction sciatic tibial diabetic dogs values ncv normal dogs laboratory ms sensory ncv lateral radial diabetic dogs months ms normal dogs potentials interosseous sciatic tibial potentials hip potentials dispersion diabetic dogs
DBT,DBT2903,obesity weight height monor index obese obesity diabetes obesity nursing thanks
DBT,DBT2904,doublet means deformability erythrocytes doublets tested doublet subsequent process red membrane bend attraction doublet medium permits doublet permanent record diabetic diabetic subjects doublet different half diabetics doublets non diabetic doublets overall correlation doublet glucose doublet microvascular complications doublet rapid means deformability diabetes
DBT,DBT2905,phospholipids diabetes fatty subjects less phosphatidylserine platelets phosphatidylserine less fatty palmitic linoleic less diabetes diabetes arachidonic less diabetics vascular diseases
DBT,DBT2906,dysfunction diabetic retinopathy microcomputer diabetic retinopathy tachycardia beatsmin manoeuvre retinopathy dysfunction less less manoeuvre less results important diabetic retinopathy dysfunction
DBT,DBT2907,due mycobacterium chelonei diabetic diabetic mycobacterium chelonei var chelonei skin tests valuable results erythromycin
DBT,DBT2908,diabetic mice serum liver serum liver alloxan swiss homozygous obob heterozygous ob dbm diabetic mice genetic diabetic mice serum liver dbm slight genetic alloxan diabetic homozygous obob fold significant results regulatory glucose metabolic gene phylogenesis group sensitivity mutations glucose sensitivity insulin regulatory mechanisms
DBT,DBT2909,fatty diabetic liver peroxisomes diabetic alloxan peroxisomal cyanide carnitine mitochondrial times level peroxisomal medium coas shorter lengths carnitine times level peroxisomal hand level mitochondrial carnitine acyltransferase peroxisomal shorter medium coas results peroxisomal fatty transport coa medium coa nadh peroxisomes urgent energy fatty diabetic condition
DBT,DBT2910,plasma diabetics microvascular plasma state standard insulin dependent diabetics severe proliferative retinopathy diabetics complications diabetic subjects diabetic subjects diabetic complications group complications significant correlation increment less correlation glucose hba evidence support hypothesis term diabetics influences diabetic microvascular complications
DBT,DBT2911,hypoglycemic dependent diabetics hypoglycemic symptomatology insulin dependent diabetics prone hypoglycemia double cross cardioselective metoprolol months hypoglycemic severe hypoglycemic metoprolol cardioselective insulin dependent diabetics direct obvious signs drugs
DBT,DBT2912,congenital palsy ipsilateral maternal diabetes congenital palsy ipsilateral insulin diabetics multidirectional hypoplasia cochlea vestibule canals normal weeks gestational ossification inner maternal diabetes
DBT,DBT2913,glucose insulin dependent diabetics diabetics checklists glucose level times day correlations level subjects glucose fluctuations subject subject glucose correlations findings glucose settings
DBT,DBT2914,persistent nonketotic hyperglycemia prognostic severe persistent nonketotic hyperglycemia nkh plasma mml sd nkh coma coma intracranial diabetes glucose nkh time nkh early severe injury nkh direct correlation level glucose
DBT,DBT2915,ischemic normal angiograms vascular ten year hemispheric ischemic free extracranial occlusive lesions terms recurrent months months due recurrent hemispheric severe risk normal angiograms hemispheric tias good
DBT,DBT2916,diabetic nephropathy perinatal effect diabetic nephropathy pregnancy perinatal infant pregnancy maternal renal maternal proteinuria pregnancy gm hours trimester proteinuria diastolic clearance pregnancy proteinuria mothers fall clearance underwent weeks related maternal clearance neonatal morbidity perinatal congenital normal months perinatal diabetic nephropathy
DBT,DBT2917,aortoiliac occlusive year aortoiliac atherosclerotic occlusive claudication ischemic problems diseases heart heart good ie femoral pulses early results claudication term significant successful intervals amputation claudication functional results amputation herein
DBT,DBT2918,risk factor single versus coronary single coronary risk factor fourth single group individuals group group fewer risk fewer ecg stress test group single versus coronary representation fewer functional noninvasive tests risk presence likely resistance atherosclerotic heart
DBT,DBT2919,hypoglycemic benzimidoylpyrazoles benzimidoylpyrazoles hypoglycemic methyl cyclohexylbenzimidoyl methyl pyrazolecarboxylate methyl methoxyphenylbenzimidoyl methyl benzimidoylpyrazoles phenformin buformin cytotrophic sulfonylureas benzimidolypyrazoles preliminary structure
DBT,DBT2920,postprandial hypoglycemia hypoglycemia norms glucose tolerance test values free nadir group ten glucose nadirs values less values hypoglycemia glucose load nadir hypoglycemic usual many plasma glucose group tests nonhypoglycemic hypoglycemia normoglycemic nadirs overlap hypoglycemia sugar times plasma glucose functional hypoglycemia food timing correlation glucose test results
DBT,DBT2921,term intraperitoneal insulin remote insulin report day programmable insulin insulin dependent diabetic prevent insulin hoechst frankfurt good metabolic date insulin hypoglycemic good siemens dfa
DBT,DBT2922,nude insulin dependent diabetic man diabetic ip nude mice mice single injections islets mice injections islets mice injected ip saline mild random post ip glucose hyperglycemia pancreatic membrane structure immune process observed
DBT,DBT2923,glucose tolerance respiratory liver possible oxidative glucose liver liver diseases persistent hepatitis normal glucose tolerance respiratory normal normal glucose tolerance whereas hepatitis diabetic glucose tolerance ie hepatitis half normal level liver cirrhotics glucose intolerance normal hypoinsulinemia oral glucose load liver tests oral glucose tolerance test respiratory liver diseases close glucose histological liver
DBT,DBT2924,liver regimens pyrazinamide group tuberculous months irsz histology liver tests months group irse results group nonalcoholic tolerance support tuberculous significant persistent dysfunction regimens sgpt
DBT,DBT2925,filaments diabetic fibrovascular preretinal membrane vitrectomy diabetic microscopy myosin subfragment identify filaments proliferative diabetic retinopathy fibrovascular preretinal membrane posterior detachment fibrovascular normal mature thick protein phenomena membrane
DBT,DBT2926,growth somatomedin insulin dependent gh somatomedin growth insulin dependent iddm glucose serum gh plasma intervals yr yr normal subjects sem hemoglobin vs serum gh ngml vs ngml evidence inadequate diabetes gh subjects normal uml normal growth significant group significant correlation group plasma serum gh serum glucose subject findings normal gh normal iddm partial gh
DBT,DBT2927,pregnancy dogs methods findings literature possible methods pregnancy drugs prevent disadvantages progestagens uterus ceh mammary mammary tumours diabetes hand untoward side due androgenic enlargement clitoris vaginitis masculinization puppies pregnancy pros methods drugs possible effect
DBT,DBT2928,laser photocoagulation circinate diabetic retinopathy diabetic retinopathy macular laser photocoagulation leaking circinate forty findings year year untreated treated ten untreated resolution macular treated none untreated acuities former group
DBT,DBT2929,disorders lithium disorders independent lithium lithium glucose tolerance frank metabolic complications diabetic state hyperosmolality salt depletion lithium risk serum management disorders lithium
DBT,DBT2930,versus diabetic primary renal march primary renal allografts uremic insulin dependent diabetes diabetic underwent limb amputation months perioperative risk months amputation diabetic renal amputation severe manifestations vascular amputees year amputation diabetics amputation nonamputees demographic transplant less transplant less dialysis less months hla nonidentical related diabetics amputation allografts hand diabetics amputation year
DBT,DBT2931,review cure evidence metabolic important term complications methods therapy effect diabetic complications many
DBT,DBT2932,growth insulin serum pancreas dogs normal serum insulin glucose pancreas serum growth day serum insulin fold growth injections glucose rise serum insulin times normal growth pancreatic insulin normal permanent diabetes growth serum insulin serum insulin glucose pancreas normal immunoreactive insulin pancreas tail regions results state insulin hyperinsulinaemia growth insulin hypoinsulinaemia serum due normal
DBT,DBT2933,trial effect dietary insulin independent diabetic insulin independent diabetic weighted dietary intakes months group total energy total energy energy group unchanged weight group obese equal kgm plasma hba triglycerides unchanged plasma total group significant deterioration diabetes weight total
DBT,DBT2934,coronary heart dependent insulin independent diabetics fate diabetics subjects presence coronary heart diabetics insulin dependent insulin independent nonobese insulin independent obese group insulin insulin independence unclear findings random general excess close relatives diabetic insulin independent non obese diabetics coronary heart close relatives dependent diabetics general close relatives independent obese group obese insulin independent diabetics excess coronary heart diabetes results coronary heart independent obese diabetics evidence
DBT,DBT2935,exogenous aorta exogenous glucose pyruvate hydroxybutyrate palmitate aorta streptozotocin mgkg metabolic weeks glucose pyruvate hydroxybutyrate palmitate effect glucose pronounced glucose diabetic aorta insulin glucose diabetic aorta glucose diabetic diabetic aorta insulin medium glucose pretreatment sacrifice glucose lactate medium glucose lactate diabetic aorta diabetic striated
DBT,DBT2936,effect term metformin diabetic mice dbm genetic diabetic obese hyperinsulinaemic mice dbm dbdb term metformin mgkg day intubation th th hypoglycemic effect hbac immunoreactive plasma insulin homozygous mice homozygous significant food lipids pancreatic islets homozygous microscopy th heterozygous morphological canalicular foreign th mice th less exhaustion degeneration th plasma iri
DBT,DBT2937,insulin human iii effect serotonin metergoline effect metergoline powerful antiserotoninergic insulin diabetic subjects daily post test insulin glucose total insulin glucose disappearance glucose insulin metergoline results support hypothesis endogenous monoamine important insulin human non insulin dependent
DBT,DBT2938,significance cyclase normoglycemic hyperglycemic sand sand normoglycemic state means conditions noradrenaline cyclase hyperglycemic hyperinsulinemic sand vitro system cyclase noradrenaline presence deaminase medium effect interference vitro deaminase medium deaminase noradrenaline effect cyclase diseases results release cyclase hyperglycemic hyperinsulinemic sand
DBT,DBT2939,glucose hyperkalemia sodium restriction normaldosteronemic hypertonic glucose serum normokalemic group hyperkalemic insulin dependent diabetes withdrawal diabetic normal plasma renin glucose hyperkalemia group diabetic normal plasma group findings different level normal compartments hyperkalemia findings sodium restriction dramatic plasma hyperkalemia glucose serum index glucose diabetic sodium group sensitivity possible hypoaldosteronism diabetic normal plasma
DBT,DBT2940,glucose hyperkalemia normaldosteronemic diabetes hypertonic glucose hyperkalemia year normaldosteronemic sodium restriction mmolday serum dramatic significant less inverse correlation serum plasma serum successful antithyroid hyperkalemia
DBT,DBT2941,diseases healthy diabetic iv fructose liver glucosefructose status different laboratory values results glucose glucose glucose values permanent insulin antilipolytic antiketogenic anticatabolic equicaloric glucose
DBT,DBT2942,diseases healthy diabetic glucose healthy liver hours glucose glucosekg status different laboratory values glucose metabolic lipolysis diabetic group sugar values energy glucose side
DBT,DBT2943,dimethyl thyronine therapy diabetic pregnancy fetal phospholipids pregnancy neonatal respiratory distress due synthesis fetal fetal maturity diabetogenic management diabetic pregnancy respiratory distress maternal dimethyl thyronine dimit results significant enhancement fetal synthesis maturity mgkg sc alloxan diabetic rabbits dimit diabetic maternal rabbits maternal glucose vs less fetal glucose vs less saline diabetic mothers fetal insulin maternal dimit therapy diabetic rabbits maternal diabetes significant fetal vs less protein vs mggm restored normal dimit diabetic rabbits maternal dimit significant fetal glycogen vs protein diabetic vs protein whereas maternal diabetes fetal dimit therapy results short term maternal dimit diabetic rabbits fetal synthesis maternal hyperglycemia potential management diabetic pregnancy
DBT,DBT2944,diabetic orthostatic hypotension hemodynamic output heart plasma splanchnic flow peripheral subcutaneous flow plasma epinephrine renin supine position quiet normal subjects diabetic beat beat heart hyperventilation severe orthostatic hypotension position diabetics orthostatic hypotension whereas decreases heart output plasma total peripheral resistance splanchnic vascular resistance subcutaneous vascular resistance less orthostatic hypotension plasma orthostatic hypotension less whereas renin diabetic hypoadrenergic orthostatic hypotension lack vascular resistance sympathetic resistance output plasma normal subjects diabetics
DBT,DBT2945,antagonistic glucose glucagon non insulin dependent normoglycemic subjects current verapamil glucose glucagon non insulin dependent niddm normoglycemic glucagon verapamil saline glucose glucagon niddm whereas glucose glucagon discrepancy verapamil insulin verapamil effect serum glucose prevail niddm healthy
DBT,DBT2946,minor hemoglobin components diabetic uremic aab automated method diabetics subjects renal hb diabetics less glucose values months diabetics hb hb uremic non diabetic periodic hemodialysis returned different hb aab diabetic subjects uremic less hemoglobin values name hb renal methods hb aab
DBT,DBT2947,decidual arteriopathy pregnancy immunofluorescent lesions uteroplacental vasculature lupus erythematosus idiopathic fetal growth decidual normotensive hypertensive diabetic direct decidual curettage snap placenta normal hypertensive disorders dependent diabetes lesions necrosis atherosis decidual primary stable normotensive diabetes fibrinoid decidual specific preeclampsia lesions subjects findings support immunoprotein decidual hypothetical specific preeclampsia preeclampsia vascular coagulation
DBT,DBT2948,ischemic heart many peripheral coronary hyperlipidemia hormones emotional stress contribute thromboxane recent ischemic transcardiac thromboxane effect important ischemic vascular correction dietary receptor specific
DBT,DBT2949,hyperglucagonemia plasma normal diabetic man normal insulin dependent diabetic glucagon plasma glucagon glucagonoma normal subjects plasma insulin uuml level diabetic insulin glucagon rise isoleucine tyrosine phenylalanine glucagon diabetics man
DBT,DBT2950,streptozotocin insulin effect insulin replacement man insulin plasma streptozotocin diabetic insulin diabetic weeks induction insulin insulin plasma insulin resistant phenylalanine typical intestinal intestinal diabetic insulin intestinal insulin withholding insulin therapy sacrifice rise plasma intestinal values observed insulin state observations insulin less insulin replacement insulin insulin replacement significant
DBT,DBT2951,plasma free insulin management dependent diabetes effect insulin glucose free insulin total free insulin insulin discrepancy free insulin total insulin values plasma glucose term glycemic diabetic ketosis ketoacidosis free insulin free insulin values management insulin dependent
DBT,DBT2952,single split insulin daily injections insulin regimens random double crossover trial ten diabetic weeks home urine hemoglobin glucose serum lipids glucose counterregulatory hormones group none indices significant indices home largest increases rise plasma glucose values decrement values split insulin metabolic short trials
DBT,DBT2953,hemoglobin values dependent diabetes conventional methods microcolumn random glucose times random daily insulin injections ukg sem ghb glucose normal ghb significant correlation ghb glucose year correlation girls recent evaluations months ghb metabolic females conventional methods short term ghb limited idd girls
DBT,DBT2954,locust bean glucose tolerance sugar motility undigestible locust bean guar pectin glucose tolerance food motility guar locust bean oral glucose tolerance test postprandial serum glucose rise serum glucose locust bean guar subsequent rebound hypoglycemia tests bean dependent test locust bean test food stomach intestine locust bean flatten postprandial serum glucose food stomach intestine probable locust bean dietary humans
DBT,DBT2955,determinants filtration plasma flow diabetic extent rpf onset human mechanisms functional unknown diabetic renal morphological man whole nephron early alloxan diabetes severe hyperglycemia growth insulin nph insulin daily results normal growth hyperglycemia diabetic untreated months untreated diabetes months diabetes insulin months diabetes diabetes sngfr sngfr rt sngpf hg fall gfr sngfr different functional diabetes months insulin months untreated diabetes significant whole nephron growth insulin onset diabetes sngfr sngfr gfr rpf increment size rt pressures ultrafiltration values untreated diabetic rt predominant hemodynamic hemodynamic insulin doses onset renal hypertrophy increases rpf rt
DBT,DBT2956,significance insulin resistance non insulin dependent receptor postreceptor insulin resistance nonobese non insulin dependent niddm insulin resistance glucose tolerance insulin monocytes insulin nonobese niddm weight resistance diabetics insulin km vs nondiabetics less normal maximal insulin insulin diabetics less insulin insulin normal postreceptor insulin diabetic subjects microunits subjects less plasma glucose glucose tolerance kivgtt less insulin sensitivity km ns nonobese niddm insulin resistance right insulin insulin receptor insulin insulin resistance predominant metabolic
DBT,DBT2957,intestinal insulin presence sodium methoxysalicylate sodium methoxysalicylate rectal drugs facilitates insulin upper gastrointestinal tract insulin glucose insulin intestine ligation viscous vehicle insulin
DBT,DBT2958,diabetic insulin release vitro humoral insulin dependent diabetic iddm insulin release islets glucose theophylline sera sera insulin release glucagon release unchanged evidence trypan exclusion test insulin release due cytotoxic effect sera damage presence sera healthy subjects non insulin dependent diabetic diseases iddm sera serum cytotoxic iddm sera human islets release iddm sera dependent cytotoxicity recent onset iddm iddm phenomena presence presence insulin release damage iddm
DBT,DBT2959,obese hyperglycemic wistar fatty fa gene zucker wistar kyoto wky th backcrossing wistar fatty wky obesity obesity hyperlipemia manner zucker fatty females hyperglycemia glucosuria early wk tolerance insulin oral glucose diabetic interaction predisposition diabetes wky fa obesity wky insulin zucker tolerance test steady state glucose method overall insulin sensitivity
DBT,DBT2960,genetic mutations locus iv male lethal cbalt mice db db gene blks cbalt subline dbdb dbdb early onset lethal diabetes dbdb obese hyperglycemic glucose hyperglucagonemic islets infiltration hyperinsulinemic normal normal plasma insulin necrosis prenecrotic intracisternal dbdb females obese healthy mice hyperglycemic hyperinsulinemia microscopy hypertrophy necrosis infection hyperglycemia ovariectomy severe females male diabetes biweekly injections estradiol progesterone diabetes remission cbaj support hypothesis steroids level db gene mice steroids important
DBT,DBT2961,genetic mutations locus iii effect different genetic mice diabetes resistant diabetogenic gene stocks severe diabetes necrosis resistance mice diabetes stock resistant mice cbalt dbdb dbdb stocks severe diabetes swrj db stock intermediate female mice haplotypes hypertrophy hyperplasia hyperglycemia resistance induction genetic diabetes stocks importance non genetic
DBT,DBT2962,tptf diabetogenic tptf induces diabetic lipemia insulin intact recent work laboratory oral tptf rabbits tptf hypertriglyceridemia rabbits single tptf glucose plasma less hand lipoprotein lipase lpl less day less ultracentrifugation remarkable chylomicron vldl plasma insulin hypertriglyceridemic rabbits significant recovery plasma lpl concomitant plasma insulin lpl significant insulin release glucose glucagon tptf rabbits less glucagon release test less pancreatic islets rabbits findings tptf inhibits release islets diabetic lipemia due insulin possible diabetic lipemia tptf rabbits
DBT,DBT2963,insulin mild insulin replacement postprandial hyperglycemia group normal glucose tolerance diabetic doses diabetic group group regular insulin daily postprandial hyperglycemia year weight intact anesthetized state contractility normals diabetic intraventricular saline end diastolic diabetes hg normals pressures group diastolic layers outer myocardium treated diabetics sodium water hypertrophy related microscopy subcellular normal diabetic postprandial hyperglycemia potential replacement
DBT,DBT2964,diabetic insulin independent atherosclerotic coronary papillary diabetic streptozotocin relaxation velocity therapy diabetic diabetic weeks pzi insulin papillary untreated diabetics contractile protein therapy diabetic plasma glucose normal recovery crystalline insulin effect diabetics gradual recovery actomyosin myosin insulin diabetic gradual papillary diabetic hyperglycemia less streptozotocin diabetic
DBT,DBT2965,second insulin dependent immunoreactive insulin iv glucose mgmmin untreated noninsulin dependent male diabetics tests saline subjects glucose vs sem vs micro uml second insulin micro minml less glucose level insulin vs effect insulin second vs micro minml less saline vs insulin subjects glucose level concurrent glucose insulin glucose second micro minml glucose micro minml less findings insulin diabetics glucose level level modulate sulfonylurea second insulin glucose effect glucose level important insulinotropic
DBT,DBT2966,insulin diabetic diabetic state pregnancy insulin insulin erythrocytes dependent diabetes trimesters trimester insulin types normal nonpregnant receptor unchanged trimester insulin concomitant hyperinsulinemia findings diabetic pregnancy mothers idd fetal gigantism neonatal hypoglycemia insulin receptor phenomena insulin erythrocytes normal mothers mothers types extent fetal hyperinsulinemia receptor presence hyperglycemia growth diabetic mothers neonatal glucose tolerance hyperinsulinemia insulin sensitivity insulin receptor
DBT,DBT2967,vitamin metabolites dependent diabetic insulin diabetic vitamin serum dihydroxyvitamin dihydroxyvitamin white insulin dependent diabetic subjects yr metacarpal thickness diabetics thickness serum phosphate normal immunoreactive parathyroid normal range total serum dihydroxyvitamin dihydroxyvitamin dihydroxyvitamin diabetics severe diabetes correlation metabolic hemoglobin urine plasma insulin replacement insulin dependent diabetic
DBT,DBT2968,osteomyelitis spine osteomyelitis lumbar spine epidural epidural severe equina lesion lumbar spine decompression necrotic fourth lumbar epidural posterior longitudinal
DBT,DBT2969,hla human leucocyte means test donors hla hypertensive hla hypertensive group ns stage iii hla hla hypertensive less previous report hla diabetic support genetic hla positive hla
DBT,DBT2970,parotid enlargement forty total overt latent diabetes enlargement parotid unaware enlargement enlargement diabetes tolerance test parotid enlargement striking enlargement parotid results enlargement parotid uncommon diabetes search diabetes parotid
DBT,DBT2971,nursing management insipidus diabetes neurosurgical discharge permanent damage hypothalamic vasopressin nursing assessements successful health permanent integral nursing
DBT,DBT2972,lymphocytic thyroiditis bbw breedingworcester bbw insulin dependent lymphocytic infiltration pancreatic destructive process pancreas thymus dependent process man thyroiditis hashimotos thyroiditis lymphocytic thyroiditis diabetic insulin bbw lymphocytic thyroiditis diabetic cohorts weight diabetic diabetic diabetic thyroiditis lymphocytic thyroiditis consistent tsh tsh trh thyroiditis primary bbw endocrinopathies unique disorders
DBT,DBT2973,effect glibenclamide therapy insulin glucose tolerance disorders year normal weight glucose tolerance igt normal glycaemia glucose tolerance normal insulin glibenclamide insulin year tolerance insulin means hours test mgkgmin year glucose tolerance year glibenclamide therapy glucose tolerance insulin general tolerance insulin extrapancreatic effect glibenclamide peripheral insulin sensitivity possible normalization glucose tolerance weight whereas tendency findings normal weight insulin glibenclamide therapy
DBT,DBT2974,insulin adipocytes diabetic ketoacidosis insulin sensitivity insulin vitro adipocytes streptozotocin diabetic insulin sensitivity vivo fall glucose insulin weight less fall glucose adipocytes ketoacidotic group ketoacidosis second group severe ketoacidosis less insulin adipocytes maximal ketoacidotic normal total diabetic less diabetic group less phs insulin diabetics normal severe ketoacidotic diabetics ketoacidosis severe ketoacidosis receptor ketoacidotic group findings insulin resistance severe ketoacidosis
DBT,DBT2975,streptococcus faecalis diabetic enterococcus diabetic water non renal microbial populations units diabetic kidneys sterile significant enterococcal pyelonephritis diabetic versus infective diabetic equal weight renal populations diabetic inflammatory kidneys diabetic ureteral obstruction renal diabetic growth vitro urine diabetic urine water glucose urine non vitro growth infection diabetic due urine organisms diabetic
DBT,DBT2976,streptozotocin diabetic non diabetic mice glibenclamide metformin possible oral drugs hdl streptozotocin diabetic non diabetic mice streptozotocin diabetic mice glibenclamide mgkgday chlorpropamide mgkgday mgkgday weeks plasma total tc hdl streptozotocin diabetic mice plasma tc hdl plasma glucose diabetic mice glibenclamide metformin weeks hdl tc hdl tc hdl weeks diabetic mice effect weight
DBT,DBT2977,size normal subjects growth size normal male subjects purified human growth filtration renal plasma flow steady state hippuran size ultrasonic excretion radioimmunoassays purified growth iu morning iu filtration sem mlmin renal plasma flow mlmin less size excretion results plasma growth range insulin dependent diabetics filtration renal plasma flow size unchanged renal plasma flow growth filtration growth enhancement filtration renal plasma flow insulin dependent diabetics
DBT,DBT2978,zygomycosis alloxan diabetic rabbits virulence zygomycetes potential different zygomycete intranasal instillation ketotic rabbits diabetes arrhizus chinensis microsporus oligosporus rhizopodiformis absidia corymbifera cunninghamella bertholletiae rhizomucor pusillus rhizopus pathogens histopathology less rh pusillus corymbifera bertholletiae cultures human lesions pulmonary ketotic rabbits pulmonary zygomycosis rhizopus absidia cunninghamella potential zygomycosis ketotic diabetic rabbits potential rh corymbifera humans
DBT,DBT2979,modulation glucose insulin arachidonic metabolites possible mechanisms recent evidence glucose insulin release release arachidonic putative system metabolic stimulus influx membrane turnover pyridine glutathione oxygen radical arachidonic release subsequent lipoxygenase cyclo oxygenase arachidonate inhibits synthesis glucose insulin release normal subjects diabetics
DBT,DBT2980,insulin effect human adipocyte lipogenesis investigation possible effect lipogenesis adipocytes human insulin effect lipogenesis vitro purified normal subjects igg whole sera igg effect adipocyte lipogenesis sera observations evidence human igg insulin metabolic effect effect nonspecific nonvariable igg igg non suppressible insulin serum
DBT,DBT2981,insulin man effect insulin humans insulin glucose iv fact insulin less glucose disappearance less acetylsalicylate las endogenous pg synthesis effect
DBT,DBT2982,cadaver insulin dependent diabetes successful stage renal insulin dependent potential cadaver many related donors donate related diabetic donors mlc index equal transplant pretransplant specific transfusions diabetic specific evidence sensitization transfusion donors therapy group quality renal good serum mldl months method results related diabetic possible cadaver
DBT,DBT2983,streptozotocin marrow direct immunosuppressant stz chhen mice evidence marrow important precursors stz diabetic mice diabetogenic insulin units daily fall nucleated stz diabetic mice second marrow diabetic mice reconstitute gamma normal syngeneic mice normal mice lethal doses radiation marrow untreated syngeneic normal mice normal mice mice post stz insulin normal syngeneic marrow thymus mice treated mice sensitivity insulin observations insulin subpopulations diabetic direct stz marrow subpopulations important populations mice
DBT,DBT2984,review early intermediate patency saphenous vein primary limb obliterans rest gangrenous saphenous vein possible tex prosthesis months cumulative patency vein months cumulative patency polytetrafluoroethylene months significant knee claudication polytetrafluoroethylene vein vein knee rest necrosis knee revascularizations statistical significance drawn cumulative patency vein polytetrafluoroethylene previous dacron femoropopliteal patency revascularizations dacron polytetrafluoroethylene onset patency nonsmokers term results ischemic optimum specific
DBT,DBT2985,effect insulin starvation level fructose alloxan starvation level fructose biphosphate starvation level normal liver synthesis fructose diabetic diabetic level normal fructose biphosphate fructose diabetes gluconeogenesis support
DBT,DBT2986,effect streptozotocin contractile diabetic contractile male female diabetic streptozotocin stz actomyosin diabetes weeks methyl glucose prevent hyperglycemia stz normal diabetic food heart weights diabetic fall actomyosin preparations diabetic dodecylsulfate contractile diabetics gels myosin diabetic contractile preparations myosin values diabetic diabetic euthyroid replacement actomyosin stz diabetes significant contractile protein isoenzymes
DBT,DBT2987,electrophysiological findings heavy tetrachlorodibenzo peripheral tetrachlorodibenzo tcdd subjects second subjects peripheral confidence limits subgroups presence occupational conditions tcdd chloracne serum peripheral subjects chloracne serum times manifestations results qualitative subjects neurological
DBT,DBT2988,dominant hypoparathyroidism concurrent insipidus report dominant hypoparathyroidism insipidus findings slight overall signs hypocalcaemia normal dominant recessive recessive hypoparathyroidism half reported dominant different genetic types documentation
DBT,DBT2989,neurointermediate enkephalin vasopressin endocrine enkephalin vasopressin ir ir end ir vp neurointermediate pituitary significant ir ir vp ir end neurointermediate pituitary drinking water microgramml significant neurointermediate pituitary ir ir ir vp whereas end significant fall ir end adenopituitary ir structure significant ir ir vp ir neurointermediate pituitary ir end ir adenohypophysis observations functional state neurointermediate pituitary concomitant ir ir vp peptides brattleboro synthesize vasopressin possess unchanged ir ir
DBT,DBT2990,hormones growth free medium hormones growth free medium dme insulin transferrin triiodothyronine prolactin growth peptone medium growth medium serum medium populations effect ngml insulin somatomedin multiplication growth factor ngml immunoreactive insulin medium medium medium insulin peptone medium growth normal islets term primary
DBT,DBT2991,ultrasound renal ultrasound histopathological findings renal glomerulonephritis interstitial nephritis glomerulosclerosis echogenicity renal echogenicity renal sinus interstitial findings direct correlation renal renal renal interstitial echogenicity possible ultrasound complications
DBT,DBT2992,plasma diabetes tendency vascular complications plasma tg healthy diabetic ischemic heart ihd diabetic platelets diabetic significant hyperaggregation adp epinephrine diabetic ihd significant diabetics diabetic diabetic vascular complications tg diabetics non diabetic ihd diabetic tg diabetics diabetic diabetics diabetic tg non diabetic tg diabetics diabetic hyperfunction vivo due diabetic vascular complications
DBT,DBT2993,histocompatibility insulin dependent diabetes histocompatibility hla insulin dependent diabetes hla risk individuals insulin dependent diabetes group individuals group diabetic lowest histocompatibility diabetic diabetic diabetic haplotypes previous genetic linkage histocompatibility system
DBT,DBT2994,supersensitivity mesenteric term diabetic investigation noradrenaline vascular contractions mesenteric short term diabetic diabetic state streptozotocin mgkg term diabetic short term diabetic hypotensive term diabetic mesenteric noradrenaline contractile force noradrenaline mesenteric adrenoreceptor antagonism effect sensitivity mesenteric diabetic noradrenaline contractile force tissues noradrenaline adrenoreceptor antagonism adrenoreceptor antagonism sensitivity term diabetic mesenteric adrenoreceptor antagonism effect contractile force term mesenteric diabetic noradrenaline term diabetes supersensitivity mesenteric phenomenon dependent diabetic state supersensitivity mesenteric vascular resistance observed
DBT,DBT2995,recent management disability conditions much examples diabetic retinopathy macular cataract ocular microsurgery
DBT,DBT2996,plasmacellular thyroiditis retrospective presence lymphocytic infiltrations thyroids diabetics thyroids post mortem size infiltrations method histological diabetic non insulin dependent diabetics infiltrations insulin dependent diabetics ie infiltrations diabetic signs
DBT,DBT2997,disorders endogenous hypertriglyceridemias concomitant findings diabetes unknown glucose therapy shows disorders retrospective glucose tolerance disorders related diabetes
DBT,DBT2998,receptor diabetic hspiperone receptor striatal diabetic alloxan streptozotocin hspiperone normal diabetic alloxan insulin dopaminergic transmission diabetes
DBT,DBT2999,true haemodialysis echocardiography hours haemodialysis dialysis normotensive radiological heart renal healthy subjects heart individuals parameters diastolic time index end systolic time index ejection time velocity circumferential fiber vcf ejection ef haemodialyzed stdi vcf ef compression results true contractile state load due fistula expansion
DBT,DBT3000,diabetic inner diabetic minority diabetics many inner diabetic clinics diabetics computer files female male past diabetes insulin total insulin dependent coma precoma hyperosmolar coma diabetics non insulin dependent hyperosmolar coma ketoacidosis diabetics different rest
HIV,HIV3001,keto hydroxy isoleucine valine chicks growth isomers hydroxy keto bcaa isoleucine dl keto isomers hydroxy inferior isomolar level support growth chicks values chicks dl dl isomers val hydroxyisovaleric hiv values chicks val val hiv dl hiv hiv val marginal growth values kiv hiv dl hiv hiv dl leu leu ketoisocaproic dl hydroxyisocaproic hic isomolar leu values leu leu hic dl hic hic bcaa keto hydroxy growth potential nitrogen free nutritional therapy
HIV,HIV3002,depressive ct depressive depressive group septum distance lsc depressive group system group significant enlargement width fissure width sylvian fissure inner skull sfis depressive group enlargement hiv width right horn rah depressive depressive group depressive group
HIV,HIV3003,lymphadenopathy homosexual homosexual bisexual lymphadenopathy genetic methods diseases prescription lymph nodes patterns hyperplasia expansion paracortical hyperplasia lymph hla infections sarcoma severe immune dysfunction previous months lymphadenopathy spectrum acquired immunodeficiency infections sarcoma malignant lymphomas
HIV,HIV3004,immunodeficiency aids immunodeficiency aids haiti healthy haitians sarcoma infections haiti infections coincides aids united aids haiti types infections haitians sarcoma infections aids united haitians sarcoma infections months infections skin test anergy potential risk bisexual transfusions male female demographic strata haitian
HIV,HIV3005,neurological complications immune fifty immune complications peripheral nervous male homosexuals abusers haitian nervous system complications infections toxoplasma gondii progressive multifocal cryptococcal possible mycobacterium avium intracellulare encephalitis cytomegalovirus infection primary lymphoma meningeal lymphoma vascular complications nonbacterial thrombotic endocarditis nervous system problems lesions peripheral
HIV,HIV3006,immunodeficiency female partners immunodeficiency current outbreak immunodeficiency aids healthy prodromal female partners male male abusers full blown second consistent prodrome aids lymphadenopathy lymphopenia ratio helper suppressor lymphadenopathy lymphopenia ratio helper suppressor findings aids heterosexual
HIV,HIV3007,immunodeficiency infant possible transmission products transfusions rhesus ill recurrent infections months hepatitis thrush dermatitis otitis mycobacterium avium intracellulare infection months helpersuppressor ratio donors time donation months infections immunodeficiency laboratory findings infectious transfusion immunodeficiency cytomegalovirus epstein hepatitis
HIV,HIV3008,infections sarcoma haitians evidence immunodeficiency state haitian pneumocystis carinii nervous system toxoplasmosis esophageal cryptococcosis cytomegalovirus progressive simplex coccidiosis invasive sarcoma ten infections recurrent infections months evidence homosexuality haiti lymphadenopathy anergy lymphopenia peripheral subsets helper normal ratio helper heterosexual haitians immunodeficiency homosexuals
HIV,HIV3009,human leukemia aids york aids risk aids cambridge kyoto identify leukemia htlv
HIV,HIV3010,guidelines aids identification immune aids crisis confidence aids subjects prevent ways confidence system protect personal invalid efforts many aids urgent guidelines multidisciplinary group public social aids institutions researchers institutional review boards public health compatible sound scientific
HIV,HIV3011,igg aids risk aids thirty homosexual aids lymphadenopathy las healthy healthy donors aids risk group igg human lymphotropic iii htlv iii aids las healthy homosexuals iii healthy hemophiliacs seropositive htlv iii none donors htlv iii
HIV,HIV3012,ribavirin lymphadenopathy cultures human vitro effect ribavirin lymphadenopathy prototype lymphadenopathy immunodeficiency ribavirin cultures human ribavirin
HIV,HIV3013,immune immune san sarcoma months infections carinii months months ks infections different infections significant
HIV,HIV3014,immunodeficiency haitian non haitian mycobacterial immunodeficiency records dade county haitians non haitians less haitians extrapulmonary whereas haitian extrapulmonary less months positive sputum cultures conventional antituberculosis drugs cultures months positive sputum cultures mycobacteria different haitian non haitian
HIV,HIV3015,lymphadenopathy disinfectants transcriptase lymphadenopathy standard disinfectants glutaraldehyde disinfect instruments sodium hypochlorite benches
HIV,HIV3016,immunodeficiency immunodeficiency purified human doses units mild partial time skin test reactivity serum
HIV,HIV3017,immunodeficiency exploration fifteen immunodeficiency aids lymphoma immunodeficiency immunodeficiency purified il human il vitro il daily daily total aids level aids minor diffuse histiocytic lymphoma il human immunodeficiency
HIV,HIV3018,humans trial human il jurkat dupont corp glenolden pa usa serum half standard therapy immunodeficiency aids microgramskg il weeks half jurkat il humans doses second clearance half headache nausea malaise fever evidence pulmonary renal evidence phenomena hyperbilirubinemia il effect immunodeficiency aids consistent total counts mononuclear therapy macrophages mononuclear il
HIV,HIV3019,determinants htlv iii immunodeficiency conditions homosexual homosexual risk immunodeficiency aids lifestyle conditions subsets aids human human leukaemia iii htlv iii htlv iii subjects seronegative subjects iii year seroconversion htlv seropositive subjects aids year minimum aids year signs immunodeficiency aids year aids aids htlv iii months stable lymphadenopathy htlv iii helper counts related htlv iii seropositivity healthy subjects univariate lifestyle risk iii seropositivity homosexual partners less equal intercourse equal synergistic interaction intercourse many homosexual partners htlv iii infection emergence lymphadenopathy manifestations aids
HIV,HIV3020,htlv iii infection possible immune aids microbiologists infectivity predilection social homosexual addicts haemophiliacs risk africa interaction human obscure
HIV,HIV3021,possible immunodeficiency aids host viruses risk immunodeficiency aids complementary potentiation infection genetic genetic recombination aids
HIV,HIV3022,immunodeficiency heterosexual zaire immunodeficiency aids kinshasa male female ratio kinshasa infections sarcoma ks infection ks infectious diseases aids female aids male aids single vs homosexuality transfusion risk findings argue situation africa significant transmission heterosexual aids females heterosexual heterosexual transmission
HIV,HIV3023,immunodeficiency rwanda immunodeficiency aids rwanda sarcoma ks endemic females infections ks multifocal ks conditions consistent prodromes aids severe defects cutaneous anergy helper ratio urban many middle upper income females prostitutes homosexuality transfusion previous aids africa entity endemic ks urban income heterosexual promiscuity factor aids africa
HIV,HIV3024,sarcoma sarcoma ks year endemic ks uganda kenya ks typical signs nodules oedematous florid tumours infiltration vincristine unusual signs lymphadenopathy oral gastrointestinal lesions respiratory distress weight nodules ks end deaths endemic
HIV,HIV3025,longitudinal persistent lymphadenopathy homosexual immunodeficiency homosexual bisexual lymphadenopathy february lymphadenopathy fatigue fever night hypergamma lymph hyperplasia months immunodeficiency aids previous heavy nitrite inhalant presence night helper anergy mumps intradermal simplex isolation stable
HIV,HIV3026,immunodeficiency healthy belgium infections cryptococcosis pneumocystis carinii nervous system toxoplasmosis cutaneous simplex infection cytomegalovirus infection cryptosporidiosis sarcoma ten consistent prodrome immunodeficiency lymphadenopathy fever helper normal ratio helper suppressor anergy evidence transfusion homosexuality africa immunodeficiency
HIV,HIV3027,immune results aids belgium denmark finland frg switzerland aids drawn usa half months important risk factor male homosexuality aids male homosexuals largest group homosexual contacts haiti important risk group male homosexuals africa natives africa homosexuality fact manner aids ethnic africa risk factor hemophiliacs aids usa important male homosexuals sarcoma former group latterabstract
HIV,HIV3028,immunodeficiency laboratory immunodeficiency single metropolitan haitian non haitian abusers transfusion findings predominant findings persistent infection oral mucosa pulmonary infiltrates lymphadenopathy subsets immune infectious infections pneumocystis carinii herpesviruses infections gram sepsis lymphadenopathic sarcoma observations perinatal postnatal transmission unidentified infectious
HIV,HIV3029,immunodeficiency aids transfusions immunodeficiency aids aids pneumocystis carinii risk components transfusion aids likely white risk months aids donors risk investigation donors risk donors helpersuppressor lymphadenopathy findings evidence aids
HIV,HIV3030,serum immunodeficiency aids igm immune immune aids functions aids serum aids statistical isotypes hypergammaglobulinemia serum igm healthy homosexual healthy heterosexual aids healthy healthy homosexuals group igm much overlap statistical aids
HIV,HIV3031,immunodeficiency wife hemophiliac year healthy unexplained thrush onychomycosis pneumocystis carinii consistent immunodeficiency risk factor infrequent monogamous husband year hemophiliac factor viii due carinii probable signs recurrent thrush onychomycosis year husband ill findings female partners factor viii partners transmission elderly risk theory hemophiliacs due infectious
HIV,HIV3032,pseudotype viruses envelope japanese human leukemia tried transmit human leukemia htlv non sl ccc htlv htlv positive stomatitis pseudotypes envelope japanese prepared human serum japanese htlvm htlvmt pseudotypes htlvpl pseudotype sera japanese leukemialymphoma atl htlv serum different pseudotypes htlvs human sera belong single serotype
HIV,HIV3033,drugs aids current aids cofactors drugs immune emphasis nitrite inhalant ni homosexual homosexual stable ni recent homosexual ni homosexual york ni risk aids direct lifestyle predisposes homosexual putative aids current evidence ni risk aids true drugs cocaine future laboratory tests putative aids cofactors
HIV,HIV3034,htlv human important process develops humans summarized close human leukemia htlv leukemialymphoma atl process infection malignant lymphoproliferation latent primary htlv infection subsequent risk trigger malignant transformation process infectious trophism way malignant transformation process lessons important therapy recent htlv iii cytopathic human likely immunodeficiency aids public health implications way identify full blown aids potential subject investigation
HIV,HIV3035,leukemialymphoma jamaica human leukemialymphoma lymphoproliferative human leukemialymphoma htlv positivity jamaican non hodgkins positive leukemialymphoma atl htlv positive skin hypercalcemia leukemia less htlv positivity marrow infiltration positive lymphadenopathy hepatomegaly splenomegaly positive typical atl proven skin infiltration iii leukemia marrow infiltration leukemic atl consistent atl atl atl ie typical consistent atl htlv positive htlv tumour positive non atl positive correlation histopathological htlv positivity atl non atl weeks atl skin leukemia prominent prognostic hypercalcemic normocalcemic atl weeks hypercalcemia deaths infections due infections due pyogenic organisms infections lymphocytic leukemic cll positiveabstract
HIV,HIV3036,htlv evidence human important membrane screen sera leukemia htlv specific membrane htlv htlv htlv iii representative sera specific htlv radioimmunoprecipitation rip page japanese leukemialymphoma atll miyazaki evidence probable htlv atll healthy endemic severe infections htlv hemophiliacs htlv status positive hemophiliacs helper seropositive gene gp significant lor gene observations infection leukemia rip gp gp gene htlv gp htlv crossreactive gp protein immune aids htlv lor gene presence positive individuals serum seronegative aids sera iii seropositive
HIV,HIV3037,htlv iii aids human leukemialymphoma htlv immunodeficiency aids aids homosexual risk aids htlv iii serological immunosorbent elisa western htlv iii serum iii aids homosexual aids transfusion aids ta aids aids iii risk donors ta aids iii risk donors risk donors positive ta aids transmission htlv iii htlv iii primary aids
HIV,HIV3038,human leukemia specific human leukemia htlv contain genomes pol putative gene lor membrane gene products healthy htlv endemic leukemialymphoma htlv immune aids homology gene products htlv serological crossreactivity htlv specific aids related htlv aids lines evidence htlv iii etiological aids gene terminal ltr kdalton kdalton htlv htlv open lor frame lor gene identification lor products direct evidence presence unidentified functional htlv
HIV,HIV3039,human leukemia gene products primary structure gag gene products human leukemia htlv sequences htlv share determinants protein normal epithelium gene primary structure gag myristylated iii prgag sequences icr htlv single terminal peptides gene htlv transmembrane protein sera specific determinants protein viruses partial sequences gene leukemia blv protein sequences htlv blv originated ancestor htlv sequences transmembrane implicated regions unidentified blv sequences related products htlv possible functions blv putative htlv gene products size rna helper viruses group specific gene codes pol gene codes transcriptase endonuclease envelope gene codes
HIV,HIV3040,kaplan lecture human lymphotropic htlv htlv leukemia atl htlv hairy htlv iii aids human short human diseases due human mimic vivo mechanisms future much prevent diseases
HIV,HIV3041,lymphotropic lymphotropic man world human leukemia atlv human leukemia htlv endemic japanese south africa populations lymphoma endemic serum gene polypeptides gp polypeptides atlv rare endemic world human lymphadenopathy htlv iii etiological immunodeficiency aids man syndromes iii endemic parts africa human react envelope gp gp gp related polypeptides iii crossreact atlvhtlv polypeptides lymphotropic macaques
HIV,HIV3042,htlv iii transfusion donations htlv iii test satisfactory cost less donation transfusion method south africas total donations cost year
HIV,HIV3043,dna aids types lymphoproliferative dna nervous system lymphocytic interstitial pneumonitis lip human lymphotropic iiilymphadenopathy infection immunodeficiency aids ten specimens dna dna pneumocystis carinii cytomegalovirus mycobacteria lip aids complications serum eb nuclear bam hi lymphoproliferative important aids
HIV,HIV3044,serological evidence related lymphotropic iii residents africa serological evidence related lymphotropic iii stlv iii man senegal africa aids aids related diseases sera individuals positive iii immunosorbent iii stlv iii western sera individuals regions aids united africa iii stlv iii sera stlv iii htlv iii reactivity sera sera positive individuals africa united sera africa united putative envelope transmembrane protein iii sera positive results healthy related stlv iii htlv iii important aids vaccine
HIV,HIV3045,lymphomas risk immune aids immune congenital risk immune aids york homosexual abuser non hodgkins types extranodal gastrointestinal tract nervous system marrow myocardium lymphomas general non non types lymphomas helper suppressor htlv iii previous lymph lesions aids related lymphoma severe infections sarcoma lymphomas group organs early deaths
HIV,HIV3046,intra synthesis htlv iii specific igg aids aids intra specific good evidence infection immuno aids unexplained diffuse progressive dementia human lymphotropic iii htlv iii aids dysfunction serum aids aids presence htlv iii htlv iii tests immunosorbent seropositive htlv iii specific unique oligoclonal igg igg synthesis immunosorbent htlv iii specific igg serum htlv iii infection aids
HIV,HIV3047,isolation htlv iii neural tissues syndromes immunodeficiency isolation nervous system human lymphotropic iii htlv iii disorders acquired immunodeficiency aids aids htlv iii aids related syndromes htlv iii htlv iii seroconversion htlv iii aids related unexplained aids related dementia positive cultures iii htlv iii spinal myelopathy sural peripheral findings htlv iii aids dementia spinal degeneration peripheral aids aids
HIV,HIV3048,aids related conditions infection guidelines health workers management investigation transmission spectrum infections sarcoma immune aids health workers aids aids related conditions instructions secretions tissues health workers protective clothing sterilization instruments needles syringes hardware need infected aids
HIV,HIV3049,iii infection presence serum human iii htlv iii different regions aids arcs individuals risk diseases positive sera aids different geographical positive sera individuals aids varied homosexuals abusers positive sera normal individuals aids infectious sera sarcoma lymphocytic leukemia none normal positive significant aids iii infection aids likely
HIV,HIV3050,htlv iiilav populations human lymphotropic iiilymphadenopathy htlv iiilav elisa test male homosexual prostitutes thalassemia none female prostitutes abusers male vd donors february serum positive homosexual subject positive elisa positive western test thalassemia positive elisa western test positive reactors htlv iiilav homosexuals homosexuals start aids
HIV,HIV3051,lack iii hepatitis vaccine evidence plasma hepatitis vaccine aids support safety vaccine vaccinees presence iii sharp dohme hepatitis vaccine force cadets lots force cadets vaccinated lots pasteur vaccine sera months immunosorbent iii positive sera western exclude non specific sera evidence safety hepatitis vaccine
HIV,HIV3052,iiilav immunosorbent risk individuals htlv iii sera risk individuals switzerland sera group addicts none positive transfusions positive values seropositive subjects aids aids
HIV,HIV3053,risk immunodeficiency largest risk group immunodeficiency aids heterosexual partners vaccines efforts needle little risk review aids impede efforts risk current risk york needles emergence needles needles
HIV,HIV3054,immunodeficiency haiti haiti immunodeficiency spectrum haitians united findings united risk transfusions haitian risk friends heterosexual contacts injections latter friends potential transmission infection human lymphotropic iii
HIV,HIV3055,sarcoma immunodeficiency sarcoma multifocal microvascular signs nodules lesions trunk general sites load general functional sarcoma immunodeficiency aids risk sarcoma aids whites homosexuals abusers overall year months overall months
HIV,HIV3056,infections immunodeficiency microorganisms immunodeficiency aids defects pneumoniae defects shigella persist unclear infections infections defects carinii cytomegalovirus infection mycobacterium avium intracellulare infection half aids nervous system toxoplasma gondii infections dissemination uncommon many infections therapy courses
HIV,HIV3057,immunodeficiency immunodeficiency aids mothers drugs transfusions subjects factor viii therapy heterosexual mothers bisexual immunodeficiency disorders aids hypergammaglobulinemia immunodeficiency aids isolation early isolation igg primary immunodeficiency deaminase purine phosphorylase aids risk factor aids hypergammaglobulinemia immunodeficiency aids isolation
HIV,HIV3058,immunodeficiency coagulation factor donors expectancy infectious free risk immunodeficiency aids laboratory evidence treated severe hemophilia immune aids severe hemophilia evidence minority human lymphotropic iii aids methods coagulation factor risk aids
HIV,HIV3059,immunopathogenesis immunodeficiency many humoral immunodeficiency preferential infection severe specific functions immune specific morbidity scientific outline immunopathogenesis
HIV,HIV3060,human lymphotropic iiilymphadenopathy gag human lymphotropic iiilymphadenopathy htlv iiilav gag polyprotein protein gene polyprotein gp gp protein humans due cost specialized sera radioimmunoprecipitation sodium sulfate polyacrylamide test optimal sensitivity gp protein vaccine htlv iiilav world healthy lymphotropic iii stlv iii stlv iii gp immune host vaccine
HIV,HIV3061,recent lymphadenopathy lentiviruses infectious viruses cross reactivity infectious structure retroviral genetic envelope gene important implications lymphotropism future immunization infection induction irreversible immunodeficiency minority infected immune infection
HIV,HIV3062,human lymphotropic htlv iii immunodeficiency human lymphotropic viruses past target growth factor transcriptase isolation htlv leukemia techniques human isolation htlv iiilymphadenopathy primary immunodeficiency aids htlv gene protein group identification primary aids specific reagents identification diseases
HIV,HIV3063,international occurrence immunodeficiency december immunodeficiency south united united united end brazil denmark switzerland united kingdom homosexual risk united heterosexual haitians countries zaire rwanda uganda full extent consistent general sites evidence index
HIV,HIV3064,human lymphotropic iii risk immunodeficiency human lymphotropic iiilymphadenopathy htlv iiilav window spectrum immunodeficiency aids related syndromes risk htlv iii close personal longitudinal htlv iii infection latent aids different different risk manner immune status host likely risk
HIV,HIV3065,immunodeficiency gay immunodeficiency aids health gay fourths double year manhattan san aids gay san related conditions human lymphotropic iiilymphadenopathy sera risk aids partners intercourse adoption gay
HIV,HIV3066,immunodeficiency immunodeficiency aids september united year human lymphotropic iiilymphadenopathy htlv iiilav aids htlv iiilav serologic tests plasma donors aids factor htlv iiilav transmission products transmission partners mothers newborns vaccine specific therapy risk transmission
HIV,HIV3067,aids fibrosarcoma report girls immune aids healthy interstitial pneumonitis months suppressor ratio second malignant fibrosarcoma liver year aids risk second cytotoxic suppressor positive vitro precursors
HIV,HIV3068,prospects infections human lymphotropic iii human lymphotropic iii sites transcriptase suramin antimoniotungstate hpa trisodium vitro trials significant interferon ribavirin ansamycin double trials inhibits serum optimal regimens trials htlv iii immunodeficiency
HIV,HIV3069,infection human lymphotropic htlv htlv iii aids early early infection human lymphotropic htlv positive immune aids htlv iii htlv iii specific postinfection synthesis polypeptides cytosine ara htlv iii positive sera progeny infected method transcriptase htlv iii pfuml htlv iii htlv htlv iii htlv htlv htlv iii interaction host good
HIV,HIV3070,slim uganda htlv infection rural uganda diarrhoea slim htlv iii infection females enteropathic immunodeficiency zaire sarcoma ks endemic uganda slim evidence possible transmission insect vectors needles timing tanzania
HIV,HIV3071,iii individuals risk infection iii individuals risk infection addicts homosexual addicts iii infection positive serum reactions iii iii group homosexual significant correlation status results iii western envelope protein gp individuals lymphadenopathy full aids typical positive reactions gp gp
HIV,HIV3072,homosexual immunodeficiency possible sarcoma identify risk manifestations immunodeficiency aids homosexual sarcoma pneumocystis carinii laboratory test results carinii sarcoma diseases different partners hepatitis sarcoma nitrite manifestations aids nitrite sarcoma cofactors aids
HIV,HIV3073,lymphotropic healthy homosexual findings lymphotropic iii htlv iii homosexual presence htlv iii lymphadenopathy cytomegalovirus isolation less skin test reactivity less episodes fever investigation significant total cytotoxic helper helper suppressor ratio ratio htlv iii positive homosexuals ratio less equal homosexual iii cytomegalovirus ratio htlv iii homosexuals non htlv homosexuals investigation aids aids investigation htlv iii subsets cutaneous htlv iii valuable prognostic htlv iii
HIV,HIV3074,glandular fever htlv iii lymph human lymphocytotropic iiilymphadenopathy htlv iiilav glandular fever hypertrophy endoplasmic reticulum endoplasmic reticulum reticular nm cytoplasmic nm lymph findings host immune infection htlv iiilav
HIV,HIV3075,iii htlv zairians zairians females maternity minor malaria specific htlv iii pre elisa sera htlv htlv iii western sera european sera elisa positive results htlv females htlv iii females range heterosexual transmission individuals positive htlv individuals positive htlv iii infection infection immunovirology htlv iii zaire immuno aids significant htlv iii infected individuals aids
HIV,HIV3076,isolation aids neurological immunodeficiency aids homosexual neurological aids viruses peripheral mononuclear induction cytopathic results arv neurological syndromes aids
HIV,HIV3077,transmission human lymphotropic iii htlv semen human lymphotropic iii htlv iii persistent lymphadenopathy free year semen year good health htlv iii observations rigorous programme potential donors semen findings semen heterosexual transmission iii subsequent infection infant
HIV,HIV3078,female prostitutes group infection human lymphotropic iii female prostitutes male prostitutes subsets lymphotropic iii htlv iii healthy prostitutes healthy rwandese prostitutes prostitutes free group lymphadenopathy group group ratio group female htlv iii prostitutes female male male male iii seropositivity different partners year africa risk group iii infection
HIV,HIV3079,isolation human lymphotropic iii tears immunodeficiency human lymphotropic iii htlv iii tears immunodeficiency aids aids tears healthy individuals htlv iii recovery htlv iii tears free contain positive consistent recovery htlv iii fluids fluids aids direct tears ophthalmologic
HIV,HIV3080,humoral immune specific immune aids immunized bacteriophage phi dependent neoantigen vaccine tetanus toxoid serum hypergammaglobulinemia bacteriophage phi primary switch igm igg vaccine tetanus toxoid concanavalin staphylococcal cowan findings aids significant humoral dysfunction plays resultant specific
HIV,HIV3081,iii aids risk human iii acquired immunodeficiency aids risk immunosorbent tests different homosexual aids homosexual lymphadenopathy aids homosexuals aids seropositive early positive results sera positive whereas donors healthy laboratory human lymphotropic iii sera prostitutes
HIV,HIV3082,htlv iii aids serum iii peripheral lymphadenopathy serum
HIV,HIV3083,homosexual seronegative htlv iii microbiological lifestyle patterns homosexual vitro related human lymphotropic iii htlv iii infection male homosexual htlv iii ten htlv iii helpersuppressor group signs intestinal giardiasis genital warts hepatitis htlv iii subjects immune months iii seroconversion helpersuppressor seroconversion vitro htlv iii infection subsets pre positive early htlv iii infection
HIV,HIV3084,htlv iiilav status spouses contacts home hemophilia hemophilia nonhemophilic human lymphotropic iiilymphadenopathy htlv iiilav status contacts spouses positive hemophiliacs normal respect htlv iiilav western serologic representative st hemophiliacs time seroconversion months seropositive hemophiliac seropositive hemophiliacs home infusions assistants seroconversion results transmission htlv iiilav hemophiliacs therapy
HIV,HIV3085,htlv iii infection suburban human lymphotropic iii htlv iii infection mr protein htlv iii group group exaggerated infection group persistent lymphadenopathy hepatitis antigenemia hypergammaglobulinemia group oral lymphadenopathy group immunodeficiency aids group group mr protein group group disorders group group disorders iii infection spread mothers partners infected infected partners homosexuals aids disorders severe intracranial defects microcephaly cranial htlv iii speed
HIV,HIV3086,spectrum htlv iii humans laboratory manifestations human lymphotropic cohorts spectrum infection state severe immunodeficiency infections structure host infection different manifestations human
HIV,HIV3087,spectrum sarcoma aids sarcoma ks immune ks immune spread diversity therapy preliminary spectrum immune
HIV,HIV3088,htlv htlv iii french indies countries elisa human lymphotropic viruses htlv iii htlv iii serosurvey french indies countries caribbean basin endemic htlv htlv donors elderly island french guyana south caribbean sea ethnic bonis hmongs clues investigation htlv transmission africa endemic continent htlv htlv iii northern equatorial sudanic preliminary africa endemic reservoir htlvs human geographical viruses
HIV,HIV3089,unique htlv iii aids recognition sera uganda sera nile uganda year reactivity human lymphotropic iii htlv iii htlv iii immunosorbent sera normal sd sera positivity western immunoperoxidase htlv iii mr positive sera status group normal immunodeficiency risk group early predecessor htlv iii htlv iii presence likely htlv iii
HIV,HIV3090,iii sera japanese hemophiliacs japanese hemophiliacs human types htlv iii whole htlv htlv iii sera hemophiliacs hemophiliacs acquired immunodeficiency positive iii sera products hemophiliacs htlv iii infection positive hemophiliacs positive residents nonendemic htlv infection future
HIV,HIV3091,findings iii infection microbiological virological lifestyle parameters homosexual finland subjects intervals human lymphotropic iii htlv iii immunoassay western immunodeficiency immunodeficiency lymphadenopathy lymphadenopathy lymph nodes helper values helpersuppressor findings progressive htlv iii positive ones specific recall protein extent primary helper infection htlv iii specific immune previous htlv iii helper mitotic
HIV,HIV3092,htlv iii infection homosexuals homosexual serum human lymphotropic iii htlv iii subsets htlv iii immunosorbent dot positive reactions western htlv iii immune persistent lymphadenopathy male donors tt helpersuppressor seronegative seronegative hemophilia iii factor viii swedish none swedish factor hemophilia swedish factor ix seronegative hemophilia imported factor ix seropositive tt seropositive seronegative hemophilia
HIV,HIV3093,trends aids united immunodeficiency aids united single san drugs serosurveys populations risk aids human leukemia iii lymphadenopathy htlv iiilav aids serological tests aids htlv iiilav infection
HIV,HIV3094,human lymphotrophic htlv way subsequent recognition human htlv aids htlv iii aids subclinical manifestations fact risk aids aids infected individuals positivity preliminary cohorts enormity aids emerge health pandemic
HIV,HIV3095,evidence htlv iii aids human lymphotropic iii htlv iii cytotoxicity immune aids htlv iii aids related seroepidemiological htlv iii transfusion manner putative aids sera htlv iii risk outbreak corresponds transfusion aids risk aids htlv iii seropositivity evidence htlv iii aids efforts maternal fetal transmission vaccine antiretroviral therapies
HIV,HIV3096,htlv iii hierarchical risk immunodeficiency aids human leukemia iii nitrite cofactor aids drugs diluents helpersuppression dna psychoactive drugs diluents virulence prostitution female prostitutes drugs risk infectious clients
HIV,HIV3097,persistent lymphadenopathy immunodeficiency peripheral mononuclear individuals immunodeficiency aids aids peripheral mononuclear healthy heterosexual homosexual level heterosexual homosexual pbms individuals aids level individuals individuals lymphotrophic iiilymphadenopathy htlv iiilav thirty individuals level thirty iiilav normal sd homosexual pmol aids individuals iiilav progressive important prognostic risk aids
HIV,HIV3098,prospects human diseases evidence human leukemia iii htlv iii primary immunodeficiency direct cytopathic effect helper vitro depletion critical individuals results infected vast general htlv iii likely fruit general genetic
HIV,HIV3099,current status diseases human lymphotropic htlv iii immunodeficiency aids therapy possible primary vaccine important identification individuals isolation epitopes protective individuals human leukemia lymphoma iii htlv iii mr vaccines transmembrane protein micelles hydrophobic nucleic less safe version peptides products envelope gene potential problems htlv gene fact htlv iii functional vaccine aids helpful vaccine human leukemia lymphomas
HIV,HIV3100,vaccines exogenous perspectives vaccines purified envelope exogenous related viruses humans leukemia immunodeficiency vaccines regimens human
HIV,HIV3101,lymph nodes homosexuals persistent aids lymph male homosexuals persistent lymphadenopathy ten immunodeficiency serum leukemia iii regard histopathology immunohistology subsets immunodeficiency sarcoma histopathological depletion whereas persistent lymphadenopathy nodes spectrum hyperplasia immunohistology disappearance dendritic reticulum observations dendritic reticulum endothelial viii many depletion observations occurrence persistent lymphadenopathy immunodeficiency lymph nodes histopathology immunohistology possible importance sarcoma
HIV,HIV3102,iii sera aids aids iii infection correlation leukemia iii htlv iii immunodeficiency immunodeficiency western weights thousands iii positive sera reactivity glycoproteins iii htlv epitopes cross epitopes htlv iii
HIV,HIV3103,aids htlv iiilav mothers report immunodeficiency aids occurrence specific htlv iiilav seropositivity seropositive mothers report seropositive seropositive mothers died aids non progressive aids liver cns gastrointestinal troubles infection homosexual risk signs months aids immunization maternal specific igg
HIV,HIV3104,aids hemophilia findings dna cytometry year female weight recurrent infections diarrhoea infection signs previous toxoplasmosis close haemophilia due fact aids serological tests time findings cytometry nuclear dna binuclear infection microscopy size contents compatible infection cytomegalovirus epstein infections tracheobronchitis urocystitis pyelonephritis oesophagitis enteritis
HIV,HIV3105,hiv infection human immunodeficiency hiv peripheral mononuclear effect dependent cytotoxic hiv initiation weeks observations potential therapy individuals hiv
HIV,HIV3106,polymorphism human immune isolation human immune hiv immune aids africa hiv aids africa usa review vitro cytopathic effect positive lines preliminary substantiated sequences genomes hiv different sizes serological cross reactivity protein envelope hiv positive sera report hiv restriction polymorphism different preliminary hiv human
HIV,HIV3107,lymphadenopathy aids seroconversion homosexual homosexual vancouver human immunodeficiency hiv time enrolment results serologic total seroconversion october methods take durations seroconversion group seroconversion seroconversion stable risk seroconversion intercourse male partners year enrolment drugs gonorrhea less oral transmission oral semen seroconversion univariate likely seroconvert homosexual likely
HIV,HIV3108,lines human leukemia cynomolgus lines human leukemia htlv leukemia lines peripheral mononuclear cultivation htlv lines il specific htlv il receptor lines specific plasma infected peripheral months signs
HIV,HIV3109,hiv seroprevalence workers zaire lack occupational seroprevalence human immunodeficiency mama yemo zaire seropositive seroprevalence year olds workers likely seropositive unmarried transfusion previous injections previous manual workers seroprevalence seropositivity needle findings consistent risks occupational transmission human immunodeficiency
HIV,HIV3110,htlv iiilav coli envelope immunization escherichia coli human lymphotropic htlv iiilav envelope protein gp gp envelope protein htlv iiilav infection vitro neutralization equivalent purified gp immunogen epitopes terminal half gp htlv iiilav fusion gp glycosylation induction important interaction receptor htlv iiilav envelope coli important ingredient vaccine immune
HIV,HIV3111,recommended infection human immunodeficiency infection update hiv health workers guidelines fluids workers pathogen infection guidelines aids potential nosocomial transmission hiv respect principles infection force prevent fluids hiv pathogens health enforcement guidelines nosocomial infections
HIV,HIV3112,neutralization human immunodeficiency human immunodeficiency hiv htlv iiilav immune aids genetic polymorphism gene sera rabbits pigs gp sera hiv infected subjects panel hiv gene htlv iiib independent htlv serum titres human sera britain uganda neutralize htlv iiirf cross hiv subject serum titres human neutralization findings hiv epitopes identification epitopes protective vaccines
HIV,HIV3113,persistent hiv antigenaemia hiv aids sequential serum homosexual human immunodeficiency hiv hiv immune aids antigenaemia aids year antigenaemia disappearance igg reactivity hiv protein none serious serum man serum igg reactivity hiv plasma transfusion single hiv antigenaemia hiv serum aids aids free aids virtual reactivity results hiv gene factor aids evidence switch latent hiv infection
HIV,HIV3114,rapid phosphorylation modulation helper protein leu mr human helper cytotoxic pma induces rapid phosphorylation dephosphorylation pma phosphorylation dephosphorylation kinetics pma pma rapid phosphorylationdephosphorylation functions unknown ligand
HIV,HIV3115,effect propiolactone htlv iiilav propiolactone bpl iii immune aids suspected aids iii occupational risk laboratory staff bpl components serum subpopulations
HIV,HIV3116,aids lymphadenopathy malignant lymphoma infection human immunodeficiency hiv depletion helperinducer subsequent state immunodeficiency evidence hyper infected hiv persistent lymphadenopathy lymph florid hyperplasia hypergammaglobulinemia humoral immune dysfunction full blown aids demographics initiated reveals evolution risk transformation aids oral hairy leukoplakia peripheral cytopenias sedimentation episode evolution aids risk subsets lymphadenopathy hiv infection malignant lymphomas aids risk male homosexuals iv abusers non hodgkins undifferentiated iv stage iv extranodal peripheral lymphadenopathy good marrow aids infections months laboratory possible lymphotropic aids serum non lymphoma seroreactivity htlv hiv lymphoma aids san findings
HIV,HIV3117,immunodeficiency aids immuno aids lesions infection toxoplasma cryptococcus neoformans encephalitis primary lymphomas gliosis primary lymphoma encephalitis cuneatus toxoplasmosis lesions consistent wernickes encephalitis infarcts lesions findings european literature
HIV,HIV3118,methylmercuric cycloheximide fetal neonatal methyl mehg migration neurons migration differentiation neonatal test mehg recognition diameters mgkg wt methylmercuric isolation reaggregate growth vitro hiv microm related reaggregate growth hiv dependent vivo vitro cycloheximide related growth mimic term vivo vitro recognition synthesis specific microtubules disruption specific recognition
HIV,HIV3119,current issues transfusion therapy risks infection parasitic infections transfusion whole components packed red plasma cryoprecipitate techniques selection laboratory evidence syphilis hepatitis human immunodeficiency hiv infection transfusion infections hepatitis non non hepatitis infectious risk transfusion today hiv infection voluntary evidence infection
HIV,HIV3120,brachioproctic transmission immune aids transmission immune aids arv brachioproctic
HIV,HIV3121,htlv iii tears human iii htlv iii immunodeficiency aids tears aids previous aids aids positive iii tears normal tears htlv iii findings cdc possible spread evidence transmission htlv iii tears possible infectious ophthalmic
HIV,HIV3122,htlv iii lymph nodes lymphadenopathy nodes iiilav seropositive individuals lymphadenopathy presence rare htlv iii rna consistent positive observed lymph nodes hyperplasia rna minority rna consistent intracellular rna histology htlv iii rna observations htlv iii subjects lymph important decisive cytopathogenic iii lymphadenopathy
HIV,HIV3123,aids seronegative syphilis aids populations homosexual populations syphilis infectious diseases results abusive evidence drugs current aids crisis review literature doses tertiary syphilis seronegative syphilis africa western therapies latent tertiary syphilis current aids crisis group aids aids related conditions evidence syphilis factor aids key aids sera etiology aids
HIV,HIV3124,envelope human immunodeficiency hiv infectivity fusion human immunodeficiency hiv envelope infectivity fusion specific infectivity fusion vaccinia hiv gene hiv fusion envelope results importance envelope glycosylation hiv infection potential mechanisms hiv infectivity cytopathology
HIV,HIV3125,aids recent immune aids africa infection migration rural urban transmission aids africans infected months aids year aids homosexual excess seropositive likely aids aids future public health workers infectious diseases
HIV,HIV3126,cytoplasmic htlv iii orf protein htlv iii etiological immunodeficiency regions open frame orf encodes infected specific orf protein subcellular htlv iii kda cytoplasmic membrane latter subcellular human sera aids infected presence immunoprecipitation western total htlv iii virions specific detect protein products mature virions intracellular
HIV,HIV3127,aids infection aids homosexual bisexual february serological subjects months enrollment subjects seropositive aids seropositive subjects normal immune profiles immunodeficiency normal immune immunodeficiency subjects seropositive seropositivity enlargement non inguinal lymph hepatomegaly ratio seronegative subjects seropositive subjects ratio different subjects subjects sera positive immunosorbent subjects positive tests results wide infection subjects arv infection
HIV,HIV3128,diphenylhydantoin dph receptor previous diphenylhydantoin dph lymphatic hapten unspecific express recognition hypothesis dph helper way infection hiv hypothesis normal dph dphday phenhydan minimum hiv radioactivity gamma counter radioactivity dph results hiv inhibits hiv recognition therapy prophylaxis aids
HIV,HIV3129,cross reactivity human lymphotropic iiilymphadenopathy lymphotropic iii lymphotropic cytopathic human immunodeficiency human lymphotropic iiilymphadenopathy htlv iiilav report nucleic cross reactivity htlv iiilav stlv structure genetic clones single stlv restriction specific dna stlv lines dna stlv lines unintegrated dna infection cytopathic strongest cross reactivity htlv iiilav pol gag whereas reactivity stlv clones human types htlv leukemia feline leukemia
HIV,HIV3130,expansions myc oncogene rearrangements immune lymphoproliferative disorders implications aids immune aids spectrum lymphoproliferative disorders lymphadenopathy las hyperplasia non lymphoma ie malignant process lymphomagenesis aids possible las populations gene presence rearrangements myc oncogene locus presence human immunodeficiency hiv sequences clonal expansions significant myc nhls las clones gene rearrangements myc gene genetic malignant lymphoma myc rearrangements aids nhls burkitt non burkitt aids lymphomas myc oncogenes hiv dna sequences las clones hiv direct observations multistep lymphomagenesis aids las condition infection las expansion clones myc rearrangements malignant transformation
HIV,HIV3131,seropositivity iii european countries group aids seropositivity iii western european countries rise seropositivity different countries dependent promiscuity enter abusers risk group rapid spread seropositivity females risk seronegative individuals aids european
HIV,HIV3132,lifestyle findings htlv iiilav status homosexual homosexual partners anogenital intercourse independent risk factor htlv iiilav transmission evidence htlv iiilav infection seropositivity oroanal orogenital penile intercourse risk strongest seropositivity homosexual infection european importance homosexual skin htlv iiilav extrainguinal lymphadenopathy commonest half seropositive quarter seropositive intercourse
HIV,HIV3133,aids experiences aids dermatology university iii hiv physicians experiences directions
HIV,HIV3134,current issues strategy immunodeficiency current issues strategy immunodeficiency aids world fact issues group critical issues outlines formulation scientific public health problems aids
HIV,HIV3135,myelodysplasia myeloblastic leukemia htlv iii positive homosexual man aids acquired immunodeficiency aids aids myelodysplasia myeloblastic leukemia infection human lymphotropic iii htlv iii documented serology htlv iii infection myelodysplasia myeloblastic leukemia possible leukemia htlv iii infection investigation
HIV,HIV3136,aids serum specimens factor factor ix hemophiliacs transfusion diseases healthy subjects donors reactivity lymphadenopathy lymphotropic iii iii elisa test abbott presence iii ifa seropositivity nonhemophiliac factor factor ix male homosexuals none healthy individuals iii serological seronegative seropositive hemophiliacs seronegative hemophiliacs seropositive seropositive hemophiliacs months suppressor seronegative hemophiliacs seropositive seronegative hemophiliacs normal subjects seropositive hemophiliacs japanese aids male homosexual aids
HIV,HIV3137,transmission human immunodeficiency transmission human immunodeficiency hiv transmission male male male female female male transmission products japanese hemophiliacs seropositive infected factor viii factor ix hemophiliacs donors hiv aids male homosexuals hiv infections male homosexuals hiv transfusion whole units future
HIV,HIV3138,iii sera hemophiliacs china elisa western techniques seropositivity lymphadenopathy virushuman lymphotropic iii iii hemophiliacs aids seropositive factor viii armour company hemophiliacs documentation introduction iii china
HIV,HIV3139,virological japanese hemophiliacs aids date hemophiliacs male homosexuals hemophiliacs aids year man hemophilia year man overt infections tt ratio nk ppd skin iii sera lymph nodes organs iii hemophiliacs seropositivity seropositive group tt ratio seronegative group seropositivity cmv pv htlv hemophiliacs iii seropositive hemophiliacs correlation ratio presence retrospective iii seropositive hemophiliacs infection hemophiliacs products factor trial products hemophiliacs seroconversion
HIV,HIV3140,test human immunodeficiency immunosorbent serological test gelatin pa test human immunodeficiency hiv sensitivity test immunosorbent elisa japanese sera positive sera elisa pa test seropositivity test test hiv donors
HIV,HIV3141,receptor positive htlv iii positive individuals il receptor peripheral homosexual persistent lymphadenopathy prodrome immune subjects positive human lymphotropic iii colour flow cytometry il receptor positive subpopulations il receptor lymphadenopathy values heterosexual less results aids normal range il lymphadenopathy aids values heterosexual il human lymphotropic iii infection il receptor
HIV,HIV3142,hepatitis hemophiliacs iii positive congenital disorders hepatitis subcutaneous injections intervals fourth months vaccine doses ten iii positive hemophiliacs iii hemophiliacs none infection prevaccination hepatitis vaccine iii positive vaccine hepatitis
HIV,HIV3143,octapeptides receptor human immunodeficiency receptor infectivity differentiation helperinducer receptor human immunodeficiency hiv kda protein immunoprecipitable mab okt human human hiv envelope gp gp affixed human indistinguishable human unfixed squirrel human mab okt neuroanatomical gp receptor patterns many neuropeptide computer gp octapeptide gp protein important hiv systematic specific gp infectivity peptides rank hiv infection human aids
HIV,HIV3144,substances infection human immunodeficiency hiv growth human immunodeficiency hiv human leukemia hiv infection results tetradecanoylphorbol hiv hiv htlv iii gamma retinoic azido deoxythymidine hiv implications
HIV,HIV3145,infection htlv htlv iiilav lytic recent htlv htlv iiilav infection concurrent lysis harada koyanagi yamamoto science possible htlv respect htlv htlv iiilav subsequent infection transcriptase rt fluids hemacytometer htlv iiilav rt postinfection presence immunofluorescent positive rt lysis double infection goat protein htlv serum pre aids htlv iiilav htlv htlv share htlv iiilav infection promotion lysis
HIV,HIV3146,homology immunodeficiency envelope protein homology protein immunodeficiency aids il il receptor homology functions possible mechanisms aids mechanisms aids protein il receptor il aids vaccine aids il receptor aids
HIV,HIV3147,influences human immunodeficiency normal dysfunction immunodeficiency aids aids influences human immunodeficiency human lymphotropic iii lymphadenopathy htlv iiilav normal human protein hiv purified differentiation normal human day initiation independent monocytes cultures hiv synthesis cycloheximide peripheral cultures dependent stimulus independent stimulus epstein herein hiv findings mechanisms components exert human dysfunction hiv infection
HIV,HIV3148,presence aids dna sequences sarcoma occurrence sarcoma ks immune aids fact etiological aids aids tumorigenic potential ks presence dna sequences homologous aids cytomegalovirus cmv hepatitis ks dna aids hepatitis dna sequences cmv dna presence cmv dna due infection cultures ks skin cultures short lifetime vitro endothelial tumorigenic nude mice rearrangements different presence positivity endothelial results aids cmv hepatitis growth ks lesion ks tendency rearrangements
HIV,HIV3149,anus homosexual depletion white homosexual short perianal lesions helper depletion human lymphotropic iii htlv iii wart infection htlv iii human papilloma infection
HIV,HIV3150,iii infection belgium iii infection belgium isolation iii group iii infection probable presence subjects evidence immune iii infection subjects severe months months months months months months presence lymphadenopathy hepatomegaly splenomegaly interstitial pulmonary infiltration parotid csf lymphocytosis diarrhoea pathogen time mothers aids months months mothers iii infection aids aids
HIV,HIV3151,risk good normal tt ratio htlv iiilav serologic test results homosexual male sarcoma immune aids aids sarcoma normal normal cdcd parameters normal months results recent serum htlv iiilav sarcoma limited skin stage persistent lymphadenopathy fever night aids igm normal range evidence proliferative skin test anergy findings healthy sarcoma functional iiilav sarcoma lesions
HIV,HIV3152,theory immune system human immunodeficiency human lymphotropic iiilymphadenopathy htlv iiilav infects positive helper immune system immune growth normal immune system positive immune system remarkable infections general system ideas observations
HIV,HIV3153,hypothesis aids immune system lymphotropic helper inducer human immunodeficiency hiv envelope normal ligand receptor histocompatibility mhc normal immune envelope cross react idiotypic immune infection progressive disruption recognition hypothesis gains profound implications
HIV,HIV3154,retroviral etiology immune aids immune aids severe defects infections human terms htlv iii arv human immunodeficiency hiv infectious induction disorders recent lines evidence etiological picture aids vivo different viruses hiv retroviral etiology aids
HIV,HIV3155,lymphotropic viruses human lymphotropic htlv iadult leukemia atlv htlv iiihuman immune hiv etiological malignant lymphoma immune ubiquitous dna herpesvirus rna atlvhtlv takatsuki viruses early transfusion normal seropositive viruses lymphoma nasopharyngeal infectious mononucleosis atlv lymphoma infects humoral mechanisms immune immune lymphoproliferative transplant aids oligoclonal immune defects cytogenetic nonintegrated immune substances immune silent atl immune atl primary infection lymphotropic viruses immunotherapy drugs
HIV,HIV3156,immuno human leukemia japanese japanese leukemia lymphoma leukemia lymphadenitis tested htlv lymphadenitis lymphoma hiv infection transfusions positive transfusions units positive hiv overall positive hiv whereas positive htlv results transmission hiv transfusions htlv tokyo
HIV,HIV3157,serological leukemia hematological diseases serological leukemia htlv hematological diseases htlv positive non hodgkins positive positive transfusions seropositive results htlv non hodgkins
HIV,HIV3158,cytopathic effect human lymphotropic iiilymphadenopathy azido deoxythymidine vitro human lymphotropic iii htlv iiilymphadenopathy immune aids aids related effect azido deoxythymidine azt htlv iiilymphadenopathy infection htlv htlv iii cytopathic effect specific effect azt htlv iii htlv iii molt htlv iii results azt htlv iii transcriptase htlv iii azido ttp inhibits transcriptase effect htlv iii molt htlv iii azt effect microm azt htlv iii infection effect inhibits growth results previous report mitsuya furman clair lehrman gallo bolognesi barry broder proc natl acad sci usa azt aids aids
HIV,HIV3159,trans human immunodeficiency terminal dna viruses dna viruses gene human immunodeficiency hiv cotransfection plasmid hiv terminal ltr chloramphenicol gene dna viruses clones jc bk lymphotropic papovavirus papilloma simplex hsv zoster sequences hiv ltr trans hiv ltr different lines hiv tat gene primer specific hiv ltr steady state rna hiv dna viruses specific rna rna protein tat simplex jc hiv ltr plasmid coinfection dna viruses hiv
HIV,HIV3160,neutralization human lymphotropic iii gp human lymphotropic iii htlv iii probable target htlv iiib prototype goats gp infection homologous sera neutralize htlv iiirf individuals htlv iii gp gp iiib rf goat gp sera nonbinding infection human envelope gene transmembrane gp infection
HIV,HIV3161,functional enzymic dependent dna human immunodeficiency dependent dna rddp human immunodeficiency hiv sucrose exchange exchange hydroxyapatite free dna dependent dna rddp template primers optimal cmn dg template primer michaelis hill
HIV,HIV3162,isolation human human iii htlv iii perivasculitis peripheral aids related ocular iii presented zoster htlv iii infection isolation htlv perivasculitis etiology ocular presence infectious htlv iii corneas donors
HIV,HIV3163,serological early human immunodeficiency infection haemophiliacs human immunodeficiency hiv hiv envelope cia specimens seropositive immunosorbent elisa hiv subjects subjects elisa seroconversion antigenaemia weeks infection months cia western cia envelope western
HIV,HIV3164,protein synthesis hiv human immunodeficiency hiv kilodalton effect hiv infection synthesis messenger rna protein products lines sup uninfected sup kilodalton envelope kilodalton envelope hiv lines steady state hiv infected due steady state specific immunoprecipitable envelope gene products protein infection envelope gene products infected retroviral envelope receptor general infection
HIV,HIV3165,epitopes hiv infection human important receptor human immunodeficiency hiv receptor hiv receptor hiv infection epitopes cross hiv group different laboratory cem epitopes important imply different gene sequences preliminary polymorphism epitopes infection
HIV,HIV3166,glycosylation iii hiv glycosylation glucose extent hydroxynorvaline hiv iii monospecific envelope gp gp infected glycosylation concomitant immunoassay synthesis incorporation hglcnac transcriptase glycosylation aids aids chemoprophylaxis hiv positive individuals
HIV,HIV3167,trans htlv iiilav human lymphotropic htlv iiilav encodes trans gene trans functional putative trans stable lines kilodalton sodium sulfate polyacrylamide gels trans increases steady state messenger rna terminal promoter sequences htlv iiilav terminal trans protein protein messenger rna cv hela trans specific final level trans
HIV,HIV3168,aids paradigm immune aids countries world aids male female ratio specific females aids africans infections cryptococcosis cryptosporidiosis sarcoma healthy donors many female prostitutes human immunodeficiency hiv infection general africa heterosexual transfusions unsterilized needles infected mothers newborns transmission hiv infection educational programs bank immediate public health priority countries
HIV,HIV3169,vitro htlv iii transmission htlv iii hxb human serum htlv iii serum positive serum serum maps patterns dna findings htlv iii specific propagation viruses minor extent specific immune htlv iii infection future envelope important neutralization vaccine
HIV,HIV3170,aids medicolegal endemicity human immunodeficiency hiv immune aids subgroups legal implications aids duty contractual contractors aids public law aids hiv reactivity infectious diseases liability
HIV,HIV3171,evidence htlv iiilav primary cultures targets iiilav infectious aids aids receptor determinants depletion aids il aids peripheral vitro pha targets iiilav term ctc zairian iii infection htlv iii evidence cytotoxicity presence okt mab htlv iii positive double ifa rhodamine presence okt mabs htlv iii ifa htlv iii mabs normal diversity results htlv iii infection
HIV,HIV3172,evidence heterosexual transmission manifestations human immunodeficiency infection conditions subjects human immunodeficiency hiv subjects year group significant educational level hiv seropositivity hiv donors workers orthopaedic std clinics previous attenders time attenders infectious oral thrush diarrhoea seropositivity hiv infection africa seropositivity implications
HIV,HIV3173,human lymphotropic iii infection nervous system preliminary immunodeficiency aids subject spectrum nervous system cns disorders recent evidence human lymphotropic iii htlv iii illnesses aids presence htlv iii rna rna limited white matter cns macrophages pleomorphic giant consistent neurons findings strengthen htlv iii aids prepared htlv iii infection cns
HIV,HIV3174,htlv iii rna lungs aids pulmonary rare immunodeficiency aids respiratory lymphocytic interstitial pneumonitis lip efforts infectious process lungs aids pulmonary presence human lymphotropic iii htlv iii rna infant lip positive htlv iii rna total htlv iii previous evidence htlv iii rna infection lip ten pulmonary diseases positive rna htlv iii direct lip diseases
HIV,HIV3175,isolation identification htlv iiilav aids primary cultures human lymphotropic iiilymphadenopathy htlv iiilav seropositive progressive dementia transcriptase microscopy presence htlv iiilav virions primary cultures trypsinization nonspecific express evidence htlv iiilav sequences nonspecific positive primary cultures peripheral macrophages macrophages primary cultures htlv iiilav results htlv iiilav phagocyte
HIV,HIV3176,polymyositis aids homosexual polymyositis immunodeficiency aids infection aids weeks typical aids months weakness human lymphotropic iii subsets positive endomysia infection aids polymyositis aids aids
HIV,HIV3177,gene encodes aids receptor immune system isolation clones human protein gene protein aids aids infection specific interaction aids transformed epithelial presence human render aids infection aids receptor gene dual lymphotropic aids manner protein important effector target human aids populations
HIV,HIV3178,year rehabilitation work voluntary rehabilitation year residents developed illnesses misusers general withdrawal misuse prescription drugs psychological support general substances residents evidence previous hepatitis infection human immunodeficiency hiv edinburgh moment spread immune misusers
HIV,HIV3179,kaposi neck immunodeficiency aids sarcoma mucous neck regions immune aids spindle vascular endothelial inflammatory endothelial irregular lymphatic luminal formations tubuloreticular helical polysomes giant tumour ultimately siderosomes mitotic tumour nm htlv iii plasma membrane sarcoma replicate sarcoma characterisation quantification relevant
HIV,HIV3180,aids state cortisol excess implications aids host successful propose primary unlocalized lesion aids disruption balanced state cortisol excess state inhibits successful pathogen directed aids downhill therapies
HIV,HIV3181,non hodgkins htlv iiilav htlv iiilav wife man transfusion aids non intestine year wife man transfusion immune aids human lymphotrophic iiilymphadenopathy htlv iiilav serum peripheral hodgkins lymphoma htlv iiilav infection lymphoma htlv iiilav infection male homosexual risk group
HIV,HIV3182,intradermal recall identification immune homosexual health cutaneous hypersensitivity recall past hepatitis infection las human lymphotropic iii htlv iii multiscore ms sum positive reactions partners regular rectal intercourse regular gay recent encounters lifetime nitrates positive htlv iii serology anergy tuberculin tu partners regular rectal intercourse inhalant nitrates lymphadenopathy htlv iii seropositivity htlv iii year immune ms tu anergy marginal intradermal tu prognostic htlv iii positive individuals aids
HIV,HIV3183,infectivity aids immune system parameters system serodiagnosis infection aids viruses immune western system suitable serodiagnosis aids infection human aids viruses
HIV,HIV3184,prospects therapy infections human immunodeficiency current immunodeficiency aids vaccine prevent infection human immunodeficiency hiv safe individuals mechanisms hiv vitro transcriptase azidothymidine phosphonoformate antimoniotungstate hpa suramin ribavirin interferon ifn hiv mechanisms early trials hiv infection identification vaccines hiv vectors laboratory chimpanzees vaccines successful trials safety human populations hiv important problems protein efforts vaccines successful
HIV,HIV3185,confidential method donors human immunodeficiency confidential donors donation immunodeficiency aids risk designate laboratory laboratory eia human immunodeficiency hiv units group donors western wb eia equal units transfusion wb eia donors laboratory times vs transfusion times general hiv laboratory group wb positive eia confidential valuable risk donors
HIV,HIV3186,human immunodeficiency risk populations human immunodeficiency hiv immunoassay genetic risk populations sites cem plasma populations specimens rip positive test positive eia results suitable screen donors
HIV,HIV3187,infection human immunodeficiency infection biosafety human immunodeficiency htlv iiilav products evidence transmission risk health workers infection specimens laboratory plastic bags biohazard disinfection sterilization waste management guidelines engage direct hiv serologic hiv risk process specimens hiv educational infection infection
HIV,HIV3188,subregions hiv gp transmembrane protein individuals dna homologous gp transmembrane human immunodeficiency hiv different plasmid vectors coli plasmid constructs induction mr coli dhfr mr sequences sera aids individuals sera strategy gene subfragments dhfr serodiagnosis positive sera western subfragments presence immunoreactive epitopes
HIV,HIV3189,significance aids obstetric speciality aids obstetric implications hiv infection maternity units management seropositive staff risks
HIV,HIV3190,immune hivlavhtlv iii infection tests immune hiv full method test hiv infection immune skin test recall helpful immune detect incipient functional final early tests prognostic stimulus diminution immune dysfunction possible effect proliferative sera hiv
HIV,HIV3191,primary human immunodeficiency significant sequences human immunodeficiency viruses hiv cdc preliminary hiv restriction hiv primary regions sequences hiv cdc sequences group specific gene extent envelope gene sequences terminal mr terminal protein mr sequences envelope important implications ultimate eradication
HIV,HIV3192,mutations orf open frame human lymphotropic iii htlv iiilav mutations human lymphotropic iii kilodalton orf replicate terminal sequences gene orf sequences retarded
HIV,HIV3193,induction peptides peptides sequences human lymphotropic htlv iii htlv iii lymphadenopathy rabbits subsequent htlv iii infectivity peptides regions gp gp human immunodeficiency hiv epitopes envelope hiv epitopes glycoproteins peptides infectivity different iii terms possible strategy vaccine immune aids
HIV,HIV3194,htlv iii infection exanthema seroconversion report homosexual malaise fever exanthema weeks months iii seroconversion weeks htlv iii infection western detect htlv iii elisa
HIV,HIV3195,telangiectases homosexual single homosexual persistent lymphadenopathy telangiectasias crescent telangiectasias erythema positive serum human immunodeficiency hiv telangiectasias seropositive skin telangiectasias endothelial hiv seronegative telangiectasias telangiectasias upper homosexual hiv infection
HIV,HIV3196,human lymphotrophic possible etiological human immunodeficiency structure
HIV,HIV3197,world human sera world different elisa human lymphotropic viruses fourth sera positive elisa tendency positive human elisa positive sera positive western positive elisa sera mandrills macaques macaques guenons positive elisa tests human contain feline leukemia infectious peritonitis panleukopenia viruses sera due non preparations normal human viruses implications protein sera previous seroepidemiologic man world
HIV,HIV3198,human immunodeficiency gp gp human immunodeficiency hiv hiv western reactivity kda human early vitro infection transcriptase fluids
HIV,HIV3199,isolation lentivirus lymphoma htlv iiilav human hut cocultivation lymph pig macaca malignant lymphoma university washington wprc immunodeficiency washington lentivirus lines human sodium sulfate polyacrylamide gag protein kilodaltons human immunodeficiency hiv fre hut htlv iiilav eiav radioimmunoassays techniques terminal gag protein cross reactivity htlv iiilav terminal htlv iiilav results htlv iiilav related human immune
HIV,HIV3200,salivary human lymphotropic iiilymphadenopathy infection individuals seropositive human lymphotropic iiilymphadenopathy salivary radioimmunoprecipitation results western salivary possible diagnostic test human lymphotropic iiilymphadenopathy venipuncture
HIV,HIV3201,time immune iiilav seroconversion longitudinal immune hemophilia missouri serum participants human lymphotropic iii htlv iiilymphadenopathy htlv iiilav hemophiliacs whereas positive seropositive hemophilia okt positive seronegative hemophiliacs lymphoproliferative normal seronegative hemophilia seropositive hemophiliacs seronegative hemophiliacs lymphoproliferative tetanus stimulations immune htlv iiilav seropositive hemophiliacs unresponsiveness months full blown aids longitudinal immune seropositive hemophiliacs unresponsiveness
HIV,HIV3202,significance postnatal mother transmission human lymphotropic leukemialymphoma htlv infection mother transmission sera endemic town year group stable date mothers overall male females mothers positive mothers mothers positive mothers mothers positive mothers mothers positive mothers postnatal early transmission htlv significant htlv leukemialymphoma
HIV,HIV3203,intrafamilial positive total presence leukemia atla status positive atla times significant atla females group subareas crude size equal independent size positive units
HIV,HIV3204,iii sera iii elisa tests risk transmission iii elisa positive sera ifa western wba sera iii elisa dr positive elisa results
HIV,HIV3205,sero reactivity envelope glycopolypeptide gp human immunodeficiency weights human immunodeficiency hiv specific hiv envelope glycopolypeptide hiv gp presence protein gp sera infectious eiav sera uninfected epitopes eiav
HIV,HIV3206,vitro human immunodeficiency infection granulocyte factor gamma interferon human granulocyte factor gm csf gamma interferon ifn gamma human immunodeficiency hiv htlv iiilav infection cultures csf units ml maximal reductions transcriptase ifn gamma reductions hiv infection system cytokines transcriptase prevent return productive infection removal results hiv infection gm csf ifn gamma hiv cytokines related disorders
HIV,HIV3207,phosphorylation azido deoxythymidine interaction triphosphate human immunodeficiency transcriptase azido deoxythymidine au azidothymidine human immunodeficiency hiv nm range mitsuya weinhold furman st clair lehrman gallo bolognesi barry broder proc natl acad sci usa growth uninfected human fibroblasts observed azidothymidine mono triphosphate uninfected hiv level azidothymidine monophosphate whereas equal microm equal microm cytosolic phosphorylation azidothymidine monophosphate phosphorylations azidothymidine km values maximal phosphorylation equal phosphorylation azidothymidine monophosphate diphosphate catalyzed host thymidylate km azidothymidine monophosphate dtmp vs microm maximal phosphorylation dtmp constants consistent results azidothymidine monophosphate thymidylate azidothymidine intracellular ic inhibits values azidothymidine triphosphate hiv transcriptase human dna azidothymidine triphosphate fold hiv transcriptase dna results azidothymidine phosphorylated triphosphate hiv transcriptase incorporation dna terminate dna elongation dna synthesis
HIV,HIV3208,transcriptase endonuclease polypeptides immunodeficiency terminal immune immunodeficiency polypeptides kilodalton kda polypeptides pol open frame orf dna kda glu thr val pol orf kda pol gene phe leu orf polypeptides rt single dna
HIV,HIV3209,human htlv iiilavarvhiv potential idiotypic human immunodeficiency hiv acquired immunodeficiency cytopathic envelope gp enzymic effect hiv cem alkylation alkylation trypsin glycolytic tertiary protein structure disulfide bonding tertiary conformations dependent noncovalent denaturants sulfate urea degrees degrees removal denaturants irreversible denaturation degrees hiv murine human murine results panel terminal okta oktd oktf leu sites idiotopes share conformational gp human hiv sera gp react idiotypic sera different idiotype conformational
HIV,HIV3210,promoter tpa htlv iiilav molt htlv iii human lymphotropic iii htlv iiilymphadenopathy ngml tetradecanoylphorbol tpa htlv iiilav viruses cultures rna htlv iiilav tpa induction specific cytopathic situation liquid cultures medium tpa tpa htlviiilav induction infection many drugs
HIV,HIV3211,ultraviolet human immunodeficiency cytopathology clonal human rh supernatants human immunodeficiency hiv ultraviolet hiv fluids rh specific cytopathic indistinguishable preparations hiv incapable dna endogenous rna template rh hiv release cytotoxic observed supernatants uninfected rh results hiv
HIV,HIV3212,htlv iiilav dideoxycytidinene dideoxycytidine dideoxycytidinene ddecyd dideoxycytidine ddcyd ddcyd htlv iiilav vitro ratio microm versus growth microm lack non rna dna human lines human nonlymphoid murine lines dependent deoxycytidine exert htlv iiilav cytostatic ddcyd ddecyd effect infected
HIV,HIV3213,oral hairy leukoplakia early htlv iii infection oral hairy entity early htlv iii infection white lesions lateral tongue lesions hairy leukoplakia papillomavirus report literature
HIV,HIV3214,htlv iii vienna end prostitutes htlv iiilav prostitutes positive test results addicts addicts htlv iii prostitute homosexuals addicts seropositive lymphadenopathy whilst latent infection
HIV,HIV3215,induction dependent fusion htlv iiilav envelope vitro cultures human lymphotropic iiilymphadenopathy htlv iiilav positive giant histological individuals vitro giant fusion dependent differentiation vaccinia gene envelope htlv iiilav protein htlv iiilav regulatory dependent fusion manifestations aids immune cytopathology process aids
HIV,HIV3216,haemophilia infection human immunodeficiency immune vivo severe haemophilia dinitrochlorobenzene skin test normal normal range skin positive human immunodeficiency human lymphotropic iii lymphadenopathy whole group seronegative inverse factor seropositive factor impairs immune infection hiv
HIV,HIV3217,histocompatibility immune immune aids functional peripheral leukocytes risk htlv iii positive donors immune aids lymphadenopathy las aids related vitro cytotoxic proliferative influenza hla donors whereas positive las aids normal aids proliferative positive donors time extent depletion helper healthy donors helper subsets human pbl helper helper depletion helper functional test helper immune functional aids
HIV,HIV3218,lymphadenopathy aids laboratory findings aids seropositive group homosexual immune aids laboratory findings aids human immunodeficiency hiv aids positive hiv laboratory aids months seropositive aids free months significant aids helper helper suppressor lifetime male partners intercourse infectious risk aids contacts aids endemic enrollment early aids endemic early infection risk aids infection unknown statistical lifestyle infection cofactors aids
HIV,HIV3219,seroepidemiologic captive world human isolation lentivirus atys sera world apes htlv iiilav aids srv sera elisa positive sera sera cage contacts western positive elisa sera true positive reactions single individuals positive specific seroreactivity htlv true positive reactions talapoins macaques specific serologic reactions many iiilav seropositive mandrills guenons talapoins srv positive tonkeana macaques seropositive talapoins htlv iiilav seropositive seropositive talapoins seropositive colobus zoo mangabey lentivirus lymphadenopathy leukopenia rhesus macaques
HIV,HIV3220,aids human immunodeficiency psychosocial perspective past leprosy direct conflict current level transmission human penchant react allay public aids recognize metaphor venereal general aids
HIV,HIV3221,zinc subsets hiv infection serum zinc aids related syndromes spectrophotometry statistical serum zinc less different picture aids serum zinc aids related less helper results serum zinc zinc therapy management hiv infection
HIV,HIV3222,vitro hiv enhancer promoter persistent lytic infection human immunodeficiency hiv gene infected tpa report tpa non types free system vitro fold hiv promoter nuclear extracts hela human globin promoter equal uninduced extracts dna protein interacts hiv tpa dnase footprint protein synthesis post hiv mutants target tpa effect vitro vivo free system induction gene specific
HIV,HIV3223,human immunodeficiency hepatitis laboratory implications specimens hepatitis human immunodeficiency hiv serum plasma laboratory urban results biohazard labels hepatitis hiv specimens specimens biohazard labels unlabeled specimens laboratory hepatitis handle specimens biohazard complacency unlabeled specimens biohazard labels risk health workers hiv hepatitis
HIV,HIV3224,hiv infectivity infection human macrophages human immunodeficiency hiv hiv envelope receptor vectors transmembrane cytoplasmic gp intact infectivity hiv gp interaction components intervention immune aids
HIV,HIV3225,human immunodeficiency hiv infection factor seropositive sera sera human immunodeficiency sera infectivity different individuals tn factor filtration micron stoichiometric sera infection iiib htlv iiirf infection target htlv none sera hiv findings igg
HIV,HIV3226,psk inhibits transcriptase vitro effect human immunodeficiency hiv mechanisms effect hiv inhibits transcriptase competitive way important hiv effect effect hiv
HIV,HIV3227,human envelope human immunodeficiency human igg benv envelope human immunodeficiency hiv hiv determinants infected western consistent transmembrane envelope western vaccinia envelope gene hiv gt vector benv gp hiv vast seropositive individuals ibenv neutralize hiv infectivity fusion results human techniques manner humoral hiv infection significant determinants hiv
HIV,HIV3228,htlv human tac human cutaneous human leukemialymphoma types htlv htlv human immunodeficiency hiv related sequences sequences htlv distinguishable leukemia htlv wife serological cross reactivity htlv hiv none risk hiv infection name htlv date etiological factor group cutaneous sporadic lymphomas fungoides
HIV,HIV3229,hiv ltr protein htlv immune human immunodeficiency hiv different terminal ltr pha myristic promoter ionomycin tat trans protein human leukemialymphoma htlv hiv ltr hiv positive regulatory overall magnitude synergistic hiv observed tat iii protein hiv ltr effect presence gene hiv ltr signals
HIV,HIV3230,sweat human immunodeficiency infection year diarrhoea recurrent cough results sodium tests cystic fibrosis organisms sweat sodium fludrocortisone test human immunodeficiency hiv positive trimoxazole zidovudine human positive hiv normal sweat sodium cystic fibrosis hiv state
HIV,HIV3231,human immunodeficiency flow cytometry flow human immunodeficiency hiv infected human lines hiv specific hiv protein fab fixation methanol fixation methanol paraformaldehyde triton latter fixation mixtures uninfected method cellss hiv rare possible flow transcriptase rt uninfected time infection cultures positive flow cytometry rt
HIV,HIV3232,termination terminal hiv tat gene human immunodeficiency hiv gene trans hiv tat arttrs tat hiv gene trans element tar hiv terminal ltr tat steady state rna tar tat subsequent rna processing tat gene translation tar tat structure synthesis rna hiv ltr presence hiv initiation tat elongation position presence tat tat trans hiv specific elongation tar
HIV,HIV3233,hiv infection receptor differentiation receptor human immunodeficiency viruses aids immune peripheral world world express homologous human helper short term human immunodeficiency viruses hiv hiv prototype aids hiv second aids africa infection evolutionary cluster hiv replicate means drugs vaccines
HIV,HIV3234,aids hiv vaccine means aids countries sophisticated methods rural regions aids evidence different pathogens laboratory populations resistance aids likely genetic argue suitable way much manufacture laboratory drugs unpleasant side ltd
HIV,HIV3235,immunodeficiency reiters human immunodeficiency hiv spectrum immunodysfunction immunodeficiency aids positive individuals mild severe immunodeficiency hiv positivity aids aids reiters urethritis conjunctivitis group second group infections staphylococcus drugs immune system flare severe risk prompt hiv prognostic hiv positive therapy methotrexate group newer therapy etretinate promising results management aids
HIV,HIV3236,infection human immunodeficiency hiv exanthematous rash primary infection human immunodeficiency hiv rare infectious mononucleosis year homosexual man serologic evidence primary infection hiv pustular exanthematous enanthematous rash serologic results immunosorbent western techniques hiv infection significant hiv infection
HIV,HIV3237,evidence early nervous system immunodeficiency aids human immunodeficiency hiv infections magnetic resonance nervous system immunodeficiency aids human immunodeficiency hiv evaluations homosexual aids aids hiv seropositivity hiv problems speed processing magnetic resonance findings aids aids related sulcal enlargement patchy white matter nervous system hiv early aids mild cognitive
HIV,HIV3238,aids aids dementia disability many aids spinal peripheral hiv infection physicians aids manifestations infectious vascular complications
HIV,HIV3239,aids infection review observations aids hiv infection world world health many different unreliable united size hiv risk results cohorts risk group whole united less aids many countries many countries aids aids ie zaire evidence aids hiv infection public health size hiv lack therapy vaccine much spread hiv infection aids
HIV,HIV3240,dideoxynucleosides vitro human immunodeficiency hiv hiv dideoxynucleosides human immunodeficiency viruses hiv hiv azido deoxythymidine hiv human lines hiv resistant hiv dideoxynucleosides results dideoxynucleosides vivo hiv infection range human vitro
HIV,HIV3241,transmission genetic human immunodeficiency hiv vivo hivyu hivyu immune mk yu infected peripheral normal individuals lines hut molt yu hand serum neutralize yu heterologous serum restriction endonuclease yu viruses clones yu method kpni yu yu transmission human immunodeficiency heterosexual possible genetic yu yu vivo
HIV,HIV3242,thymus lysate early infection second report thymus lysate maturation fifteen hiv infection different reed wrb subjects parameters unchanged sarcoma laboratory remission neoplasia wr wrb therapy normalization cdcd ratio less helperssuppressors due significant enhancement neopterin
HIV,HIV3243,aids risk aids individuals aids aids male homosexuals haemophiliacs dependent cytotoxicity non lines raji aids aids positive human immune hiv serology target cytotoxic target standard cytotoxicity aids aids peripheral mononuclear pbmc non sensitization target serum cytotoxicity hla dr non raji titres ho aids non raji targets titres group different hiv ho hiv aids
HIV,HIV3244,thalassemia positive htlv iii iii none signs immuno positive thalassemic iii htlv iii infection thalassemic condition
HIV,HIV3245,human immunodeficiency positive individuals test human immunodeficiency hiv positive test los subjects hiv infection group laboratory evidence immunodeficiency lymphadenopathy onychomycosis oral sarcoma anergic intradermal normal white helper less subjects immune severe approximated immunodeficiency pneumocystis carinii findings seropositive test sites
HIV,HIV3246,human immunodeficiency hiv hiv infected chimpanzees peripheral chimpanzees infected months human immunodeficiency hiv normal proliferative recall hiv infection chimpanzees infected humans reactivity peripheral chimpanzees proliferative hiv envelope glycoproteins hiv envelope gp gp hiv gag protein hiv specific chimpanzees immunodeficiency
HIV,HIV3247,downregulation infection human immunodeficiency infection human cr human immunodeficiency hiv cem gradual hiv receptor okt okt okt okt transferrin receptor receptor rapid hiv multireceptor downregulation lines cem hbd hivnt hut hivsf hiv uninfected cr mrnas hla hla cr tubulin uninfected cr hiv hbd receptor gene cr infection hiv results weeks postinfection reductions receptor hiv infection induces posttranscriptional downregulation
HIV,HIV3248,laboratory aids morphogenesis genetics human immunodeficiency aids different aids prospects diagnostic techniques gene engineering
HIV,HIV3249,bells hiv infection hiv neurological paralysis year man bells palsy unusual hiv infection
HIV,HIV3250,spectrum oral hairy leukoplakia oral hairy leukoplakia specific early human immunodeficiency immune aids time aids lateral tongue white lesions size lesions wide flat lesions tongue dominant epithelial hyperparakeratosis hairlike projections hyperplasiaacanthosis koilocytes connective candidal hyphae epithelium lesions flat lacked size aids parameters subgroups risk aids white lesion tongue risk aids lesion tongue hiv infection typical exclusion lesions
HIV,HIV3251,serological chimpanzees human immunodeficiency gp vaccine envelope human immunodeficiency hiv utilized prototype vaccine gp human htlv iiib final htlv iiib chimpanzees gp gp vitro infection htlv iiib iiib gp immunized chimpanzees peripheral leukocytes tt ratio immunization ligand gp effect current hiv chimpanzee immunization chimpanzees system effectiveness prototype vaccines hiv infection vivo
HIV,HIV3252,gallium interstitial pneumonitis aids interstitial pneumonitis lip pulmonary immune aids human immunodeficiency hiv infection report gallium findings aids gallium scintigraphy radionuclide lungs indistinguishable carinii pcp nuclear practitioners physicians gallium uptake lungs aids
HIV,HIV3253,dependent cytotoxicity human immunodeficiency human immunodeficiency hiv specific individuals serum hiv infected individuals dependent cytotoxicity vitro cr release system peripheral mononuclear healthy donors seronegative hiv uninfected target presence serum hiv uninfected donors hiv uninfected donors targets uninfected group serum mice peptides envelope determinants transmembrane hiv envelope
HIV,HIV3254,dna probes human immunodeficiency nucleic methods human immunodeficiency hiv laboratory dna probes translation datp direct covalent biotinylation photobiotin direct covalent standard translation dna probes dilutions target hiv dna strepavidin tetrazolium bromo indolyl phosphate probes less pg biotin pg probes pg pg probes detect hiv dna cem non dna methods detect hiv dna conditions compatible laboratory
HIV,HIV3255,phosphonylmethoxyalkyl pyrimidines hydroxy hpmp phosphonylmethoxyethyl pme diaminopurine monoaminopurine hx pyrimidine cytosine uracil hpmpa phosphonate thereof chpmpa hpmpc pmeg pmea hpmpg hpmpdap simplex
HIV,HIV3256,management human immunodeficiency hemophilia severe hemophilia human immunodeficiency hiv infection seropositive gammaglobulin danazol rash fever fall gammaglobulin counts counts months ten months months
HIV,HIV3257,investigation aids citizen spread infection human immunodeficiency infection homosexual infected africa partners infection heterosexual intercourse seropositive transfusion homosexual infected
HIV,HIV3258,findings normal normal serious unsuspected conditions persistent hepatitis lesion seropositivity hepatitis hiv findings subject questions institutional guidelines potential legal liability problems subject unsuspected
HIV,HIV3259,evidence aids related lymphoadenopathy las system aids related lymphoadenopathy las presence cleavage significant many severe las abusers homosexuals acquired possible importance hiv
HIV,HIV3260,world health organizations strategy aids human immunodeficiency hiv pandemic impact underestimated underappreciated programme aids immunodeficiency world health february architect aids plan programme aids strategy strategy support world aids worlds aids vital aids countries aids programs world technical support whos programme aids level programme scientific technical resources aids countries programme support world
HIV,HIV3261,aids uganda aids uganda serious immunodeficiency aids cumulative total aids uganda aids march less seropositivity heterosexual united male female ratio heterosexual risk important transmission household contacts partners year plan health thrust sterile notification terminal plan integration primary health issues tell truth aids healthy seropositive countries everyone guardians
HIV,HIV3262,aids immunodeficiency aids september february seropositive human immunodeficiency hiv total clinics educational health workers physicians posters programs concerned aids laboratory support tests programs public international legislation parliament hiv infection debate law international travelers foreign immigrants
HIV,HIV3263,manifestations hiv infection infection human immunodeficiency hiv manifestations due diseases hiv spinal peripheral hiv lymphocytic interstitial etiology papular skin hiv infection unclear hiv immunodeficiency aids year time state microbial hiv infection hiv gene persistent antigenemia deterioration genetic cofactors unclear
HIV,HIV3264,aids perspective total immunodeficiency aids world health world human immunodeficiency hiv infections perinatal patterns transmission transmission homosexual bisexual urban abusers products ratio perinatal transmission uncommon united western transmission heterosexual perinatal transmission products unsterile needles instruments transmission magnitude ratio seroprevalence africa iii aids due products middle asia
HIV,HIV3265,hiv stage infection risk group human immunodeficiency hiv immunoassay eia hiv hiv positive pre hiv seroconversion sera results stage infection risk group homosexual hiv serum months time hiv seroconversion hiv seroconversion half aids aids none hiv seroconversions haemophiliacs hiv hiv seropositive hiv dutch homosexual aids persistent lymphadenopathy sera iv hiv positive ten sera africans slim hiv positive infected aids positive hiv eia identify hiv infection hiv significant hiv deterioration hiv suitable independent status individuals therapy therapy
HIV,HIV3266,human immunodeficiency human immunodeficiency hiv human immunodeficiency dnase footprinting ltr hela regions ltr critical dna regulatory enhancer sp tata untranslated regions mutagenesis significant level tat protein mutations regulatory untranslated regions factor enhancer complementary factor results hiv
HIV,HIV3267,cholangitis immunodeficiency report literature report immunodeficiency human immunodeficiency lymphadenopathy human lymphotrophic iii hiv htlv iii infection aids human immunodeficiency lymphadenopathy hiv infection cholangitis manifestations possible mechanisms cholangitis
HIV,HIV3268,human immunodeficiency infection investigation infected human immunodeficiency hiv mechanisms hiv latent mechanisms interference receptor hiv transcriptase integration interference interference release work hiv transcriptase suramin ribavirin tungsten hpa foscarnet phosphonoformate pfa pranobex isoprinosine ampligen dideoxycytidine azidothymidine antiretroviral vitro date zidovudine antiretroviral fda serious neutropenia therapy zidovudine cure hiv infection way hiv ultimately hiv search less zidovudine short time cure
HIV,HIV3269,human immunodeficiency escherichia coli specific maturation gag mature gag pol human immunodeficiency hiv gag gag pol polyprotein precursors cleavage specific proteolytic processing gene escherichia coli autocatalyze maturation hiv hiv gag polyprotein coli system structure hiv potential critical
HIV,HIV3270,serologic human immunodeficiency infection laboratory methods serum human immunodeficiency hiv uses laboratory safety test results
HIV,HIV3271,immunocytochemistry human immunodeficiency early intracellular human immunodeficiency hiv cultures human lines peripheral mononuclear hours hiv dna cytoplasmic rna infected subsequent ten free transcriptase pgag capture methods monitor cultures sero positive cytoplasmic rna infected pmcs day subsequent intracellular free immunocytochemistry complementary specific early immune vitro
HIV,HIV3272,human immunodeficiency demonstration human immunodeficiency viruses infected membrane serological method hiv determinants sera individuals react infected different hiv sera unreactive sera hiv specific sera immunoprecipitation page predominant serological reactions likely different hiv diversity hivs importance epitopes important issues vaccine
HIV,HIV3273,effect hiv disclosure subsequent homosexual aids homosexual bisexual hiv status safe disclosure hiv serologic status subsequent time points previous months male partners intercourse intercourse insertive intercourse disclosure partners unaware status seropositive seronegative partners less partners unprotected intercourse unaware seronegatives partners unprotected insertive intercourse unaware seronegatives test activitiesabstract
HIV,HIV3274,antigenaemia hiv infection homosexual persistent lymphadenopathy march aids year laboratory risk fifty sera abbott protein hiv direct immunosorbent elisa aids aids aids months aids months transitional state humoral gag status consistent way antigenaemia laboratory
HIV,HIV3275,hiv replicates human human embryo infected hiv hiv sequential months hiv time human embryo glial glial fibrillary protein microscopy infected glial gag western possible detect results hiv replicates malignant strengthens hiv dementia neurological infected
HIV,HIV3276,hiv infection healthy uganda results serological uganda hiv infection different individuals wide range seropositivity uganda primary pupils residents homes serological evidence hiv infection hiv seropositivity whereas rural lifetime partners seropositivity dependent sexuality
HIV,HIV3277,hiv infection healthy subjects sera individuals healthy subjects es salaam capital tanzania capital northwest corner tanzania northeast tanzania mbeya southwest tanzania immunosorbent elisa positive sera western es salaam hiv donors barmaids male workers male female diseases suspected aids barmaids seropositivity hiv seropositive barmaids hiv hiv seropositivity healthy risk subjects bukoba donors none workers donors none positive mbeya seropositive hiv infection parts tanzania
HIV,HIV3278,hiv rural africa potential risk seropositivity hiv immunoenzymatic western serum murunda rural rwanda africa strict rural market attenders hiv seropositive seropositivity previous travel rwandese urban previous seroprevalence rural africa urban seropositivity rural urban ie heterosexual promiscuity many hiv seropositive rural subjects likely hiv infection contacts rwandese
HIV,HIV3279,risk seropositivity urban rwandese hiv means immunoenzymatic western male urban professionals health workers rwanda univariate hiv seropositivity diseases transfusion injections injections related conditions hiv seropositivity health workers hiv seropositivity hiv fluids hiv seropositivity std transfusion africa std transfusion risk seropositivity injections transmission hiv africa
HIV,HIV3280,aids risk aids immunosorbent serum immunodeficiency aids aids related hiv positive lymphadenopathy positive hemophiliacs hiv positive homosexual abusers heterosexual contacts hiv hemophiliacs homosexual abusers none lymphadenopathy sil overall risk individuals values positive individuals values less
HIV,HIV3281,human immunodeficiency infection year homo bisexual year risk group finland slow hiv typical hiv infection seroconversion ts functions il signs hiv infection phases infection th serum hiv infection functions th il correlation th monocytes infected hiv results hiv infection slow early phases infection functions th
HIV,HIV3282,aids infection human immunodeficiency immunodeficiency review picture transmission hiv infection
HIV,HIV3283,subpopulations hiv dependent group slight immunoregulatory cytotoxic suppressor ratio due presence quantity suppressor subsets normal ratio suppressor conjunction lymphocytosis due effect infections viruses group pathogens
HIV,HIV3284,dermatologic findings human immunodeficiency infection risk individuals dermatologic disorders human immunodeficiency hiv infection mucocutaneous findings individuals risk hiv infection hiv seropositive months hiv seronegative mucous whereas seropositive individuals conditions oral infectious eczematoid dermatitis ichthyosis dermatologic disorders hiv seropositive individuals skin deterioration
HIV,HIV3285,rectal mucosa human immunodeficiency infection mucosa cytochemical methods subsets plasma mast human immunodeficiency hiv heterosexual homosexual homosexual rectal gonorrhoea lamina propria hiv individuals infection intercourse suppressor helper non rectal gonorrhoea significant plasma mast
HIV,HIV3286,polyipolycu human clones human immunodeficiency alloreactive human clones hla dr hla dr determinants specific proliferative infection hiv system effect polyipolycu hiv immune rna transcriptase cytopathic alloreactivity clones hivpolyipolycu level subsequent host infection effect enhancement gene tatiii findings early infection specific allodeterminants presence polyipolycu potential aids
HIV,HIV3287,leukemialymphoma human immunodeficiency japanese immigrant colonies bolivian natives estimate human leukemia lymphoma htlv infection human immunodeficiency hiv infection japanese immigrant colonies seroepidemiological htlv hiv healthy japanese bolivian natives colonies overall htlv japanese immigrant populations significant immigrants southwestern island leukemia endemic htlv seroprevalence issei none bolivian htlv seroprevalence overall hiv japanese bolivian populations results htlv japanese immigrant populations immigrants htlv bolivian natives htlv transmission japanese immigrants endemic bolivia
HIV,HIV3288,infections complications hiv related infections aids literature complications nervous system cns peripheral nervous system disorders infections hiv subjects aids aids underwent nervous conduction velocity tests puncture nervous muscular subclinical polyneuropathy severe types polyradiculoneuritis sensorimotor polyneuropathy much rarer lesions subjects aids direct lesion hiv immune mechanisms humoral mechanisms
HIV,HIV3289,human immunodeficiency related current human immunodeficiency hiv related group genetic structure growth genetic human world health group experts rapid identification public health different nomenclature evolution viruses system nomenclature group system developed influenza descriptive
HIV,HIV3290,sclerosis human lymphotropic serological results total sera csf sclerosis ms human lymphotropic htlv human immunodeficiency hiv elisa tests none sera csf hiv sera ms csf reactions test htlv positive reactions non specific immunoprecipitation serological evidence infection hiv htlv
HIV,HIV3291,superinduction trans human immunodeficiency htlv human immunodeficiency hiv evidence effect level hiv gene
HIV,HIV3292,human immunodeficiency transactivator different human immunodeficiency human immunodeficiency hiv human immunodeficiency hiv hiv hiv encode transactivator terminal ltr hiv transactivator transactivator hiv ltr hiv transactivators sequences downstream start full hiv transactivator sequences unique hiv ltr nucleotides transactivates hiv transactivate ltr hiv hiv vivo transactivators hiv
HIV,HIV3293,dideoxycytidine retroviral pyrimidine nucleosides synthesis antiretroviral dideoxycytidine ddcyd intracellular triphosphate ddctp effect pyrimidines pyrimidine nucleosides synthesis ie phosphonacetyl azauridine pyrazofurin deazauridine hydroxyurea human immunodeficiency ddcyd human murine lines dcyd cytidine cyd intracellular phosphorylation ddcyd dcyd deoxycytidine cyd diphosphate observations cytostatic human moltf dcyd hman immunodeficiency human ath dcyd cyd iii metabolites ddcyd deoxycytidine murine leukemia iv ddcyd cytostatic effect arac resistant dcyd ddcyd metabolites dependent preincubation time correlation ddctp preincubation dcyd triphosphate cytidine diphosphate triphosphate discover ddctp conditions hydroxyurea ddcyd phosphorylation protective effect ddcyd human immunodeficiency ath
HIV,HIV3294,term persistent infection immunodeficiency rhesus macaques months immunodeficiency siv human immunodeficiency aids hiv siv normal human peripheral presence human tumour hut macaques post findings aids humans macaques persistent lymphadenopathy siv infection siv infection macaques infectious doses siv correlation inoculum results siv infection macaques aids term persistent infection
HIV,HIV3295,immune cytomegalovirus immunodeficiency aids mechanisms immunodeficiency immunodeficiency aids functional vitro aids profound reductions many aids cytomegalovirus cmv infections cmv specific cmv specific aids serum human lymphotropic iii htlv iii human immunodeficiency hiv aids healthy seropositive htlv iii seronegative significant precursors immune cmv aids normal significant parallel aids results specific cmv aids
HIV,HIV3296,lentivirus gene sequences infection sequential extent eiav sequential episodes infected restriction minor restriction patterns genomes gene sequences substitutions gene sequences gene sequential episodes substitutions year gene human immunodeficiency mechanisms gene lentiviruses
HIV,HIV3297,immediate early gene human cytomegalovirus trans promoter human immunodeficiency homosexual immunodeficiency infected human cytomegalovirus hcmv interaction hcmv human immunodeficiency hiv immunodeficiency level contribute manifestations infection report early gene immediate early trans gene chloramphenicol hiv terminal plasmid phiv hcmv early trans increases plasmid phiv sequences trans hcmv early hiv sequences hiv tat hiv gene gene functions hiv infection previous concurrent hcmv infection
HIV,HIV3298,evidence hypervariable gene homology lentivirus envelope lentiviruses human immunodeficiency level homology homology transmembrane homology strongest close functional envelope lv demonstrates substitutions year vivo dna genomes hiv significant cluster mutations gene hypervariable potential rna gene hypervariable little potential correlation hypervariability rna structure fact hypervariable gene hiv
HIV,HIV3299,leukemia hemophilic hemophilic human immunodeficiency hiv leukemia year remission months hiv southern hiv hiv related sequences presence specific sequences myc rearrangements exon myc malignant kappa lymphoblasts igg unusual hla genetic
HIV,HIV3300,clonal functional human immunodeficiency hiv different iiib arv human immunodeficiency hiv transcriptase rt pfu preparations values infectious viruses infectivity values clones iiib values clones arv clones infectious viruses clones arv infectivity values htlv iiib cytocidal htlv iiib clones release progeny htlv iiib viruses cytopathic infectivity cytopathic fusion method
HIV,HIV3301,azido deoxythymidine triphosphate human immunodeficiency transcriptase transcriptase human immunodeficiency hiv utilized primer template polyra thymus dna polyri oligodc polyrc oligodg polyrcm oligodg presence mgcl azido deoxythymidine triphosphate dttp hiv transcriptase different constants different primer ki values polyra values thymus dna microm template host dna km ki values thymus dna primer template microm dna microm dna azido deoxythymidine triphosphate hiv transcriptase incorporation azido deoxythymidine triphosphate polyra oligodt termination primer incubated dttp hiv transcriptase
HIV,HIV3302,ready aids immunodeficiency aids individuals human immunodeficiency hiv aids components transmission hiv workers risk workers hiv infection results workers risk infection hiv cdc hiv transmission universal workers infected hiv workers settings fluids emphasis sharp objects
HIV,HIV3303,aids duty aids positive hiv test dilemma physicians physicians direct conflict duty spouses conflict physicians
HIV,HIV3304,azidothymidine inhibits growth dna repair human peripheral deoxythymidine azt aids therapy positive hiv effect severe side marrow effect uv dna growth healthy azt
HIV,HIV3305,homologous recombination human immunodeficiency human recombination recombination hiv dna optimal conditions recombination plasmid dna hiv recombination viable hybrid process recombination hiv dependent homology hiv hiv primary system homologous recombination recombination hybrid hivs specific gene functions
HIV,HIV3306,infection hu hiv hu mice human fetal lymph implants human immunodeficiency hiv jr csf time dependent spread human organs immunohistochemistry rna transcripts transcripts infected medulla thymus infection human organs hu
HIV,HIV3307,recovery transgenic mice hiv dna transgenic mice intact copies human immunodeficiency hiv dna founder hiv healthy nontransgenic founder rise progeny epidermal hyperplasia lymphadenopathy splenomegaly pulmonary growth day infectious hiv indistinguishable lymph nodes
HIV,HIV3308,hiv short yeast pol gene human immunodeficiency hiv fusion frameshift gag pol hiv short rna importance run hiv dependent stem frameshift requirements yeast
HIV,HIV3309,plasma hepatitis vaccines homosexual double trial plasma dna hepatitis vaccines homosexual months immunization doses seroconversion plasma group vaccine group positive human immunodeficiency hiv nonresponse vaccine infected homosexual nonresponse hepatitis vaccine hiv seropositive vs hiv seronegative subjects confidence confidence plasma dna vaccines
HIV,HIV3310,uptake tat protein human immunodeficiency tat protein human immunodeficiency hiv purified protein promoter trans trans tat nm presence protein tat localized tat proteolytic degradation results conditions growth factor
HIV,HIV3311,functional human immunodeficiency tat trans protein hiv encodes trans protein tat gene tat trans tat protein tat peptides specific hiv driven rna synthesis peptides significant regions trans nucleic nuclear substitutions regions trans functional significance terminal tat regulatory bpv oncogenes
HIV,HIV3312,hiv hiv sivmac important vaccines hiv infection different determinants destroy antigenicity receptor human hiv hiv sivmac aids viruses gene products gag pol epitopes hiv highlights hiv hiv vaccine human vaccines
HIV,HIV3313,isolation hiv hiv aids human immunodeficiency viruses sf hiv coast aids hiv subtypes human lines specific viruses southern results infected hiv subtypes
HIV,HIV3314,isolation human herpesvirus lytic infection peripheral immunodeficiency human helper lymphotropic herpesvirus february peripheral immunodeficiency pbl hairy leukaemia lymphoproliferative human lymphotropic infection viruses pbl cultures helper multinucleate giant lysis microscopy cultures herpesviruses specific dna related cytomegalovirus epstein herpesvirus types zoster target human immunodeficiency pbl cultures potential immune diagnostic serological test priority infection
HIV,HIV3315,rna protein synthesis cytocidal infection laboratory hiv htlv iiib peripheral lines hiv copies synchronous infection rna much total protein synthesis gag rna protein synthesis
HIV,HIV3316,gp sera evidence interaction hiv host infection specific envelope gp individuals hiv vitro specific ta infectivity unclear gp way related system relevant hiv infection ie hiv optimal conditions degrees nm gp dissociation gp mab ta healthy seronegatives seronegatives connective htlv hiv sera specific hiv sera dilutions correlation bi stage hiv infection correlation bi hiv bi gp gp western hiv unclear hiv hiv infected individuals hiv infection vaccine trials
HIV,HIV3317,htlv specific risk cross normal donors swiss human leukemia htlv elisa western true positive sera individuals aids hiv hiv different group infection hiv double infection switzerland normal donors individuals aids size gag normal donors strictness western sera htlv hiv htlv human goat results different htlv swiss stretches homology htlv normal infectious viruses protozoa results human donors tests positive results stringent hiv
HIV,HIV3318,neuropsychological zidovudine azt aids aids immunodeficiency aids aids double trial safety zidovudine azidothymidine azt significant experiences trial neuropsychiatric dysfunction human immunodeficiency hiv infection neuropsychological weeks trial neuropsychological zidovudine aids cognition zidovudine significant distress trial cognitive cognitive aids related results hiv cognitive zidovudine
HIV,HIV3319,hiv transcriptase crystallization structure hiv transcriptase homodimer mr mr heterodimer cleavage terminal mr crystallization transcriptase purified mr preparations mr polypeptides mr polypeptides hiv infected virions homodimer chymotrypsin cleavage stable mr trypsin mr results consistent transcriptase linker mr trypsin cleavage mr peptides mr minor mr cleavage mr half mr polypeptides resistant peptides chymotrypsin trypsin transcriptase vmax little km dttpabstract
HIV,HIV3320,effect glycyrrhizin human immunodeficiency hiv glycyrrhizin gl dependent human immunodeficiency hiv molt range range gl dependent protein pkc pkc isoquinolinesulfonyl methylpiperazine dihydrochloride hiv molt pkc mechanisms gl inhibits gl hiv interference inhibited hiv gl giant molt htlv iiib pkc
HIV,HIV3321,synthesis human immunodeficiency hiv nuclease resistant oligos sulfurization internucleoside phosphite manner hydrogen phosphonate single tested human immunodeficiency hiv cytopathic effect hiv tetanus specific normal infected oligomers cytopathic effect hiv oligos transmission infection free human
HIV,HIV3322,immune hiv seropositive immune hiv subjects peripheral immune presence normal counts hiv infected subjects mere occurrence immune insufficient induction different specific antiplatelet infection
HIV,HIV3323,malaria switzerland swiss travellers anopheles chemoprophylaxis malaria africa industrialized countries travel severe malaria repeated slow quinine infusions sulfadoxine mefloquine single corresponds tablets fansidar fansimef resistance fansidar chemoprophylaxis mefloquine fansidar resistance mefloquine lariam weeks fortnight return risk transmission chemoprophylaxis prescription reserve fever headache sulfadoxine mefloquine ie tablets ineffective chemoprophylaxis syndromes hepatosplenomegaly episodes positive subjects countries chemoprophylaxis
HIV,HIV3324,prognostic significance cdc iii hiv infected human immunodeficiency hiv iii regard helper iv addicts homosexuals risk infection less aids year infection cdc iii
HIV,HIV3325,normal oligodeoxyribonucleotides preliminary kinetics oligo normal significant hiv proc natl acad sci usa report tm oligos normal oligomers pairs normal oligos less tm tms dt oligomers normal da oligomers results dcg sequences message gene synthesis phosphoramidite synthesis replacement thiophenol substituent tms methylene normal dtn duplex equivalent dan increases tm methylene shorter oligos normal oligos oligos uptake energy dependent process possible membrane receptor oligos results potential gene
HIV,HIV3326,drugs zovirax zidovudine retrovir therapy interfere multiplication acyclovir hiv zidovudine incorporation nascent dna nucleotides types infection simplex acyclovir important infections severe typical immunocompetent doses skin lesions post herpetic neuralgia zidovudine early aids pneumocystis carinii much effectiveness zidovudine year thirds aids zidovudine ineffective sarcoma counts monitor myelotoxicity
HIV,HIV3327,target specific dependent cytotoxicity cem infected hiv target standard cr release hiv specific dependent cytotoxicity cem hiv sensitivity lysis hiv specific day infection cem clones hiv express targets clones lysis stable target hiv specific system
HIV,HIV3328,aids recent seroprevalence york human immunodeficiency hiv estimate future aids seroprevalence current limited parametric non parametric methods aids infection maternal knee months risk populations consistent growth
HIV,HIV3329,universal employee resistance health organizations implement spread hivaids dramatic impact work health workers dominant health values likely reactions resistance health workers employee resistance dilemma terms values objectives managerial
HIV,HIV3330,peptides human immune specific polyprotein infectivity human immune dna technology autocatalytic processing polyprotein specific peptides investigation peptides putative cleavage polyprotein gag pol precursors purified liquid observed peptides cleavage protein parallel human immune cut proline proline prerequisite statin uncleaved optimum
HIV,HIV3331,nebulisers pulmonary pentamidine way different human immunodeficiency positive previous pneumocystis carinii pentamidine human serum total ml way jet nebulisers system system gas flow ultrasound nebuliser pulmonary non pulmonary isotope tests doses pentamidine system mizer largest pulmonary isotope shortest time oropharyngeal fewest system mizer pentamidine significant reductions pulmonary system nebulised pentamidine
HIV,HIV3332,jejunal male homosexuals human immunodeficiency diarrhoea weight human immunodeficiency hiv enteropathogens triolein test jejunal villous male homosexuals enteropathogens subject time jejunal stool jejunal mucosa partial villous sole histological stage hiv test jejunal villous presence diarrhoea malabsorption diarrhoeal hiv enteropathogens jejunal enteropathy early
HIV,HIV3333,early lateral sclerosis subsets csf idiopathic ms specific peripheral subsets results findings ms igg serum lymphopenia positive cdcd ratio positive ms standard htlv hiv group significant toxoplasma simplex cytomegalovirus viruses early stage findings support immune mechanisms complications evolution
HIV,HIV3334,gp immunosorbent human immunodeficiency human immunodeficiency hiv gp rs protein homologous terminal gp immunosorbent sera immunodeficiency aids aids types human sera elisa purified gp protein specific rs elisa
HIV,HIV3335,acyclovir ophthalmicus aids homosexual abusers transfusions risk contract disorders immunodeficiency aids aids serious complications serious complications acyclovir complications zoster individuals zoster ophthalmicus day acyclovir serious complications results human immunodeficiency hiv
HIV,HIV3336,serum human immunodeficiency hiv infection cross seropositive individuals united force serum human immunodeficiency seropositivity serum serum igm normal serum igg significant different serum significant serum serum human immunodeficiency seropositivity
HIV,HIV3337,human macrophages gestational human villous macrophages trimester mom phi membrane determinants phi correlation phi specific functions results villous mononuclear many phi hofbauer spindle cytoplasmic villous phi dominant structure tissues trimester gestational histocompatibility mhc determinants dr hla dp villous much trimester phi hla trimester trimester lh villous phi thirds different epitopes tissues villous phi dendritic share phi trimester reactivity mabs leu receptor human immunodeficiency hiv entry reservoir hiv
HIV,HIV3338,membrane human immunodeficiency mabs hiv receptor hiv induces functional receptor mechanisms hiv gp receptor phenomenon due release gp infection hivvaccinia viruses hiv gene prevent gp release induces gpcd second induces dramatic rapid transcripts mechanisms modulation reinfection infectious results interference interaction receptor gene
HIV,HIV3339,effect human peripheral protein rst infection vitro rst hence rst therapy aids hiv infection individuals risk concerns rst implicated enhancement engagement mhc effect functional parameters il cytolytic report fold hiv infection human peripheral pha tetanus toxoid results rst exert trials aids implications results mhc
HIV,HIV3340,release il human macrophages human immunodeficiency vitro vivo infection macrophages human immunodeficiency immunodeficiency macrophages prime il vitro purified human monocytes hiv dv intracellular macrophages viable supernatants infection murine contain il il il supernatants infection uninfected il filtration weight chymotrypsin staphylococcal il il il dependent murine lines il il il il normal peripheral mononuclear tetanus toxoid exogenous il messenger rna infected macrophages northern presence message il message presence il concomitant release il macrophages message il macrophages aids immune vitro il il immune dysfunction aids
HIV,HIV3341,neopterin ratio subpopulations human immunodeficiency neopterin immune reactions urines individuals infection human immunodeficiency hiv seropositive hiv subsets helperinducer ratio neopterin urine cdcd hiv seropositive subjects statistical neopterin hiv seronegative seropositive subjects cdcd results neopterin hiv infection subpopulations infected subjects
HIV,HIV3342,protein glycosylation human immunodeficiency human immunodeficiency hiv immunodeficiency aids envelope gp gp virions receptor cytopathic processing infectivity cytopathicity target gp electrophoretic importance protein glycosylation hiv electrophoretic gp gp presence castanospermine deoxynojirimycin gp presence deoxymannojirimycin mannosidase mannosidase gp presence bromoconduritol glucosidase tunicamycin synthesis castanospermine deoxynojirimycin deoxymannojirimycin hiv infectivity hiv cytopathicity bromoconduritol none infected target hiv infected results protein glycosylation critical hiv infectivity cytopathicity level host
HIV,HIV3343,aminosugar potential human immunodeficiency recent aminosugar potential human immunodeficiency hiv disruption fusion subsequent transmission immunodeficiency aids free positive presence partial infectivity report parallel effect aminosugar dideoxy imino arabinitol carboxymethyl imino cytopathic effect giant hiv yield infectious methyldeoxynojirimycin ethyldeoxynojirimycin yield infectious hiv iii butyldeoxynojirimycin reduces infectious logarithmic noncytotoxic term growth presence butyldeoxynojirimycin eventual hiv reinfection important implications aids
HIV,HIV3344,infected human immunodeficiency peripheral mononuclear human immunodeficiency hiv independent homologous presence peripheral mononuclear normal individuals rhinitis supernatants normal human results infected
HIV,HIV3345,tomograms hm dementia hiv parkinsons results preliminary functional mtc dl hm single photon emission spect hiv dementia parkinsons group posterior parietal psychometric group mesial perfusion group significant patterns compatible perfusion posterior parietal perfusion different group spect evidence perfusion parkinsons levodopa therapy withdrawal levodopa significant uptake mtc dl hm thalamus findings functional dementia mtc dl hm flow rcbfspect disorders neuropsychiatric conditions
HIV,HIV3346,human immunodeficiency lymphocytic infected lymphocytic different subsets infections group lavage lymphocytosis aids hiv non aids evidence infection group lymphocytic group lymphocytic respiratory interstitial group free respiratory aids infection positive dual subjects findings hiv infection infections positive hiv infected cough interstitial pneumonitis pulmonary tests
HIV,HIV3347,fear aids public aids prominent public specific hiv infection aids emotional
HIV,HIV3348,nervous system hiv infection hiv subjects serum ubiquitous group csf serum lack subjects seropositive csf hiv nervous system subjects persistent lymphadenopathy immunodeficient aids related aids oligoclonal csf subjects stage infection hiv infection nervous system early infection hiv subjects primary neurological resistance nervous system damage hiv date immunodeficient developed neurological
HIV,HIV3349,immunodeficiency editors constance md director aids general associate professor university san infectious san general aids contribute important subject physicians questions immunodeficiency aids human immunodeficiency hiv
HIV,HIV3350,hiv infection cohorts york issues capture scientific public manner immunodeficiency aids significant many somber reminders portions subject desirable health status efforts methods populations important health minority group
HIV,HIV3351,hiv south hiv sera south true positive individuals hiv infected pregnancy positive results fifty hiv test anonymous sera single true hiv positive hiv infection norwegian programme future hiv infection positive results diagnostic
HIV,HIV3352,transmission human immunodeficiency heterosexual contacts hiv infection hiv infection mother hiv transfusion weeks hiv
HIV,HIV3353,serologic immunodeficiency infection serological hiv infection presence foreigners countries risk homosexual homosexual partners homosexual heterosexual partners hiv foreigners presence hiv infection transfusion mother
HIV,HIV3354,hiv hiv subjects clinics hiv investigation donors northeast thailand total elisa western elisa test hiv thalassemic second elisa western thalassemia subjects group western test westerners thais hiv infection spread thalassemia transfusion
HIV,HIV3355,sinusitis typical ent diseases scope aids report positive different lymphadenopathy inflammatory diseases esophagus sinusitis retrospective radiology inflammatory las aids
HIV,HIV3356,human hhv vitro effect human immunodeficiency hiv human hhv peripheral human immunodeficiency hiv western infection hiv presence hhv
HIV,HIV3357,neurological csf infection spectrum neurological manifestations aids neurological disorders presence hiv envelope hiv csf infection aids neurological manifestations hiv infection
HIV,HIV3358,prostitution prostitutes prostitutes sauna girls fewer walkers methods clients tests human immunodeficiency hiv walkers sheffield potential heterosexual spread hiv trichomonas vaginalis walkers diseases gonococcal cervicitis prostitutes prostitutes methods regular prostitutes dysplasia prostitutes
HIV,HIV3359,patterns gay york vaccine aids health strategy spread homosexual bisexual aids risk factor public health efforts potential risks hiv infection gay bisexual patterns total partners anonymous partners significant engage risky risk guidelines findings gay
HIV,HIV3360,hydrolysis serum hiv sera hiv hiv hiv hydrolysis hydrolysis neutralization means immune recovery hydrolysis hiv igg results hiv hiv
HIV,HIV3361,persistent diarrhoea zairian aids histological persistent diarrhoea immunodeficiency aids human immunodeficiency hiv persistent diarrhoea microbiological endoscopic histological intestinal isospora belli histological duodenal mucosa non specific inflammatory seropositive seronegative diarrhoea likely inflammatory reactions seropositive less pathogens histological hiv seropositive cryptosporidia isospora cryptococcus histological rectal mucosa hiv seropositive eosinophils likely inflammatory hiv seropositive pathogens hiv seropositive cytomegalovirus schistosoma mansoni persistent diarrhoea aids unclear
HIV,HIV3362,infection human immunodeficiency peruvian prostitutes female prostitutes callao peru evidence infection human immunodeficiency hiv chlamydia trachomatis treponema simplex viruses hepatitis prostitutes fourth foreign sailors condoms narcotic unsterile needles injections vitamins steroids thought unsterile needles none prostitutes seropositive hiv trachomatis hsv hepatitis positive hiv female prostitutes peruvian port unsterile needles countries serious health spread hiv
HIV,HIV3363,vitro hiv fluoro deoxythymidine tested hiv vitro test peripheral cytotoxicity human lines deoxythymidine cytotoxicity deoxythymidine cytotoxicity deoxythymidine deoxythymidine antiretroviral investigation
HIV,HIV3364,evolution human immunodeficiency synonymous ks replacement substitutions gag hiv sequences ks ka protein gp gp overall protein gag gene murine leukemia feline leukemia envelope results hiv unusual gp rest much neutral
HIV,HIV3365,different doses interferon hepatitis human immunodeficiency total hbeag hepatitis dna trial group group group iii group alpham times months group dna dna iii iv group dna months therapy group group dna knodells index final liver group ifn doses effect significant histological therapy ifn
HIV,HIV3366,general practitioners french diseases hiv general practitioners march subjects test male subjects risk whereas second male subjects subjects risk months aids second fact past fewer seropositive subjects second subject risk factor seropositive hiv infection
HIV,HIV3367,phenotypical functional lavage hiv infection lungs immunodeficiency aids nonopportunistic infections pulmonary sarcoma human immunodeficiency hiv infections pulmonary stage complications functional lavage bal signs infections manifestations full blown aids hiv pulmonary full blown aids aids significant bal ta respect tc td tf bal related determinants nk lungs mechanisms immunodeficiency state pulmonary complications aids
HIV,HIV3368,hiv lymph las immunohistology identification target hiv envelope hiv lymph las express nucleic results phases lysis mab dendritic reticulum endothelial paracortical fdr extent lysis infiltration flat
HIV,HIV3369,human immunodeficiency platelets seropositive thrombocytopenic homosexuals narcotic addicts human immunodeficiency hiv infection thrombocytopenic purpura igg igm immune polyethylene glycol peg method serum peg precipitable immune presence hiv void sephadex filtration column normal platelets hiv gp hiv dna immune hiv immune igg hiv due presence hiv clearance immunodeficiency related
HIV,HIV3370,human immunodeficiency terminal enhancer cooperative factor enhancer element human immunodeficiency hiv terminal ltr copies sequences ggggactttcc important single kappa kappa enhancer motif hiv enhancer extracts unstimulated hela extracts hela esters pma hiv enhancer due phosphorylation protein pma hela nuclear extracts intestinal nuclear hela factor hiv enhancer phosphorylation dna protein protein recognition enhancer sequences independent hiv enhancer factor time chloramphenicol mutants hiv enhancer repeats tat enhancer element pma hela results enhancer duplication hiv enhancer cooperative nf kappa
HIV,HIV3371,gene qualitative methods dna methods human retroviral sequences pcr formats direct incorporation specific human leukemia htlv homologous regions htlv seronegative human immunodeficiency prototype diagnostic detect sequences endogenous exogenous homologous primers human dna preparations discrete products weight products prototype sequences proportional input target dna load dna
HIV,HIV3372,discharges hiv seropositive hemophiliacs human immunodeficiency hiv seropositive peripheral nervous system results findings stage hiv seropositive hemophiliacs total october
HIV,HIV3373,oligoclonal hiv infection csf human immunodeficiency hiv oligoclonal csf primary hiv infection early autochthonous oligoclonal igg infections immunodeficiency independent oligoclonal
HIV,HIV3374,human immunodeficiency human immunodeficiency hiv equal igg contents csf hiv immunosorbent elisa csf serum hiv qhiv csf qhiv specific intrathecal hiv qhiv signs immunodeficiency aids related dementia ard qhiv
HIV,HIV3375,hiv encephalitis encephalitis human immunodeficiency hiv infection contradictory literature group encephalitis steady karnofsky index reed parameters okt subsets rapid encephalitis social status hiv positivity cytomegalovirus
HIV,HIV3376,immunodeficiency phosphate isomerase lactate dehydrogenase serum normal hiv seropositive individuals western immunodeficiency aids significant seropositive individuals aids progressive aids
HIV,HIV3377,primary lateral sclerosis reemerges progressive noninherited gait disorders signs tracts primary lateral sclerosis pls exclusion technology exclude disorders lesions spinal sclerosis lateral sclerosis persistent infection human immunodeficiency human lymphotrophic living evaluations pls human immunodeficiency seropositivity pls primary lateral sclerosis
HIV,HIV3378,human immunodeficiency presence cerulenin synthesis human immunodeficiency hiv infected cerulenin molt htlv iiib proteolytic cleavage polyprotein gp gp gp cem infected molt presence effect reversible withdrawal medium cem processing gp gp synthesis processing gag regulatory cerulenin fatty myristoylation proteolytic cleavage gag polyprotein prgag gp cerulenin hiv infection foreseen vitro
HIV,HIV3379,immunization immunodeficiency immunodeficiency infection human immunodeficiency hiv vigorous immune immunodeficiency aids aids infected individuals healthy hiv infected individuals aids antigenemia observations immunization aids positive months clearance synthesis unchanged months none merits aids
HIV,HIV3380,missense mutations infectious human immunodeficiency functional tat identification splice single infectious human immunodeficiency missense mutants mutations rich rich wild mutations rich tat cysteine tat tat cotransfection plasmid gene terminal tat tat splice provide evidence tat
HIV,HIV3381,strategy health providers aids aids health staff aids hiv infection health workers health system fear aids serious deterrent principles techniques foundation aids train immediate aids health providers resources health professionals position hysteria health workers protective humane aids hiv infection
HIV,HIV3382,salivary lymph human immunodeficiency infection lymph nodes salivary parotid lymph nodes parotid lymph nodes submaxillary ectopic salivary acini lymph nodes salivary lymph nodes primary lymphadenopathy malignant lymphomas human immunodeficiency hiv infection report hiv lymphatic lesions salivary lymph nodes salivary salivary lymph lesions occur immunodeficiency hiv related infections salivary lymph nodes questions possible oral entry recognition
HIV,HIV3383,impact hiv homosexual october amsterdam months start subjects hiv seropositive hiv status partners seronegatives partners partners seronegatives subjects likely terminate orogenital intercourse anogenital intercourse
HIV,HIV3384,racialethnic risk aids united risk aids racialethnic whites hispanic hiv infection risks northeast suburbs aids aids male bisexuality range whites racialethnic
HIV,HIV3385,patterns condom homosexual magnitude risk homosexual march september total subjects seronegative seropositive partners serologic subjects intercourse condom intercourse subjects condom intercourse regular partners versus partners versus subjects second seronegatives usual condom intercourse partners risk reductions safe universal individuals risk
HIV,HIV3386,human immunodeficiency human immunodeficiency hiv infection laboratory hiv marrow normal megakaryocytes immune significant cns remission subjects iv globulin counts remission subject oral thirds counts iv gamma globulin manifestations counts counts therapy hiv immune mechanisms morbidity iv globulin half thrombocytopenic therapy
HIV,HIV3387,second hiv envelope second hiv immunoassay abbott hiv eia escherichia coli abbott hiv eia results western standard hiv serum panel specimens total specimens sera confidence limits second panel specimens hiv eia overall sensitivity range sensitivity eia sensitivity second specific reactions due human hla
HIV,HIV3388,aids pacific populations hiv infection pacific populations aids asians pacific racial ethnic aids asians whites natives aids asians pacific racial ethnic homosexual bisexual transfusion pacific ethnic aids japanese filipinos southeast asians aids asians pacific
HIV,HIV3389,dependent cytotoxicity htlv hiv presence dependent cytotoxicity lines normal peripheral mononuclear spastic paraparesis sera persistent lymphadenopathy aids aids seropositive hiv infection laboratory conditions seropositive sera hiv seropositive sera sera htlv positive sera sets prozone phenomenon hiv quantitation htlv hiv lines presence specific previous hiv specific igg htlv true lines
HIV,HIV3390,hepatitis reinfection hiv infection hepatitis infection individuals hbc hbc report serum hbc evidence second reappearance serum hepatitis second positivity due reinfection findings hiv seropositive time reappearance evidence hbc protective effect infection intact hiv infection reinfection hbc infection hiv infection
HIV,HIV3391,hiv infection risk aids mothers seropositive laboratory evidence hiv infection infectious hiv peripheral mononuclear laboratory evidence hiv infection seropositive positive months septicemia hiv hiv cultures serologic evidence hiv infection normal laboratory positive months months observations many infected mothers hiv maternal positive hiv infection utero cultures valuable early hiv infection
HIV,HIV3392,hiv test hypothesis hiv infection hiv seropositive barcelona hiv seronegative thirty aids addicts pulmonary pleural less lymph nodes none less joints nervous system isoniazid rifampin months pyrazinamide months months none months severe side less hiv addicts extrapulmonary short months side
HIV,HIV3393,sera mycobacterial infections leprosy healthy contacts leprosy normal healthy normal healthy hiv igg positive leprosy healthy contacts leprosy normal healthy normal healthy western hiv igg healthy subjects prominent leprosy leprosy contacts sera hiv specific subjects leprosy leprosy contacts single hiv mycobacteria leprae
HIV,HIV3394,methods protein human immunodeficiency protein human immunodeficiency hiv immunoaffinity immunosorbent human sera test elisa compelisa hiv protein tests overall fifty positive positive compelisa compelisa positive healthy individuals hiv infection healthy individuals arcaids healthy normal helper sensitivity suitable
HIV,HIV3395,transgenic human transgenic technology introduce gene germline types effect functions technology wide genetic issues stage specific gene immunology oncology gene therapy intent gene technology human lymphotropic htlv human immunodeficiency hiv
HIV,HIV3396,cholangitis immunodeficiency literature immunodeficiency aids cdc group iv presence severe upper none upper ultrasound endoscopic cholangiographic evidence intrahepatic cholangitis primary cholangitis irregular suprapapillary dilation papillary evidence gastrointestinal cryptosporidiosis cytomegalovirus infection endoscopic good propose name aids cholangitis cholangitis unclear recent evidence due infection likely
HIV,HIV3397,vitro oral infected human immunodeficiency oral human immunodeficiency hiv infected different infection persistent lymphadenopathy immunodeficiency aids full blown aids typical oral general microbiological recovery oral infection ketoconazole nystatin means microdilution method drugs less equal ketoconazole equal equal equal resistant resistant resistant full blown aids less api system biotype repeated biotype
HIV,HIV3398,human immunodeficiency plasma extracts peripheral mononuclear due human immunodeficiency hiv significant specific terminal hiv presence specific serum plasma mononuclear positive individuals healthy female donors presence hiv types specimens infected subjects none healthy donors test results
HIV,HIV3399,method hiv hiv plasma hiv infected individuals critical infectious seroconversion pretreatment sera plasma hiv degrees
HIV,HIV3400,protein segments envelope orf human immunodeficiency pjl vector panh synthesis level coli restriction orf bh clones human immunodeficiency hiv sequential detergent extraction filtration liquid gene
HIV,HIV3401,diagnostic findings differentiation liver types non hepatitis cah non destructive cholangitis pbc primary cholangitis lupoid cah membrane second cah liver microsomal specific cytochrome cah cytoplasmic liver sla cah therapy ie azathioprin hepatitis infection interferon dna serum less hiv pbc antimitochondrial pbc specific pbc unknown liver therapy endstage pbc true primary cholangitis psc
HIV,HIV3402,anorectal host host ubiquitous term transplant many term human immunodeficiency hiv literature current conditions anorectum direct host pathophysiology current therapy conditions infectious iatrogenic congenital colorectal encounter conditions many infrequent current review herein provide categorization
HIV,HIV3403,protein therapy hiv immune preliminary report homosexual immune plasma silica staphylococcus protein pretreatment counts cellsmm cellsmm therapy platelets cellsmm less normal counts individuals months increases decreases igg igg immune fold fold total hemolytic components removal igg therapy
HIV,HIV3404,human immunodeficiency hiv term dialysis university longitudinal seroprevalence human immunodeficiency hiv positive eia term dialysis positive eia western test positive results hiv infection positive eia renal transfusions months positive eia lifetime transfusions positive test hiv term dialysis positive eia results risk infection
HIV,HIV3405,rna human immunodeficiency hiv lymph nodes infected individuals presence envelope protein gene segments human immunodeficiency hiv nodes infected individuals lymph nodes hyperplasia degeneration total depletion dendritic presence extent gp patterns occur immune protein gp positive positive hyperplastic positive hiv gene segments presence significant correlation presence hiv components hiv components segregated manner lymph compartments presence hiv components cdc correlation gp positive positive
HIV,HIV3406,murine leukemia human immunodeficiency integration escherichia coli hiv integration escherichia coli weight mulv hiv wild mulv induces integration protein full hiv integration protein coli modify initiation coli possible plasmid full protein protein mulv hiv integration coli following filter integration dna
HIV,HIV3407,evidence phosphorylation trans px human leukemia insect baculovirus vector human leukemia htlv encodes trans protein px rna receptor px baculovirus bombyx nuclear polyhedrosis bmnpv vectors bmn insect mori px px protein intact nih integration htlv ltr gene px cytoplasmic nuclear subsequent immunoprecipitation px subcellular post protein metabolic bmn phosphorylation
HIV,HIV3408,infections renal infection renal transplant due interaction net state net state therapy presence technical primary mucocutaneous metabolic hyperglycemia state immunomodulating cmv hepatitis viruses types infection renal transplant viruses group monocytogenes asteroides fungi neoformans protozoans carinii stercoralis gondii
HIV,HIV3409,pregnancy parameters united concomitant substances infant risk problems growth neonatal abstinence risk infections hiv term mothers substances licit substances many maximal many intervention health early neurobehavioral newborns earmark risk problems
HIV,HIV3410,immunodeficiency aids varied laboratory tests current hiv infection psychosocial public health issues
HIV,HIV3411,human immunodeficiency infection much hiv infection many issues questions investigation current hiv infected aids aids signs oral laboratory test results poorer specific situation laboratory aids hiv diseases infected cofactors investigation universal cofactor immune latent hiv infectious diseases iv drugs hiv hiv hiv infected laboratory health hiv diagnostic scope review points
HIV,HIV3412,human immunodeficiency hiv infection demonstration hiv sequences sera seroreactive human immunodeficiency hiv hiv whole eias seroprevalence cote divoire africa sera hiv hiv specific eias western wb peripheral monocytes representative individuals presence normal pbmcs cultures hiv hiv sequences dna pcr outgrowth report serological techniques sequences hiv pcr hiv hiv infection single
HIV,HIV3413,primary cns hiv infection human immunodeficiency hiv infection primary hiv infections manifestations infected due important diseases rare complications immunodeficiency aids cns toxoplasmosis primary manifestations aids
HIV,HIV3414,integration hiv nursing health roles administrator health promotion integral nursing emergence hiv infection
HIV,HIV3415,ethical issues quality nursing hiv individuals respects individuals regard values lifestyle infection obligation beneficence ways remove good personal risk nursing right hiv individuals unwarranted disclosure personal ethical guidelines health violation party come conflict duty issues hiv infection regard disclosure risk hiv transmission partners hiv
HIV,HIV3416,hiv infection risks health workers risk occupational transmission hiv health current health workers fluids hiv transmission infection needlestick injury risk occupational transmission hepatitis infection transmission infection needlestick injury risk transmission infections infection minimize risk hiv infection cdc aids infected hiv serologic inability infected individuals occurrence infections health workers infected hiv enforcement universal health fluids risk occupational transmission hiv infections health
HIV,HIV3417,nursing infection infection hiv ill deals issues shadow aids
HIV,HIV3418,hiv immunopathogenesis hiv infection largest united different parts world spectrum hiv infection hiv gradual progressive damage human immune system many resultant infections possible neuropsychiatric current efforts interaction human immune system means hiv infection immunopathogenesis hiv infection contribute hiv infected individuals many needs
HIV,HIV3419,human immunodeficiency hiv nucleic nonradioactive dna probes system rapid nonradioactive methods human immunodeficiency hiv test hiv dna goat bromochloroindolyl phosphate tetrazolium system quantitate hiv methods hiv hiv day post infection day day day results transcriptase capture hiv hiv dna hiv nucleic system sensitivity objectivity
HIV,HIV3420,nervous system treponema implications objectives treponema csf syphilis effect concurrent hiv infection nervous system conventional therapy fifty untreated lumbar puncture puncture test viable normal recommended benzathine penicillin therapy stage syphilis csf day therapy neurosyphilis results csf untreated primary syphilis isolation presence laboratory protein csf venereal laboratory test early latent latent syphilis csf tests protein concurrent infection human immunodeficiency hiv isolation csf csf serologic tests csf subjects hiv conventional benzathine penicillin miu cure syphilis therapy hiv seropositive nervous system early syphilis independent hiv infection csf early syphilis therapy nervous system conventional benzathine penicillin therapy early syphilis hiv
HIV,HIV3421,hiv positive clients mental health administrators mental health programs policy impediments needs related hiv clients hiv infected clients clients programs status administrators little staff opposition liability clientstaff safety concerns clients impediments critical training needs mental health grief neuropsychological complications policy legal ethical issues
HIV,HIV3422,patterns serologic human immunodeficiency hiv brazilians different infection igg hiv components sera brazilians total spectrum hiv infection western sera positive hiv immuno elisa sera gag patterns sera different reactivity gag aids patterns igg counterparts
HIV,HIV3423,cardiologist aids atlanta aids risk male homosexuals addicts hemophiliacs haitians africans ones probable western world aids cardiologists concerned infectious specialists respiratory diseases aids transfusions risk important ecc risk posttransfusion aids aids months gauss many systematic time risk non pre serology contamination hiv transfusions possible autotransfusion
HIV,HIV3424,antimyristoylation gag human immunodeficiency myristoyl diethylacetal gag human human immunodeficiency hiv myristoyl diethylacetal antimyristoylation gag inhibited protein myristoylation observed microm noticeable mature hiv hiv system myristoylation gag protein results myristoylation gag protein hiv maturation
HIV,HIV3425,crystallizable hiv pol gene coli plasmid vector express hiv pol open frame trp promoter system lysate tetragonal bipyramidal resolution
HIV,HIV3426,specific human immunodeficiency acyclouridine acyclouridine hydroxy ethoxy methyl phenylthiothymine hept human immunodeficiency hiv vitro inhibits hiv cultures peripheral hiv htlv iiib cytotoxic mock hept effect hiv dideoxynucleoside azidothymidine hept hiv transcriptase hept subject
HIV,HIV3427,hypericin pseudohypericin protein possible antiretroviral hypericin pseudohypericin polycyclic meruelo hypericin pseudohypericin antiretroviral human immunodeficiency antiretroviral specific protein ic values antiproliferative antiretroviral hypericin pseudohypericin phosphorylation protein infection
HIV,HIV3428,specific dna gene gene regulatory protein element heterologous gene lines non lines functional vivo presence specific dna protein electrophoretic extracts hiv element dna hiv gene element
HIV,HIV3429,hiv positive clients mental health administrators mental health programs policy impediments needs related hiv clients hiv infected clients clients programs status administrators little staff opposition liability clientstaff safety concerns clients impediments critical training needs mental health grief neuropsychological complications policy legal ethical issues
HIV,HIV3430,patterns serologic human immunodeficiency hiv brazilians different infection igg hiv components sera brazilians total spectrum hiv infection western sera positive hiv immuno elisa sera gag patterns sera different reactivity gag aids patterns igg counterparts
HIV,HIV3431,cardiologist aids atlanta aids risk male homosexuals addicts hemophiliacs haitians africans ones probable western world aids cardiologists concerned infectious specialists respiratory diseases aids transfusions risk important ecc risk posttransfusion aids aids months gauss many systematic time risk non pre serology contamination hiv transfusions possible autotransfusion
HIV,HIV3432,antimyristoylation gag human immunodeficiency myristoyl diethylacetal gag human human immunodeficiency hiv myristoyl diethylacetal antimyristoylation gag inhibited protein myristoylation observed microm noticeable mature hiv hiv system myristoylation gag protein results myristoylation gag protein hiv maturation
HIV,HIV3433,crystallizable hiv pol gene coli plasmid vector express hiv pol open frame trp promoter system lysate tetragonal bipyramidal resolution
HIV,HIV3434,specific human immunodeficiency acyclouridine acyclouridine hydroxy ethoxy methyl phenylthiothymine hept human immunodeficiency hiv vitro inhibits hiv cultures peripheral hiv htlv iiib cytotoxic mock hept effect hiv dideoxynucleoside azidothymidine hept hiv transcriptase hept subject
HIV,HIV3435,hypericin pseudohypericin protein possible antiretroviral hypericin pseudohypericin polycyclic meruelo hypericin pseudohypericin antiretroviral human immunodeficiency antiretroviral specific protein ic values antiproliferative antiretroviral hypericin pseudohypericin phosphorylation protein infection
HIV,HIV3436,specific dna gene gene regulatory protein element heterologous gene lines non lines functional vivo presence specific dna protein electrophoretic extracts hiv element dna hiv gene element
HIV,HIV3437,human immunodeficiency infection jackson infection human immunodeficiency hiv mothers hiv heterosexual transfusion months manifestations interstitial recurrent infections esophagitis times months carinii months months time year proportional hazard term hiv infection year early important short initiate progressive
HIV,HIV3438,alignment retroviral sequences retroviral proteases alignment sarcoma human immunodeficiency proteases
HIV,HIV3439,vaccines immunodeficiency literature prospects vaccines immunodeficiency aids reviews subject review literature potential successful aids impart concerns different types vaccine focused vaccine much previous review articles vaccine safety aids
HIV,HIV3440,hiv social sudden rapid spread impact hiv infection unprecedented hiv afflicts racial countries likely transmission manifestations hiv short progressive deterioration hiv spread carriage infectious countries fear ignorance millions countries resources end problems aids remarkable expansion aids serious diseases reviews pivotal issues aids
HIV,HIV3441,nosocomial hiv infected investigation nosocomial outbreak hiv mycobacterium index total likely counts skin positive tuberculin skin test none
HIV,HIV3442,functional car target protein human immunodeficiency hiv presence protein open frame target car repression rna mutagenesis car structure stem disruption many critical car components specific recognition regulatory
HIV,HIV3443,cpg dinucleotide genomes htlv genomes opposite way hiv rich cytosine htlv cytosine rich cpg dinucleotides underrepresented hiv htlv genomes htlv mimic rich rich host dramatic human direct integration retroviral genomes specific segments human
HIV,HIV3444,results human immunodeficiency pilot potential laboratory human immunodeficiency sets serum serum reactions serum positive reactions positive results kits specimens half serum positive human immunodeficiency laboratory final positive report report laboratory results incorrect htlv iii human lymphotropic iii test positive results evidence many potential confuse enlighten
HIV,HIV3445,tat protein purified human immunodeficiency hiv tat protein tetanus toxoid nanomolar tat significant cysteine rich tat tat tat lines tat monocytes specific tat effect infected individuals tat infection
HIV,HIV3446,nef hiv implications host stable lines human immunodeficiency hiv nef gene presence hiv nef important hiv cytopathic hiv effect nef lines nef gene vivo host
HIV,HIV3447,hiv human immunodeficiency hiv immunodeficiency rhesus macaques mangabey sivsm hiv related hiv healthy ghanaian prototypic hiv sivsm sivmac hiv hiv viruses group humans hiv
HIV,HIV3448,hemophilia immunodeficiency french hemophiliacs hiv factor viii french factor viii ix methods plasma infection individuals complications related immunodeficiency aids tests early therapy educational hiv infection spread female partners
HIV,HIV3449,management hemophilia severe haemophilia viii ix home haemophilia normal contamination hiv french haemophiliacs
HIV,HIV3450,methods flow normal nonactivated human peripheral different methods erythrocytes aminoethylisothiouronium hydrobromide okt leu leu gelatinplasma plastic dishes sepracell contamination human immunodeficiency hiv non specific positive specific monocytes results methods gelatinplasma purity recovery satisfactory hiv fewest
HIV,HIV3451,method card method involves analyte dependent adre immunoassay examples horseradish peroxidase adre biotin biotins adre results adre method flexible easy implement
HIV,HIV3452,glucosamine myristoylation human myristoyl transferase nmt liver vitro peptides nmt hiv pnef microm vmax pmolmg presence glucosamine vmax glucosamine non competitive glucosamine incorporation myristic vivo liver src vmax
HIV,HIV3453,hiv general practitioners therapy hiv general practitioners results addicts hiv positive confidence limits official drugs danish board health months group means method investigation method limited spread hiv infection addicts methadone therapy
HIV,HIV3454,hiv transmission risk addicts copenhagen autumn addicts hiv positive hiv status positive test results autumn addicts risk syringes needles commencement thirty risk risk risk aids addicts risk important informative efforts prescription syringes efforts infection heterosexual perinatal infection addicts
HIV,HIV3455,foreign determinants insertion foreign oligopeptide sequences pro position hepatitis hbcag chimeric capsids coli capsids hbcag oligopeptides outer determinants dna copies pre hepatitis transmembrane protein gp human immunodeficiency envelope protein gp leukemia determinants chimeric capsids presence rich hbcag
HIV,HIV3456,human immunodeficiency results college hiv infection pregnancy current human immunodeficiency hiv obstetric units kingdom republic ireland postal units hiv units positive units thames regions positive infection infected findings support
HIV,HIV3457,necrosis factor hiv human effect tnf cytokine inflammatory reactions human human jjhan vectors chloramphenicol transferase gene terminal ltr hiv rtnf hiv ltr transactivation pha esters tnf receptor jjhan tnf hiv ltr induction tnf whole hiv jjhan constructs hiv ltr bandshift tnf kb enhancer element ltr induction protein factor findings compatible hypothesis tnf aids hiv
HIV,HIV3458,marrow zidovudine human immunodeficiency hiv infection non lymphoma human immunodeficiency hiv non lymphoma acquired immunodeficiency aids marrow successful therapy therapy marrow zidovudine potential hematopoietic infection year man hiv lymphoma cyclophosphamide total marrow zidovudine weeks hours mgkg hours untoward zidovudine marrow day restriction polymorphism chimerism peripheral mononuclear marrow hiv gene evidence hiv marrow lymph specimens gene hiv rna dna sequences marrow heart liver hiv tetanus infected marrow chemo radiotherapy zidovudine prevent hiv infection hematopoietic
HIV,HIV3459,human immunodeficiency hiv infection months diagnostic western evidence homosexual human immunodeficiency hiv infection vitro hiv nucleic sequences sequential peripheral mononuclear homosexual aids longitudinal homosexual positive hiv recent results immunosorbent whole gp gp western capture cocultivation regions gag open frames hiv seroconversion months seroconversion months months months months months months months hiv concurrent seroconversion western diagnostic serum due persistent infection lentiviruses retroviridae
HIV,HIV3460,effect human immunodeficiency gene cytokines il il il il il granulocyte factor csf factor gm csf interferon ifn interferon ifn interferon gamma ifn gamma il hiv terminal chloramphenicol transferasecat protein independent manner il due necrosis factor hiv significant il cytotoxic molt hiv
HIV,HIV3461,chimeric human hiv gp lysis hiv murine mab bat envelope gp htlv iiib hiv hiv htlv iiib vitro fusion uninfected infected potential hiv vivo human chimeric rdna techniques bears bat cr human bat reactivity hiv gp western bat hiv infection parent murine presence human mononuclear chimeric bat igg induces dependent cytotoxicity findings potential chimeric hiv
HIV,HIV3462,quantitation human immunodeficiency infected end level infectious human immunodeficiency hiv peripheral mononuclear infected hiv plasma pbmc seropositive none seronegative subjects infective doses milliliter infection immunodeficiency aids aids pbmc aids aids tcid pbmc pbmc values mononuclear hiv hiv aids aids weeks plasma pbmc plasma term zidovudine tcid milliliter fold untreated aids aids much previous hiv viremia direct cytopathic effect much aids
HIV,HIV3463,plasma viremia human immunodeficiency infection human immunodeficiency hiv progressive following isolation peripheral mononuclear pbmc isolation free plasma plasma viremia presence plasma presence positive hiv hiv pbmc positive stage infection plasma viremia stage infection infection iva aids ivc aids less plasma hiv aids viremia hiv serum plasma correlation plasma plasma hiv tests plasma viremia plasma viremia stage hiv infection presence plasma whole free plasma hiv infectious
HIV,HIV3464,specific hiv protein element vitro human immunodeficiency hiv encodes regulatory protein transcripts synthesis hiv exert level messenger synthesis element rre envelope gene processing dependent manner genetic gene mutants dominant hypothesis rre protein escherichia coli specific manner rre element vitro
HIV,HIV3465,mother infant transmission human immunodeficiency prematurity gp human immunodeficiency hiv york usa hiv immunodeficiency severe manifestations infection free seropositive hiv months weeks risk infection weeks vs months hiv transmission predelivery maternal full term mothers gp mothers gp peptides hypervariable gp gp non mothers mothers uninfected full term hiv infection way gp importance vaccine perinatal immunotherapy
HIV,HIV3466,human immunodeficiency seroconversion navy corps corps immunosorbent tests human immunodeficiency duty officer test results positive human immunodeficiency seroconverters seroconversions total seroconversion poisson confidence intervals navy confidence times times whites seroconversion corps confidence demographic patterns navy human immunodeficiency seroconversion demographic healthy
HIV,HIV3467,formalin whole siv vaccine macaques human immunodeficiency hiv immunodeficiency aids potential vaccine means aids potential immunodeficiency siv infection rhesus macaques infection humans whole siv vaccine alum syntex dipeptide rhesus ten infectious doses results whole vaccine immune lentivirus infection aids
HIV,HIV3468,specific rna hiv protein human immunodeficiency hiv protein gag pol messenger infected uncertain effect targets modulation pre mrnas pol mrnas element rre specific protein rre
HIV,HIV3469,hiv mutagenesis dimer hiv potential target immunodeficiency retroviral coli gene complementary oligonucleotides coli process hiv protein galactosidase gag fusion protein heptapeptide proteolytic cleavage single position significant mutagenesis representative correlation position potential homodimeric protein hence interaction
HIV,HIV3470,aidshiv risk surgeons routines risk transmission human immunodefiency hiv aids year risk splash injury instruments fingers sharp instruments possible types loads needles forceps sharp instruments neutral sharp time movements accompanied eye prevent injury time routines prevent transmission hiv hiv status
HIV,HIV3471,hiv occupational risk specialists saint amsterdam needle specialists middle amsterdam st fifty wounds wounds asked participate anonymous participation seropositive hiv literature risk infection single hiv risk general surgeons infection year occupational specialists functions risk general protective group
HIV,HIV3472,glutathione free hiv seropositive individuals glutathione human immunodeficiency hiv infection immunodeficiency state glutathione venous plasma epithelial lining free hiv seropositive normal individuals total glutathione infected subjects normal individuals substances infected subjects correlation total glutathione glutathione immune glutathione progressive immune dysfunction hiv infection
HIV,HIV3473,oral manifestations infection mucous oral mucosa preferential infections infected human immunodeficiency hiv infections oral mucosa aids aids related hiv seropositive individuals infections infection periodontitis expansion resistance therapy oral hairy leukoplakia lesion hiv infected individuals non lymphoma oral mucosa morbidity aids oral lesions hiv infection dentists oral manifestations infection initiate diagnostic
HIV,HIV3474,prophylaxis pneumocystis carinii infected human immunodeficiency due human immunodeficiency hiv infection pneumocystis carinii pcp prophylaxis standard unique problems infected need lifelong therapy reactions infected risk pcp episode pcp less cellsmicrol sulfamethoxazole significant reactions term prophylaxis oral sulfadoxine promising pentamidine safe prophylaxis nebulizer latter airway irritation cough wheezing zidovudine synergistic pcp aerosolized pentamidine
HIV,HIV3475,gag infected human immunodeficiency gag sera standpoint western positive gag positive test serological prognostic results gag presence severe manifestations subpopulations hiv gag protective unfavorable
HIV,HIV3476,oral human immunodeficiency infection oral human immunodeficiency hiv infection immunodeficiency aids pandemic oral premonitory signs hiv infection prognostic implications eventual full blown aids hiv seropositive individuals management respect triazole antifungals current concepts laboratory management oral hiv infection
HIV,HIV3477,hiv strategy western profiles risk hiv strategy manufacturer sera positive competitive positive western hiv less seroconverter stage aids sera discordant elisa positive western seroconverter non specific western profiles proportional kits envelope elisa hiv envelope gp western guidelines hiv laboratory typical western profiles western patterns western hiv glycoproteins group envelope specific envelope elisa seroconversion
HIV,HIV3478,flow hiv gp insect baculovirus vector baculovirus system hiv envelope gp flow gp gp gp gp gp insect infection baculovirus fixation permeabilization reagents intracellular sensitivity reactivity post infection intracellular hiv protein reactivity gp baculovirus infection degrees scatter insect flow cytometry kinetics gp insect infection baculovirus
HIV,HIV3479,serology hiv infection serological human immunodeficiency hiv world screen transfusion hiv infection aids aids report serum hiv overview methods tests hiv demonstration serological igm hiv serology hiv serology important dermatologist hiv infection syphilis dermatological manifestations dermatoses
HIV,HIV3480,hiv sperm hiv semen hiv host hiv free seminal results spermatozoa genital tract infections possible cofactor risk hiv transmission way semen potential hiv host semen
HIV,HIV3481,total marrow standard risk leukemia december standard risk leukaemia marrow total tbi months total gy daily lateral position lungs vivo rejection free deaths sepsis occlusive liver severe versus host pneumonitis hiv infection tbi
HIV,HIV3482,malignant immunodeficiency disorders malignant primary immune defects proliferative aldrich immunodeficiency latter cytostatic therapy hiv infection spectrum different immune defects leukemia malignant cytostatic therapy skin lip non hodgkins sarcoma non lymphoma predominant hiv infection sarcoma non hodgkins infections epstein coactivation potential aids sarcoma homosexual hiv infected non hodgkins intermediate extranodal manifestations types related hiv infection overall malignant state immunodeficiency intervention risk pre mechanisms
HIV,HIV3483,prospects aids hiv leukocytes introduction hiv aids resistance hiv hiv hiv
HIV,HIV3484,addiction review experiences situation federal republic literature criminological experiences serological toxicological drugs deaths federal republic deaths hamburg year annum female abusers histopathological findings foreign infectious diseases hiv infection hiv deaths berlin heroin copious deaths overdosage international prerequisite
HIV,HIV3485,immunology hiv infection aids aids importance protective mechanisms intracellular pathogens current concepts hiv infection host immunopathogenic mechanisms vaccine
HIV,HIV3486,antigenicity hiv specific gene coli hiv gene detect specific serum free seropositive specific specific specific persistent specific subjects months seroconversion specific transectional sera free aids related conditions aids related conditions time aids specific free aids related conditions aids specific early infection antigenicity specific aids aids related conditions free hiv individuals progressive hiv
HIV,HIV3487,cleavage hiv gag polyprotein vitro sequential cleavage human immunodeficiency processing gag gag pol polyprotein precursors polypeptides polypeptides infectious hiv potential target aids full gag polyprotein vitro serve hiv coli promoter fold potential mature cultures coli plasmid gag polyprotein size mature immunoprecipitations polypeptides cleavage gag polyprotein junction ic cleavage junction cleavage junction
HIV,HIV3488,human immunodeficiency vitro human immunodeficiency hiv hiv cleavage prgag scissile dipeptide bond stable state intermediate statine hydroxyethylene phosphinic isostere difluoroketone competitive hiv constants nm microm full hydroxyethylene proteolytic processing prgag hiv free
HIV,HIV3489,migrant aids immune aids different aids occurs ratio risk iv aids occurs world countries southern africa different ratio different risk patterns hiv key aids migratory system southern africa system absences partners market diseases patterns evidence contemporary transmission aids contemporary aids seropositivity systematic aids good southern africa support migrant transmission aids
HIV,HIV3490,nef protein human immunodeficiency evidence human immunodeficiency hiv kda protein nef factor nef regulate gene hiv terminal possible nef initiation different nef vectors hxb pnef hxb hxb vector frameshift hxb pnef consistent pnef pnef kda size myristoylation cytoplasmic membrane previous hiv terminal types primary human jurkat yt leukemic nonlymphoid cos hxb clones wild version gene indistinguishable manner cos findings factor conditions primary hiv protein vitro hiv
HIV,HIV3491,growth nef gene human immunodeficiency human immunodeficiency hiv open frame nef end nef gene regulate growth interaction terminal hiv hiv wi nef little vitro growth entry dna synthesis rna hiv specific weight dna rna infection qualitative rna synthesis nef nef growth transcriptase infection presence nef gene slow growth different types human lines cem ss human primary human lines thp nef types results nef nef different hiv nef effect growth nef protein factor
HIV,HIV3492,intrapartum management hiv infant hiv united seroprevalence many epicenters management hiv stage many usual concomitant infections aids related conditions infected mothers hiv infection transmission hiv mother infant utero intrapartum infection hiv maternal secretions time intrapartum secretions mucous possible disruption intact skin possible maternal secretions risk nosocomial transmission less needlestick times fluids anticipated prevent mucous nonintact skin health workers fluids
HIV,HIV3493,hiv recognition splice protein hiv cytoplasmic level rna globin gene element dependent splice sites globin pre element splice unspliced precursors recognition components presence dissociation components pre
HIV,HIV3494,structure hiv resolution structure thr nle psich nle gln nle hiv human immunodeficiency resolution factor single orientation homodimeric protein protein underwent flaps movements
HIV,HIV3495,human immunodeficiency peripheral mononuclear presence human immunodeficiency hiv peripheral mononuclear hiv mothers mothers uninfected mother infant specific regions pbmc pcr gene products oligomer pbmcs mothers hiv oligomer uninfected seropositive hiv seronegative hiv gene preliminary pcr valuable diagnostic detect exclude hiv infection
HIV,HIV3496,dependent cytotoxicity aids aids polymorphonuclear pmn important host fungal infections pmn dependent cytotoxicity non target pmn immunodeficiency aids aids red crbc presence crbc targets subjects aids healthy aids sarcoma ks infections observed aids aids aids significant pmn human immunodeficiency hiv infection predisposition infections hiv infection
HIV,HIV3497,hepatitis hiv sudan serosurvey hepatitis human immunodeficiency port sudan sudan march risk transmission hepatitis human immunodeficiency hiv syphilis sudan total subjects female prostitutes distance drivers ethiopian sudanese female subjects prostitution serologic syphilis hiv none sera risk hepatitis infection prostitution positive serology syphilis schistosomal therapy hiv infection prostitutes current aids sub saharan countries hiv coast sudan serologic syphilis potential hiv
HIV,HIV3498,malaria orissa lack htlv iii reactivity correlation seropositivity human lymphotrophic htlv parasitic infections parts world malaria sera none test htlv iii
HIV,HIV3499,morphological human human immunodeficiency mitochondrial condition cemt human immunodeficiency mitochondrial intact extent mitochondrial profiles dichotomous former inner membrane mitochondrial junctions contacts outer profiles contacts little net mutual goniometer adapter reconstruction mitochondrial junction zones single size neighbouring ones
HIV,HIV3500,quaternary structure iscom hiv hepatitis rabies quil iscom regular microscopy micellar nm stain water quil holes quil quil fragile nm matrix cage isometric stable iscom quil nm uniform cage structure icosahedral rotational iscoms morphological pentagonal dodecahedron hole pentagonal shape iscom remarkable immune system
HIV,HIV3501,immunodeficiency complications records positive elisa test hiv related cns neurological hiv infection male homosexuals range headache toxoplasmosis diagnostic lesions infections cryptococcal tuberculous hiv csf findings specific demonstration cryptococcus neoformans direct csf unique hypodense lesions lesions enhancement vacuum ct normal time neurological complications resolution shorter months months end year
HIV,HIV3502,morbidity amsterdam inner diseases social problems diseases unexplained infections respiratory tract severe dental caries hiv related group tourists countries insurance money
HIV,HIV3503,neurological early latent human immunodeficiency infection neurological manifestations unknown hiv positive normal immune report normal episode seroconversion context seroconversion encephalitis confusion neuralgic infection infections static mild cognitive report range seroconversion documents presence progressive cognitive latent hiv infection
HIV,HIV3504,dysfunction evidence hiv infection hiv seropositive subjects hiv seropositive subjects serologic evidence hiv infection evidence dysfunction standard methods hiv csf oligoclonal serum oligoclonal unique oligoclonal intracerebral synthesis hiv specific subjects significant frontal subjects oligoclonal unique csf significant neuropsychological ct subject results evidence hiv damage normal subjects frontal early hiv infection group tests hiv infection
HIV,HIV3505,hiv pregnancy hiv edinburgh september pregnancy informed results serostatus individuals time infected hiv little pregnancy pregnancy seropositive known hiv seropositive steady hiv seropositive forty former risk risk seropositive minimum hiv infection edinburgh serostatus infection edinburgh partners male total
HIV,HIV3506,aids september december aids findings infections infections cryptococcus cytomegalovirus toxoplasma infections papovavirus progressive multifocal histoplasmosis infection mycobacterium avium intracellulare infection malignant lymphoma primary metastatic lymphomas encephalitis aids dementia general diffuse pallor white matter gliosis cns perivascular infiltration macrophages giant nodules techniques hiv macrophages lesions lesions aids search microinfarcts microinfarcts
HIV,HIV3507,disorders nervous system immunodeficiency aids immunodeficiency aids human immunodeficiency hiv disorders nervous system infection cdc system group hiv infection group group persistent lymphadenopathy group iv subgroups iva ivc infectious diseases ive conditions nervous system disorders types hiv immunodeficiency infectious former inflammatory polyneuropathy aidp group whereas polyneuropathy dspn vacuolar myelopathy group iv group problems hiv infection aidp utmost importance index look evidence hiv infection
HIV,HIV3508,serology donors hiv donations seropositive donations donors year seropositive donors females donations female male donors seropositive donors hiv units donation donors units regular donors hiv donations military donors donations civilian donors seropositive military donors male recruits system subjects risk
HIV,HIV3509,deaminase perinatal human immunodeficiency infection deaminase ada human immuno hiv positive mothers values infected free group subjects sd red vs rbc significant less vs free values group state hiv infection rbc significant vs ada hiv infection possible prognostic values overt infections disorders erythrocytes healthy donors hiv erythroid
HIV,HIV3510,diagnostic flexible human immunodeficiency hiv positive laboratory evidence human immunodeficiency hiv infection underwent diagnostic flexible lavage bellevue girls months months respiratory distress persistent right middle collapse etiology pneumocystis carinii pcp streptococcus viridans obstruction cytomegalovirus cmv diagnostic techniques maximal yield flexible hiv positive
HIV,HIV3511,aids health workers fifty health workers hiv transmission isolation nonteaching hundred questions transmission transfusion intercourse sharp instruments scores non isolation non emphasizes urgent need hiv infections
HIV,HIV3512,intrafamilial non transmission human immunodeficiency intrafamilial transmission human immunodeficiency serological seropositive subjects contacts risk subjects seropositive hiv infection sc sanitary conditions sp sc group blades combs hair brushes none sc results hiv transmission infected subjects
HIV,HIV3513,uveitis human immunodeficiency noninfected luetic uveitis human immunodeficiency hiv lumbar puncture hiv positive status syphilis positive hiv lumbar hiv results spinal taps ocular severe positive group
HIV,HIV3514,laboratory hiv infection implications hiv infection laboratory tests critical tests
HIV,HIV3515,preliminary evidence azidothymidine hepatitis immunodeficiency aids effect azt hepatitis immunodeficiency aids serum dna aids human immunodeficiency hiv infections hiv infection results preliminary evidence azt vivo
HIV,HIV3516,human immunodeficiency hiv dna infected immunosorbent isolation human immunodeficiency hiv positive pcr isolation hiv identification hiv dna pcr different pairs primers primer pairs isolation pcr results limited correlation stage hiv dna equal different azido azt
HIV,HIV3517,sentinel human immunodeficiency secular trends york pneumocystis carinii pcp bronx residents neighbourhood deaths immune disorders non recurrent human immunodeficiency hiv related geographical females group aids rise females less immune disorders ecological correlation aids residents geographical related underlying patterns hiv significant health system excess pneumonias bronx equal total aids
HIV,HIV3518,hiv infection findings hiv infection depressive dsm iii depressive disorders dementia disorders mood hiv infection ill hiv infection fear contagion homosexuals reactions
HIV,HIV3519,human immunodeficiency infection clinics total clinics pregnancy responders hiv infection non ie regard tests infectious diseases specimens syphilis implications anonymous hiv hiv infection clinics transmission
HIV,HIV3520,human immunodeficiency enantiomer gossypol enantiomer gossypol good peripheral mononuclear human immunodeficiency cytotoxicity cytotoxic
HIV,HIV3521,antimicrobial formula vitro human immunodeficiency health hand parachlorometaxylenol sodium olefin sulfonate formula vitro tests human immunodeficiency hiv presence whole human htlv iiirf hiv medium whole human dilutions hand residual infectivity lytic cytopathogenic infectious hiv hand dilutions dilutions dilutions times
HIV,HIV3522,rheumatological lesions individuals human immunodeficiency infection human immunodeficiency infection rheumatologists musculoskeletal homosexual peripheral non erosive joints knees keratoderma blenorrhagica plantar fasciitis urethritis conjunctivitis uveitis hla positive none raised titres infections onset recent diarrhoea serological evidence yersinia infection micro organisms hiv time individuals immunodeficiency aids positive aids individuals aids severe persistent non steroidal inflammatory drugs synovitis hiv infection lesions myalgiamyositis non inflammatory peripheral spinal soft lesions myalgia unknown infective lesions infection due histoplasmosis mycobacterial infection likely hiv infection risk factor seronegative lesions
HIV,HIV3523,group norwegian identify promiscuity condoms empirical stem postal representative medium norwegian town promiscuity strongest promiscuity dolce ie visits marital status strongest promiscuity marital status intercourse hivaids significant effect female male promiscuity promiscuity hivaids condom intercourse significant condoms
HIV,HIV3524,prehospital providers aids prehospital providers maryland aids ems due risk hiv infection
HIV,HIV3525,risk infection maryland std clinics diseases risk hiv infections std health needs risk hiv infection
HIV,HIV3526,trends public aids south health aids state populations aids hiv transmission year random stage cluster questions telephone aids questions general hiv transmission hiv transmission iv hiv transmission donation transfusion respondents hiv transmission risk respondents hiv transmission incorrect incorrect donation incorrect general level state transmission risk many misconceptions transmission hiv donation aids hiv
HIV,HIV3527,neurological aids test hiv aids presented neurological manifestations aids needs dementia diffuse syndromes myelopathy peripheral syndromes need diagnostic hiv many neurological syndromes
HIV,HIV3528,workloads clinics work loads venereal std clinics recent infections time workloads figures health social security clinics terms current forecast workloads clinics aids recommend manpower manpower training resources accommodation ill demands priority need resources ministers health districts std hiv infection day open clinics general general standard clinics roles coordination hiv infection many ministers many problems countries
HIV,HIV3529,epithelial hyperplasia hecks sudanese report epithelial hyperplasia rare oral condition ethnic patterns unknown condition recent report condition oral manifestations infection report epithelial hyperplasia year sudanese emphasis importance
HIV,HIV3530,tumour necrosis factor tnf il aids level tnf cytotoxic tnf il lipopolysaccharide peripheral mononuclear ria infected individuals different infection cdc tnf endogenous sera normal level group group less group normal level il sera level vitro cytotoxic effect pbmc hiv individuals cytotoxicity group effect pre tnf
HIV,HIV3531,aids ethical issues illustration aids ethical issues disciplinary perspective issues issues diagnostic management staff issues discharge issues important staff issues guidelines staff level possible many aids concerns ward
HIV,HIV3532,hiv risk non hiv risk equipment retail pharmacy individuals concerned hivaids many optimistic equipment many individuals equipment unprepared injectors potential transmission injectors policy implications
HIV,HIV3533,deoxyadenosine hiv different retroviral rna dependent dna preference dna dependent dna hiv host pans pans deoxyadenosine triphosphate hiv infected significant pans infected effect pans early hiv likely
HIV,HIV3534,hiv specific cytotoxicity neutralization hiv specific cytotoxicity csf sera subjects hiv infection infected htlv iiib hiv csf sera positive csf different presence htlv iiib csf serum htlv iiib csf csf specimens csf none htlv iiib intact many subjects contribute
HIV,HIV3535,hiv ghana genetic human immunodeficiency hiv total hiv genetic hiv hiv ghana hiv gh homology overall hiv gag pol hiv gh homology hiv gene regions presence genetic hiv specific functions hiv
HIV,HIV3536,ethical issues immunodeficiency aids immunodeficiency aids much publicity issues problems hiv dilemmas hiv infection
HIV,HIV3537,infection health risks transmission human immunodeficiency hiv infection system plan general sfgh acquired immunodeficiency aids infections health workers hiv infected risk infection hiv infection health workers laboratory subcutaneous open skin lesions mucous risk infection single needle stick hiv viruses hepatitis human lymphotropic viruses leukemia lymphoma infection system containers transparent containers wear protective clothing specific needle stick health plan employee health immunizations keeps records hot committee educational infection infections
HIV,HIV3538,risk hiv infection pharmacists risk pharmacists human immunodeficiency hiv risk pharmacists risk hiv participation resuscitation teams drugs drugs wide primary duties settings immunodeficiency aids oncology clinics pharmacists hiv infection infection time safety pharmacy residents health workers many institutions educators pharmacists dissemination date hiv infection substances pharmacists risk hiv infection fight aids
HIV,HIV3539,pharmacists occupational hiv pharmacists occupational hazard human immunodeficiency hiv transmission needle stick pharmaceuticals products needle stick health workers occur needles needle pharmacists purchase products safe single vials syringes factor safety syringes need safety needle units pharmacists transmission hiv health workers educators risk stick injury
HIV,HIV3540,management human immunodeficiency infection hiv infection primary physicians management flow laboratory signs regular office visits matters legality physicians insurance lifestyle management infections zidovudine azt drugs needs hiv primary serve future
HIV,HIV3541,protein hiv gene hiv siv mutants functional hiv plasmid cos mutants rise equivalent cem lines peripheral equal cytopathic dan presence sequences mutations lines immunoprecipitation kda protein infected mx viruses equivalent infected preparations dispensable cytopathicity
HIV,HIV3542,aids hiv infection symptomatology recurrent infections infections sarcoma infrequent occur hiv
HIV,HIV3543,human immunodeficiency hiv human lymphotropic htlv dual infections specific human lymphotropic htlv coinfection immunodeficiency aids utilized primer pairs htlv htlv pol regions human immunodeficiency hiv primer pairs specific detect htlv coinfection aids
HIV,HIV3544,neopterin total neopterins neopterin early eg infected human immunodeficiency hiv total neopterins dihydroneopterin significant hiv infection total neopterins urine homosexual hiv infection hiv seropositive homosexual total neopterins urine hiv seronegative close correlation total neopterins neopterin cdcd hiv seropositive neopterin total equal potential total neopterins dihydroneopterin neopterin strict requirements degradation
HIV,HIV3545,ethical issues fertility aids issues clients aids hiv infections important sides ethical concerns issues related principles beneficence nonmaleficence possible ethical debate fertility clients aids positive sides principles ethical violation thereof sides scenario reality anticipated aids clients potential dilemmas dilemmas manner ethical values clients aids
HIV,HIV3546,immune infected human immunodeficiency specific human immunodeficiency hiv specific humoral functions toxoid blastogenesis tetanus toxoid time hiv populations hemophilia values functional functional infected normal specific normal specific results hiv specific immune
HIV,HIV3547,urbs rure human immunodeficiency infection rural tennessee aids past months questions infectious diseases physicians epicenters need hiv outside metropolitan problems unique stigma aids important pneumocystic aids steven berk felix sarubbi veterans tennessee state university problems health officers spread aids rural
HIV,HIV3548,immunochemistry transmembranous protein human immunodeficiency immunochemistry homologous peptides cys transmembrane immunodeficiency rhesus sivmac related hiv hiv htlv iiib resolution single different sites sivmac mab different sites hiv specific mab sites mab narrow epitopic sivmac mabs narrow glu tyr mabs trp gln react human postinfection hiv reactivity mab specific leu gln single hiv serum distance cross mab hyperimmune sera peptides intact transmembrane elisa western tests mab sites sera tests specific unique reagents
HIV,HIV3549,internalization hela niht internalization differentiation receptor human immunodeficiency viruses hela murine fab pepsin specific monovalent non ligand fab hiv gp hiv infection lymphocytic fab transfected hela niht total ifab ifab steady state internalization total pool results intact divalent transfected non
HIV,HIV3550,pulmonary non hodgkins aids whereas extralymphatic lymphomas hiv infection pulmonary lymphoma aids non hodgkins pulmonary manifestations fever weight lymphadenopathy cough nodules interstitial infiltrates transbronchial months pulmonary nodules stage ie slow radiographic months radiation months pulmonary nodules pulmonary lymphoma hiv infection nodules
HIV,HIV3551,open interferon hiv positive interferon roferon mega units months positive hiv related interferon safe lack deterioration hiv lymphadenopathy thrombocytopenic purpura nail fungal infection hiv months deterioration
HIV,HIV3552,pilot zidovudine day aids evidence mab workshop mab vitro hiv infection signals clearance fc induces idiotypic immune parameters zidovudine day mab aids group iv mab pharmacokinetics virological parameters increment serum rt second steady increment serum
HIV,HIV3553,aids escalation trial rifamycin hiv aids weeks evidence hiv immune status deterioration status stable trial deterioration trial single
HIV,HIV3554,dependent cytotoxicity hiv hiv haemophiliacs sera hiv uninfected haemophiliacs healthy subjects presence lymphocytotoxic cr release test hiv haemophiliacs serum dependent cytotoxic effect hiv infected target concanavalin results dependent cytotoxicity membrane tests envelope cytotoxic
HIV,HIV3555,hiv obstetrics obstetric december hiv elisa seropositive
HIV,HIV3556,pharmacokinetics pharmacokinetics dideoxycytidine ddc hiv kg plasma urine hplc non parameters areamoment ddc plasma terminal half sd significant parameters doses total renal non renal clearance values independent kg unchanged urine steady state independent kg protein ddc serum independent disposition ddc independent doses significant correlations total renal non renal clearance steady state superimposable plasma ddc time laboratory man plasma ddc humans parameters laboratory
HIV,HIV3557,immunization homosexual hepatitis vaccine homosexual human immunodeficiency hiv positive hiv hbc micrograms hepatitis vaccine hiv positive homosexuals nonresponders independent positive hiv individuals doses positive positive individuals fall positive matching nonvaccinated hiv positive homosexuals hiv positive individuals evidence hepatitis hiv positive subjects
HIV,HIV3558,prognostic seropositive fetal transmission seropositive necker enfants malades till september due fetal transmission lymphoadenopathy hepatosplenomegaly total infections severe neurological problems laboratory okt proliferative serological profiles hiv values findings minimum much estimate infectious complications
HIV,HIV3559,infections human immunodeficiency infection current evidence immunodeficiency aids infectious diseases infections different human immunodeficiency hiv hiv infection aids pneumocystis carinii occur hiv infection helper less infections pyogenic hiv infection occurrence pulmonary infections different different times pulmonary infections hiv infection pentamidine aerosol isoniazid chemoprophylaxis little evidence isoniazid hiv positive tuberculin skin test effect vaccine aids specific antiretroviral zidovudine infections months strategy hiv infection hiv seropositivity tuberculous infection tuberculin skin test seropositive individuals vaccine evidence infection year zidovudine range prophylaxis pneumocystis infection range
HIV,HIV3560,plasma glutamate prognostic immunodeficiency plasma glu occur syndromes ids glu prognostic plasma colorectal crc brc hiv infection hiv results diseases healthy brc values crc tumours hiv stage wr crc brc significant direct correlations operative diseases mastopathy mtp glu tumour hiv wr brc stage results plasma glu discrimination different
HIV,HIV3561,downregulation hla infected effect hiv infection hla report hela peripheral infection hiv downregulation posttranscriptional level hla specific uninfected phenomenon state infection presence hiv time infection hla downregulation hiv infection specific lysis peripheral
HIV,HIV3562,hiv normal peripheral mononuclear specific regions chimera phx zairian full clones viruses phxbgpt pha normal peripheral mononuclear pbmc leukemic lines phx pbmc lines infectivity pbmc lines intact parent cos findings regions important
HIV,HIV3563,human immunodeficiency neutralization lines target human immunodeficiency hiv infection hiv immunodeficiency siv cytopathic rise macroscopic hiv siv
HIV,HIV3564,human immunodeficiency hiv infection diphenylhydantoin human immunodeficiency hiv host infection process building recent membrane epileptic diphenylhydantoin pht hiv relevant hiv infection dependent manner infection lines hiv infection vivo growth hiv weeks induction cotreatment infected pht induction methylation dna flow hiv infection due dependent subsequent intracellular cai postinfection synthesis protein cai due hiv hiv rise cai pht pht infection normal pha pbls synergistic azt microgramml infection lines dependent hiv infection pht hiv infection therapy individuals hiv
HIV,HIV3565,patterns dysfunction human immunodeficiency seropositive independence helper potential hiv seropositive hiv vitro il peripheral leukocytes hiv donors th influenza flu tetanus toxoid hla pha hiv different patterns flu pha flu pha results time dependent stage stage th mhc pha il severe th dysfunction none th unresponsiveness hiv individuals vitro th detect dysregulation early hiv infection hiv vitro th functional
HIV,HIV3566,zidovudine acyclovir human immunodeficiency seropositive individuals zidovudine vitro antiretroviral short term human immunodeficiency hiv zidovudine acyclovir gday hiv seropositive pharmacokinetics safety tolerance methods fifty hiv seropositive homosexual bisexual san zidovudine acyclovir open results interaction parameters stable weeks significant total overall skin test reactivity peripheral safe months term tolerance results trials
HIV,HIV3567,human lymphotropic htlv leukemia lymphoma human immunodeficiency hiv leukemia unusual coinfection human immunodeficiency hiv human lymphotropic htlv leukemic positive clonal genetic receptor cytogenetic clonal seropositive hiv htlv htlv hiv dna sequences peripheral leukocytes htlv sequences whereas hiv sequences remission htlv positive mononuclear whereas hiv positive unchanged leukemia lymphoma hiv coinfection retroviral coinfections
HIV,HIV3568,year laboratory immune hemophiliacs seropositive seronegative hiv fifty hiv positive hemophiliacs year hiv group leu counts intervals seropositive microliters leu counts stable normal range counts cdc stage overt aids serum stage antigenemic non antigenemic seropositive stage iv significant reductions nk subsets seropositive dr leu nk significant increases dr leu valuable hiv hemophiliacs reflect progressive subsets supervenes hiv turn optimal intervention
HIV,HIV3569,alithiasic cholangitis cytomegalovirus hiv infection year female abuser hiv infection pericholangitic lithiasic cholangitis cytomegalovirus clues diagnostic endoscopic therapy transendoscopic papillotomy review diseases cytomegalovirus literature
HIV,HIV3570,cross rex htlv blv protein nonreciprocal regulatory human leukemia htlv leukemia blv protein human immunodeficiency hiv cytoplasmic translation messenger mrnas rex rna rex rex blv interchangeable rex protein substitute hiv rex htlv hiv rre mechanisms hiv htlv blv nonreciprocal rex rna viruses
HIV,HIV3571,gp hiv independent recognition gp hiv probes neoglycolipids conjunction intact protein protein human serum evidence oligosaccharides serum recognition macrophages human monocytes specific receptor human evidence receptor propose healthy tissues
HIV,HIV3572,retinopathy aids records ocular inflammatory year retinopathy documented immunodeficiency aids homosexual abusers aids related aids ophthalmologic severe immunodeficiency infection human immunodeficiency hiv ophthalmologist ophthalmologic findings endogenous staphylococcus endophthalmitis cytomegalovirus retinitis time ophthalmologic noninfectious retinopathy infections hiv infection aids ophthalmologist important early
HIV,HIV3573,gastrointestinal cytomegalovirus manifestations aids cytomegalovirus cmv infection important intestinal infections aids severe commonest manifestations positive gastrointestinal gastrointestinal tract histology results methods lesions erosions lesions positive histology positive serious manifestations early gastrointestinal tract histological microbiological
HIV,HIV3574,structure oral hairy leukoplakia specimens oral hairy leukoplakia specific epithelial epstein different cytoplasmic structure epstein different size shape lesional keratinocytes keratinocytes mucosa perichromatin productive formations formations bilayers sides nuclear membrane productive parallel tubules many observations diagnostic significance morphogenesis morphological identification unclear
HIV,HIV3575,effect azido deoxythymidine duck hepatitis vivo vitro azido deoxythymidine azt human immunodeficiency hiv bond hiv infection effect azt primary hepatocytes duck hepatitis dhbv dhbv dna azt dhbv system dna synthesis duck hepatocytes azt effect dhbv transcriptase
HIV,HIV3576,phosphonylmethoxyethyl diaminopurine pmedap human immunodeficiency murine sarcoma vivo phosphonylmethoxyethyl diaminopurine pmedap human immunodeficiency hiv human microm murine sarcoma msv transformation murine embryo fibroblasts dependent mice mgkgday pmedap significant enhancement mice pmedap pmea antiretroviral vivo pmedap index equivalent pmea
HIV,HIV3577,human herpesvirus hhv infection human herpesvirus human lymphotropic lymphoproliferative disorders aids hhv latent infection hhv infects diseases infection lymphotropic latent hhv infection subnormal host persistent infection postinfectious fatigue picfs immune disorders progressive lymphoproliferation coinfection hhv human immunodeficiency hiv aids hiv immune investigation
HIV,HIV3578,spectrum infected hiv peripheral different human immunodeficiency hiv infection csf findings neuromuscular hiv inflammatory polyneuropathy cidp inflammatory polyneuropathy aidp csf endoneurium epineurium mononuclear aids related sensory peripheral dspn cidp painful dspn electrophysiological segmental demyelination infiltration months
HIV,HIV3579,biloma hepatocellular hiv seropositive biloma extraductular biloma biloma hepatocellular hepatocellular hiv seropositive seropositive hepatocellular biloma
HIV,HIV3580,disparate herpesvirus immediate early gene trans ltr bmlf epstein immediate early ie human cytomegalovirus hcmv encode trans heterologous transferase human immunodeficiency promotercat trans bmlf gene post gene dependent trans hcmv ie gene products rna level human growth galactosidase gene specific sequences hiv promoter trans hcmv ie gene products
HIV,HIV3581,aminoacyl trnas translation frameshift sites htlv blv frameshift signals signals sequences genetic trna wybutoxine queuine anticodon phe trna hiv anticodon trna htlv blv anticodon phe trna uuu frameshift hiv trna aac frameshift signals blv modified anticodon trnas retroviral participation trnas frameshift trnas jacks isoacceptors
HIV,HIV3582,risks health workers occupational hepatitis human immunodeficiency cytomegalovirus transmission hepatitis hiv intact skin health current risks transmission infection
HIV,HIV3583,aids immune therapies vaccines aids related disorders subfamily lymphocytopathic lentiviruses human immuno hiv human immuno hiv hiv infection chimpanzee gibbon ape aids macaques hiv aids suitable hiv hu mice aids subfamilies cytopathic immune immunodeficiency syndromes mice onco feline leukemia lentivirus feline immunodeficiency fiv macaques aids macaques immunodeficiency healthy lentivirus related hiv infections macaques closest hiv infection aids aids therapy vaccinology
HIV,HIV3584,positive papulosis anus hiv positive man homosexual man stage iv hiv infection positive papulosis positive anus papulosis individuals risk papulosis
HIV,HIV3585,human immunodeficiency hiv epstein lymph nodes positive persistent lymphadenopathy presence human immunodeficiency hiv epstein lymph nodes persistent lymphadenopathy serum level hiv immunohistochemistry protein lymph nodes reticular positive results nodes rare positive centrocyte presence hiv lymph nodes southern positive lymph nodes southern presence lymph nodes southern peripheral positive results single evidence results lymph nodes possible immune aids lymphoma
HIV,HIV3586,chimpanzees human immunodeficiency envelope gp human immunodeficiency hiv immunodeficiency infects humans chimpanzees immunization infection chimpanzees purified human lymphotrophic iiib htlv iiib homologous htlv iiib stock htlv iiib htlv iiib stock human chimpanzee peripheral mononuclear human lines infectivity chimpanzees infectious units infected isolation seroconversion chimpanzees infectious units infected chimpanzees alum gp htlv iiib peripheral mononuclear hiv hiv peripheral mononuclear non hiv chimpanzees alum chimpanzees htlv iiib stock infectious units infectious units infected hiv immune immunization gp alum infection hiv
HIV,HIV3587,functional tat trans human immunodeficiency trans tat human immunodeficiency viruses hiv functional reciprocity possible computer potential rna trans tar tat rna sequences full hiv tat single stem structure hiv terminal independent tar second tar element hiv tar element context intact hiv terminal evidence tar initiation hiv tar element proximal trans hiv tat functional redundancy hiv vivo
HIV,HIV3588,effect immunization immune baboons hiv envelope hiv potential vaccine aids baboons suitable humans primary different doses immunization schedules possible immunization liquid radioimmunoprecipitation rip doses indistinguishable serum significant enhancement serum second magnitude kinetics schedules immunization none humoral immune significance rip immune immunized baboons vitro hiv serum rip significant effect laboratory
HIV,HIV3589,dermatologic complications dideoxycytidine human immunodeficiency infection mucocutaneous human immunodeficiency infection dideoxycytidine day therapy oral ulcers cutaneous oral lesions dideoxycytidine mucocutaneous lesions therapy
HIV,HIV3590,necrosis factor induces specific dna protein human hepatoblastoma hepg necrosis factor inducer protein synthesis liver necrosis factor gene unknown necrosis factor human immunodeficiency terminal gene human hepatoblastoma hepg trans kappa dna sequences lymphocytic nuclear kappa sequences necrosis factor hepg protein synthesis hepg gene necrosis factor
HIV,HIV3591,current urogenital situation countries due hygienic health steady group world short antituberculous drugs problems hiv infection
HIV,HIV3592,structure synergistic effect phosphonoformate human immunodeficiency substitutions human immunodeficiency hiv hiv degrees fluoro deoxythymidine fluoro deoxyadenosine deoxy deoxy position cytidine position fluoro deoxythymidine synergistic hiv ppi phosphonoformate
HIV,HIV3593,multidisciplinary san general aids immunodeficiency aids related san general sfgh programs occupational risk infection human immunodeficiency hiv legal ethical implications infection support public officials health professionals sfgh aids related budget treating units aids many support contribute hiv training physicians housing home emotional support sfgh contributions public needle stick seroconversions concerns general caring aids workers infected hiv
HIV,HIV3594,potentials early infection potentials hiv hiv infected aids neurological potentials checkerboard vep hiv vep significant peripheral helper vep significant hiv helper microliters significant aep interpeak lesions peripheral endings hair less microliters significant aep interpeak iii conduction hiv immune somatosensory potentials tibial normal range vep hiv normal aep aep different mechanisms
HIV,HIV3595,job accommodation key public occupational health management work force immune aids human immunodeficiency hiv
HIV,HIV3596,human immunodeficiency infection homosexual bisexual hepatitis vaccine trials seronegative homosexual bisexual san hepatitis vaccine trials participants human immunodeficiency human immunodeficiency infection vaccine trial participants human immunodeficiency infection seroconversion entry statistical seroconversion demographic kaplan meier cumulative immunodeficiency human immunodeficiency infection confidence acquired immunodeficiency infection proportional hazard stepwise correlation seroconversion race year seroconversion immunodeficiency
HIV,HIV3597,flow human immunodeficiency subsets human immunodeficiency hiv whole method subtypes counts cdcd cdcd cdcd putative gamma delta receptor cdcd cdcd method contamination scatter monocytes unlysed erythrocytes compatible identification subsets informative method therapy hiv
HIV,HIV3598,suppressor probable transmitters human immunodeficiency infection related transmission human immunodeficiency homosexual intercourse homosexualbisexual pairs health logistic risk intercourse nitrite gonorrhea syphilis many aids probable transmitters hiv uninfected partners unprotected insertive intercourse hiv isolation peripheral mononuclear hiv presence hiv helper different transmitters nontransmitters
HIV,HIV3599,human immunodeficiency infection public health committee hiv infection much work recent efforts infection signs aids efforts many efforts public health phs aids committee phs date chimpanzee hiv signs human aids recent gibbon infection hiv mice chimera human immune system support growth progeny transgenic mice intact copies dna resembles human aids rabbits baboons infected conditions aids symptomatology report efforts hiv infection
HIV,HIV3600,hiv salivary hiv salivary hiv sgd enlargement salivary xerostomia hiv direct immunohistochemistry salivary salivary epithelial hiv sgd direct infection salivary
HIV,HIV3601,networks contacts implications hiv patterns aids male homosexual mathematical transmission dynamics hiv range possible networks contacts assortative extreme rapid growth infection early extreme largest magnitude group assortative results context patterns spread hiv patterns
HIV,HIV3602,participate seroprevalence hiv infection impact social aids hypothetical seroprevalence hiv infection aids health aids related serosurvey logistic simultaneously aids related participate results dissimilar aids willing participate aids hiv test willing participate general respondents aids level willing participate level second respondents risk level willing risk less
HIV,HIV3603,aids risk homeless implications health aids homeless systematic political social health concerns ethnic minority pragmatic health programs closed homeless shelters programs specific aids prevented relevant health former homeless health educators related negotiation safe partners process health educators promotion aids risk hiv infection homeless united
HIV,HIV3604,health promotion human immunodeficiency infection minority programs protective avert hiv infection minority populations potential risk proactive programs critical components hand maximal outreach effectiveness spread hiv infection minority populations
HIV,HIV3605,immune abusers hiv serology total abusers immune serum none signs aids aids hiv uml hiv hiv cddr peripheral mononuclear hiv versus versus cic serum hiv group versus seropositive group igg versus total versus significant level cic results nonspecific cic infection ivda
HIV,HIV3606,interferon gamma human immunodeficiency gag gene hiv preparations contain interferon gamma ifn gamma hiv ifn gamma presence hiv protein ifn gamma western questions ifn gamma interaction hiv
HIV,HIV3607,human interferon hiv vitro human interferon azido deoxythymidine human immunodeficiency hiv hiv progeny synthesis cultures hiv azt hiv hela cultures hiv human fold azt hiv synthesis hiv lysis results therapy hiv infections doses
HIV,HIV3608,electrophysiological findings hiv infections tremor hands rapid voluntary index finger movements times rapid voluntary isometric index finger psychometric tests vocabulary test short test version standard progressive psychic somatic findings amdp system hiv infected cdc nervous psychic tranquilizer infections tremor times significant group motor parameters significant group cdc normal psychometric tests significant group statistical level scales diseases parkinson hiv positive lesions early subclinical nervous system hiv motor tests mri
HIV,HIV3609,resolution eye complications infection hiv eye fixation saccadic antisaccadic resolution eye movements valuable non invasive aids dementia early dysfunction hiv seropositive subjects aids risk therapy
HIV,HIV3610,motor coordination aids positive healthy computer method potential neural processing positive hiv seroreactivity hiv positive aids pilot normals hiv positive healthy aids worse hiv group significant spectrum test aids spectral range synchronization networks synchronization turn possible damage hiv infection parameters early processing cns
HIV,HIV3611,spect manifestations aids diagnostic spect findings cns manifestations aids infected encephalitis toxoplasmosis dtpa mr mtc hm spect intracranial lesions encephalitis mr spect inhomogeneous perfusion lymphoma toxoplasmic lesions spect rcbf regions diffuse signs lesions thalamus signs concordance findings mr toxoplasmosis sharp waves parallel methods scientific relevant diagnostic aids manifestations unknown etiology
HIV,HIV3612,topography hiv positive hemophiliacs hiv nervous system manifestations aids dementia moment topography possible positive hemophiliacs wr wr hiv seronegative topography critical results parameters group statistical significance less wr index index recognize statistical significance less wr
HIV,HIV3613,findings hiv infection neurological complications infection human immunodeficiency eegs different infection hiv seronegative total cns dysfunction diffuse cns dysfunction early infection diffuse infection aids correlation related specific valuable cns dysfunction hiv infection
HIV,HIV3614,electroencephalography neurological hiv neurological hiv nonspecific technical findings multiplicity aids neuromanifestations limited diagnostic primary neuromanifestation ie aids hiv infection typical neurological signs parietooccipital aids method invasive neuromanifestations cct mri diagnostic
HIV,HIV3615,mycobacterium endemic aids mycobacterium infected human immunodeficiency hiv hiv infection mycobacterial cultures fifteen positive cultures infected hiv positive mycobacterial cultures hiv serologic positive mycobacterial cultures hiv aids infection hiv infected infection less less cultures mycobacterial growth time mycobacterial growth occurrence hiv mycobacterial cultures group
HIV,HIV3616,military exercises corps reserve duty training human immunodeficiency hiv solar flare cadre teams train hiv exercises navy inspector indoctrination minutes phlebotomies phlebotomies identification process phlebotomy hiv military exercises good training cost
HIV,HIV3617,human immunodeficiency results nonproductive infection human fetal dorsal root glial human immunodeficiency hiv immunodeficiency aids aids dysfunction hiv infection human fetal neural populations infection human fetal dorsal root glial release infectious hiv cocultivation transcriptase rt direct hiv neural supernatants infected neural supernatants rt hiv drg glial supernatants supernatants infected neural intervals supernatants less infection infectious input infection hiv cytoplasmic level postinfection postinfection conjunction dna hiv specific dna hiv infection human fetal drg glial nonproductive infection infectious
HIV,HIV3618,infectious hiv urine seropositive subjects urine peripheral human immunodeficiency hiv seropositive individuals presence hiv cocultivation hiv none urine hiv peripheral mononuclear hiv none urine hiv peripheral serum hiv individuals hiv nephropathy pyuria sensitivity maximal mycostatin findings urine hiv seropositive individuals infectious hiv risk transmission urine nonexistent
HIV,HIV3619,progressive non non hepatitis human immunodeficiency infection non non hepatitis immune suspected non non hepatitis human immunodeficiency latter yr onset hepatitis rapid liver rare non non hepatitis human immunodeficiency infection findings human immunodeficiency infection liver injury non non hepatitis
HIV,HIV3620,year man immunodeficiency extramedullary plasmacytomas lymphoma leukemia immunodeficiency aids malignant transformation report year man aids unusual review literature seropositive human immunodeficiency hiv extramedullary plasmacytomas diseases rare aids list diseases infection
HIV,HIV3621,hiv infection hiv aids homosexuals heterosexual half half pulmonary cavitations infiltrates mediastinal lymphatic enlargement populations favorable
HIV,HIV3622,hiv transcriptase deoxyuridine transcriptase human immunodeficiency hiv dna competitive dttp polyraoligodt template inhibited constants transcriptase nprearautp etdutp npredutp hmdutp cedutp npredutp less nprearautp conditions competitive npredutp time dependent transcriptase template excess dttp primer azidothymidine npredutp nprearautp support dna synthesis incorporation primer template
HIV,HIV3623,gag oligopeptides reactivity hiv mer overlapped hiv hiv sf identify gag mabs sequences terminal conformational protein mab cross hiv hiv mab terminal conformational react peptides mabs mab inwards mab peptides terminal mabs mice none mabs cross reactivity hiv
HIV,HIV3624,hiv neutralization mutants hiv presence mab selection hiv resistant neutralization mab mab neutralization hiv mab pcr complementary dna rna position pcr rna dna specific observed wild glyarg subsequent subclones homozygous wild times neutralization hiv mutations neutralization
HIV,HIV3625,tetrazolium hiv hiv human immunodeficiency hiv results hiv hiv method tetrazolium mtt infectious units infective ccid cultures group doses doses id cultures hiv htlv iiib hiv azidothymidine azt true didehydrodideoxythymidine dt hiv pentosan polysulfate fold hiv hiv fold stage
HIV,HIV3626,rapid hiv mild shock degrees healthy pbl cultivation transcriptase short time pbl rapid hiv
HIV,HIV3627,human immunodeficiency aids aids little human immunodeficiency hiv csf csf serum specimens aids aids hiv infection predominant western serum csf gene products gene products csf less gag serum level hiv csf level spectrum stage quantity serumcsf pairs presence hiv hiv serum csf
HIV,HIV3628,azidothymidine triphosphate human immunodeficiency transcriptase dna gamma transcriptase human immunodeficiency possess rna dependent dna dependent dna dna polyra oligodt michaelis constants nucleotides template primer azidothymidine triphosphate respect dttp respect nucleotides triphosphate dna gamma eucaryotic dna dna dna acquired immunodeficiency side therapy
HIV,HIV3629,human cross reactions products human vitro immunization normal human hiv subsequent fusion epstein monoclonals gag protein gp transmembrane reactivity gp peptides peptides share sequences peptides unsuccessful due non specific reactivity short peptides
HIV,HIV3630,oligodeoxynucleotides nonspecific novo infection hiv homo oligodeoxynucleotides protect ath cytopathic effect infection hiv effect dependent effect mers oligomers sequences dependent cytoprotective effect maximal oligomer sequences sequences results effect mers mers
HIV,HIV3631,hiv nef protein cytotoxic seropositive individuals different hla target regulatory nef protein human immunodeficiency hiv identify specific cytolytic seropositive nef specific cytolytic different donors unique nef protein different hla vaccine
HIV,HIV3632,pseudomonas hybrid protein human immunodeficiency infection envelope glycoproteins immunodeficiency unusual protein pe gp human regions exotoxin protein synthesis envelope human immunodeficiency hiv infected individuals potential vitro toxin pe cytotoxic hiv ic values pm coculture system mixtures uninfected hybrid toxin spread infection hiv dramatic free protective effect due hiv effect hybrid toxin vaccinia viruses vectors hybrid toxin envelope glycoproteins hiv immunodeficiency results support potential pe hiv individuals
HIV,HIV3633,term human cytotoxic clones human immunodeficiency human immunodeficiency hiv aids vaccine hiv transcriptase specific cytotoxic clones peripheral seropositive subjects clones target infected hiv vaccinia vectors transcriptase target transcriptase different epitopes recognition human hla clones specific cytolytic months periodic restimulation specific results hiv specific histocompatibility recognize epitopes single gene conjunction different host hla human specific term need
HIV,HIV3634,mutations transcriptase level resistance zidovudine human immunodeficiency hiv sensitivity zidovudine azido deoxythymidine azt individuals immunodeficiency aids aids genetic resistance sequential initiation therapy transcriptase rt pairs resistant substitutions resistant thr phe tyr fourth gln infectious mutations resistant hiv mutations possible rapid zidovudine resistance nucleic peripheral current hiv isolation sensitivity
HIV,HIV3635,trans human immunodeficiency specific single bulge trans mutagenesis delineate specific human immunodeficiency hiv trans tar element trans tat protein recent report nucleotides tar important trans cuggg mutants substitutions wild second important trans bulge tar cross trans hiv tar tat protein recognition trans hiv hiv
HIV,HIV3636,human immunodeficiency rnase polyanions transcriptase rt human immunodeficiency hybrid rnase retroviral effect polysaccharides human immunodeficiency rt rnase heparin xylan rt infective doses nm fold rt attractive drugs
HIV,HIV3637,infection human fetal dorsal root ganglion glial human immunodeficiency independent ta human immunodeficiency hiv immunodeficiency neurological dysfunction presence nervous system neural populations infection guyton sarin glial human fetal dorsal root ganglion drg hiv infection hiv infection hiv human fetal drg glial slight hiv specific gag preincubation hiv inoculum infection hiv hiv gag detect synthesis neural populations drg specific rna human fetal drg spinal rnase specific antisense rna rna total rna human fetal drg spinal specific rna mature unique rna sizes rna human fetal spinal hiv infection human fetal drg glial entry independent ta
HIV,HIV3638,requirements mhc cytotoxic recognition immunodominant human immunodeficiency envelope protein mice immunodominant hiv iiib gp envelope dd mhc targets requirements recognition mhc transfectants ddld allorecognition dd ld hypervariable hiv envelope peptides interaction mhc tcr effect recognition specific hiv iiib hiv rf higpgrviyatgq peptides single substitutions iiib hiv rf test effect recognition peptides wild mhc interaction dd mhc interaction tcr known hiv mhc infection mhc dominant hiv epitopes limited spot immune aids
HIV,HIV3639,potential insect transmission hiv cimex hemipterus human immunodeficiency human immunodeficiency hiv bedbugs cimex hemipterus oral hiv replicate bedbugs toxorhynchites bedbug feces transmission hiv bedbugs vitro hiv insect many transmission risk transmission hiv nonexistent
HIV,HIV3640,topography putative tertiary structure human gp gene precursors thymus fetal terminal homologous kappa terminal proline rich stalk potential functional regions topography peptides sequences sera computer primary sera ria radioimmunoprecipitation western computer protein sequences epitopes peptides computer kappa terminal spatial kappa homologous terminal computer putative structure regions terminal transmembrane hiv transmembrane sequences syncytial fusion sequences
HIV,HIV3641,psychovegetative resonance aids habituation specific computer habituation underneath emotional db habituation reactions aids public health investigation aids aids hiv homosexual aids healthy normals aids group hiv group healthy normals homosexual dependent aids healthy normals hiv homosexual aids emotional excitement dependent aids emotional emotional results level statistical significance homosexual aids healthy normals hiv stage iii iv
HIV,HIV3642,zidovudine marrow deoxythymidine zidovudine azt presence succinate ats murine hematopoietic azt ats dependent hiv test system microm whereas presence ats microm fold hiv murine marrow significant azt cfu cfu gm values presence ats microm cfu gm microm overall azt ats hiv
HIV,HIV3643,hiv fluoro nucleosides cytotoxicity fluoro nucleosides dideoxy fluorouridine fddurd thio dideoxy fddurd hiv doses fold doses fddurd parent fddurd millimolar range human lines cfu gm triphosphate fddurd transcriptase ic microm
HIV,HIV3644,lines infection hiv progeny different lines terms human immunodeficiency hiv lines infection hiv months significant different hiv terms multiplicity infection initiate infection positive lines persistent infection hiv cytopathic techniques transcriptase results lines progeny hiv express
HIV,HIV3645,hiv infection haemophiliacs necropsy discover findings different haemophiliacs subjects positive hiv findings haemophiliacs non homosexual south england subjects range non homosexual range aids haemophiliacs non haemophiliacs haemophiliacs non haemophiliacs test results infections nervous system non haemophiliacs toxoplasmosis progressive multifocal leucoencephalopathy cytomegalovirus infection haemophiliacs intracranial haemorrhages haemophiliacs intracranial intracranial liver haemophiliacs haemophiliacs haemophiliacs necropsy haemophiliacs positive hiv intracranial liver haemophiliacs hiv infection early stage
HIV,HIV3646,induction immunotolerance hemophilia eradication term hemophiliacs medium fviii iukg daily immunotolerance status hiv serology normal fviii kinetics months eradication hiv positive beginning months full blown aids died second whole immunotolerance latter aids free mild severe cost fviii status
HIV,HIV3647,time donors motives voluntary donors voluntary donors time donors donors motives motives altruistic humanitarian importance tests letting support hypothesis donors enroll donors hiv
HIV,HIV3648,dispenser year syringes important battle hepatitis hiv kind county norway dispensers addicts sterile syringes day night results reactions positive programme syringes syringes pollution problems hepatitis channel group public health foundation future group dispensers important factor battle hepatitis hiv work
HIV,HIV3649,condoms risk heterosexual random norwegians condoms intercourse level group representative respect socio demographic condom subjects extra marital partners condoms permanent extra marital whereas condoms single condom condoms risk hiv infection partners risk hiv condoms
HIV,HIV3650,hepatitis interferon thirty hepatitis stable hbeag dna stable delta thirty heterosexual abuser months therapy subsequent maximal doses interferon ifn weeks times weeks dna hbeag developed seroconversion treated results ifn heterosexual delta hiv infection
HIV,HIV3651,perinatal transmission hiv occurrence transmission hiv positive labour hiv positive lusaka subjects seropositive positive hiv seropositive mothers mothers serological mothers western subsequent signs seroconversion infection aids aids results seropositive mothers months aids seropositive months months seropositive infected ill aids overall perinatal transmission overall year recurrent coughs recurrent diarrhoea fever lymphodenopathy vaccines months transmission mothers perinatal transmission aids positive hiv future pregnancy
HIV,HIV3652,hiv resolution homology retroviral tertiary structure human immunodeficiency hiv important aids retroviral ancestor sarcoma hiv overall folds report hiv resolution adopts terminal strands helix precedes single terminal sarcoma hiv cysteines aminobuytric structure invariance retroviral cleavage processing polyprotein
HIV,HIV3653,significance human immunodeficiency human immunodeficiency hiv infected individuals igg kappa igg igg kappa liquid hiv reactivity serum specimens igg sodium sulfate polyacrylamide page hiv igg react hiv page subsequent paraproteinemias presence lymphoma year support hypothesis igg sera hiv infected individuals normal exuberant immune significance igg paraprotein unclear
HIV,HIV3654,hiv hiv rapid hn gln phe psichn val gln oh hiv coli hiv final crystallization hydrophobic interaction hiv competitive column
HIV,HIV3655,nih pneumocystis bench pneumocystis carinii lungs little organisms carinii transplant infected human immunodeficiency hiv carinii emphasis sophisticated metabolic tools therapy specific human carinii diagnostic tests specific serologic metabolic identification drugs libraries wide range techniques ways
HIV,HIV3656,didehydro dideoxy chlorocytidine didehydro dideoxy chlorocytidine dcc dideoxy chlorocytidine ddclcyd didehydro dideoxy chlorouridine dcu human immunodeficiency hiv types immunodeficiency siv aids srv dcc phosphorylation deoxycytidine dcyd dcyd ki microm findings little cyddcyd deaminase dcu iii antiretroviral dcc dcyd dcc cyd dcc need exert antiretroviral
HIV,HIV3657,nmr investigation structure azido dideoxyribosylthymine azt hiv aids nmr azido dideoxyribosylthymine azt hiv human immunodeficiency modified karplus structure constants nmr results consistent glycosyl sugar pucker endo endo geometries bond results state
HIV,HIV3658,magnetic resonance health mri conditions healthy intracerebral lesions importance early neurodiagnostic techniques disorders preliminary episode onset dementia hiv infections conjunction findings diagnostic mental health resources
HIV,HIV3659,cytomegalovirus infection monocytes macrophages important roles host infections human cytomegalovirus hcmv hiv latent infections inflammatory mediators hcmv infection effect cytokine hcmv infection il peripheral monocytes promyelocytic ml inflammatory promyelocytic ml ml induction differentiation little gene induction pretreatment ml hcmv il tnf csf rna dot infection human peripheral monocytes il monocytes intracellular protein ml protein infected intracellular il monocytes western cotransfection il chimeric hcmv immediate early gene products transactivation il gene early gene ml differentiate il promoter ml undifferentiated hcmv infection productive infection infection enhancement inflammatory gene subsequent protein synthesis
HIV,HIV3660,human lymphotropic coinfection human immunodeficiency hemophilic transmission human lymphotropic htlv infection products tests units hemophilic united infected human immunodeficiency hiv hiv products htlv htlv status factor viii hemophilia factor hemophilia hiv seronegative hiv seropositive immunosorbent elisa serum htlv ib serum ib reactivity radioimmunoprecipitation ripa peripheral mononuclear htlv ib htlv sequences stable year early htlv seroconversion results safety factor components united htlv importance htlv elisa results second specific
HIV,HIV3661,transcriptase rnadna hybrid gag hiv rnase pp hiv transcriptase rt dna synthesis rnadna sp transcripts gag hiv complementary single dna subclone vector subclone hybrids mismatch nucleotides hiv pp rt rnase oligonucleotide products hydrolysis hybrids rt mulv rt escherichia coli rnase significant time dependent products rt vs coli rnase cleavage hybrids hiv free rnase hiv rt rnase many general mechanistic retroviral gerard unique end products hydrolysis hybrids significant kinetics cleavage hiv rt mulv rt
HIV,HIV3662,hiv positive homosexual bisexual health social hiv positive homosexual bisexual anonymous investigation isoprinosin aids total participants health good friends fifty daily normal participants manner risk hiv transmission transmit hiv past year possible determinants limited extent hiv eliminate
HIV,HIV3663,aids hiv early intervention public human immunodeficiency hiv infection state art possible hiv positive term early conditions gains quality expectancy transmission hiv uninfected scarce resources total hiv possible disadvantages psychological reactions hiv infection societal cost trust infected infection
HIV,HIV3664,homologous heart risks transfusion context operative open heart products methods homologous hand surgeons hand infectious complications viruses hepatitis group reactions programme work excess demands staff needs programme components donation hematocrit coagulation process
HIV,HIV3665,problems evidence time heroin ireland social problems misuse aids deterrent effect
HIV,HIV3666,problems problems soft drugs cannabis methadone heroin successful heroin
HIV,HIV3667,clinics positive organisation positive successful clinics day
HIV,HIV3668,protein glomeruli normal proximal kidneys renal damage nephron tubulo interstitial nephropathy urine filtration serum normal renal serum malignant diseases size tumour cytostatic lymphatic leukaemia serum remission leukaemia malignant lymphoma infiltration conditions csf non specific infection hiv positive serum level prognostic aids aids latent cns infections malignant stage
HIV,HIV3669,risk hiv infection health manpower review world literature probable occupational hiv infection health staff needle skinmucosal infection lesions injections laboratory staff infection total seroconversion ie occupational risk hiv infection health staff denmark needle carrieres infection needle hiv risk staff
HIV,HIV3670,mutations terminal hiv transcriptase repress rnase single substitutions terminal rnase hiv transcriptase escherichia coli ni nitrilotriacetic rnase wild transcriptase
HIV,HIV3671,gastrointestinal cytomegalovirus human immunodeficiency infection human immunodeficiency hiv male female male homosexuals iv abuser wr wr intestinal cytomegalovirus cmv manifestations group hiv respect serological results histological microbiological risk infection stage status bloody important cmv non cmv intestinal manifestations cmv cmv esophagitis serological findings consistent cmv infection cmv manifestations intestinal cmv manifestations serological findings cmv infection intestinal mucosa powerful intestinal cmv endoscopical cmv unchanged infection hsv cmv histology intestinal cmv cmv
HIV,HIV3672,igg lymph serum human immunodeficiency hiv subclasses igg immunohistochemistry lymph persistent lymphadenopathy due infection hiv nodes igg immunocyte igg hiv infection igg igg lymph igg lymphadenopathy serum igg igg panel
HIV,HIV3673,sensitivity cfu gm normal human marrow leukaemic myelogenous leukaemia deoxy azido deoxythymidine deoxy ft hiv vitro vitro effect normal human marrow cfu gm human peripheral leukaemic methylcellulose azido deoxythymidine azt aids colonies marrow stem ic times ic ft cluster azt ft colonies cfu gm cfu ft side marrow possible ft aids potential leukaemic drugs
HIV,HIV3674,puncture surgeons risk hiv infection occupational risk human immunodeficiency hiv infection surgeons york metropolitan surgeons puncture injury year year interquartile range year injury hours surgeons injury hours independent operative work load index finger nondominant hand hiv infection year risk seroconversion less group group surgeons surgeons
HIV,HIV3675,aerosolized pentamidine individuals risk pneumocystis carinii pentamidine isethionate rosemont ill food prophylaxis pneumocystis carinii individuals human immunodeficiency risk infection pentamidine isethionate weeks nebulizer products colo individuals human immunodeficiency carinii individuals equal carinii safety nebulizer
HIV,HIV3676,dementia early human immunodeficiency hiv documented report homosexual man fatigue early hiv dementia neurological aids months epistaxis white matter mild pallor myelin giant
HIV,HIV3677,neurological neuropsychological healthy hiv individuals results aids neurological healthy individuals human immunodeficiency hiv public health policy issues future health needs aids cross neurological seropositive homosexual bisexual iii group seronegative homosexual neurological neuropsychological neuropsychiatric neuropsychological nineteen subjects tests neuropsychological neurological normal results neurological neuropsychological hiv seropositive subjects subject mild hiv dementia confidence magnetic resonance sulcal white matter hiv seropositive subjects hiv infected individuals dementia hiv related neurological disorders healthy hiv seropositive homosexual conditions neurological
HIV,HIV3678,neurological neuropsychological manifestations infection aids hiv infection neurological neuropsychological manifestations human immunodeficiency hiv infection immunodeficiency aids cross hiv seropositive homosexual bisexual aids lymphadenopathy signs hiv infection hiv seronegative infection neuropsychological tests seropositive subjects aids neurological cognitive hiv seronegative subjects risk neuropsychological subjects level seronegative group subjects aids related hiv seronegative subjects results neuropsychological tests ratio neuropsychological tests group aids subjects lymphadenopathy subjects signs infection different hiv seronegative subjects neuropsychological testsabstract
HIV,HIV3679,los angeles county sentinel immunodeficiency aids los county white white females white acquired immunodeficiency aids aids trends human immunodeficiency hiv transmission future gay
HIV,HIV3680,tell ethical dilemmas hiv test notification hiv human immunodeficiency ethical dilemmas seropositive subjects designs notification notification anonymous single trade valid ethical strategy effect longitudinal subjects test results subjects hiv risk institutional review boards potential subjects partners aids immunodeficiency
HIV,HIV3681,lymphocytic leukemia hiv positive non lymphoma human immunodeficiency hiv immunodeficiency aids many burkitt burkitt lymphoma lymphocytic leukemia burkitt hiv positive risk aids burkitt herein laboratory positive stage iv burkitt lymphoma burkitt burkitt hiv positive support aids
HIV,HIV3682,human immunodeficiency hiv infection underwent hiv infection immune thrombocytopenic purpura itp splenomegaly anemic thrombocytopenic mycobacterium avium intracellulare mai infection splenic due group cytomegalovirus cmv splenitis sarcoma ks evidence extramedullary splenic enlargement splenic splenomegaly presence findings leukopenia presence mai cmv infection presence conditions
HIV,HIV3683,hemophilia aids united effect aids group aids hemophilic united aids february cumulative aids seropositive hemophilia excess risk aids htcs hemophilia hemophilia aids risk aids risk hemophilia aids risk aids seropositive htcs risk seropositive overall derived hemophilic whereas likely coagulation aids risk htcs factor risk aids seropositive findings support aids importance hemophilia aids populations
HIV,HIV3684,primary sarcoma immune yr homosexual male human immune hiv infection hepatosplenomegaly serum nodules histopathology lesions consistent sarcoma weeks cutaneous sarcoma neck unusual intrahepatic sarcoma moreover evidence extrahepatic sarcoma documentation liver
HIV,HIV3685,marrow aids aids marrow immune aids aids fever unknown leukopenia aids perivascular plasma aids human immunodeficiency hiv nucleic method marrow aids positive endothelial reticulum red immature positive results positive related size peripheral marrow latent persistent infection hiv
HIV,HIV3686,health infection inroads hiv infection many health providers hopelessness pity healthy hope personal individuals hiv infection freedom harmful methods health chooses assesses health perspective methods needs harmful nonjudgmental maintain health prevent specific stress situations individuals level health possible important critical health optimum comfort health
HIV,HIV3687,psychosocial issues infection hiv infection stigmatized bisexual related stigma discrimination job home denial insurance estrangement friends infectious hiv individuals values psychosocial problems nursing
HIV,HIV3688,human immunodeficiency murine leukemia different myristic myristoyl myristoyltransferase nmt catalyzes cotranslational linkage terminal glycine sulfur oxygen myristic fatty equivalent decanoate previous vitro metabolic subsets myristoyl specific incorporation cooperative coa sites nmt human immunodeficiency hiv murine leukemia momlv myristoylation gag polyprotein precursors methoxydodecanoic hiv methoxydodecanoic dependent transcriptase hiv equivalent microm azido deoxythymidine nucleic synthesis inhibits momlv dependent methoxydodecanoic effect nmt cotranslational strategy way fatty
HIV,HIV3689,human immunodeficiency group aids serologic human immunodeficiency hiv nervous system cns peripheral lymph nodes pairs infected individuals hiv peripheral inability lines iii inability iv peripheral macrophages serum neutralization cns peripheral lines lines cns primary macrophages results viruses cns infected individuals specific hiv
HIV,HIV3690,kda protein regulatory receptor gene human immunodeficiency terminal receptor il gene promoter regulatory element nre nucleotides start element il promoter il nre regulatory element ttcatcccagg protein terminal human immunodeficiency hiv hiv gene protein dna kda protein il hiv nre il element protein il promoter sp functions
HIV,HIV3691,human immunodeficiency dna hemophilic partners aids group pcr detect human immunodeficiency hiv dna peripheral mononuclear hemophilic hiv seropositive uninfected seronegative seronegative partners seropositive hemophilic infected seropositive positive pcr pcr none seronegative coagulation factor products positive noninactivated products positive helper pcr second primer hiv dna seronegative female partners seropositive aids aids related positive seropositive hemophilic infected infection status seropositive pcr seronegative pcr positive hiv dna seroconversion
HIV,HIV3692,human immunodeficiency dna incorporation deoxynucleotides methods vitro dna method involves oligonucleotides products primers dna pg dna method second method deoxynucleotides dna methods detect products ethidium techniques
HIV,HIV3693,hiv ish detect hiv seropositive individuals hiv dna human immunodeficiency hiv peripheral positive rapid day rare single positive seropositive hemophiliacs hiv seropositive coculture normal pbl dupont capture ish positive capture shorter times half hiv hemophilia positive whereas capture fourth positive positive coculture hemophiliacs sensitivity confidence ish
HIV,HIV3694,nf kappa sites human immunodeficiency terminal infectivity mutations regulatory sequences terminal infectious human immunodeficiency viruses kappa sites ones sp sites human nf kappa sites sp tat sequences human immunodeficiency infectivity
HIV,HIV3695,human immunodeficiency peripheral healthy seropositive individuals evidence latent human immunodeficiency hiv infection healthy seropositive individuals virions cocultivation dna seropositive individuals presence hiv sequences peripheral mononuclear enriched subpopulations peripheral mononuclear harbors sequences hiv infected healthy individuals vitro infection eventual true vivo harbors disparity latent infection lytic vitro
HIV,HIV3696,uv human immunodeficiency hiv terminal uv factor induces uv sunlight induces human immunodeficiency hiv chimeric constructs parts terminal gene hela murine human lines element uv factor nf kappa uv kappa uv cocultivation uv nontransfected hiv uv protein factor medium uv treated factor uv murine human lines hela molt jurkat uv human skin spread deeper layers uv hiv humans
HIV,HIV3697,serologic human immunodeficiency infection correlation status serum human immunodeficiency hiv infection presence hiv humoral immune hiv specific isotypic serum specimens dependent cytotoxicity hiv envelope results immunodeficiency aids likely serum antigenemia aids related significant stable status longitudinal antigenantibody profiles hiv infection sera aids correlation status
HIV,HIV3698,va engelhardt institute porcine pepsin refinement resolution group protein structure university important chymosin engineering work chymosin template template hiv hiv
HIV,HIV3699,dendritic dendritic obstacle dendritic human tissues skin tonsil dendritic specific monoclonals many dendritic man clonal expansion dendritic hiv infection
HIV,HIV3700,search substances human immunodeficiency semisynthetic perspectives semisynthetic different human immunodeficiency absorbtion synthesis protein translation processing
HIV,HIV3701,zidovudine current status azido deoxythymidine vitro hiv infection zidovudine intracellular phosphorylation transcriptase half oral biodisponibility results demonstration effect stage iv aids pcp episode year zidovudine hiv related nervous system disorders axes standard therapies early stage
HIV,HIV3702,microbiology hiv periodontal lesions intraoral lesions human immunodeficiency hiv infection gingivitis progressive periodontitis microbiota gingival periodontal lesions subgingival seropositive homosexual seronegative classified hiv gingivitis hiv periodontitis healthy hiv seropositive subject healthy conventional gingivitis periodontitis subject detect gingivalis intermedius fusobacterium actinobacillus actinomycetemcomitans detect actinomycetemcomitans findings gingivalis intermedius hiv periodontitis sites hiv gingivitis sites seropositive healthy less results microbiota periodontitis periodontitis hiv gingivitis different conventional gingivitis organisms gingivitis hiv periodontitis gingivitis lesion hiv periodontitis early hiv gingivitis lesion rapid periodontal tissues hiv periodontitis
HIV,HIV3703,human immunodeficiency protein trans gene human immunodeficiency hiv downregulate gene protein wild synthesis target downregulation trans tar enhancer sequences terminal ltr level
HIV,HIV3704,pneumocystis carinii prophylaxis pneumocystis carinii management strategy populations infectious populations human immunodeficiency infection recent marrow lymphocytic leukemia sulfamethoxazole daily sulfamethoxazolekg hours populations pentamidine scrutiny safety
HIV,HIV3705,infection human immunodeficiency identification human immunodeficiency hiv aids host targets hiv drugs drugs different sites vitro many promise vitro zidovudine azt trial subsets hiv infection drugs trials united united timely identification preclinical hiv
HIV,HIV3706,pulmonary complications aids infection hiv pneumocystis carinii half aids infection interstitial diseases due pneumocystis carinii interstitial recurrent likewise infections epstein identification future aids diagnostic infections
HIV,HIV3707,status prophylaxis hiv thirty hemophiliacs hiv infection glycyrrhizin neo snmc ml snmc ml group aids arcaids group snmc daily weeks second day weeks positive hemophilia accordance japanese committee positive counts significant slight concanavalin group ml snmc liver dysfunction hemophiliacs products snmc hiv positive hemophiliacs liver dysfunction prevent acarc aids
HIV,HIV3708,hiv serologic hiv infection human immunodeficiency hiv immunoassay specimens hiv infection subsequent serum specimens nonreactive specimens hiv hiv western serum hiv immunoassay whole lysate hiv specific hiv western human immunodeficiency sequences peripheral mononuclear gene technology human immunodeficiency peripheral typical microscopy western specific individuals evidence hiv infection nonreactive hiv immunoassay reactivity patterns
HIV,HIV3709,hiv infection humoral malaria serological malaria hiv infected malaria transmission group immunodeficiency aids aids densities pnan naag peptides hiv seropositive hiv seronegative non parametric seropositive aids stage group seronegative stage peptides significant hiv seropositive hiv seronegative hiv infection hiv seropositive aids results malaria
HIV,HIV3710,primary lymphoma liver immune hepatitis homosexual man infection human immunodeficiency hepatitis primary lymphoma lymphoma rapid enlargement liver ultrasound hypoechoic lesions histological liver replacement lymphomatous hepatitis hepatitis positive whereas occurrence lymphoma related hiv infection possible hepatitis hiv infection presence lesions liver hiv infection lymphoma evidence lymphadenopathy
HIV,HIV3711,human immunodeficiency protein coli genetic human immunodeficiency hiv protein protein stretch histidine escherichia coli single metal histidine
HIV,HIV3712,hiv envelope human immunodeficiency hiv hiv peripheral coast aids hiv eho envelope hiv weight protein hiv hiv gene hiv kda hiv eho kda hiv envelope hiv eho dimer maturation hiv kda endoglycosidase kda hiv due envelope precursors weight kda partial envelope precursors polypeptides results envelope hiv due hiv envelope envelope hiv eho immunoprecipitation rapid hiv africa
HIV,HIV3713,human immunodeficiency csf subjects human immunodeficiency hiv infection frontal aids aids related aids neurologicalpsychiatric complications csf peripheral mononuclear free transmission infection none early csf different lines cytopathic effect protein radioimmunoprecipitation results viruses csf
HIV,HIV3714,functional different immunodeficiency lentiviruses subgroups human immunodeficiency hiv related hiv hiv immunodeficiency siv hiv encode post trans gene hiv sivmac functional trans cytoplasmic transcripts incapable cytoplasmic hiv transcripts hiv functional hiv siv system nonreciprocal direct recognition rna target
HIV,HIV3715,induces human immunodeficiency hiv hiv enhancer human vectors human fibroblasts test hypothesis membrane transductor human immunodeficiency hiv vectors chloramphenicol transferase terminal ltr hiv vectors val ha gene normal gene transactivation hiv ltr direct sequences hiv enhancer ltr transactivation ltr sequences vectors tar tat gene oncogene hiv enhancer dna hiv findings mechanisms membrane signals hiv
HIV,HIV3716,htlv rex hiv mechanisms unspliced rna human human leukemia htlv human immunodeficiency viruses early intron expressions rex hiv early mrnas intron gag mrnas sequences rex splice sd element rxe end whereas specific repressive element rre intron sd sequences hiv element rre htlv rex hiv results rex rna chimeric constructs hiv rre repressive element dispensable intronic exonic rre important observations rex cytoplasmic rna sd
HIV,HIV3717,review human immunodeficiency infection human immunodeficiency hiv seroprevalence united clinics related reproductive health settings clinics prenatal clinics settings risk hiv infection observed urban york baltimore san settings maternal hiv neonatal heel stick specimens massachusetts york upstate york york female military applicants female donors stable time early middle syphilis serology clinics sites hiv infection united specific populations hiv infection target efforts
HIV,HIV3718,zidovudine zidovudine azidothymidine azt hiv infection inhibits drugs side management zidovudine therapy side washington university aids trials
HIV,HIV3719,prophylaxis pneumocystis carinii update dr merle sande appreciate fact successful infections aids induction therapy infections successful current regimens lifelong therapy true human immunodeficiency hiv infected individuals carinii cryptococcosis histoplasmosis toxoplasmosis infection joseph henry health instrumental management carinii current chemoprophylaxis infection aids
HIV,HIV3720,human immunodeficiency total serum human immunodeficiency hiv ifa denmark bissau results immunosorbent elisa western immuno wb results serum true positive hiv wb radioimmunoprecipitation results positive hiv ifa serum hiv reactivity hiv cross hiv none sera cross hiv ifa total serum danish unspecific results ifa hiv ifa specific elisa ifa wb hiv hiv infections
HIV,HIV3721,aids immune aids human immunodeficiency hiv related disorders neuropsychiatric complications systematic neurobehavioral emotional hiv spectrum disorders management hiv infection
HIV,HIV3722,hiv infection immune aids human immunodeficiency hiv infection neuropsychiatric complications disorders isolation fear stigma hiv aids stigma
HIV,HIV3723,hepatitis infection interferon therapy statistical pretreatment significance interferon hepatitis infection minimum units total weeks human immunodeficiency status less hepatitis liver less level hepatitis dna level hepatitis univariate stepwise logistic hepatitis dna hepatitis human immunodeficiency status positive icteric hepatitis iu liter icteric hepatitis iu liter less hbeag hepatitis dna likely occur infection less less
HIV,HIV3724,gene human immunodeficiency method human immunodeficiency hiv gene subgenomic constructs dna occurs hiv different sizes conventional method general rna method hiv gene mutagenesis infectious hiv jr csf wild constructs unspliced rna tat nef mrnas standard rna results protein hiv jr csf tat nef level unspliced full hiv rna sequences ultimate effect direct possible mechanisms
HIV,HIV3725,cleavage human immunodeficiency envelope gp envelope human immunodeficiency hiv gp envelope glycoproteins gp cleavage host retroviral envelope precursors requirements cleavage single terminal cleavage mutations hiv envelope results glutamic glycine gp isoleucine gp cleavage results results envelope cleavage murine leukemia risser virol threonine gp terminal gp abolishes cleavage findings gp cleavage envelope report cleavage gp hiv envelope fusion
HIV,HIV3726,hiv total specimens csf stool participants aids risk group laboratory sera csf aids positive reactions western sera csf risk group laboratory overall positive specimens aids positive sera csf stool
HIV,HIV3727,visceral leishmaniasis aids pivotal recovery mechanisms visceral leishmaniasis vl aids severe vl relevant infections aids aids identification leishmania donovani marrow lymph leishmania positive significant esophageal carinii toxoplasmosis pulmonary esophageal sarcoma cmv hepatitis specific ineffective fact recovery free year think infection hiv infection time conditions satisfactory slight marrow fever dramatic second specific ineffective second specific important presence organs marrow liver granulomatous lesions
HIV,HIV3728,hiv infection concerns positive psoriatic hiv infection unclear hiv infection draw behalf evolution unresponsiveness hiv seropositivity therapy methotrexate phototherapy specific
HIV,HIV3729,hiv specific immuno diagnostic test system competitive eia hiv ngml system phenomenon hiv sera infected determinants hiv system competitive eia phenomenon clearance excess vitro results hiv antigenemia exhaustion specific immune
HIV,HIV3730,hiv azido dideoxynucleosides azido dideoxynucleoside phosphate azido dideoxythymidine methylphosphonate phosphite azido dideoxythymidine azido dideoxyadenosine guanosine cultures human hiv azido dideoxynucleosides nucleosides substances transported triphosphate possible dna
HIV,HIV3731,phenolic licorice licoarylcoumarin glisoflavone xanthine oxidase hiv human immunodeficiency phenolic licopyranocoumarin licoarylcoumarin glisoflavone pei licorice licorice root stolon glycyrrhiza western china spectroscopic kaempferol methyl licocoumarone licorice ten licorice xanthine oxidase licochalcone glycyrrhisoflavone licochalcone
HIV,HIV3732,condom male zimbabweans condoms position strategy transmission human immunodeficiency hiv diseases cure aids sight condom celibacy health immediate sole weapons hiv infection cluster zimbabwean condoms current condom condom condoms condoms wife condoms previous condoms health condoms
HIV,HIV3733,aids massachusetts massachusetts residents telephone explore educational efforts gaybisexual heterosexual respondents whites respondents stories aids previous aids white respondents gaybisexual iv hiv homosexual heterosexual intercourse needles drugs unaware male homosexual transmission heterosexual transmission risks needle respondents someone healthy fifty gaybisexual heterosexual partners recent abstinence monogamous hiv risky hiv transmission likely report aids vs results resources physicians transmission efforts translate hiv transmission
HIV,HIV3734,damage hiv infection status infected stage lymphadenopathy intravital needle latter signs protein synthesis dysfunction morphological evidence mild inflammatory specimens aids lesions intralobular infiltration liver due hiv infection aids
HIV,HIV3735,curry cabral hiv infections retrospective positive infectious diseases curry cabral lisbon till march positive hiv hiv hiv male risk homosexuals reed cdc heterosexual kaposi pneumocystis carinii wr group wr wr risks situations risk status statistical significance test immunodeficiency lymphadenopathy dermatological lesions
HIV,HIV3736,aids condom promotion likely resistance condom risk partners york aids programs lack social options immediate risks homelessness disruption support resistance condom related promiscuity process condoms related social influences human immunodeficiency hiv implications findings context imbalances male partners many aids
HIV,HIV3737,azt azt problems general imply interaction drugs drugs pharmacies psychological investment azt time coercitive weapon problems gp work
HIV,HIV3738,pharmacokinetics deoxy azt hemodialysis zidovudine aids pharmacokinetics stage renal esrd report pharmacokinetics hemodialysis esrd year man esrd hemodialysis aids tt ratio immunosorbent western igg hiv zidovudine times daily pharmacokinetics hemodialysis zidovudine venous start hemodialysis day microgram milliliter zidovudine azt micrograms milliliter day half hours clearance zidovudine ml half zidovudine times normal
HIV,HIV3739,pharmacokinetics azt healthy pharmacokinetics zidovudine oral seronegative subjects severe renal clearance mlmin healthy subjects healthy subjects azt auc mumolhl azt limits half uremic azt auc mumolhl half unchanged renal clearance vs mlmin azt auc mumolhl renal clearance vs mlmin half vs hemodialysis negligible whereas azt
HIV,HIV3740,hiv therapy hiv human infections therapy different antiretroviral therapy immune system modulation stage today little mechanisms infections humans drugs middle short term trials parameters thought immunomodulators treated months year hiv phosphorylation today vitro glycosylation trial effect
HIV,HIV3741,management results retrospective la valencia neurological onset hepatitis hypertransaminemia hemolytic outbreaks interruption positive hepatitis positive hiv normal ceruloplasminemia values diagnostic ceruloplasminemia urine copper intrahepatic copper copper vital importance normal deliveries intolerance severe intolerance therapeutical trientine transplant
HIV,HIV3742,neuro manifestations immune neurological disorders immune aids bangui world health bangui aids positive human immunodeficiency hiv hiv western neurological aids neuro disorders
HIV,HIV3743,voluntary hiv prenatal evolution mechanisms reactions voluntary hiv prenatal
HIV,HIV3744,infection homeless infection homeless york primary method issues transmission aids
HIV,HIV3745,midwives occupational infections diseases objectives certified midwives extent prevent incidents aids associate college midwives midwives fluids soaked skin face splashes universal interference midwife client midwives minimize midwife client
HIV,HIV3746,cocaine ethnicity early human immunodeficiency york infection human immunodeficiency hiv immune aids york hiv infection aids hiv york cocaine hiv injectors less white hiv hispanic hiv logistic hiv heroin hispanic hispanic early cocaine heroin hiv hiv infection problems specific needs cocaine hispanic
HIV,HIV3747,time hiv hiv tests report middle hiv serum elisa tests propose hiv hiv individuals risk hiv infection hiv hiv tests infectious
HIV,HIV3748,methods endoscopic results international methods endoscopic equipment western endoscopic year specialized units fewer endoscopic year disinfection infected positive gastrointestinal unknown status endoscopic infected subjects disinfection gastroscopy ercp endoscopic endoscopic equipment risk infections
HIV,HIV3749,mycobacterium hiv positive immunodeficiency infections positive male partners antituberculous therapy
HIV,HIV3750,thoracic manifestations aids immunodeficiency aids immunodeficiency human immunodeficiency hiv severe helpers dysfunction many aids pulmonary manifestations infectious infectious diseases many year seropositive subjects respiratory radiographs picture gallium scintigraphy transbronchial tbb lavage bal aids diseases infections due pneumocystis carinii radiographic laboratory diagnostic specific diagnostic
HIV,HIV3751,hiv infections state aids hot problems aids urgent need ministry health hot aids year outline emotional impact public problems callers belong group ratio correlations questions caller vast questions concepts notions infections risk related subjects year questions subjects questions specific
HIV,HIV3752,sudden sensorineural hiv infection positive sudden sensorineural importance ct possible condition
HIV,HIV3753,hiv dental pulp aids dental pulp immune aids presence human immunodeficiency hiv results hiv dna
HIV,HIV3754,human immunodeficiency hiv infection female prostitutes state nigeria year serological female prostitutes resident borno state nigeria seroprevalence hiv infection year sero prostitutes previous health campaigns prostitution spite aids means halt hiv infection fact prostitutes condoms importance risks hiv infection health campaigns hiv infection female prostitutes state nigeria likely serious efforts health campaigns risk
HIV,HIV3755,aids international work aids health resources extent health many countries world aids health many countries socio economical demographic health extent review extent aids tendency important africa south sahara documented countries aids africa direct turn year orphans aids south sahara end aids countries problems unorthodox health specific countries roles voluntary danish organisations aids obvious risk programme resources structure
HIV,HIV3756,cytoplasmic monocytes normal hiv infected individuals monocytes monocytes results immunofluorescent flow cytometry microscopy normal donors infected leu specific normal individuals dual positivity flow cytometry monocytes colour monocytes cytoplasmic monocytes unconjugated cytoplasmic negligible monocytes normal individuals monocytes cytoplasmic hiv
HIV,HIV3757,modulation hematopoietic stem peripheral tgf severe growth factor tgf optimum growth factor gm csf il stem peripheral healthy individuals infection tgf tgf significant erythroid individuals tgf significant erythroid slight significant plasma hiv presence results consistent tgf myelopoiesis vitro tgf factor recruitment granulocytes stem growth
HIV,HIV3758,hiv infection aids mathematical st aids officer homobisexual effect total aids outside time half aids time dt months months dt aids growth homobisexual months months growth dt months rest months aids hiv aids st
HIV,HIV3759,estimate hiv seropositive implications aids estimate total hiv version time summit total hiv infected hiv minimum values aids future aids year mid findings aids underline policy risk iv clinics travellers applicants political asylum endemic
HIV,HIV3760,heterosexual transmission hiv hemophiliacs hemophiliacs hiv sero positive heterosexual partners hemophiliacs hiv positive none seropositive partners aids heterosexual transmission hiv infected index correlation index stage isolation hiv index seronegative female partners hiv female von husband aids heterosexual hiv transmission hemophiliacs immunopathological findings seronegative partners
HIV,HIV3761,important human immunodeficiency transcriptase retroviral rna dependent dna transcriptase rt oh end trna primer initiate dna synthesis previous work transcriptase selection trnas primer trna primer end rna mechanisms support retroviral trna specific ones human immunodeficiency hiv primer hiv transcriptase chymotrypsin transcriptase putative primer specific retroviral trnas
HIV,HIV3762,hiv positive respiratory pneumocystis carinii respiratory pneumocystis carinii pcp aids prognostic aids significant regard hiv risk time aids vital signs heart respiratory hemoglobin white platelets total lactate dehydrogenase apache saps scores oxygen hg oxygen alveolo prognostic prompt severe
HIV,HIV3763,lack evidence infection effect growth hematopoietic vivo vitro human immunodeficiency acquired immunodeficiency aids report growth cfu gm erythroid bfu different normal human immunodeficiency hiv seronegative donors gm marrow observed aids cfu gm bfu dna colonies gm bfu pcr hiv dna peripheral mononuclear normal marrow vitro different hiv envelope gp growth gm bfu mock marrow dna pcr colonies hiv marrow erythroid hematopoietic growth contain hiv dna envelope gp growth hematopoietic vitro evidence hiv infection aids direct
HIV,HIV3764,hiv signals results latent infection hiv sequences terminal ltr comprise enhancer sites nuclear factor kappa nf kappa second aids hiv nf kappa hiv ltr hiv ltr signals qualitative hiv hiv heterologous promoter ltr electrophoretic nf kappa sites enhancer single hiv enhancer nf kappa protein hiv hiv hiv signals hiv hiv infection
HIV,HIV3765,dependent cytotoxicity hiv target peripheral monocytes seropositive cytotoxic effector cytotoxic nk hiv presence hiv cytotoxic mechanisms hiv infection early hiv effector mechanisms elusive hiv seropositive peripheral monocytes dependent cytotoxicity hiv target presence heterologous serum test specific hiv cemtr resistant tnf cytotoxicity vitro cr release cemtr hiv pbm normal significant pbm hiv seropositive presence hiv specific hiv dependent ratio pbm gamma normal hiv pbm hiv cemtr pbm hiv seropositive presence serum significant dependent serum findings hiv hiv seropositive individuals sera support vivo
HIV,HIV3766,serum il correlation serum il hiv diseases luminescence sandwich quantification il sera supernatants fgml test luminescence sandwich pgml sera normal individuals serum hiv seropositive il hiv aids pgml aids pgml sera aids mw stable mw minor size exclusion hplc significant correlation serum il il hiv infection pha pbmc release il supernatants il release exogenous il whereas il mab cultures results il sil receptor hiv infection serum il serum il hiv infection reflect stage hiv
HIV,HIV3767,persistent parvovirus infection infected human immunodeficiency hiv aids parvovirus red infected human immunodeficiency hiv trial serum peripheral marrow dna immunocytochemistry techniques findings results therapy university red serologic evidence infection hiv results giant marrow crisis parvovirus infection parvovirus sera weeks months dna capsid protein marrow southern antivirus igg capture igm fifth normal treated rapid serum full recovery dna parvovirus remediable severe hiv recognition therapy parvovirus transfusion prevent transmission
HIV,HIV3768,notification hiv public health diseases notification hiv infection issues cost effectiveness concerns review recent
HIV,HIV3769,pyomyositis haematogenous primary pyomyositis staphylococcus entity regions non recognition pyomyositis state pyogenic concomitant transcutaneous drainages osteomyelitis carditis typical complications pyomyositis
HIV,HIV3770,purulent university infections retrospective significant slight state consciousness csf hiv
HIV,HIV3771,hiv infection misusers drugs programme methadone see misusers drugs switch programme methadone risk hiv infection group persistent misusers seropositive subjects current past misusing drugs hiv university zurich switzerland current former misusers hiv infection subjects programme methadone misuse former misusers free drugs antiretroviral hiv infection stage iv rank test proportional hazards results months misuse enrollment significant counts hiv methadone group former misusers persistent misusers risk confidence persistent misusers less group former misusers misuse drugs hiv infected subjects hiv morbidity
HIV,HIV3772,drugs hiv aztmp conjugates hiv azido deoxythymidine azt monophosphate human vitro covalent neoglycoproteins vivo side azt aids rationale neoglycoprotein sugar linkage sugar human serum fucose glucose neoglycoproteins hiv neoglycoproteins vitro hiv protein manhsa shows hiv effect interference manhsa gp interaction aztmp conjugates pronounced conjugates hsa hsa less spite fact fucose neoglycoproteins aztmp times hiv hsa aztmp indices man azt aztmp indices conjugates fucose hsa aztmp conjugates due hydrolysis covalent protein bond manhsa range effect neoglycoprotein membrane subsequent internalization release
HIV,HIV3773,membrane human hiv membrane tl induction human immunodeficiency hiv hattori koito takatsuki kido kutunuma human kda permeation liquid sodium sulfate polyacrylamide boc gln methyl coumaryl boc gln methyl coumaryl optimum envelope gp hiv peptides gpgr gp hiv gpcr trypstatin hi microbial antipain subcellular tl radioiodination plasma membrane
HIV,HIV3774,hepatitis quantification products haemophiliacs pcr specific hepatitis hcv rna sequences haemophiliacs hcv positive positive quantification rna positive copies infected haemophiliacs human immunodeficiency hiv positive hiv batches factor viii plasma donations viii donations pcr sequences infected scottish factor viii preparations sequences factor viii
HIV,HIV3775,evidence gpcd interaction hiv infection hiv dependent hiv fusion dependent hiv infection vitro gp envelope peptides dependent infection fusion cdgp benzylation gp positive infection fusion gpcd interaction hiv infection fusion fusion infection cdgp interaction hiv infection fusion effect dependent fusion hiv infection cdgp okta leu gp evidence gp dependent hiv infection previous observations mutants homologous gp cdr cdr hiv envelope hiv infection hiv fusion
HIV,HIV3776,neurotoxins hiv mononuclear macrophages giant targets human immunodeficiency hiv nervous system cns hiv infect neurons cns dysfunction immunodeficiency aids uncertain hiv human monocytoid human neurons stable resistant way methyl hiv
HIV,HIV3777,hypervariable hiv pnd human immunodeficiency hiv envelope protein peptides neutralize human lymphoma htlv iiimn pnd rp mn htlv iiib iiib pnd rp sera cross glyproglyargalaphe gpgraf pnds hiv rabbits gpgraf iiib mn
HIV,HIV3778,rapid nuclear oligodeoxyribonucleotides intracellular transport fate nucleic process oligodeoxyribonucleotides cv epithelial primary human fibroblasts nuclear pd pt methylphosphonate mp human immunodeficiency migration diffusion oligos nuclear incorporation energy dependent oligos internucleoside extent pt nuclear ribonucleoproteins whereas mp oligos regions dna important implications transport exogenous nucleic oligos
HIV,HIV3779,modulation hiv gene rna protein coat protein single rna bacteriophages target rna replicase gene rna protein coat protein hiv leader rna effect bacteriophage protein hiv ltr context trans rna genetic modulators eucaryotic
HIV,HIV3780,recognition oral lesions infection gingival periodontal lesions articles oral lesions infection deals rare lesions
HIV,HIV3781,postherpetic postherpetic ophthalmic signs ct ischemic infarcts regions consistent vasculitis ipsilateral herpetic lesion neurological stable ischemic episodes cutaneous lesions unnoticed zoster infection
HIV,HIV3782,guidelines transmission health hiv issues transmission risk health settings recent outbreaks health settings outbreaks multidrug resistant mycobacterium nosocomial transmission many risk human immunodeficiency hiv transmission infection risk health workers transmission settings infection settings cough sputum induction pentamidine transmission likely occur pulmonary laryngeal antituberculosis therapy bacilli isolation health risk work minimize risk transmission settings transmission health settings infectious airborne early identification tuberculous infection spread infectious general methods infectious health facility tuberculous infection inadequate transmission specific risk transmission tuberculous infection rapid diagnostic therapy microbial contamination isolation infectious health facility tuberculous infection outbreaks risk transmission health settings guidelines risk settings
HIV,HIV3783,hiv transcriptase human immunodeficiency hiv transcriptase bi rg nanomolar hiv rt noncompetitive respect deoxyguanosine triphosphate bi rg specific hiv rt effect feline rt dna rg hiv vitro protein lack human lines human peripheral cytotoxicity rg human index
HIV,HIV3784,fastidious gram pathogen fever motile gram bacillus persistent human immunodeficiency infection marrow transplant septicemia immunocompetent illnesses antimicrobial therapy methods results primary cultures lysis white iridescent heterogeneous colonies subcultures yeast organisms safranin tests francisella reactivity vitro antimicrobial fatty rochalimaea quintana brucella pylori legionella membrane preparations patterns quintana dna ecorv restriction endonuclease quintana immunodiffusion convalescent identity pathogen slow growth antimicrobial possible lysis recovery unexplained fever
HIV,HIV3785,bacillary human immunodeficiency infection cystic spaces infections therapy steroids cutaneous bacillary angiomatosis infection human immunodeficiency hiv infection pseudoneoplastic vascular methods hiv cutaneous bacillary angiomatosis hiv infection tissues microscopy results hiv infection hiv infection myxoid granular purple warthin microscopy bacilli bacilli skin lesions cutaneous bacillary angiomatosis courses bacillary bacillary unusual infection cutaneous bacillary angiomatosis bacilli non hiv mechanisms
HIV,HIV3786,bacillary angiomatosis identification pathogens bacillary angiomatosis infectious visceral organs human immunodeficiency infection visualized lesions bacillus bacillus methods identify primers complementary rna gene bacillary angiomatosis dna organisms normal tissues parallel results bacillary angiomatosis unique gene fourth bacillary angiomatosis gene normal tissues sequences bacillary angiomatosis uncharacterized related rochalimaea quintana bacillary angiomatosis uncharacterized rickettsia related quintana method identification pathogen infectious diseases unknown
HIV,HIV3787,tyrosine protein mobilization hiv hiv gp protein integral membrane tyrosine protein plck normal receptor tyrosine phosphorylation tyrosine transduction engagement growth factor endogenous tyrosine receptor human immunodeficiency hiv gp protein specific types plck trigger report hiv gp human elicit plck dependent tyrosine phosphotyrosine
HIV,HIV3788,risk management hiv infection hiv infection terms risk managers health malpractice workmans bank commission accreditation health organizations conditions importance risk managers position components management select aidsline
HIV,HIV3789,crystallization fab human gp human immunodeficiency igg gp human immunodeficiency hiv intact fab intact tetragonal prisms conventional fab suitable belong group constants fab spacings
HIV,HIV3790,human immunodeficiency pancreatic rnase tyr sites human immunodeficiency hiv gag polyprotein precursors hiv maturation performic rnase rnase alkylation iodoacetate cleavage hiv single cys neutral carboxyamido methylcysteinyl times methyl substituent succinylation rnase second cleavage succinyl phe cleavage rnase hiv sites hydrolysis important
HIV,HIV3791,hiv human immunodeficiency random nonfederal general administrator thirds immunodeficiency formal human immunodeficiency contain pretest human immunodeficiency seropositive many providers test results records review tests transferring adoption
HIV,HIV3792,rna human immunodeficiency hiv retroviral rna ends dimer linkage structure hiv bona hiv rna mutants vitro report rna nucleocapsid nc protein mutagenesis rna nucleotides nucleotides hiv rna encapsidation element splice initiator aug gag little different cross hiv rna encapsidation element hiv rna dimer nucleocapsid protein murine ribonucleoprotein structure template rna protein human immunodeficiency hiv virions results nc protein rna dimer retroviral rna packaging element encapsidation sequences factor protein related
HIV,HIV3793,aids human impact implications year urgent need immune aids human aids paradigm hivaids principles diseases formal evaluations courses prejudices positive aids aids paradigm preclinical courses important educational aids time curricular
HIV,HIV3794,exotic mundane human immunodeficiency haiti hivaids haiti mystery striking haiti sub saharan occurrence aids haitians theories haitian aids haitians early pandemic exotic theories haitian united patterns many haitians aids risk hiv transfusion haitian patterns sub saharan africa aids patterns caribbean nations importance caribbean aidshiv political economy
HIV,HIV3795,seropositive human immunodeficiency infection human immunodeficiency serostatus crisis physicians hiv physicians emotional reactions issues methods
HIV,HIV3796,polyneuropathy human immunodeficiency seropositive immune electrophysiological polyneuropathy human immunodeficiency hiv infection ten immunodeficiency aids immune electrophysiological signs polyneuropathy sural peroneal sd sural potential aids less peroneal conduction velocity ms aids ms aids less findings hiv immune state polyneuropathy azidothymidine azt months group untreated effect sural conduction velocity vibratory
HIV,HIV3797,social support homophobia gay social support homophobia positive hiv gay mood state regressions avoidant proactive social support planful homophobia less avoidant less time proactive time avoidant less homophobia mood state total
HIV,HIV3798,isolation mycobacteria intestinal seropositive hiv seronegative kinshasa zaire preliminary results mycobacteria hiv enteritis africa mama yemo kinshasa zaire stool intestinal seropositive hiv seronegative mycobacterium infection bacilli fecal smears seropositive none hiv seronegative isolation hiv seropositive hiv seronegative vs mycobacterium avium intracellulare hiv seropositive hiv seronegative intestinal hiv seropositive persistent histological evidence mycobacterial infection mycobacteria hiv seropositive
HIV,HIV3799,opioid current quarters subjects needle subjects needle past someone needle level condom subjects condom regular subjects condom hiv risk needle current level heroin risky subjects risk risky importance transmission hiv risk
HIV,HIV3800,business health health limited primary health health health spread hiv health health problems drugs peripheral peripheral level infection hepatitis need hepatitis
HIV,HIV3801,potential versatile potential management critical infections human immunodeficiency viruses anemias likely induction dogs double presumptive key humans
HIV,HIV3802,immunodeficiency aids mother recent papers stress transfusion aids episodes hiv infection months hiv obvious important public health implications potential infected units transfusion hiv infection repercussions level term vigilance aids
HIV,HIV3803,aids condoms aids denial confusion risk group condoms future encounters conflict confusion aids attitudinal
HIV,HIV3804,institute party report infection party hiv hiv need hiv status voluntary diagnostic briefing
HIV,HIV3805,aids cognitive workshop neuropsychological hours hours early cognitive seropositive nimh workgroup principles speed visuoperception motor assesses wide psychological specific emphasis speed retrieval term tests tasks cognitive workgroup sensitivity recognizes possible neuropsychological tests cdc stage iii seropositive individuals trained neuropsychologists workgroup incorporate bank
HIV,HIV3806,hiv tutorial mental health professionals mental health training mental health professionals clients hiv tutorial innovative orientation group faculty day workshop participants experiences clients hivaids mental health system training programs schools public health health
HIV,HIV3807,microorganisms microflora throat urine skin surfaces face upper inguinal gluteal fold perirectal vaginal penis scrotal feet finger toenail streptococcal streptolysin dnase giemsa smears preparations yeast dermatophyte presence organisms psoriatic streptococcal viridans klebsiella pneumoniae escherichia enterobacter aerogenes agglomerans mirabilis diversus morganella morganii pseudomonas maltiphilia putida calbio aceticus luoffi flavobacterium cdc bacillus staphylococcus parapsilosis glabrata rhodotorula antistreptococal tests positive hiv
HIV,HIV3808,subjects infected hiv cts group societe transfusion sanguine hiv seroprevalence regular donors seropositive months due exclusion donors hbc residual risk transmit transfusion donations year significant ratio repartition hiv infected subjects heterosexual homosexuals homosexuals risk group
HIV,HIV3809,kings theory nursing psychotic client human immunodeficiency infection nursing theory framework psychotic client human immunodeficiency infection immunodeficiency general kings theory client plan successful nursing
HIV,HIV3810,human immunodeficiency infection homeless human immunodeficiency infection homeless little literature serious nineteen health types programs results little formal health status daily conflicts nonsystem gaps human immunodeficiency infection homeless inform future nursing
HIV,HIV3811,schizophrenia risk factor hiv mental risk group human immunodeficiency literature sexuality schizophrenia problems programs mental problematic programs
HIV,HIV3812,human immunodeficiency infection human immunodeficiency hiv infection nineteen immunodeficiency aids homosexual bisexual heterosexual countries infection range transfusion aids haemophiliac aids infections pneumocystis carinii aids time months
HIV,HIV3813,statistical issues aids infection human immunodeficiency subsequent onset aids many statistical issues problems statistical methods needs aids future identification key infectivity transmission
HIV,HIV3814,hiv infection prison homosexual ward jailed savoia usl turin condition hiv infection non imprisoned subjects assistential operative clinico psychological socio
HIV,HIV3815,hiv kampala hiv infection mission uganda hiv infection hiv infection overall aids unspecific positive malaria positive hiv
HIV,HIV3816,diseases leprosy search human immunodeficiency leprosy diseases std female eunuch chancroid ulcer gonococcal urethritis lymphogranuloma inguinale primary chancre std due treponema simplex histolytica hepatitis cytomegalovirus chlamydia trachomatis human immunodeficiency hiv sera sera normal hiv total normal sera leprosy sera hiv leprosy incidences std seropositivity simplex viruses types cytomegalovirus search serological promiscuity hiv risk
HIV,HIV3817,antifusion sera human immunodeficiency fusion important human immunodeficiency hiv infections antifusion serum fusion hiv fusion neutral red uptake occur presence serum dilutions antifusion neutral red uptake direct optimal ratio speed serum specimens free virions hiv immune human sera neutralization potential protective immune important investigation immunodeficiency vaccine investigation fusion level counts facilitates direct computer
HIV,HIV3818,potts urban populations literature queens spine status minority abusers positive human immunodeficiency homeless united endemic hiv positive tuberculin skin test results radiographic signs pulmonary anemic marrow positive bacilli significant radiographic findings index spine
HIV,HIV3819,liposomes human immunodeficiency infectivity fusion human immunodeficiency hiv lva infect hiv fuses liposomes cardiolipin dioleyloxy propyl trimethyl dioleoylphosphatidylcholine liposomes hiv liposomes gag medium dependent manner infection preincubation hiv microm subsequent presence hiv infectivity fold hiv liposomes inhibited infection dependent liposomes infectivity conditions results fusion hiv target
HIV,HIV3820,psychological formal psychotherapeutic intervention haemophilia positive hiv haemophiliac diabetic healthy scotland mild severe disorders diabetic healthy teacher report report presence emotional problems scores scores range results group haemophiliac diabetic healthy range parent teacher significant scores significant single diabetic haemophiliac scotland diabetic healthy identification hiv infection publicity aids infection
HIV,HIV3821,pneumocystis carinii invasive respiratory secretions hiv tachypnoea radiological evidence pneumonitis pneumocystis carinii hours secretions nasopharyngeal rapid invasive method investigation carinii
HIV,HIV3822,hiv infection risk nonhealth workers risk transmission hiv review reassurance workers management evidence exists spread hands touching evidence spread inanimate objects typewriters telephones water equipment bathing saunas swimming evidence airborne spread hiv potential risk transmission units office fear aids risk aids way potential educational
HIV,HIV3823,hiv infection risk health workers human immunodeficiency hiv infection health workers needlestick hiv needle needlestick hiv occupational hiv infection health workers unpreventable strict current infection technical risk
HIV,HIV3824,pneumocystis carinii pneumocystis carinii pcp pulmonary infection immunodeficiency aids pcp defects transplant immune virginia pcp pulmonary infections aids early non specific infiltrates definitive sputum bronchoscopic techniques iv pentamidine prophylaxis science carinii non hiv infections
HIV,HIV3825,gingivitis cancrum oris noma ibadan nigeria gingivitis ibadan university college dental year occurrence year range positive recent significant possible cancrum oris malnutrition infectious diseases infection immune risk good oral hygiene
HIV,HIV3826,human immunodeficiency hiv mycobacterium tb current spread human immunodeficiency hiv infection risk mycobacterium tb cdc rise dual tb hiv infection inner racial ethnic intradermal tuberculin hiv infected guidelines potential occupational health
HIV,HIV3827,hiv terminal contains unusual element induces short snrna unusual element synthesis short transcripts wide nuclear rna snrna rna iii promoter inducer short transcripts hiv ltr presence ist total different rna short position ist rna target tar tat trans relies ist rna targets trans full
HIV,HIV3828,necrosis hip man infection osteonecrotic necrosis hip cdc stage radiological radioisotope musculoskeletal hiv infection
HIV,HIV3829,diseases ambrose rape diseases vaginosis commonest neisseria trichomonas eleven genital warts trachomatis simplex infection serological evidence hepatitis infection human immunodeficiency infections smears intraepithelial neoplasia iii possible infection assailant review rape risk diseases
HIV,HIV3830,treponemal dna csf hiv infection pcr detect treponema dna csf syphilis csf positive serological tests syphilis treponemal dna positive csf syphilis dna positive csf hiv positive nervous system cns dna positive whereas none cns dna positive dna positive syphilis hiv positive cns treponemal dna csf pcr sensitivity syphilis treponemal
HIV,HIV3831,seroprevalence hiv infection south wales hiv seropositivity south wales regular std attenders seropositivity regular attenders partners intercourse episodes overall seropositivity clinics
HIV,HIV3832,types aids non lymphoma non lymphoma human immunodeficiency hiv aids condition poorer hiv st september proven malignant lymphoma burkitt lymphoma lymphoma immunoblastic due inadequate immunodeficiency weeks group immune weeks lymphoma prognostic infected guide prognostic
HIV,HIV3833,intracellular thiols nuclear factor kappa human immunodeficiency nuclear factor kappa nf kappa terminal human immunodeficiency hiv ltr intracellular thiol key process necrosis factor nf kappa intracellular thiols cysteine thiol thiol lack nf kappa hiv ltr findings genetic regulatory cytokine shifts intracellular thiol nf kappa spectrum cytokine
HIV,HIV3834,human immunodeficiency dimer homologous single dimer single dimer human immunodeficiency hiv gene escherichia coli dimer dimer dimer dimer stable hiv dimer dissociation hiv dimer dissociation dimer dimer mutants effect single glycine consistent constitute hiv
HIV,HIV3835,clock evolution neutral theory evolution speed nuclear eukaryotic organisms evolutionary substitutions retroviral oncogenes human immunodeficiency viruses hepatitis viruses influenza viruses results evolutionary process neutral theory evolution neutral theory synonymous substitutions nonsynonymous substitutions viruses evolutionary substitutions mutants viruses fits theory time clock evolution clock influenza viruses man
HIV,HIV3836,serum seropositive male homosexuals homosexual male subjects human immunodeficiency hiv infection immunodeficiency aids infections group iv iii iv iv rhinitis conjunctivitis hiv seroconversion twofold iv serum group hiv seropositive group seronegative homosexual male subjects iv positive panel hiv seropositive seronegative group typical infections laboratory manifestations diseases
HIV,HIV3837,hiv immune endomyocardial human immunodeficiency hiv positive aids risk multifocal interstitial infiltrates necrosis usual nk hiv positive non hiv less hla hla dr hiv identify specimens consistent injury myocytes positive non hiv group
HIV,HIV3838,current human immunodeficiency weight management infection healthy decreases increases infection cytokines human immunodeficiency hiv infection nutritional depletion immune aids weakness important quality mechanisms malabsorption hypermetabolism ie primary homeostatic excess cytokine uncertain mechanisms current options diseases possible alimentation megestrol therapies cytokine nutritional status mechanisms trials
HIV,HIV3839,megestrol cachexia human immunodeficiency infection cachexia human immunodeficiency hiv megestrol metastatic hiv positive treated oral megestrol times daily preillness weight kg range preliminary therapy weeks weight weight kg range weight day megestrol day day weight day megestrol time weight megestrol weeks kg normal megestrol zidovudine due weight initiation zidovudine megestrol vein peripheral impotence true effectiveness megestrol hiv cachexia quality double trial
HIV,HIV3840,term zidovudine therapy hiv sarcoma side ifn treating hiv aids drugs effect hiv ifn zidovudine hiv ks tolerance homosexual ks open trial iu second day zidovudine intolerance severe infections cachexia fifteen months months cytotoxicity remission partial remission stable overall positive extracutaneous remission helper therapy azt hiv sarcoma monotherapy ifn immune
HIV,HIV3841,context human immunodeficiency infection implications male depressive symptomatology hiv infection review university settings individuals positive hiv infection individuals risk review hiv infection depressive positive individuals decreases hiv group overall fluoxetine favorable side effect positive hiv hiv positive group aids
HIV,HIV3842,lateral obvious phenomenon manifestations undergone ct group lateral lesions intracranial recent group exclusion mild severe ratio frontal horn lateral manifestations group positive human immunodeficiency hiv status ischemic group independent less less group less lateral ct important
HIV,HIV3843,induction human immunodeficiency infection il multifunctional cytokine monocytes fibroblasts types viruses cytokines normal cultures human immunodeficiency hiv htlv iiiba significant bioactivity supernatants time evidence hiv normal cultures peripheral mononuclear infected individuals hiv cultures il serum bioactivity hiv seropositive individuals stage infection uml stage infection uml normals uml il different normal stage infection group seropositive individuals hiv cultures serum il level uml less hiv seropositive individuals monocytropic hiv uml serum il seropositive individuals serum igg less monocytes level il il seropositive individuals monocytotropic hiv serum igg il hiv
HIV,HIV3844,different effect benzylacyclouridine azidothymidine mice vitro azidothymidine cytotoxicity human immunodeficiency hiv daily oral doses bau azt plasma murine effect exogenous doses bau daily azt mice concomitant azt daily doses mgkg peripheral azt range doses doses bau related dependent manner daily doses bau doses rauscher murine leukemia rlv bau antiretroviral effect azt doses azt leukopenia findings significant immunodeficiency aids aids
HIV,HIV3845,benzylacyclouridine azidothymidine marrow human immunodeficiency azidothymidine azt human granulocyte immunodeficiency hiv bau effect vivo azt leukopenia inhibits vivo increases dependent manner related mice anemic azt water mgml azt daily bau mgkg azt leukopenia peripheral reticulocytes less marrow megaloblastosis azt bau marrow vitro bau hiv effect hiv cytopathic effect implications findings
HIV,HIV3846,monocytoid human immunodeficiency infection demonstration human immunodeficiency sequences lymph malignant lymphoma immunodeficiency aids presence monocytoid aids related lymphadenopathy monocytoid aids human immunodeficiency hiv positive hiv lymphadenopathy monocytoid lymphoma monocytoid lymph cdcd ratio moreover dna lymph monocytoid lymphoma hiv positive hiv paraffin lymph
HIV,HIV3847,severe important mycobacterium avium intracellulare immunodeficiency mycobacterium avium intracellulare mai immunodeficiency aids antimycobacterial therapy laboratory organisms aids mai serum positive helper infection mai infection related total hematocrit hematocrit total profound aids mai mai peripheral red nutritional hiv load general effect platelets mai aids mai index infection infections infection much shorter time mai
HIV,HIV3848,pylori infection immune human immunodeficiency hiv infection upper pylori pylori infection different pylori specimens immune aids aids infected pylori versus aidsarc aids related esophagogastroduodenal findings pylori versus endoscopic findings typical aids propria pylori gastritis aidsarc fifty gastritis pylori pylori infections gastritis aidsarc pylori infection gastritis referred upper endoscopic aids related findings immune risk infection pylori
HIV,HIV3849,nucleosides human immunodeficiency halo halo dideoxypurine ddps tested vitro infectivity cytopathic effect gag protein dna synthesis human immunodeficiency hiv vitro hiv halo ddps fluoro bromo iodo bromo iodo fluoro fluoro ddps hiv dideoxyinosine ddi dideoxyguanosine ddg infectivity hiv growth target lipophilicity iodo bromo ddg ddi halo ddps deaminase ada aminohydrolase ada dda bromo iodo ddg strategy purine nucleosides desirable lipophilicity
HIV,HIV3850,yeast tfiid general factor gene specific factor usf tata factor tfiid saccharomyces regulatory factor functions free system general initiation hela nucleosome system yeast tfiid purified prevent nucleosome repression enhancement promoter gene specific usf yeast tfiid usf system purified general conditions yeast tfiid usf sp human immunodeficiency promoter extent purified human tfiid implications findings respect structure yeast human tata possible specific tfiid
HIV,HIV3851,vital provisional lowest final wide discrepancy white infant state georgia countries lowest fertility mothers prenatal unchanged deaths excess deaths marriage unchanged whereas lowest level human immunodeficiency infection homicide pulmonary declines perinatal conditions increases half diseases related obstructive pulmonary respiratory group diseases
HIV,HIV3852,azido diphosphohexose metabolic azdu cs human immunodeficiency human peripheral mononuclear limited human marrow human pbmc azido monophosphate azdu mp predominant intracellular radioactivity pbmc times azdu diphosphate triphosphate intracellular azdu mp azdu triphosphate human exchange radioactivity anabolites resistant azdu mp pbmc double labeled retention time azdu liquid method nucleosides nucleotides specific method putative azdu peaks metabolites azido diphosphoglucose azido diphospho acetylglucosamine much azdu metabolites pbmc cultures intracellular diphosphohexose manner half gradual azdu mp azdu process short half terminal half diphosphohexoses deoxyuridine durd human pbmc hdurd durd manner metabolic azdu unique metabolic hiv human actionabstract
HIV,HIV3853,human factor hiv restriction hiv growth nih hiv murine leukemia dominant selectable hiv ltr clones murine hiv nuclear transport integration murine lines regulatory gene human induces cytoplasmic hiv mrnas hiv murine rex vector rex infected murine uninfected human hiv trans factor critical
HIV,HIV3854,hiv tat protein rich bulge stem tar rna structure hiv trans protein tat rna rich bulge tip stem rna stem structure trans tar tat purified protein one hiv tar rna dissociation nm wild tar introduction nearby stem structure tat mutations tip tar rna structure mutations stem crick tat direct correlation tat tar rna hiv ltrs tar sequences mutations transcripts tat tat vivo
HIV,HIV3855,risks human immunodeficiency infection nosocomial human immunodeficiency hiv infection exclusively transfusion products current hiv infection transfusion components probable hiv infection infection level aids ie window current risk hemophiliacs coagulation factor negligible risk hiv infection puncture hiv fluids episode seroconversions sharp objects hiv positive risk workers
HIV,HIV3856,identification igm normal aids sera implications igm normal sera subsets aids normal sera aids sera igm normal sera igm positive immune aids free months normal sera aids months normal sera sera resistance hiv
HIV,HIV3857,splenic rupture human immunodeficiency primary splenic lymphoma splenic rupture primary malignant lymphoma rare report occurrence man primary immunoblastic lymphoma positive serologic tests unusual malignant lymphoma
HIV,HIV3858,angiocentric immunoproliferative non lymphoma immune report review literature lesions lymphocytic vasculitis midline malignant lethal midline granuloma angiocentric lymphoma angiocentric immunoproliferative lesions recent clonal rearrangements receptor lesions spectrum post non lymphoma immune aids intermediate infected epstein ail granular lethal midline granuloma hiv aids review literature hiv etiology ailt hiv
HIV,HIV3859,independent infection human immunodeficiency human leukemia human immunodeficiency hiv immunodeficiency related disorders cofactors evidence human hiv hiv human leukemia htlv htlv progeny hiv nonsusceptible human mature epithelial infection independent hiv receptor ie okta infection gp envelope pretreatment stock htlv human serum hiv results htlv htlv hiv spectrum spread
HIV,HIV3860,human immunodeficiency gp envelope membrane fusion membrane human immunodeficiency gp envelope mutants glycoproteins wild envelope glycoproteins sequences proximal membrane gp important membrane fusion process
HIV,HIV3861,intracellular interaction human immunodeficiency envelope gp maturation plasma membrane envelope human immunodeficiency hiv receptor system interaction hiv envelope intracellular membrane traffic glyprotein gp endoplasmic reticulum minor gp gp gp gp medium hand gp specific intracellular gp gp specific gp endoplasmic reticulum endoglycosidase resistance specific intracellular interaction gp envelope hiv receptor
HIV,HIV3862,terminal circle junctions human immunodeficiency circle junctions unintegrated human immunodeficiency iiib colonies unique circle junction circle junctions inserts terminal
HIV,HIV3863,envelope gene human immunodeficiency human immunodeficiency hiv nervous system cns host different peripheral lymph cns hiv sfa primary lines viruses sfa peripheral hiv sf gene sequences homologous hypervariable regions viruses hiv sfa gene hiv sfa macrophages gp gp fusion
HIV,HIV3864,coordinate enhancement cytokine gene human immunodeficiency cytokine gene iiib human immunodeficiency hiv interferon interferon ifn ifn ifn il il il necrosis factor tnf iiib coinfection lipopolysaccharide hiv infection iiib level tnf il sendai il il tnf iiib rna iiib tnf ifn iiib cytokine gene hiv infection inducer cytokine gene iiib il ifn ifn transcripts lps results hiv infection subsequent coordinate enhancement cytokine gene
HIV,HIV3865,wild human immunodeficiency tat human immunodeficiency transactivator protein wheat free translation system exon tat resistant trypsin protein tat trypsin wild transactivation single substitutions transactivation mutants regions mutants wild structure identify wild protein
HIV,HIV3866,different sites tev rex element human immunodeficiency tev human immunodeficiency hiv rex protein human leukemia htlv element rre mutants rre nucleotides tev rex sequences structure rre specific rre deletions targets rex mutants rex vice versa tev types mutants relaxed rex rex targets rre trans dominant rre interaction rex rex rre deletions results presence sites rre interaction sites different mutations rre different sites
HIV,HIV3867,human immunodeficiency protein target element rna context rna structure human immunodeficiency protein mrnas interaction rna element rre functional rres vitro vivo context gag critical functional fold structure stem ends rre branched stem nucleotides rredde structure nonfunctional vivo functional rre excision stem vivo severe deletions nucleotides stem excision stem rre structure recognition many mutations primary structure critical rna mutations cacuauggg stem overall structure vitro vivo
HIV,HIV3868,hybrid recombination human immunodeficiency recombination homologous sequences chimeric regions yield single portions regions spectrum hybrid sequences recombination hybrid human immunodeficiency vaccinia viruses maintain recombination homologous regions wide range progeny hybrid gene recombination specific pharmaceuticals hybrid interferons receptor diversity pathogens
HIV,HIV3869,diversity hypervariable regions human immunodeficiency sequences hypervariable regions human immunodeficiency hiv gene peripheral mononuclear infected individuals single target sequences nested primers process sequences sequences different individuals interpatient individuals infected substitutions hypervariable regions potential glycosylation sites sequences hypervariable regions short duplications deletions peripheral mononuclear dna resolution total sequences many individuals substitutions key cytotoxic recognition immunodominant synonymous nonsynonymous regions positive selection diversity
HIV,HIV3870,identification human immunodeficiency gp important receptor receptor human immunodeficiency gp envelope important entry cytopathic effect gp gp cysteines immunodeficiency viruses receptor hydrophobic regions trp hydrophilic regions glu significant reductions mutations conformational disruption gp recognition hydrophilic regions epitopes hypervariable regions gp important attractive targets intervention
HIV,HIV3871,diseases rectum anus growth types diseases homosexual anorectal gonorrhea syphilis homosexuals homosexual homosexuals anorectal simplex host protozoan rampant homosexual aids plethora colorectal manifestations cytomegalovirus ileocolitis emergency homosexual aids cryptosporidia isospora colorectal bloody weight human immunodeficiency hiv colorectal sarcoma anorectal lymphoma seropositivity hiv manifestations aids colorectal condylomata anorectal sepsis proctitis hiv anorectal results hiv positive aids hiv positive disastrous results incumbent recognize manifestations conditions
HIV,HIV3872,effect human immunodeficiency hiv infection syphilis evidence concurrent infection human immunodeficiency hiv syphilis neurosyphilis penicillin identification review works english files systematic search index extraction works early neurosyphilis relevant hiv infection results nervous system early syphilis standard doses penicillin cure relies host immune early neurosyphilis infection treponema uncommon inadequate therapy rare hiv infection neurosyphilis cranial cranial infection immunodeficiency aids aids hiv syphilis benzathine penicillin previous months preliminary skin lesions venereal laboratory hiv syphilis conventional penicillin therapy therapy early syphilis hiv infected subjects systematic
HIV,HIV3873,aids related experiences primary physicians angeles telephone angeles primary physicians aids related experiences mid aids hiv infection months aids aids questions year
HIV,HIV3874,hiv seroconversion homosexual oral intercourse ejaculation implications safe seroconversion hiv homosexual intercourse equal oral intercourse ejaculation man products oral intercourse ejaculation potential risk hiv transmission
HIV,HIV3875,hepatitis manifestations human immunodeficiency hiv infection seropositivity hepatitis presence human immunodeficiency hiv hiv helper immunodeficiency aids serologic hiv hepatitis homosexual participants aids previous infection incident infection hiv seropositivity infection hiv infection enrollment hbc seropositivity subsequent seroconversion hiv odds seroconversion diseases hiv infection seropositivity infection entry rapid subsequent helper counts aids hiv infection subsequent immunodeficiency infection hiv infection rapid hiv immunodeficiency
HIV,HIV3876,hiv dna integrative recombination integration integration specific dna subsequent recombination host sequences integration results intact dna terminal ltr circle junction end ligation junction nucleotides gtac ends hiv gt dinucleotide right hand dna dinucleotide left hand size ltr structure dna infected hiv dna ends extent consistent protein dna structure hiv
HIV,HIV3877,gag protein gag baculovirus insect baculovirus gag gene sequences human immunodeficiency hiv baculovirus infect insect level gag protein microscopy gag plasma membrane medium spherical nm metabolic demonstrates gag results hiv gag rabbits purified gag western gag sera gag hiv results gag gag hiv epitopes
HIV,HIV3878,human immunodeficiency envelope intermolecular disulfide normal proteolytic processing envelope human immunodeficiency gp gp cleavage gp vaccinia velocity sedimentation significant gp oligomers intermolecular disulfide gp oligomers oligomers unlinked envelope protein time results populations precursors gp gp intermolecularly disulfide uncleaved propose intermolecular disulfide intermediate maturation gp
HIV,HIV3879,human induces maturation signals eosinophils immunotherapy il il lak immunodeficiency aids man feline leukemia infection human immunodeficiency hiv infection man hematological il daily injections ukg human il cbc red rbc neutrophil day group day weeks day day day day normal values day magnitude day marrow hyperplasia eosinophil precursors day group maturation early normal whereas stage maturation precursors pretreatment weeks hyperplasia maturation eosinophil precursors contributor maturation induces eosinophils significance eosinophil
HIV,HIV3880,western tests healthy risk human immunodeficiency infection niaid aids vaccine trails trial aids vaccine specimens healthy risk human immunodeficiency hiv specimens evidence hiv infection biotechdu pont western none subjects positive test western tests single envelope unusual gp gp serum months individuals western results positive eia western test results second serum western different lots pont western test results hiv infection subject
HIV,HIV3881,confocal human immunodeficiency rna aids infected peripheral dramatic depletion human immunodeficiency hiv rna method confocal laser microscopy hiv individuals different hiv individuals aids aids mononuclear hiv rna group individuals mononuclear hiv rna method hiv rna infected individuals condition karnofsky viremia infection
HIV,HIV3882,seroprevalence human leukemia viruses populations homosexual seroprevalence human leukemia htlv types populations homosexual specimens human immunodeficiency hiv specimens positive results western radioimmunoprecipitation ripa pcr peripheral mononuclear specimens ripa pcr dna pbmc subjects htlv htlv results seroprevalence previous specific tests
HIV,HIV3883,human immunodeficiency individuals magnetic resonance individuals human immunodeficiency hiv hiv seronegative homosexual heterosexual magnetic resonance white matter aids related aids hiv seropositive seronegative homosexual hiv dna group aids lesions presence hiv neopterin aids dementia findings early infection extent hiv seronegative homosexual lesions presence immunodeficiency
HIV,HIV3884,azt hiv lines implications immunotherapy immunoassay different human immunodeficiency hiv drugs lines azidothymidine azt interferon ifn hiv envelope ricin azt effect early infection lines effect removal ifn infected infection persistent hiv infection azt ifn doses azt protocols
HIV,HIV3885,astrocyte medium promonocyte human human immunodeficiency hiv presence primary transcriptase lipopolysaccharide lps hiv fold uninfected lines effect magnitude induction time dependent necrosis factor tnf astrocyte medium hiv medium murine tnf results hiv hiv infection
HIV,HIV3886,pregnancy human immunodeficiency months laboratory parameters female human immunodeficiency hiv stage iii cdc viable infant weeks group second trimester group female group time significant laboratory parameters group time leucocyte less less sedimentation related pregnancy hiv laboratory parameters significant pregnancy term evolution hiv infection stage iii
HIV,HIV3887,anonymous seroprevalence hiv infection territory anonymous seroprevalence human immunodeficiency hiv infection hiv prenatal yukon territory mar hiv positive yielded crude overall seroprevalence confidence positive vancouver seroprevalence group positive seroprevalence total female yukon territory many infection likely minimum likely lowest risk hiv infection true hiv infection times trends hiv seroprevalence territory
HIV,HIV3888,zidovudine retrovir update zidovudine azt antiretroviral human immunodeficiency hiv infection trial immunodeficiency aids hiv infection aids zidovudine infection review physicians hiv infection current infection zidovudines medline articles term zidovudine therapy zidovudine therapy hiv related conditions management reactions international meetings significant zidovudine therapy fewer group hiv infection less reactions early stage infection demonstration zidovudine resistant months therapy deterioration zidovudine therapy less unclear zidovudine aids hiv infection severe infection start therapy preferred therapy prevent resistance zidovudine prophylaxis hiv results infection immediate prophylaxis investigation
HIV,HIV3889,human promoter jcv hiv tat protein hiv tat protein jcv jcv promoter jcvl jcvl promoter chloramphenicol plasmid pjcl human glial tat protein jcv hiv tat jcv gene level induction tat jcv tat jcvl promoter narrow range ptat expressor plasmid tat optimal jcvl promoter mechanisms exert mutations jcvl promoter different regions jcv important tat induction targets jcvl promoter
HIV,HIV3890,epstein infection hairy leukoplakia nucleic noninvasive techniques presence dna epithelial oral hairy leukoplakia lesion human immunodeficiency hairy leukoplakia immune important lesions dna noninvasive techniques epithelial surfaces lesions sensitivity dna filter techniques noninvasive techniques human immunodeficiency lesion
HIV,HIV3891,oral hairy leukoplakia oral hairy leukoplakia infected human immunodeficiency hiv parakeratosis thickness acanthosis little inflammatory herpetic keratinocytes glass top stratum spinosum parakeratotic possible human herpesvirus group hpv papillomavirus nuclear positivity contradictory results cross hpv epstein
HIV,HIV3892,immune cytomegalovirus cmv hiv infection humoral reactivity hiv cmv individuals delineate cmv hiv infection patterns hiv infected individuals cmv page lymphoproliferative healthy hiv cmv individuals cmv whole cmv cmv weight contain hiv cmv individuals significant whole cmv hiv individuals healthy proliferative uptake equal whole cmv less half hiv subjects sera subject aids reactivity hiv subjects whereas hiv cmv serum igg igm values hiv individuals findings specific lesions immune cmv occur hiv individuals
HIV,HIV3893,oral melanotic infected human immunodeficiency group seropositive human immunodeficiency hiv time lesions oral mucosa lesions excision zidovudine laboratory evidence melanotic melanocytes epstein normal oral mucosa epithelial group health workers risk abusers seronegative hiv oral melanotic significant oral infected lesions different hiv infection hiv zidovudine drugs unknown due
HIV,HIV3894,due parvovirus infection man infection infection parvovirus persistent erythroid hypoplasia parvovirus list pathogens hiv infection severe red
HIV,HIV3895,removal human viruses insoluble pyridinium cross polyn benzyl vinylpyridinium bvp human viruses removal gl bvp degrees level infectivity simplex poliovirus human immunodeficiency fold coxsackievirus echovirus fold haemagglutination titres human rotavirus influenza human japanese encephalitis fold removal flow column method poliovirus coxsackievirus ml infectivity viruses poliovirus coxsackievirus input viruses infectivity
HIV,HIV3896,topoisomerase human immunodeficiency hiv infectious topoisomerase topo human immunodeficiency hiv infectious eiav eiav cores topo ionic requirements topo cores topo protein protein hiv lysate eiav lysate protein topo eiav nucleocapsid protein topo protein protein vice versa protein topo results eiav nucleocapsid protein topo share epitopes
HIV,HIV3897,primary lymphoma nervous system immune nervous system non hodgkins immune aids months signs gene latter presence single episomal infection possible early lymphomagenesis
HIV,HIV3898,lymphoproliferation marrow lymphoproliferative syndromes disorders epstein infection different lymphoproliferative leukemia calla positive leukemia myelogenous leukemia marrow hla hla parent severe versus host malignant lymphoproliferation months malignant host evidence human lymphotropic human immunodeficiency human herpesvirus
HIV,HIV3899,bzlf gene human immunodeficiency terminal epstein early gene bzlf human immunodeficiency hiv terminal ltr bzlf gene fold galactosidase hiv ltr lacz vector hiv transactivator tat fold galactosidase bzlf pebv tat ptat vectors ltr lacz plasmid plron fold galactosidase synergistic effect bzlf tat hiv ltr lacz gene bzlf tat requirements maximal hiv ltr tat maximal ltr synergistic effect due tat gene coordinate tat hiv ltr synergistic hiv ltr
HIV,HIV3900,human immunodeficiency implications human immunodeficiency strands polypurine tract vitro integration human immunodeficiency pairs tract terminal end
HIV,HIV3901,due cytomegalovirus aids report lesions due cytomegalovirus cmv aids rectum regions due cmv aids lesions specific resistance current report lesions infected subjects
HIV,HIV3902,aids lesions aids evidence intracerebral lesions toxoplasmosis fourth chagas encephalitis complications safe aids intracerebral lesions
HIV,HIV3903,determinants hiv infection addicts determinants human immunodeficiency hiv infection heterosexual public overall seroprevalence hiv confidence hiv hiv infection risk whereas risk infection ratio seropositivity geographical western risk infection equipment important risk factor share equipment risk hiv infection addiction odds heroin ratio cocaine heroin odds prostitution odds ratio important determinants hiv infection heroin prostitution
HIV,HIV3904,aids pedodontics risk daily latest estimate utmost risk contagion extent pedodontist situations contagion social position guide pedodontists
HIV,HIV3905,nk infection depletion cdcdcd nk human immunodeficiency hiv infection infected stage stage iii stage iv healthy individuals flow cytometry group significant less cdcd significant stage cdc infection nk subsets cdcd subdivision shows depletion cdcd cdcd depletion cdcd cdc stage cdc iv cdcd complementary depletion cdcd depletion total significant hiv infection nk due depletion cdcdcd severe depletion early infection
HIV,HIV3906,identification gene human immunodeficiency vpr gene human immunodeficiency hiv eucaryotic vectors protein gene western pig terminal oligopeptide vpr protein specific protein preimmune sera oligopeptide size human lines hiv western subcellular wildtype vpr protein protein membrane vpr stable vpr
HIV,HIV3907,hiv tat due stabilization elongation tat general trans esters human immunodeficiency hiv gene interaction types trans quiesence gene productive infection tat fourfold full cytoplasmic hiv rna rna pma tat hiv rna hiv tat promoter proximal tat gene findings tat general due elongation furthermore promoter proximal presence effect tat initiation level findings importance tat elongation initiation hiv
HIV,HIV3908,aids perspective oncologist mid hiv infections year recent aids hope trial nci azidothymidine evidence therapy increases weight reductions hepatosplenomegaly increases preliminary results trials dideoxyinosine
HIV,HIV3909,dermatitis hiv infection qualitative skin lipids seronegative hiv skin lipids free fatty triglycerides esters squalene seropositive human immunodeficiency hiv seronegative hiv dermatitis triglycerides free fatty hiv positive presence dermatitis correlation free fatty lipids dermatitis hiv positive hiv infection
HIV,HIV3910,multiforme human immunodeficiency hiv infection severe erythema multiforme zimbabwe phenobarbitone immunodeficiency serological tests congenital hiv infection
HIV,HIV3911,serum thyroxine globulin cortisol globulin globulin human immunodeficiency infection tests human immunodeficiency hiv infection hormones thyroxine globulin tbg cortisol globulin globulin shbg serum necrosis factor tnf hiv seropositive subjects different methods thirty hiv seropositive stage stage iii stage iv results stage stage iii stage iv tbg total thyroxine tt values normal total triiodothyronine tt triiodothyronine rt iv tt values iv tbg shbg normal limits whole hiv significant correlation tbg less shbg values pgml stage iv stage iii tnf less serum tbg hiv infection serum tnf tbg shbg hiv normal tt rt state
HIV,HIV3912,human immunodeficiency viruses specific regulatory element hiv receptor human immunodeficiency viruses types genetic nucleic infection immunodeficiency recent potential time induction report receptor hiv hiv gene receptor hiv regulatory element cdr specific dna protein nf cdr jurkat leukemia lines hiv receptor hiv findings induction hiv hiv different cofactors hiv hiv aids
HIV,HIV3913,hiv seroprevalence male houston hiv seroprevalence heterosexual male time injected drugs daily syphilis odds positive participants
HIV,HIV3914,immunodeficiency many odontology positive serious manifestations immuno aids different diseases hematological results presence subjects hemophilia
HIV,HIV3915,hiv infectivity lactoperoxidase hiv arv equal glucose glucose oxidase thiocyanate pre degrees mixtures cultures growth elisa specific protein intra extra hiv system sec little protein pre
HIV,HIV3916,digestive tract fungal infections important morbidity severe hematological digestive mucosa venousperitoneal endogenous esophageal serious individuals infection overt aids seropositive review tract marrow dialysis hiv
HIV,HIV3917,iii trichosanthin hiv protein macrophages hiv escalation injections day range microgramskg microgramskg reversible severe fatigue side mild leucocytosis transaminases reversible non reversible mental status dementia coma serum values end months cellsl significant sedimentation increases infusions
HIV,HIV3918,hiv diagnostics hiv infection mothers diagnostic methods courses laboratory results obvious hiv infection status monitor hiv longitudinal exclude hiv infection
HIV,HIV3919,immune hiv infection neopterin interferon gamma ifn gamma csf human immunodeficiency hiv infection csf serum neopterin serum serum ifn gamma healthy hiv seronegatives neopterin neopterin ifn gamma immune hiv infection induction indoleamine ifn gamma
HIV,HIV3920,identification regions sera results electrophoretic peptides sera hiv igg reactivity hiv hiv host electrophoretic sera hiv eib hiv positive sera sera none shorter peptides compatible conformational discontinuous many positive hiv reactions sera terminal terminal sera peptides peptides hiv sera reactivity peptides terminal reactivity true hiv positive sera different sera explanations functional selection immunization noninfectious infection non hiv endogenous exogenous retroviral gains reactions viruses sarcoma ssav pfizer sera
HIV,HIV3921,hiv voluntary voluntary presence human immunodeficiency hiv optimal settings hiv disadvantages hiv serum seroprevalence different hiv ten risk group time hiv evidence infection policy nosocomial hiv transmission hiv favorable detect unknown hiv positive hiv cost optimal different populations
HIV,HIV3922,tar independent human immunodeficiency regulatory human immunodeficiency terminal hiv ltr hiv gene previous ltr constructs chloramphenicol gene regulatory regions enhancer sp tata tar regions important hiv gene regulatory mutations regions hiv infectious constructs constructs hela jurkat presence esters hiv gene gene level gag protein cultures constructs results lines mutations tata tar stem structure decreases gene mutations motif tar primary slight decreases viruses mutations tar sequences structure gene jurkat wild gene jurkat hela level gene tar constructs jurkat second mutations disruption tat geneabstract
HIV,HIV3923,mutations htlv envelope gene non functional protein envelope envelope protein human leukemia htlv observed human immunodeficiency hiv envelope linker insertion random mutations htlv envelope gene eukaryotic vector envelope products immunoprecipitation cos mutations non functional envelope lack mutants envelope gp mature gp gp propose conformational fusion htlv mutants observed mutations regions important htlv functions
HIV,HIV3924,hla infected individuals interferon gamma hla monocytes infected individuals hla dr hla hla dp monocytes aids hiv aids uninfected individuals hiv infected individuals aids human interferon gamma ifn gamma aids uninfected individuals ifn gamma aids different largest increases hla dr smallest monocytes populations
HIV,HIV3925,crystallization human immunodeficiency fab human immunodeficiency capsid protein escherichia coli mab terminal papain fab fab fab different fab vapor diffusion method peg parameters gamma degrees degrees group resolution
HIV,HIV3926,galactosidase human immunodeficiency cleavage human immunodeficiency cleavage cassette human immunodeficiency hiv cleavage different galactosidase galactoside galactohydrolase coli constructs galactosidase insertion cleavage cassette hiv galactosidase vitro cleavage hiv galactosidase hiv galactosidase polio cleavage polio system cleavage proteases
HIV,HIV3927,transfusion human immunodeficiency tests coagulation disorders haemophilia clinics baragwanath human immunodeficiency hiv south products donors pool viii haemophilia imported factor viii seropositive pool products seropositive factor viii pool products introduction donations strict exclusion donors products factor ix donors hiv products south africa
HIV,HIV3928,dependent human immunodeficiency gp drosophila melanogaster human immunodeficiency hiv protein trans nuclear gag regions hiv gene melanogaster synthesis gp envelope protein dependent gp total rna overall rna gp whereas results independent gp protein system gp critical nuclear retention gp transcripts results insect system machinery
HIV,HIV3929,concurrent evolution human immunodeficiency mutations direct segments gene human immunodeficiency peripheral mononuclear hemophiliacs single factor viii share related sequences hypervariable regions intrapatient distance sequences sequences edinburgh related united distance distance sequences group year year twofold range substitutions total kb gag
HIV,HIV3930,hepatitis liver serological work specific hbc modified hepatopathies avidin biotin peroxidase immunostaining cytoplasmic hbc antihbc cytoplasmic nuclear hbcag presence serum index infection antihb injury
HIV,HIV3931,synthesis hiv anhydrides acylamino carbylamino deoxythymidine hiv
HIV,HIV3932,synthesis nitroimidazol yl dideoxynucleosides hiv dideoxy phthalimido erythro fur pyrimidinediones lewis triflate catalyst nucleosides methylamineethanol aminonucleosides imidazolyldideoxynucleosides sub ineffective hiv
HIV,HIV3933,needle aids transmission needles transmission hiv general liberal laws needles easy needle significant results clients needle addicts needles hiv infection seattles immediate intervention efforts public health rapid infection
HIV,HIV3934,idiopathic thrombocytopenic purpura hiv infection idiopathic thrombocytopenic purpura hiv infections stage severe risks possible doses positive severe therapy different results significant disorders
HIV,HIV3935,milk banks human immunodeficiency hiv limited transmission transfusion hiv infections date zimbabwe world united screen transfusion products hiv transmission milk countries milk unhygienic feeding seropositive mothers
HIV,HIV3936,diseases diseases many infections important primary methods abstinence selection partners vaginal hepatitis condoms vaginal risk health providers methods risk
HIV,HIV3937,search isolation regions protein search extent modeling techniques cast color electrostatic steric ligand
HIV,HIV3938,hiv serology male military recruits discharge hiv screenings military recruits none former latter seropositive elisa western report results hiv diagnostic laboratory seropositive subjects haemophiliac partners seropositive subjects prisoners homosexual health prison guards hiv infection risk military periodic evolution hiv
HIV,HIV3939,aids related serological infectious diseases university immune aids aids diseases results manifestations presence concomitant parasitic infections february antimycotic yeast oral mycosis esophageal cryptococcosis meningeal less biotyping september february system
HIV,HIV3940,receptor entry viruses hiv perspective researches diseases aids receptor process many intracellularly process important viruses hypothesis receptor entry viruses hiv current receptor different viruses list internalization release protein intraendosomal values diseases aids
HIV,HIV3941,fluorometric hiv fluorogenic human immunodeficiency energy pp cleavage thr nle nle gln incorporation aminobenzoic group phe position fluorogenic cleavage hiv terminal tripeptide close group fluorometric throughput hiv
HIV,HIV3942,human immunodeficiency risk transmission dental health workers potential risk transmission hiv human immunodeficiency dental health workers hypothetical risk world infection eg africa potential cumulative term hiv transmission dental workers risk homosexuals infection dental united workers potential risk educational efforts dhcw united educational efforts world efforts public health dhcws potential hiv transmission
HIV,HIV3943,hiv infections infected hiv different transmission transmission therapy hiv
HIV,HIV3944,hiv igg elisas hiv peptides serum csf igg hiv hiv peptides igg neurological csf reactivity serum reactivity hiv peptides gp cns igg gag intrathecal igg synthesis gp igg intrathecal igg synthesis igg synthesis elisas igg hiv peptides intrathecal igg igg cns components immune
HIV,HIV3945,intrathecal synthesis shla hiv infection tuberculous shla early shla index ih csf shlacsf albuminserum intrathecal synthesis abusers nervous system cns hiv infection ih igg hiv total group tuberculous ih index tuberculous infection ih index cns hiv infection presence meningeal infection due mycobacterium
HIV,HIV3946,trans dominant protein human immunodeficiency element fate protein human immunodeficiency hiv element rre trans dominant inhibits vitro rre rre mutants target rre steady state protein rex protein human leukemia htlv rex element terminal htlv hybrid rre rex rre rre positive utilized presence functional rex interaction results vivo vitro inhibits
HIV,HIV3947,infection hiv hiv serious infections salmonellae report aids aids infection hiv non aids parameters consistent gram therapy neurological deterioration related
HIV,HIV3948,seroprevalence manifestations infection kananga zaire seroprevalence manifestations infection kananga zaire kananga prenatal seropositive donors seropositive seropositive ill fever group male female ratio seropositive petty traders wholesale brokers prostitutes seropositive less
HIV,HIV3949,edinburgh positive potentials progressive slowing stage iv potential aep hiv positive individuals infection aep components past current electrophysiological positive normal group group seronegative stage iv year significant iv stage stage iii results hiv infection stage iv
HIV,HIV3950,aids hiv infection uganda countries saharan africa hiv hiv infection aids health maternal infection hiv infection maternal health uganda review aids equal hiv serosurveys infection aids seroprevalence infection hiv infection hiv infected heterosexual hiv transmission africa findings infection important implications health uganda transmission group
HIV,HIV3951,trends risk seropositivity zaire recent trends hiv infection early impact kinshasa zaire emergency ward citys largest hiv seroprevalence seropositivity months months less seropositive equal year seronegative anemic signs previous transfusion hiv seropositivity equal year less seropositive equal year transfusion etiological seropositivity transfusion transfusion findings stable hiv seroprevalence kinshasa risk transfusions expansion transfusion programs transfusions severe
HIV,HIV3952,diminution individuals aids disorders lak peripheral hiv seropositive aids subjects healthy panel nk nk resistant infected targets lak seropositive populations significant raji target lines healthy reductions hiv seropositive aids populations significant cytotoxic potential lak maximal lak cytotoxic potentials seropositive aids populations lak seropositive populations hiv targets uninfected counterparts versus maximal cytolytic plateau depletion peripheral subsequent specific total lak peripheral depletion results lak cytolytic whereas depletion lak
HIV,HIV3953,safety pharmacokinetics subjects aids aids escalation safety pharmacokinetics single subjects aids aids ingredient trichosanthin programs hiv infection subjects aids subjects tolerance virological parameters subject severe neurological consistent populations serum vitro exert antiretroviral optimal hiv infection
HIV,HIV3954,azido dideoxythymidine synthesis structure dideoxynucleoside azido dideoxy pentofuranosylthymine anhydro different prepared oxirane lietbh mesylation introduction azido substituent method deoxy butyldimethylsilyl anhydrouridine sodium hexamethylphosphoramide presence benzoic single crystallographic state opposite azt fluoro dideoxy erythropentofuranosylthymine fddthd azido dideoxy diaminopurine whereas latter significant human immunodeficiency hiv fddthd
HIV,HIV3955,synthesis hiv phosphoramidate azt effect elongation hiv azt membrane pro drugs vitro hiv terminal hiv effect effect methylene results consistent intracellular cleavage phosphoramidate bond release thereof full spectroscopic products phosphorochloridate precursors
HIV,HIV3956,human immunodeficiency pharmacokinetics acyclouridine acyclouridine phenylthiothymine hept hydroxyethoxymethyl methylphenylthiothymine hept cyclohexylthio hydroxyethoxy methylthymine hept hydroxyethoxymethyl phenylthio thiothymine hept human immunodeficiency hiv peripheral hiv congener microm hiv human lymphotropic iiib pharmacokinetics oral plasma microm hept oral mgkg promising hiv infections
HIV,HIV3957,potential potential growth human immunodeficiency hiv recognition resistance protein plasmid escherichia coli hiv protein growth presence hiv resistance potential hiv resistance rapid inexpensive search proteases
HIV,HIV3958,prenatal postnatal morbidity positive mothers maternal hiv infection fetal neonatal morbidity maternal positive healthy newborns pregnancy fetal growth neonatal morbidity hiv infection mother parameters hiv
HIV,HIV3959,psychosocial problems infected psychosocial problems hiv infected hemophiliacs immuno university addiction housing problems important group hemophiliacs stable conditions home visits legal support furthermore regular meetings short time term addiction hemophilic problems sexuality training
HIV,HIV3960,due method hiv infection back hiv infection incorporate due effect zidovudine azt way apply method
HIV,HIV3961,statistical aids health statistical methods current future individuals different human immunodeficiency aids infection impact method multistage hazard functions stage depend time key health needs squares parametric infection independent human immunodeficiency hiv methods aids united short term projections aids infected aids free individuals depletion impact hazard important interpreting results hazard functions parametric infection aids infected individuals
HIV,HIV3962,statistical hiv infectivity infection status partners individuals infected human immunodeficiency hiv contacts previous transmission infectivity infectivity parametric nonparametric risk infection contacts graphical methods techniques infectivity impact infectivity contacts methods software fit concepts techniques related ideas discrete heterosexual transmission methods
HIV,HIV3963,primary nervous system lymphomas primary nervous system lymphomas cnsl uncommon primary congenital aids transplant risk cnsl occurrence important literature cnsl virtue aids spread unclear normal myc oncogene infection cnsl tendency lymphomas cns putative cns neurological disorders radiological hyperdense deposits white matter enhancement multicentric types types non lymphoma formalin paraffin conjunction stereotactic needle cnsl cnsl time radiotherapy cns shortest aids
HIV,HIV3964,glycosylation sites human immunodeficiency gp infectivity infection human immunodeficiency hiv interaction envelope gp receptor target possible glycosylation hiv gp different glycosylation putative single mutations gp baculovirus system hiv serum furthermore glycosylation mutants full triple different gp infectious dna hiv maximal triple glycosylation hiv typical giant results gp protein receptor interaction
HIV,HIV3965,myopathy human immunodeficiency infection year homosexual man progressive muscular weakness proximal myopathic serum cpk csf damage open quadriceps myopathic inflammatory fiber size necrotic fiber myosin myopathic types microscopy patterns myofibrillar degeneration morphological results hiv positive specific myopathy aids
HIV,HIV3966,cryptococcal hiv individuals cryptococcal hiv infection index ink csf cryptococcus hiv seropositive csf white
HIV,HIV3967,aidshiv infection staff employee hiv infection hiv position suspected hiv occupational health management health promotion important non occurs
HIV,HIV3968,narcotic addiction expectant mother retrospective records narcotic mothers mothers record natal mothers past hepatitis positive gestational group twins hiv recent positive results mothers infant immune
HIV,HIV3969,hiv periodontal lesions literature unusual periodontal conventional hiv infection hiv gingivitis hiv periodontitis prompt management
HIV,HIV3970,paranasal lymphoma human immunodeficiency hiv positive male infected hiv malignant sarcoma non hodgkins hiv seropositive lymphoma report hiv seropositive man paranasal lymphoma maxillary sinusitis successful remission
HIV,HIV3971,throat sore throats due infections many specific signs influenza croup occurrence conjunctivitis adenoviral infections lymphadenopathy splenomegaly glandular fever presence simplex infection need therapy conditions typical membrane rash infection due streptococcus pyogenes haemolyticum cherry red epiglottis infection mycoplasma pneumoniae chlamydia pneumoniae pharyngitis due neisseria infection sites diseases candidal infection circumstance hiv infection drainage peritonsillar noninfectious throat eg thyroiditis uncommon pharyngitis recognise streptococcal pharyngitis risk fever
HIV,HIV3972,human immunodeficiency hiv infection human immunodeficiency hiv seropositive individuals immune thrombocytopenic purpura work sera hiv seropositive individuals thrombocytopenic presence western results nonthrombocytopenic thrombocytopenic less less reactivity positive sera determinants membrane glycoproteins vero results underscore mechanisms hiv infection
HIV,HIV3973,sensitivity free hiv implications free human immunodeficiency hiv vitro hours cem ss cytopathology transcriptase infectivity free subsequent neutral infect neutral infectivity values entry human hiv
HIV,HIV3974,vitro hiv infectivity human salivas human immunodeficiency hiv infrequent isolation salivary oral transmission hiv hiv human partial vitro whole specific glandular salivas hiv infectivity cytopathic whole hiv htlv iiib quantity parotid hiv whole contain filterable components growth micron pore size filter whole salivas parotid hiv filtration weight
HIV,HIV3975,oxophenarsine antisyphilis inhibits specific protein synthesis drugs persistent human immunodeficiency hiv infection immunodeficiency aids hiv drugs azidothymidine azt hiv infection effect persistent infection report oxophenarsine hydroxyphenylarsineoxide hydrochloride antisyphilus inhibits infected peripheral pbl significant cytotoxicity hiv transcriptase effect hiv specific dna rna synthesis hiv protein synthesis
HIV,HIV3976,infection human gastrointestinal hiv human immunodeficiency hiv primary cultures normal human ileal epithelial replicate gastrointestinal hiv htlv iiib cultures months intestinal epithelium target reservoir hiv vector dissemination transmission
HIV,HIV3977,hiv coli protein human immunodeficiency hiv gene escherichia coli protein cii fusion protein terminal transcriptase insoluble partial reactivity positive sera western immunosorbent elisa antigenicity protein elisa protein infected hiv different aids hiv positive human sera protein react elisa western homologous protein hiv transcriptase western hiv protein human hiv hiv hiv hiv specific hiv hiv western
HIV,HIV3978,human immunodeficiency oxidative stress important infection human immunodeficiency hiv latent time primary infection heterologous reactivate latent denominator stress oxidative stress hydrogen peroxide ho hiv ho recovery post stress express transcriptase supernatants hiv ho hiv gene release hela chloramphenicol transferase gene terminal ltr oxidative stress ho transactivation ltr intracellular factor hoabstract
HIV,HIV3979,extraction yield protocols human immunodeficiency hiv recovery gp consistent method gp extraction water enrich hiv htlv iiib medium polyethylene glycol system gp gag protein purified transcriptase infectious ratio gp ultracentrifugation extraction hiv adaptable ultracentrifugation method recovery gp
HIV,HIV3980,aids risk patterns united iv san metropolitan findings results united iv race ethnic group belong geographical hiv risk overall iv puerto rican hispanic less whites united fact half puerto rican iv united illegal income islands iv puerto rican iv hiv risk drugs drugs likely clean needles condoms puerto fact largest group risk immunodeficiency aids rico puerto united risk heterosexual transmission perinatal transmission resources aids puerto rico iv subjects positive
HIV,HIV3981,human immunodeficiency hiv fetal utilized serum vitro fetal serum fcs laboratory hiv random fetal johns cross positive hiv western elisa fcs risk vitro day hiv semen donors fcs risk fcs
HIV,HIV3982,morphological embryonic tissues semen human immunodeficiency infections curettage immunodeficiency semen husband microscopy membrane hyperplasia hofbauer placenta unknown fetal red endothelial seminal plasma results early pregnancy
HIV,HIV3983,serum polymorphonuclear haemophilia haemophiliacs range immune defects functional polymorphonuclear pmn group human immunodeficiency hiv hiv results evidence significant pmn chemotactic phagocytosis haemophiliacs hiv infection reflect pmn dysfunction respiratory release haemophilic pmn healthy donors pretreatment pmn normal donors hiv hiv haemophilic sera rise pmn effect serum findings serum pmn functional haemophilia hiv infection
HIV,HIV3984,functional morphological findings infection mtc hmpao ct mri infection flow mtc hmpao spect results ct mri findings aids dementia spect results multilocular patchy uptake defects infection positive spect findings functional spect methods mri hiv spect findings ct mri reed neurological positive spect hiv infection neurological cns hmpao spect perfusion early infection flow noticeable defects hmpao spect hiv
HIV,HIV3985,outreach populations hiv outreach strategy health risk human immunodeficiency hiv subsequent immune aids cdc outreach mechanisms technical state health organizations organizations recent systematic review outreach cdc outreach need
HIV,HIV3986,questions aids aids hiv infection dissemination dialogue relays reductive equation aids condom questions concepts risk
HIV,HIV3987,aids foremost specific networks individuals patterns constitutes hiv infection identity dynamic values norms values relays early patterns easier unifying values transmit positive group norms process
HIV,HIV3988,effectiveness double otolaryngology thirty sets double gloves pairs otolaryngologists assistants risk glove perforation inner layers second gloves intact staff
HIV,HIV3989,fluoroquinolone dr human lines hiv cytotoxicity hiv infection human lines results pretreatment dr significant subfraction cem express infective cem stable
HIV,HIV3990,sequential tests infection tests hiv infection persistent lymphadenopathy sarcoma times subject normal test results correlations tests immune test results tests months zidovudine time evidence hiv immune dysfunction significant deterioration single zidovudine
HIV,HIV3991,immunodeficiency hiv infection bissau bissau africa seropositive immuno avidin biotin status hiv seropositive individuals total cdcd total equal ratio equal total equal ratio equal hiv odds confidence hiv hiv fewer total total hiv lymphadenopathy significant effect
HIV,HIV3992,feline immunodeficiency feline immunodeficiency fiv feline immunodeficiency faids hiv human aids obvious hiv infection cdcd true fiv infection flow cytometry panel populations report fiv percentile normal normal months consistent infected shows due normal group diseases feline leukemia infections normal cdcd findings hiv infections hiv fiv aids
HIV,HIV3993,hiv aids longitudinal evolution infection group hiv seropositive iv abusers year hiv subjects cytopathic cultures rapid slow viruses workers rapid viruses arcaids slow viruses related infection fact important subjects rapid infection subjects cultures viruses subjects cultures signs slow rapid aids
HIV,HIV3994,warfare aids report international aids countries heterosexual rise subsequent implications maternity risk hiv unprotected intercourse rampant legal orphans mothers
HIV,HIV3995,human immunodeficiency hiv immune immune presence human immunodeficiency hiv hiv human immunodeficiency hiv cic hiv hiv cic gp cic cic free serum hiv hiv cic severe hiv cic months cic free hiv hiv cic early hiv infection
HIV,HIV3996,histocompatibility hiv infection ancestral haplotypes hla hla loci infection human immunodeficiency hiv hla cw cw dr dr manifestations furthermore pilot hla limited ancestral haplotypes ahs caucasoid group seronegative homosexual bisexual hiv infection iv seronegative subjects less cdc iii iv seronegative subjects ahs increases hla specific ahs longitudinal months cw bfs caq dr deaths immunodeficiency sequential early progressive individuals contain deletions histocompatibility mhc hiv infection mhc
HIV,HIV3997,hiv infection haemophilic hiv infection haemophilic laboratory tests time months aids brodt nineteen helper positive cellsmicroliters helper peripheral positive cultures hiv infection haemophilic months hiv infection immunodeficiency ratio helper deterioration immune system
HIV,HIV3998,evolution aids infection evolution aids hiv infection work hand infection stage institute infection stage hand thorough condition date matter important
HIV,HIV3999,human immunodeficiency glycoproteins gp cdt receptor transduction interference hiv glycoproteins gp cdt receptor tcr process toxoid specific human pd free system cross specific tcr gps cdtcr plc transduction cdtcr inositol phosphate phosphatidic turnover intracellular free intracellular cdtcr specific mabs gps pd gps observed inhibitions maximal inhibitions term gps early effect gps gp gp functional pd results interaction mhc hiv envelope glycoproteins cdtcr plc uninfected
HIV,HIV4000,aids antigenemia human immunodeficiency hiv immunodeficiency aids methods counts status year seropositive aids results hiv seropositive antigenemia rapid cellsmicrol incident antigenemia aids year cumulative aids counts cellsmicrol presence antigenemia rapid less antigenemia depletion rapid individuals risk findings important hiv year
